FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Massad, E
   Laporta, GZ
   Conn, JE
   Chaves, LS
   Bergo, ES
   Figueira, EAG
   Coutinho, FAB
   Lopez, LF
   Struchiner, C
   Sallum, MAM
AF Massad, Eduardo
   Laporta, Gabriel Zorello
   Conn, Jan Evelyn
   Chaves, Leonardo Suveges
   Bergo, Eduardo Sterlino
   Guimaraes Figueira, Elder Augusto
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   Struchiner, Claudio
   Mureb Sallum, Maria Anice
TI The risk of malaria infection for travelers visiting the Brazilian
   Amazonian region: A mathematical modeling approach
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Malaria risk; Mathematical modeling; Rural settlements; Amazon; Brazil
ID PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; IMPORTED MALARIA;
   ORIGINS; SPREAD; VIVAX
AB Background: Human mobility between malaria endemic and malaria-free areas can hinder control and elimination efforts in the Amazon basin, maintaining Plasmodium circulation and introduction to new areas.
   Methods: The analysis begins by estimating the incidence of malaria in areas of interest. Then, the risk of infection as a function of the duration of stay after t(0) was calculated as the number of infected travelers over the number of arrived travelers. Differential equations were employed to estimate the risk of nonimmune travelers acquiring malaria in Amazonian municipalities. Risk was calculated as a result of the force of the infection in terms of local dynamics per time of arrival and duration of visit.
   Results: Maximum risk occurred at the peak or at the end of the rainy season and it was nonlinearly (exponentially) correlated with the fraction of infected mosquitoes. Relationship between the risk of malaria and duration of visit was linear and positively correlated. Relationship between the risk of malaria and the time of arrival in the municipality was dependent on local effects of seasonality.
   Conclusions: The risk of nonimmune travelers acquiring malaria is not negligible and can maintain regional circulation of parasites, propagating introductions in areas where malaria has been eliminated.
C1 [Massad, Eduardo; Struchiner, Claudio] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, Brazil.
   [Laporta, Gabriel Zorello] Fundacao ABC, Ctr Univ Saude ABC, Setor Posgrad Pesquisa & Inovacao, Santo Andre, SP, Brazil.
   [Conn, Jan Evelyn] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   [Chaves, Leonardo Suveges; Mureb Sallum, Maria Anice] Univ Sao Paulo, Fac Saude Pabl, Dept Epidemiol, Sao Paulo, SP, Brazil.
   [Bergo, Eduardo Sterlino] Secretaria Estado Saude Sao Paulo, Superintendencia Controle Endemias, Araraquara, SP, Brazil.
   [Guimaraes Figueira, Elder Augusto] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez] LIM01 HCFMUSP, Sao Paulo, SP, Brazil.
RP Sallum, MAM (corresponding author), Univ Sao Paulo, Fac Saude Pabl, Dept Epidemiol, Sao Paulo, SP, Brazil.
EM masallum@usp.br
RI Laporta, Gabriel/P-3621-2019; Suveges Moreira Chaves,
   Leonardo/R-8787-2017
OI Laporta, Gabriel/0000-0001-7412-9390; Suveges Moreira Chaves,
   Leonardo/0000-0002-7632-1842
FU National Institutes of Health (NIH), U.S. AUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01AI110112-01A1]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo, FAPESP, BrazilFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2014/26229-7, 2014/09774-1]; Conselho Nacional de
   Pesquisa, CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq) [301877/2016-5, 304612/2014-6]; ZikaPLAN European
   Union, European Comission Horizon 2020 research and innovation programme
   [734584]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ), BrazilCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E 26/202.828/2017]
FX This work was supported by National Institutes of Health (NIH), U.S. A
   R01AI110112-01A1 (to JEC); Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo, FAPESP, Brazil [grant number 2014/26229-7 to MAMS, EM, ESB]
   and [grant number 2014/09774-1 to GZL]; Conselho Nacional de Pesquisa,
   CNPq, Brazil [grant number 301877/2016-5 to MAMS]; ZikaPLAN European
   Union, European Comission Horizon 2020 research and innovation programme
   [grant no. 734584 to EM, CJS]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ), Brazil [grant no. E 26/202.828/2017 to CJS];
   and Conselho Nacional de Pesquisa, CNPq [grant no. 304612/2014-6 to
   CJS], Brazil.
CR Angelo JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172330
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Ashley EA, 2018, LANCET, V391, P1608, DOI 10.1016/S0140-6736(18)30324-6
   Askling HH, 2005, EMERG INFECT DIS, V11, P436, DOI 10.3201/eid1103.040677
   Bickersmith SA, 2015, MEM I OSWALDO CRUZ, V110, P573, DOI 10.1590/0074-02760150031
   Carlos BC, 2019, PATHOG GLOB HEALTH, V113, P1, DOI 10.1080/20477724.2019.1581463
   Cohen JM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2106-3
   de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103
   Padilha MAD, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2938-0
   de Rios MD, 2010, ANTHR CONSCIOUS, V16, P298
   Douine M, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2721-2
   Douine M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2306-5
   Douine M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1367-6
   Ferreira Marcelo U, 2019, Methods Mol Biol, V2013, P57, DOI 10.1007/978-1-4939-9550-9_4
   Grillet ME, 2019, LANCET INFECT DIS, V19, pE149, DOI 10.1016/S1473-3099(18)30757-6
   Grillet ME, 2018, SCIENCE, V359, P528, DOI 10.1126/science.aar5440
   Guerra CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10339-1
   Gutierrez-Ocampo E, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101560
   Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/s1473-3099(17)30048-8, 10.1016/S1473-3099(17)30048-8]
   Lai SJ, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2736-8
   Lalloo DG, 2019, TRAVEL MED, P137
   Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139
   Lima NF, 2012, EXP PARASITOL, V132, P348, DOI 10.1016/j.exppara.2012.08.010
   Luthi B, 2015, TRAVEL MED INFECT DI, V13, P48, DOI 10.1016/j.tmaid.2014.04.014
   Massad E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-130
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Menard D, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025619
   Ministerio da Saude do Brasil, 2018, SIV MAL SIST EL SERV
   Chaves LSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25344-5
   Packard RM, 2014, NEW ENGL J MED, V371, P397, DOI 10.1056/NEJMp1403340
   Pasco M., 2018, Journal of Tourism and Leisure Studies, V3, P1, DOI 10.18848/2470-9336/CGP/v03i01/1-22
   Rampling T, 2019, CLIN MED, V19, P153, DOI 10.7861/clinmedicine.19-2-153
   Richards P, 2015, ANN ASSOC AM GEOGR, V105, P806, DOI 10.1080/00045608.2015.1052337
   Rodriguez-Morales AJ, 2019, TRAVEL MED INFECT DI, V30, P4, DOI 10.1016/j.tmaid.2019.05.014
   Rodriguez-Morales AJ, 2019, TRAVEL MED INFECT DI, V28, P98, DOI 10.1016/j.tmaid.2019.02.004
   Rodriguez-Morales AJ, 2019, TRAVEL MED INFECT DI, V27, P5, DOI 10.1016/j.tmaid.2018.10.010
   Ruschmann D. v. d. M., 1992, Tourism Management, V13, P125, DOI 10.1016/0261-5177(92)90048-C
   Sallum MAM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2753-7
   Shretta R, 2017, MAJOR INFECT DIS
   Silveira Luciana Braga, 2013, Rev. Adm. Pública, V47, P671, DOI 10.1590/S0034-76122013000300007
   Smith JL, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2791-1
   Sturrock HJW, 2015, AM J TROP MED HYG, V93, P139, DOI 10.4269/ajtmh.14-0256
   Tedrow RE, 2019, TRENDS PARASITOL, P30215
   Tejedor-Garavito N, 2010, TRAVEL PATTERNS DEMO
   Uherek CB, 2014, INT J ECOL, P1
   WHO, 2018, WORLD MAL REP 2018
   Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x
   Winkelman M, 2005, J PSYCHOACTIVE DRUGS, V37, P209, DOI 10.1080/02791072.2005.10399803
   Woodrow CJ, 2017, FEMS MICROBIOL REV, V41, P34, DOI 10.1093/femsre/fuw037
   Zhang SS, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0571-3
NR 50
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2020
VL 37
AR 101792
DI 10.1016/j.tmaid.2020.101792
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA OE4BD
UT WOS:000580476900054
PM 32771653
DA 2020-12-16
ER

PT J
AU Ribas, LM
   Massad, MRR
   Pinto, ACBCF
   Heng, HG
   Tremori, TM
   Reis, STJ
   Baroni, CO
   Massad, E
   Rocha, NS
AF Ribas, Laila M.
   Massad, Mara R. R.
   Pinto, Ana C. B. C. F.
   Heng, Hock Gan
   Tremori, Talia M.
   Reis, Servio T. J.
   Baroni, Carina O.
   Massad, Eduardo
   Rocha, Noeme S.
TI Post-mortem CT vs necropsy in feline medicine
SO JOURNAL OF FELINE MEDICINE AND SURGERY
LA English
DT Article
DE Post-mortem examination; radiology; multislice computed tomography;
   veterinary pathology
ID COMPUTED-TOMOGRAPHY ANGIOGRAPHY; FORENSIC NECROPSY; VIRTOPSY APPROACH;
   AUTOPSY; RADIOLOGY; PMCT
AB Objectives
   The aim of this study was to compare post-mortem CT findings with necropsy findings in domestic cats.
   Methods
   Post-mortem CT and necropsies were performed in 20 cadavers of domestic cats. The sensitivity, specificity and agreement between the post-mortem CT and necropsy findings were determined.
   Results
   There were a total of 315 post-mortem findings; 183 were identified by post-mortem CT and 132 were identified by necropsy. Post-mortem CT demonstrated a higher sensitivity to identify the findings mainly in bones. The higher indices of agreement between post-mortem CT and necropsy were related to abnormalities of pleural space, bones and joints.
   Conclusions and relevance
   This study demonstrated that post-mortem CT and necropsy provided different information. Thus, their use in conjunction with each other might improve the understanding of the cause of death and the identification of post-mortem lesions.
C1 [Ribas, Laila M.; Massad, Mara R. R.; Tremori, Talia M.; Reis, Servio T. J.; Rocha, Noeme S.] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Clin Sci, Prof Doutor Walter Mauricio Correa S-N, BR-18618681 Botucatu, SP, Brazil.
   [Pinto, Ana C. B. C. F.; Baroni, Carina O.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Surg Dept, Sao Paulo, Brazil.
   [Heng, Hock Gan] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
RP Ribas, LM (corresponding author), Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Clin Sci, Prof Doutor Walter Mauricio Correa S-N, BR-18618681 Botucatu, SP, Brazil.
EM lailamassad@gmail.com
RI Ribas, Laila Massad/I-9651-2016
OI Ribas, Laila Massad/0000-0002-1390-8523
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [10, 99999.000199/2016-08]
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES) and belongs to the project entitled `The Legal
   Veterinary Medicine Applied to Expertise in Cases of Crime Against
   Fauna', approved in the Forensic Science Publication Notice 25/2014
   (grant number 10. 99999.000199/2016-08).
CR Allen M., 2006, PRACTICE, V18, P167, DOI DOI 10.1080/09503150600904060
   Ampanozi G, 2017, FORENSIC SCI MED PAT, V13, P284, DOI 10.1007/s12024-017-9878-1
   Baglivo M, 2013, J FORENSIC RADIOL IM, V1, P3, DOI 10.1016/j.jofri.2012.10.003
   Brownlie HWB, 2016, VET PATHOL, V53, P919, DOI 10.1177/0300985816655851
   Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005
   Christe A, 2009, J TRAUMA, V66, P1302, DOI 10.1097/TA.0b013e31818c1441
   Christine C, 2013, INT J LEGAL MED, V127, P981, DOI 10.1007/s00414-012-0814-3
   Pinto ACBDF, 2017, J FORENSIC RADIOL IM, V8, P48, DOI 10.1016/j.jofri.2017.03.006
   Pinto ACBDF, 2017, J FORENSIC RADIOL IM, V8, P45, DOI 10.1016/j.jofri.2016.11.006
   de Siqueira A, 2012, J FELINE MED SURG, V14, P723, DOI 10.1177/1098612X12451374
   Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001
   Ebert LC, 2016, J FORENSIC RADIOL IM, V5, P1, DOI 10.1016/j.jofri.2015.11.007
   Franckenberg S, 2015, J FORENSIC RADIOL IM, V3, P72, DOI 10.1016/j.jofri.2014.11.001
   Heng HG, 2008, VET RADIOL ULTRASOUN, V49, P26, DOI 10.1111/j.1740-8261.2007.00312.x
   Hoey BA, 2007, J TRAUMA, V63, P979, DOI 10.1097/TA.0b013e318154011f
   Hostettler FC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0544-0
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Blanc-Louvry I, 2013, EUR RADIOL, V23, P1829, DOI 10.1007/s00330-013-2779-0
   Lee KJ, 2011, J ZOO WILDLIFE MED, V42, P128, DOI 10.1638/2010-0015.1
   Lockwood R., 2005, STATE ANIMALS, VIII, P15
   Marlet E. F., 2010, Brazilian Journal of Veterinary Research and Animal Science, V47, P385
   Martinez RM, 2015, J FORENSIC RADIOL IM, V3, P80, DOI 10.1016/j.jofri.2014.11.004
   Schweitzer W, 2014, J FORENSIC RADIOL IM, V2, P28, DOI 10.1016/j.jofri.2013.12.002
   Sugimoto M, 2016, LEGAL MED-TOKYO, V18, P62, DOI 10.1016/j.legalmed.2015.12.007
   Thali MJ, 2007, FORENSIC SCI INT, V171, P63, DOI 10.1016/j.forsciint.2006.05.044
   Thali MJ, 2003, J FORENSIC SCI, V48, P386
   Watson E, 2017, VET RADIOL ULTRASOUN, V58, P245, DOI 10.1111/vru.12484
NR 27
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1098-612X
EI 1532-2750
J9 J FELINE MED SURG
JI J. Feline Med. Surg.
PD DEC
PY 2020
VL 22
IS 12
BP 1206
EP 1213
AR 1098612X20919310
DI 10.1177/1098612X20919310
EA MAY 2020
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA OV7WE
UT WOS:000534764100001
PM 32436802
DA 2020-12-16
ER

PT J
AU Kurauchi, A
   Struchiner, CJ
   Wilder-Smith, A
   Massad, E
AF Kurauchi, Ana
   Struchiner, Claudio Jose
   Wilder-Smith, Annelies
   Massad, Eduardo
TI Modelling the effect of a dengue vaccine on reducing the evolution of
   resistance against antibiotic due to misuse in dengue cases
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Dengue; Antibiotic resistance; Vaccine; Mathematical models
ID RESPIRATORY-TRACT INFECTIONS; RISK
AB Background This paper intends to check whether and how a hypothetical dengue vaccine could contribute to issue of evolution of bacteria resistance against antibiotics by reducing the number of patients that would inappropriately being treated with antibiotics. Methods We use a new mathematical model that combines, in a novel way, two previously published papers, one on the evolution of resistance against antibiotics and one classical Ross-Macdonald model for dengue transmission. Results The model is simulated numerically and reproduces a real case of evolution of resistance against antibiotics. In addition the model shows that the use of a hypothetical dengue vaccine could help to curb the evolution of resistance against an antibiotic inappropriately used in dengue patients. Both the increase in the proportion of resistant bacteria due to the misuse of antibiotics in dengue cases as a function of the fraction of treated patients and the reduction of that proportion as a function of vaccination coverage occur in a highly non-linear fashion. Conclusion The use of a dengue vaccine is helpful in reducing the rate of evolution of antibiotic resistance in a scenario of misuse of the antibiotics in dengue patients.
C1 [Kurauchi, Ana; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Struchiner, Claudio Jose; Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rua Praia Botafogo 190, BR-22250900 Rio De Janeiro, Brazil.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelber, Germany.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rua Praia Botafogo 190, BR-22250900 Rio De Janeiro, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
FU project ZikaPLAN - European Union's Horizon 2020 research and innovation
   programme [734584]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); LIM01-HFMUSP
FX This work was partially supported by the project ZikaPLAN, funded by the
   European Union's Horizon 2020 research and innovation programme under
   Grant Agreement No. 734584, by LIM01-HFMUSP, CNPq and FAPESP.
CR Adrizain R, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007438
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Collineau L, 2017, ZOONOSES PUBLIC HLTH, V64, P165, DOI 10.1111/zph.12298
   Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096
   Daneman N, 2015, JAMA INTERN MED, V175, P1331, DOI 10.1001/jamainternmed.2015.2770
   Fridkin SK, 2011, ANN INTERN MED, V135, P183
   Frost I, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz036
   Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0
   Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9
   Lim C, 2016, ELIFE, V5, DOI 10.7554/eLife.18082
   Mainous AG, 1998, ARCH FAM MED, V7, P45, DOI 10.1001/archfami.7.1.45
   Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9
   MASSAD E, 1993, INT J BIOMED COMPUT, V33, P65, DOI 10.1016/0020-7101(93)90060-J
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875
   Sandopa D, 2018, PAEDIATR INDONES, V58, P53, DOI 10.14238/pi58.1.2018.53-8
   Scott JG, 2001, J FAM PRACTICE, V50, P853
   Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848
   Trunfio M, 2017, INFECTION, V45, P1, DOI 10.1007/s15010-016-0927-6
   United Nations, DRAFT POL DECL HIGH
   WHO, GLOB ACT PLAN ANT RE
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   World Health Organization, INT SURV ANT RES
   2009, WHO TECH REP SER, V958, P1
NR 26
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD MAY 13
PY 2020
VL 17
IS 1
AR 7
DI 10.1186/s12976-020-00125-8
PG 7
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA LS1LC
UT WOS:000536152200001
PM 32404100
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Estofolete, CF
   Milhim, BHGD
   de Franca, CCG
   da Silva, GCD
   Augusto, MT
   Terzian, ACB
   Zini, N
   Durigon, EL
   Oliveira, DBL
   Massad, E
   Nogueira, ML
AF Estofolete, Cassia Fernanda
   Goncalves de Aguiar Milhim, Bruno Henrique
   Galvao de Franca, Carolina Cunha
   Dutra da Silva, Gislaine Celestino
   Augusto, Marcos Tayar
   Bernardes Terzian, Ana Carolina
   Zini, Nathalia
   Durigon, Edison Luis
   Leal Oliveira, Daniele Bruna
   Massad, Eduardo
   Nogueira, Mauricio Lacerda
TI Prevalence of Measles Antibodies in Sao Jose do Rio Preto, Sao Paulo,
   Brazil: A serological survey model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RUBELLA ANTIBODIES; SEROPREVALENCE; MUMPS; VACCINATION; INFECTION; VIRUS
AB Measles is an acute and highly contagious but vaccine-preventable infectious disease. Despite years of being considered eliminated, decreased vaccination rates have produced virus reemergence in several countries, including Brazil. Measles can be controlled through immunization programs, through which aim to achieve 95% coverage with two doses of the vaccine. Measles can also be controlled if suspected cases can be properly identified in order to contain outbreaks. This cross-sectional study determined the prevalence of measles antibodies and their correlation with rubella antibodies (resulting from the combination vaccine used in Brazil's public immunization program) in individuals aged higher 10 years old in Sao Jose do Rio Preto, Sao Paulo State, Brazil, participants of a prospective cohort of arbovirosis surveillance before virus reemergence in the country. Our findings presented that 32.9% of individuals aged 10-40 years old had not antibodies against measles; 39.3% of total individuals with documented evidence of measles vaccination did not have anti-measles IgG, though only 20.2% of individuals with documented evidence of rubella vaccination lacked anti-rubella IgG. Besides, the most of measles cases reported in the city, following the virus spreading in the country, occurred especially in groups defined by us as susceptible. Because the combination MMR vaccine is part of Brazil's national vaccine schedule, the possible reasons for this relatively high rate of seronegativity need to be investigated further, once that it reflects outbreak risk.
C1 [Estofolete, Cassia Fernanda; Goncalves de Aguiar Milhim, Bruno Henrique; Galvao de Franca, Carolina Cunha; Dutra da Silva, Gislaine Celestino; Augusto, Marcos Tayar; Bernardes Terzian, Ana Carolina; Zini, Nathalia; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Med Sch FAMERP, Lab Pesquisas Virol, Sao Jose, SP, Brazil.
   [Durigon, Edison Luis; Leal Oliveira, Daniele Bruna] Univ Sao Paulo, Clin & Mol Virol Lab, Dept Biomed Sci, Sao Jose, SP, Brazil.
   [Massad, Eduardo] Getulio Vargas Fdn FGV, Sch Appl Math, Rio De Janeiro, RJ, Brazil.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Med Sch FAMERP, Lab Pesquisas Virol, Sao Jose, SP, Brazil.
EM mauricio.nogueira@edu.famerp.br
RI Nogueira, Mauricio L/B-7599-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Oliveira,
   Danielle/0000-0002-0534-0886
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This study received financial support from the Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) number 2013/21719-3 for MLN.
CR Abbas Moustafa, 2007, J Egypt Public Health Assoc, V82, P283
   [Anonymous], 2018, EP UPD MEASL
   Brasil, 2016, PLANO CONTINGENCIA R
   Brasil, 2019, COBERTURAS VACINAIS
   Brasil, 2019, COBERTURA IMUNO 2 AN
   Carryn S, 2019, VACCINE, V37, P5323, DOI 10.1016/j.vaccine.2019.07.049
   CVE, B EP FEBR AM
   Domingues CMAS, 2012, REV INST MED TROP SP, V54, pS22, DOI 10.1590/S0036-46652012000700009
   dos Santos E, 1998, EPIDEMIOLOGICA SERIE, V4
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Gershon A., 2005, MEASLES HARRISONS PR
   Gohil DJ, 2016, VIRAL IMMUNOL, V29, P159, DOI 10.1089/vim.2015.0070
   Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9
   Lebo EJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv006
   Mandell G. L, 2010, MANDELL DOUGLAS BENN
   McLean HQ, 2013, MMWR RECOMM REP, V62, P1
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Moten M, 2018, BRIT J GEN PRACT, V68, P404, DOI 10.3399/bjgp18X697961
   PAHO, 2016, PLAN ACT MAINT MEASL
   SES-SP, 2019, SAR B EP
   Shamsizadeh A, 2012, JUNDISHAPUR J MICROB, V5, P578, DOI 10.5812/jjm.4563
   Sharma HJ, 2011, J INFECT DEV COUNTR, V5, P874, DOI 10.3855/jidc.1847
   SMS, 2020, B SAR AN 1 SINT 2019
   SMS, 2015, IND 2014
   SMS, 2016, IND 2015
   Strebel P., 2018, VACCINES
   Strebel PM, 2019, NEW ENGL J MED, V381, P349, DOI 10.1056/NEJMcp1905181
   Wicker S, 2012, VACCINE, V30, P4407, DOI 10.1016/j.vaccine.2012.05.015
   World Health Organization, 1999, WHO GUID EP PREP RES
NR 31
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 20
PY 2020
VL 10
IS 1
AR 5179
DI 10.1038/s41598-020-62151-3
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NF6PI
UT WOS:000563417100017
PM 32198469
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Maier, SB
   Massad, E
   Amaku, M
   Burattini, MN
   Greenhalgh, D
AF Maier, Sandra B.
   Massad, Eduardo
   Amaku, Marcos
   Burattini, Marcelo N.
   Greenhalgh, David
TI The Optimal Age of Vaccination Against Dengue with an Age-Dependent
   Biting Rate with Application to Brazil
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Dengue; Vaccination; Optimal vaccination age; Age-structured model;
   Biting rate; Hospitalisation
ID HEMORRHAGIC-FEVER; YELLOW-FEVER; DYNAMICS; INFECTIONS; ANTIBODIES;
   DISEASES; INFANTS; BURDEN; MODELS; RISKS
AB In this paper we introduce a single serotype transmission model, including an age-dependent mosquito biting rate, to find the optimal vaccination age against dengue in Brazil with Dengvaxia. The optimal vaccination age and minimal lifetime expected risk of hospitalisation are found by adapting a method due to Hethcote (Math Biosci 89:29-52). Any number and combination of the four dengue serotypes DENv1-4 is considered. Successful vaccination against a serotype corresponds to a silent infection. The effects of antibody-dependent enhancement (ADE) and permanent cross-immunity after two heterologous infections are studied. ADE is assumed to imply risk-free primary infections, while permanent cross-immunity implies risk-free tertiary and quaternary infections. Data from trials of Dengvaxia indicate vaccine efficacy to be age and serostatus dependent and vaccination of seronegative individuals to induce an increased risk of hospitalisation. Some of the scenarios are therefore reconsidered taking these findings into account. The optimal vaccination age is compared to that achievable under the current age restriction of the vaccine. If vaccination is not considered to induce risk, optimal vaccination ages are very low. The assumption of ADE generally leads to a higher optimal vaccination age in this case. For a single serotype vaccination is not recommended in the case of ADE. Permanent cross-immunity results in a slightly lower optimal vaccination age. If vaccination induces a risk, the optimal vaccination ages are much higher, particularly for permanent cross-immunity. ADE has no effect on the optimal vaccination age when permanent cross-immunity is considered; otherwise, it leads to a slight increase in optimal vaccination age.
C1 [Maier, Sandra B.; Greenhalgh, David] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
   [Massad, Eduardo; Amaku, Marcos; Burattini, Marcelo N.] Univ Sao Paulo, Fac Med, Hosp Clin, LIM01, Sao Paulo, SP, Brazil.
   [Burattini, Marcelo N.] Univ Fed Sao Paulo, Escola Paulista Med, Hosp Sao Paulo, Sao Paulo, SP, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, RJ, Brazil.
RP Greenhalgh, D (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
EM david.greenhalgh@strath.ac.uk
RI Amaku, Marcos/D-5252-2012
OI Amaku, Marcos/0000-0003-4752-6774
FU University of Strathclyde; Leverhulme TrustLeverhulme Trust
   [RF-2015-88]; British Council Malaysia [DTC 16022]; Science Without
   Borders Program for a Special Visiting Fellowship (CNPq) [30098/2014/7]
FX DG and SM are grateful to the University of Strathclyde for support for
   a Ph.D. studentship. DG is grateful to the Leverhulme Trust for support
   from a Leverhulme Fellowship (RF-2015-88) and the British Council
   Malaysia for funding from the Dengue Tech Challenge (Application
   Reference DTC 16022). EM and DG are grateful to the Science Without
   Borders Program for a Special Visiting Fellowship (CNPq Grant
   30098/2014/7).
CR Aguiar M, 2018, CLIN INFECT DIS, V66, P641, DOI 10.1093/cid/cix882
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Martinez-Vega RA, 2017, VACCINE, V35, P3910, DOI 10.1016/j.vaccine.2017.06.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Billings L, 2008, MATH BIOSCI, V211, P265, DOI 10.1016/j.mbs.2007.08.004
   Burattini MN, 2016, CLINICS, V71, P455, DOI 10.6061/clinics/2016(08)08
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Flasche S., 2016, COMP MODELLING DENGU
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2016, TRAVEL MED INFECT DI, V14, P378, DOI 10.1016/j.tmaid.2016.06.005
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   Knipl D, 2015, B MATH BIOL, V77, P2212, DOI 10.1007/s11538-015-0120-6
   Leong ASY, 2007, SEMIN DIAGN PATHOL, V24, P227, DOI 10.1053/j.semdp.2007.07.002
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2015, COMMUNICATION
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   SAGE/World Health Organization, 2016, BACKGR PAP DENG VACC
   Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308
   United States Central Intelligence Agency, 2016, BRAZ WORLD FACTB
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
   WHO, 2012, GLOB STRAT DENG PREV
NR 45
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD JAN 14
PY 2020
VL 82
IS 1
AR 12
DI 10.1007/s11538-019-00690-1
PG 32
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA KM9LV
UT WOS:000514463600005
PM 31933012
OA Other Gold, Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
   Amaku, M
   Wilder-Smith, A
   dos Santos, PCC
   Struchiner, CJ
   Coutinho, FAB
AF Massad, Eduardo
   Amaku, Marcos
   Wilder-Smith, Annelies
   Costa dos Santos, Paulo Cesar
   Struchiner, Claudio Jose
   Bezerra Coutinho, Francisco Antonio
TI Two complementary model-based methods for calculating the risk of
   international spreading of a novel virus from the outbreak epicentre.
   The case of COVID-19
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Coronavirus; mathematical modelling
AB We present two complementary model-based methods for calculating the risk of international spread of the novel coronavirus SARS-CoV-2 from the outbreak epicentre. One model aims to calculate the number of cases that would be exported from an endemic country to disease-free regions by travellers. The second model calculates the probability that an infected traveller will generate at least one secondary autochthonous case in the visited country. Although this paper focuses on the data from China, our methods can be adapted to calculate the risk of importation and subsequent outbreaks. We found an averageR(0)= 5.31 (ranging from 4.08 to 7.91) and a risk of spreading of 0.75 latent individuals per 1000 travellers. In addition, one infective traveller would be able to generate at least one secondary autochthonous case in the visited country with a probability of 23%.
C1 [Massad, Eduardo; Amaku, Marcos; Costa dos Santos, Paulo Cesar; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo; Amaku, Marcos; Costa dos Santos, Paulo Cesar; Bezerra Coutinho, Francisco Antonio] LIM01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo; Struchiner, Claudio Jose] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, Sao Paulo, Brazil.
   [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Dept Publ Hlth & Clin, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Umea Univ, Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Costa dos Santos, Paulo Cesar] UNIP Univ Paulista, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), LIM01 HCFMUSP, Sao Paulo, Brazil.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012; Amaku, Marcos/D-5252-2012
OI Massad, Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774;
   Costa dos Santos, Paulo Cesar/0000-0002-1987-7211
FU project ZikaPLAN - European Union's Horizon 2020 research and innovation
   programme [734584]; LIM01-HFMUSP; CNPqNational Council for Scientific
   and Technological Development (CNPq); FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Butantan
FX This work was partially supported by the project ZikaPLAN, funded by the
   European Union's Horizon 2020 research and innovation programme under
   Grant Agreement No. 734584, by LIM01-HFMUSP, CNPq and FAPESP and
   Fundacao Butantan.
CR Bogoch I. I., 2020, J TRAVEL MED, V27
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Halstead S, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz062
   Kraemer MUG, 2020, NAT HUM BEHAV, V4, P800, DOI 10.1038/s41562-020-0875-0
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Lytras T, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa054
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Redondo-Bravo L, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz072
   Tuite AR, 2019, J TRAVEL MED, V26
   Tuite Ashleigh R, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa070
   Wolf Timo, 2020, J Travel Med, V27, DOI 10.1093/jtm/taaa035
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
NR 16
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2020
VL 148
AR e109
DI 10.1017/S0950268820001223
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA ME0YP
UT WOS:000544389600001
PM 32513345
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Karami, M
   Doosti-Irani, A
   Ardalan, A
   Gohari-Ensaf, F
   Berangi, Z
   Massad, E
   Rebi Yeganeh, M
   Asadi-Lari, M
   Gouya, MM
AF Karami, Manoochehr
   Doosti-Irani, Amin
   Ardalan, Ali
   Gohari-Ensaf, Fathemeh
   Berangi, Zainab
   Massad, Eduardo
   Rebi Yeganeh, Mohammad
   Asadi-Lari, Mohsen
   Gouya, Mohammad Mehdi
TI Public Health Threats in Mass Gatherings: A Systematic Review
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Review
DE illness; infectious diseases; injuries; mass gatherings
ID FIFA WORLD CUP; MEDICAL-CARE; PATIENT PRESENTATIONS; OLYMPIC GAMES;
   DISEASE RISKS; HAJJ; SURVEILLANCE; PILGRIMAGE; EVENT; PREPAREDNESS
AB Mass gatherings (MGs) are held throughout the world. The aim of this review was to assess and identify the health threats based on the type of the MG, type of diseases, and injuries. Research platforms such as Web of Science, Medline, and Scopus were searched through June 2017. All epidemiologic studies that investigated the health threats during the MGs, such as communicable diseases, injuries, high-risk behaviors, and environmental health problems, were included in this review. Out of 1264 references, 45 articles were included in the review. Three main types of MGs include religious, festival, and sporting event; and fairs such as trade, book, and agricultural types were also reported in the selected studies. In the religious MGs, infectious diseases were the most common health threat. Road traffic accidents and environmental health problems were additional health threats. At MG sporting events, injuries were the most common health problems. Infectious diseases and alcohol and drug-related disorders were other reported public health concerns. In the festival MGs, alcohol and drug-related problems were commonly reported. This review showed that health threats vary, based on the type of mass gathering. The health organizers of MGs should consider the type of the MG and the health needs and safety of the participants to help them plan their action and provide the needed health care services.
C1 [Karami, Manoochehr] Hamadan Univ Med Sci, Social Determinants Hlth Res Ctr, Hamadan, Iran.
   [Karami, Manoochehr; Doosti-Irani, Amin; Gohari-Ensaf, Fathemeh; Berangi, Zainab] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Iran.
   [Doosti-Irani, Amin] Hamadan Univ Med Sci, Res Ctr Hlth Sci, Hamadan, Iran.
   [Ardalan, Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Disaster Publ Hlth, Tehran, Iran.
   [Massad, Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Rebi Yeganeh, Mohammad] Hamadan Univ Med Sci, Deputy Hlth, Hamadan, Iran.
   [Asadi-Lari, Mohsen] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran.
   [Gouya, Mohammad Mehdi] Minist Hlth & Med Educ, Ctr Communicable Dis Control, Tehran, Iran.
RP Doosti-Irani, A (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Iran.
EM a.doosti@umsha.ac.ir
RI ; Doosti-Irani, Amin/Q-1260-2016
OI Karami, Manoochehr/0000-0002-9026-3757; Gohari Ensaf,
   Fatemeh/0000-0001-9369-1549; Doosti-Irani, Amin/0000-0003-0623-7503
FU Vice Chancellor for Research and Technology, Hamedan University of
   Medical Sciences [9603091590, 960129639]
FX This study was supported by the Vice Chancellor for Research and
   Technology, Hamedan University of Medical Sciences (Grant No. 9603091590
   and 960129639).
CR Abd El Ghany M, 2017, EMERG INFECT DIS, V23, P1640, DOI 10.3201/eid2310.161642
   Abdullah S, 2013, E MEDITERR HEALTH J, V19, pS29
   Al-Shaqsi S, 2013, EMERG MED J, V30, P611, DOI 10.1136/emermed-2011-200293
   Al-Tawfiq JA, 2016, ANN AM THORAC SOC, V13, P759, DOI 10.1513/AnnalsATS.201511-772FR
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Algarni H, 2016, J EPIDEMIOL GLOB HEA, V6, P7, DOI 10.1016/j.jegh.2015.07.001
   Alqahtani AS, 2016, J EPIDEMIOL GLOB HEA, V6, P147, DOI 10.1016/j.jegh.2015.07.005
   Anikeeva O, 2018, PREHOSP DISASTER MED, V33, P368, DOI 10.1017/S1049023X1800050X
   Arbon P, 2001, Prehosp Disaster Med, V16, P150
   Arbon Paul, 2004, Prehosp Disaster Med, V19, P208
   Athanasopoulos S, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.035204
   Baranwal A, 2015, PLOS CURR, V7, P1
   Bledsoe B, 2012, PREHOSP EMERG CARE, V16, P469, DOI 10.3109/10903127.2012.695432
   Bortolin M, 2013, PREHOSP DISASTER MED, V28, P239, DOI 10.1017/S1049023X13000216
   Burton JO, 2012, PREHOSP DISASTER MED, V27, P458, DOI 10.1017/S1049023X12000830
   Chen Zhi, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P32
   Crabtree N, 2017, PREHOSP DISASTER MED, V32, P187, DOI 10.1017/S1049023X16001540
   Dutch MJ, 2008, EMERG MED AUSTRALAS, V20, P228, DOI 10.1111/j.1742-6723.2008.01085.x
   Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014
   Elliot AJ, 2012, EMERG MED J, V29, P954, DOI 10.1136/emermed-2011-200684
   Feldman Michael J, 2004, Prehosp Disaster Med, V19, P287
   Friedman MS, 2017, PREHOSP DISASTER MED, V32, P78, DOI 10.1017/S1049023X16001187
   Gallego V, 2014, TRAVEL MED INFECT DI, V12, P208, DOI 10.1016/j.tmaid.2014.04.004
   Ganjeh M, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.43253
   Gautret P, 2016, INT J INFECT DIS, V47, P46, DOI 10.1016/j.ijid.2016.03.007
   Glassman T, 2007, J AM COLL HEALTH, V56, P255, DOI 10.3200/JACH.56.3.255-260
   Gocotano AE, 2015, B WORLD HEALTH ORGAN, V93, P810, DOI 10.2471/BLT.15.158089
   Goldberg SA, 2018, DISASTER MED PUBLIC, V12, P752, DOI 10.1017/dmp.2018.7
   Guy A, 2017, PREHOSP DISASTER MED, V32, P329, DOI 10.1017/S1049023X17000139
   Hadjichristoulou C, 2005, J ENVIRON HEALTH, V67, P52
   Hassan S, 2013, E MEDITERR HEALTH J, V19, pS24
   Hawkins ER, 2010, J EMERG MED, V38, P182, DOI 10.1016/j.jemermed.2008.08.028
   Hoy D, 2016, WEST PAC SURVEILL RE, V7, DOI 10.5365/wpsar.2016.7.1.004
   Hutton A, 2015, PREHOSP DISASTER MED, V30, P175, DOI 10.1017/S1049023X15000187
   Hutton A, 2014, PREHOSP DISASTER MED, V29, P160, DOI 10.1017/S1049023X14000156
   Hutton A, 2013, PREHOSP DISASTER MED, V28, P292, DOI 10.1017/S1049023X13000228
   Joseph JK, 2016, INT J DISAST RISK RE, V17, P95, DOI 10.1016/j.ijdrr.2016.04.008
   Kao W F, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P525
   Karami M, 2018, J RES HEALTH SCI, V18
   Karami M, 2013, IRAN J PUBLIC HEALTH, V42, P791
   Kelly B D, 2003, Ir Med J, V96, P121
   Khan ID, 2018, J INFECT PUBLIC HEAL, V11, P165, DOI 10.1016/j.jiph.2017.06.004
   Leeka J, 2010, AM J MED, V123, P972, DOI 10.1016/j.amjmed.2010.03.026
   Lim HC, 2010, BRIT J SPORT MED, V44, P528, DOI 10.1136/bjsm.2009.069831
   Locoh-Donou S, 2013, AM J EMERG MED, V31, P843, DOI 10.1016/j.ajem.2013.01.016
   Loncarevic G, 2009, EUROSURVEILLANCE, V14, P14
   Lund A, 2017, PREHOSP DISASTER MED, V32, P437, DOI 10.1017/S1049023X1700022X
   Memish ZA, 2014, J INFECT DIS, V210, P1067, DOI 10.1093/infdis/jiu150
   Merlo LJ, 2011, DRUG ALCOHOL DEPEN, V116, P242, DOI 10.1016/j.drugalcdep.2010.12.013
   Milsten Andrew M, 2003, Prehosp Disaster Med, V18, P334
   Mirza TA, 2011, POL ARCH MED WEWN, V121, P327, DOI 10.20452/pamw.1085
   Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Morimura Naoto, 2004, Prehosp Disaster Med, V19, P278
   Munn MB, 2016, PREHOSP DISASTER MED, V31, P228, DOI 10.1017/S1049023X16000054
   Noweir M, 2008, ENVIRON MONIT ASSESS, V147, P279, DOI 10.1007/s10661-007-0120-6
   Pakravan AH, 2013, PREHOSP DISASTER MED, V28, P529, DOI 10.1017/S1049023X13008819
   Piat SC, 2010, J EMERG MED, V39, P454, DOI 10.1016/j.jemermed.2009.08.028
   Perez-Gomez HR, 2015, GAC MED MEX, V151, P519
   Riccardo F, 2016, HEALTH SECUR, V14, P161, DOI 10.1089/hs.2015.0075
   Selig B, 2013, J EMERG NURS, V39, pE39, DOI 10.1016/j.jen.2011.10.002
   Shafi Shuja, 2008, J Infect Public Health, V1, P27, DOI 10.1016/j.jiph.2008.08.008
   Sindy AI, 2015, PAK J MED SCI, V31, P1099, DOI 10.12669/pjms.315.8017
   Sokhna C, 2017, TRAVEL MED INFECT DI, V19, P56, DOI 10.1016/j.tmaid.2017.08.005
   Steffen R, 2013, THER UMSCH, V70, P350, DOI 10.1024/0040-5930/a000415
   Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X
   Todkill D, 2016, PREHOSP DISASTER MED, V31, P628, DOI 10.1017/S1049023X16000923
   van Gemert C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-482
   Varon J, 2003, J EMERG MED, V25, P409, DOI 10.1016/j.jemermed.2003.03.001
   Venkatesh S, 2003, INT J ANTIMICROB AG, V21, P200, DOI 10.1016/S0924-8579(02)00366-7
   White P, 2018, WEST PAC SURVEILL RE, V9, DOI 10.5365/wpsar.2016.7.4.001
   Wilson ME, 2014, TRAVEL MED INFECT DI, V12, P205, DOI 10.1016/j.tmaid.2014.04.001
   Yazawa K, 2007, PREHOSP DISASTER MED, V22, P431, DOI 10.1017/S1049023X00005161
   Youbi M, 2013, E MEDITERR HEALTH J, V19, pS19
   Zeitz K, 2015, AUSTRALAS J PARAMED, V3, P1
NR 74
TC 3
Z9 3
U1 2
U2 8
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD DEC
PY 2019
VL 13
IS 5-6
BP 1035
EP 1046
AR PII S1935789318001611
DI 10.1017/dmp.2018.161
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JZ4OS
UT WOS:000505082200029
PM 31250774
DA 2020-12-16
ER

PT J
AU Sallum, MAM
   Conn, JE
   Bergo, ES
   Laporta, GZ
   Chaves, LSM
   Bickersmith, SA
   de Oliveira, TMP
   Figueira, EAG
   Moresco, G
   Oliver, L
   Struchiner, CJ
   Yakob, L
   Massad, E
AF Sallum, Maria Anice M.
   Conn, Jan E.
   Bergo, Eduardo S.
   Laporta, Gabriel Z.
   Chaves, Leonardo S. M.
   Bickersmith, Sara A.
   de Oliveira, Tatiane M. P.
   Figueira, Elder Augusto G.
   Moresco, Gilberto
   Oliver, Leuda
   Struchiner, Claudio J.
   Yakob, Laith
   Massad, Eduardo
TI Vector competence, vectorial capacity of Nyssorhynchus darlingi and the
   basic reproduction number of Plasmodium vivax in agricultural
   settlements in the Amazonian Region of Brazil
SO MALARIA JOURNAL
LA English
DT Article
DE Epidemiology; Transmission; Malaria metrics; Rural settlements;
   Brazilian Amazon
ID HUMAN-LANDING CATCHES; ANOPHELES-DARLINGI; TRANSMISSION DYNAMICS;
   MALARIA; INFECTION; CULICIDAE; DIPTERA; FALCIPARUM; MOSQUITOS; FRONTIER
AB Background: Brazilian malaria control programmes successfully reduced the incidence and mortality rates from 2005 to 2016. Since 2017, increased malaria has been reported across the Amazon. Few field studies focus on the primary malaria vector in high to moderate endemic areas, Nyssorhynchus darlingi, as the key entomological component of malaria risk, and on the metrics of Plasmodium vivax propagation in Amazonian rural communities.
   Methods: Human landing catch collections were carried out in 36 houses of 26 communities in five municipalities in the Brazilian states of Acre, Amazonas and Rondonia states, with API (>30). In addition, data on the number of locally acquired symptomatic infections were employed in mathematical modelling analyses carried out to determine Ny. darlingi vector competence and vectorial capacity to P. vivax; and to calculate the basic reproduction number for P. vivax.
   Results: Entomological indices and malaria metrics ranged among localities: prevalence of P. vivax infection in Ny. darlingi, from 0.243% in Mancio Lima, Acre to 3.96% in Machadinho D'Oeste, Rondonia; daily human-biting rate per person from 23 +/- 1.18 in Cruzeiro do Sul, Acre, to 66 +/- 2.41 in Labrea, Amazonas; vector competence from 0.00456 in Sao Gabriel da Cachoeira, Amazonas to 0.04764 in Mancio Lima, Acre; vectorial capacity from 0.0836 in Mancio Lima, to 1.5 in Machadinho D'Oeste. The estimated R-0 for P. vivax (PvR(0)) was 3.3 in Mancio Lima, 7.0 in Labrea, 16.8 in Cruzeiro do Sul, 55.5 in Sao Gabriel da Cachoeira, and 58.7 in Machadinho D'Oeste. Correlation between P. vivax prevalence in Ny. darlingi and vector competence was non-linear whereas association between prevalence of P. vivax in mosquitoes, vectorial capacity and R-0 was linear and positive.
   Conclusions: In spite of low vector competence of Ny. darlingi to P. vivax, parasite propagation in the human population is enhanced by the high human-biting rate, and relatively high vectorial capacity. The high PvR(0) values suggest hyperendemicity in Machadinho D'Oeste and SAo Gabriel da Cachoeira at levels similar to those found for P. falciparum in sub-Saharan Africa regions. Mass screening for parasite reservoirs, effective anti-malarial drugs and vector control interventions will be necessary to shrinking transmission in Amazonian rural communities, Brazil.
C1 [Sallum, Maria Anice M.; Chaves, Leonardo S. M.; de Oliveira, Tatiane M. P.] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil.
   [Conn, Jan E.; Bickersmith, Sara A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.
   [Bergo, Eduardo S.] Secretaria Estado Saude Sao Paulo, Superintendencia Controle Endemias, Araraquara, SP, Brazil.
   [Laporta, Gabriel Z.] Fac Med ABC, Setor Posgrad Pesquisa & Inovacao, Santo Andre, SP, Brazil.
   [Figueira, Elder Augusto G.] Fundacao Vigilancia Saude Amazonas, Manaus, AM, Brazil.
   [Moresco, Gilberto] Minist Saude, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Oliver, Leuda; Massad, Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Dept Doencas Endem Samuel Pessoa, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.
   [Massad, Eduardo] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, RJ, Brazil.
RP Sallum, MAM (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil.
EM masallum@usp.br
RI Sallum, Maria Anice Mureb/B-8537-2012; Chaves, Leonardo Suveges
   Moreira/R-8787-2017; Laporta, Gabriel/P-3621-2019; Yakob,
   Laith/AAD-4521-2019
OI Sallum, Maria Anice Mureb/0000-0002-7051-2891; Chaves, Leonardo Suveges
   Moreira/0000-0002-7632-1842; Laporta, Gabriel/0000-0001-7412-9390;
   Yakob, Laith/0000-0001-8639-4511; Conn, Jan/0000-0002-5301-7020;
   Bickersmith, Sara/0000-0002-2748-0425
FU National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI110112];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/26229-7];
   Conselho Nacional de Pesquisa-CNPqNational Council for Scientific and
   Technological Development (CNPq) [301877/2016-5]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/09774-1];
   European UnionEuropean Union (EU) [734584]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI110112,
   R01AI110112, R01AI110112, R01AI110112] Funding Source: NIH RePORTER
FX This work has been partially funded by the National Institutes of
   Health, USA, Grant R01 AI110112 to JEC and MAS; Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo-FAPESP Grant No. 2014/26229-7 to MAMS
   and EM; Conselho Nacional de Pesquisa-CNPq no. 301877/2016-5 to MAMS;
   FAPESP Grant No. 2014/09774-1 to GZL; ZikaPLAN, funded by the European
   Union's Horizon 2020 research and innovation programme, Grant No.
   734584.
CR Adde A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164685
   Almeida ACG, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2787-7
   ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005
   Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265
   Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042
   Bickersmith SA, 2015, MEM I OSWALDO CRUZ, V110, P573, DOI 10.1590/0074-02760150031
   Brady OJ, 2015, INT HEALTH, V7, P121, DOI 10.1093/inthealth/ihv010
   Center for Disease Control (CDC, 2010, MAL GLOSS TERMS
   Cohen JM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2106-3
   Conn JE, 2002, AM J TROP MED HYG, V66, P18, DOI 10.4269/ajtmh.2002.66.18
   Conn JE, MALARIA TRANSMISSION, DOI [10.5772/intechopen.76964, DOI 10.5772/INTECHOPEN.76964]
   da Silva-Vasconcelos A, 2002, MEM I OSWALDO CRUZ, V97, P151, DOI 10.1590/S0074-02762002000200002
   de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006
   de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103
   DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6
   DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347
   Dietz K, 1980, MATH MODEL TRANSMISS, P261
   Elliott RC, 2018, MATH BIOSCI, V300, P187, DOI 10.1016/j.mbs.2018.04.005
   Flores-Mendoza C, 2004, J MED ENTOMOL, V41, P489, DOI 10.1603/0022-2585-41.3.489
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   Garrett-Jones C., 1964, WHO METHOD ESTIMATIN
   Grillet ME, 2018, SCIENCE, V359, P528, DOI 10.1126/science.aar5440
   Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0
   Hiwat H, 2011, J MED ENTOMOL, V48, P1039, DOI 10.1603/ME10245
   Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177
   Klein T.A., 1991, Revista da Sociedade Brasileira de Medicina Tropical, V24, P13, DOI 10.1590/S0037-86821991000100003
   KLEIN TA, 1991, AM J TROP MED HYG, V45, P463, DOI 10.4269/ajtmh.1991.45.463
   Laporta GZ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0680-9
   Lima JMT, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0125
   MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P369
   Massad E, 2012, MEM I OSWALDO CRUZ, V107, P564, DOI 10.1590/S0074-02762012000400022
   Ministerio da Saude do Brasil, 2018, DAT SIV MAL SIST EL
   de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388
   de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x
   Chaves LSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25344-5
   Moreno M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0804-2
   Moreno M, 2014, AM J TROP MED HYG, V90, P612, DOI 10.4269/ajtmh.13-0708
   Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174
   Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014
   Lima JBP, 2014, MEM I OSWALDO CRUZ, V109, P685, DOI 10.1590/0074-0276140134
   Povoa MM, 2006, MEM I OSWALDO CRUZ, V101, P163, DOI 10.1590/S0074-02762006000200008
   Prussing C, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2234-4
   Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Ross R., 1911, PREVENTION MALARIA
   Rubio-Palis Y, 2012, MEM I OSWALDO CRUZ, V107, P546, DOI 10.1590/S0074-02762012000400017
   Rufalco-Moutinho P, 2016, ACTA TROP, V164, P243, DOI 10.1016/j.actatropica.2016.08.032
   Schoeler GB, 2003, J AM MOSQUITO CONTR, V19, P286
   Shretta R, 2017, MAJOR INFECT DIS
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   TADEI WP, 1988, REV I MED TROP, V30, P221, DOI 10.1590/S0036-46651988000300017
   Taylor LH, 1999, ANN TROP MED PARASIT, V93, P659, DOI 10.1080/00034989958168
   WHO, 2018, WORLD MAL REP 2018
NR 55
TC 8
Z9 8
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD APR 4
PY 2019
VL 18
AR 117
DI 10.1186/s12936-019-2753-7
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3DY
UT WOS:000463744200001
PM 30947726
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU de Barros, ACWG
   Santos, KG
   Massad, E
   Coelho, FC
AF de Barros, Ana Carolina W. G.
   Santos, Kaline G.
   Massad, Eduardo
   Coelho, Flavio Codeco
TI Sex-Specific Asymmetrical Attack Rates in Combined Sexual-Vectorial
   Transmission Epidemics
SO MICROORGANISMS
LA English
DT Article
DE epidemiology; R-0; vector-borne disease; sexually-transmitted disease
ID ZIKA VIRUS OUTBREAK; REPRODUCTION NUMBER; MATHEMATICAL-MODELS; HISTORY;
   MEN
AB In 2015-2016, South America went through the largest Zika epidemic in recorded history. One important aspect of this epidemic was the importance of sexual transmission in combination with the usual vectorial transmission, with asymmetrical transmissibilities between sexual partners depending on the type of sexual contact; this asymmetry manifested itself in data as an increased risk to women. We propose a mathematical model for the transmission of the Zika virus including sexual transmission via all forms of sexual contact, as well as vector transmission, assuming a constant availability of mosquitoes. From this model, we derive an expression for <mml:semantics>R0</mml:semantics>, which is used to study and analyze the relative contributions of the male to female sexual transmission route vis-a-vis vectorial transmission. We also perform Bayesian inference of the model's parameters using data from the 2016 Zika epidemic in Rio de Janeiro.
C1 [de Barros, Ana Carolina W. G.; Santos, Kaline G.; Massad, Eduardo; Coelho, Flavio Codeco] Fundacao Getulio Vargas, Escola Matemat Aplicada, BR-22250900 Rio De Janeiro, Brazil.
RP Coelho, FC (corresponding author), Fundacao Getulio Vargas, Escola Matemat Aplicada, BR-22250900 Rio De Janeiro, Brazil.
EM acwgdb@gmail.com; kaline96.st@gmail.com; eduardo.massad@fgv.br;
   fccoelho@fgv.br
RI Coelho, Flavio/L-1089-2018
OI Coelho, Flavio/0000-0003-3868-4391; Gomes Santos,
   Kaline/0000-0002-4697-9328
FU projectZikaPLAN - European Union's Horizon 2020 research and innovation
   programme [734584]
FX This work has been partially supported by the he projectZikaPLAN, funded
   by the European Union's Horizon 2020 research and innovation programme
   under Grant Agreement No. 734584, which funded the APC.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   ANDERSON R M, 1991
   Anderson RM, 2000, SEX TRANSM DIS, V27, P636, DOI 10.1097/00007435-200011000-00012
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Bastos MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205001
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coelho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019616
   dos Santos BMC, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00038218, 10.1590/0102-311x00038218]
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7
   Hess KL, 2017, AIDS BEHAV, V21, P2811, DOI 10.1007/s10461-017-1799-1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Isea Raul, 2016, AM J MODERN PHYS APP, V3, P11
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD APR
PY 2019
VL 7
IS 4
DI 10.3390/microorganisms7040112
PG 14
WC Microbiology
SC Microbiology
GA HX3JN
UT WOS:000467288300020
PM 31027271
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Orsborne, J
   Furuya-Kanamori, L
   Jeffries, CL
   Kristan, M
   Mohammed, AR
   Afrane, YA
   O'Reilly, K
   Massad, E
   Drakeley, C
   Walker, T
   Yakob, L
AF Orsborne, James
   Furuya-Kanamori, Luis
   Jeffries, Claire L.
   Kristan, Mojca
   Mohammed, Abdul Rahim
   Afrane, Yaw A.
   O'Reilly, Kathleen
   Massad, Eduardo
   Drakeley, Chris
   Walker, Thomas
   Yakob, Laith
TI Investigating the blood-host plasticity and dispersal of Anopheles
   coluzzii using a novel field-based methodology
SO PARASITES & VECTORS
LA English
DT Article
DE Blood-meal analysis; Host preference; Mosquito; Biting preference; Blood
   index
ID SENSU-STRICTO DIPTERA; GAMBIAE; CULICIDAE; SURVIVAL; COMPLEX;
   PREFERENCE; MOSQUITOS; SELECTION; FUNESTUS; DENSITY
AB BackgroundThe biting behaviour and dispersal of insect vectors in the field underlies the transmission of many diseases. Here, a novel collection methodology coupled with the molecular analysis of blood-meal sources and digestion rates is introduced with the aim of aiding the understanding of two critical and relatively understudied mosquito behaviours: plasticity in blood-host choice and vector dispersal.ResultsA collection strategy utilising a transect of mosquito traps placed at 50 m intervals allowed the collection of blood-fed Anopheles coluzzii from a malaria-endemic village of southern Ghana where human host availability ranged from zero (a cattle pen), increasing until humans were the dominant host choice (the middle of the village). Blood-meal analysis using PCR showed statistically significant variation in blood-meal origins for mosquitoes collected across the 250 m transect: with decreasing trend in Bovine Blood Index (OR=0.60 95% CI: 0.49-0.73, P<0.01) and correspondingly, an increasing trend in Human Blood Index (OR=1.50 95% CI: 1.05-2.16, P=0.028) as the transect approached the village. Using qPCR, the host DNA remaining in the blood meal was quantified for field-caught mosquitoes and calibrated according to timed blood digestion in colony mosquitoes. Time since blood meal was consumed and the corresponding distance the vector was caught from its blood-host allowed the estimation of An. coluzzii dispersal rates. Within 7hours of feeding, mosquitoes typically remained within 50m of their blood-host but at 60hours they had dispersed up to 250m.ConclusionsUsing this methodology the remarkably small spatial scale at which An. coluzzii blood-host choice can change was demonstrated. In addition, conducting qPCR on host blood from field-caught mosquitoes and calibrating with timed experiments with colonised mosquitoes presents a novel methodology for investigating the dispersal behaviour of vectors. Future adaptations to this novel method to make it broadly applicable to other types of setting are also discussed.
C1 [Orsborne, James; Jeffries, Claire L.; Kristan, Mojca; O'Reilly, Kathleen; Walker, Thomas; Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Furuya-Kanamori, Luis] Qatar Univ, Dept Populat Med, Coll Med, Doha, Qatar.
   [Furuya-Kanamori, Luis] Australian Natl Univ, Res Sch Populat Hlth, Coll Hlth & Med, Canberra, ACT, Australia.
   [Mohammed, Abdul Rahim; Afrane, Yaw A.] Univ Ghana, Dept Med Microbiol, Coll Hlth Sci, Korle Bu, Accra, Ghana.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England.
RP Yakob, L (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.
EM james.orsborne@lshtm.ac.uk; Laith.yakob@lshtm.ac.uk
RI Yakob, Laith/AAD-4521-2019; Walker, Thomas/B-9198-2014
OI Yakob, Laith/0000-0001-8639-4511; Afrane, Yaw/0000-0001-5653-5993;
   Furuya-Kanamori, Luis/0000-0002-4337-9757; Walker,
   Thomas/0000-0002-3545-012X
FU MRC London Intercollegiate Doctoral Training Partnership Studentship;
   Wellcome Trust/Royal Society Sir Henry Dale FellowshipWellcome Trust
   [101285/Z/13/Z]; Royal Society Research ProjectRoyal Society of London
   [RSG\R1\180203]; National Institute of Health, USUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI123074]; Australian National Health and Medical Research
   Council FellowshipNational Health and Medical Research Council of
   Australia [APP1158469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI123074, R01AI123074, R01AI123074,
   R01AI123074] Funding Source: NIH RePORTER
FX JO has an MRC London Intercollegiate Doctoral Training Partnership
   Studentship. TW and CLJ are funded through a Wellcome Trust/Royal
   Society Sir Henry Dale Fellowship (101285/Z/13/Z) awarded to TW. LY
   received funds from a Royal Society Research Project (RSG\R1\180203).
   YAA has funding from the National Institute of Health, US (R01AI123074).
   LFK is supported by an Australian National Health and Medical Research
   Council Fellowship (APP1158469). Funding bodies had no role in the
   design of the study and collection, analysis and interpretation of data
   nor in writing the manuscript.
CR BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478
   Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007
   Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401
   Chaccour CJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2872-y
   CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X
   Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x
   Dumonteil E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22455-x
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309
   GILLIES MT, 1964, NATURE, V203, P852, DOI 10.1038/203852a0
   Gunathilaka N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1279-5
   Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000198
   Lyimo IN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2823
   Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2
   Orsborne J, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2632-7
   Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7
   Poche RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0883-0
   Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579
   Sousa CA, 2001, J MED ENTOMOL, V38, P122, DOI 10.1603/0022-2585-38.1.122
   Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639
   Takken W, 1998, B ENTOMOL RES, V88, P561, DOI 10.1017/S0007485300026080
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Thomsen EK, 2017, J INFECT DIS, V215, P790, DOI 10.1093/infdis/jiw615
   THOMSON MC, 1995, MED VET ENTOMOL, V9, P413, DOI 10.1111/j.1365-2915.1995.tb00015.x
   WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738
   Yakob L., 2016, Parasite Epidemiology and Control, V1, P2, DOI 10.1016/j.parepi.2015.12.001
   Yakob L, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1748-5
NR 27
TC 2
Z9 2
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 25
PY 2019
VL 12
AR 143
DI 10.1186/s13071-019-3401-3
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HQ9JQ
UT WOS:000462744000002
PM 30909960
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Preet, R
   Brickley, EB
   Ximenes, RAD
   Miranda, DD
   Martelli, CMT
   de Araujo, TVB
   Montarroyos, UR
   Moreira, ME
   Turchi, MD
   Solomon, T
   Jacobs, BC
   Villamizar, CP
   Osorio, L
   de Filipps, AMB
   Neyts, J
   Kaptein, S
   Huits, R
   Arien, KK
   Willison, HJ
   Edgar, JM
   Barnett, SC
   Peeling, R
   Boeras, D
   Guzman, MG
   de Silva, AM
   Falconar, AK
   Romero-Vivas, C
   Gaunt, MW
   Sette, A
   Weiskopf, D
   Lambrechts, L
   Dolk, H
   Morris, JK
   Orioli, IM
   O'Reilly, KM
   Yakob, L
   Rocklov, J
   Soares, C
   Ferreira, MLB
   Franca, RFD
   Precioso, AR
   Logan, J
   Lang, T
   Jamieson, N
   Massad, E
AF Wilder-Smith, Annelies
   Preet, Raman
   Brickley, Elizabeth B.
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Turchi Martelli, Celina Maria
   Barreto de Araujo, Thalia Velho
   Montarroyos, Ulisses Ramos
   Moreira, Maria Elisabeth
   Turchi, Marilia Dalva
   Solomon, Tom
   Jacobs, Bart C.
   Pardo Villamizar, Carlos
   Osorio, Lyda
   de Filipps, Ana Maria Bispo
   Neyts, Johan
   Kaptein, Suzanne
   Huits, Ralph
   Arien, Kevin K.
   Willison, Hugh J.
   Edgar, Julia M.
   Barnett, Susan C.
   Peeling, Rosanna
   Boeras, Debi
   Guzman, Maria G.
   de Silva, Aravinda M.
   Falconar, Andrew K.
   Romero-Vivas, Claudia
   Gaunt, Michael W.
   Sette, Alessandro
   Weiskopf, Daniela
   Lambrechts, Louis
   Dolk, Helen
   Morris, Joan K.
   Orioli, Ieda M.
   O'Reilly, Kathleen M.
   Yakob, Laith
   Rocklov, Joacim
   Soares, Cristiane
   Ferreira, Maria Lucia Brito
   Franca, Rafael Freitas de Oliveira
   Precioso, Alexander R.
   Logan, James
   Lang, Trudie
   Jamieson, Nina
   Massad, Eduardo
TI ZikaPLAN: addressing the knowledge gaps and working towards a research
   preparedness network in the Americas
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika; congenital Zika syndrome; birth defect; epidemic preparedness;
   research capacity building; European Commission; microcephaly;
   Guillain-Barr? syndrome; encephalitis; sustainability
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; TRAVELERS; BRAZIL;
   EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; DIAGNOSIS; OUTBREAK; HISTORY
AB Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here we present a report on ZikaPLAN`s mid-term achievements since its initiation in October 2016 to June 2019, illustrating the research objectives of the 15 work packages ranging from virology, diagnostics, entomology and vector control, modelling to clinical cohort studies in pregnant women and neonates, as well as studies on the neurological complications of Zika infections in adolescents and adults. For example, the Neuroviruses Emerging in the Americas Study (NEAS) has set up more than 10 clinical sites in Colombia. Through the Butantan Phase 3 dengue vaccine trial, we have access to samples of 17,000 subjects in 14 different geographic locations in Brazil. To address the lack of access to clinical samples for diagnostic evaluation, ZikaPLAN set up a network of quality sites with access to well-characterized clinical specimens and capacity for independent evaluations. The International Committee for Congenital Anomaly Surveillance Tools was formed with global representation from regional networks conducting birth defects surveillance. We have collated a comprehensive inventory of resources and tools for birth defects surveillance, and developed an App for low resource regions facilitating the coding and description of all major externally visible congenital anomalies including congenital Zika syndrome. Research Capacity Network (REDe) is a shared and open resource centre where researchers and health workers can access tools, resources and support, enabling better and more research in the region. Addressing the gap in research capacity in LMICs is pivotal in ensuring broad-based systems to be prepared for the next outbreak. Our shared and open research space through REDe will be used to maximize the transfer of research into practice by summarizing the research output and by hosting the tools, resources, guidance and recommendations generated by these studies. Leveraging on the research from this consortium, we are working towards a research preparedness network.
C1 [Wilder-Smith, Annelies; Preet, Raman; Rocklov, Joacim] Umea Univ, Dept Epidemiol & Global Hlth, S-90185 Umea, Sweden.
   [Brickley, Elizabeth B.; Peeling, Rosanna; Boeras, Debi; Falconar, Andrew K.; Gaunt, Michael W.; O'Reilly, Kathleen M.; Yakob, Laith; Logan, James] London Sch Hyg & Trop Med, London, England.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros] Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Montarroyos, Ulisses Ramos] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Turchi, Marilia Dalva] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Pardo Villamizar, Carlos] Johns Hopkins Univ, Baltimore, MD USA.
   [Pardo Villamizar, Carlos; Osorio, Lyda] Univ Valle, Cali, Colombia.
   [de Filipps, Ana Maria Bispo] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Neyts, Johan; Kaptein, Suzanne] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.
   [Huits, Ralph; Arien, Kevin K.] Inst Trop Med, Antwerp, Belgium.
   [Willison, Hugh J.; Edgar, Julia M.; Barnett, Susan C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Guzman, Maria G.] Inst Med Trop, Pedro Kouri, Cuba.
   [de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Falconar, Andrew K.; Romero-Vivas, Claudia] Fdn Univ Norte, Dept Med, Barranquilla, Colombia.
   [Sette, Alessandro; Weiskopf, Daniela] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Lambrechts, Louis] Inst Pasteur, CNRS, Insect Virus Interact Unit, UMR2000, Paris, France.
   [Dolk, Helen] Ulster Univ, Inst Nursing & Hlth Res, Maternal Fetal & Infant Res Ctr, Newtownabbey, North Ireland.
   [Morris, Joan K.] St Georges Univ London, Populat Hlth Res Inst, London, England.
   [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Inst Biol, Assoc Tecn Cient Estudo Colaborat Latino Amer Mal, Dept Genet, Rio De Janeiro, Brazil.
   [Soares, Cristiane] Hosp Fed Serv Estado, Rio De Janeiro, Brazil.
   [Ferreira, Maria Lucia Brito] Hosp Restauracao, Recife, PE, Brazil.
   [Franca, Rafael Freitas de Oliveira] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Precioso, Alexander R.] Inst Butantan, Sao Paulo, Brazil.
   [Precioso, Alexander R.] Univ Sao Paulo, Sch Med, Pediat Dept, Sao Paulo, Brazil.
   [Lang, Trudie; Jamieson, Nina] Univ Oxford, Global Hlth Network Masters & Scholars, Oxford, England.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Epidemiol & Global Hlth, S-90185 Umea, Sweden.
EM anneliesws@gmail.com
RI Precioso, Alexander Roberto/A-9712-2013; Montarroyos,
   Ulisses/AAJ-7527-2020; Kaptein, Suzanne JF/O-4714-2019; Moreira, Maria
   Elisabeth Lopes/AAA-3775-2020; O'Reilly, Kathleen/H-9170-2019; Huits,
   Ralph/I-8361-2019; Lambrechts, Louis/ABF-2520-2020; Brickley,
   Elizabeth/U-3625-2017; NEYTS, Johan/U-8267-2017
OI Precioso, Alexander Roberto/0000-0001-8657-9292; Kaptein, Suzanne
   JF/0000-0002-7935-0219; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; O'Reilly, Kathleen/0000-0002-4892-8022;
   Huits, Ralph/0000-0001-8803-9468; Lambrechts, Louis/0000-0001-5958-2138;
   Solomon, Tom/0000-0001-7266-6547; Brickley,
   Elizabeth/0000-0003-0280-2288; Rocklov, Joacim/0000-0003-4030-0449;
   Wilder-Smith, Annelies/0000-0003-0362-5375; Preet, Raman
   Kaur/0000-0002-4371-5941; NEYTS, Johan/0000-0002-0033-7514
FU European UnionEuropean Union (EU) [734584]; National Institute for
   Health Research (NIHR), Health Protection Research Unit in Emerging and
   Zoonotic Infections [IS-HPU-1112-10117]; NIHR Global Health Research
   Group on Brain Infections [17/63/110]; Wellcome Trust UKWellcome Trust;
   Department for International Development UK; Medical Research Council
   UKMedical Research Council UK (MRC); CNPqNational Council for Scientific
   and Technological Development (CNPq); Secretaria de Vigilancia de Saude
   (SVS); Fundacao do Amparo a Ciencia e Tecnologia (FACEPE)
FX This project, ZikaPLAN is funded by the European Union's Horizon 2020
   research and innovation programme under Grant Agreement No. 734584. Some
   authors have received additional research funding. For example, TS is
   supported by the National Institute for Health Research (NIHR), Health
   Protection Research Unit in Emerging and Zoonotic Infections (Grant No.
   IS-HPU-1112-10117), and NIHR Global Health Research Group on Brain
   Infections (No. 17/63/110). MERG as a group has received funding from
   Wellcome Trust UK, Department for International Development UK, Medical
   Research Council UK, the Brazilian funding through CNPq, Secretaria de
   Vigilancia de Saude (SVS), and Fundacao do Amparo a Ciencia e Tecnologia
   (FACEPE).
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Albuquerque MSV, 2019, HLTH POLICY PLAN
   Angelo KM, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay074
   Awadh A, 2017, PLOS CURR, V9
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beran D, 2017, LANCET GLOB HEALTH, V5, pE567, DOI 10.1016/S2214-109X(17)30180-8
   Black WC, 2011, TRENDS PARASITOL, V27, P362, DOI 10.1016/j.pt.2011.04.004
   Boggild AK, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay117
   Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay095
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tax097
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Falconar AKI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021024
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fischer C, 2019, LANCET INFECT DIS, V19, P240, DOI 10.1016/S1473-3099(19)30049-0
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gubler DJ, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay097
   Hamer DH, 2019, J TRAVEL MED, V26
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huits R, 2019, INT J INFECT DIS, V78, P39, DOI 10.1016/j.ijid.2018.10.010
   Huits R, 2019, TRAVEL MED INFECT DI, V27, P107, DOI 10.1016/j.tmaid.2018.08.007
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Massad E, 2017, EPIDEMIOL INFECT, P1
   Massad E, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000712, 10.1017/s0950268819000712]
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Michal Stevens A, 2017, J TRAVEL MED, V24
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   dos Santos SFM, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0429-3
   Msall ME, 2010, ARCH PEDIAT ADOL MED, V164, P391, DOI 10.1001/archpediatrics.2010.25
   Neumayr A, 2017, EURO SURVEILL, V22
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Ritchie SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay084
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Salzer HJF, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay055
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Shanks GD, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz003
   Sheldrick RC, 2013, ACAD PEDIATR, V13, P577, DOI 10.1016/j.acap.2013.07.001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Torresi J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax064
   Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   Watts AG, 2018, J TRAVEL MED, V25
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026092
   Wilder-Smith A, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay157
   Wilder-Smith A, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1549930
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay139
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Xu X, 2016, PLOS CURR, V8
   Yakob L, 2017, PLOS CURR, V9
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 96
TC 4
Z9 4
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD JAN 1
PY 2019
VL 12
IS 1
AR 1666566
DI 10.1080/16549716.2019.1666566
PG 16
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JF7EZ
UT WOS:000491550400001
PM 31640505
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI Modelling an optimum vaccination strategy against ZIKA virus for
   outbreak use
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Control strategies; mathematical models; vaccines; Zika virus
AB We present a model to optimise a vaccination campaign aiming to prevent or to curb a Zika virus outbreak. We show that the optimum vaccination strategy to reduce the number of cases by a mass vaccination campaign should start when the Aedes mosquitoes' density reaches the threshold of 1.5 mosquitoes per humans, the moment the reproduction number crosses one. The maximum time it is advisable to wait for the introduction of a vaccination campaign is when the first ZIKV case is identified, although this would not be as effective to minimise the number of infections as when the mosquitoes' density crosses the critical threshold. This suboptimum strategy, however, would still curb the outbreak. In both cases, the catch up strategy should aim to vaccinate at least 25% of the target population during a concentrated effort of 1 month immediately after identifying the threshold. This is the time taken to accumulate the herd immunity threshold of 56.5%. These calculations were done based on theoretical assumptions that vaccine implementation would be feasible within a very short time frame.
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] LIM01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Germany G Dept Publ Hlth & Clin, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Umea Univ, Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), LIM01 HCFMUSP, Sao Paulo, Brazil.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
FU project ZikaPLAN - European Union's Horizon 2020 research and innovation
   programme [734584]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP);  [LIM01-HFMUSP]
FX This work was supported by the project ZikaPLAN, funded by the European
   Union's Horizon 2020 research and innovation programme under Grant
   Agreement No. 734584, by LIM01-HFMUSP, CNPq and FAPESP.
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   [Anonymous], 2018, PHARM J, V300, DOI [10.1211/PJ.2018.20204340, DOI 10.1211/PJ.2018.20204340]
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Chernick M., 2008, BOOTSTRAP METHODS GU
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2018, EPIDEMIOL INFECT, V146, P1219, DOI [10.1017/S0950268818001334, 10.1017/s0950268818001334]
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mbio.01390-17, 10.1128/mBio.01390-17]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pan American Health Organization (PAHO)/ World Health Organization (WHO), 2016, ZIK EP UPD
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   WHO, 2018, VACC PIP TRACK
   WHO, 2018, ZIK VACC DEV TECHN R
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
NR 31
TC 2
Z9 2
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR e196
DI 10.1017/S0950268819000712
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IJ4ZI
UT WOS:000475912200127
PM 31364534
OA Green Published, Green Accepted, Other Gold
DA 2020-12-16
ER

PT J
AU Orsborne, J
   Furuya-Kanamori, L
   Jeffries, CL
   Kristan, M
   Mohammed, AR
   Afrane, YA
   O'Reilly, K
   Massad, E
   Drakeley, C
   Walker, T
   Yakob, L
AF Orsborne, James
   Furuya-Kanamori, Luis
   Jeffries, Claire L.
   Kristan, Mojca
   Mohammed, Abdul Rahim
   Afrane, Yaw A.
   O'Reilly, Kathleen
   Massad, Eduardo
   Drakeley, Chris
   Walker, Thomas
   Yakob, Laith
TI Using the human blood index to investigate host biting plasticity: a
   systematic review and meta-regression of the three major African malaria
   vectors
SO MALARIA JOURNAL
LA English
DT Review
DE Blood meal analysis; Host preference; Mosquito; Biting preference; Blood
   index
ID FEEDING-BEHAVIOR; MOSQUITOS
AB BackgroundThe proportion of mosquito blood-meals that are of human origin, referred to as the human blood index' or HBI, is a key determinant of malaria transmission.MethodsA systematic review was conducted followed by meta-regression of the HBI for the major African malaria vectors.ResultsEvidence is presented for higher HBI among Anopheles gambiae (M/S forms and Anopheles coluzzii/An. gambiae sensu stricto are not distinguished for most studies and, therefore, combined) as well as Anopheles funestus when compared with Anopheles arabiensis (prevalence odds ratio adjusted for collection location [i.e. indoor or outdoor]: 1.62; 95% CI 1.09-2.42; 1.84; 95% CI 1.35-2.52, respectively). This finding is in keeping with the entomological literature which describes An. arabiensis to be more zoophagic than the other major African vectors. However, analysis also revealed that HBI was more associated with location of mosquito captures (R-2=0.29) than with mosquito (sibling) species (R-2=0.11).ConclusionsThese findings call into question the appropriateness of current methods of assessing host preferences among disease vectors and have important implications for strategizing vector control.
C1 [Orsborne, James; Jeffries, Claire L.; Kristan, Mojca; O'Reilly, Kathleen; Walker, Thomas; Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Furuya-Kanamori, Luis] Qatar Univ, Dept Populat Med, Coll Med, Doha, Qatar.
   [Mohammed, Abdul Rahim; Afrane, Yaw A.] Univ Ghana, Dept Med Microbiol, Coll Hlth Sci, Korle Bu, Accra, Ghana.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England.
RP Yakob, L (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.
EM Laith.yakob@lshtm.ac.uk
RI Yakob, Laith/AAD-4521-2019; Walker, Thomas/B-9198-2014
OI Yakob, Laith/0000-0001-8639-4511; Furuya-Kanamori,
   Luis/0000-0002-4337-9757; Walker, Thomas/0000-0002-3545-012X; Afrane,
   Yaw/0000-0001-5653-5993
FU Wellcome Trust/Royal Society Sir Henry Dale FellowshipWellcome Trust
   [101285/Z/13/Z]; Royal Society Research ProjectRoyal Society of London
   [RSG\ R1\ 180203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI123074, R01AI123074, R01AI123074]
   Funding Source: NIH RePORTER
FX JO has an MRC London Intercollegiate Doctoral Training Partnership
   Studentship. TW and CLJ are funded through a Wellcome Trust/Royal
   Society Sir Henry Dale Fellowship (101285/Z/13/Z) awarded to TW. LY
   received funds from a Royal Society Research Project (RSG\ R1\ 180203).
   Funding bodies had no role in the design of the study and collection,
   analysis and interpretation of data nor in writing the manuscript.
CR Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x
   Chaccour C, 2010, J INFECT DIS, V202, P113, DOI 10.1086/653208
   Chaccour CJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2872-y
   Chaccour CJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08906-x
   CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X
   DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   Guelbeogo WM, 2018, ELIFE, V7, DOI 10.7554/eLife.32625
   Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124
   Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Orsborne J, 2018, BIORXIV, V26, P49
   PAMPIGLIONE S, 1985, T ROY SOC TROP MED H, V79, P797, DOI 10.1016/0035-9203(85)90121-X
   Poche RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0883-0
   Pombi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31117-x
   Rabinovich NR, 2018, LANCET INFECT DIS, V18, P584, DOI 10.1016/S1473-3099(18)30176-2
   Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80
   Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32
   Smit MR, 2018, LANCET INFECT DIS, V18, P615, DOI 10.1016/S1473-3099(18)30163-4
   Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Waite H, 1910, BIOMETRIKA, V7, P421
   Yakob L., 2016, Parasite Epidemiology and Control, V1, P2, DOI 10.1016/j.parepi.2015.12.001
   Yakob L, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1748-5
NR 25
TC 4
Z9 4
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD DEC 18
PY 2018
VL 17
AR 479
DI 10.1186/s12936-018-2632-7
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HE9SX
UT WOS:000453795900003
PM 30563533
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Tissera, H
   AbuBakar, S
   Kittayapong, P
   Logan, J
   Neumayr, A
   Rocklov, J
   Byass, P
   Louis, VR
   Tozan, Y
   Massad, E
   Preet, R
AF Wilder-Smith, Annelies
   Tissera, Hasitha
   AbuBakar, Sazaly
   Kittayapong, Pattamaporn
   Logan, James
   Neumayr, Andreas
   Rocklov, Joacim
   Byass, Peter
   Louis, Valerie R.
   Tozan, Yesim
   Massad, Eduardo
   Preet, Raman
TI Novel tools for the surveillance and control of dengue: findings by the
   dengueTools research consortium
SO GLOBAL HEALTH ACTION
LA English
DT Review
DE Dengue; DengueTools; surveillance; impregnated clothing; schools; Aedes;
   vectorial capacity; predictive modelling; importation; travel; Zika;
   reverse transcription-recombinase polymerase amplification
ID RIO-DE-JANEIRO; ZIKA VIRUS; SENTINEL SURVEILLANCE; SRI-LANKA; TRAVELERS;
   RISK; IMPREGNATION; IMPORTATIONS; INFECTIONS; PERMETHRIN
AB Background: Dengue fever persists as a major global disease burden, and may increase as a consequence of climate change. Along with other measures, research actions to improve diagnosis, surveillance, prevention, and predictive models are highly relevant. The European Commission funded the DengueTools consortium to lead a major initiative in these areas, and this review synthesises the outputs and findings of this work conducted from 2011 to 2016.
   Research areas: DengueTools organised its work into three research areas, namely [1] Early warning and surveillance systems; [2] Strategies to prevent dengue in children; and [3] Predictive models for the global spread of dengue.
   Research area 1 focused on case-studies undertaken in Sri Lanka, including developing laboratory-based sentinel surveillance, evaluating economic impact, identifying drivers of transmission intensity, evaluating outbreak prediction capacity and developing diagnostic capacity. Research area 2 addressed preventing dengue transmission in school children, with case-studies undertaken in Thailand. Insecticide-treated school uniforms represented an intriguing potential approach, with some encouraging results, but which were overshadowed by a lack of persistence of insecticide on the uniforms with repeated washing. Research area 3 evaluated potential global spread of dengue, particularly into dengue-naive areas such as Europe. The role of international travel, changing boundaries of vectors, developing models of vectorial capacity under different climate change scenarios and strategies for vector control in outbreaks was all evaluated.
   Concluding remarks: DengueTools was able to make significant advances in methods for understanding and controlling dengue transmission in a range of settings. These will have implications for public health agendas to counteract dengue, including vaccination programmes.
   Outlook: Towards the end of the DengueTools project, Zika virus emerged as an unexpected epidemic in the central and southern America. Given the similarities between the dengue and Zika viruses, with vectors in common, some of the DengueTools thinking translated readily into the Zika situation.
C1 [Wilder-Smith, Annelies; Rocklov, Joacim; Byass, Peter; Preet, Raman] Umea Univ, Unit Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [Tissera, Hasitha] Hlth, Epidemiol Unit, Colombo, Sri Lanka.
   [AbuBakar, Sazaly] Univ Malaya, CWHO Collaborating Ctr Arbovirus Reference & Res, TIDREC, Kuala Lumpur, Malaysia.
   [Kittayapong, Pattamaporn] Mahidol Univ, Ctr Excellence Vectors & Vector Borne Dis, Dept Biol, Fac Sci, Bangkok, Thailand.
   [Logan, James] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Neumayr, Andreas] Swiss Trop & Publ Hlth Inst, Dept Med Serv, Basel, Switzerland.
   [Louis, Valerie R.; Tozan, Yesim] Heidelberg Univ, Heidelberg Inst Global Hlth, Med Sch, Heidelberg, Germany.
   [Tozan, Yesim] NYU, Coll Global Publ Hlth, New York, NY USA.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
RP Wilder-Smith, A (corresponding author), Umea Univ, Unit Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden.
EM anneliesws@gmail.com
RI abubakar, sazaly/B-3957-2010; Tissera, Hasitha/AAQ-2516-2020
OI abubakar, sazaly/0000-0002-9267-1420; Preet, Raman
   Kaur/0000-0002-4371-5941; Byass, Peter/0000-0001-5474-4361; Rocklov,
   Joacim/0000-0003-4030-0449; Tozan, Yesim/0000-0001-8997-8897
FU Health theme of the Seventh Framework Programme of the European
   Community [282589]; Innovative tools and strategies for surveillance and
   control of dengue - DengueTools
FX This project was funded under the Health theme of the Seventh Framework
   Programme of the European Community, Grant Agreement number 282589.
   Project: Innovative tools and strategies for surveillance and control of
   dengue - DengueTools.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384
   Angelo KM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax046
   Arya SC, 2013, J TRAVEL MED, V20, P268, DOI 10.1111/jtm.12036
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   Bodinayake CK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004995
   Boubidi SC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1881-y
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   de Laval F, 2013, J TRAVEL MED, V20, P259, DOI 10.1111/j.1708-8305.2012.00674.x
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472
   Ferguson RW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw010
   Franco L, 2015, CLIN MICROBIOL INFEC, V21, p713e5
   Gjenero-Margan I., 2011, EURO SURVEILL, V16
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Griffiths KM, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay007
   Harris CL, 2013, BIOTECHNIQUES, V54, P95, DOI 10.2144/000113951
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Horstick O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003632
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Liyanage P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111087
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Louis VR, 2016, PATHOG GLOB HEALTH, V110, P79, DOI 10.1080/20477724.2016.1175158
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Massad E, 2016, LANCET, V388, P658, DOI 10.1016/S0140-6736(16)31228-4
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20473
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   Mues KE, 2014, CLIN INFECT DIS, V58, P546, DOI 10.1093/cid/cit746
   Murray N, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24887
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neuberger A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw003
   Neumayr A, 2017, EURO SURVEILL, V22
   Neumayr AM, 2016, EURO SURVEILL, V22
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Poddighe D, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav013
   Quam MB, 2015, J TRAVEL MED
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Ratanawong P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161895
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Riddell A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax015
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Sebeny PJ, 2013, J TRAVEL MED, V20, P214, DOI 10.1111/jtm.12033
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Stevens AM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw099
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259
   Tan KK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3065-1
   Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Thalagala N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004466
   Tissera H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004477
   Torresi J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax064
   Tozan Y, 2016, EXPERT REV VACCINES, V15, P519, DOI 10.1586/14760584.2016.1129278
   Tozan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108017
   Uehara A, 2017, AM J TROP MED HYG, V97, P130, DOI 10.4269/ajtmh.16-0540
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2011, MED HYPOTHESES, V76, P861, DOI 10.1016/j.mehy.2011.02.037
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   Wilder-Smith A, 2018, LANCET INFECT DIS
   Wilder-Smith A, 2012, GLOB HLTH ACTION, V5
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31620
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   Zhang J, 2016, J TRAVEL MED, V23
NR 92
TC 4
Z9 4
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD DEC 3
PY 2018
VL 11
IS 1
AR 1549930
DI 10.1080/16549716.2018.1549930
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HC5MO
UT WOS:000451847300001
PM 30560735
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Greenhalgh, D
   Liang, YF
   Nazni, WA
   Teoh, GN
   Lee, HL
   Massad, E
AF Greenhalgh, David
   Liang, Yanfeng
   Nazni, Wasi Ahmad
   Teoh, Guat-Ney
   Lee, Han Lim
   Massad, Eduardo
TI MODELING THE EFFECT OF A NOVEL AUTO-DISSEMINATION TRAP ON THE SPREAD OF
   DENGUE IN HIGH-RISE CONDOMINIA, MALAYSIA
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE Dengue; Auto-Dissemination Trap; Mosquito Home System; Ordinary
   Differential Equations; Delayed Model; Aedes Aegypti; Aedes Albopictus;
   Numerical Simulations; Malaysia
ID VECTOR CONTROL; YELLOW-FEVER
AB In this paper, we use the classical Ross-Macdonald model to analyze the effect of the Mosquito Home System (MHS), which is an example of an auto-dissemination trap, in controlling the spread of dengue in Malaysia in a high-rise condominium environment. By using the national dengue data from Malaysia, we are able to estimate lambda which represents the initial growth rate of the dengue epidemic and thus allows us to estimate the number of mosquitoes in Malaysia. The basic reproduction number R-0 is also obtained. We have constructed a mathematical expression which allows us to estimate the potential number of breeding sites for Aedes mosquitoes. Later on, by using the data available from the 11 months trials carried out in three blocks of flats in Selangor, we improved on our dengue model by including the effect of the MHS and thus modeling the impact it has on the spread of dengue within the flats. Numerical simulations and tables are also produced to illustrate our results.
C1 [Greenhalgh, David; Liang, Yanfeng] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
   [Nazni, Wasi Ahmad; Teoh, Guat-Ney] Inst Med Res, Med Entomol Unit, Jalan Pahang, Kuala Lumpur 50588, Malaysia.
   [Lee, Han Lim] Minist Hlth, Vector Borne Dis Control Branch, Dis Control Div, Putrajaya, Malaysia.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Dept Legal Informat, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Massad, Eduardo] LIM 01 HCFMUSP, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Greenhalgh, D (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
EM david.greenhalgh@strath.ac.uk
FU Dengue Tech Challenge 2016 grant under the Newton-Ungku Omar Fund
   partnership [DTC 16022]; UK Department for Business, Energy and
   Industrial Strategy and Malaysian Industry-Government Group for High
   Technology (MIGHT); Science Without Borders Program, Brazil
   [30098/2014-7]; Leverhulme TrustLeverhulme Trust [RF-2015-88]
FX This work was supported by the Dengue Tech Challenge 2016 grant
   (Application Reference DTC 16022), under the Newton-Ungku Omar Fund
   partnership. The grant is funded by the UK Department for Business,
   Energy and Industrial Strategy and Malaysian Industry-Government Group
   for High Technology (MIGHT) and delivered by the British Council and
   PlaTCOM Ventures. The authors are grateful to One Team Networks Sdn Bhd,
   in Malaysia, as our principal collaborator in Malaysia for the Dengue
   Tech Challenge 2016 and for providing the data.; DG is grateful to the
   Science Without Borders Program, Brazil, for a Special Visiting
   Fellowship (CNPq grant 30098/2014-7), with Professor E. Massad, School
   of Applied Mathematics, Fundacao Getulio Vargas, Rio de Janeiro, Brazil,
   and to the Leverhulme Trust for support from a Leverhulme Research
   Fellowship (RF-2015-88).
CR Amaku M, 2016, EPIDEMIOL INFECT, V144, P3435, DOI 10.1017/S0950268816001448
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Cheng Q, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004417
   Department of Statistics Malaysia, 2017, OFF PORT FED TERR KU
   Derouich M, 2006, APPL MATH COMPUT, V177, P528, DOI 10.1016/j.amc.2005.11.031
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lee HL, 2015, INT MED J MALAYS, V14, P11
   Liew SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157631
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Mutebi JP, 2004, EMERG INFECT DIS, V10, P1657
   Myhealth Dengue Official Portal of Malaysian Health Ministry, 2017, HIST EP DENG
   Nazni WA, SUPPRESSION CO UNPUB
   Olivera-Botello G, 2016, J INFECT DIS, V214, P994, DOI 10.1093/infdis/jiw297
   Packierisamy PR, 2015, AM J TROP MED HYG, V93, P1020, DOI 10.4269/ajtmh.14-0667
   Scanpap (Asia Pacific) Pte Ltd and One Team Networks Sdn Bhd, 2016, PROJ REP FIELD UNPUB
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Singapore National Environment Agency, 2018, DENG ZIK PREV AED MO
   Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097
   World Bank, 2017, DAT IND
   World Health Organization, 2018, DENG CONTR
   World Health Organization, 2017, DENG CONTR DENG SEV
NR 24
TC 2
Z9 2
U1 0
U2 4
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3390
EI 1793-6470
J9 J BIOL SYST
JI J. Biol. Syst.
PD DEC
PY 2018
VL 26
IS 4
BP 553
EP 578
DI 10.1142/S0218339018500250
PG 26
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA HH4HO
UT WOS:000455683300004
OA Green Accepted, Other Gold
DA 2020-12-16
ER

PT J
AU Massad, E
AF Massad, Eduardo
TI Measles and human movement in Europe
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Letter
C1 [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Amaku M, 2018, COMPUT MATH METHOD M, DOI 10.1155/2018/6289681
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Leong WY, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay080
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
NR 5
TC 7
Z9 7
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD OCT 11
PY 2018
VL 25
AR tay091
DI 10.1093/jtm/tay091
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0ZG
UT WOS:000451527900001
PM 30312454
OA Bronze
DA 2020-12-16
ER

PT J
AU O'Reilly, KM
   Lowe, R
   Edmunds, WJ
   Mayaud, P
   Kucharski, A
   Eggo, RM
   Funk, S
   Bhatia, D
   Khan, K
   Kraemer, MUG
   Wilder-Smith, A
   Rodrigues, LC
   Brasil, P
   Massad, E
   Jaenisch, T
   Cauchemez, S
   Brady, OJ
   Yakob, L
AF O'Reilly, Kathleen M.
   Lowe, Rachel
   Edmunds, W. John
   Mayaud, Philippe
   Kucharski, Adam
   Eggo, Rosalind M.
   Funk, Sebastian
   Bhatia, Deepit
   Khan, Kamran
   Kraemer, Moritz U. G.
   Wilder-Smith, Annelies
   Rodrigues, Laura C.
   Brasil, Patricia
   Massad, Eduardo
   Jaenisch, Thomas
   Cauchemez, Simon
   Brady, Oliver J.
   Yakob, Laith
TI Projecting the end of the Zika virus epidemic in Latin America: a
   modelling analysis
SO BMC MEDICINE
LA English
DT Article
DE Zika virus; Epidemic; Mathematical modelling; Latin America and the
   Caribbean; Connectivity
ID VECTOR-BORNE TRANSMISSION; INFECTION; BRAZIL; RISK; DYNAMICS; OUTBREAK;
   NUMBER; SIZE
AB Background: Zika virus (ZIKV) emerged in Latin America and the Caribbean (LAC) region in 2013, with serious implications for population health in the region. In 2016, the World Health Organization declared the ZIKV outbreak a Public Health Emergency of International Concern following a cluster of associated neurological disorders and neonatal malformations. In 2017, Zika cases declined, but future incidence in LAC remains uncertain due to gaps in our understanding, considerable variation in surveillance and the lack of a comprehensive collation of data from affected countries.
   Methods: Our analysis combines information on confirmed and suspected Zika cases across LAC countries and a spatio-temporal dynamic transmission model for ZIKV infection to determine key transmission parameters and projected incidence in 90 major cities within 35 countries. Seasonality was determined by spatio-temporal estimates of Aedes aegypti vectorial capacity. We used country and state-level data from 2015 to mid-2017 to infer key model parameters, country-specific disease reporting rates, and the 2018 projected incidence. A 10-fold cross-validation approach was used to validate parameter estimates to out-of-sample epidemic trajectories.
   Results: There was limited transmission in 2015, but in 2016 and 2017 there was sufficient opportunity for wide-spread ZIKV transmission in most cities, resulting in the depletion of susceptible individuals. We predict that the highest number of cases in 2018 would present within some Brazilian States (Sao Paulo and Rio de Janeiro), Colombia and French Guiana, but the estimated number of cases were no more than a few hundred. Model estimates of the timing of the peak in incidence were correlated (p < 0.05) with the reported peak in incidence. The reporting rate varied across countries, with lower reporting rates for those with only confirmed cases compared to those who reported both confirmed and suspected cases.
   Conclusions: The findings suggest that the ZIKV epidemic is by and large over within LAC, with incidence projected to be low in most cities in 2018. Local low levels of transmission are probable, but the estimated rate of infection suggests that most cities have a population with high levels of herd immunity.
C1 [O'Reilly, Kathleen M.; Wilder-Smith, Annelies; Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [O'Reilly, Kathleen M.; Lowe, Rachel; Edmunds, W. John; Kucharski, Adam; Eggo, Rosalind M.; Funk, Sebastian; Brady, Oliver J.; Yakob, Laith] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel; Edmunds, W. John; Kucharski, Adam; Eggo, Rosalind M.; Funk, Sebastian; Rodrigues, Laura C.; Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Bhatia, Deepit; Khan, Kamran] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [Bhatia, Deepit; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Wilder-Smith, Annelies] Umea Univ, Dept Med & Publ Hlth, Umea, Sweden.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Heidelberg Univ, Dept Infect Dis, Dept Infect Dis & Parasitol, Heidelberg, Germany.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Cauchemez, Simon] CNRS, URA3012, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
RP O'Reilly, KM (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.; O'Reilly, KM (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
EM kathleen.oreilly@lshtm.ac.uk
RI Yakob, Laith/AAD-4521-2019; Brady, Oliver/P-9421-2019; O'Reilly,
   Kathleen/H-9170-2019; Bhatia, Deepit/AAC-1444-2020
OI Yakob, Laith/0000-0001-8639-4511; Brady, Oliver/0000-0002-3235-2129;
   O'Reilly, Kathleen/0000-0002-4892-8022; Bhatia,
   Deepit/0000-0001-8168-6873; Eggo, Rosalind M/0000-0002-0362-6717; Lowe,
   Rachel/0000-0003-3939-7343; MAYAUD, Philippe/0000-0001-5730-947X; Funk,
   Sebastian/0000-0002-2842-3406
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant [734548]; ZikaPLAN Grant [734584]; Royal Society
   Dorothy Hodgkin FellowshipRoyal Society of London; Sir Henry Dale
   Fellowship; Royal SocietyRoyal Society of London [206250/Z/17/Z]; Sir
   Henry Wellcome Fellowship; Wellcome TrustWellcome Trust [206250/Z/17/Z,
   206471/Z/17/Z]; Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious
   Disease Agent Study of the National Institute of General Medical
   Sciences; AXA Research Fund; Branco Weiss Fellowship - Society in
   Science; National Institute of Child Health and Human DevelopmentUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD040128]; National Library of
   Medicine of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM) [R01LM010812, R01LM011965]; EUNICE
   KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128] Funding Source: NIH RePORTER; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY
   OF MEDICINEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM011965, R01LM010812, R01LM010812, R01LM010812, R01LM010812,
   R01LM010812, R01LM011965, R01LM011965, R01LM010812, R01LM011965,
   R01LM010812, R01LM010812] Funding Source: NIH RePORTER
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant Agreement no.
   734548 and ZikaPLAN Grant Agreement No 734584. RL was funded by a Royal
   Society Dorothy Hodgkin Fellowship. AK was funded by a Sir Henry Dale
   Fellowship jointly funded by the Wellcome Trust and the Royal Society
   (grant Number 206250/Z/17/Z). OJB was funded by a Sir Henry Wellcome
   Fellowship funded by the Wellcome Trust (grant number 206471/Z/17/Z). SC
   was funded by the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, and the AXA Research Fund. MUGK is supported
   by The Branco Weiss Fellowship - Society in Science, administered by the
   ETH Zurich and acknowledges funding from a Training Grant from the
   National Institute of Child Health and Human Development (T32HD040128)
   and the National Library of Medicine of the National Institutes of
   Health (R01LM010812, R01LM011965). The funders had no role in in the
   design of the study, the collection, analysis and interpretation of
   data, or in writing the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Andronico A, 2017, AM J EPIDEMIOL, V16, P1
   Asher J, 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Mallet H, 2015, B INFORM SANIT EPIDE
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Nelson B, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.ac6d0f8c9c35e88825c1a1147697531c, DOI 10.1371/CURRENTS.OUTBREAKS.AC6D0F8C9C35E88825C1A1147697531C]
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mbio.01390-17, 10.1128/mBio.01390-17]
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Roberts MG, 2013, J MATH BIOL, V66, P1463, DOI 10.1007/s00285-012-0540-y
   Rodriguez-Barraquer I, 2016, BIORXIV, DOI [10.1101/041095, DOI 10.1101/041095]
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Sinan B., SISTEMA INFORM AGRAV
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172
   WHO, 2016, ZIK STRAT RESP PLAN
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   World Health Organization, 2017, ZIK SIT REP
   World Health Organization, 2017, WHO VACC PIP TRACK Z
   World Health Organization Fifth Meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 55
TC 24
Z9 24
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD OCT 3
PY 2018
VL 16
AR 180
DI 10.1186/s12916-018-1158-8
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV6DT
UT WOS:000446198400001
PM 30285863
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Miguel, MM
   Coutinho, FAB
AF Massad, Eduardo
   Miguel, Monica Manir
   Bezerra Coutinho, Francisco Antonio
TI Is vaccinating monkeys against yellow fever the ultimate solution for
   the Brazilian recurrent epizootics?
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Editorial Material
DE Mathematical modelling; medical informatics (veterinary and medical);
   dengue fever
ID PRIMATES; RISK
AB Vaccinating monkeys against yellow fever (YF) has been a common practice in the beginning of the 17D vaccine development. Although it may seem strange at first sight, vaccinating monkeys as a public health strategy is, we think, feasible and theoretically could eliminate the infection among non-human primates, interrupting the virus circulation (or significantly reducing it) and therefore reducing the risk of spilling over to the human population. We propose a series of studies that could demonstrate (or not) the efficacy and feasibility of vaccinating non-human primates YF reservoirs living in green areas of urban centres to cut off or curb the virus circulation that recurrently spill over to the human population. Therefore, vaccinating monkeys in relatively small green areas of the urban centres is perhaps the ultimate solution for the Brazilian recurrent YF epizootics.
C1 [Massad, Eduardo; Miguel, Monica Manir; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo; Miguel, Monica Manir; Bezerra Coutinho, Francisco Antonio] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeior, Brazil.
   [Massad, Eduardo] Univ Derby, Coll Lifeand Nat Sci, Derby, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), LIM 01 HCFMUSP, Sao Paulo, Brazil.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeior, Brazil.; Massad, E (corresponding author), Univ Derby, Coll Lifeand Nat Sci, Derby, England.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Brazilian Ministry of Health [777588/2012]; ZikaPLAN; European
   Union's Horizon 2020 research and innovation programme [734584]; 
   [LIM01-HCFMUSP]
FX This work has been funded by LIM01-HCFMUSP, CNPq, by the Brazilian
   Ministry of Health (grant #777588/2012), by ZikaPLAN, funded by the
   European Union's Horizon 2020 research and innovation programme under
   Grant Agreement No. 734584.
CR Agencia Brasil, 2017, MAIS DEZ PARQ CAP PA
   Amato-Lourenço Luís Fernando, 2016, Estud. av., V30, P113, DOI 10.1590/S0103-40142016.00100008
   [Anonymous], 2017, DIS OUTBREAK NE 0208
   Bicca-Marques JC, 2010, TROP CONSERV SCI, V3, P78, DOI 10.1177/194008291000300107
   COELHO A M JR, 1976, Primates, V17, P63, DOI 10.1007/BF02381567
   Findlay GM, 1934, LANCET, V2, P983
   Manir M, 2017, QUE BRASIL NAO VACIN
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2018, EPIDEMIOL INFECT, V146, P1219, DOI [10.1017/S0950268818001334, 10.1017/s0950268818001334]
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   PINTO LPS, 1993, FOLIA PRIMATOL, V61, P135, DOI 10.1159/000156740
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   SCOTT N J JR, 1976, Primates, V17, P527, DOI 10.1007/BF02382910
   Strode GK, 1951, YELLOW FEVER
   THEILER MAX, 1928, ANN TROP MED & PARASITOL, V22, P449
   Wolfe ND, 2012, IMPROVING FOOD SAFET, P349
NR 18
TC 1
Z9 1
U1 0
U2 9
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2018
VL 146
IS 13
BP 1622
EP 1624
DI 10.1017/S0950268818002273
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GS3QS
UT WOS:000443535400003
PM 30103835
OA Bronze
DA 2020-12-16
ER

PT J
AU Massad, MRR
   Shimozako, HJ
   Ribas, LM
   Pinto, ACBDF
   Heng, HG
   Tremori, TM
   Reis, STJ
   Massad, E
   Rocha, NS
AF Rodrigues Massad, Mara Rita
   Shimozako, Helio Junji
   Ribas, Laila Massad
   de Campos Fonseca Pinto, Ana Carolina Brandao
   Heng, Hock Gan
   Tremori, Talia Missen
   Jacinto Reis, Servio Tulio
   Massad, Eduardo
   Rocha, Noeme Sousa
TI A new method for the interpretation of veterinary forensic necropsy and
   PMCT finding with Bayesian decision theory
SO JOURNAL OF FORENSIC RADIOLOGY AND IMAGING
LA English
DT Article
DE Forensic science; Post-mortem radiology; Bayesian theory; Post-mortem
   computed tomography; Veterinary medicine
ID POSTMORTEM-COMPUTED-TOMOGRAPHY; VACCINATION; ANGIOGRAPHY
AB This work proposes a novel approach to estimate the sensitivity of post-mortem computed tomography (PMCT) with respect to traditional necropsy (gold standard). Using concepts of Bayes theorem and the opinion of 57 veterinarians of how a relevant finding (RF) on PMCT or at necropsy can be a determinant in the animal's death, the general sensitivity was estimated. Such sensitivity can be interpreted as the probability to identify a specific RF in a necropsied animal. In the study, we included 18 animals that were subjected to traditional necropsy and underwent PMCT, which provided 48 different findings; all were assumed as a potential cause of death. This study aimed to understand the probability of death, given that a necropsied animal presented a specific RF. To estimate all contributions of the 48 RF, we designed a simple survey based on the Delphi method. In this survey, we invited veterinarians to evaluate the 48 NF and to assign a grade in a Likert scale from 0 to 10 for each of the RFs. In this scale, 0 (zero) indicates that the NF does not contribute to the animal's death, and 10 (ten) indicates that this NFdoes totally contributes to the animal's death. Therefore, each veterinarian, according to their own professional experience, assigns a grade describing how important each necroscopic finding is to the animal's death. Our results demonstrated that the problem of sensitivity analysis in the absence of a gold standard could be circumvented by the method proposed here.
C1 [Rodrigues Massad, Mara Rita; Ribas, Laila Massad; Tremori, Talia Missen; Jacinto Reis, Servio Tulio; Rocha, Noeme Sousa] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Clin Sci, Botucatu, SP, Brazil.
   [Shimozako, Helio Junji; Massad, Eduardo] Univ Sao Paulo, Sch Med, Dept Legal Med LIM 01, Sao Paulo, Brazil.
   [Shimozako, Helio Junji; Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Shimozako, Helio Junji; Massad, Eduardo] Univ Derby, Sch Nat & Life Sci, Derby, England.
   [de Campos Fonseca Pinto, Ana Carolina Brandao] Univ Sao Paulo, Sch Vet Med & Anim Sci, Surg Dept, Sao Paulo, Brazil.
   [Heng, Hock Gan] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA.
RP Ribas, LM (corresponding author), Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Clin Sci, Botucatu, SP, Brazil.
EM laila@usp.br
RI Shimozako, Helio Junji/AAX-2805-2020; Ribas, Laila Massad/I-9651-2016;
   Rocha, Noeme Suosa/G-1264-2012; Brandao de Campos Fonseca Pinto, Ana
   Carolina/L-4633-2016; Massad, Eduardo/B-1169-2012
OI Shimozako, Helio Junji/0000-0003-1941-9330; Ribas, Laila
   Massad/0000-0002-1390-8523; Rocha, Noeme Suosa/0000-0001-9676-116X;
   Brandao de Campos Fonseca Pinto, Ana Carolina/0000-0003-2833-2069;
   Tremori, Talia/0000-0002-6082-9596; Massad, Eduardo/0000-0002-7200-2916
FU "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" -
   CAPESCAPES [99999.000199/2016-08, 25/2014]
FX This work was supported by "Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior" - CAPES, Edital Ciencias Forenses 25/2014. Process
   number 99999.000199/2016-08.
CR Busardo FP, 2015, RADIOL MED, V120, P810, DOI 10.1007/s11547-015-0559-4
   Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005
   DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458
   Pinto ACBDF, 2017, J FORENSIC RADIOL IM, V8, P48, DOI 10.1016/j.jofri.2017.03.006
   Pinto ACBDF, 2017, J FORENSIC RADIOL IM, V8, P45, DOI 10.1016/j.jofri.2016.11.006
   Heinemann A, 2015, RADIOL MED, V120, P835, DOI 10.1007/s11547-015-0574-5
   Likert R., 1932, ARCH PSYCHOL, P1, DOI DOI 10.1111/J.1540
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E., 2004, METODOS QUANTITATIVO, P189
   Moskala A, 2016, LEGAL MED-TOKYO, V18, P25, DOI 10.1016/j.legalmed.2015.11.005
   Ribeiro AF, 2015, MEM I OSWALDO CRUZ, V110, P230, DOI 10.1590/0074-02760140345
   Rutjes AW, 2007, HEALTH TECHNOL ASSES, V11, P1
NR 12
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-4780
EI 2212-4799
J9 J FORENSIC RADIOL IM
JI J. Forensic Radiol. Imaging
PD SEP
PY 2018
VL 14
BP 8
EP 11
DI 10.1016/j.jofri.2018.05.004
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA GT5GX
UT WOS:000444535900002
OA Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
   Amaku, M
   Coutinho, FAB
   Struchiner, CJ
   Lopez, LF
   Coelho, G
   Wilder-Smith, A
   Burattini, MN
AF Massad, Eduardo
   Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Struchiner, Claudio Jose
   Lopez, Luis Fernandez
   Coelho, Giovanini
   Wilder-Smith, Annelies
   Burattini, Marcelo Nascimento
TI The risk of urban yellow fever resurgence in Aedes-infested American
   cities
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Aedes aegypti; dengue; mathematical models; risk; yellow fever
ID RIO-DE-JANEIRO; DENGUE; VIRUS; VISITORS; OUTBREAK; AEGYPTI; SPREAD
AB Aedes aegypti, historically known as yellow fever (YF) mosquito, transmits a great number of other viruses such as Dengue, West Nile, Chikungunya, Zika, Mayaro and perhaps Oropouche, among others. Well established in Africa and Asia, Aedes mosquitoes are now increasingly invading large parts of the American continent, and hence the risk of urban YF resurgence in the American cities should because of great concern to public health authorities. Although no new urban cycle of YF was reported in the Americas since the end of an Aedes eradication programme in the late 1950s, the high number of non-vaccinated individuals that visit endemic areas, that is, South American jungles where the sylvatic cycle of YF is transmitted by canopy mosquitoes, and return to Aedes-infested urban areas, increases the risk of resurgence of the urban cycle of YF. We present a method to estimate the risk of urban YF resurgence in dengue-endemic cities. This method consists in (1) to estimate the number of Aedes mosquitoes that explains a given dengue outbreak in a given region; (2) calculate the force of infection caused by the introduction of one infective individual per unit area in the endemic area under study; (3) using the above estimates, calculate the probability of at least one autochthonous YF case per unit area produced by one single viraemic traveller per unit area arriving from a YF endemic or epidemic sylvatic region at the city studied. We demonstrate that, provided the relative vector competence, here defined as the capacity to being infected and disseminate the virus, of Ae. aegypti is greater than 0.7 (with respect to dengue), one infected traveller can introduce urban YF in a dengue endemic area.
C1 [Massad, Eduardo; Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Burattini, Marcelo Nascimento] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo; Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo] Univ Derby, Coll Life & Nat Sci, Derby, England.
   [Massad, Eduardo; Struchiner, Claudio Jose] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programme Sci Computat, Rio De Janeiro, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, Ctr Internet Augmented Res & Assessment, Miami, FL 33199 USA.
   [Coelho, Giovanini] CHA VT PAHO WHO, Neglected Trop & Vector Borne Dis Program, Washington, DC USA.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Escola Paulista Med, Hosp Sao Paulo, Sao Paulo, SP, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Massad, E (corresponding author), Univ Derby, Coll Life & Nat Sci, Derby, England.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012; Struchiner,
   Claudio J/M-9360-2013; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Lopez, Luis
   F/0000-0003-4097-6887; Struchiner, Claudio J/0000-0003-2114-847X; Amaku,
   Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [LIM01-HCFMUSP]; Brazilian Ministry of Health [777588/2012]; ZikaPLAN
   through the European Union [734584]; Canadian Institutes of Health
   Research (CIHR)Canadian Institutes of Health Research (CIHR) [372512]
FX This work has been funded by LIM01-HCFMUSP, CNPq, by the Brazilian
   Ministry of Health (grant #777588/2012), by ZikaPLAN through the
   European Union's Horizon 2020 research and innovation programme under
   grant agreement No. 734584, and the Canadian Institutes of Health
   Research (CIHR), consortium Canada-Latin/America-Caribean Zika Virus
   Program (Grant no. 372512). Data used in this paper are available at
   http://portalsinan.saude.gov.br/dengue, accessed in January 2017.
CR Amaku M, 2016, EPIDEMIOLOGY INFECT, V19, P1
   Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   Bailey NT, 2006, ELEMENTS STOCHASTIC
   Bryan CS, 2004, INFECT DIS CLIN N AM, V18, P275, DOI 10.1016/j.idc.2004.01.007
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CDC, 2016, ZIK VIR POT RANG US
   Chernick M., 2008, BOOTSTRAP METHODS GU
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   Magalhaes R. C. S, 2016, ERRADICACAO AEDES AE
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   PAHO, EP UPD YELL FEV
   Strode WK, 1951, YELLOW FEVER
   WHO, YELL FEV ANG
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 25
TC 9
Z9 9
U1 0
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2018
VL 146
IS 10
BP 1219
EP 1225
DI 10.1017/S0950268818001334
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GO3YN
UT WOS:000439936400003
PM 29843824
OA Bronze, Green Accepted
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Massad, E
AF Wilder-Smith, A.
   Massad, E.
TI Estimating the number of unvaccinated Chinese workers against yellow
   fever in Angola
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Yellow fever; International health regulations; Air travel; Importation;
   Proof of yellow fever vaccination; Angola; Chinese
AB Background: A yellow fever epidemic occurred in Angola in 2016 with 884 laboratory confirmed cases and 373 deaths. Eleven unvaccinated Chinese nationals working in Angola were also infected and imported the disease to China, thereby presenting the first importation of yellow fever into Asia. In Angola, there are about 259,000 Chinese foreign workers. The fact that 11 unvaccinated Chinese workers acquired yellow fever suggests that many more Chinese workers in Angola were not vaccinated.
   Methods: We applied a previously developed model to back-calculate the number of unvaccinated Chinese workers in Angola in order to determine the extent of lack of vaccine coverage.
   Results: Our models suggest that none of the 259,000 Chinese had been vaccinated, although yellow fever vaccination is mandated by the International Health Regulations.
   Conclusion: Governments around the world including China need to ensure that their citizens obtain YF vaccination when traveling to countries where such vaccines are required in order to prevent the international spread of yellow fever.
C1 [Wilder-Smith, A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, A.] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, A.] London Sch Trop Med & Hyg, London, England.
   [Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, E.] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, E.] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
RP Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.; Wilder-Smith, A (corresponding author), London Sch Trop Med & Hyg, London, England.
EM anneliesws@gmail.com
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Hardiman M, 2007, J TRAVEL MED, V14, P141, DOI 10.1111/j.1708-8305.2007.00117.x
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Wang G, 2014, SE ASIAN J TROP MED, V45, P290
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   World Bank, 2015, WORLD DEV IND
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
NR 12
TC 12
Z9 12
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 17
PY 2018
VL 18
AR 185
DI 10.1186/s12879-018-3084-y
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA GE2OG
UT WOS:000431053900006
PM 29665797
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   dos Santos, PCC
   da Rocha, AF
   Stupple, EJN
AF Massad, Eduardo
   Costa dos Santos, Paulo Cesar
   da Rocha, Armando Freitas
   Stupple, Edward J. N.
TI The Monty Hall problem revisited: Autonomic arousal in an inverted
   version of the game
SO PLOS ONE
LA English
DT Article
ID DECISION-MAKING; LOSS AVERSION; LOSSES; GAINS
AB The asymmetry of autonomic arousal for potential losses and gains was assessed by the galvanic skin response (GSR) of participants playing classic and inverted versions of the Monty Hall problem (MHP). In both versions, the prize remained the same (a pen valued at 10 pound for the right answer), but in the modified version, prizes were received prior to choosing the door. Both experimental groups showed increased levels of GSR while completing the task, demonstrating increased autonomic arousal during the game. However, a robust difference in GSR was detected between classic and inverted versions of the MHP, thus demonstrating the differing autonomic arousal involved in deciding between the alternatives presented by the game. Participants experienced a stronger autonomic response when they could lose the prize than when they could win the prize. This experiment presents the first demonstration of this effect on the MHP. The stronger autonomic arousal for the inverted task may indicate a stronger emotional reaction and/or greater attentional focus than for the standard version of the task. These data demonstrate that potential losses increase arousal in more complex tasks than is typically shown.
C1 [Massad, Eduardo; Costa dos Santos, Paulo Cesar; da Rocha, Armando Freitas] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo; Stupple, Edward J. N.] Univ Derby, Coll Life & Nat Sci, Derby, England.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Costa dos Santos, Paulo Cesar] Univ Paulista, Sao Paulo, Brazil.
   [Costa dos Santos, Paulo Cesar] Univ Sao Paulo, Inst Adv Studies, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Massad, E (corresponding author), Univ Derby, Coll Life & Nat Sci, Derby, England.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Stupple, Edward J N/H-2925-2016
OI Massad, Eduardo/0000-0002-7200-2916; Stupple, Edward J
   N/0000-0001-8545-9504
CR Atkinson K.E., 1989, INTRO NUMERICAL ANAL
   Baumeister R. F., 2001, REV GEN PSYCHOL, V5, P323, DOI DOI 10.1037/1089-2680.5.4.323
   Bland M., 2000, INTRO MED STAT
   Burns BD, 2004, J EXP PSYCHOL GEN, V133, P434, DOI 10.1037/0096-3445.133.3.434
   Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007
   De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008
   Gardner M., 1959, SCI AM, V201, P174
   Gokay R, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON MULTISENSOR FUSION AND INTEGRATION FOR INTELLIGENT SYSTEMS (MFI), P178, DOI 10.1109/MFI.2015.7295805
   GRANBERG D, 1995, PERS SOC PSYCHOL B, V21, P711
   Hochman G, 2014, J ECON BEHAV ORGAN, V107, P582, DOI 10.1016/j.jebo.2014.01.014
   Hochman G, 2011, J BEHAV DECIS MAKING, V24, P140, DOI 10.1002/bdm.692
   KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193
   Krauss S, 2003, J EXP PSYCHOL GEN, V132, P3, DOI 10.1037/0096-3445.132.1.3
   LeDoux J. E., 2015, ANXIOUS MODERN MIND
   Lejarraga T, 2017, PSYCHON B REV, V24, P708, DOI 10.3758/s13423-016-1158-7
   Lwa nga S.K., 1991, SAMPLE SIZE DETERMIN
   Oviatt S., 2006, P 14 ANN ACM INT C M, P871, DOI DOI 10.1145/1180639.1180831
   Page SE, 1998, ECON LETT, V61, P175, DOI 10.1016/S0165-1765(98)00158-X
   Piattelli-Palmarini M., 1991, BOSTONIA         MAR, P28
   Rick S, 2011, J CONSUM PSYCHOL, V21, P453, DOI 10.1016/j.jcps.2010.04.004
   Rosenhouse J., 2009, MONTY HALL PROBLEM
   THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7
   Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239
   Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383
   Yechiam E, 2014, PSYCHOL SCI, V25, P494, DOI 10.1177/0956797613510725
   Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383
NR 26
TC 0
Z9 0
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2018
VL 13
IS 3
AR e0192542
DI 10.1371/journal.pone.0192542
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA5DH
UT WOS:000428351800005
PM 29579122
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Amaku, M
   Coutinho, FAB
   Struchiner, CJ
   Burattini, MN
   Khan, K
   Liu-Helmersson, J
   Rocklov, J
   Kraemer, MUG
   Wilder-Smith, A
AF Massad, Eduardo
   Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Struchiner, Claudio Jose
   Burattini, Marcelo Nascimento
   Khan, Kamran
   Liu-Helmersson, Jing
   Rocklov, Joacim
   Kraemer, Moritz U. G.
   Wilder-Smith, Annelies
TI Estimating the probability of dengue virus introduction and secondary
   autochthonous cases in Europe
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RIO-DE-JANEIRO; TEMPERATURE-FLUCTUATIONS; AEDES-ALBOPICTUS; FOREIGN
   VISITORS; OLYMPIC GAMES; IMPORTATIONS; OUTBREAK; SPREAD; TRAVEL; RISK
AB Given the speed of air travel, diseases even with a short viremia such as dengue can be easily exported to dengue naive areas within 24 hours. We set out to estimate the risk of dengue virus introductions via travelers into Europe and number of secondary autochthonous cases as a result of the introduction. We applied mathematical modeling to estimate the number of dengue-viremic air passengers from 16 dengue-endemic countries to 27 European countries, taking into account the incidence of dengue in the exporting countries, travel volume and the probability of being viremic at the time of travel. Our models estimate a range from zero to 167 air passengers who are dengue-viremic at the time of travel from dengue endemic countries to each of the 27 receiving countries in one year. Germany receives the highest number of imported dengue-viremic air passengers followed by France and the United Kingdom. Our findings estimate 10 autochthonous secondary asymptomatic and symptomatic dengue infections, caused by the expected 124 infected travelers who arrived in Italy in 2012. The risk of onward transmission in Europe is reassuringly low, except where Aedes aegypti is present.
C1 [Massad, Eduardo; Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Burattini, Marcelo Nascimento] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo] Univ Derby, Coll Nat & Life Sci, Derby, England.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programme Sci Computat, Rio De Janeiro, Brazil.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Liu-Helmersson, Jing; Rocklov, Joacim; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Massad, E (corresponding author), Univ Derby, Coll Nat & Life Sci, Derby, England.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012; Amaku, Marcos/D-5252-2012; Burattini,
   Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011; Struchiner,
   Claudio J/M-9360-2013
OI Massad, Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774;
   Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; Struchiner, Claudio J/0000-0003-2114-847X;
   Rocklov, Joacim/0000-0003-4030-0449; Helmersson,
   Jing/0000-0001-9647-1015
FU HealthTheme of the Seventh Framework Programme of the European Community
   [282589]; project ZikaPLAN - European Union's Horizon research and
   innovation programme [734584]; International Research Consortium on
   Dengue Risk Assessment Management and Surveillance (IDAMS) (European
   Commission) [21803]
FX The study was funded under the HealthTheme of the Seventh Framework
   Programme of the European Community (DengueTools, Grant No. 282589), and
   by the project ZikaPLAN, funded by European Union's Horizon 2020
   research and innovation programme under Grant Agreement No. 734584. MK
   was funded at the time through the International Research Consortium on
   Dengue Risk Assessment Management and Surveillance (IDAMS, Grant No.
   21803, European Commission).
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Hamer DH, 2016, ANN INTERN MED
   Khan K., 2014, PLOS CURRENTS, V6
   Khan K., 2013, PLOS CURRENTS, V5
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Neumayr A, 2017, EURO SURVEILL, V22
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
   Zhou YP, 2014, J TRAVEL MED, V21, P272, DOI 10.1111/jtm.12133
NR 35
TC 21
Z9 21
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 15
PY 2018
VL 8
AR 4629
DI 10.1038/s41598-018-22590-5
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ3DF
UT WOS:000427465800009
PM 29545610
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU de Assis, LME
   Massad, E
   de Assis, RA
   Martorano, SR
   Venturino, E
AF Elias de Assis, Luciana Mafalda
   Massad, Eduardo
   de Assis, Raul Abreu
   Martorano, Silvia R.
   Venturino, Ezio
TI A mathematical model for bovine tuberculosis among buffaloes and lions
   in the Kruger National Park
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article
DE disease transmission; herd behavior
ID HERD BEHAVIOR; GROUP DEFENSE; PREY; ECOEPIDEMICS; WILDLIFE
AB In this paper, a model for the spread of tuberculosis between buffaloes and lions is presented and analyzed. The most important system parameters are identified: vertical and horizontal disease transmission among the buffaloes and the influence of intraspecific competition between healthy and diseased buffaloes on the infected buffaloes population. Removal of diseased prey appears to be the most effective strategy to render the ecosystem disease free.
C1 [Elias de Assis, Luciana Mafalda; de Assis, Raul Abreu] Univ Estado Mato Grosso, Fac Ciencias Exatas & Tecnol, Av Ingas 3001, BR-78555000 Sinop, MG, Brazil.
   [Massad, Eduardo; Martorano, Silvia R.] Univ Sao Paulo, Fac Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
   [Elias de Assis, Luciana Mafalda; Venturino, Ezio] Univ Turin, Dipartimento Matemat Giuseppe Peano, Via Carlo Alberto 10, I-10123 Turin, Italy.
RP de Assis, LME (corresponding author), Univ Estado Mato Grosso, Fac Ciencias Exatas & Tecnol, Av Ingas 3001, BR-78555000 Sinop, MG, Brazil.
EM lucianam@unemat-net.br
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916; Venturino, Ezio/0000-0001-7215-5114
FU UNEMAT; FAPEMAT [005-2015, 204271/2015]; Metodi numerici nelle scienze
   applicate of the Dipartimento di Matematica Giuseppe Peano
FX UNEMAT; FAPEMAT, Grant/Award Number: 005-2015, 204271/2015; Metodi
   numerici nelle scienze applicate of the Dipartimento di Matematica
   Giuseppe Peano
CR Ajrald V, 2009, P INT C CMMSE 2009, V1, P57
   Ajraldi V, 2011, NONLINEAR ANAL-REAL, V12, P2319, DOI 10.1016/j.nonrwa.2011.02.002
   Banerjee M, 2017, MATH MODEL NAT PHENO, V12, P133, DOI 10.1051/mmnp/201712208
   Bengis RG, 1996, ONDERSTEPOORT J VET, V63, P15
   Brauer F., 2008, MATH EPIDEMIOLOGY
   Bulai IM, MATH COMPUT IN PRESS
   Cagliero E, 2016, INT J COMPUT MATH, V93, P108, DOI 10.1080/00207160.2014.988614
   Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266
   El-Sheikh M. M. A., 2004, INT J MATH MATH SCI, V56, P2971
   Gimmelli G, 2015, ECOL COMPLEX, V22, P50, DOI 10.1016/j.ecocom.2015.02.004
   Kooi BW, 2016, MATH BIOSCI, V274, P58, DOI 10.1016/j.mbs.2016.02.003
   Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035
   Miller M, 2015, TUBERCULOSIS S AFRIC
   Naji RK, 2016, J APPL MATH, P16
   Perko L, 2001, DIFFERENTIAL EQUATIO
   Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Venturino E, 2013, ECOL COMPLEX, V14, P37, DOI 10.1016/j.ecocom.2013.01.004
   Venturino E, 2011, J BIOL SYST, V19, P763, DOI 10.1142/S0218339011004184
   Zhou XY, 2011, NONLINEAR DYNAM, V63, P639, DOI 10.1007/s11071-010-9826-z
NR 20
TC 1
Z9 1
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
PD JAN 30
PY 2018
VL 41
IS 2
BP 525
EP 543
DI 10.1002/mma.4568
PG 19
WC Mathematics, Applied
SC Mathematics
GA FZ1EI
UT WOS:000427318700008
DA 2020-12-16
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Armstrong, M
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Armstrong, Margaret
   Massad, Eduardo
TI A Note on the Risk of Infections Invading Unaffected Regions
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID TRAVEL; STRATEGIES; EPIDEMIC; MODELS; VIRUS; ZIKA
AB We present two probabilistic models to estimate the risk of introducing infectious diseases into previously unaffected countries/regions by infective travellers. We analyse two distinct situations, one dealing with a directly transmitted infection (measles in Italy in 2017) and one dealing with a vector-borne infection (Zika virus in Rio de Janeiro, which may happen in the future). To calculate the risk in the first scenario, we used a simple, nonhomogeneous birth process. The second model proposed in this paper provides a way to calculate the probability that local mosquitoes become infected by the arrival of a single infective traveller during his/her infectiousness period. The result of the risk ofmeasles invasion of Italy was of 93% and the result of the risk of Zika virus invasion of Rio de Janeiro was of 22%.
C1 [Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Armstrong, Margaret; Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Univ Derby, Coll Nat & Life Sci, Derby, England.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Amaku, M (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
EM amaku@usp.br
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [LIM01-HCFMUSP]; Brazilian Ministry of Health [777588/2012]; ZikaPLAN
   through the European Union's Horizon 2020 Research and Innovation
   Programme [734584]; Canadian Institutes of Health Research (CIHR),
   Consortium Canada-Latin/America-Caribean Zika Virus ProgramCanadian
   Institutes of Health Research (CIHR) [372512]
FX This work has been funded by LIM01-HCFMUSP, CNPq, by the Brazilian
   Ministry of Health (Grant no. 777588/2012), by ZikaPLAN through the
   European Union's Horizon 2020 Research and Innovation Programme (Grant
   no. 734584), and the Canadian Institutes of Health Research (CIHR),
   Consortium Canada-Latin/America-Caribean Zika Virus Program (Grant no.
   372512).
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   ANDERSON R M, 1991
   Bailey NT, 2006, ELEMENTS STOCHASTIC
   Bossak BH, 2009, MED HYPOTHESES, V72, P749, DOI 10.1016/j.mehy.2008.12.045
   Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143
   ECDC, 2018, MEASL EU EEA CURR OU
   European Asylum Support Office(EASO), LAT AS TRENDS
   Gomes M. F. C., 2014, PLOS CURRENTS, DOI [10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5, 10.1371/currents.outbreaks]
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2004, MED HYPOTHESES, V63, P911, DOI 10.1016/j.mehy.2004.03.028
   Massad E, 2007, MED HYPOTHESES, V68, P442, DOI 10.1016/j.mehy.2006.07.041
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2010, MEM I OSWALDO CRUZ, V105, P179, DOI 10.1590/S0074-02762010000200012
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Stannard David E., 1993, P35, DOI 10.1017/CHOL9780521332866.006
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   UNWTO. World, 2018, TOUR ORG NEWS, V9
   van den Broek J, 2007, BIOSTATISTICS, V8, P453, DOI 10.1093/biostatistics/kxl023
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Voice of Europe, 2018, MOR 5 MILL 3 WORLD I
   Wilder-Smith A, 2003, J TRAVEL MED, V10, P257
   Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004
NR 28
TC 1
Z9 1
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2018
AR 6289681
DI 10.1155/2018/6289681
PG 8
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GN2XK
UT WOS:000438865600001
PM 30073032
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Azevedo, F
   Amaku, M
   Coutinho, FAB
   Lopez, LF
   Massad, E
AF Azevedo, Franciane
   Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   Massad, Eduardo
TI The effect of the infection within the individual host on its
   propagation in the population
SO INFECTIOUS DISEASE MODELLING
LA English
DT Article
DE Nested model; Multiscale model; Within-host infection; Between-host
   transmission; Infectious disease
AB We consider nested or multiscale models to study the effect of the temporal evolution of the disease within the host in the population dynamics of the disease, for one and two infectious agents. We assumed a coupling between the within-host infection rate and the between-host transmission rate. The age of infection within each individual in a population affects the probability of transmission of the disease to a susceptible host and this will affect the temporal evolution of the disease in the host population. To analyze the infection within the host, we consider bacterial-like and viral-like infections. In the model for two infectious agents, we found that, when strain 2 has a basic reproduction number R-02 greater than the basic reproduction number R-01 of strain 1, strain 2 replaces strain 1 in the population. However, if R-02 > R-01 but the values are closer, the replacement does not occur immediately and both strains can coexist for a long time. We applied the model to a scenario in which patients infected with the hepatitis C virus (HCV) are cleared of HCV when super-infected with the hepatitis A virus (HAV). We compared the time for the replacement of HCV by HAV in the population considering instantaneous and non-instantaneous replacement within the individuals. The model developed can be generalized for more than two infectious agents. (C) 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Azevedo, Franciane] Univ Fed Sul & Sudeste Para, Fac Engn Computacao & Engn Eletr, Marab a, PA, Brazil.
   [Azevedo, Franciane; Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] Univ Sao Paulo, Fac Med, Av Dr Arnaldo 455, Sao Paulo 01246903, SP, Brazil.
   [Amaku, Marcos] LIM01 HCFMUSP, Av Dr Arnaldo 455, Sao Paulo 01246903, SP, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo 05508270, SP, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Univ Derby, Coll Nat & Life Sci, Derby, England.
RP Azevedo, F (corresponding author), Univ Fed Sul & Sudeste Para, Fac Engn Computacao & Engn Eletr, Marab a, PA, Brazil.
EM franazevedo@unifesspa.edu.br
RI Amaku, Marcos/D-5252-2012
OI Amaku, Marcos/0000-0003-4752-6774
FU CAPESCAPES; LIM-01 HCFMUSP; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CNPqNational Council for Scientific and
   Technological Development (CNPq) [501799/2013-3]
FX The authors thank CAPES, LIM-01 HCFMUSP and FAPESP for partial financial
   support. FA thanks CNPq for financial support through a post doctoral
   fellowship (grant number 501799/2013-3).
CR Amaku M, 2013, B MATH BIOL, V75, P82, DOI 10.1007/s11538-012-9795-0
   Amaku M, 2010, PHYTOPATHOLOGY, V100, P1042, DOI 10.1094/PHYTO-10-09-0289
   Amaku M, 2010, B MATH BIOL, V72, P1294, DOI 10.1007/s11538-009-9495-6
   ANTIA R, 1994, AM NAT, V144, P457, DOI 10.1086/285686
   Apostol TM, 1967, CALCULUS, VI
   Barlow ND, 1997, WILDLIFE RES, V24, P129, DOI 10.1071/WR95027
   BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102
   Britton N.F., 2003, ESSENTIAL MATH BIOL
   Burattini M. N., 2008, BIOSCI HYPOTHESES, V1, P168, DOI DOI 10.1016/J.BIHY.2008.05.003
   Coombs D, 2007, THEOR POPUL BIOL, V72, P576, DOI 10.1016/j.tpb.2007.08.005
   Deterding K, 2006, J HEPATOL, V45, P770, DOI 10.1016/j.jhep.2006.07.023
   Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007
   Gilchrist MA, 2006, THEOR POPUL BIOL, V69, P145, DOI 10.1016/j.tpb.2005.07.002
   Gilchrist MA, 2002, J THEOR BIOL, V218, P289, DOI 10.1006/jtbi.2002.3076
   Handel A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0302
   Ianelli M., 1994, MATH THEORY AGE STRU
   Lion S, 2013, J EVOLUTION BIOL, V26, P2107, DOI 10.1111/jeb.12207
   Magal P, 2010, APPL ANAL, V89, P1109, DOI 10.1080/00036810903208122
   MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138
   Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009
   Murillo LN, 2013, J THEOR BIOL, V332, P267, DOI 10.1016/j.jtbi.2013.03.024
   Nowak MA, 2004, VIRUS DYNAMICS MATH
   Park M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0333
   Scholle SO, 2013, AM NAT, V182, P494, DOI 10.1086/672000
   Shen MW, 2015, MATH BIOSCI, V263, P37, DOI 10.1016/j.mbs.2015.02.003
   Sofonea MT, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0303
NR 26
TC 0
Z9 0
U1 0
U2 0
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2468-0427
J9 INFECT DIS MODEL
JI Infect. Dis. Model.
PY 2018
VL 3
BP 345
EP 361
DI 10.1016/j.idm.2018.11.002
PG 17
WC Mathematical & Computational Biology; Infectious Diseases
SC Mathematical & Computational Biology; Infectious Diseases
GA VJ0TG
UT WOS:000528697600025
PM 30839922
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Preet, R
   Renhorn, KE
   Ximenes, RA
   Rodrigues, LC
   Solomon, T
   Neyts, J
   Lambrechts, L
   Willison, HJ
   Peeling, R
   Falconar, AK
   Precioso, AR
   Logan, J
   Lang, T
   Endtz, HP
   Massad, E
AF Wilder-Smith, A.
   Preet, R.
   Renhorn, K. E.
   Ximenes, R. A.
   Rodrigues, L. C.
   Solomon, T.
   Neyts, J.
   Lambrechts, L.
   Willison, H. J.
   Peeling, R.
   Falconar, A. K.
   Precioso, A. R.
   Logan, J.
   Lang, T.
   Endtz, H. P.
   Massad, E.
TI ZikaPLAN: Zika Preparedness Latin American Network
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika; congenital Zika syndrome; public health emergency; epidemic
   preparedness; research capacity building network; collaboration;
   European Commission
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; DENGUE VIRUS; INFANTS; BRAZIL;
   RISK; IMPORTATIONS; OUTBREAK
AB The ongoing Zika virus (ZIKV) outbreak in Latin America, the Caribbean, and the Pacific Islands has underlined the need for a coordinated research network across the whole region that can respond rapidly to address the current knowledge gaps in Zika and enhance research preparedness beyond Zika. The European Union under its Horizon 2020 Research and Innovation Programme awarded three research consortia to respond to this need. Here we present the ZikaPLAN (Zika Preparedness Latin American Network) consortium. ZikaPLAN combines the strengths of 25 partners in Latin America, North America, Africa, Asia, and various centers in Europe. We will conduct clinical studies to estimate the risk and further define the full spectrum and risk factors of congenital Zika virus syndrome (including neurodevelopmental milestones in the first 3 years of life), delineate neurological complications associated with ZIKV due to direct neuroinvasion and immune-mediated responses in older children and adults, and strengthen surveillance for birth defects and Guillain-Barre Syndrome. Laboratory-based research to unravel neurotropism and investigate the role of sexual transmission, determinants of severe disease, and viral fitness will underpin the clinical studies. Social messaging and engagement with affected communities, as well as development of wearable repellent technologies against Aedes mosquitoes will enhance the impact. Burden of disease studies, data-driven vector control, and vaccine modeling as well as risk assessments on geographic spread of ZIKV will form the foundation for evidence-informed policies. While addressing the research gaps around ZIKV, we will engage in capacity building in laboratory and clinical research, collaborate with existing and new networks to share knowledge, and work with international organizations to tackle regulatory and other bottlenecks and refine research priorities. In this way, we can leverage the ZIKV response toward building a long-term emerging infectious diseases response capacity in the region to address future challenges.
C1 [Wilder-Smith, A.; Preet, R.; Renhorn, K. E.] Umea Univ, Dept Publ Hlth & Clin Med, Unit Epidemiol & Global Hlth, Umea, Sweden.
   [Ximenes, R. A.; Rodrigues, L. C.] Univ Pernambuco, Inst Apoio Fundacao, Recife, PE, Brazil.
   [Rodrigues, L. C.; Peeling, R.; Falconar, A. K.; Logan, J.] London Sch Hyg & Trop Med, London, England.
   [Solomon, T.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Neyts, J.] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium.
   [Lambrechts, L.] Inst Pasteur, CNRS, Insect Virus Interact Grp, Dept Genomes & Genet,Unite Rech Associee 3012, Paris 15, France.
   [Willison, H. J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Falconar, A. K.] Fdn Univ Norte, Dept Med, Barranquilla, Colombia.
   [Precioso, A. R.] Inst Butantan, Sao Paulo, SP, Brazil.
   [Logan, J.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Endtz, H. P.] Fdn Merieux, Lyon, France.
   [Endtz, H. P.] Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Massad, E.] Univ Sao Paulo, Fundacao Apoio, Sao Paulo, Brazil.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Unit Epidemiol & Global Hlth, Umea, Sweden.
EM awilder-smith@ntu.edu.sg
RI Massad, Eduardo/B-1169-2012; Lambrechts, Louis/ABF-2520-2020; Precioso,
   Alexander Roberto/A-9712-2013; Neyts, Johan/U-8267-2017
OI Massad, Eduardo/0000-0002-7200-2916; Lambrechts,
   Louis/0000-0001-5958-2138; Precioso, Alexander
   Roberto/0000-0001-8657-9292; Neyts, Johan/0000-0002-0033-7514; Preet,
   Raman Kaur/0000-0002-4371-5941; Renhorn, Karl-Erik/0000-0003-1855-8902;
   Solomon, Tom/0000-0001-7266-6547; Willison, Hugh/0000-0002-5997-1683
FU European Union's Horizon research and innovation programme [734584];
   Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15096,
   G116/194] Funding Source: researchfish; National Institute for Health
   ResearchNational Institute for Health Research (NIHR) [EME/12/205/28,
   RP-PG-0108-10048, 12/205/28, NF-SI-0514-10177] Funding Source:
   researchfish
FX The project, ZikaPLAN, is funded by European Union's Horizon 2020
   research and innovation programme under Grant Agreement No. 734584.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Vieira MADES, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759022, 10.1590/s1678-9946201759022]
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   de Sa TH, 2016, LANCET GLOB HEALTH, V4, pE603, DOI 10.1016/S2214-109X(16)30174-7
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Furtado T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003225
   Lang T, 2015, NATURE, V524, P29, DOI 10.1038/524029a
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2016, LANCET, V388, P658, DOI 10.1016/S0140-6736(16)31228-4
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Wilder-Smith A, 2012, GLOB HLTH ACTION, V5
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 32
TC 15
Z9 15
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD DEC 13
PY 2017
VL 10
IS 1
AR 1398485
DI 10.1080/16549716.2017.1398485
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FS3BL
UT WOS:000419653800001
PM 29235414
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Amaku, M
   Burattini, MN
   Chaib, E
   Coutinho, FAB
   Greenhalgh, D
   Lopez, LF
   Massad, E
AF Amaku, Marcos
   Burattini, Marcelo Nascimento
   Chaib, Eleazar
   Bezerra Coutinho, Francisco Antonio
   Greenhalgh, David
   Lopez, Luis Fernandez
   Massad, Eduardo
TI Estimating the prevalence of infectious diseases from under-reported
   age-dependent compulsorily notification databases
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Hepatitis C; Mathematical models; Notifications system incidence;
   Prevalence
ID UNITED-STATES; COMPLETENESS; SURVEILLANCE
AB Background: National or local laws, norms or regulations (sometimes and in some countries) require medical providers to report notifiable diseases to public health authorities. Reporting, however, is almost always incomplete. This is due to a variety of reasons, ranging from not recognizing the diseased to failures in the technical or administrative steps leading to the final official register in the disease notification system. The reported fraction varies from 9 to 99% and is strongly associated with the disease being reported.
   Methods: In this paper we propose a method to approximately estimate the full prevalence (and any other variable or parameter related to transmission intensity) of infectious diseases. The model assumes incomplete notification of incidence and allows the estimation of the non-notified number of infections and it is illustrated by the case of hepatitis C in Brazil. The method has the advantage that it can be corrected iteratively by comparing its findings with empirical results.
   Results: The application of the model for the case of hepatitis C in Brazil resulted in a prevalence of notified cases that varied between 163,902 and 169,382 cases; a prevalence of non-notified cases that varied between 1,433,638 and 1,446,771; and a total prevalence of infections that varied between 1,597,540 and 1,616,153 cases.
   Conclusions: We conclude that the model proposed can be useful for estimation of the actual magnitude of endemic states of infectious diseases, particularly for those where the number of notified cases is only the tip of the iceberg. In addition, the method can be applied to other situations, such as the well-known underreported incidence of criminality (for example rape), among others.
C1 [Amaku, Marcos; Burattini, Marcelo Nascimento; Chaib, Eleazar; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] Univ Sao Paulo, Fac Med, Hosp Clin LIM01, Sao Paulo, SP, Brazil.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Greenhalgh, David] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland.
   [Lopez, Luis Fernandez] Florida Int Univ, Ctr Internet Augmented Res & Assessment, Miami, FL 33199 USA.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin LIM01, Sao Paulo, SP, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.
EM edmassad@dim.fm.usp.br
RI Lopez, Luis F/C-4721-2012; Burattini, Marcelo N/J-9272-2014; Coutinho,
   Francisco A B/H-5644-2011; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012
OI Lopez, Luis F/0000-0003-4097-6887; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
FU LIM01-HCFMUSP; CNPqNational Council for Scientific and Technological
   Development (CNPq); Brazilian Ministry of Health [TED 27/2015];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   Leverhulme Trust from a Leverhulme Research Fellowship [RF-2015-88];
   British Council, Malaysia from the Dengue Tech Challenge [DTC 16022];
   Science Without Borders Program for a Special Visiting Fellowship (CNPq)
   [30098/2014-7]
FX This work was partially funded by LIM01-HCFMUSP, CNPq, Brazilian
   Ministry of Health (Grant TED 27/2015) and FAPESP. DG is grateful to the
   Leverhulme Trust for support from a Leverhulme Research Fellowship
   (RF-2015-88) and the British Council, Malaysia for funding from the
   Dengue Tech Challenge (Application Reference DTC 16022). EM and DG are
   grateful to the Science Without Borders Program for a Special Visiting
   Fellowship (CNPq grant 30098/2014-7).
CR Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Amaku M, 2016, B MATH BIOL, V78, P970, DOI 10.1007/s11538-016-0170-4
   American Liver Foundation, PROGR LIV DIS
   Brabazon ED, 2008, EPIDEMIOL INFECT, V136, P241, DOI 10.1017/S0950268807008230
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2014, J TRANSPLANT, V2014, DOI 10.1155/2014/219789
   Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866
   Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147
   Gibney KB, 2016, EPIDEMIOL INFECT, V144, P3263, DOI 10.1017/S0950268816001072
   Keramarou M, 2012, J INFECTION, V64, P555, DOI 10.1016/j.jinf.2012.03.005
   KONOWITZ PM, 1984, PUBLIC HEALTH REP, V99, P31
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Mann Jonathan, 1996, Health Hum Rights, V2, P1, DOI 10.2307/4065231
   MMWR - Summary of notifiable diseases United States, 1998, MMWR-MORBID MORTAL W, V47, P92
   NHS Choices, HEP C
   Roberts EA, 2002, HEPATOLOGY, V36, pS106, DOI 10.1053/jhep.2002.36792
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170
   ROSENBERG ML, 1977, J INFECT DIS, V136, P458, DOI 10.1093/infdis/136.3.458
   Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164
   Rowe SL, 2016, AUST NZ J PUBL HEAL, V40, P148, DOI 10.1111/1753-6405.12434
   Schiffman EK, 2016, UNDER REPORTING LYME
   Serra I, 1999, REV MED CHILE, V127, P485
   THACKER SB, 1983, JAMA-J AM MED ASSOC, V249, P1181
   TRUCCO E, 1965, B MATH BIOPHYS, V27, P285, DOI 10.1007/BF02478406
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 25
TC 2
Z9 2
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD DEC 12
PY 2017
VL 14
AR 23
DI 10.1186/s12976-017-0069-2
PG 18
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA FP8CO
UT WOS:000417868000001
PM 29228966
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Maier, SB
   Huang, X
   Massad, E
   Amaku, M
   Burattini, MN
   Greenhalgh, D
AF Maier, Sandra B.
   Huang, Xiao
   Massad, Eduardo
   Amaku, Marcos
   Burattini, Marcelo N.
   Greenhalgh, David
TI Analysis of the optimal vaccination age for dengue in Brazil with a
   tetravalent dengue vaccine
SO MATHEMATICAL BIOSCIENCES
LA English
DT Article
DE Dengue; Vaccination; Optimal vaccination age; Age-structured model;
   Serotype; Risk function; Mortality; Hospitalisation; Mathematical model
ID ANTIBODY-DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; TRANSMISSION
   DYNAMICS; YELLOW-FEVER; SAO-PAULO; RISK; DISEASE; PERSISTENCE;
   SEROTYPES; INFECTION
AB In this paper we study a mathematical model to analyse the optimal vaccination age against Dengue in Brazil. Data from Brazil are used to estimate the basic reproduction numbers for each of the four Dengue serotypes and then the optimal vaccination age is calculated using a method due to Hethcote [1]. The vaccine has different efficacies against each serotype. Vaccination that is too early is ineffective as individuals are protected by maternal antibodies but leaving vaccination until later may allow the disease to spread.
   First of all the optimal vaccination ages ate calculated where there is just one serotype in circulation and then when there are multiple serotypes. The calculations are done using data both assuming constant vaccine efficacy and age-dependent vaccine efficacy against a given serotype. The multiple serotype calculations are repeated assuming that the first infection is a risky infection and that it is not (to model Dengue Antibody Enhancement). The calculations are then repeated when any third or fourth Dengue infections are asymptomatic, so that two Dengue infections with different serotypes provide effective permanent immunity. The calculations are also repeated when the age-dependent risk function (fitted to Brazilian data) is hospitalisation from Dengue and when it is mortality due to Dengue. We find a wide variety of optimal vaccination ages depending on both the serotypes in circulation and the assumptions of the model. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Maier, Sandra B.; Huang, Xiao; Greenhalgh, David] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
   [Massad, Eduardo; Amaku, Marcos; Burattini, Marcelo N.] Univ Sao Paulo, LIM01 Hosp Clin, Fac Med, Sao Paulo, SP, Brazil.
   [Burattini, Marcelo N.] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
RP Greenhalgh, D (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
EM david.greenhalgh@strath.ac.uk
RI Amaku, Marcos/D-5252-2012; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916
FU University of Strathclyde; Leverhulme TrustLeverhulme Trust
   [RF-2015-88]; British Council Malaysia from the Dengue Tech Challenge
   [DTC 16022]; Science Without Borders Program (CNPq) [30098/2014/7]
FX DG and SM are grateful to the University of Strathclyde for support for
   a Ph.D. studentship. DG is grateful to the Leverhulme Trust for support
   from a Leverhulme Fellowship (RF-2015-88) and the British Council
   Malaysia for funding from the Dengue Tech Challenge (Application
   reference DTC 16022). EM and DG are grateful to the Science Without
   Borders Program for a Special Visiting Fellowship (CNPq grant
   30098/2014/7).
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   Amaku M, 2012, REV INST MED TROP SP, V54, pS18, DOI 10.1590/S0036-46652012000700008
   ANDERSON R M, 1991
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Billings L, 2008, MATH BIOSCI, V211, P265, DOI 10.1016/j.mbs.2007.08.004
   Burattini M.N., 2017, COMMUNICATION
   Burattini MN, 2016, CLINICS, V71, P455, DOI 10.6061/clinics/2016(08)08
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244
   Derouich M, 2006, APPL MATH COMPUT, V177, P528, DOI 10.1016/j.amc.2005.11.031
   Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Esteva L, 2003, J MATH BIOL, V46, P31, DOI 10.1007/s00285-002-0168-4
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Flasche S., 2016, COMP MODELLING DENGU
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Friedrich MJ, 2016, JAMA-J AM MED ASSOC, V315, P242, DOI 10.1001/jama.2015.18460
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2016, AM J TROP MED HYG, V95, P741, DOI 10.4269/ajtmh.16-0222
   Halstead SB, 2016, TRAVEL MED INFECT DI, V14, P378, DOI 10.1016/j.tmaid.2016.06.005
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   Knipl D, 2015, B MATH BIOL, V77, P2212, DOI 10.1007/s11538-015-0120-6
   MACDONALD G, 1957, EPIDEMIOLOGY CONTROL
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Supriatna AK, 2008, MATH BIOSCI, V216, P114, DOI 10.1016/j.mbs.2008.08.011
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
   WHO, 2012, GLOB STRAT DENG PREV
   World Health Organization, 2016, SUMM APR 2016 M STRA
   Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5
NR 51
TC 9
Z9 9
U1 1
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-5564
EI 1879-3134
J9 MATH BIOSCI
JI Math. Biosci.
PD DEC
PY 2017
VL 294
BP 15
EP 32
DI 10.1016/j.mbs.2017.09.004
PG 18
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FR9SU
UT WOS:000419414200002
PM 28935561
OA Green Accepted
DA 2020-12-16
ER

PT J
AU Garcia, MK
   Rizzo, L
   Yazbek, P
   Yutiyama, D
   da Silva, FJ
   Matheus, D
   Mastrocolla, LE
   Massad, E
AF Garcia, Mauricio Koprowski
   Rizzo, Limanara
   Yazbek-Junior, Paulo
   Yutiyama, Daniela
   da Silva, Fabiola Jomar
   Matheus, Denise
   Mastrocolla, Luiz Eduardo
   Massad, Eduardo
TI Cardiorespiratory performance of coronary artery disease patients on
   land versus underwater treadmill tests: a comparative study
SO CLINICS
LA English
DT Article
DE Cardiopulmonary Stress Test; Immersion; Individual Capability; Exercise
ID CENTRAL VENOUS-PRESSURE; OUT WATER IMMERSION; HEMODYNAMIC-CHANGES;
   HEART-VOLUME; EXERCISE; HUMANS
AB OBJECTIVE: To compare responses to a cardiopulmonary exercise test on land versus on an underwater treadmill, to assess the cardiorespiratory performance of coronary artery disease patients while immersed in warm water and to compare with the performance of healthy individuals.
   METHODS: The sample population consisted of 40 subjects, which included 20 coronary artery disease patients aged 63.7 +/- 8.89 years old, functional class I and II, according to the New York Hearth Association, and 20 healthy subjects aged 64.7 +/- 7.09 years old. The statistical significances were calculated through an ANOVA test with a (1 - beta) power of 0.861. ClinicalTrials.gov: NCT00989248 (22).
   RESULTS: Significant differences were uncovered in coronary artery disease group regarding the variables heart beats (HB), (p>0.01), oxygen consumption (VO2), (p>0.01) and carbon dioxide production (VCO2) (p<0.01). Also, for the same group, in relation to the environment, water versus on land for HB, VO2, VCO2 and oxygen for each heart beat (VO2/HB) all of than (p<0.01). The stages for data collected featured the subject's performance throughout the experiment, and within the given context, variables rating of perceived exertion (RPE), HB, VO2, VCO2 and VO2/HB (p<0.01) showed significant interactions between test stages and environment. Additionally, there was a significant interaction between the etiology and the test stages for the variables HB, VO2 and VCO2 (p<0.01). Electrocardiographic changes compatible with myocardial ischemia or arrhythmia were not observed. The subjects exhibited lower scores on Borg's perceived exertion scale in the water than at every one of the test stages on land (p<0.01).
   CONCLUSION: This study show that a cardiopulmonary exercise test can be safely conducted in subjects in immersion and that the procedures, resources and equipment used yielded replicable and reliable data. Significant differences observed in water versus on land allow us to conclude that coronary artery disease patients are able to do physical exercise in water and that the physiological effects of immersion do not present any risk for such patients, as exercise was well tolerated by all subjects.
C1 [Garcia, Mauricio Koprowski; Yazbek-Junior, Paulo; Yutiyama, Daniela; da Silva, Fabiola Jomar; Matheus, Denise] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Med Reabil, Sao Paulo, SP, Brazil.
   [Rizzo, Limanara; Massad, Eduardo] Univ Sao Paulo, Fac Med FMUSP, Dept Med Legal & Et Med, Sao Paulo, SP, Brazil.
   [Mastrocolla, Luiz Eduardo] Inst Cardiol Dante Pazzanase, Sao Paulo, SP, Brazil.
RP Garcia, MK (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Med Reabil, Sao Paulo, SP, Brazil.
EM mauriciokg@usp.br
RI Garcia, Mauricio/G-6252-2011; Massad, Eduardo/B-1169-2012
OI Garcia, Mauricio/0000-0003-0807-7048; Massad,
   Eduardo/0000-0002-7200-2916
FU Institute of Rehabilitation Medicine; Clinics Hospital - School of
   Medicine University of Sao Paulo [LIM 01]; Dante Pazzanese Institute of
   Cardiology, Sao Paulo, Brazil; CNPqNational Council for Scientific and
   Technological Development (CNPq) [LIM01-HCFMUSP]; Institute of
   Rehabilitation and Medicine Clinics Hospital - School of Medicine -
   University of Sao Paulo
FX We gratefully acknowledge the support provided by the Institute of
   Rehabilitation Medicine and LIM 01 - Clinics Hospital - School of
   Medicine University of Sao Paulo and Dante Pazzanese Institute of
   Cardiology, Sao Paulo, Brazil. This work was partially supported by
   grants provided by LIM01-HCFMUSP, CNPq, Institute of Rehabilitation and
   Medicine Clinics Hospital - School of Medicine - University of Sao
   Paulo.
CR ARBORELIUS M, 1972, AEROSPACE MED, V43, P592
   Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69
   Becker BE, 2005, PHYS MED REHABILITAT, P479
   Brandao MR, 1989, REV BRASILEIRA CIENC, V3, P34
   BRUCE RA, 1949, J CLIN INVEST, V28, P1431, DOI 10.1172/JCI102208
   CHRISTIE JL, 1990, J APPL PHYSIOL, V69, P657
   Cider A, 2005, CLIN PHYSIOL FUNCT I, V25, P313, DOI 10.1111/j.1475-097X.2005.00633.x
   CRAIG AB, 1967, J APPL PHYSIOL, V23, P423
   Craig ABJ, 1969, MED SCI SPORTS, V1, P124
   Criteria Committee of the New York Heart Association, 1994, NOM CRIT DIAGN DIS H, P253, DOI DOI 10.3378/027.083.0506
   EPSTEIN M, 1992, PHYSIOL REV, V72, P563
   GABRIELSEN A, 1993, J APPL PHYSIOL, V75, P581
   Gleim GW, 1998, AM J SPORTS MED, V17, P248
   GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823
   Hall J, 1998, EUR J APPL PHYSIOL O, V77, P278, DOI 10.1007/s004210050333
   HALL J, 1990, PHYSIOTHERAPY, V76, P517, DOI DOI 10.1016/S0031-9406(10)63019-2
   Harrison RA, 1992, PHYSIOTHERAPY, V78, P164, DOI DOI 10.1016/S0031-9406(10)61377-6
   LANGE L, 1974, PFLUG ARCH EUR J PHY, V352, P219, DOI 10.1007/BF00590487
   Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915
   NORSK P, 1986, EUR J APPL PHYSIOL O, V54, P608, DOI 10.1007/BF00943349
   RISCH WD, 1978, PFLUG ARCH EUR J PHY, V374, P115, DOI 10.1007/BF00581289
   Schmid JP, 2007, HEART, V93, P722, DOI 10.1136/hrt.2006.094870
   WESTON CFM, 1987, CLIN SCI, V73, P613, DOI 10.1042/cs0730613
   Yazbek Junior P, 1998, Arq Bras Cardiol, V71, P719
NR 24
TC 0
Z9 0
U1 0
U2 1
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PD NOV
PY 2017
VL 72
IS 11
BP 667
EP 674
DI 10.6061/clinics/2017(11)04
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FP7XY
UT WOS:000417854800004
PM 29236912
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Ferreira, CP
   Lyra, SP
   Azevedo, F
   Greenhalgh, D
   Massad, E
AF Ferreira, Claudia P.
   Lyra, Silas P.
   Azevedo, Franciane
   Greenhalgh, David
   Massad, Eduardo
TI Modelling the impact of the long-term use of insecticide-treated bed
   nets on Anopheles mosquito biting time
SO MALARIA JOURNAL
LA English
DT Article
DE Agent based model; Mosquito plasticity; Sensitivity analysis; Fitness
ID WESTERN KENYA HIGHLANDS; VECTOR CONTROL; MALARIA TRANSMISSION;
   SENSITIVITY-ANALYSIS; MORTALITY; CHILDREN; TANZANIA; RESISTANCE;
   EFFICACY; BEHAVIOR
AB Background: Evidence of changing in biting and resting behaviour of the main malaria vectors has been mounting up in recent years as a result of selective pressure by the widespread and long-term use of insecticide-treated bed nets (ITNs), and indoor residual spraying. The impact of resistance behaviour on malaria intervention efficacy has important implications for the epidemiology and malaria control programmes. In this context, a theoretical framework is presented to understand the mechanisms determining the evolution of feeding behaviour under the pressure of use of ITNs.
   Methods: An agent-based stochastic model simulates the impact of insecticide-treated bed nets on mosquito fitness by reducing the biting rates, as well as increasing mortality rates. The model also incorporates a heritability function that provides the necessary genetic plasticity upon which natural selection would act to maximize the fitness under the pressure of the control strategy.
   Results: The asymptotic equilibrium distribution of mosquito population versus biting time is shown for several daily uses of ITNs, and the expected disruptive selection on this mosquito trait is observed in the simulations. The relative fitness of strains that bite at much earlier time with respect to the wild strains, when a threshold of about 50% of ITNs coverage highlights the hypothesis of a behaviour selection. A sensitivity analysis has shown that the top three parameters that play a dominant role on the mosquito fitness are the proportion of individuals using bed nets and its effectiveness, the impact of bed nets on mosquito oviposition, and the mosquito genetic plasticity related to changing in biting time.
   Conclusion: By taking the evolutionary aspect into account, the model was able to show that the long-term use of ITNs, although representing an undisputed success in reducing malaria incidence and mortality in many affected areas, is not free of undesirable side effects. From the evolutionary point of view of the parasite virulence, it should be expected that plasmodium parasites would be under pressure to reduce their virulence. This speculative hypothesis can eventually be demonstrated in the medium to long-term use of ITNs.
C1 [Ferreira, Claudia P.; Lyra, Silas P.] UNESP, IBB, Dept Bioestat, BR-18618689 Botucatu, SP, Brazil.
   [Azevedo, Franciane] UNIFESSPA, Fac Comp & Engn Eletr, BR-68507590 Maraba, PA, Brazil.
   [Greenhalgh, David] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012; ferreira, claudia P/C-8016-2012
OI Massad, Eduardo/0000-0002-7200-2916; ferreira, claudia
   P/0000-0002-9404-6098
FU Leverhulme Research FellowshipLeverhulme Trust [RF-2015-88];
   LIM01-HCFMUSP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); British Council, Malaysia [DTC 16022]; Science Without
   Borders Program for a Special Visiting Fellowship (CNPq) [30098/2014-7];
   Sao Paulo Research Fundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [14/07615-3]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [501799/2013-3]
FX This work was partially funded by LIM01-HCFMUSP, CNPq, and FAPESP. DG is
   grateful to the Leverhulme Trust for support from a Leverhulme Research
   Fellowship (RF-2015-88) and the British Council, Malaysia for funding
   from the Dengue Tech Challenge (Application Reference DTC 16022). EM and
   DG are grateful to the Science Without Borders Program for a Special
   Visiting Fellowship (CNPq Grant 30098/2014-7). SPL is supported by grant
   14/07615-3 Sao Paulo Research Fundation (FAPESP). FA thanks to CNPq
   501799/2013-3.
CR ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E
   Bradley J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0679-2
   Briet OJT, 2002, MED VET ENTOMOL, V16, P22, DOI 10.1046/j.0269-283x.2002.00335.x
   da Silva DR, 2014, APPL MATH SCI, V8, P5065
   Ewald PW, 1994, EVOLUTION INFECT DIS, P293
   Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256
   Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214
   Kateera F., 2015, MALARIA J, V14
   Killeen G.F., 2016, MALAR J, V15
   Lengeler C, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2
   Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091
   Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571
   LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x
   Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   MTANGO FDE, 1986, T ROY SOC TROP MED H, V80, P851, DOI 10.1016/0035-9203(86)90241-5
   Ndenga BA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1115-y
   Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368
   Ojuka P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0653-z
   Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7
   Paintain LS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-71
   Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439
   Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23
   Russell TL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1195-8
   Russell TL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1168-y
   Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80
   Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d
   Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002
   Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474
   Voorham J, 2002, REV SAUDE PUBL, V36, P75, DOI 10.1590/S0034-89102002000100012
   Wamae PM, 2015, ACTA TROP, V150, P136, DOI 10.1016/j.actatropica.2015.07.008
   White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337
   World Health Organization, 2015, GLOB TECHN STRAT MAL
NR 35
TC 7
Z9 7
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD SEP 15
PY 2017
VL 16
AR 373
DI 10.1186/s12936-017-2014-6
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FH0CE
UT WOS:000410806000001
PM 28915892
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Khan, K
   Struchiner, CJ
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, E.
   Nascimento Burattini, M.
   Khan, K.
   Struchiner, C. J.
   Coutinho, F. A. B.
   Wilder-Smith, A.
TI On the origin and timing of Zika virus introduction in Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Force of infection; French Polynesia; mathematical models; risk; Zika
   virus
ID RIO-DE-JANEIRO; OLYMPIC GAMES; FOREIGN VISITORS; WORLD CUP; DENGUE;
   RISK; INFECTION; TRAVELERS; AMERICA
AB The timing and origin of Zika virus (ZIKV) introduction in Brazil has been the subject of controversy. Initially, it was assumed that the virus was introduced during the FIFA World Cup in June-July 2014. Then, it was speculated that ZIKV may have been introduced by athletes from French Polynesia (FP) who competed in a canoe race in Rio de Janeiro in August 2014. We attempted to apply mathematical models to determine the most likely time window of ZIKV introduction in Brazil. Given that the timing and origin of ZIKV introduction in Brazil may be a politically sensitive issue, its determination (or the provision of a plausible hypothesis) may help to prevent undeserved blame. We used a simple mathematical model to estimate the force of infection and the corresponding individual probability of being infected with ZIKV in FP. Taking into account the air travel volume from FP to Brazil between October 2013 and March 2014, we estimated the expected number of infected travellers arriving at Brazilian airports during that period. During the period between December 2013 and February 2014, 51 individuals travelled from FP airports to 11 Brazilian cities. Basing on the calculated force of ZIKV infection (the per capita rate of new infections per time unit) and risk of infection (probability of at least one new infection), we estimated that 18 (95% CI 12-22) individuals who arrived in seven of the evaluated cities were infected. When basic ZIKV reproduction numbers greater than one were assumed in the seven evaluated cities, ZIKV could have been introduced in any one of the cities. Based on the force of infection in FP, basic reproduction ZIKV number in selected Brazilian cities, and estimated travel volume, we concluded that ZIKV was most likely introduced and established in Brazil by infected travellers arriving from FP in the period between October 2013 and March 2014, which was prior to the two aforementioned sporting events.
C1 [Massad, E.; Nascimento Burattini, M.; Coutinho, F. A. B.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, London, England.
   [Nascimento Burattini, M.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Khan, K.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Struchiner, C. J.] Fundacao Oswaldo Cruz, Programme Sci Computat, Rio De Janeiro, Brazil.
   [Wilder-Smith, A.] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, A.] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.
EM edmassad@usp.br
RI Wilder-Smith, Annelies/F-8751-2015; Struchiner, Claudio J/M-9360-2013;
   Burattini, Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/B-1169-2012
OI Struchiner, Claudio J/0000-0003-2114-847X; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); ZikaPLAN through the European Union's Horizon 2020 Research and
   Innovation Programme [734584]; Canadian Institutes of Health Research
   (CIHR)Canadian Institutes of Health Research (CIHR); consortium
   Canada-Latin/America-Caribbean Zika Virus Program [372512]; 
   [LIM01-HCFMUSP]
FX This work has been funded by LIM01-HCFMUSP; CNPq; ZikaPLAN through the
   European Union's Horizon 2020 Research and Innovation Programme under
   grant agreement No. 734584; and Canadian Institutes of Health Research
   (CIHR), consortium Canada-Latin/America-Caribbean Zika Virus Program
   (Grant 372512).
CR Amaku M, 2016, B MATH BIOL, V78, P970, DOI 10.1007/s11538-016-0170-4
   Brasil P., 2016, NEW ENGLAND J MED
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Enserink M., 2015, INFECT DIS OBSCURE M, P1012
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S, 2016, BIORXIV, DOI [10.1101/043265, DOI 10.1101/043265]
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2016, LANCET, V388, P658, DOI 10.1016/S0140-6736(16)31228-4
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, LANCET INFECT DIS, V14, P552, DOI 10.1016/S1473-3099(14)70807-2
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-130
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Tabatabaei S, 2015, INT J INFECT, V2
   World Health Organization, HIST ZIK VIR
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 25
TC 19
Z9 20
U1 0
U2 19
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD AUG
PY 2017
VL 145
IS 11
BP 2303
EP 2312
DI 10.1017/S0950268817001200
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FF6MC
UT WOS:000409124100015
PM 28675351
OA Bronze
DA 2020-12-16
ER

PT J
AU Melo, M
   Gusso, GDF
   Levites, M
   Amaro, E
   Massad, E
   Lotufo, PA
   Zeidman, P
   Price, CJ
   Friston, KJ
AF Melo, Marcio
   Gusso, Gustavo D. F.
   Levites, Marcelo
   Amaro, Edson, Jr.
   Massad, Eduardo
   Lotufo, Paulo A.
   Zeidman, Peter
   Price, Cathy J.
   Friston, Karl J.
TI How doctors diagnose diseases and prescribe treatments: an fMRI study of
   diagnostic salience
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DECISION-MAKING; FUNCTIONAL-ORGANIZATION; ATTENTION NETWORK;
   INTERNAL-MEDICINE; SPEECH PRODUCTION; SPOKEN LANGUAGE; HUMAN BRAIN;
   CORTEX; CONSCIOUSNESS; ARTICULATION
AB Understanding the brain mechanisms involved in diagnostic reasoning may contribute to the development of methods that reduce errors in medical practice. In this study we identified similar brain systems for diagnosing diseases, prescribing treatments, and naming animals and objects using written information as stimuli. Employing time resolved modeling of blood oxygen level dependent (BOLD) responses enabled time resolved (400 milliseconds epochs) analyses. With this approach it was possible to study neural processes during successive stages of decision making. Our results showed that highly diagnostic information, reducing uncertainty about the diagnosis, decreased monitoring activity in the frontoparietal attentional network and may contribute to premature diagnostic closure, an important cause of diagnostic errors. We observed an unexpected and remarkable switch of BOLD activity within a right lateralized set of brain regions related to awareness and auditory monitoring at the point of responding. We propose that this neurophysiological response is the neural substrate of awareness of one's own (verbal) response. Our results highlight the intimate relation between attentional mechanisms, uncertainty, and decision making and may assist the advance of approaches to prevent premature diagnostic closure.
C1 [Melo, Marcio; Massad, Eduardo] Univ Sao Paulo, Fac Med, Lab Med Invest, LIM 01, Av Dr Arnaldo 455, BR-01246904 Sao Paulo, Brazil.
   [Melo, Marcio; Amaro, Edson, Jr.] IIEP, Albert Einstein Israelite Hosp, Av Albert Einstein 627, BR-05652900 Sao Paulo, Brazil.
   [Gusso, Gustavo D. F.; Levites, Marcelo; Lotufo, Paulo A.] Univ Sao Paulo, Fac Med, Dept Internal Med, Av Dr Eneas de Carvalho Aguiar 155, BR-05403000 Sao Paulo, Brazil.
   [Amaro, Edson, Jr.] Univ Sao Paulo, Fac Med, Dept Radiol, Travessa R Dr Ovidio Pires de Campos 75, BR-05403010 Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Derby, Coll Life & Nat Sci, Kedleston Rd, Derby KE22 1GB, England.
   [Zeidman, Peter; Price, Cathy J.; Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.
RP Melo, M (corresponding author), Univ Sao Paulo, Fac Med, Lab Med Invest, LIM 01, Av Dr Arnaldo 455, BR-01246904 Sao Paulo, Brazil.; Melo, M (corresponding author), IIEP, Albert Einstein Israelite Hosp, Av Albert Einstein 627, BR-05652900 Sao Paulo, Brazil.
EM marciomelo@me.com
RI Amaro, Edson/B-6653-2009; Massad, Eduardo/B-1169-2012; Friston,
   Karl/D-9230-2011
OI Amaro, Edson/0000-0002-5889-1382; Massad, Eduardo/0000-0002-7200-2916;
   Price, Catherine/0000-0001-7448-4835; Friston, Karl/0000-0001-7984-8909
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/15438-9]; LIM-01
   Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao
   Paulo; Wellcome TrustWellcome Trust; Medical Research CouncilMedical
   Research Council UK (MRC) [MR/M023672/1] Funding Source: researchfish;
   Stroke Association [TSA2014/02] Funding Source: researchfish
FX We thank the team of the Instituto Israelita de Ensino e Pesquisa Albert
   Einstein for support during fMRI data collection. Rodrigo Olmos was very
   helpful in the recruitment of participants. This project was funded by
   the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant
   2012/15438-9) and LIM-01 Hospital das Clinicas, Faculdade de Medicina da
   Universidade de Sao Paulo. Peter Zeidman, Cathy J. Price, and Karl J.
   Friston are funded by the Wellcome Trust.
CR Allen M, 2016, NEUROIMAGE, V127, P34, DOI 10.1016/j.neuroimage.2015.11.030
   Amiez C, 2006, J NEUROSCI, V26, P2724, DOI 10.1523/JNEUROSCI.4739-05.2006
   Berbaum KS, 2010, HDB MED IMAGE PERCEP, P107
   Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911
   Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006
   Carota F, 2010, CEREB CORTEX, V20, P1891, DOI 10.1093/cercor/bhp255
   Chen Z, 2016, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00083
   Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755
   Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555
   Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457
   Cristescu TC, 2006, NEUROIMAGE, V33, P1178, DOI 10.1016/j.neuroimage.2006.08.017
   Croskerry P, 2009, ACAD MED, V84, P1022, DOI 10.1097/ACM.0b013e3181ace703
   Davelaar EJ, 2015, TOP COGN SCI, V7, P494, DOI 10.1111/tops.12146
   de Lange FP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001203
   Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018
   DENNETT DANIEL C., 1991, CONSCIOUSNESS EXPLAI
   Downar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027768
   Durning SJ, 2016, MED TEACH, V38, P570, DOI 10.3109/0142159X.2015.1047755
   Durning SJ, 2012, MIL MED, V177, P72, DOI 10.7205/MILMED-D-12-00242
   Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035
   Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215
   FitzGerald THB, 2015, NEUROIMAGE, V107, P219, DOI 10.1016/j.neuroimage.2014.12.015
   Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058
   Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1
   Friston K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0481
   Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013
   Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7
   Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306
   Garagnani M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.010.2009
   Gluth S, 2012, J NEUROSCI, V32, P10686, DOI 10.1523/JNEUROSCI.0727-12.2012
   Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493
   Greenhouse I, 2015, J NEUROSCI, V35, P10675, DOI 10.1523/JNEUROSCI.1436-15.2015
   Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211
   Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145
   Hruska P, 2016, ADV HEALTH SCI EDUC, V21, P935, DOI 10.1007/s10459-015-9649-2
   Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779
   Ilgen JS, 2012, ACAD EMERG MED, V19, P1454, DOI 10.1111/acem.12034
   Jackson Hughlings, 1874, MED PRESS CIRCULAR, V68, P19
   Jones OP, 2013, J NEUROSCI, V33, P2376, DOI 10.1523/JNEUROSCI.3289-12.2013
   Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315
   Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034
   Kostopoulou O, 2015, BRIT J GEN PRACT, V65, pE49, DOI 10.3399/bjgp15X683161
   Kristensen LB, 2013, CEREB CORTEX, V23, P1836, DOI 10.1093/cercor/bhs164
   Lewis LD, 2016, P NATL ACAD SCI USA, V113, pE6679, DOI 10.1073/pnas.1608117113
   Lind A, 2014, PSYCHOL SCI, V25, P1198, DOI 10.1177/0956797614529797
   LINELL P, 1982, J PHONETICS, V10, P37, DOI 10.1016/S0095-4470(19)30910-6
   Martin EM, 2010, J NEUROPHYSIOL, V103, P2326, DOI 10.1152/jn.01122.2009
   Mcnamara T. P., 2005, SEMANTIC PRIMING PER
   Melo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028752
   Monteiro SM, 2013, TEACH LEARN MED, V25, pS26, DOI 10.1080/10401334.2013.842911
   Morel A., 2007, STEREOTAXIC ATLAS HU
   Nobre A., 2014, OXFORD HDB ATTENTION, P105
   PAXINOS G, 1995, ATLAS HUMAN BRAIN ST
   POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398
   Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062
   Price CJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00237
   Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783
   SAMUEL S, 1995, RADIOLOGY, V194, P895, DOI 10.1148/radiology.194.3.7862998
   Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459
   Scolari M, 2015, CURR OPIN BEHAV SCI, V1, P32, DOI 10.1016/j.cobeha.2014.08.003
   Sherbino J, 2012, ACAD MED, V87, P785, DOI 10.1097/ACM.0b013e318253acbd
   Shtyrov Y, 2010, J COGNITIVE NEUROSCI, V22, P1465, DOI 10.1162/jocn.2009.21292
   Snyder HR, 2011, J COGNITIVE NEUROSCI, V23, P3470, DOI 10.1162/jocn_a_00023
   Sprenger A, 2012, J EXP PSYCHOL LEARN, V38, P550, DOI 10.1037/a0026036
   Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105
   Symmonds M, 2010, J NEUROSCI, V30, P14380, DOI 10.1523/JNEUROSCI.1459-10.2010
   van der Linden L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01213
NR 67
TC 2
Z9 2
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 2
PY 2017
VL 7
AR 1304
DI 10.1038/s41598-017-01482-0
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET7BS
UT WOS:000400449000016
PM 28465538
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Shimozako, HJ
   Wu, JH
   Massad, E
AF Shimozako, Helio Junji
   Wu, Jianhong
   Massad, Eduardo
TI The Preventive Control of Zoonotic Visceral Leishmaniasis: Efficacy and
   Economic Evaluation
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID INDIAN SUBCONTINENT; DOGS; TRANSMISSION; INFANTUM; COLLARS; VECTOR;
   IMPACT; BRAZIL; STATE
AB Zoonotic Visceral Leishmaniasis (ZVL) is one of the world's deadliest and neglected infectious diseases, according to World Health Organization. This disease is one of major human and veterinary medical significance. The sandfly and the reservoir in urban areas remain among the major challenges for the control activities. In this paper, we evaluated five control strategies (positive dog elimination, insecticide impregnated dog collar, dog vaccination, dog treatment, and sandfly population control), considering disease control results and cost-effectiveness. We elaborated a mathematical model based on a set of differential equations in which three populations were represented (human, dog, and sandfly). Humans and dogs were divided into susceptible, latent, clinically ill, and recovery categories. Sandflies were divided into noninfected, infected, and infective. As the main conclusions, the insecticide impregnated dog collar was the strategy that presented the best combination between disease control and cost-effectiveness. But, depending on the population target, the control results and cost-effectiveness of each strategy may differ. More and detailed studies are needed, specially one which optimizes the control considering more than one strategy in activity.
C1 [Shimozako, Helio Junji; Massad, Eduardo] Univ Sao Paulo, Fac Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Shimozako, Helio Junji; Massad, Eduardo] LIM 01 HCFMUSP, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Wu, Jianhong] York Univ, York Inst Hlth Res, Ctr Dis Modelling, 4700 Keele St, Toronto, ON M3J 1P3, Canada.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London, England.
RP Shimozako, HJ (corresponding author), Univ Sao Paulo, Fac Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.; Shimozako, HJ (corresponding author), LIM 01 HCFMUSP, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM hjunji21@usp.br
RI Shimozako, Helio Junji/AAX-2805-2020; Massad, Eduardo/B-1169-2012
OI Shimozako, Helio Junji/0000-0003-1941-9330; Massad,
   Eduardo/0000-0002-7200-2916
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2011/02633-5, 2013/13347-9]; Mathematics
   of Information Technology and Complex Systems (MITACS)
FX The authors would like to acknowledge all suggestions and considerations
   received from several research colleagues. Particularly, they thank
   Professor Dr. Eunice Aparecida Biachi Galati, Professor Dr. Dirce Maria
   Trevisan Zanetta, Professor Dr. Marcelo Nascimento Burattini, Professor
   Dr. Maria Irma Seixas Duarte, and Professor Dr. Hiroshi Nishiura for
   important suggestions. They also acknowledge Sao Paulo Research
   Foundation (FAPESP) (Grants 2011/02633-5 and 2013/13347-9) and
   Mathematics of Information Technology and Complex Systems (MITACS) for
   partial financial support.
CR Adhikari SR, 2010, J VECTOR DIS, V47, P127
   Akhavan D., 1996, Revista de Patologia Tropical, V25, P203
   Anderson RM, 2010, INFECT DIS HUMANS DY
   Andrade AM, 2008, CAD SAUDE PUBLICA, V24, P927, DOI 10.1590/S0102-311X2008000400024
   Andrade Eli Iola Gurgel, 2007, Rev. Adm. Pública, V41, P211, DOI 10.1590/S0034-76122007000200003
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Boelaert M, 1999, B WORLD HEALTH ORGAN, V77, P667
   Brazilian Institute of Geography and Statistic, 2008, HLTH EC MACR PERSP 2
   Brazilian Institute of Geography and Statistics. Brazil (BIGS), 2013, 2012 LIF EXP BIRTH W
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   Camargo-Neves V. L. F., 2010, P 2 INT C CAN LEISHM, P118
   Camargo-Neves V. L. F., 2004, THESIS
   Centre of Epidemiological Surveillance of Sao Paulo State (CES-SP); Brazil, 2016, VISC LEISHM REP DAT
   Das M, 2008, ANN TROP MED PARASIT, V102, P729, DOI 10.1179/136485908X355274
   Day MJ, 2012, EMERGING INFECT DIS, V18
   Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005
   Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125
   Epidemiological Surveillance Direction; Santa Catarina State; Brazil, GUID MAN TRAIN ENT L
   Fernandes CB, 2014, VACCINE, V32, P1287, DOI 10.1016/j.vaccine.2013.12.046
   Greene CE, 2011, INFECT DIS DOG CAT
   Halbig P, 2000, MED VET ENTOMOL, V14, P223, DOI 10.1046/j.1365-2915.2000.00229.x
   KAULT DA, 1991, MATH BIOSCI, V103, P17, DOI 10.1016/0025-5564(91)90088-Z
   Killick-Kendrick R, 2010, B WORLD HEALTH ORGAN, V88, P11, DOI 10.2471/BLT.10.040110
   LANOTTE G, 1979, ANN PARASIT HUM COMP, V54, P277, DOI 10.1051/parasite/1979543277
   Laurenti MD, 2013, VET PARASITOL, V196, P296, DOI 10.1016/j.vetpar.2013.03.017
   Lee BY, 2012, AM J TROP MED HYG, V86, P417, DOI 10.4269/ajtmh.2012.10-0415
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Marinho DS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003527
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Ministry of Health, HUM CAS VISC LEISHM
   Ministry of Health. Brazil, 2006, GUID SURV CONTR VISC
   Miro G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-52
   Molineaux L, 1980, THE GARKI PROJECT
   Moreira M. C, 2013, THESIS
   Neva F., 1990, Tropical and Geographical Medicine., P296
   Oliveira GMG, 2010, REV PAN AMAZ SAUDE, V1, P83, DOI DOI 10.5123/S2176-62232010000300012
   Palatnik-de-Sousa CB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-197
   Pan American Health Organization, 2001, ZOON COMM DIS COMM M, V580
   Pearson R. D., 1990, Principles and practice of infectious diseases., P2066
   Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006
   Ribas LM, 2013, SCI WORLD J, DOI 10.1155/2013/810380
   Selman C, 2013, CURR BIOL, V23, pR451, DOI 10.1016/j.cub.2013.04.005
   Sharma DA, 2006, TROP MED INT HEALTH, V11, P757, DOI 10.1111/j.1365-3156.2006.01604.x
   Shimozako H. J., 2017, INFECT DIS MODELLING, P1
   Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929
   TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85
   WHO, VISC LEISHM
   World Health Organization, NEGL TROP DIS NTD RE
   Zhao S, 2016, J MATH BIOL, V73, P1525, DOI 10.1007/s00285-016-0999-z
NR 51
TC 11
Z9 11
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2017
AR 4797051
DI 10.1155/2017/4797051
PG 21
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA EW1ZU
UT WOS:000402296600001
PM 28588642
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Amaku, M
   Azevedo, F
   Burattini, MN
   Coelho, GE
   Coutinho, FAB
   Greenhalgh, D
   Lopez, LF
   Motitsuki, RS
   Wilder-Smith, A
   Massad, E
AF Amaku, M.
   Azevedo, F.
   Burattini, M. N.
   Coelho, G. E.
   Coutinho, F. A. B.
   Greenhalgh, D.
   Lopez, L. F.
   Motitsuki, R. S.
   Wilder-Smith, A.
   Massad, E.
TI Magnitude and frequency variations of vector-borne infection outbreaks
   using the Ross-Macdonald model: explaining and predicting outbreaks of
   dengue fever
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Dengue; geo-spatial epidemiology; mathematical models; outbreak
   patterns; vectorborne infections
ID THRESHOLD CONDITIONS; TRANSMISSION
AB The classical Ross-Macdonald model is often utilized to model vector-borne infections; however, this model fails on several fronts. First, using measured (or estimated) parameters, which values are accepted from the literature, the model predicts a much greater number of cases than what is usually observed. Second, the model predicts a single large outbreak that is followed by decades of much smaller outbreaks, which is not consistent with what is observed. Usually towns or cities report a number of recurrences for many years, even when environmental changes cannot explain the disappearance of the infection between the peaks. In this paper, we continue to examine the pitfalls in modelling this class of infections, and explain that, if properly used, the Ross-Macdonald model works and can be used to understand the patterns of epidemics and even, to some extent, be used to make predictions. We model several outbreaks of dengue fever and show that the variable pattern of yearly recurrence (or its absence) can be understood and explained by a simple Ross-Macdonald model modified to take into account human movement across a range of neighbourhoods within a city. In addition, we analyse the effect of seasonal variations in the parameters that determine the number, longevity and biting behaviour of mosquitoes. Based on the size of the first outbreak, we show that it is possible to estimate the proportion of the remaining susceptible individuals and to predict the likelihood and magnitude of the eventual subsequent outbreaks. This approach is described based on actual dengue outbreaks with different recurrence patterns from some Brazilian regions.
C1 [Amaku, M.; Azevedo, F.; Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Motitsuki, R. S.; Massad, E.] Univ Sao Paulo, Fac Med, Hosp Clin LIM01, Sao Paulo, SP, Brazil.
   [Burattini, M. N.] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Coelho, G. E.] Minist Saude, Brasilia, DF, Brazil.
   [Greenhalgh, D.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland.
   [Lopez, L. F.] Florida Int Univ, Ctr Internet Augmented Res & Assessment, Miami, FL 33199 USA.
   [Wilder-Smith, A.] Nanyang Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Massad, E.] London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin LIM01, Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Wilder-Smith, Annelies/F-8751-2015;
   Coutinho, Francisco A B/H-5644-2011; Lopez, Luis F/C-4721-2012; Amaku,
   Marcos/D-5252-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; Lopez, Luis F/0000-0003-4097-6887; Amaku,
   Marcos/0000-0003-4752-6774
FU LIM01 HCFMUSP, Fapesp [2014/26229-7, 2014/26327-9]; CNPqNational Council
   for Scientific and Technological Development (CNPq); Dengue Tools under
   the Seventh Framework Programme of the European Community [282589];
   MS/FNS [777588/2012]
FX This work was partially supported by LIM01 HCFMUSP, Fapesp (2014/26229-7
   and 2014/26327-9), CNPq, Dengue Tools under the Seventh Framework
   Programme of the European Community, grant agreement no. 282589, and
   MS/FNS (grant no. 777588/2012).
CR Amaku M, 2015, EPIDEMIOL INFECT, V143, P1803, DOI 10.1017/S0950268814002660
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Amaku M, 2010, B MATH BIOL, V72, P1294, DOI 10.1007/s11538-009-9495-6
   Ball F, 2015, EPIDEMICS-NETH, V10, P63, DOI 10.1016/j.epidem.2014.08.001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Burattini M. N., 2008, BIOSCI HYPOTHESES, V1, P168, DOI DOI 10.1016/J.BIHY.2008.05.003
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Li J, 2011, COMPUT MATH METHOD M, DOI 10.1155/2011/527610
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Massad E, 2004, MED HYPOTHESES, V63, P911, DOI 10.1016/j.mehy.2004.03.028
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Monath TP, 1996, FIELD VIROL, V3, P961
NR 16
TC 7
Z9 7
U1 0
U2 26
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 2016
VL 144
IS 16
BP 3435
EP 3450
DI 10.1017/S0950268816001448
PG 16
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA ED1QY
UT WOS:000388621200010
PM 27538702
OA Green Accepted, Bronze
DA 2020-12-16
ER

PT J
AU DalBen, MD
   Mendes, ET
   Moura, ML
   Rahman, DA
   Peixoto, D
   dos Santos, SA
   de Figueiredo, WB
   Mendes, PV
   Taniguchi, LU
   Coutinho, FAB
   Massad, E
   Levin, AS
AF DalBen, Mirian de Freitas
   Mendes, Elisa Teixeira
   Moura, Maria Luisa
   Rahman, Dania Abdel
   Peixoto, Driele
   dos Santos, Sania Alves
   de Figueiredo, Walquiria Barcelos
   Mendes, Pedro Vitale
   Taniguchi, Leandro Utino
   Bezerra Coutinho, Francisco Antonio
   Massad, Eduardo
   Levin, Anna Sara
TI A Model-Based Strategy to Control the Spread of Carbapenem-Resistant
   Enterobacteriaceae: Simulate and Implement
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID TERM ACUTE-CARE; RISK-FACTORS; COLONIZATION; TRANSMISSION; INFECTIONS;
   PREVALENCE; CARRIAGE; DURATION
AB OBJECTIVE. To reduce transmission of carbapenem-resistant Enterobacteriaceae (CRE) in an intensive care unit with interventions based on simulations by a developed mathematical model.
   DESIGN. Before-after trial with a 44-week baseline period and 24-week intervention period.
   SETTING. Medical intensive care unit of a tertiary care teaching hospital.
   PARTICIPANTS. All patients admitted to the unit.
   METHODS. We developed a model of transmission of CRE in an intensive care unit and measured all necessary parameters for the model input. Goals of compliance with hand hygiene and with isolation precautions were established on the basis of the simulations and an intervention was focused on reaching those metrics as goals. Weekly auditing and giving feedback were conducted.
   RESULTS. The goals for compliance with hand hygiene and contact precautions were reached on the third week of the intervention period. During the baseline period, the calculated R0 was 11; the median prevalence of patients colonized by CRE in the unit was 33%, and 3 times it exceeded 50%. In the intervention period, the median prevalence of colonized CRE patients went to 21%, with a median weekly Rn of 0.42 (range, 0-2.1).
   CONCLUSIONS. The simulations helped establish and achieve specific goals to control the high prevalence rates of CRE and reduce CRE transmission within the unit. The model was able to predict the observed outcomes. To our knowledge, this is the first study in infection control to measure most variables of a model in real life and to apply the model as a decision support tool for intervention.
C1 [DalBen, Mirian de Freitas; Mendes, Elisa Teixeira; Moura, Maria Luisa; Rahman, Dania Abdel; Peixoto, Driele; dos Santos, Sania Alves; Levin, Anna Sara] Univ Sao Paulo, Hosp Clin, Infect Control Dept, Sao Paulo, Brazil.
   [DalBen, Mirian de Freitas; Mendes, Elisa Teixeira; Moura, Maria Luisa; Rahman, Dania Abdel; Peixoto, Driele; dos Santos, Sania Alves; Levin, Anna Sara] Univ Sao Paulo, Hosp Clin, LIM54, Sao Paulo, Brazil.
   [DalBen, Mirian de Freitas; Mendes, Elisa Teixeira; dos Santos, Sania Alves; Levin, Anna Sara] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [DalBen, Mirian de Freitas; Mendes, Elisa Teixeira; dos Santos, Sania Alves; Levin, Anna Sara] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [de Figueiredo, Walquiria Barcelos] Univ Sao Paulo, Hosp Clin, Nursing Div, Fac Med, Sao Paulo, Brazil.
   [Mendes, Pedro Vitale; Taniguchi, Leandro Utino] Univ Sao Paulo, Hosp Clin, Intens Care Unit, Emergency Med Discipline, Sao Paulo, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Discipline Med Informat, Sao Paulo, Brazil.
RP DalBen, MD (corresponding author), Univ Sao Paulo, Dept Infect Control, Hosp Clin, Fac Med, Rua Frei Caneca,640-252 Vereda, BR-01307000 Sao Paulo, Brazil.
EM miriandalben@gmail.com
RI Levin, Anna S/C-8831-2012; Massad, Eduardo/B-1169-2012; Moura, Maria
   Luisa/N-5654-2015; Taniguchi, Leandro Utino/L-6471-2015; Coutinho,
   Francisco A B/H-5644-2011; Taniguchi, Leandro U/J-2099-2015
OI Levin, Anna S/0000-0003-2427-8368; Massad, Eduardo/0000-0002-7200-2916;
   Moura, Maria Luisa/0000-0003-1013-8233; Taniguchi, Leandro
   Utino/0000-0003-4384-0408; Coutinho, Francisco A B/0000-0003-3127-3071;
   Taniguchi, Leandro U/0000-0003-4384-0408; Teixeira Mendes,
   Elisa/0000-0003-4251-8185
CR Bhargava A, 2014, INFECT CONT HOSP EP, V35, P398, DOI 10.1086/675614
   Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647
   D'Agata EMC, 2005, J INFECT DIS, V192, P2004, DOI 10.1086/498041
   Feldman N, 2013, CLIN MICROBIOL INFEC, V19, pE190, DOI 10.1111/1469-0691.12099
   GAYNES RP, 1992, INFECT CONT HOSP EP, V13, P10, DOI 10.1086/646417
   Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202
   Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3
   LARSON EL, 1980, J CLIN MICROBIOL, V12, P355, DOI 10.1128/JCM.12.3.355-360.1980
   Lin MY, 2014, INFECT CONT HOSP EP, V35, P440, DOI 10.1086/675613
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Pereira GH, 2013, MEM I OSWALDO CRUZ, V108, P113, DOI 10.1590/S0074-02762013000100019
   Rossi F, 2011, CLIN INFECT DIS, V52, P1138, DOI 10.1093/cid/cir120
   Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770
   Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270
   Sypsa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041068
   van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294
   World Health Organization, 2009, WHO GUID HAND HYG HL
   Zimmerman FS, 2013, AM J INFECT CONTROL, V41, P190, DOI 10.1016/j.ajic.2012.09.020
NR 18
TC 11
Z9 13
U1 0
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD NOV
PY 2016
VL 37
IS 11
BP 1315
EP 1322
DI 10.1017/ice.2016.168
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA2EA
UT WOS:000386404400007
PM 27609341
DA 2020-12-16
ER

PT J
AU Furlan, T
   Massad, E
AF Furlan, Teresa
   Massad, Eduardo
TI Cost-effectiveness analysis of diagnostics tests of respiratory tract
   infection in cancer patients
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Meeting Abstract
DE Molecular pathology; Viruses; Epidemiology
NR 0
TC 0
Z9 0
U1 0
U2 0
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD SEP 1
PY 2016
VL 48
SU 60
MA PA2594
DI 10.1183/13993003.congress-2016.PA2594
PG 2
WC Respiratory System
SC Respiratory System
GA VF5GZ
UT WOS:000443059703486
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI The olympically mismeasured risk of Zika virus in Rio de Janeiro Reply
SO LANCET
LA English
DT Letter
ID VISITORS; DENGUE; GAMES
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015;
   Coutinho, Francisco A B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071
CR Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 7
TC 3
Z9 3
U1 0
U2 76
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 13
PY 2016
VL 388
IS 10045
BP 658
EP 659
DI 10.1016/S0140-6736(16)31228-4
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UX
UT WOS:000381268700023
PM 27480043
OA Bronze
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic
   Games?
SO LANCET
LA English
DT Letter
ID FOREIGN VISITORS; BRAZIL; DENGUE; CARNIVAL
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Public Health England, ZIK VIR UPD TRAV ADV
   World Health Organization, 2016, PREGN MAN CONT ZIK V
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 8
TC 18
Z9 18
U1 0
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 2
PY 2016
VL 388
IS 10039
BP 25
EP 25
DI 10.1016/S0140-6736(16)30842-X
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP9PM
UT WOS:000378828400016
PM 27323918
OA Bronze
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Ximenes, R
   Quam, M
   Wilder-Smith, A
   Massad, E
AF Burattini, M. N.
   Coutinho, F. A. B.
   Lopez, L. F.
   Ximenes, R.
   Quam, M.
   Wilder-Smith, A.
   Massad, E.
TI Potential exposure to Zika virus for foreign tourists during the 2016
   Carnival and Olympic Games in Rio de Janeiro, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
C1 [Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Ximenes, R.; Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
   [Burattini, M. N.] Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Lopez, L. F.] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Quam, M.] Umea Univ, Epidemiol & Global Hlth, Umea, Sweden.
   [Wilder-Smith, A.] Lee Kong Chian Sch Med, Nanyang, Singapore.
   [Wilder-Smith, A.] Nanyang Technol Univ, Singapore 639798, Singapore.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Wilder-Smith, Annelies/F-8751-2015; Coutinho, Francisco A B/H-5644-2011;
   Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Ximenes,
   Raphael/G-2881-2014; Lopez, Luis F/C-4721-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Ximenes,
   Raphael/0000-0003-2536-951X; Lopez, Luis F/0000-0003-4097-6887
FU HSP/ UNIFESP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/18463-4]; Ministry of Health (Fundo Nacional de
   Saude) [27835/2012]; DengueTools under Health theme of Seventh Framework
   Programme of the European Community [282589]; DengueTools: innovative
   tools and strategies for the surveillance and control of dengue; 
   [LIM01-HCFMUSP]
FX This study received partial funding from LIM01-HCFMUSP, HSP/ UNIFESP,
   CNPq, FAPESP (grant no. 2012/18463-4), Ministry of Health (Fundo
   Nacional de Saude, grant no. 27835/2012), and was also partially funded
   by DengueTools under the Health theme of the Seventh Framework Programme
   of the European Community (grant agreement no. 282589), DengueTools:
   innovative tools and strategies for the surveillance and control of
   dengue.
CR Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   WHO, DENGUE
   World Health Organization, ZIK VIR POT COMPL
NR 7
TC 18
Z9 18
U1 0
U2 41
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2016
VL 144
IS 9
BP 1904
EP 1906
DI 10.1017/S0950268816000649
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO5JV
UT WOS:000377820300013
PM 27040593
OA Bronze
DA 2020-12-16
ER

PT J
AU Raimundo, SM
   Yang, HM
   Massad, E
AF Raimundo, Silvia Martorano
   Yang, Hyun Mo
   Massad, Eduardo
TI MODELING VACCINE PREVENTABLE VECTOR-BORNE INFECTIONS: YELLOW FEVER AS A
   CASE STUDY
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE Mathematical Models; Vaccination; Vector-Borne; Yellow Fever
ID THRESHOLD CONDITIONS; SAO-PAULO; TRANSMISSION; DENGUE; DISEASES; BRAZIL;
   STATE; RISK
AB In this paper, we propose and simulate a deterministic model for a vector-borne disease in the presence of a vaccine. The model allows the assessment of the impact of an imperfect vaccine with various characteristics, which include waning protective immunity, incomplete vaccine-induced protection and adverse events. We find three threshold parameters which govern the existence and stability of the equilibrium points. Our stability analysis suggests that the reduction in the mosquito fertility theoretically is the most effective factor of reducing disease prevalence in both low and high transmission areas. To illustrate the theoretical results, the model is simulated by the example of yellow fever. We also perform sensitivity analyses to determine the importance of both vaccine-induced mortality rate and disease-induced mortality rate for determining a control strategy. We found that there is an optimum vaccination rate, above which people die by the vaccination and below which people die by the disease.
C1 [Raimundo, Silvia Martorano; Massad, Eduardo] Univ Sao Paulo, Sch Med, Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Raimundo, Silvia Martorano; Massad, Eduardo] LIM01 HCFMUSP, Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Yang, Hyun Mo] Univ Estadual Campinas, Dept Appl Math, Praca Sergio Buarque de Holanda 651, BR-13083859 Campinas, SP, Brazil.
RP Raimundo, SM (corresponding author), Univ Sao Paulo, Sch Med, Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.; Raimundo, SM (corresponding author), LIM01 HCFMUSP, Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM silviamr@dim.fm.usp.br; hyunyang@ime.unicamp.br; edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012; Raimundo, Silvia Martorano/D-4624-2012;
   Yang, Hyun M/K-6873-2014
OI Massad, Eduardo/0000-0002-7200-2916; Raimundo, Silvia
   Martorano/0000-0002-9960-7341; Yang, Hyun M/0000-0002-1711-363X
FU FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq);  [LIM01-HCFMUSP]
FX The authors acknowledge financial support from Fapesp, CNPq and
   LIM01-HCFMUSP. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the paper.
CR Alexander ME, 2006, J MATH BIOL, V52, P290, DOI 10.1007/s00285-005-0356-0
   Alsaleh AA, 2014, J BIOL SYST, V22, P555, DOI 10.1142/S0218339014500211
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Beaty B.J., 1996, BIOL DIS VECTORS
   Brousseau N, 2015, EPIDEMIOL INFECT, V143, P3405, DOI 10.1017/S0950268815000667
   CDC (Centers for Disease Control), 2014, CDC YELL FEV
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O, 2000, MATH EPIDEMIOLOGY IN
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Dietz K, 1975, EPIDEMIOLOGY, P104
   Elbasha EH, 2011, NONLINEAR ANAL-REAL, V12, P2692, DOI 10.1016/j.nonrwa.2011.03.015
   Esteva L, 2015, J BIOL SYST, V23, P527, DOI 10.1142/S0218339015500278
   Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   GODDARD J, 2000, INFECT DIS ARTHROPOD
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hyun Mo Yang, 2015, Applied Mathematics and Computation, V265, P103, DOI 10.1016/j.amc.2015.04.112
   Kribs-Zaleta CM, 2000, MATH BIOSCI, V164, P183, DOI 10.1016/S0025-5564(00)00003-1
   Lashmikantham V, 1989, STABILITY ANAL NONLI
   Logullo P, 2008, VACCINE, V26, P141, DOI 10.1016/j.vaccine.2007.09.075
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Lutambi AM, 2013, MATH BIOSCI, V241, P198, DOI 10.1016/j.mbs.2012.11.013
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/s0037-86822011005000041, 10.1590/S0037-86822011005000041]
   Morse SS, 1995, EMERG INFECT DIS, DOI 10.3201/eid0101.950102
   Oldstone M, 2009, VIRUSES PLAGUES HIST, P102
   Raimundo SM, 2007, APPL MATH COMPUT, V189, P1723, DOI 10.1016/j.amc.2006.12.051
   Raimundo SM, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/482091
   Ribeiro AF, 2015, MEM I OSWALDO CRUZ, V110, P230, DOI 10.1590/0074-02760140345
   Sao-Joao TM, 2013, REV SAUDE PUBL, V47, P1
   Seligman SJ, 2011, EMERG INFECT DIS, V17, P1891, DOI 10.3201/eid1710.101789
   Smith Billy G., 2013, SHIP DEATH VOYAGE CH
   Struchiner CJ, 2008, CIENC SAUDE COLETIVA, V13, P1743, DOI 10.1590/S1413-81232008000600009
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Wang L, 2012, J THEOR BIOL, V300, P100, DOI 10.1016/j.jtbi.2012.01.004
   Yang HM, 2014, BIOSYSTEMS, V126, P52, DOI 10.1016/j.biosystems.2014.10.002
NR 46
TC 1
Z9 1
U1 0
U2 15
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3390
EI 1793-6470
J9 J BIOL SYST
JI J. Biol. Syst.
PD JUN-SEP
PY 2016
VL 24
IS 2-3
BP 193
EP 216
DI 10.1142/S0218339016500108
PG 24
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA DW1KX
UT WOS:000383403200001
DA 2020-12-16
ER

PT J
AU Amaku, M
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Mesquita, F
   Naveira, MCM
   Pereira, GFM
   Santos, ME
   Massad, E
AF Amaku, Marcos
   Burattini, Marcelo Nascimento
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   Mesquita, Fabio
   Moscoso Naveira, Marcelo Contardo
   Mendes Pereira, Gerson Fernando
   Santos, Melina Erica
   Massad, Eduardo
TI Estimating the Size of the HCV Infection Prevalence: A Modeling Approach
   Using the Incidence of Cases Reported to an Official Notification System
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Hepatitis C; Mathematical models; Notification system incidence;
   Prevalence
ID HEPATITIS-C-VIRUS; GLOBAL EPIDEMIOLOGY; BRAZILIAN PRISONERS; HIV;
   TRANSMISSION; PROGRESSION
AB In this paper we propose two methods to give a first rough estimate of the actual number of hepatitis C virus (HCV)-infected individuals (prevalence) taking into account the notification rate of newly diagnosed infections (incidence of notification) and the size of the liver transplantation waiting list (LTWL) of patients with liver failure due to chronic HCV infection. Both approaches, when applied to the Brazilian HCV situation converge to the same results, that is, the methods proposed reproduce both the prevalence of reported cases and the LTWL with reasonable accuracy. We use two methods to calculate the prevalence of HCV that, as a first, and very crude approximation, assumes that the actual prevalence of HCV in Brazil is proportional to the reported incidence to the official notification system with a constant denoted . In the paper we discuss the limitations and advantages of this assumption. With the two methods we calculated , which reproduces both the reported incidence and the size of the LTWL. With the value of we calculated the prevalence I(a) (the integral of which resulted in 1.6 million people living with the infection in Brazil, most of whom unidentified). Other variables related to HCV infection (e.g., the distribution of the proportion of people aged a who got infected n years ago) can be easily calculated from this model. These new variables can then be measured and the model can be recursively updated, improving its accuracy.
C1 [Amaku, Marcos; Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] Univ Sao Paulo, Fac Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
   [Amaku, Marcos; Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] LIM01 HCFMUSP, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Hosp Sao Paulo, Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, Miami, FL 33199 USA.
   [Mesquita, Fabio; Moscoso Naveira, Marcelo Contardo; Mendes Pereira, Gerson Fernando; Santos, Melina Erica] Minist Saude Brazil, Dept DST AIDS & Hepatites Virais, Brasilia, DF, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.; Massad, E (corresponding author), LIM01 HCFMUSP, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London WC1, England.
EM edmassad@dim.fm.usp.br
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Mesquita, Fabio/AAZ-7021-2020; Burattini,
   Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Lopez, Luis F/0000-0003-4097-6887; Naveira,
   Marcelo/0000-0002-0555-5254; Mesquita, Fabio/0000-0002-8297-0224
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Ministry of Health of Brazil;  [LIM01-HCFMUSP]
FX This work was partially supported by grants from LIM01-HCFMUSP, FAPESP,
   CNPq and Ministry of Health of Brazil.
CR Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93
   Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Chaib E, 2013, ABCD-ARQ BRAS CIR DI, V26, P324, DOI 10.1590/S0102-67202013000400014
   Chaib E, 2010, MED HYPOTHESES, V75, P324, DOI 10.1016/j.mehy.2010.03.013
   Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076
   Cox AL, 2015, SCIENCE, V349, P790, DOI 10.1126/science.aad1302
   CROFTS N, 1999, TECHNICAL REPORT SER, V3
   Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008
   Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121
   Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027
   Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737
   Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227
   Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107
   Lawrence S P, 2000, Adv Intern Med, V45, P65
   Massad E, 2009, EPIDEMIOL INFECT, V137, P241, DOI 10.1017/S0950268808000873
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   Nakano T, 2012, LIVER INT, V32, P339, DOI 10.1111/j.1478-3231.2011.02684.x
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170
   Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613
   Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4
   Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1
   Strazza L, 2007, CAD SAUDE PUBLICA, V23, P197, DOI 10.1590/S0102-311X2007000100021
   Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375
   VANDENHOEK JAR, 1990, J INFECT DIS, V162, P823, DOI 10.1093/infdis/162.4.823
   Reiche EMV, 2008, INT J MOL MED, V21, P387
NR 26
TC 7
Z9 7
U1 0
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD MAY
PY 2016
VL 78
IS 5
BP 970
EP 990
DI 10.1007/s11538-016-0170-4
PG 21
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA DO7AF
UT WOS:000377933900006
PM 27160282
DA 2020-12-16
ER

PT J
AU Liu-Helmersson, J
   Quam, M
   Wilder-Smith, A
   Stenlund, H
   Ebi, K
   Massad, E
   Rocklov, J
AF Liu-Helmersson, Jing
   Quam, Mikkel
   Wilder-Smith, Annelies
   Stenlund, Hans
   Ebi, Kristie
   Massad, Eduardo
   Rocklov, Joacim
TI Climate Change and Aedes Vectors: 21st Century Projections for Dengue
   Transmission in Europe
SO EBIOMEDICINE
LA English
DT Article
DE Dengue; Vectorial capacity; Aedes aegypti; Aeries albopictus;
   Temperature; Climate change
ID BASIC REPRODUCTION NUMBER; TEMPERATURE-FLUCTUATIONS; GLOBAL
   DISTRIBUTION; CHIKUNGUNYA VIRUS; ALBOPICTUS; OUTBREAK; AEGYPTI; FEVER;
   INFECTION; IMPACT
AB Warming temperatures may increase the geographic spread of vector-bome diseases into temperate areas. Although a tropical mosquito-borne viral disease, a dengue outbreak occurred in Madeira, Portugal, in 2012; the first in Europe since 1920s. This outbreak emphasizes the potential for dengue re-emergence in Europe given changing climates. We present estimates of dengue epidemic potential using vectorial capacity (VC) based on historic and projected temperature (1901-2099). VC indicates the vectors ability to spread disease among humans. We calculated temperature-dependent VC for Europe, highlighting 10 European cities and three non-European reference cities. Compared with the tropics, Europe shows pronounced seasonality and geographical heterogeneity. Although low, VC during summer is currently sufficient for dengue outbreaks in Southern Europe to commence-if sufficient vector populations (either Ae. aegypti and Ae albopictus) were active and virus were introduced. Under various climate change scenarios, the seasonal peak and time window for dengue epidemic potential increases during the 21st century. Our study maps dengue epidemic potential in Europe and identifies seasonal time windows when major cities are most conducive for dengue transmission from 1901 to 2099. Our findings illustrate, that besides vector control, mitigating greenhouse gas emissions crucially reduces the future epidemic potential of dengue in Europe. (C) 2016 The Authors. Published by ElsevierB.V. This is an open access article under the CC BY license (hiip://c-reaiivecommons.org/licenses,/by/4.0/).
C1 [Liu-Helmersson, Jing; Quam, Mikkel; Wilder-Smith, Annelies; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden.
   [Stenlund, Hans] Umea Univ, Dept Mol Biol, Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Ebi, Kristie] Univ Washington, Seattle, WA 98195 USA.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RP Liu-Helmersson, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden.
EM Jing.Helmersson@umu.se
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015
OI Massad, Eduardo/0000-0002-7200-2916; Stenlund, Hans/0000-0001-9943-296X;
   Rocklov, Joacim/0000-0003-4030-0449; Helmersson,
   Jing/0000-0001-9647-1015
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V12060
   Bouzid M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-781
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Centers for Disease Control and Prevention (CDC), 2015, MOSQ HORN TRANSM INF
   Chan M., 2012, INCUBATION PERIODS D
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   European Centre for Disease Prevention and Control, 2014, ANN EP REP EM VECT B
   European Centre for Disease Prevention and Control, 2012, EP UPD OUTBR DENG MA
   European Centre for Disease Prevention and Control (ECDC), 2016, MOSQ MAPS AED AEG CU
   European Centre for Disease Prevention and Control (ECDC), 2013, AED ALB
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hales S, 1996, LANCET, V348, P1664, DOI 10.1016/S0140-6736(05)65737-6
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Hofstra N, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010100
   Jones P., 2014, CRU TS3 22 CLIMATIC
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Massad E, 2012, MEM I OSWALDO CRUZ, V107, P564, DOI 10.1590/S0074-02762012000400022
   McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341
   Morillon M, 2002, EUROPEAN ANTHR ASS B, P211
   Murray C J L, 2015, LANCET
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   PERICCHI LR, 1991, INT STAT REV, V59, P1, DOI 10.2307/1403571
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rogers DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0562
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1
   THEILER M, 1960, P SOC EXP BIOL MED, V103, P244, DOI 10.3181/00379727-103-25474
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612
   Warszawski L, 2014, P NATL ACAD SCI USA, V111, P3228, DOI 10.1073/pnas.1312330110
   Weyant J., 2009, IPCC, V2015
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2014, EURO SURVEILL, V19
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   World Climate, 2015, GLOB CLIM AGR HAS BE
   World Health Organization, 2015, CLIM HLTH COUNTR PRO
   Yang HM, 2014, BIOSYSTEMS, V126, P52, DOI 10.1016/j.biosystems.2014.10.002
NR 64
TC 59
Z9 60
U1 1
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD MAY
PY 2016
VL 7
BP 267
EP 277
DI 10.1016/j.ebiom.2016.03.046
PG 11
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DO0HJ
UT WOS:000377459700039
PM 27322480
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Ximenes, R
   Amaku, M
   Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Greenhalgh, D
   Wilder-Smith, A
   Struchiner, CJ
   Massad, E
AF Ximenes, Raphael
   Amaku, Marcos
   Lopez, Luis Fernandez
   Bezerra Coutinho, Francisco Antonio
   Burattini, Marcelo Nascimento
   Greenhalgh, David
   Wilder-Smith, Annelies
   Struchiner, Claudio Jose
   Massad, Eduardo
TI The risk of dengue for non-immune foreign visitors to the 2016 summer
   olympic games in Rio de Janeiro, Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Mathematical models; Risk assessment; Olympic games; Travel
   medicine
ID FIFA WORLD CUP; REEMERGENCE; VIRUSES
AB Background: Rio de Janeiro in Brazil will host the Summer Olympic Games in 2016. About 400,000 non-immune foreign tourists are expected to attend the games. As Brazil is the country with the highest number of dengue cases worldwide, concern about the risk of dengue for travelers is justified.
   Methods: A mathematical model to calculate the risk of developing dengue for foreign tourists attending the Olympic Games in Rio de Janeiro in 2016 is proposed. A system of differential equation models the spread of dengue amongst the resident population and a stochastic approximation is used to assess the risk to tourists. Historical reported dengue time series in Rio de Janeiro for the years 2000-2015 is used to find out the time dependent force of infection, which is then used to estimate the potential risks to a large tourist cohort. The worst outbreak of dengue occurred in 2012 and this and the other years in the history of Dengue in Rio are used to discuss potential risks to tourists amongst visitors to the forthcoming Rio Olympics.
   Results: The individual risk to be infected by dengue is very much dependent on the ratio asymptomatic/symptomatic considered but independently of this the worst month of August in the period studied in terms of dengue transmission, occurred in 2007.
   Conclusions: If dengue returns in 2016 with the pattern observed in the worst month of August in history (2007), the expected number of symptomatic and asymptomatic dengue cases among tourists will be 23 and 206 cases, respectively. This worst case scenario would have an incidence of 5.75 (symptomatic) and 51.5 (asymptomatic) per 100,000 individuals.
C1 [Ximenes, Raphael; Amaku, Marcos; Lopez, Luis Fernandez; Bezerra Coutinho, Francisco Antonio; Burattini, Marcelo Nascimento; Greenhalgh, David; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
   [Ximenes, Raphael; Amaku, Marcos; Lopez, Luis Fernandez; Bezerra Coutinho, Francisco Antonio; Burattini, Marcelo Nascimento; Greenhalgh, David; Massad, Eduardo] HCFMUSP LIM01, Sao Paulo, SP, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, Ctr Internet Augmented Res & Assessment, Miami, FL 33199 USA.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Greenhalgh, David] Univ Strathclyde, Glasgow, Lanark, Scotland.
   [Wilder-Smith, Annelies] Nanyang Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programme Sci Computat, Rio De Janeiro, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.; Massad, E (corresponding author), HCFMUSP LIM01, Sao Paulo, SP, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London WC1, England.
EM edmassad@usp.br
RI Wilder-Smith, Annelies/F-8751-2015; Coutinho, Francisco A B/H-5644-2011;
   Burattini, Marcelo N/J-9272-2014; Struchiner, Claudio J/M-9360-2013;
   Lopez, Luis F/C-4721-2012; Massad, Eduardo/B-1169-2012; Ximenes,
   Raphael/G-2881-2014; Amaku, Marcos/D-5252-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Struchiner, Claudio J/0000-0003-2114-847X; Lopez,
   Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Ximenes, Raphael/0000-0003-2536-951X; Amaku, Marcos/0000-0003-4752-6774
FU LIM01-HCFMUSP; CNPqNational Council for Scientific and Technological
   Development (CNPq) [300981/2014-7]; FAPESPFundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [2012/18463-4]; Brazilian Ministry of
   Health (Fundo Nacional de Saude) [777588/2012]; Dengue Tools under the
   Health theme of the Seventh Framework Programme of the European
   Community [282589]; Leverhulme Trust Research FellowshipLeverhulme Trust
   [RF-2015-88]
FX Funding This study received partial funding from LIM01-HCFMUSP, CNPq
   (grant 300981/2014-7), FAPESP (grant 2012/18463-4), Brazilian Ministry
   of Health (Fundo Nacional de Saude, grant 777588/2012), Dengue Tools
   under the Health theme of the Seventh Framework Programme of the
   European Community (Grant Agreement Number 282589) and was also
   partially funded by Leverhulme Trust Research Fellowship grant
   (RF-2015-88) (DG).
CR Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10570
   Aguiar M, 2015, LANCET INFECT DIS, V15, P765, DOI 10.1016/S1473-3099(15)00073-0
   Amaku M, 2015, EPIDEMIOL INFECT, V143, P1803, DOI 10.1017/S0950268814002660
   [Anonymous], COORD GER PROGR NAC
   Barcellos C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003022
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Duong V, 2015, PNAS, P1
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Harley D, 2014, LANCET INFECT DIS, V14, P543, DOI 10.1016/S1473-3099(14)70797-2
   Hay S, 2013, NATURE, V503, P439, DOI 10.1038/503439a
   Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006
   Khan K, 2010, CAN MED ASSOC J, V182, P579, DOI 10.1503/cmaj.100093
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387
NR 26
TC 20
Z9 20
U1 0
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 29
PY 2016
VL 16
AR 186
DI 10.1186/s12879-016-1517-z
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DK7BU
UT WOS:000375080600001
PM 27129407
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Massad, E
AF Wilder-Smith, Annelies
   Massad, Eduardo
TI Age specific differences in efficacy and safety for the CYD-tetravalent
   dengue vaccine
SO EXPERT REVIEW OF VACCINES
LA English
DT Article
DE dengue; vaccine; efficacy; age indication; efficacy
ID LATIN-AMERICA; RECOMBINANT; THAILAND; DISEASE; TRIAL
AB CYD-TDV is the first dengue vaccine to have completed Phase 3 efficacy trials. Efficacy was consistently higher in those aged 9 and above for all variables studied: efficacy against virologically confirmed dengue of any severity and serotype, serotype specific efficacy, efficacy dependent on baseline seropositivity, efficacy against hospitalizations and efficacy against severe disease. Because of the higher efficacy and the absence of a safety signal, the age group with the best benefit of the use of CYD-TDV is individuals aged 9 and above - the age group for which licensure is now being sought.
C1 [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RP Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
EM awilder-smith@ntu.edu.sg
RI Wilder-Smith, Annelies/F-8751-2015; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Dorigatti I, 2015, VACCINE, V33, P3746, DOI 10.1016/j.vaccine.2015.05.059
   Gessner BD, 2014, VACCINE, V32, P3133, DOI 10.1016/j.vaccine.2014.04.019
   Gubler D, 2011, VACCINE COMPANION, V4, P1
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079
   Kelly H, 2004, VACCINE, V22, P2192, DOI 10.1016/j.vaccine.2003.11.052
   Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224
   Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
   Wilder-Smith A, 2014, LANCET, V384, P1327, DOI 10.1016/S0140-6736(14)61142-9
NR 20
TC 15
Z9 17
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD APR 2
PY 2016
VL 15
IS 4
SI SI
BP 437
EP 441
DI 10.1586/14760584.2016.1143366
PG 5
WC Immunology
SC Immunology
GA DG6CH
UT WOS:000372169300001
PM 26775653
DA 2020-12-16
ER

PT J
AU Lopez, LF
   Amaku, M
   Coutinho, FAB
   Quam, M
   Burattini, MN
   Struchiner, CJ
   Wilder-Smith, A
   Massad, E
AF Lopez, Luis Fernandez
   Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Quam, Mikkel
   Burattini, Marcelo Nascimento
   Struchiner, Claudio Jose
   Wilder-Smith, Annelies
   Massad, Eduardo
TI Modeling Importations and Exportations of Infectious Diseases via
   Travelers
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Infectious disease importation; Infectious disease exportation;
   Travelers; Modeling; Risk
ID RISK; DENGUE; TRANSMISSION; SPREAD; TRENDS; VIRUS; EBOLA
AB This paper is an attempt to estimate the risk of infection importation and exportation by travelers. Two countries are considered: one disease-free country and one visited or source country with a running endemic or epidemic infectious disease. Two models are considered. In the first model (disease importation), susceptible individuals travel from their disease-free home country to the endemic country and come back after some weeks. The risk of infection spreading in their home country is then estimated supposing the visitors are submitted to the same force of infection as the local population but do not contribute to it. In the second model (disease exportation), it is calculated the probability that an individual from the endemic (or epidemic) country travels to a disease-free country in the condition of latent infected and eventually introduces the infection there. The input of both models is the force of infection at the visited/source country, assumed known. The models are deterministic, but a preliminary stochastic formulation is presented as an appendix. The models are exemplified with two distinct real situations: the risk of dengue importation from Thailand to Europe and the risk of Ebola exportation from Liberia to the USA.
C1 [Lopez, Luis Fernandez; Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Burattini, Marcelo Nascimento; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Quam, Mikkel] Umea Univ, Epidemiol & Global Hlth, Umea, Sweden.
   [Burattini, Marcelo Nascimento] Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Struchiner, Claudio Jose] Fiocruz MS, PROCC, BR-21045900 Rio De Janeiro, Brazil.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Nanyang, Singapore.
   [Wilder-Smith, Annelies] Technol Univ, Singapore, Singapore.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London WC1, England.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012;
   Wilder-Smith, Annelies/F-8751-2015; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011; Struchiner,
   Claudio J/M-9360-2013
OI Burattini, Marcelo N/0000-0002-5407-6890; Lopez, Luis
   F/0000-0003-4097-6887; Amaku, Marcos/0000-0003-4752-6774; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; Struchiner, Claudio J/0000-0003-2114-847X
FU HSP/UNIFESP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); Ministry of Health (Fundo Nacional de Saude)
   [27835/2012]; DengueTools [282589];  [LIM01-HCFMUSP]
FX This study received partial funding from LIM01-HCFMUSP, HSP/UNIFESP,
   CNPq, FAPESP, Ministry of Health (Fundo Nacional de Saude, grant
   27835/2012), and was also partially funded by DengueTools (22) under the
   Health theme of the Seventh Framework Programme of the European
   Community (Grant Agreement Number 282589), DengueTools: innovative tools
   and strategies for the surveillance and control of dengue.
   <http://www.ncbi.nlm.nih.gov/pubmed/22451836> (Wilder-Smith et al.
   2012).
CR Amaku M, 2015, EPIDEMIOL INFECT, V143, P1803, DOI 10.1017/S0950268814002660
   ANDERSON R M, 1991
   Bossak BH, 2009, MED HYPOTHESES, V72, P749, DOI 10.1016/j.mehy.2008.12.045
   Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143
   Cox D R, 1965, THEORY STOCHASTIC PR
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Khan K, 2010, J TRAVEL MED, V17, P75, DOI 10.1111/j.1708-8305.2010.00397.x
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Leder K, 2008, J TRAVEL MED, V15, P263, DOI 10.1111/j.1708-8305.2008.00218.x
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/s1473-3099(14)70995-8, 10.1016/S1473-3099(14)70995-8]
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2004, MED HYPOTHESES, V63, P911, DOI 10.1016/j.mehy.2004.03.028
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2007, MED HYPOTHESES, V68, P442, DOI 10.1016/j.mehy.2006.07.041
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2010, MEM I OSWALDO CRUZ, V105, P179, DOI 10.1590/S0074-02762010000200012
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   WHO World Health Organization, 2014, WHO WHO EB RESP ROAD
   Wilder-Smith A, 2007, TROP MED INT HEALTH, V12, P1137, DOI 10.1111/j.1365-3156.2007.01912.x
   Wilder-Smith A, 2003, J TRAVEL MED, V10, P257
   Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
NR 29
TC 28
Z9 28
U1 1
U2 23
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD FEB
PY 2016
VL 78
IS 2
BP 185
EP 209
DI 10.1007/s11538-015-0135-z
PG 25
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA DF3LG
UT WOS:000371244900001
PM 26763222
OA Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
   Tan, SH
   Khan, K
   Wilder-Smith, A
AF Massad, Eduardo
   Tan, Ser-Han
   Khan, Kamran
   Wilder-Smith, Annelies
TI Estimated Zika virus importations to Europe by travellers from Brazil
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika virus; travel; importations; Brazil; Europe
ID DENGUE HEMORRHAGIC-FEVER; TRANSMISSION; OUTBREAK; AREAS; RISK
AB Background: Given the interconnectivity of Brazil with the rest of the world, Zika virus (ZIKV) infections have the potential to spread rapidly around the world via viremic travellers. The extent of spread depends on the travel volume and the endemicity in the exporting country. In the absence of reliable surveillance data, we did mathematical modelling to estimate the number of importations of ZIKV from Brazil into Europe.
   Design: We applied a previously developed mathematical model on importations of dengue to estimate the number of ZIKV importations into Europe, based on the travel volume, the probability of being infected at the time of travel, the population size of Brazil, and the estimated incidence of ZIKV infections.
   Results: Our model estimated between 508 and 1,778 imported infections into Europe in 2016, of which we would expect between 116 and 355 symptomatic Zika infections; with the highest number of importations being into France, Portugal and Italy.
   Conclusions: Our model identified high-risk countries in Europe. Such data can assist policymakers and public health professionals in estimating the extent of importations in order to prepare for the scale up of laboratory diagnostic assays and estimate the occurrence of Guillain-Barre Syndrome, potential sexual transmission, and infants with congenital ZIKV syndrome.
C1 [Massad, Eduardo] Univ Sao Paolo, Dept Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
   [Tan, Ser-Han] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Bergheimer Str 58, D-69115 Heidelberg, Germany.
   [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RP Wilder-Smith, A (corresponding author), Lee Kong Chian Sch Med, 11 Mandalay Rd, Singapore 308232, Singapore.
EM anneliesws@gmail.com
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015
OI Massad, Eduardo/0000-0002-7200-2916; 
FU European Commission 7th framework, under Dengue Tools consortium
   [282589]
FX This work was partially funded for AWS and EM through the European
   Commission 7th framework, under the Dengue Tools consortium (Grant No.
   282589). The funders played no role in the study design, data
   collection, analysis, or preparation of the manuscript.
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], LANCET INFECT DIS, V387, P719
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   ECDC, 2016, EP SIT ZIK OUTBR EUR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Helmerson J. L., 2016, EBIOMEDICINE
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Venturi G, 2016, EURO SURVEILL, V21
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   World Health Organization, 2016, ZIK VIR SIT REP
NR 30
TC 35
Z9 35
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2016
VL 9
BP 1
EP 7
AR 31669
DI 10.3402/gha.v9.31669
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM0ZZ
UT WOS:000376076100001
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Lopez, LF
   Coutinho, FAB
   Siqueira, JB
   Homsani, S
   Sarti, E
   Massad, E
AF Burattini, Marcelo N.
   Lopez, Luis F.
   Coutinho, Francisco A. B.
   Siqueira-, Joao B., Jr.
   Homsani, Sheila
   Sarti, Elsa
   Massad, Eduardo
TI Age and regional differences in clinical presentation and risk of
   hospitalization for dengue in Brazil, 2000-2014
SO CLINICS
LA English
DT Article
DE Dengue; Morbidity; Epidemiology; Surveillance System; Hospitalization;
   Brazil
ID HEMORRHAGIC-FEVER; CASE DEFINITIONS; CLASSIFICATION; COUNTRIES
AB OBJECTIVES: Dengue cases range from asymptomatic to severe, eventually leading to hospitalization and death. Timely and appropriate management is critical to reduce morbidity. Since 1980, dengue has spread throughout Brazil, affecting an increasing number of individuals. This paper describes age and regional differences in dengue's clinical presentation and associated risk of hospitalization based on more than 5 million cases reported to the Brazilian Ministry of Health from 2000-2014.
   METHODS: We performed a retrospective analysis of similar to 5,450,000 dengue cases, relating clinical manifestations and the risk of hospitalization to age, gender, previous infection by dengue, dengue virus serotype, years of formal education, delay to first attendance and the occurrence of dengue during outbreaks and in different Brazilian regions.
   RESULTS: Complicated forms of dengue occurred more frequently among those younger than 10 years (3.12% vs 1.92%) and those with dengue virus 2 infection (7.65% vs 2.42%), with a delay to first attendance >2 days (3.18% vs 0.82%) and with <= 4 years of formal education (2.02% vs 1.46%). The risk of hospitalization was higher among those aged 6-10 years old (OR 4.57; 95% CI 1.43-29.96) and those who were infected by dengue virus 2 (OR 6.36; 95% CI 2.52-16.06), who lived in the Northeast region (OR 1.38; 95% CI 1.11-2.10) and who delayed first attendance by >5 days (composite OR 3.15; 95% CI 1.33-8.9).
   CONCLUSIONS: In Brazil, the occurrence of severe dengue and related hospitalization is associated with being younger than 10 years old, being infected by dengue virus 2 or 3, living in the Northeast region (the poorest and the second most populated) and delaying first attendance for more than 2 days.
C1 [Burattini, Marcelo N.; Lopez, Luis F.; Coutinho, Francisco A. B.; Massad, Eduardo] Univ Sao Paulo, Fac Med, Div Informat Med, Sao Paulo, SP, Brazil.
   [Burattini, Marcelo N.] Escola Paulista Med, Hosp Sao Paulo, Sao Paulo, SP, Brazil.
   [Lopez, Luis F.] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Siqueira-, Joao B., Jr.] Univ Fed Goias, Inst Trop Patol & Saude Publ, Goiania, Go, Brazil.
   [Homsani, Sheila] Sanofi Pasteur, Sao Paulo, SP, Brazil.
   [Sarti, Elsa] Sanofi Pasteur Latinoamer, Mexico City, DF, Mexico.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Fac Med, Div Informat Med, Sao Paulo, SP, Brazil.; Burattini, MN (corresponding author), Escola Paulista Med, Hosp Sao Paulo, Sao Paulo, SP, Brazil.
EM mnburatt@usp.br
RI Lopez, Luis F/C-4721-2012; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014
OI Lopez, Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890
FU Fundo Nacional de Saude of the Brazilian Ministry of Health (FNS)
   [777588/2012]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Hospital Sao Paulo (HSP); EPM-UNIFESP; Sanofi Pasteur; Dengue
   TOOLS (under the health theme of the Seven Framework Program of the
   European Community) [282589];  [LIM 01-HCFMUSP]
FX This work was partially supported by Fundo Nacional de Saude of the
   Brazilian Ministry of Health (FNS, Grant#777588/2012); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): MNB, LFL, EM;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq):
   MNB, LFL, EM; LIM 01-HCFMUSP: MNB, LFL, EM; Hospital Sao Paulo (HSP) and
   EPM-UNIFESP: MNB; Sanofi Pasteur: SH & ES; and Dengue TOOLS (under the
   health theme of the Seven Framework Program of the European Community,
   Grant #282589): EM. The sponsors did not participate in the data
   collection, data analysis, or data interpretation or in the writing of
   the manuscript.
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Castillo VMS, 2011, REV CLIN MED FAM, V4, P25
   Cattand P, 2006, DIS CONTROL PRIORITI
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Cordeiro R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-355
   Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Dom NC, 2013, PROCD SOC BEHV, V105, P183, DOI 10.1016/j.sbspro.2013.11.019
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Lima FR, 2013, CLINICS, V68, P1299, DOI 10.6061/clinics/2013(10)02
   Margolis HS, 2014, 2014 YELLOW BOOK
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Ministerio da Saude, 2013, DENG DIAGN MAN CLIN
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
NR 22
TC 14
Z9 15
U1 0
U2 6
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2016
VL 71
IS 8
BP 455
EP 463
DI 10.6061/clinics/2016(08)08
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV4CK
UT WOS:000382872200008
PM 27626476
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU da Rocha, AF
   Massad, E
   dos Santos, PCC
   Pereira, A
AF da Rocha, Armando Freitas
   Massad, Eduardo
   dos Santos, Paulo Cesar C.
   Pereira, Alfredo, Jr.
TI A neurobiologically inspired model of social cognition: Memes spreading
   in the Internet
SO BIOLOGICALLY INSPIRED COGNITIVE ARCHITECTURES
LA English
DT Article
DE Memetics; Fuzzy logics; Biologically inspired architectures; Internet;
   Facebook
ID REWARD; CORTEX; BRAIN
AB The field of memetics has attracted interdisciplinary attention as a biologically inspired approach to animal communication and sharing of human cultural patterns. Here a formalization of the theory of memes is proposed, making use of a formal language that is adequate to represent neural information processing. This formalization is the basis for our development of a model of social cognition including mathematical tools derived from the field of epidemiology. The model describes processes of communication between individuals of the same biological species, which share the same computational mechanisms of neural information processing. An example of the 'modus operandi' of the model is shown, consisting of a brief study of meme spreading in the Internet. Among the results of this study, we highlight: (1) The operationalization of memetics in a cognitive architecture that is based on biological constraints and possible to be implemented in digital computers; (2) the proposed model of meme spreading in an online social network may be of interest for public organisations, private corporations and people in general; and (3) the limitation of modeling should be considered when interpreting data about any dynamical phenomenon. (C) 2015 Elsevier B.V. All rights reserved.
C1 [da Rocha, Armando Freitas; Massad, Eduardo; dos Santos, Paulo Cesar C.] Univ Sao Paulo, Dept Med Informat, BR-05508 Sao Paulo, Brazil.
   [Pereira, Alfredo, Jr.] State Univ Sao Paulo UNESP, Inst Biosci, Dept Educ, Sao Paulo, Brazil.
RP Pereira, A (corresponding author), State Univ Sao Paulo UNESP, Inst Biosci, Dept Educ, Sao Paulo, Brazil.
EM apj@ibb.unesp.br
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514
   ANDERSON R M, 1991
   Blackmore Susan, 1999, MEME MACHINE
   Chomsky Noam, 1965, ASPECTS THEORY SYNTA
   Da Rocha AF, 2009, J BIOL SYST, V17, P597, DOI 10.1142/S021833900900306X
   Dawkins R., 1976, SELFISH GENE
   Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a
   Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176
   Frith C., 2007, CURR BIOL, V17, P315
   Frith C, 2010, NEURON, V65, P739, DOI 10.1016/j.neuron.2010.03.015
   Gal N., 2015, NEW MEDIA SOC, V1, P17
   Giiroglu B., 2010, SOCIAL COGNITIVE AFF
   Guroglu B, 2011, NEUROIMAGE, V57, P634, DOI 10.1016/j.neuroimage.2011.04.032
   Hollerman JR, 1998, NAT NEUROSCI, V1, P304
   Hoperoft J. E., 1979, INTRO AUTOMATA THEOR
   JafariAsbagh M, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0237-x
   Kligler-Vilenchik N., 2015, NEW MEDIA SOC, V1, P19
   Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052
   LEE ET, 1969, INFORM SCIENCES, V1, P421, DOI 10.1016/0020-0255(69)90025-5
   Massad E, 2006, KYBERNETES, V35, P1653, DOI 10.1108/03684920610688649
   Massad E., 2013, APPL MATH SCI, V7, P2295
   OECD, 2011, PERSP GLOB DEV 2012
   Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230
   Rocha A., 2005, BRAIN FUZZY GRAMMAR
   Rocha A. F., 1980, Fuzzy Sets and Systems, V3, P11, DOI 10.1016/0165-0114(80)90003-2
   Rocha AF, 2006, KYBERNETES, V35, P1414, DOI 10.1108/03684920610662449
   Rocha A.F., 2002, EVOLVING ARITHMETICA
   Rocha AF, 1998, INFORM SCIENCES, V106, P123, DOI 10.1016/S0020-0255(97)10005-6
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   Ropp C., 2015, J CONSCIOUSNESS EXPL, V6, P164
   Stepanyuk A, 2015, BIOL INSPIR COGN ARC, V13, P48, DOI 10.1016/j.bica.2015.06.006
   Teixeira J.F., 2008, ABSTRACTA, V4, P123
   Tomasello M., 1999, CULTURAL ORIGINS HUM
   Tremblay L, 1999, NATURE, V398, P704
   White T. D., 1997, NATURE, V243, P742
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
   Zamir M, 2001, J GEN PHYSIOL, V118, P267, DOI 10.1085/jgp.118.3.267
NR 37
TC 2
Z9 2
U1 0
U2 34
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-683X
EI 2212-6848
J9 BIOL INSPIR COGN ARC
JI Biol. Inspired Cogn. Archit.
PD OCT
PY 2015
VL 14
BP 86
EP 96
DI 10.1016/j.bica.2015.09.001
PG 11
WC Computer Science, Artificial Intelligence; Neurosciences
SC Computer Science; Neurosciences & Neurology
GA CW5TS
UT WOS:000365060100007
OA Green Published
DA 2020-12-16
ER

PT J
AU Helmersson, JL
   Quam, M
   Stenlund, H
   Wilder-Smith, A
   Ebi, K
   Massad, E
   Rocklov, J
AF Helmersson, J. L.
   Quam, M.
   Stenlund, H.
   Wilder-Smith, A.
   Ebi, K.
   Massad, E.
   Rocklov, J.
TI Seasonality of dengue epidemic potential in Europe - based on vectorial
   capacity for Aedes mosquitoes
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Helmersson, J. L.; Quam, M.; Rocklov, J.] Publ Hlth & Internal Med, Umea, Sweden.
   [Stenlund, H.] Umea Univ, Dept Mol Biol, Umea, Sweden.
   [Wilder-Smith, A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Ebi, K.] Univ Washington, Publ Hlth, Seattle, WA 98195 USA.
   [Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
BP 113
EP 113
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758800276
DA 2020-12-16
ER

PT J
AU Massad, E
   Lopez, LF
   Amaku, M
   Coutinho, FAB
   Quam, M
   Burattini, MN
   Struchiner, CJ
   Wilder-Smith, A
AF Massad, E.
   Lopez, L. F.
   Amaku, M.
   Coutinho, F. A. B.
   Quam, M.
   Burattini, M. N.
   Struchiner, C. J.
   Wilder-Smith, A.
TI The risk of infectious diseases introduction into non-infected countries
   by travelers visiting endemic countries
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Massad, E.; Lopez, L. F.; Amaku, M.; Coutinho, F. A. B.; Burattini, M. N.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Quam, M.] Umea Univ, Umea, Sweden.
   [Struchiner, C. J.] Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil.
   [Wilder-Smith, A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RI Burattini, Marcelo N/J-9272-2014; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011; Struchiner,
   Claudio J/M-9360-2013; Lopez, Luis F/C-4721-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Amaku,
   Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071; Struchiner, Claudio
   J/0000-0003-2114-847X; Lopez, Luis F/0000-0003-4097-6887
NR 0
TC 0
Z9 0
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.098
BP 340
EP 340
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802088
DA 2020-12-16
ER

PT J
AU Quam, MB
   Helmersson, JL
   Massad, E
   Wilder-Smith, A
   Rockl, J
AF Quam, M. B.
   Helmersson, J. L.
   Massad, E.
   Wilder-Smith, A.
   Rockl, J.
TI Madeira's dengue outbreak in 2012: could it happen again in the near
   future?
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Quam, M. B.; Helmersson, J. L.; Wilder-Smith, A.; Rockl, J.] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden.
   [Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Wilder-Smith, A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.282
BP 408
EP 409
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802261
DA 2020-12-16
ER

PT J
AU Struchiner, CJ
   Rocklov, J
   Wilder-Smith, A
   Massad, E
AF Struchiner, Claudio Jose
   Rockloev, Joacim
   Wilder-Smith, Annelies
   Massad, Eduardo
TI Increasing Dengue Incidence in Singapore over the Past 40 Years:
   Population Growth, Climate and Mobility
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI; VIRUS; URBANIZATION; EPIDEMIOLOGY; SURVEILLANCE;
   TEMPERATURE; INFECTION; EMERGENCE; IMPACT
AB In Singapore, the frequency and magnitude of dengue epidemics have increased significantly over the past 40 years. It is important to understand the main drivers for the rapid increase in dengue incidence. We studied the relative contributions of putative drivers for the rise of dengue in Singapore: population growth, climate parameters and international air passenger arrivals from dengue endemic countries, for the time period of 1974 until 2011. We used multivariable Poisson regression models with the following predictors: Annual Population Size; Aedes Premises Index; Mean Annual Temperature; Minimum and Maximum Temperature Recorded in each year; Annual Precipitation and Annual Number of Air Passengers arriving from dengue-endemic South-East Asia to Singapore. The relative risk (RR) of the increase in dengue incidence due to population growth over the study period was 42.7, while the climate variables (mean and minimum temperature) together explained an RR of 7.1 (RR defined as risk at the end of the time period relative to the beginning and goodness of fit associated with the model leading to these estimates assessed by pseudo-R2 equal to 0.83). Estimating the extent of the contribution of these individual factors on the increasing dengue incidence, we found that population growth contributed to 86% while the residual 14% was explained by increase in temperature. We found no correlation with incoming air passenger arrivals into Singapore from dengue endemic countries. Our findings have significant implications for predicting future trends of the dengue epidemics given the rapid urbanization with population growth in many dengue endemic countries. It is time for policy-makers and the scientific community alike to pay more attention to the negative impact of urbanization and urban climate on diseases such as dengue.
C1 [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Struchiner, Claudio Jose] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Rockloev, Joacim; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] LIM01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden.
EM anneliesws@gmail.com
RI Struchiner, Claudio J/M-9360-2013; Massad, Eduardo/B-1169-2012;
   Wilder-Smith, Annelies/F-8751-2015
OI Struchiner, Claudio J/0000-0003-2114-847X; Massad,
   Eduardo/0000-0002-7200-2916; Rocklov, Joacim/0000-0003-4030-0449
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [282589]; Brazilian Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); State of Rio de Janeiro
   Research Funding Agency (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX The research was funded by the European Commission under the 7th
   Framework, Grant Agreement Number: 282589. CJS was partially funded by
   The Brazilian Research Council (CNPq) and the State of Rio de Janeiro
   Research Funding Agency (FAPERJ).
CR Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Fahrmeir L., 2013, REGRESSION MODELS ME
   Fokianos K, 2009, J AM STAT ASSOC, V104, P1430, DOI 10.1198/jasa.2009.tm08270
   GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Harrell FE, 2001, REGRESSION MODELING
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Jones P, 2008, CRU TIME SERIES TS H
   Kedem KF, 2002, REGRESSION MODELS TI
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu-Helmersson J, 2014, PLOS ONE PRINT
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Oki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048258
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Reiter P, 1996, B SOC PATHOL EXOT, V89, P120
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Team RC. R Core Team, 2013, R LANG ENV STAT COMP
   Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701
   Wilder-Smith A, 2012, GLOBAL HLTH ACTION, V5
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 42
TC 57
Z9 58
U1 2
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 31
PY 2015
VL 10
IS 8
AR e0136286
DI 10.1371/journal.pone.0136286
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ2MT
UT WOS:000360435500017
PM 26322517
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Amaku, M
   Azevedo, F
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Massad, E
AF Amaku, M.
   Azevedo, F.
   Burattini, M. N.
   Coutinho, F. A. B.
   Lopez, L. F.
   Massad, E.
TI Interpretations and pitfalls in modelling vector-transmitted infections
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Dengue; mathematical modelling; vector-borne infections
ID THRESHOLD CONDITIONS; DENGUE; DYNAMICS; COMPLEX; SPREAD; NUMBER; FEVER;
   RISK
AB In this paper we propose a debate on the role of mathematical models in evaluating control strategies for vector-borne infections. Mathematical models must have their complexity adjusted to their goals, and we have basically two classes of models. At one extreme we have models that are intended to check if our intuition about why a certain phenomenon occurs is correct. At the other extreme, we have models whose goals are to predict future outcomes. These models are necessarily very complex. There are models in between these classes. Here we examine two models, one of each class and study the possible pitfalls that may be incurred. We begin by showing how to simplify the description of a complicated model for a vector-borne infection. Next, we examine one example found in a recent paper that illustrates the dangers of basing control strategies on models without considering their limitations. The model in this paper is of the second class. Following this, we review an interesting paper (a model of the first class) that contains some biological assumptions that are inappropriate for dengue but may apply to other vector-borne infections. In conclusion, we list some misgivings about modelling presented in this paper for debate.
C1 [Amaku, M.] Univ Sao Paulo, Sch Vet Med, Sao Paulo, Brazil.
   [Azevedo, F.; Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Azevedo, F.; Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Massad, E.] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Lopez, L. F.] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Massad, E.] Univ London, London Sch Hyg & Trop Med, London, England.
RP Coutinho, FAB (corresponding author), Ave Doutor Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM coutinho@dim.fm.usp.br
RI Amaku, Marcos/D-5252-2012; Coutinho, Francisco A B/H-5644-2011; Lopez,
   Luis F/C-4721-2012; Massad, Eduardo/B-1169-2012; Burattini, Marcelo
   N/J-9272-2014
OI Amaku, Marcos/0000-0003-4752-6774; Coutinho, Francisco A
   B/0000-0003-3127-3071; Lopez, Luis F/0000-0003-4097-6887; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890
FU FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Dengue Tools [282589]; MS/FNS [27835/2012];  [LIM01 HCFMUSP]
FX This work was partially supported by LIM01 HCFMUSP, Fapesp, CNPq, Dengue
   Tools under the Seventh Framework Programme of the European Community,
   grant agreement no. 282589, and MS/FNS (grant no. 27835/2012).
CR Amaku M, 2013, COMP MATH MATH PHYS, V2013
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   ANDERSON R M, 1991
   Burattini MN, 2009, MED HYPOTHESES, V73, P110, DOI 10.1016/j.mehy.2009.01.036
   Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Lopez LF, 1999, MATH COMPUT MODEL, V29, P55, DOI 10.1016/S0895-7177(99)00062-X
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108
   Mazilu DA, 2012, EUR J PHYS, V33, P793, DOI 10.1088/0143-0807/33/4/793
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Postnikov EB, 2007, MATH BIOSCI, V208, P205, DOI 10.1016/j.mbs.2006.10.004
   Riley S, EPIDEMICS IN PRESS
   Ross R., 1911, PREVENTION MALARIA
NR 22
TC 5
Z9 5
U1 0
U2 24
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2015
VL 143
IS 9
BP 1803
EP 1815
DI 10.1017/S0950268814002660
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CJ8NU
UT WOS:000355760600002
PM 25417817
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Leong, WY
   Lopez, LF
   Amaku, M
   Quam, M
   Khan, K
   Massad, E
AF Wilder-Smith, Annelies
   Leong, Wei-Yee
   Lopez, Luis Fernandez
   Amaku, Marcos
   Quam, Mikkel
   Khan, Kamran
   Massad, Eduardo
TI Potential for international spread of wild poliovirus via travelers
SO BMC MEDICINE
LA English
DT Article
DE Poliomyelitis; Travel; Importation; International spread; Secondary
   cases; Polio vaccination; India; Hajj pilgrimage; Policy; Polio
   eradication; Mathematical model
ID POLIOMYELITIS; ERADICATION; PROGRESS; SURVEILLANCE; IMPORTATION;
   WORLDWIDE; OUTBREAK
AB Background: The endgame of polio eradication is hampered by the international spread of poliovirus via travelers. In response to ongoing importations of poliovirus into polio-free countries, on 5 May 2014, WHO's Director-General declared the international spread of wild poliovirus a public health emergency of international concern. Our objective was to develop a mathematical model to estimate the international spread of polio infections.
   Methods: Our model took into account polio endemicity in polio-infected countries, population size, polio immunization coverage rates, infectious period, the asymptomatic-to-symptomatic ratio, and also the probability of a traveler being infectious at the time of travel. We applied our model to three scenarios: (1) number of exportations of both symptomatic and asymptomatic polio infections out of currently polio-infected countries, (2) the risk of spread of poliovirus to Saudi Arabia via Hajj pilgrims, and (3) the importation risk of poliovirus into India.
   Results: Our model estimated 665 polio exportations (>99 % of which were asymptomatic) from nine polio-infected countries in 2014, of which 78.3 % originated from Pakistan. Our model also estimated 21 importations of poliovirus into Saudi Arabia via Hajj pilgrims and 20 poliovirus infections imported to India in the same year.
   Conclusion: The extent of importations of asymptomatic and symptomatic polio infections is substantial. For countries that are vulnerable to polio outbreaks due to poor national polio immunization coverage rates, our newly developed model may help guide policy-makers to decide whether imposing an entry requirement in terms of proof of vaccination against polio would be justified.
C1 [Wilder-Smith, Annelies; Leong, Wei-Yee] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Lopez, Luis Fernandez] Florida Int Univ, Miami, FL 33199 USA.
   [Amaku, Marcos] Univ Sao Paulo, Fac Vet Med, Sao Paulo, Brazil.
   [Quam, Mikkel] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada.
   [Khan, Kamran] Univ Toronto, Fac Med, Div Infect Dis, Toronto, ON, Canada.
   [Lopez, Luis Fernandez; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Mandalay Rd 11, Singapore 308232, Singapore.
EM anneliesws@gmail.com
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012; Lopez, Luis
   F/C-4721-2012; Wilder-Smith, Annelies/F-8751-2015
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916;
   Lopez, Luis F/0000-0003-4097-6887; 
CR Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8
   Andre M, 2014, MMWR-MORBID MORTAL W, V63, P756
   [Anonymous], 2014, POLIO PUBLIC HLTH EM
   Arie S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2481
   Atkinson W, 2009, EPIDEMIOLOGY PREVENT
   Aylward RB, 2014, LANCET, V383, P489, DOI 10.1016/S0140-6736(14)60132-X
   Chambers ST, 2011, NEW ZEAL MED J, V124, P100
   Cochi SL, 2014, J INFECT DIS, V210, pS1, DOI 10.1093/infdis/jiu383
   FRIEDRICH MJ, 2014, JAMA J AM MED ASSOC, V311, P666
   GELFAND HM, 1957, AM J HYG, V65, P367, DOI 10.1093/oxfordjournals.aje.a119876
   Kamadjeu R, 2014, J INFECT DIS, V210, pS181, DOI 10.1093/infdis/jiu453
   Khan K, 2013, PLOS CURRENTS OUTBRE
   Levitt A, 2014, MMWR-MORBID MORTAL W, V63, P356
   Mach O, 2014, J INFECT DIS, V210, pS275, DOI 10.1093/infdis/jit454
   Ministry of Tourism. Government of India, COUNTR WIS DISTR FTA
   Moturi EK, 2014, MMWR-MORBID MORTAL W, V63, P468
   O'Reilly KM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001109
   Plotkin S, 2008, VACCINES, P634
   Polio Global Eradicatio Initiative, DAT MON WILD POL LIS
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   The World Bank, DAT LIF EXP BIRTH TO
   The World Bank, DAT TOT POP
   Wen N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-113
   Wilder-Smith A, 2008, EMERG INFECT DIS, V14, P351, DOI 10.3201/eid1402.071245
   World Health Organization, GLOB HLTH OBS DAT RE
   World Tourism Organization, 2013, YB TOUR STAT DAT
   Yakovenko ML, 2014, EUROSURVEILLANCE, V19, P41, DOI 10.2807/1560-7917.ES2014.19.7.20706
NR 27
TC 28
Z9 29
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUN 4
PY 2015
VL 13
DI 10.1186/s12916-015-0363-y
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA CK8JC
UT WOS:000356483300001
PM 26044336
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Laporta, GZ
   Burattini, MN
   Levy, D
   Fukuya, LA
   de Oliveira, TMP
   Maselli, LMF
   Conn, JE
   Massad, E
   Bydlowski, SP
   Sallum, MAM
AF Laporta, Gabriel Zorello
   Burattini, Marcelo Nascimento
   Levy, Debora
   Fukuya, Linah Akemi
   Porangaba de Oliveira, Tatiane Marques
   Ferreira Maselli, Luciana Morganti
   Conn, Jan Evelyn
   Massad, Eduardo
   Bydlowski, Sergio Paulo
   Mureb Sallum, Maria Anice
TI Plasmodium falciparum in the southeastern Atlantic forest: a challenge
   to the bromeliad-malaria paradigm?
SO MALARIA JOURNAL
LA English
DT Article
DE Atlantic forest; Anopheles; Forest fragment; Landscape; Malaria;
   Plasmodium falciparum; Transmission dynamics
ID ASYMPTOMATIC BLOOD-DONORS; SOUTH-EASTERN BRAZIL; SAO-PAULO;
   AUTOCHTHONOUS MALARIA; UNEXPECTED DETECTION; INFECTIOUS-DISEASES;
   NATURAL INFECTION; HOWLER MONKEYS; RAIN-FOREST; VIVAX
AB Background: Recently an unexpectedly high prevalence of Plasmodium falciparum was found in asymptomatic blood donors living in the southeastern Brazilian Atlantic forest. The bromeliad-malaria paradigm assumes that transmission of Plasmodium vivax and Plasmodium malariae involves species of the subgenus Kerteszia of Anopheles and only a few cases of Plasmodium vivax malaria are reported annually in this region. The expectations of this paradigm are a low prevalence of Plasmodium vivax and a null prevalence of Plasmodium falciparum. Therefore, the aim of this study was to verify if Plasmodium falciparum is actively circulating in the southeastern Brazilian Atlantic forest remains.
   Methods: In this study, anophelines were collected with Shannon and CDC-light traps in seven distinct Atlantic forest landscapes over a 4-month period. Field-collected Anopheles mosquitoes were tested by real-time PCR assay in pools of ten, and then each mosquito from every positive pool, separately for Plasmodium falciparum and Plasmodium vivax. Genomic DNA of Plasmodium falciparum or Plasmodium vivax from positive anophelines was then amplified by traditional PCR for sequencing of the 18S ribosomal DNA to confirm Plasmodium species. Binomial probabilities were calculated to identify non-random results of the Plasmodium falciparum-infected anopheline findings.
   Results: The overall proportion of anophelines naturally infected with Plasmodium falciparum was 4.4% (21/480) and only 0.8% (4/480) with Plasmodium vivax. All of the infected mosquitoes were found in intermixed natural and human-modified environments and most were Anopheles cruzii (22/25 = 88%, 18 Plasmodium falciparum plus 4 Plasmodium vivax). Plasmodium falciparum was confirmed by sequencing in 76% (16/21) of positive mosquitoes, whereas Plasmodium vivax was confirmed in only 25% (1/4). Binomial probabilities suggest that Plasmodium falciparum actively circulates throughout the region and that there may be a threshold of the forested over human-modified environment ratio upon which the proportion of Plasmodium falciparum-infected anophelines increases significantly.
   Conclusions: These results show that Plasmodium falciparum actively circulates, in higher proportion than Plasmodium vivax, among Anopheles mosquitoes of fragments of the southeastern Brazilian Atlantic forest. This finding challenges the classical bromeliad-malaria paradigm, which considers Plasmodium vivax circulation as the driver for the dynamics of residual malaria transmission in this region.
C1 [Laporta, Gabriel Zorello; Porangaba de Oliveira, Tatiane Marques; Mureb Sallum, Maria Anice] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01246904 Sao Paulo, SP, Brazil.
   [Laporta, Gabriel Zorello; Burattini, Marcelo Nascimento; Massad, Eduardo] Univ Sao Paulo, Fac Med, Lab Informat Med LIM 01, BR-05405000 Sao Paulo, SP, Brazil.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Escola Paulista Med, Hosp Sao Paulo, Div Doencas Infecc, BR-04024002 Sao Paulo, Brazil.
   [Levy, Debora; Ferreira Maselli, Luciana Morganti; Bydlowski, Sergio Paulo] Univ Sao Paulo, Fac Med, Lab Genet & Hematol Mol LIM 31, BR-05403000 Sao Paulo, SP, Brazil.
   [Fukuya, Linah Akemi; Ferreira Maselli, Luciana Morganti] Univ Sao Paulo, Fac Med, Fundacao Prosangue Hemoctr Sao Paulo, Divisao Pesquisa, BR-05403000 Sao Paulo, SP, Brazil.
   [Conn, Jan Evelyn] Wadsworth Ctr, Dept Hlth, Slingerlands, NY 12159 USA.
   [Conn, Jan Evelyn] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
RP Laporta, GZ (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01246904 Sao Paulo, SP, Brazil.
EM gabrielzorelo@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Sallum,
   Maria Anice Mureb/B-8537-2012; Laporta, Gabriel/B-8662-2012; Levy,
   Debora/G-8208-2014; Laporta, Gabriel/P-3621-2019
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Sallum, Maria Anice
   Mureb/0000-0002-7051-2891; Laporta, Gabriel/0000-0001-7412-9390; Levy,
   Debora/0000-0001-7492-997X; Laporta, Gabriel/0000-0001-7412-9390; Conn,
   Jan/0000-0002-5301-7020
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20397-7];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [301666/2011-3]; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2009/53141-5, 2012/09939-5, 2014/09774-1];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX We are in debited to Marcelo Jacobs-Lorena for providing Anopheles
   mosquitoes infected with Plasmodium; Marcelo Urbano Ferreira for
   Plasmodium samples used as positive controls for the PCRs; financial
   support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP Grant 2011/20397-7) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq no. 301666/2011-3) to MAMS; financial
   support from FAPESP (Grant 2009/53141-5) and CNPq to SBP. GZL had a
   postdoctorate fellowship from FAPESP (Grant 2012/09939-5), and is
   currently supported by FAPESP (Grant 2014/09774-1).
CR Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Branquinho M S, 1997, Rev Panam Salud Publica, V2, P189, DOI 10.1590/S1020-49891997000900004
   Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
   Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578
   Couto RD, 2010, REV SOC BRAS MED TRO, V43, P52, DOI 10.1590/S0037-86822010000100012
   Curado I, 2006, ACTA TROP, V100, P54, DOI 10.1016/j.actatropica.2006.09.010
   de Duarte AMR, 2006, J MED PRIMATOL, V35, P87, DOI 10.1111/j.1600-0684.2006.00148.x
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001
   Duarte AMRC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-58
   Foley DH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-145
   Forattini OP, 1996, REV SAUDE PUBL, V30, P107, DOI 10.1590/S0034-89101996000200001
   Forattini OP, 2002, CULICIDOLOGIA MEDICA
   Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063
   Gadelha P., 1994, Parassitologia (Rome), V36, P175
   Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265
   Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765
   Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54
   Laporta GZ, 2011, MEM I OSWALDO CRUZ, V106, P239, DOI 10.1590/S0074-02762011000900029
   Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442
   LUTZ Adolpho, 2005, CENTRALBLATT BAKTERI, P733
   Marques TC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-41
   Marrelli MT, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-127
   Maselli LMF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-224
   Mendrone A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-336
   Miguel RB, 2014, MEM I OSWALDO CRUZ, V109, P634, DOI 10.1590/0074-0276130558
   Miller SA, 1998, NUCLEIC ACIDS RES, V16, P1215, DOI DOI 10.1093/NAR/16.3.1215
   Sallum MAM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-337
   Neves A, 2013, ACTA TROP, V125, P102, DOI 10.1016/j.actatropica.2012.08.014
   Norman GR, 1994, BARE ESSENTIALS
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004
   Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006
   Rezende HR, 2009, NEOTROP ENTOMOL, V38, P272, DOI 10.1590/S1519-566X2009000200017
   Ribeiro AF, 2012, J VECTOR ECOL, V37, P316, DOI 10.1111/j.1948-7134.2012.00233.x
   Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SERVICE MW, 1993, MOSQUITO ECOLOGY
   Sharp PM, 2013, SCIENCE, V340, P284, DOI 10.1126/science.1236958
   Smith LB, 1952, ANN REP SMITHSON I, V1952, P385
   Sundararaman SA, 2013, P NATL ACAD SCI USA, V110, P7020, DOI 10.1073/pnas.1305201110
   Wayant NM, 2010, GEOSPATIAL HEALTH, V4, P179, DOI 10.4081/gh.2010.199
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x
   Zavortink T.J., 1973, CONTRIBUTIONS AM ENT, V9, P1
NR 46
TC 15
Z9 15
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD APR 25
PY 2015
VL 14
AR 181
DI 10.1186/s12936-015-0680-9
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CH0CI
UT WOS:000353686200001
PM 25909655
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Ribeiro, AF
   Tengan, C
   Sato, HK
   Spinola, R
   Mascheretti, M
   Franca, ACC
   Port-Carvalho, M
   Pereira, M
   de Souza, RP
   Amaku, M
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Massad, E
AF Ribeiro, Ana Freitas
   Tengan, Cilea
   Sato, Helena Keico
   Spinola, Roberta
   Mascheretti, Melissa
   Costa Franca, Ana Cecilia
   Port-Carvalho, Marcio
   Pereira, Mariza
   de Souza, Renato Pereira
   Amaku, Marcos
   Burattini, Marcelo Nascimento
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   Massad, Eduardo
TI A public health risk assessment for yellow fever vaccination: a model
   exemplified by an outbreak in the state of Sao Paulo, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE yellow fever; vaccination; side-effects; mathematical models;
   optimisation; risk estimation
ID REEMERGENCE
AB We propose a method to analyse the 2009 outbreak in the region of Botucatu in the state of Sao Paulo (SP), Brazil, when 28 yellow fever (YF) cases were confirmed, including 11 deaths. At the time of the outbreak, the Secretary of Health of the State of Sao Paulo vaccinated one million people, causing the death of five individuals, an unprecedented number of YF vaccine-induced fatalities. We apply a mathematical model described previously to optimise the proportion of people who should be vaccinated to minimise the total number of deaths. The model was used to calculate the optimum proportion that should be vaccinated in the remaining, vaccine-free regions of SP, considering the risk of vaccine-induced fatalities and the risk of YF outbreaks in these regions.
C1 [Ribeiro, Ana Freitas; Tengan, Cilea; Sato, Helena Keico; Spinola, Roberta; Mascheretti, Melissa; Costa Franca, Ana Cecilia] Ctr Vigilancia Epidemiol, Sao Paulo, SP, Brazil.
   [Port-Carvalho, Marcio] Inst Florestal, Sao Paulo, SP, Brazil.
   [Pereira, Mariza] Superintendencia Controle Endemias Estado Sao Paul, Sao Paulo, SP, Brazil.
   [de Souza, Renato Pereira] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Amaku, Marcos] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, SP, Brazil.
   [Amaku, Marcos; Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Burattini, Marcelo Nascimento] Escola Paulista Med, Hosp Sao Paulo, BR-04023 Sao Paulo, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, Ctr Internet Augmented Res & Assessment, Miami, FL 33199 USA.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Lopez, Luis F/C-4721-2012; Ribeiro, Ana Freitas/P-6862-2015; Amaku,
   Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012; Burattini, Marcelo
   N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011
OI Lopez, Luis F/0000-0003-4097-6887; Amaku, Marcos/0000-0003-4752-6774;
   Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Pereira de Souza, Renato/0000-0003-1315-7085
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); LIM01-HCFMUSP
FX LIM01-HCFMUSP, CNPq, FAPESP
CR Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100
   Costa ZGA, 2011, REV PAN AMAZ SAUDE, V2, P11, DOI DOI 10.5123/S2176-62232011000100002
   DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458
   Fortaleza CMCB, 2009, J VENOM ANIM TOXINS, V15, P186, DOI 10.1590/S1678-91992009000200002
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Monath T, 1991, HUNTERS TROPICAL MED, P233
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moreno ES, 2011, REV INST MED TROP SP, V53, P335, DOI 10.1590/S0036-46652011000600007
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/s0037-86822011005000041, 10.1590/S0037-86822011005000041]
   Ortega N, 2003, KYBERNETES, V32, P460, DOI 10.1108/03684920310463876
   Sao-Joao TM, 2013, REV SAUDE PUBL, V47, P1
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 14
TC 3
Z9 4
U1 0
U2 14
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2015
VL 110
IS 2
BP 230
EP 234
DI 10.1590/0074-02760140345
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CH5HN
UT WOS:000354066400010
PM 25946247
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Raimundo, SM
   Amaku, M
   Massad, E
AF Raimundo, Silvia Martorano
   Amaku, Marcos
   Massad, Eduardo
TI Equilibrium Analysis of a Yellow Fever Dynamical Model with Vaccination
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID POPULATION-DYNAMICS; INFECTIOUS-DISEASES; CONTROL STRATEGIES; DENGUE;
   TRANSMISSION; BRAZIL
AB We propose an equilibrium analysis of a dynamical model of yellow fever transmission in the presence of a vaccine. The model considers both human and vector populations. We found thresholds parameters that affect the development of the disease and the infectious status of the human population in the presence of a vaccine whose protection may wane over time. In particular, we derived a threshold vaccination rate, above which the disease would be eradicated from the human population. We show that if the mortality rate of the mosquitoes is greater than a given threshold, then the disease is naturally (without intervention) eradicated from the population. In contrast, if the mortality rate of the mosquitoes is less than that threshold, then the disease is eradicated from the populations only when the growing rate of humans is less than another threshold; otherwise, the disease is eradicated only if the reproduction number of the infection after vaccination is less than 1. When this reproduction number is greater than 1, the disease will be eradicated from the human population if the vaccination rate is greater than a given threshold; otherwise, the disease will establish itself among humans, reaching a stable endemic equilibrium. The analysis presented in this paper can be useful, both to the better understanding of the disease dynamics and also for the planning of vaccination strategies.
C1 [Raimundo, Silvia Martorano; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, SP, Brazil.
   [Raimundo, Silvia Martorano; Massad, Eduardo] LIM01 HC FMUSP, BR-01246903 Sao Paulo, SP, Brazil.
   [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med & Zootechnol, BR-05508270 Sao Paulo, SP, Brazil.
   [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Avenida Doutor Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012; Raimundo, Silvia
   Martorano/D-4624-2012
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916;
   Raimundo, Silvia Martorano/0000-0002-9960-7341
FU FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); LIM01-HCFMUSP
FX The authors acknowledge financial support from Fapesp, CNPq, and
   LIM01-HCFMUSP. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the paper.
CR Amaku M, 2013, COMP MATH MATH PHYS, V2013
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   CDC (Centers for Disease Control), 2014, CDC YELL FEV
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Forattini O. P., 1996, MED CULICIDOLOGY
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   Hale HK, 1969, ORDINARY DIFFERENTIA
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Mascheretti M, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004341
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/s0037-86822011005000041, 10.1590/S0037-86822011005000041]
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Oldstone M. B. A, 2009, VIRUSES PLAGUES HIST
   Raimundo SM, 2007, APPL MATH COMPUT, V189, P1723, DOI 10.1016/j.amc.2006.12.051
   Smith Billy G., 2013, SHIP DEATH VOYAGE CH
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
NR 27
TC 6
Z9 6
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2015
AR 482091
DI 10.1155/2015/482091
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA CF2QC
UT WOS:000352391200001
PM 25834634
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Ximenes, R
   Amaku, M
   Wilder-Smith, A
AF Massad, Eduardo
   Burattini, Marcelo N.
   Ximenes, Raphael
   Amaku, Marcos
   Wilder-Smith, Annelies
TI Dengue outlook for the World Cup in Brazil
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Massad, Eduardo; Burattini, Marcelo N.; Ximenes, Raphael] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
   [Amaku, Marcos] Univ Sao Paulo, Fac Vet Med, Sao Paulo, Brazil.
   [Burattini, Marcelo N.] Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, Brazil.
   [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
EM anneleisws@gmail.com
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015;
   Ximenes, Raphael/G-2881-2014; Burattini, Marcelo N/J-9272-2014; Amaku,
   Marcos/D-5252-2012
OI Massad, Eduardo/0000-0002-7200-2916; Ximenes,
   Raphael/0000-0003-2536-951X; Burattini, Marcelo N/0000-0002-5407-6890;
   Amaku, Marcos/0000-0003-4752-6774; Wilder-Smith,
   Annelies/0000-0003-0362-5375
CR Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Wilson ME, 2014, TRAVEL MED INFECT DI
NR 4
TC 7
Z9 7
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2014
VL 14
IS 7
BP 552
EP 553
DI 10.1016/S1473-3099(14)70807-2
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA AJ8XG
UT WOS:000337990800016
PM 24929925
DA 2020-12-16
ER

PT J
AU Quam, M
   Massad, E
   Wilder-Smith, A
AF Quam, Mikkel
   Massad, Eduardo
   Wilder-Smith, Annelies
TI Effects of India's new polio policy on travellers
SO LANCET
LA English
DT Letter
C1 [Quam, Mikkel] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RP Quam, M (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden.
EM anneliesws@gmail.com
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015
OI Massad, Eduardo/0000-0002-7200-2916; Wilder-Smith,
   Annelies/0000-0003-0362-5375
CR Chakraborty K, KENYA TOURISM BOARD
   FRIEDRICH MJ, 2014, JAMA J AM MED ASSOC, V311, P666
   Ministry of Tourism, IND TOUR STAT 2012
   O'Reilly KM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001109
   Wilder-Smith A, 2007, TROP MED INT HEALTH, V12, P1137, DOI 10.1111/j.1365-3156.2007.01912.x
NR 5
TC 6
Z9 6
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 10
PY 2014
VL 383
IS 9929
BP 1632
EP 1632
DI 10.1016/S0140-6736(14)60537-7
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA AG8LV
UT WOS:000335670800016
PM 24793057
DA 2020-12-16
ER

PT J
AU de Almeida, MF
   Trezza-Netto, J
   Aires, CC
   de Barros, RF
   da Rosa, AR
   Massad, E
AF de Almeida, Marilene Fernandes
   Trezza-Netto, Jose
   Aires, Caroline Cotrin
   de Barros, Rodrigo Fernandes
   da Rosa, Adriana Ruckert
   Massad, Eduardo
TI Hematologic profile of hematophagous Desmodus rotundus bats before and
   after experimental infection with rabies virus
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Bats; Hematology; Rabies
AB Introduction: Hematophagous Desmodus rotundus bats play an important role in the rabies lifecycle. This study describes the hematological profile of these bats before and after experimental infection with rabies virus. Methods: Cells counts were performed in a Neubauer chamber. Results: The average values of erythrocytes and leucocytes counts in blood before experimental infections were 9.97 x 10(6)mm(3) and 4.80 x 10(3)mm(3), respectively. Neutrophils represented 69.9% of white blood cells and the lymphocytes represented 26.9%. Following the experimental infections, the average numbers of erythrocytes and leucocytes was 9.43 x 10(6)mm(3) and 3.98 x 10(3)mm(3), respectively. Neutrophils represented 40% of white blood cells and the lymphocytes represented 59%. Conclusions: The hematological profile given in this study can serve as reference values for D. rotundus bats.
C1 [de Almeida, Marilene Fernandes; Trezza-Netto, Jose; da Rosa, Adriana Ruckert] Prefeitura Cidade Sao Paulo, Coordenacao Vigilancia Saude, Ctr Controle Zoonoses, Sao Paulo, Brazil.
   [Aires, Caroline Cotrin] Prefeitura Cidade Sao Paulo, Secretaria Municipal Saude, Supervisao Vigilancia Saude, Sao Paulo, Brazil.
   [de Barros, Rodrigo Fernandes] Univ Nove de Julho, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
RP de Almeida, MF (corresponding author), CCZ CVS Prefeitura Cidade Sao Paulo, Rua Santa Eulalia 86, BR-02031020 Sao Paulo, Brazil.
EM lenefalmeida@hotmail.com
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Almeida BFM, 2010, CHIROPTERA NEOTROPIC, V16, P780
   Almeida MF, 2005, EPIDEMIOL INFECT, V133, P523, DOI 10.1017/S0950268804003656
   Almeida MF, 2009, CHIROPTERA NEOTROPIC, V15, P433
   Baptista M, 1997, REV CIENT I PESQ GON, V3, P11
   Krutzsch PH, 1963, J MAMMAL, V44, P547
   Neuweiler G., 2000, BIOL BATS
   Pan-American Health Organization, 2011, SIST INF EP HIST AN
   Ratnasooriya WD, 2005, J SCI U KELANIYA, V2, P27
   Reis N.R., 2007, MORCEGOS BRASIL, P17
   Santos AP, 2007, ACTA SCI VET, V35, P55
   Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X
   Sealander J. A., 1964, Journal of Mammalogy, V45, P598, DOI 10.2307/1377331
   VALDIVIESO D, 1971, CAN J ZOOLOG, V49, P31, DOI 10.1139/z71-007
   Vilar TD, 2005, REV U RURAL, V25, P57
   WITT W, 1994, CIRCULATION, V90, P421, DOI 10.1161/01.CIR.90.1.421
NR 15
TC 0
Z9 1
U1 0
U2 10
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2014
VL 47
IS 3
BP 371
EP 373
DI 10.1590/0037-8682-0169-2013
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AN0SR
UT WOS:000340294800017
PM 25075489
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Massad, E
   Wilder-Smith, A
   Ximenes, R
   Amaku, M
   Lopez, LF
   Coutinho, FAB
   Coelho, GE
   da Silva, JB
   Struchiner, CJ
   Burattini, MN
AF Massad, Eduardo
   Wilder-Smith, Annelies
   Ximenes, Raphael
   Amaku, Marcos
   Lopez, Luis Fernandez
   Bezerra Coutinho, Francisco Antonio
   Coelho, Giovanini Evelim
   da Silva, Jarbas Barbosa, Jr.
   Struchiner, Claudio Jose
   Burattini, Marcelo Nascimento
TI Risk of symptomatic dengue for foreign visitors to the 2014 FIFA World
   Cup in Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Editorial Material
DE dengue; risk; foreign travellers; probabilistic; modelling; World Cup
ID TRAVELERS; FEVER; CHIKUNGUNYA; OUTBREAK; ILLNESS; TRENDS; AREAS
AB Brazil will host the FIFA World Cup T, the biggest single-event competition in the world, from June 12-July 13 2014 in 12 cities. This event will draw an estimated 600,000 international visitors. Brazil is endemic for dengue. Hence, attendees of the 2014 event are theoretically at risk for dengue. We calculated the risk of dengue acquisition to non-immune international travellers to Brazil, depending on the football match schedules, considering locations and dates of such matches for June and July 2014. We estimated the average per-capita risk and expected number of dengue cases for each host-city and each game schedule chosen based on reported dengue cases to the Brazilian Ministry of Health for the period between 2010-2013. On the average, the expected number of cases among the 600,000 foreigner tourists during the World Cup is 33, varying from 3-59. Such risk estimates will not only benefit individual travellers for adequate pre-travel preparations, but also provide valuable information for public health professionals and policy makers worldwide. Furthermore, estimates of dengue cases in international travellers during the World Cup can help to anticipate the theoretical risk for exportation of dengue into currently non-infected areas.
C1 [Massad, Eduardo; Ximenes, Raphael; Lopez, Luis Fernandez; Bezerra Coutinho, Francisco Antonio; Burattini, Marcelo Nascimento] Univ Sao Paulo, Fac Med, Hosp Clin LIM01, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Fac Med Vet, Sao Paulo, Brazil.
   [Wilder-Smith, Annelies] Univ Sao Paulo, Nucleo Anal Interdisciplinares Polit Publ & Estra, Sao Paulo, Brazil.
   [Amaku, Marcos] London Sch Hyg & Trop Med, London WC1, England.
   [Lopez, Luis Fernandez] Nanyang Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Lopez, Luis Fernandez; Bezerra Coutinho, Francisco Antonio; Burattini, Marcelo Nascimento] Florida Int Univ, Ctr Internet Augmented Res & Assesssment, Miami, FL 33199 USA.
   [Coelho, Giovanini Evelim; da Silva, Jarbas Barbosa, Jr.] Minist Saude, Brasilia, DF, Brazil.
   [Struchiner, Claudio Jose] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Escola Paulista Med, Hosp Sao Paulo, Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin LIM01, Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Ximenes, Raphael/G-2881-2014; Amaku, Marcos/D-5252-2012; Coutinho,
   Francisco A B/H-5644-2011; Wilder-Smith, Annelies/F-8751-2015;
   Burattini, Marcelo N/J-9272-2014; Struchiner, Claudio J/M-9360-2013;
   Massad, Eduardo/B-1169-2012; Lopez, Luis F/C-4721-2012
OI Ximenes, Raphael/0000-0003-2536-951X; Amaku, Marcos/0000-0003-4752-6774;
   Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Struchiner, Claudio J/0000-0003-2114-847X;
   Massad, Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Wilder-Smith, Annelies/0000-0003-0362-5375
FU FNS-SVS; MS [27835/2012]; CNPqNational Council for Scientific and
   Technological Development (CNPq); LIM01-HCFMUSP; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); DengueTools/Seventh
   Framework Programme of the European Community [282589]
FX FNS-SVS, MS, CNPq, LIM01-HCFMUSP, FAPESP, MS (27835/2012),
   DengueTools/Seventh Framework Programme of the European Community
   (282589)
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Hay S, 2013, NATURE, V503, P439, DOI 10.1038/503439a
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Oliver L, 2014, J ENVIRON HEALTH, V76, P66
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Seyler T, 2009, EPIDEMICS-NETH, V1, P175, DOI 10.1016/j.epidem.2009.06.003
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Ximenes R, 2013, STUDY RISK DENGUE TO
NR 24
TC 22
Z9 22
U1 0
U2 24
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2014
VL 109
IS 3
BP 394
EP +
DI 10.1590/0074-0276140133
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AJ7VV
UT WOS:000337909100022
PM 24863976
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Boccia, TMQR
   Burattini, MN
   Coutinho, FAB
   Massad, E
AF Boccia, T. M. Q. R.
   Burattini, M. N.
   Coutinho, F. A. B.
   Massad, E.
TI Will people change their vector-control practices in the presence of an
   imperfect dengue vaccine?
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE epidemiology; health policy; infectious disease control; Dengue fever;
   vaccines
ID THRESHOLD CONDITIONS; SAO-PAULO; IMMUNOGENICITY; RECOMBINANT;
   POPULATION; SAFETY; IMPACT; STATE
AB Human behaviours, which are influenced by social, cultural, economic and political factors, can increase or decrease the risk of dengue infection, depending on the relationship with the insect vector. Because no vaccine is currently available, the spread of dengue can only be curtailed by controlling vector populations (Aedes aegypti and others) and by protecting individuals. This study tested the hypothesis that dengue-affected populations are likely to relax their vector-control habits if a potentially protective vaccine becomes available. The hypothesis was tested using two approaches: a mathematical model designed to describe dengue transmission and an empirical field test in which the local population of an endemic area was interviewed about their vector-control habits given the presence of a theoretical vaccine. The model demonstrated that depending on the level of vector-control reduction, there is a threshold in vaccine efficacy below which it is better not to introduce the vaccine. The interview showed that people who were informed that a very effective vaccine is available would reduce their vector-control habits significantly compared to a group that was informed that the vaccine is not very effective.
C1 [Boccia, T. M. Q. R.; Burattini, M. N.; Coutinho, F. A. B.; Massad, E.] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Boccia, T. M. Q. R.; Burattini, M. N.; Coutinho, F. A. B.; Massad, E.] LIM01 HC FMUSP, Sao Paulo, Brazil.
   [Massad, E.] Univ London, London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A B/0000-0003-3127-3071
FU European Union from LIM01 HCFMUSP [282589]; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX This research received funding from the European Union's Seventh
   Framework Programme (FP7/2007-2013) under grant agreement no. 282589
   from LIM01 HCFMUSP and CNPq. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amaku M, REV I MED TROPIC S18, V54, pS18
   Bland M., 2000, INTRO MED STAT
   Buchbinder S., 1999, IAVI REPORT, V4, P9
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Heggenhougen K, 2003, TDRSTRSEBVOL031 WHO
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Kanesa-thasan N, 2001, VACCINE, V19, P3179, DOI 10.1016/S0264-410X(01)00020-2
   Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40
   Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E, 2001, MATH COMPUT MODEL, V34, P345, DOI 10.1016/S0895-7177(01)00066-8
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/s0037-86822011005000041, 10.1590/S0037-86822011005000041]
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   Perez Gonzalez K, 1999, Gac Sanit, V13, P7
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
NR 22
TC 7
Z9 7
U1 0
U2 24
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAR
PY 2014
VL 142
IS 3
BP 625
EP 633
DI 10.1017/S0950268813001350
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AD0PZ
UT WOS:000332937900020
PM 23735007
DA 2020-12-16
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Raimundo, SM
   Lopez, LF
   Burattini, MN
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Raimundo, Silvia Martorano
   Lopez, Luis Fernandez
   Burattini, Marcelo Nascimento
   Massad, Eduardo
TI A Comparative Analysis of the Relative Efficacy of Vector-Control
   Strategies Against Dengue Fever
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Dengue; Basic reproduction number; Force of infection; Sensitivity
   analysis; Vector control
ID POPULATION-DYNAMICS; SENSITIVITY-ANALYSIS; THRESHOLD CONDITIONS;
   AEDES-AEGYPTI; TRANSMISSION; PARAMETERS; DISEASES; MALARIA; SYSTEM; COST
AB Dengue is considered one of the most important vector-borne infection, affecting almost half of the world population with 50 to 100 million cases every year. In this paper, we present one of the simplest models that can encapsulate all the important variables related to vector control of dengue fever. The model considers the human population, the adult mosquito population and the population of immature stages, which includes eggs, larvae and pupae. The model also considers the vertical transmission of dengue in the mosquitoes and the seasonal variation in the mosquito population. From this basic model describing the dynamics of dengue infection, we deduce thresholds for avoiding the introduction of the disease and for the elimination of the disease. In particular, we deduce a Basic Reproduction Number for dengue that includes parameters related to the immature stages of the mosquito. By neglecting seasonal variation, we calculate the equilibrium values of the model's variables. We also present a sensitivity analysis of the impact of four vector-control strategies on the Basic Reproduction Number, on the Force of Infection and on the human prevalence of dengue. Each of the strategies was studied separately from the others. The analysis presented allows us to conclude that of the available vector control strategies, adulticide application is the most effective, followed by the reduction of the exposure to mosquito bites, locating and destroying breeding places and, finally, larvicides. Current vector-control methods are concentrated on mechanical destruction of mosquitoes' breeding places. Our results suggest that reducing the contact between vector and hosts (biting rates) is as efficient as the logistically difficult but very efficient adult mosquito's control.
C1 [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, BR-05508270 Sao Paulo, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Raimundo, Silvia Martorano; Lopez, Luis Fernandez; Burattini, Marcelo Nascimento; Massad, Eduardo] Univ Sao Paulo, Sch Med, LIM HCFMUSP 01, BR-01246903 Sao Paulo, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London W1C 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, LIM HCFMUSP 01, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012; Lopez, Luis F/C-4721-2012; Raimundo, Silvia
   Martorano/D-4624-2012; Coutinho, Francisco A B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Amaku,
   Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916; Lopez,
   Luis F/0000-0003-4097-6887; Raimundo, Silvia
   Martorano/0000-0002-9960-7341; Coutinho, Francisco A
   B/0000-0003-3127-3071
FU European UnionEuropean Union (EU) [282589]; LIM01 HCFMUSP; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX The research from which these results were obtained has received funding
   from the European Union's Seventh Framework Programme (FP7/2007-2013)
   under grant agreement no. 282589, from LIM01 HCFMUSP and CNPq. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Aguiar M, 2013, ECOL COMPLEX, V16, P31, DOI 10.1016/j.ecocom.2012.09.001
   Amaku M., 2013, PHIL T R SOC A
   Amaku M, 2013, COMPUT MATH METHOD M, DOI 10.1155/2013/659038
   Amaku M, 2009, MEM I OSWALDO CRUZ, V104, P897, DOI 10.1590/S0074-02762009000600013
   Anguelov R, 2012, COMPUT MATH APPL, V64, P374, DOI 10.1016/j.camwa.2012.02.068
   Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Beatty ME, 2008, P 2 INT C DENG DENG
   Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho F. A. B., 2004, AM J PHYS, V72, P1068
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9
   Forattini O. P., 1996, MED CULICIDOLOGY
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guy B, 2011, LANCET, V377, P381, DOI 10.1016/S0140-6736(11)60128-1
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041
   Kooi BW, 2013, J COMPUT APPL MATH, V252, P148, DOI 10.1016/j.cam.2012.08.008
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Reiter P, 2001, DENGUE DENGUE HEMORR, P425
   Rodrigues H. S., 2012, ARXIV12040544V1
   Ross R., 1911, PREVENTION MALARIA
   Silverman MP, 2004, AM J PHYS, V72, P1068, DOI 10.1119/1.1738426
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   UNWTO, 2011, TOUR HIGHL
   Wahl LM, 2000, P ROY SOC B-BIOL SCI, V267, P835, DOI 10.1098/rspb.2000.1079
   Wang WD, 2008, J DYN DIFFER EQU, V20, P699, DOI 10.1007/s10884-008-9111-8
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
NR 47
TC 28
Z9 29
U1 0
U2 44
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD MAR
PY 2014
VL 76
IS 3
BP 697
EP 717
DI 10.1007/s11538-014-9939-5
PG 21
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA AD3GD
UT WOS:000333125400008
PM 24619807
DA 2020-12-16
ER

PT B
AU Coutinho, FAB
   Chaib, E
   Amaku, M
   Burattini, MN
   Massad, E
AF Bezerra Coutinho, Francisco Antonio
   Chaib, Eleazar
   Amaku, Marcos
   Burattini, Marcelo Nascimento
   Massad, Eduardo
BE Mondaini, RP
TI THE MATHEMATICS OF LIVER TRANSPLANTATION
SO BIOMAT 2013: INTERNATIONAL SYMPOSIUM ON MATHEMATICAL AND COMPUTATIONAL
   BIOLOGY
SE BIOMAT-International Symposium on Mathematical and Computational Biology
LA English
DT Proceedings Paper
CT International Symposium on Mathematical and Computational Biology
   (BIOMAT)
CY NOV 04-08, 2013
CL Fields Inst Res Math Sci, Toronto, CANADA
HO Fields Inst Res Math Sci
DE Liver transplantation; hepatocellular carcinoma; expanded criteria;
   model
ID WAITING-LIST; SAO-PAULO; BRAZIL; STATE; DYNAMICS; NUMBER; IMPACT
AB Sao Paulo is the pioneer Brazilian state in transplantation surgery. The Brazilian model for organ sharing has developed a system that prioritizes liver transplantion (LT) for patients who have the highest risk of wait-list mortality. In this paper we present a brief review of the application of mathematical models to the problem of how to improve the speed with which patients with liver failure can receive a liver graft and how alternative criteria for prioritizing patients in the waiting list can be proposed.
C1 [Bezerra Coutinho, Francisco Antonio; Chaib, Eleazar; Amaku, Marcos; Burattini, Marcelo Nascimento; Massad, Eduardo] Univ Sao Paulo, HCFMUSP, Sch Med LIM 01 & LIM 37, BR-01246903 Sao Paulo, SP, Brazil.
RP Coutinho, FAB (corresponding author), Univ Sao Paulo, HCFMUSP, Sch Med LIM 01 & LIM 37, Ave Doutor Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM coutinho@dim.fm.usp.br
RI Coutinho, Francisco A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014;
   Amaku, Marcos/D-5252-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Amaku, Marcos/0000-0003-4752-6774
CR Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2009, TRANSPL P, V41, P3775, DOI 10.1016/j.transproceed.2009.05.035
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chaib E, 2007, TRANSPLANTATION, V84, P1209, DOI 10.1097/01.tp.0000287192.32090.2b
   Chaib E, 2010, MED HYPOTHESES, V75, P324, DOI 10.1016/j.mehy.2010.03.013
   Chaib E, 2008, LIVER TRANSPLANT, V14, P1732, DOI 10.1002/lt.21611
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   Massad E, 2009, EPIDEMIOL INFECT, V137, P241, DOI 10.1017/S0950268808000873
NR 8
TC 0
Z9 0
U1 0
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-4602-21-1
J9 BIOMAT INT S MATH CO
JI BIOMAT-Int. S. Math. Comput. Biol.
PY 2014
BP 234
EP 249
PG 16
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BD1LK
UT WOS:000358137000014
DA 2020-12-16
ER

PT B
AU Sanches, RP
   Massad, E
AF Sanches, R. P.
   Massad, E.
BE Mondaini, RP
TI ANALYSIS OF THE BASIC REPRODUCTION NUMBER FROM THE INITIAL GROWTH PHASE
   OF THE OUTBREAK IN DISEASES CAUSED BY VECTORS
SO BIOMAT 2013: INTERNATIONAL SYMPOSIUM ON MATHEMATICAL AND COMPUTATIONAL
   BIOLOGY
SE BIOMAT-International Symposium on Mathematical and Computational Biology
LA English
DT Proceedings Paper
CT International Symposium on Mathematical and Computational Biology
   (BIOMAT)
CY NOV 04-08, 2013
CL Fields Inst Res Math Sci, Toronto, CANADA
HO Fields Inst Res Math Sci
DE basic reproduction number; dengue; mathematical model
ID THRESHOLD CONDITIONS; DENGUE VIRUS; TRANSMISSION; INFECTION; EPIDEMIC;
   MODELS; RATIO
AB The basic reproduction number, R-0, is defined as the expected number of secondary cases of a disease produced by a single infection in a completely susceptible population. The value of R-0 can be estimated in several ways, for example, of the stability analysis of a compartmental model, through the matrix of next generation, etc. In this work we studied the method for estimating R-0 from the initial growth phase of the outbreak. Some authors proposed different methods for estimating the value of (R)0 using the initial growth phase of the outbreak without assuming exponential growth of cases, which is suggested in most studies. We used the method proposed by Macdonald and studied by Massad et. al.(2010)(1) and the method proposed by Nishiura(2010)(2). Massad et. al.(2010)(1) studied the basic reproduction number proposed by Macdonald's, which it was divided in two components: the vector-to-human component (TV-H) and the human-to-vector component (TH-V), R-0 is the product of those two components. Nishiura(2010)(2) presented a correction of the actual reproduction number (R-a), he showed through this correction that the basic reproduction number and actual reproduction number are equal, then he offered a framework for estimating R-0. Our objective is to evaluate which technique best estimates the basic reproduction number applying them to diseases caused by vectors, in this particular case we used data of dengue.
C1 [Sanches, R. P.; Massad, E.] Univ Sao Paulo, Sch Med, BR-01246000 Sao Paulo, SP, Brazil.
RP Sanches, RP (corresponding author), Univ Sao Paulo, Sch Med, Ave Doutor Arnaldo 455, BR-01246000 Sao Paulo, SP, Brazil.
EM rosangela@dim.fm.usp.br; edmassad@usp.br
CR Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x
   [Anonymous], 2008, MS, V7
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001
   Coura J.R., 2005, GUANABARA KOOGAN
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Favier C., 2006, TROP MED INT HEALTH, VII, P343
   Gubler D., 1995, EMERGING INFECT DIS, V1, P2
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Nishiura N., 2010, J ENV RES PUBLIC HLT, V7, P291
   Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4338
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136
   White PJ, 2006, AIDS, V20, P1898, DOI 10.1097/01.aids.0000244213.23574.fa
NR 21
TC 0
Z9 0
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-4602-21-1
J9 BIOMAT INT S MATH CO
JI BIOMAT-Int. S. Math. Comput. Biol.
PY 2014
BP 340
EP 351
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BD1LK
UT WOS:000358137000020
DA 2020-12-16
ER

PT B
AU Rocha, FT
   Thomaz, CE
   da Rocha, AF
   Massad, E
AF Rocha, Fabio Theoto
   Thomaz, Carlos Eduardo
   da Rocha, Armando Freitas
   Massad, Eduardo
GP IEEE
TI Brain Mapping and Interpretation of Reading Processing in Children Using
   EEG and Multivariate Statistical Analysis
SO 2014 27TH SIBGRAPI CONFERENCE ON GRAPHICS, PATTERNS AND IMAGES
   (SIBGRAPI)
LA English
DT Proceedings Paper
CT 27th SIBGRAPI Conference on Graphics, Patterns and Images (SIBGRAPI)
CY AUG 27-30, 2014
CL Sch Appl Math Getulio Vargas Fdn, Rio de Janeiro, BRAZIL
SP Fundacao Carlos Chagas Filho Amparo Pesquisa Estado Rio de Janerio, CAPES, Conshello Nacl Desenvolvimento Cientifico Tecnologico, Samsung
HO Sch Appl Math Getulio Vargas Fdn
ID WORKING-MEMORY; DUAL-ROUTE; DYSLEXIA; LANGUAGE; COGNITION; COMMON;
   GENES; CONSCIOUSNESS; PERFORMANCE; ATTENTION
AB Difficulties in learning to read may have a number of causes and children tend to experience on the phonological route the most common disturbance in this cognitive task. Using two sample groups of children with and without reading difficulties and their corresponding EEG signals captured during the reading processing, we describe in this work a set of techniques that investigates such disturbance by generating whole brain mappings based on the entropy of each EEG electrode and non-supervised and supervised multivariate statistical analyses. Our experimental results have clearly showed specific neural organizations well suited to interpreting the word/phrase reading processing in these children. We believe that these techniques might become an effective computational tool in helping the diagnostic process of children with learning disabilities.
C1 [Rocha, Fabio Theoto; Thomaz, Carlos Eduardo] FEI, Dept Elect Engn, Sao Paulo, Brazil.
   [da Rocha, Armando Freitas] Res Artificial & Nat Intelligence, Sao Paulo, Brazil.
   [Massad, Eduardo] FMUSP, Dept Med Informat, Sao Paulo, Brazil.
RP Rocha, FT (corresponding author), FEI, Dept Elect Engn, Sao Paulo, Brazil.
RI Thomaz, Carlos/AAF-1878-2019; Massad, Eduardo/B-1169-2012
OI Thomaz, Carlos/0000-0001-5566-1963; Massad, Eduardo/0000-0002-7200-2916
CR Alarcon M, 1997, PERS INDIV DIFFER, V22, P793, DOI 10.1016/S0191-8869(96)00267-X
   Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4
   CHANDRASEKARAN B, 1981, IEEE T SYST MAN CYB, V11, P1, DOI 10.1109/TSMC.1981.4308573
   Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204
   COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589
   COLTHEART M, 1994, J EXP PSYCHOL HUMAN, V20, P1197, DOI 10.1037/0096-1523.20.6.1197
   Cone-Wesson B, 2005, J COMMUN DISORD, V38, P279, DOI 10.1016/j.jcomdis.2005.02.004
   da Rocha A. F., 2013, J BEHAV BRA IN PRESS
   da Rocha AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017355
   da Rocha AF, 2010, BRAIN RES, V1351, P198, DOI 10.1016/j.brainres.2010.06.046
   DAVIS R, 1983, ARTIF INTELL, V20, P63, DOI 10.1016/0004-3702(83)90015-2
   de Arruda Lucia Helena Favaro, 2008, J Cosmet Dermatol, V7, P246, DOI 10.1111/j.1473-2165.2008.00401.x
   DEVIJVER P, 1982, PATTERN CLASSIFICATI
   Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2
   Fisher SE, 2006, TRENDS COGN SCI, V10, P250, DOI 10.1016/j.tics.2006.04.003
   Foz FB, 2002, PEDIATR NEUROL, V26, P106, DOI 10.1016/S0887-8994(01)00368-X
   Francks C., 2002, LANCET NEUROLOGY, V1
   Fukunaga K., 1990, INTRO STAT PATTERN R
   Gibson CJ, 2008, J COMMUN DISORD, V41, P409, DOI 10.1016/j.jcomdis.2008.03.003
   Giraldi Gilson A, 2008, Journal of the Brazilian Computer Society, V14, P7, DOI 10.1007/BF03192556
   Gordon N, 1998, Eur J Paediatr Neurol, V2, P1, DOI 10.1016/1090-3798(98)01000-1
   HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5
   HANLEY JR, 1995, NEUROPSYCHOLOGIA, V33, P909, DOI 10.1016/0028-3932(95)00038-5
   Hayashi A, 1998, INT J DEV NEUROSCI, V16, P209, DOI 10.1016/S0736-5748(98)00028-8
   Hinojosa JA, 2000, CLIN NEUROPHYSIOL, V111, P552, DOI 10.1016/S1388-2457(99)00275-8
   Hong KS, 2000, J NEUROL SCI, V181, P50, DOI 10.1016/S0022-510X(00)00412-3
   Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9
   Ishida A, 1997, PEDIATR NEUROL, V16, P319, DOI 10.1016/S0887-8994(97)00043-X
   Johnson R. A., 1998, APPL MULTIVARIATE ST
   KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233
   Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3
   Knopik VS, 1998, PERS INDIV DIFFER, V25, P269, DOI 10.1016/S0191-8869(98)00040-3
   LESSER VR, 1991, IEEE T SYST MAN CYB, V21, P1347, DOI 10.1109/21.135681
   McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007
   MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9
   Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003
   Okado N, 2001, BRAIN DEV-JPN, V23, pS11, DOI 10.1016/S0387-7604(01)00371-0
   Pennington B., 2001, INT ENCY SOCIAL BEHA
   Ramus F, 2006, COGNITION, V101, P247, DOI 10.1016/j.cognition.2006.04.003
   Ribas LM, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-109
   Rocha AF, 2004, MED HYPOTHESES, V63, P895, DOI 10.1016/j.mehy.2004.03.044
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   ROCHA AF, 1992, NEURAL NETS THEORY B
   Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008
   Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024
   SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x
   Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043
   TALLAL P, 1991, PSYCHONEUROENDOCRINO, V16, P203, DOI 10.1016/0306-4530(91)90079-9
   Temple CM, 2006, CORTEX, V42, P898, DOI 10.1016/S0010-9452(08)70434-9
   Thomaz C. E., 2006, J BRAZILIAN COMPUTER, V12, P7, DOI DOI 10.1007/BF03192391
   Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846
   Trauzettel-Klosinski S, 2006, CLIN NEUROPHYSIOL, V117, P1085, DOI 10.1016/j.clinph.2006.01.012
   Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002
NR 53
TC 2
Z9 2
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-4260-2
PY 2014
BP 251
EP 258
DI 10.1109/SIBGRAPI.2014.19
PG 8
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BC4LK
UT WOS:000352613900033
DA 2020-12-16
ER

PT J
AU Oliver, L
   Burattini, MN
   Coutinho, FAB
   Coelho, GE
   Struchiner, CJ
   Massad, E
AF Oliver, Leuda
   Burattini, Marcelo N.
   Coutinho, Francisco A. B.
   Coelho, Giovanini E.
   Struchiner, Claudio J.
   Massad, Eduardo
TI A Negative Correlation Between Dengue and Bushfires in Brazil
SO JOURNAL OF ENVIRONMENTAL HEALTH
LA English
DT Editorial Material
C1 [Oliver, Leuda; Burattini, Marcelo N.; Coutinho, Francisco A. B.; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Coelho, Giovanini E.] Minist Hlth Brazil, Natl Program Dengue Control, Porto Alegre, RS, Brazil.
   [Struchiner, Claudio J.] Fiocruz MS, Program Sci Computat, Rio De Janeiro, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Dept Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; OLIVEIRA, LEUDA/C-5578-2016; Massad,
   Eduardo/B-1169-2012; Struchiner, Claudio J/M-9360-2013; Coutinho,
   Francisco A B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; OLIVEIRA,
   LEUDA/0000-0002-2762-3705; Massad, Eduardo/0000-0002-7200-2916;
   Struchiner, Claudio J/0000-0003-2114-847X; Coutinho, Francisco A
   B/0000-0003-3127-3071
CR Ciencia e Technologia e Meio Ambiente, 2010, VEG FIR FIR MON
   Massad E, 2010, EPIDEMIOL INFECT, V138, P951, DOI 10.1017/S0950268809990501
   Wilder-Smith A, 2010, EPIDEMIOL INFECT, V138, P962, DOI 10.1017/S0950268810000683
NR 3
TC 3
Z9 3
U1 0
U2 14
PU NATL ENVIRON HEALTH ASSOC
PI DENVER
PA 720 S COLORADO BLVD SUITE 970, SOUTH TOWER, DENVER, CO 80246 USA
SN 0022-0892
J9 J ENVIRON HEALTH
JI J. Environ. Health
PD JAN-FEB
PY 2014
VL 76
IS 6
SI SI
BP 66
EP 67
PG 2
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA AO7NQ
UT WOS:000341540300009
PM 24645415
DA 2020-12-16
ER

PT J
AU Chaib, E
   Amaku, M
   Coutinho, FAB
   Lopez, LF
   Burattini, MN
   D'Albuquerque, LAC
   Massad, E
AF Chaib, Eleazar
   Amaku, Marcos
   Coutinho, Francisco A. B.
   Lopez, Luis F.
   Burattini, Marcelo N.
   D'Albuquerque, Luiz A. C.
   Massad, Eduardo
TI A mathematical model for optimizing the indications of liver
   transplantation in patients with hepatocellular carcinoma
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Liver transplantation; Hepatocellular carcinoma; Expanded criteria;
   Modelling
ID WAITING-LIST; SAO-PAULO; RESECTION; STATE; VACCINATION; DYNAMICS;
   NUMBER; IMPACT
AB Background: The criteria for organ sharing has developed a system that prioritizes liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) who have the highest risk of wait-list mortality. In some countries this model allows patients only within the Milan Criteria (MC, defined by the presence of a single nodule up to 5 cm, up to three nodules none larger than 3 cm, with no evidence of extrahepatic spread or macrovascular invasion) to be evaluated for liver transplantation. This police implies that some patients with HCC slightly more advanced than those allowed by the current strict selection criteria will be excluded, even though LT for these patients might be associated with acceptable long-term outcomes.
   Methods: We propose a mathematical approach to study the consequences of relaxing the MC for patients with HCC that do not comply with the current rules for inclusion in the transplantation candidate list. We consider overall 5-years survival rates compatible with the ones reported in the literature. We calculate the best strategy that would minimize the total mortality of the affected population, that is, the total number of people in both groups of HCC patients that die after 5 years of the implementation of the strategy, either by post-transplantation death or by death due to the basic HCC. We illustrate the above analysis with a simulation of a theoretical population of 1,500 HCC patients with tumor size exponentially. The parameter. obtained from the literature was equal to 0.3. As the total number of patients in these real samples was 327 patients, this implied in an average size of 3.3 cm and a 95% confidence interval of [2.9; 3.7]. The total number of available livers to be grafted was assumed to be 500.
   Results: With 1500 patients in the waiting list and 500 grafts available we simulated the total number of deaths in both transplanted and non-transplanted HCC patients after 5 years as a function of the tumor size of transplanted patients. The total number of deaths drops down monotonically with tumor size, reaching a minimum at size equals to 7 cm, increasing from thereafter. With tumor size equals to 10 cm the total mortality is equal to the 5 cm threshold of the Milan criteria.
   Conclusion: We concluded that it is possible to include patients with tumor size up to 10 cm without increasing the total mortality of this population.
C1 [Chaib, Eleazar; D'Albuquerque, Luiz A. C.] Univ Sao Paulo, Liver & Pancreas Transplantat Surg Unit, Dept Gastroenterol, LIM 37,Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Amaku, Marcos; Coutinho, Francisco A. B.; Lopez, Luis F.; Burattini, Marcelo N.; Massad, Eduardo] Univ Sao Paulo, Dept Med Informat, LIM 01, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Dept Med Informat, LIM 01, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012; Amaku,
   Marcos/D-5252-2012; D'Albuquerque, Luiz Augusto Carneiro/A-8812-2013;
   D'ALBUQUERQUE, Luiz Carneiro Augusto/I-4011-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Lopez, Luis
   F/0000-0003-4097-6887; Coutinho, Francisco A B/0000-0003-3127-3071;
   Massad, Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774;
   D'Albuquerque, Luiz Augusto Carneiro/0000-0001-7607-7168; 
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); LIMS [01, 37 HCFMUSP]
FX This work is supported by grants FAPESP, CNPq and LIMS 01 and 37
   HCFMUSP.
CR BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2012, CLIN TRANSPLANT, V26, pE590, DOI 10.1111/ctr.12030
   Chaib E, 2008, TRANSPL INT, V21, P704, DOI 10.1111/j.1432-2277.2008.00661.x
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chaib E, 2007, TRANSPLANTATION, V84, P1209, DOI 10.1097/01.tp.0000287192.32090.2b
   Chaib E, 2008, LIVER TRANSPLANT, V14, P1732, DOI 10.1002/lt.21611
   Chawla YK, 2011, J CLIN EXP HEPATOL, V1, P161, DOI 10.1016/S0973-6883(11)60233-8
   Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9
   FREIRE J.G.C., 1968, REV ASSOC MED BRAS, V14, P133
   IWATSUKI S, 1991, ANN SURG, V214, P221, DOI 10.1097/00000658-199109000-00005
   Machado M C, 1972, Rev Hosp Clin Fac Med Sao Paulo, V27, P1
   Marsh JW, 2000, CANCER, V88, P538, DOI 10.1002/(SICI)1097-0142(20000201)88:3<538::AID-CNCR7>3.0.CO;2-H
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E, 2008, STUD FUZZ SOFT COMP, V232, P1
   Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5
   Onaca N, 2007, LIVER TRANSPLANT, V13, P391, DOI 10.1002/lt.21095
   Ortega N, 2003, KYBERNETES, V32, P460, DOI 10.1108/03684920310463876
   RINGE B, 1991, WORLD J SURG, V15, P270, DOI 10.1007/BF01659064
   Roayaie S, 2002, ANN SURG, V235, P533, DOI 10.1097/00000658-200204000-00012
   Ryckman FC, 2008, SEMIN PEDIATR SURG, V17, P123, DOI 10.1053/j.sempedsurg.2008.02.008
   Samuel D, 2011, LIVER TRANSPLANT, V17, pS6, DOI 10.1002/lt.22423
   Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x
   Toso C, 2012, HEPATOLOGY, V56, P149, DOI 10.1002/hep.25603
   Volk ML, 2008, AM J TRANSPLANT, V8, P839, DOI 10.1111/j.1600-6143.2007.02138.x
   Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563
NR 27
TC 0
Z9 0
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD OCT 20
PY 2013
VL 10
AR 60
DI 10.1186/1742-4682-10-60
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA 267QT
UT WOS:000328113400001
PM 24139285
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU de Oliveira, LG
   dos Santos, B
   Goncalves, PD
   Carvalho, HD
   Massad, E
   Leyton, V
AF de Oliveira, Lucio Garcia
   dos Santos, Bernardo
   Goncalves, Priscila Dib
   Carvalho, Heraclito de Barbosa
   Massad, Eduardo
   Leyton, Vilma
TI Attention performance among Brazilian truck drivers and its association
   with amphetamine use: pilot study
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Automobile Driving; Motor Vehicles; Amphetamines, adverse effects; Task
   Performance and Analysis; Transportation, manpower; Cross-Sectional
   Studies
AB The aim of this article was to describe the attention functioning of twenty-two truck drivers and its relationship with amphetamine use. Those drivers who reported using amphetamines in the twelve months previous to the interview had the best performance in a test evaluating sustained attention functioning. Although amphetamine use may initially seem advantageous to the drivers, it may actually impair safe driving. The findings suggest the importance of monitoring the laws regarding amphetamine use in this country.
C1 [de Oliveira, Lucio Garcia; Massad, Eduardo; Leyton, Vilma] Univ Sao Paulo, Fac Med, Dept Med Legal Et Med & Med Social & Trabalho, Inst Oscar Freire, Sao Paulo, Brazil.
   [dos Santos, Bernardo] Univ Sao Paulo, Escola Enfermagem, Serv Apoio Pesquisa, Sao Paulo, Brazil.
   [Goncalves, Priscila Dib] Univ Sao Paulo, Fac Med, Serv Psicol & Neuropsicol, Inst Psiquiatria,Hosp Clin, Sao Paulo, Brazil.
   [Carvalho, Heraclito de Barbosa] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil.
RP de Oliveira, LG (corresponding author), FMUSP, Dept Med Legal Et Med & Med Social & Trabalho, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM lucgoliver@gmail.com
RI Leyton, Vilma/G-8183-2012; de Oliveira, Lucio G/J-7608-2012; Massad,
   Eduardo/B-1169-2012; Leyton, Vilma/O-6935-2019; Carvalho,
   Heraclito/C-1334-2012
OI Leyton, Vilma/0000-0002-5101-1290; de Oliveira, Lucio
   G/0000-0001-9805-8347; Massad, Eduardo/0000-0002-7200-2916; Leyton,
   Vilma/0000-0002-5101-1290; Carvalho, Heraclito/0000-0002-7037-5655
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11682-0,
   2012/00973-6]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP - Research support, Young Researcher Program; Process
   no s 2011/11682-0 and 2012/00973-6).
CR do Nascimento EC, 2007, REV SAUDE PUBL, V41, P290
   Knauth DR, 2012, REV SAUDE PUBL, V46, P886, DOI 10.1590/s0034-89102012000500016
   Miotto EC, 2012, NEUROPSICOLOGIA CLIN, P31
   Murray JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00035
   Musshoff F, 2012, J FORENSIC SCI, V57, P413, DOI 10.1111/j.1556-4029.2012.02055.x
   Souza JC, 2005, ARQ NEURO-PSIQUIAT, V63, P925, DOI 10.1590/S0004-282X2005000600004
   Strauss ES, 2006, COMPENDIUM NEUROPSYC
   Tonglet EM, 2007, BATERIA FUNCOES MENT
   Wickens CM, 2008, ACCIDENT ANAL PREV, V40, P1223, DOI 10.1016/j.aap.2008.01.006
   World Health Organization, 2009, GLOB HLTH RISKS MORT
   World Health Organization, 2013, GLOB STAT REP ROAD S
NR 11
TC 1
Z9 1
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD OCT
PY 2013
VL 47
IS 5
DI 10.1590/S0034-8910.2013047004702
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AA8YV
UT WOS:000331381800020
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Ribas, LM
   Rocha, FT
   Ortega, NRS
   da Rocha, AF
   Massad, E
AF Ribas, Laila Massad
   Rocha, Fabio Theoto
   Siqueira Ortega, Neli Regina
   da Rocha, Armando Freitas
   Massad, Eduardo
TI Brain activity and medical diagnosis: an EEG study
SO BMC NEUROSCIENCE
LA English
DT Article
DE Medical diagnosis; EEG analysis; Brain mapping; Human cognition;
   Decision-making
ID DECISION-MAKING; WORKING-MEMORY; FRONTAL-CORTEX; TASK; RECOGNITION;
   ACTIVATION; KNOWLEDGE; TIME; PET
AB Background: Despite new brain imaging techniques that have improved the study of the underlying processes of human decision-making, to the best of our knowledge, there have been very few studies that have attempted to investigate brain activity during medical diagnostic processing. We investigated brain electroencephalography (EEG) activity associated with diagnostic decision-making in the realm of veterinary medicine using X-rays as a fundamental auxiliary test. EEG signals were analysed using Principal Components (PCA) and Logistic Regression Analysis
   Results: The principal component analysis revealed three patterns that accounted for 85% of the total variance in the EEG activity recorded while veterinary doctors read a clinical history, examined an X-ray image pertinent to a medical case, and selected among alternative diagnostic hypotheses. Two of these patterns are proposed to be associated with visual processing and the executive control of the task. The other two patterns are proposed to be related to the reasoning process that occurs during diagnostic decision-making.
   Conclusions: PCA analysis was successful in disclosing the different patterns of brain activity associated with hypothesis triggering and handling (pattern P-1); identification uncertainty and prevalence assessment (pattern P-3), and hypothesis plausibility calculation (pattern P-2); Logistic regression analysis was successful in disclosing the brain activity associated with clinical reasoning success, and together with regression analysis showed that clinical practice reorganizes the neural circuits supporting clinical reasoning.
C1 [Ribas, Laila Massad; Siqueira Ortega, Neli Regina; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Ribas, Laila Massad; Siqueira Ortega, Neli Regina; Massad, Eduardo] LIM 01 HCMFMUSP, BR-01246903 Sao Paulo, Brazil.
   [Rocha, Fabio Theoto; da Rocha, Armando Freitas] RANI, Jundiai, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Ribas, Laila Massad/I-9651-2016
OI Massad, Eduardo/0000-0002-7200-2916; Ribas, Laila
   Massad/0000-0002-1390-8523
FU CNPqNational Council for Scientific and Technological Development
   (CNPq);  [LIM01-HCFMUSP]
FX This work was supported by grants obtained from LIM01-HCFMUSP and CNPq.
CR Andres P, 2003, CORTEX, V39, P871, DOI 10.1016/S0010-9452(08)70868-2
   Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2
   Bechtereva NP, 2004, INT J PSYCHOPHYSIOL, V53, P11, DOI 10.1016/j.ijpsycho.2004.01.001
   Bland AR, 2011, BRAIN RES, V1417, P55, DOI 10.1016/j.brainres.2011.08.031
   Bordage G, 1997, ACAD MED, V72, pS37, DOI 10.1097/00001888-199710001-00013
   Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1
   Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114
   Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056
   da Rocha AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017355
   da Rocha AF, 2010, BRAIN RES, V1351, P198, DOI 10.1016/j.brainres.2010.06.046
   Davis CE, 2011, INT J PSYCHOPHYSIOL, V79, P175, DOI 10.1016/j.ijpsycho.2010.10.004
   Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009
   Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5
   Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104
   Esposito F, 2009, NEUROIMAGE, V47, P112, DOI 10.1016/j.neuroimage.2009.03.074
   Foz FB, 2002, PEDIATR NEUROL, V26, P106, DOI 10.1016/S0887-8994(01)00368-X
   Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048
   Heldmann M, 2005, J PSYCHOPHYSIOL, V19, P270, DOI 10.1027/0269-8803.19.4.270
   Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060
   Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018
   Karch S, 2010, NEUROIMAGE, V51, P356, DOI 10.1016/j.neuroimage.2010.02.028
   Knottnerus JA, 2002, EVIDENCE BASE CLIN D
   Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021
   LEAO BF, 1990, METHOD INFORM MED, V29, P30
   Lindsen JP, 2010, NEUROIMAGE, V50, P1626, DOI 10.1016/j.neuroimage.2010.01.079
   Maguire MJ, 2010, BRAIN LANG, V114, P16, DOI 10.1016/j.bandl.2010.03.005
   Mandin H, 1997, ACAD MED, V72, P173, DOI 10.1097/00001888-199703000-00009
   Mangiameli P, 2004, DECIS SUPPORT SYST, V36, P247, DOI 10.1016/S0167-9236(02)00143-4
   Martin-Loeches M, 2008, NEUROIMAGE, V41, P614, DOI 10.1016/j.neuroimage.2008.02.047
   Massad E, 2008, STUD FUZZ SOFT COMP, V232, P1
   Melo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028752
   Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048
   Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011
   Norman G, 2005, MED EDUC, V39, P418, DOI 10.1111/j.1365-2929.2005.02127.x
   Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006
   Pandey B, 2009, COMPUT BIOL MED, V39, P215, DOI 10.1016/j.compbiomed.2008.12.008
   Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003
   Polezzi D, 2010, NEUROIMAGE, V49, P1886, DOI 10.1016/j.neuroimage.2009.08.068
   Pulvermuller F, 2009, BRAIN LANG, V110, P81, DOI 10.1016/j.bandl.2008.12.001
   Rocha AF, 1992, LECT NOTES ARTIFICIA
   Rocha AF, 2004, BRAIN FUZZY ARITHMET
   Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008
   Selimbeyoglu A, 2012, CLIN NEUROPHYSIOL, V123, P1158, DOI 10.1016/j.clinph.2011.10.037
   Sieborger FT, 2007, BRAIN RES, V1166, P77, DOI 10.1016/j.brainres.2007.05.079
   Tzovara A, 2012, NEUROIMAGE, V60, P1959, DOI 10.1016/j.neuroimage.2012.01.136
   Wu X, 2007, NEUROIMAGE, V35, P1654, DOI 10.1016/j.neuroimage.2007.02.011
NR 46
TC 1
Z9 1
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2202
J9 BMC NEUROSCI
JI BMC Neurosci.
PD OCT 1
PY 2013
VL 14
AR 109
DI 10.1186/1471-2202-14-109
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 246WS
UT WOS:000326572200001
PM 24083668
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
   Roklov, J
   Coutinho, F
   Struchiner, C
   Wilder-Smith, A
AF Massad, E.
   Roklov, J.
   Coutinho, F.
   Struchiner, C.
   Wilder-Smith, A.
TI Determining the main driver for the increase of epidemic dengue in
   Singapore
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Massad, E.; Coutinho, F.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Roklov, J.; Wilder-Smith, A.] Umea Univ, S-90187 Umea, Sweden.
   [Struchiner, C.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RI Struchiner, Claudio/M-9360-2013
OI Struchiner, Claudio/0000-0003-2114-847X
NR 0
TC 0
Z9 0
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2013
VL 18
SU 1
SI SI
BP 54
EP 54
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 213BS
UT WOS:000324029000136
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Rocklov, J
   Sessions, O
   Massad, E
   Khan, K
AF Wilder-Smith, A.
   Rocklov, J.
   Sessions, O.
   Massad, E.
   Khan, K.
TI The dengue outbreak in Madeira 2012: exploring the origins
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Wilder-Smith, A.; Rocklov, J.] Umea Univ, S-90187 Umea, Sweden.
   [Sessions, O.] Duke NUS, Singapore, Singapore.
   [Massad, E.] Univ Sao Paolo, Sao Paulo, Brazil.
   [Khan, K.] Univ Toronto, Toronto, ON M5S 1A1, Canada.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2013
VL 18
SU 1
SI SI
BP 116
EP 116
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 213BS
UT WOS:000324029000313
DA 2020-12-16
ER

PT J
AU Lopes, MHBD
   Ortega, NRS
   Silveira, PSP
   Massad, E
   Higa, R
   Marin, HD
AF Baena de Moraes Lopes, Maria Helena
   Siqueira Ortega, Neli Regina
   Panse Silveira, Paulo Sergio
   Massad, Eduardo
   Higa, Rosangela
   Marin, Heimar de Fatima
TI Fuzzy cognitive map in differential diagnosis of alterations in urinary
   elimination: A nursing approach
SO INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
LA English
DT Article
DE Fuzzy logic; Urinary incontinence; Nursing diagnosis; Differential
   diagnosis
ID EXPERT-SYSTEM; LOGIC; INCONTINENCE; MODEL; CONTINENCE
AB Purpose: To develop a decision support system to discriminate the diagnoses of alterations in urinary elimination, according to the nursing terminology of NANDA International (NANDA-I).
   Methods: A fuzzy cognitive map (FCM) was structured considering six possible diagnoses: stress urinary incontinence, reflex urinary incontinence, urge urinary incontinence, functional urinary incontinence, total urinary incontinence and urinary retention; and 39 signals associated with them. The model was implemented in Microsoft Visual C++(R) Edition 2005 and applied in 195 real cases. Its performance was evaluated through the agreement test, comparing its results with the diagnoses determined by three experts (nurses). The sensitivity and specificity of the model were calculated considering the expert's opinion as a gold standard. In order to compute the Kappa's values we considered two situations, since more than one diagnosis was possible: the overestimation of the accordance in which the case was considered as concordant when at least one diagnoses was equal; and the underestimation of the accordance, in which the case was considered as discordant when at least one diagnosis was different.
   Results: The overestimation of the accordance showed an excellent agreement (kappa = 0.92, p < 0.0001); and the underestimation provided a moderate agreement (kappa = 0.42, p < 0.0001). In general the FCM model showed high sensitivity and specificity, of 0.95 and 0.92, respectively, but provided a low specificity value in determining the diagnosis of urge urinary incontinence (0.43) and a low sensitivity value to total urinary incontinence (0.42).
   Conclusions: The decision support system developed presented a good performance compared to other types of expert systems for differential diagnosis of alterations in urinary elimination. Since there are few similar studies in the literature, we are convinced of the importance of investing in this kind of modeling, both from the theoretical and from the health applied points of view.
   Limitations: In spite of the good results, the FCM should be improved to identify the diagnoses of urge urinary incontinence and total urinary incontinence. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Baena de Moraes Lopes, Maria Helena] Univ Estadual Campinas, Fac Med Sci, Dept Nursing, Campinas, SP, Brazil.
   [Siqueira Ortega, Neli Regina; Panse Silveira, Paulo Sergio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Ctr Fuzzy Syst Hlth, Sao Paulo, Brazil.
   [Higa, Rosangela] Univ Estadual Campinas, Womans Hosp Prof Jose Aristodemo Pinotti, Campinas, SP, Brazil.
   [Marin, Heimar de Fatima] Univ Fed Sao Paulo, Dept Nursing, Sao Paulo, Brazil.
RP Lopes, MHBD (corresponding author), Rua Conceicao,552 Apto 25 Ctr, BR-13010050 Campinas, SP, Brazil.
EM mhbaena@fcm.unicamp.br
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012; Silveira, Paulo
   SP/C-9077-2014
OI Massad, Eduardo/0000-0002-7200-2916; Higa,
   Rosangela/0000-0002-2347-4116; Lopes, Maria Helena Baena de
   Moraes/0000-0001-7747-1140
FU National Council of Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   476854/2004-0]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [D43TW007015]; BRIGHT;
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [301735/2009]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [D43TW007015, D43TW007015,
   D43TW007015, D43TW007015, D43TW007015, D43TW007015, D43TW007015,
   D43TW007015, D43TW007015, D43TW007015, D43TW007015] Funding Source: NIH
   RePORTER
FX This work was supported by the National Council of Scientific and
   Technological Development - CNPq 476854/2004-0.; Dr. Marin was partially
   supported by grant NIH D43TW007015, BRIGHT and CNPq 301735/2009.
CR Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4
   Albers-Heitner P, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-84
   Lopes MHBD, 2005, REV BRAS ENFERM, V58, P27, DOI 10.1590/S0034-71672005000100005
   Lopes MHBD, 2009, CIN-COMPUT INFORM NU, V27, P324, DOI 10.1097/NCN.0b013e3181b21e6d
   Barbosa SD, 2009, MUNDO SAUDE, V33, P449
   Brenner B, 1997, NEW ZEAL MED J, V110, P425
   Carpenito L.J., 1997, NURSING DIAGNOSIS AP
   Costa AJL, 2004, INT J MED INFORM, V73, P647, DOI 10.1016/j.ijmedinf.2004.04.010
   Davis G, 1999, MIL MED, V164, P182
   Georgopoulos V., 2002, ARTIF INTELL, V679, P1
   Higa R, 2008, REV BRAS ENFERM, V61, P565, DOI 10.1590/S0034-71672008000500006
   Jensen R, 2011, REV LAT-AM ENFERM, V19, P195, DOI 10.1590/S0104-11692011000100026
   John RI, 2005, IEEE T SYST MAN CY B, V35, P1340, DOI 10.1109/TSMCB.2005.855588
   Kopecky D, 2007, MED INFORM INTERNET, V32, P199, DOI 10.1080/14639230701446570
   KOSKO B, 1986, INT J MAN MACH STUD, V24, P65, DOI 10.1016/S0020-7373(86)80040-2
   Laurikkala J, 1998, COMPUT METH PROG BIO, V55, P217, DOI 10.1016/S0169-2607(97)00067-9
   Marin Heimar F, 2007, Int J Med Inform, V76 Suppl 2, pS267, DOI 10.1016/j.ijmedinf.2007.07.003
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E, 2008, STUD FUZZ SOFT COMP, V232, P1
   Nascimento LFC, 2002, REV SAUDE PUBL, V36, P686, DOI [10.1590/S0034-89102002000700005, 10.1590/s0034-89102002000700005]
   Nobrega MML, 1994, UNIFORMIZACAO LINGUA, P32
   North American Nursing Diagnosis Association, 2002, PORTO ALEGRE ARTMED, V101, P128
   North American Nursing Diagnosis Association, 2002, PORTO ALEGRE ARTMED, V101, P200
   Phuong NH, 2001, INT J MED INFORM, V62, P165, DOI 10.1016/S1386-5056(01)00160-5
   Reis MAM, 2004, BRAZ J MED BIOL RES, V37, P755, DOI 10.1590/S0100-879X2004000500018
   Reis R.B., 2003, ACTA CIR BRAS S5, V18, P47
   RISS PA, 1988, J PERINAT MED, V16, P283, DOI 10.1515/jpme.1988.16.4.283
   Souza C.A., P 29 NAT C COMP APPL
   Tanaka H, 2008, CLINICS, V63, P363, DOI 10.1590/S1807-59322008000300013
   Wadie BS, 2002, J UROLOGY, V168, P132, DOI 10.1016/S0022-5347(05)64845-8
   Woodtli A, 1995, Nurs Diagn, V6, P135
NR 31
TC 11
Z9 11
U1 0
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1386-5056
EI 1872-8243
J9 INT J MED INFORM
JI Int. J. Med. Inform.
PD MAR
PY 2013
VL 82
IS 3
BP 201
EP 208
DI 10.1016/j.ijmedinf.2012.05.012
PG 8
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 101UL
UT WOS:000315799800007
PM 22743142
OA Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Rocklov, J
   Wilder-Smith, A
AF Massad, E.
   Rocklov, J.
   Wilder-Smith, A.
TI Dengue infections in non-immune travellers to Thailand
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Dengue; mathematical modelling; risk estimates; Thailand; travellers
ID DISEASE; FEVER; RISK
AB Dengue is the most frequent arboviral disease and is expanding geographically. Dengue is also increasingly being reported in travellers, in particular in travellers to Thailand. However, data to quantify the risk of travellers acquiring dengue when travelling to Thailand are lacking. Using mathematical modelling, we set out to estimate the risk of non-immune persons acquiring dengue when travelling to Thailand. The model is deterministic with stochastic parameters and assumes a Poisson distribution for the mosquitoes' biting rate and a Gamma distribution for the probability of acquiring dengue from an infected mosquito. From the force of infection we calculated the risk of dengue acquisition for travellers to Thailand arriving in a typical year (averaged over a 17-year period) in the high season of transmission. A traveller arriving in the high season of transmission and remaining for 7 days has a risk of acquiring dengue of 0.2% (95% CI 0.16-0.23), whereas the risk for travel of 15 and 30 days' duration is 0.46% (95% CI 0.41-0.50) and 0.81% (95% CI 0.76-0.87), respectively. Our data highlight that the risk of non-immune travellers acquiring dengue in Thailand is substantial. The incidence of 0.81% after a 1-month stay is similar to that reported in prospective seroconversion studies in Israeli travellers to Thailand, highlighting that our models are consistent with actual data. Risk estimates based on mathematical modelling offer more detailed information depending on various travel scenarios, and will help the travel medicine provider give better evidence-based advice for travellers to dengue-endemic countries.
C1 [Massad, E.] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
   [Rocklov, J.; Wilder-Smith, A.] Umea Univ, Ctr Global Hlth Res, S-90187 Umea, Sweden.
   [Wilder-Smith, A.] Heidelberg Univ, Inst Publ Hlth, D-69120 Heidelberg, Germany.
RP Wilder-Smith, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Neuenheimer Feld 365, D-69120 Heidelberg, Germany.
EM epvws@pacific.net.sg
RI Wilder-Smith, Annelies/F-8751-2015; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916; Rocklov,
   Joacim/0000-0003-4030-0449; Wilder-Smith, Annelies/0000-0003-0362-5375
FU Health theme of the Seventh Framework Programme of the European
   Community [282589]
FX This research was undertaken by partners from the 'DengueTools'
   consortium [15]. DengueTools is funded under the Health theme of the
   Seventh Framework Programme of the European Community, Grant Agreement
   Number: 282589.
CR Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   Forattini O. P., 1996, MED CULICIDOLOGY
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Freedman DO, 1999, J TRAVEL MED, V6, P94, DOI 10.1111/j.1708-8305.1999.tb00839.x
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Potasman I, 1999, EMERG INFECT DIS, V5, P824, DOI 10.3201/eid0506.990615
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith A, GLOBAL HLTH IN PRESS
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
NR 18
TC 14
Z9 14
U1 0
U2 19
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD FEB
PY 2013
VL 141
IS 2
BP 412
EP 417
DI 10.1017/S0950268812000507
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 077FN
UT WOS:000314013400023
PM 22651899
OA Green Published, Bronze
DA 2020-12-16
ER

PT B
AU Amaku, M
   Coutinho, FAB
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Massad, Eduardo
BE Mondaini, RP
TI QUANTIFYING THE RISK OF MOSQUITO-BORNE INFECTIONS BASING ON THE
   EQUILIBRIUM PREVALENCE IN HUMANS
SO BIOMAT 2012: INTERNATIONAL SYMPOSIUM ON MATHEMATICAL AND COMPUTATIONAL
   BIOLOGY
LA English
DT Proceedings Paper
CT International Symposium on Mathematical and Computational Biology
   (BIOMAT)
CY NOV 06-10, 2012
CL Univ Arizona, Tempe, AZ
HO Univ Arizona
ID THRESHOLD CONDITIONS; YELLOW-FEVER; SYSTEM; TRANSMISSION; DISEASES;
   MALARIA
AB This paper proposes a general model for vector-borne infections that is flexible enough to comprise the dynamics of some known diseases transmitted by arthropods. From equilibrium analysis, we determined the number of infected vectors as an explicit function of the model's parameters and the prevalence of infection in the hosts. From the analysis, it is also possible to derive the Basic Reproduction Number and the equilibrium force of infection as a function of those parameters and variables. From the force of infection, we were able to conclude that, depending on the disease's structure and the model's parameters, it is possible to estimate a risk quantifier for those diseases. The analysis is exemplified by the case of malaria.
C1 [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, BR-05508 Sao Paulo, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London, England.
RP Amaku, M (corresponding author), Univ Sao Paulo, Sch Vet Med, BR-05508 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Amaku, Marcos/D-5252-2012; Coutinho,
   Francisco A B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774;
   Coutinho, Francisco A B/0000-0003-3127-3071
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Amaku M., COMP ANAL RELA UNPUB
   ANDERSON R M, 1991
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   CDC (Centers for Diseases Control), 2005, INF ARB ENC
   CIESIN (Center for International Earth Science Information Network), 2012, CHANG INC VECT BORN
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999
   Gubler D. J., 2005, INTEGRATION PUBLIC H, P44
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048
   IOM (Institute of Medicine), 1992, EM INF MICR THREATS
   Karunamoorthi K., 2012, J SOCIALOMICS, V1, P2
   Lemon S.M., 2008, VECTOR BORNE DIS UND
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MacDonald G., 1952, TROP DIS B, V49
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2012, MEM I OSWALDO CRUZ, V107, P564, DOI 10.1590/S0074-02762012000400022
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024
   *WHO, 2005, STAT ART VACC RES DE
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization (WHO), 2004, GLOB STRAT FRAM INT
NR 32
TC 0
Z9 0
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-4520-81-2
PY 2013
BP 44
EP 55
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BA4LH
UT WOS:000335953100003
DA 2020-12-16
ER

PT J
AU Amaku, M
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Massad, E
AF Amaku, Marcos
   Burattini, Marcelo Nascimento
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   Massad, Eduardo
TI Maximum Equilibrium Prevalence of Mosquito-Borne Microparasite
   Infections in Humans
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID THRESHOLD; DISEASES; SYSTEM; TRANSMISSION; STRATEGIES; DYNAMICS; DENGUE
AB To determine the maximum equilibrium prevalence of mosquito-borne microparasitic infections, this paper proposes a general model for vector-borne infections which is flexible enough to comprise the dynamics of a great number of the known diseases transmitted by arthropods. From equilibrium analysis, we determined the number of infected vectors as an explicit function of the model's parameters and the prevalence of infection in the hosts. From the analysis, it is also possible to derive the basic reproduction number and the equilibrium force of infection as a function of those parameters and variables. From the force of infection, we were able to conclude that, depending on the disease's structure and the model's parameters, there is a maximum value of equilibrium prevalence for each of the mosquito-borne microparasitic infections. The analysis is exemplified by the cases of malaria and dengue fever. With the values of the parameters chosen to illustrate those calculations, the maximum equilibrium prevalence found was 31% and 0.02% for malaria and dengue, respectively. The equilibrium analysis demonstrated that there is a maximum prevalence for the mosquito-borne microparasitic infections.
C1 [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, BR-05508270 Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Massad, Eduardo] LIM 01 HCFMUSP, BR-05405000 Sao Paulo, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Amaku, M (corresponding author), Univ Sao Paulo, Sch Vet Med, Ave Prof Dr Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, Brazil.
EM amaku@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Lopez, Luis F/C-4721-2012; Massad,
   Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Amaku,
   Marcos/D-5252-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Lopez, Luis
   F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916; Burattini,
   Marcelo N/0000-0002-5407-6890; Amaku, Marcos/0000-0003-4752-6774
FU European UnionEuropean Union (EU) [282589]; LIM01 HCFMUSP; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX The research from which these results were obtained has received funding
   from the European Union's Seventh Framework Programme (FP7/2007-2013)
   under Grant agreement no. 282589, from LIM01 HCFMUSP and CNPq. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the paper.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Amaku M., COMP ANAL RELATIVE E
   ANDERSON R M, 1991
   Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   CDC (Centers for Diseases Control), 2005, INF ARB ENC
   CIESIN (Center for International Earth Science Information Network), 2012, CHANG INC VECT BORN
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999
   Gubler D. J., 2005, INTEGRATION PUBLIC H, P44
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   IOM (Institute of Medicine), 1992, EM INF MICR THREATS
   Karunamoorthi K., 2012, J SOCIALOMICS, V1
   Lemon S.M., 2008, VECTOR BORNE DIS UND
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2012, MEM I OSWALDO CRUZ, V107, P564, DOI 10.1590/S0074-02762012000400022
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024
   Wahl LM, 2000, P ROY SOC B-BIOL SCI, V267, P835, DOI 10.1098/rspb.2000.1079
   Wang WD, 2008, J DYN DIFFER EQU, V20, P699, DOI 10.1007/s10884-008-9111-8
   *WHO, 2005, STAT ART VACC RES DE
   Wilder-Smith A., 2012, GLOBAL HLTH ACTION, V5
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization (WHO), 2004, GLOB STRAT FRAM INT
NR 32
TC 1
Z9 1
U1 0
U2 19
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2013
AR 659038
DI 10.1155/2013/659038
PG 7
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA 289HA
UT WOS:000329671300001
PM 24454539
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Ribas, LM
   Zaher, VL
   Shimozako, HJ
   Massad, E
AF Ribas, Laila Massad
   Zaher, Vera Lucia
   Shimozako, Helio Junji
   Massad, Eduardo
TI Estimating the Optimal Control of Zoonotic Visceral Leishmaniasis by the
   Use of a Mathematical Model
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID THRESHOLD CONDITIONS; CANINE; COHORT; DOGS; LEISHMUNE(R); INFECTION;
   BRAZIL; FEVER; RISK; AREA
AB We argue that the strategy of culling infected dogs is not the most efficient way to control zoonotic visceral leishmaniasis (ZVL) and that, in the presence of alternative control strategies with better potential results, official programs of compulsory culling adopted by some countries are inefficient and unethical. We base our arguments on a mathematical model for the study of control strategies against ZVL, which allows the comparison of the efficacies of 5, alternative strategies. We demonstrate that the culling program, previously questioned on both theoretical and practical grounds is the less effective control strategy. In addition, we show that vector control and the use of insecticide-impregnated dog collars are, by far, more efficient at reducing the prevalence of ZVL in humans.
C1 [Ribas, Laila Massad; Zaher, Vera Lucia; Shimozako, Helio Junji; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Ribas, Laila Massad; Zaher, Vera Lucia; Shimozako, Helio Junji; Massad, Eduardo] LIM 01 HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Ribas, Laila Massad/I-9651-2016; Shimozako, Helio Junji/AAX-2805-2020;
   Massad, Eduardo/B-1169-2012
OI Ribas, Laila Massad/0000-0002-1390-8523; Shimozako, Helio
   Junji/0000-0003-1941-9330; Massad, Eduardo/0000-0002-7200-2916
FU Laboratorio de Investigacao Medica do Hospital das Clinicas da Faculdade
   de Medicina da Universiidade de Sao Pulo -01 [IM01-HCFMUSP]; Conselho
   Nacionla de Pesquisas (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa de Sao
   Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX This work was supported by the Laboratorio de Investigacao Medica do
   Hospital das Clinicas da Faculdade de Medicina da Universiidade de Sao
   Pulo -01 (IM01-HCFMUSP), Conselho Nacionla de Pesquisas (CNPq), and
   Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP).
CR Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53
   Bailey N., 1975, MATH THEORY INFECT D
   Baker SE, 2005, J APPL ECOL, V42, P921, DOI 10.1111/j.1365-2664.2005.01069.x
   Barreto A.V.P., 2010, CLIN VET, V84, P12
   Beauchamp Tom L., 2008, HUMAN USE ANIMALS
   Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   Cohen N, 2009, J AGR ENVIRON ETHIC, V22, P341, DOI 10.1007/s10806-009-9157-6
   Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125
   Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559
   Hartnack S, 2009, DEUT TIERARZTL WOCH, V116, P152, DOI 10.2376/0341-6593-116-152
   Ikeda-Garcia FA, 2007, RES VET SCI, V83, P105, DOI 10.1016/j.rvsc.2006.10.008
   Joao A, 2006, J VET MED A, V53, P540, DOI 10.1111/j.1439-0442.2006.00869.x
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Palatnik-De-Sousa CB, 2009, VACCINE, V27, P3505, DOI 10.1016/j.vaccine.2009.03.045
   Paranhos-Silva M, 1998, ACTA TROP, V69, P75, DOI 10.1016/S0001-706X(97)00116-2
   QUINNELL RJ, 1994, MED VET ENTOMOL, V8, P219, DOI 10.1111/j.1365-2915.1994.tb00502.x
   Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200
   Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006
   Saraiva EM, 2006, VACCINE, V24, P2423, DOI 10.1016/j.vaccine.2005.11.061
   Shivik JA, 2003, CONSERV BIOL, V17, P1531, DOI 10.1111/j.1523-1739.2003.00062.x
   Singer P., 2003, ANIMAL LIBERATION
   Singer P, 2006, PRIMATES AND PHILOSOPHERS: HOW MORALITY EVOLVED, P140
   TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287
   Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85
   WHO Expert Committee, 1990, WHO TECHNICAL REPORT, V793
NR 32
TC 17
Z9 17
U1 0
U2 10
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2013
AR 810380
DI 10.1155/2013/810380
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 204DE
UT WOS:000323344400001
PM 23990761
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Chaib, E
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Chaib, Eleazar
   Massad, Eduardo
TI The Impact of Hepatitis A Virus Infection on Hepatitis C Virus
   Infection: A Competitive Exclusion Hypothesis
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Hepatitis A; Hepatitis C; Competitive exclusion principle; Mathematical
   models
ID SUPERINFECTION; DYNAMICS
AB We address the observation that, in some cases, patients infected with the hepatitis C virus (HCV) are cleared of HCV when super-infected with the hepatitis A virus (HAV). We hypothesise that this phenomenon can be explained by the competitive exclusion principle, including the action of the immune system, and show that the inclusion of the immune system explains both the elimination of one virus and the co-existence of both infections for a certain range of parameters. We discuss the potential clinical implications of our findings.
C1 [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, Sao Paulo, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Chaib, Eleazar; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Amaku,
   Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
FU HCFMUSP [LIM-01]; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX This work was partially supported by LIM-01 HCFMUSP, CNPq and FAPESP. M.
   A., F. A. B. C., E. C., and E. M. designed the work, performed the
   analysis, and wrote the paper.
CR Ajelli M, 2008, VACCINE, V26, P1697, DOI 10.1016/j.vaccine.2007.12.058
   Amaku M, 2010, PHYTOPATHOLOGY, V100, P1042, DOI 10.1094/PHYTO-10-09-0289
   Amaku M, 2010, B MATH BIOL, V72, P1294, DOI 10.1007/s11538-009-9495-6
   ANDERSON R M, 1991
   Andraud M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002418
   BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102
   Burattini M. N., 2008, BIOSCI HYPOTHESES, V1, P168, DOI DOI 10.1016/J.BIHY.2008.05.003
   Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657
   Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060
   Deterding K, 2006, J HEPATOL, V45, P770, DOI 10.1016/j.jhep.2006.07.023
   EDELSTEINKESHET L, 2005, MATH MODELS BIOL
   Gruener NH, 2002, J HEPATOL, V37, P866, DOI 10.1016/S0168-8278(02)00303-3
   Jeger MJ, 2011, VIRUS RES, V159, P215, DOI 10.1016/j.virusres.2011.05.012
   Lecoq H, 2011, VIRUS RES, V159, P115, DOI 10.1016/j.virusres.2011.05.004
   LIAW YF, 1994, GASTROENTEROLOGY, V106, P1048, DOI 10.1016/0016-5085(94)90766-8
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Marcos R, 2006, LIVER INT, V26, P116, DOI 10.1111/j.1478-3231.2005.01201.x
   MAY R. M., 1974, STABILITY COMPLEXITY
   MCGEHEE R, 1977, J DIFFER EQUATIONS, V23, P30, DOI 10.1016/0022-0396(77)90135-8
   Nelson DR, 1997, J IMMUNOL, V158, P1473
   Nowak M., 2001, VIRUS DYNAMICS MATH
   Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571
   Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931
   Rong L, 2010, CRIT REV IMMUNOL, V30, P131, DOI 10.1615/CritRevImmunol.v30.i2.30
   Sagnelli E, 2006, J CLIN VIROL, V35, P317, DOI 10.1016/j.jcv.2005.10.006
   Thomas D. L., 2005, PRINCIPLES PRACTICE
   Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503
NR 27
TC 5
Z9 5
U1 1
U2 39
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD JAN
PY 2013
VL 75
IS 1
BP 82
EP 93
DI 10.1007/s11538-012-9795-0
PG 12
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 073DO
UT WOS:000313723900004
PM 23192400
DA 2020-12-16
ER

PT J
AU Massad, E
   Amaku, M
   Coutinho, FAB
   Kittayapong, P
   Wilder-Smith, A
AF Massad, Eduardo
   Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Kittayapong, Pattamaporn
   Wilder-Smith, Annelies
TI Theoretical impact of insecticide-impregnated school uniforms on dengue
   incidence in Thai children
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE dengue; school children; impregnated clothes; insecticide-treated
   uniforms; force of infection; mathematical models; Thailand
ID POPULATION-DYNAMICS; ECONOMIC-IMPACT; AEDES-AEGYPTI; MALARIA;
   INFECTIONS; AMERICA; SYSTEM; COST
AB Background: Children carry the main burden of morbidity and mortality caused by dengue. Children spend a considerable amount of their day at school; hence strategies that reduce human-mosquito contact to protect against the day-biting habits of Aedes mosquitoes at schools, such as insecticide-impregnated uniforms, could be an effective prevention strategy.
   Methodology: We used mathematical models to calculate the risk of dengue infection based on force of infection taking into account the estimated proportion of mosquito bites that occur in school and the proportion of school time that children wear the impregnated uniforms.
   Principal findings: The use of insecticide-impregnated uniforms has efficacy varying from around 6% in the most pessimistic estimations, to 55% in the most optimistic scenarios simulated.
   Conclusions: Reducing contact between mosquito bites and human hosts via insecticide-treated uniforms during school time is theoretically effective in reducing dengue incidence and may be a valuable additional tool for dengue control in school-aged children. The efficacy of this strategy, however, is dependent on the compliance of the target population in terms of proper and consistent wearing of uniforms and, perhaps more importantly, the proportion of bites inflicted by the Aedes population during school time.
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, Sao Paulo, Brazil.
   [Kittayapong, Pattamaporn] Mahidol Univ Salaya, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Nakhon Phatom, Thailand.
   [Wilder-Smith, Annelies] Umea Univ, Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore.
   [Wilder-Smith, Annelies] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore.
RP Wilder-Smith, A (corresponding author), Umea Univ, Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.
EM anneliesws@gmail.com
RI Amaku, Marcos/D-5252-2012; Wilder-Smith, Annelies/F-8751-2015; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Coutinho, Francisco A
   B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916;
   Wilder-Smith, Annelies/0000-0003-0362-5375
FU European Union's Seventh Framework Programme (FP7)European Union (EU)
   [282589]; LIM01 HCFMUSP; FAPESPFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP); CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX The research leading to these results has received funding from the
   European Union's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no. 282589, from LIM01 HCFMUSP, FAPESP, and CNPq.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218
   Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Enayati AA, 2006, PESTIC BIOCHEM PHYS, V84, P116, DOI 10.1016/j.pestbp.2005.06.001
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Greenwood B, 2012, SCIENCE, V338, P49, DOI 10.1126/science.1229177
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HALLORAN ME, 2012, DESIGN ANAL VACCINE
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Kroeger A, 1999, T ROY SOC TROP MED H, V93, P565, DOI 10.1016/S0035-9203(99)90048-2
   Lengeler C, 2004, DATABASE SYS REV, V2
   Massad E, 2012, EPIDEMIOL INFECT, V24, P1
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Massad E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-130
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Okell LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-327
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002
   Strickman D, 2000, AM J TROP MED HYG, V63, P27, DOI 10.4269/ajtmh.2000.63.27
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Wilder-Smith A, 2011, MED HYPOTHESES, V76, P861, DOI 10.1016/j.mehy.2011.02.037
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
NR 31
TC 8
Z9 8
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2013
VL 6
BP 1
EP 6
DI 10.3402/gha.v6i0.20473
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 115HE
UT WOS:000316802400001
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Chaib, E
   Coimbra, BGMM
   Galvao, FHF
   Tatebe, ER
   Shinzato, MS
   D'Albuquerque, LAC
   Massad, E
AF Chaib, E.
   Coimbra, B. G. M. M.
   Galvao, F. H. F.
   Tatebe, E. R.
   Shinzato, M. S.
   D'Albuquerque, L. A. C.
   Massad, E.
TI Does anti-hepatitis B virus vaccine make any difference in long-term
   number of liver transplantation?
SO CLINICAL TRANSPLANTATION
LA English
DT Article
DE hepatitis B; liver transplantation; mathematical model; vaccination
ID WAITING-LIST; SAO-PAULO; BRAZIL; STATE; CHINA; POPULATION; DYNAMICS;
   IMPACT
AB Background: Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality worldwide. Chronic hepatitis B infection is associated with an increased risk of cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Our aim is to analyze, through a mathematical model, the potential impact of anti-HBV vaccine in the long-term (that is, decades after vaccination) number of LT.
   Methods: The model simulated that the prevalence of HBV infection was 0.5% and that approximately 20% of all the liver transplantation carried out in the state of Sao Paulo are due to HBV infection.
   Results: The theoretical model suggests that a vaccination program that would cover 80% of the target population would reach a maximum of about 14% reduction in the LT program.
   Conclusion: Increasing the vaccination coverage against HBV in the state of Sao Paulo would have a relatively low impact on the number of liver transplantation. In addition, this impact would take several decades to materialize due to the long incubation period of liver failure due to HBV.
C1 [Chaib, E.; Coimbra, B. G. M. M.; Galvao, F. H. F.; Tatebe, E. R.; Shinzato, M. S.; D'Albuquerque, L. A. C.] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Liver Transplantat Surg Unit, BR-01296900 Sao Paulo, Brazil.
   [Massad, E.] Univ Sao Paulo, Sch Med, Dept Med Informat, BR-01296900 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Oscar Freire Inst, Dept Informat, Av Dr Arnaldo 455, BR-01296900 Sao Paulo, Brazil.
EM edmassad@usp.br
RI D'ALBUQUERQUE, Luiz Carneiro Augusto/I-4011-2012; D'Albuquerque, Luiz
   Augusto Carneiro/A-8812-2013; Massad, Eduardo/B-1169-2012; Galvao,
   Flavio Henrique Ferreira/D-3487-2017
OI D'Albuquerque, Luiz Augusto Carneiro/0000-0001-7607-7168; Massad,
   Eduardo/0000-0002-7200-2916; Galvao, Flavio Henrique
   Ferreira/0000-0003-1924-3208
CR Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chaib E, 2007, TRANSPLANTATION, V84, P1209, DOI 10.1097/01.tp.0000287192.32090.2b
   Chaib E, 2010, MED HYPOTHESES, V75, P324, DOI 10.1016/j.mehy.2010.03.013
   Chaib E, 2008, LIVER TRANSPLANT, V14, P1732, DOI 10.1002/lt.21611
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   Hepatitis B Foundation UK, 2007, RIS CURV CHRON HBV I
   Hilleman M, 1993, HEPATITIS B VACCINES, P17
   Hilleman MR, 2011, HISTORY OF VACCINE DEVELOPMENT, P233, DOI 10.1007/978-1-4419-1339-5_25
   Lu FM, 2009, CHINESE MED J-PEKING, V122, P2925, DOI 10.3760/cma.j.issn.0366-6999.2009.24.001
   Luo ZB, 2011, EUR J GASTROEN HEPAT, V23, P695, DOI 10.1097/MEG.0b013e328347322b
   Massad E, 2009, EPIDEMIOL INFECT, V137, P241, DOI 10.1017/S0950268808000873
   MSB, 2012, 30 AN PROGR NAC IM
   Nicholson ML, 1997, TRANSPL P, V29, P1386, DOI 10.1016/S0041-1345(96)00605-7
   Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321
NR 15
TC 4
Z9 4
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0902-0063
J9 CLIN TRANSPLANT
JI Clin. Transplant.
PD NOV-DEC
PY 2012
VL 26
IS 6
BP E590
EP E595
DI 10.1111/ctr.12030
PG 6
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 051LS
UT WOS:000312129100003
PM 23083337
DA 2020-12-16
ER

PT J
AU Amaku, M
   Coudeville, L
   Massad, E
AF Amaku, Marcos
   Coudeville, Laurent
   Massad, Eduardo
TI DESIGNING A VACCINATION STRATEGY AGAINST DENGUE
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
ID ADOLESCENTS; CHILDREN; ADULTS
AB In this work we propose a mathematical approach to estimate the dengue force of infection, the average age of dengue first infection, the optimum age to vaccinate children against dengue in a routine fashion and the optimum age interval to introduce the dengue vaccine in a mass vaccination campaign. The model is based on previously published models for vaccination against other childhood infections, which resulted in actual vaccination programmes in Brazil. The model was applied for three areas of distinct levels of endemicity of the city of Recife in Northeastern State of Pernambuco, Brazil. Our results point to an optimal age to introduce the dengue vaccine in the routine immunization programme at two years of age and an age interval to introduce a mass vaccination between three and 14 years of age.
C1 [Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Massad, Eduardo] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
   [Coudeville, Laurent] Dengue Co, F-69007 Lyon, France.
   [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, BR-05508 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
CR Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   ANDERSON R M, 1991
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Dietz K, 1976, LECTURE NOTES BIOMAT, V11, P1
   Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Guy B, 2011, LANCET, V377, P381, DOI 10.1016/S0140-6736(11)60128-1
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916
   Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003
   Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09
   Poo J, 2011, PEDIATR INFECT DIS J, V30, pE9, DOI 10.1097/INF.0b013e3181fe05af
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
NR 16
TC 6
Z9 7
U1 0
U2 9
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD OCT
PY 2012
VL 54
SU 18
BP S18
EP S21
DI 10.1590/S0036-46652012000700008
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 012NI
UT WOS:000309242600008
PM 23011455
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
AF Massad, E.
TI Potential impact of dengue vaccination: a modeling approach
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Massad, E.] Univ Sao Paulo, Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2012
VL 16
SU 1
BP E5
EP E5
DI 10.1016/j.ijid.2012.05.017
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 999YX
UT WOS:000308353100010
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
TI Vectorial capacity, basic reproduction number, force of infection and
   all that: formal notation to complete and adjust their classical
   concepts and equations
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Editorial Material
DE vector-borne infections; basic reproduction rate; sporozoite rate;
   vectorial capacity; force of infection; dimensional analysis
ID TRANSMISSION; R-0
AB A dimensional analysis of the classical equations related to the dynamics of vector-borne infections is presented. It is provided a formal notation to complete the expressions for the Ross' threshold theorem, the Macdonald's basic reproduction "rate" and sporozoite "rate", Garret-Jones' vectorial capacity and Dietz-Molineaux-Thomas' force of infection. The analysis was intended to provide a formal notation that complete the classical equations proposed by these authors.
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Fac Med, LIM Hosp Clin 01, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, LIM Hosp Clin 01, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071
FU European UnionEuropean Union (EU) [282589]; LIM01 HCFMUSP; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX European Union's Seventh Framework Programme (FP7/2007-2013) (282589),
   LIM01 HCFMUSP, CNPq
CR Aron J.L., 1982, P139
   Bailey N.T.J., 1982, BIOMATHEMATICS MALAR
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Dietz K, 1980, GARKI PROJECT, P261
   Dye, 1986, PARASITOL TODAY, V2, P203
   DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245
   DYE C, 1990, PARASITOLOGY, V101, P409, DOI 10.1017/S0031182000060601
   FINE PEM, 1975, P ROY SOC MED, V68, P547, DOI 10.1177/003591577506800903
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   GARRETT-JONES C, 1969, Bulletin of the World Health Organization, V40, P531
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   Gibbings JC, 2011, DIMENSIONAL ANALYSIS, P1, DOI 10.1007/978-1-84996-317-6
   Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804
   Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Molyneux DH, 2003, T ROY SOC TROP MED H, V97, P129, DOI 10.1016/S0035-9203(03)90097-6
   Newton I, 1686, PHILOS NATURALIS PRI
   Ross R., 1911, PREVENTION MALARIA
   Ross R, 1923, MEMOIRS WHIT FULL AC
   Sonin AA, 2012, PHYS BASIS DIMENSION
   STAHL WR, 1961, B MATH BIOPHYS, V23, P355, DOI 10.1007/BF02476492
NR 27
TC 19
Z9 19
U1 0
U2 10
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2012
VL 107
IS 4
BP 564
EP 567
DI 10.1590/S0074-02762012000400022
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 953FY
UT WOS:000304853500022
PM 22666873
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Raimundo, SM
   Yang, HM
   Venturino, E
   Massad, E
AF Raimundo, Silvia Martorano
   Yang, Hyun Mo
   Venturino, Ezio
   Massad, Eduardo
TI Modeling the emergence of HIV-1 drug resistance resulting from
   antiretroviral therapy: Insights from theoretical and numerical studies
SO BIOSYSTEMS
LA English
DT Article
DE HIV; Antiretroviral therapy; Drug resistance; Hopf bifurcation
ID EPIDEMIC MODEL; INFECTION; TRANSMISSION; DYNAMICS; BIFURCATIONS;
   PROPHYLAXIS; FAILURE; VIRUS
AB The use of antiretroviral therapy has proven to be remarkably effective in controlling the progression of human immunodeficiency virus (HIV) infection and prolonging patient's survival. Therapy however may fail and therefore these benefits can be compromised by the emergence of HIV strains that are resistant to the therapy. In view of these facts, the question of finding the reason for which drug-resistant strains emerge during therapy has become a worldwide problem of great interest. This paper presents a deterministic HIV-1 model to examine the mechanisms underlying the emergence of drug-resistance during therapy. The aim of this study is to determine whether, and how fast, antiretroviral therapy may determine the emergence of drug resistance by calculating the basic reproductive numbers. The existence, feasibility and local stability of the equilibriums are also analyzed. By performing numerical simulations we show that Hopf bifurcation may occur. The model suggests that the individuals with drug-resistant infection may play an important role in the epidemic of HIV. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Raimundo, Silvia Martorano; Massad, Eduardo] Univ Sao Paulo, Fac Med, HCFMUSP, BR-05405000 Sao Paulo, Brazil.
   [Raimundo, Silvia Martorano] Fdn ISI, I-10133 Turin, Italy.
   [Yang, Hyun Mo] Univ Estadual Campinas, IMECC, Dept Matemat Aplicada, BR-13083859 Campinas, SP, Brazil.
   [Venturino, Ezio] Univ Turin, Dipartimento Matemat Giuseppe Peano, I-10123 Turin, Italy.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Raimundo, SM (corresponding author), Univ Sao Paulo, Fac Med, HCFMUSP, LIM01,Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM silviamr@dim.fm.usp.br
RI Venturino, Ezio/C-5221-2011; Raimundo, Silvia Martorano/D-4624-2012;
   Yang, Hyun M/K-6873-2014; Massad, Eduardo/B-1169-2012
OI Raimundo, Silvia Martorano/0000-0002-9960-7341; Yang, Hyun
   M/0000-0002-1711-363X; Massad, Eduardo/0000-0002-7200-2916; Venturino,
   Ezio/0000-0001-7215-5114
FU Fondazione CRTFondazione CRT; Progetto Lagrange; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX This work was supported by partial grants from Fondazione CRT, Progetto
   Lagrange and FAPESP. S.M.R. would like to thank for Fondazione CRT,
   Progetto Lagrange and FAPESP for their support. The authors also thank
   to Raphael Vilamiu (EMBRAPA, Campinas, SP, Brazil) for his helpful
   numerical aid on the research presented in this paper.
CR Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9
   Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124
   Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650
   Blower SM, 2001, NAT MED, V7, P1016, DOI 10.1038/nm0901-1016
   Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971
   Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631
   Breban R, 2006, LANCET, V367, P1285, DOI 10.1016/S0140-6736(06)68543-7
   Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   De Jong M, 1994, EPIDEMIC MODELS THEI, V1994, P84
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001
   Gallant JE, 2000, JAMA-J AM MED ASSOC, V283, P1329, DOI 10.1001/jama.283.10.1329
   Gilchrist MA, 2004, J THEOR BIOL, V229, P281, DOI 10.1016/j.jtbi.2004.04.015
   Guckenheimer J., 1983, NONLINEAR OSCILLATIO
   Gumel AB, 2000, MATH COMPUT SIMULAT, V54, P169, DOI 10.1016/S0378-4754(00)00222-6
   Gumel AB, 2001, COMPUT BIOL MED, V31, P287, DOI 10.1016/S0010-4825(01)00012-9
   Hale J. K., 1980, ORDINARY DIFFERENTIA
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hoare A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010981
   Kirschner DE, 1997, B MATH BIOL, V59, P763, DOI 10.1007/BF02458429
   Krakovska O, 2007, J THEOR BIOL, V246, P499, DOI 10.1016/j.jtbi.2006.12.038
   Krakovska O, 2007, J MATH BIOL, V54, P385, DOI 10.1007/s00285-006-0059-1
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   May R.M., 1973, STABILITY COMPLEXITY
   MCLEAN AR, 1992, AIDS, V6, P71, DOI 10.1097/00002030-199201000-00009
   Moghadas S., 2003, J THEOR MED, V5, P171
   Moghadas SM, 2006, MATH MED BIOL, V23, P231, DOI 10.1093/imammb/dql011
   Moghadas SM, 2003, ANZIAM J, V45, P181, DOI 10.1017/S1446181100013250
   Nowak MA, 1997, J THEOR BIOL, V184, P205, DOI 10.1006/jtbi.1996.0307
   Qiu Zhipeng, 2010, Journal of Biological Dynamics, V4, P506, DOI 10.1080/17513758.2010.498925
   Quinones-Mateu ME, 2005, AIDS, V19, P1689, DOI 10.1097/01.aids.0000186018.39673.1c
   Quinones-Mateu ME, 2001, HIV SEQUENCE COMPEND, P134
   Rong LB, 2007, B MATH BIOL, V69, P2027, DOI 10.1007/s11538-007-9203-3
   Sharomi O, 2007, MATH BIOSCI, V210, P436, DOI 10.1016/j.mbs.2007.05.012
   Sharomi O., 2008, Journal of Biological Dynamics, V2, P323, DOI 10.1080/17513750701775599
   Smith RJ, 2005, B MATH BIOL, V67, P783, DOI 10.1016/j.bulm.2004.10.004
   Snedecor SJ, 2005, B MATH BIOL, V67, P1315, DOI 10.1016/j.bulm.2005.02.004
   Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107
   Vardavas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000152
   Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8
   Wein LM, 1998, J THEOR BIOL, V192, P81, DOI 10.1006/jtbi.1997.0622
   WHO, 2010, ANT THER HIV INF AD
   WHO, 2006, ANT THER HIV INF AD
   Zhou YG, 2007, CHAOS SOLITON FRACT, V32, P1903, DOI 10.1016/j.chaos.2006.01.002
NR 45
TC 4
Z9 4
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0303-2647
EI 1872-8324
J9 BIOSYSTEMS
JI Biosystems
PD APR-JUN
PY 2012
VL 108
IS 1-3
BP 1
EP 13
DI 10.1016/j.biosystems.2011.11.009
PG 13
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 920VN
UT WOS:000302436700001
PM 22155363
DA 2020-12-16
ER

PT J
AU Massad, E
   Pereira, A
   Bobbitt, N
AF Massad, Eduardo
   Pereira, Alfredo, Jr.
   Bobbitt, Nathaniel
TI Special Issue: Pointing at Boundaries: Integrating Cognition and
   Computation on Biological Grounds
SO COGNITIVE COMPUTATION
LA English
DT Editorial Material
C1 [Bobbitt, Nathaniel] Cent Washington Univ, Program Expt Psychol, Ellensburg, WA 98296 USA.
   [Massad, Eduardo] Univ Sao Paulo, Dept Med Informat, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
   [Pereira, Alfredo, Jr.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Educ, BR-18618970 Botucatu, SP, Brazil.
RP Bobbitt, N (corresponding author), Cent Washington Univ, Program Expt Psychol, Ellensburg, WA 98296 USA.
EM edmassad@dim.fm.usp.br; apj@ibb.unesp.br; eye@nabslab.com
RI Massad, Eduardo/B-1169-2012; Pereira Junior, Alfredo/K-1846-2014
OI Massad, Eduardo/0000-0002-7200-2916; Pereira Junior,
   Alfredo/0000-0002-5960-041X
CR Bellman R, 1962, AM MATH SOC S APPL M
   BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X
   Crick F., 1990, Seminars in the Neurosciences, V2, P263
   DurstAndersen P, 2011, SEMIOT COMMUN COGNIT, V6, P1, DOI 10.1515/9783110253153
   Fromherz P, 2006, ANN NY ACAD SCI, V1093, P143, DOI 10.1196/annals.1382.011
   Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719
   Hodos William, 2001, P113
   Iriki A, 2006, CURR OPIN NEUROBIOL, V16, P660, DOI 10.1016/j.conb.2006.10.008
   Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4
   Marder E, 2011, P NATL ACAD SCI USA, P1
   Wegner P, 1997, COMMUN ACM, V40, P80, DOI 10.1145/253769.253801
   Wooley J. C., 2005, CATALYZING INQUIRY I
NR 12
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1866-9956
EI 1866-9964
J9 COGN COMPUT
JI Cogn. Comput.
PD MAR
PY 2012
VL 4
IS 1
SI SI
BP 1
EP 3
DI 10.1007/s12559-012-9127-6
PG 3
WC Computer Science, Artificial Intelligence; Neurosciences
SC Computer Science; Neurosciences & Neurology
GA 958CG
UT WOS:000305213200001
OA Bronze
DA 2020-12-16
ER

PT J
AU Coelho, MSZS
   Massad, E
AF Coelho, Micheline S. Z. S.
   Massad, Eduardo
TI The impact of climate on Leptospirosis in Sao Paulo, Brazil
SO INTERNATIONAL JOURNAL OF BIOMETEOROLOGY
LA English
DT Article
DE Leptospirosis; Negative binomial regression; Hospital admission; Climate
ID TRENDS
AB In this work, we correlate the daily number of human leptospirosis cases with several climatic factors. We used a negative binomial model that considers hospital daily admissions due to leptospirosis as the dependent variable, and the climatic variables of daily precipitation pattern, and maximum and minimum temperature as independent variables. We calculated the monthly leptospirosis admission probabilities from the precipitation and maximum temperature variables. The month of February showed the highest probability, although values were also high during the spring months. The month of February also showed the highest number of hospital admissions. Another interesting result is that, for every 20 mm precipitation, there was an average increase of 31.5% in hospital admissions. Additionally, the relative risk of leptospirosis varied from 1.1 to 2.0 when the precipitation varied from 20 to 140 mm.
C1 [Massad, Eduardo] Univ Sao Paulo, Sao Paulo, Brazil.
   [Massad, Eduardo] LIM01 HCFMUSP, Sao Paulo, Brazil.
   [Coelho, Micheline S. Z. S.] Inst Nacl Meteorol INMET, Coordenacao Desenvolvimento & Pesquisa CDP, BR-01246903 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Coelho, Micheline S. Z. S./A-4480-2012
OI Massad, Eduardo/0000-0002-7200-2916; Coelho, Micheline S. Z.
   S./0000-0002-9732-1278
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); LIM01/HCFMUSP
FX This work was partially supported by FAPESP, CNPq and LIM01/HCFMUSP.
CR Baranton G, 2006, INT J INFECT DIS, V10, P162, DOI 10.1016/j.ijid.2005.02.010
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bussab WO, 2004, ESTATISTICA BASICA 5
   DOMM BM, 1960, MEDICINE, V39, P117
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   FEIGIN R D, 1975, Critical Reviews in Clinical Laboratory Sciences, V5, P413, DOI 10.3109/10408367509107050
   JOHNSON RC, 1977, ANNU REV MICROBIOL, V31, P89, DOI 10.1146/annurev.mi.31.100177.000513
   Johnson RC, 1990, TROPICAL GEOGRAPHICA, P889
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P1291, DOI 10.1016/B978-0-12-369408-9.00064-0
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Long J. S., 2006, REGRESSION MODELS CA
   Mazumdar S, 1992, ARCH ENVIRON HEALTH, V37, P213
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   RAMOSMORALES F, 1959, ANN INTERN MED, V51, P861, DOI 10.7326/0003-4819-51-5-861
   Scott G, 1996, MANSONS TROPICAL DIS, P963
   Shieh W. J., 1999, TROPICAL INFECT DIS, P547
   Vanasco N. B., 2002, Revista Argentina de Microbiologia, V34, P124
   Vanasco NB, 2004, SALUD CIENCIA, V12, p[26, 31]
   Vanasco NB, 2000, REV PANAM SALUD PUBL, V7, P35
   WHO, 2003, 420 WHO WC INT LEPT
NR 22
TC 19
Z9 21
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0020-7128
EI 1432-1254
J9 INT J BIOMETEOROL
JI Int. J. Biometeorol.
PD MAR
PY 2012
VL 56
IS 2
BP 233
EP 241
DI 10.1007/s00484-011-0419-4
PG 9
WC Biophysics; Environmental Sciences; Meteorology & Atmospheric Sciences;
   Physiology
SC Biophysics; Environmental Sciences & Ecology; Meteorology & Atmospheric
   Sciences; Physiology
GA 893HL
UT WOS:000300346800003
PM 21369729
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Renhorn, KE
   Tissera, H
   Abu Bakar, S
   Alphey, L
   Kittayapong, P
   Lindsay, S
   Logan, J
   Hatz, C
   Reiter, P
   Rocklov, J
   Byass, P
   Louis, VR
   Tozan, Y
   Massad, E
   Tenorio, A
   Lagneau, C
   L'Ambert, G
   Brooks, D
   Wegerdt, J
   Gubler, D
AF Wilder-Smith, Annelies
   Renhorn, Karl-Erik
   Tissera, Hasitha
   Abu Bakar, Sazaly
   Alphey, Luke
   Kittayapong, Pattamaporn
   Lindsay, Steve
   Logan, James
   Hatz, Christoph
   Reiter, Paul
   Rocklov, Joacim
   Byass, Peter
   Louis, Valerie R.
   Tozan, Yesim
   Massad, Eduardo
   Tenorio, Antonio
   Lagneau, Christophe
   L'Ambert, Gregory
   Brooks, David
   Wegerdt, Johannah
   Gubler, Duane
TI DengueTools: innovative tools and strategies for the surveillance and
   control of dengue
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE dengue; dengue control; dengue diagnostics; economic evaluation;
   entomology; climate change; early warning systems; risk mapping;
   surveillance; globalization
ID AEDES-AEGYPTI; DIPTERA; CULICIDAE; RESPONSES; INSECTICIDE; INFUSIONS;
   CHILDREN; THAILAND; IMPACT; SCHOOL
AB Dengue fever is a mosquito-borne viral disease estimated to cause about 230 million infections worldwide every year, of which 25,000 are fatal. Global incidence has risen rapidly in recent decades with some 3.6 billion people, over half of the world's population, now at risk, mainly in urban centres of the tropics and subtropics. Demographic and societal changes, in particular urbanization, globalization, and increased international travel, are major contributors to the rise in incidence and geographic expansion of dengue infections. Major research gaps continue to hamper the control of dengue. The European Commission launched a call under the 7th Framework Programme with the title of 'Comprehensive control of Dengue fever under changing climatic conditions'. Fourteen partners from several countries in Europe, Asia, and South America formed a consortium named 'DengueTools' to respond to the call to achieve better diagnosis, surveillance, prevention, and predictive models and improve our understanding of the spread of dengue to previously uninfected regions (including Europe) in the context of globalization and climate change.
   The consortium comprises 12 work packages to address a set of research questions in three areas:
   Research area 1: Develop a comprehensive early warning and surveillance system that has predictive capability for epidemic dengue and benefits from novel tools for laboratory diagnosis and vector monitoring.
   Research area 2: Develop novel strategies to prevent dengue in children.
   Research area 3: Understand and predict the risk of global spread of dengue, in particular the risk of introduction and establishment in Europe, within the context of parameters of vectorial capacity, global mobility, and climate change.
   In this paper, we report on the rationale and specific study objectives of 'DengueTools'. DengueTools is funded under the Health theme of the Seventh Framework Programme of the European Community, Grant Agreement Number: 282589 Dengue Tools.
C1 [Wilder-Smith, Annelies; Renhorn, Karl-Erik; Rocklov, Joacim; Byass, Peter; Wegerdt, Johannah] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Tissera, Hasitha] Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka.
   [Abu Bakar, Sazaly] Univ Malaya, TIDREC, WHO Collaborating Ctr Arbovirus, Kuala Lumpur, Malaysia.
   [Alphey, Luke] Oxitec Ltd, Oxford, England.
   [Kittayapong, Pattamaporn] Mahidol Univ, Fac Sci, Dept Biol, Ctr Excellence Vectors & Vector Borne Dis, Bangkok 10400, Thailand.
   [Lindsay, Steve; Logan, James] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
   [Hatz, Christoph] Swiss Trop & Publ Hlth Inst, Dept Med Serv, Basel, Switzerland.
   [Reiter, Paul] Inst Pasteur, Insects & Infect Dis Unit, Paris, France.
   [Wilder-Smith, Annelies; Louis, Valerie R.; Tozan, Yesim] Heidelberg Univ, Sch Med, Inst Publ Hlth, Heidelberg, Germany.
   [Tozan, Yesim] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA.
   [Massad, Eduardo] Univ Sao Paulo, Sao Paulo, Brazil.
   [Tenorio, Antonio] Inst Salud Carlos III, Madrid, Spain.
   [Lagneau, Christophe; L'Ambert, Gregory] Entente Interdept Demousticat Littoral Mediterran, Montpellier, France.
   [Brooks, David] TwistDx Ltd, Cambridge, England.
   [Gubler, Duane] DUKE NUS, Grad Sch Med, Singapore, Singapore.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
EM epvws@pacific.net.sg
RI Wilder-Smith, Annelies/F-8751-2015; abubakar, sazaly/B-3957-2010;
   Tissera, Hasitha/AAQ-2516-2020; Massad, Eduardo/B-1169-2012
OI abubakar, sazaly/0000-0002-9267-1420; Massad,
   Eduardo/0000-0002-7200-2916; Alphey, Luke/0000-0002-2916-3802; Byass,
   Peter/0000-0001-5474-4361; Rocklov, Joacim/0000-0003-4030-0449;
   Wilder-Smith, Annelies/0000-0003-0362-5375; Renhorn,
   Karl-Erik/0000-0003-1855-8902
FU GSKGlaxoSmithKline; Sanofi Pasteur; NovartisNovartis; NITD; European
   CommunityEuropean Community (EC) [282589 Dengue Tools]
FX A Wilder-Smith was the Principal Investigator of a Sanofi Pasteur funded
   Phase 2b vaccine trial for dengue. She has received speaker fees from
   GSK, Sanofi Pasteur and Novartis. Luke Alphey has employment and equity
   interest in Oxitec, Ltd. Oxitec is developing novel methods for the
   control of pest insects including Aedes aegypti and owns intellectual
   property relevant to the subject matter of this paper. Duane Gubler is
   on the scientific advisory boards of NITD, Inviragen, DVI, and ADITEC.
   He has received consultant fees from NITD and royalties and stock
   options from Inviragen. David Brooks works for TwistDx, a company that
   develops diagnostic assays. All other authors have no conflict of
   interest.; In this paper, we report on the rationale and specific study
   objectives of 'DengueTools'. DengueTools is funded under the Health
   theme of the Seventh Framework Programme of the European Community,
   Grant Agreement Number: 282589 Dengue Tools
CR Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Baggett HC, 2009, J TRAVEL MED, V16, P112, DOI 10.1111/j.1708-8305.2008.00284.x
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Beatty ME, 2008, 2 INT C DENG DENG HA
   Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Ganesan K, 2006, AUST J ENTOMOL, V45, P75, DOI 10.1111/j.1440-6055.2006.00513.x
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Jackson BT, 2005, J AM MOSQUITO CONTR, V21, P360, DOI 10.2987/8756-971X(2006)21[360:OPOCRA]2.0.CO;2
   Knols BGJ, 1997, B ENTOMOL RES, V87, P151, DOI 10.1017/S0007485300027292
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Muller O, 2006, B WORLD HEALTH ORGAN, V84, P120, DOI 10.2471/BLT.05.023150
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951
   REITER P, 1983, MOSQ NEWS, V43, P496
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   ROSEN L, 1977, AM J TROP MED HYG, V26, P337, DOI 10.4269/ajtmh.1977.26.337
   Runge-Ranzinger S, 2008, TROP MED INT HEALTH, V13, P1022, DOI 10.1111/j.1365-3156.2008.02112.x
   Sant'ana AL, 2006, J MED ENTOMOL, V43, P214, DOI 10.1603/0022-2585(2006)043[0214:COGIAO]2.0.CO;2
   Sharma KR, 2008, PARASITOL RES, V103, P1065, DOI 10.1007/s00436-008-1094-1
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith A, 2011, MED HYPOTHESES, V76, P861, DOI 10.1016/j.mehy.2011.02.037
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
NR 34
TC 52
Z9 52
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2012
VL 5
BP 1
EP 9
DI 10.3402/gha.v5i0.17273
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 914IB
UT WOS:000301941900001
PM 22451836
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Massad, Eduardo
TI Why dengue and yellow fever coexist in some areas of the world and not
   in others?
SO BIOSYSTEMS
LA English
DT Article
DE Yellow fever; Dengue; Cross-immunity; Competitive exclusion principle;
   Mathematical models
ID SAO-PAULO STATE; AEDES-ALBOPICTUS; THRESHOLD CONDITIONS; AEGYPTI;
   VECTOR; HOST; RISK
AB Urban yellow fever and dengue coexist in Africa but not in Asia and South America. In this paper, we examine four hypotheses (and various combinations thereof) to explain the absence of yellow fever in urban areas of Asia and South America. In addition, we examine an additional hypothesis that offers an explanation of the coexistence of the infections in Africa while at the same time explaining their lack of coexistence in Asia. The hypotheses we tested to explain the nonexistence of yellow fever in Asia are the following: (1) the Asian Aedes aegypti is relatively incompetent to transmit yellow fever; (2) there would exist a competition between dengue and yellow fever viruses within the mosquitoes, as suggested by in vitro studies in which the dengue virus always wins; (3) when an A. aegypti mosquito that is infected by or latent for yellow fever acquires dengue, it becomes latent for dengue due to internal competition within the mosquito between the two viruses: (4) there is an important cross-immunity between yellow fever and other flaviviruses, dengue in particular, such that a person recovered from a bout of dengue exhibits a diminished susceptibility to yellow fever. This latter hypothesis is referred to below as the "Asian hypothesis." Finally, we hypothesize that: (5) the coexistence of the infections in Africa is due to the low prevalence of the mosquito Aedes albopictus in Africa, as it competes with A. aegypti. We will refer to this latter hypothesis as the "African hypothesis."
   We construct a model of transmission that allows all of the above hypotheses to be tested. We conclude that the Asian and the African hypotheses can explain the observed phenomena, whereas other hypotheses fail to do so. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, BR-05508 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071
FU LIM01-HCFMUSP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX The authors thank the support of LIM01-HCFMUSP, CNPq and FAPESP.
CR Abrao E.P., 2007, 26 ANN M AM SOC VIR, V1, P273
   Abrao E.P., 2006, 17 NAT M VIR CAMP JO, V11, P130
   Amaku M, 2010, B MATH BIOL, V72, P1294, DOI 10.1007/s11538-009-9495-6
   ANDERSON R M, 1991
   [Anonymous], 1993, Wkly Epidemiol Rec, V68, P209
   Arunachalam N, 2008, INDIAN J MED RES, V127, P395
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102
   Burattini M. N., 2008, BIOSCI HYPOTHESES, V1, P168, DOI DOI 10.1016/J.BIHY.2008.05.003
   Costa E.P.A., 2006, 55 ANN M AM SOC TROP, V75, P136
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a
   Fields B.N., 1966, VIROLOGY
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Gubler D, 1997, DENGUE DENGUE HEMORR
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2003, LANCET INFECT DIS, V3, P751, DOI 10.1016/S1473-3099(03)00826-0
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Monath T.P., 1989, VIRUS INFORM EXCHANG, V6, P106
   MONATH TP, 1994, SEMIN VIROL, V5, P133, DOI 10.1006/smvy.1994.1014
   Monath TP, 1996, FIELDS VIROLOGY, P961
   MONATH TP, 1988, ARBOVIRUSES EPIDEMIO, V5, P139
   Ruan SG, 2008, B MATH BIOL, V70, P1098, DOI 10.1007/s11538-007-9292-z
   THEILER M, 1975, AM J TROP MED HYG, V24, P115, DOI 10.4269/ajtmh.1975.24.115
   Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x
   WHO, 2003, YELL FEV AFR
   WHO, 2010, DENG SE REG
NR 31
TC 24
Z9 25
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0303-2647
EI 1872-8324
J9 BIOSYSTEMS
JI Biosystems
PD NOV-DEC
PY 2011
VL 106
IS 2-3
BP 111
EP 120
DI 10.1016/j.biosystems.2011.07.004
PG 10
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 851AC
UT WOS:000297239700005
PM 21839800
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Lopez, LF
   da Silva, DR
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   da Silva, Daniel Rodrigues
TI Modeling the impact of global warming on vector-borne infections
SO PHYSICS OF LIFE REVIEWS
LA English
DT Review
DE Global warming; Vectors; Infections; Modeling
ID ANTHROPIC ENVIRONMENT; PARASITE TRANSMISSION; MALARIA TRANSMISSION;
   THRESHOLD CONDITIONS; POPULATION-DYNAMICS; MOSQUITOS DIPTERA;
   CLIMATE-CHANGE; EVOLUTION; VIRULENCE; CULICIDAE
AB Global warming will certainly affect the abundance and distribution of disease vectors. The effect of global warming, however, depends on the complex interaction between the human host population and the causative infectious agent. In this work we review some mathematical models that were proposed to study the impact of the increase in ambient temperature on the spread and gravity of some insect-transmitted diseases. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; da Silva, Daniel Rodrigues] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; da Silva, Daniel Rodrigues] LIM01 HCFMUSP, Sao Paulo, SP, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Lopez, Luis F/C-4721-2012; Massad,
   Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011
OI Lopez, Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   ANDERSON R M, 1991
   ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005
   Bates M, 1949, NATURAL HIST MOSQUIT
   Bates Marston, 1947, ANN ENT SOC AMERICA, V40, P1, DOI 10.1093/aesa/40.1.1
   Beaty B.J., 1996, BIOL DIS VECTORS
   Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161
   Bishopp FC, 1915, J ECON ENTOMOL, V8, P54, DOI 10.1093/jee/8.1.54
   Bloom A. J., 2010, GLOBAL CLIMATE CHANG
   BREMERMANN HJ, 1983, J THEOR BIOL, V100, P411, DOI 10.1016/0022-5193(83)90438-1
   Buffet P A, 2003, Bull Soc Pathol Exot, V96, P383
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   Carpenter S.J., 1955, MOSQUITOES N AM
   Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Day T, 2002, THEOR POPUL BIOL, V62, P199, DOI 10.1006/tpbi.2002.1595
   Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021
   Day T, 2001, EVOLUTION, V55, P2389, DOI 10.1111/j.0014-3820.2001.tb00754.x
   Day T, 2007, P ROY SOC B-BIOL SCI, V274, P2685, DOI 10.1098/rspb.2007.0809
   Dieckmann U, 2002, CA ST AD DY, V2, P39
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O, 2000, MATH EPIDEMIOLOGY IN
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   DOBSON A, 1993, LANCET, V342, P1096, DOI 10.1016/0140-6736(93)92069-6
   DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245
   ELSGOLTS EL, 1966, INTRO THEORY DIFFERE
   EWALD EW, 1994, EVOLUTION INFECT DIS
   Floore T., 2004, MOSQUITO INFORM
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   FORATTINI OP, 2002, MED CULICIDOLOGY
   Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   GILL C. A., 1921, Indian Journal of Medical Research, V8, P633
   HAINES A, 1991, J PUBLIC HEALTH MED, V13, P69
   HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389
   Hay SI, 1996, ANN TROP MED PARASIT, V90, P1
   Houghton J, 2005, REP PROG PHYS, V68, P1343, DOI 10.1088/0034-4885/68/6/R02
   HUN GD, 2003, AM FAM PHYSICIAN, V68, P653
   *INT FED RED CROSS, 2004, WORLD DIS REP 2004, pCH2
   Intergovt Panel Climate Change, 1990, CLIMATE CHANGE: THE IPCC SCIENTIFIC ASSESSMENT, P1
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041
   KOELLA JC, 2008, EVOLUTION HLTH DIS, P229
   KOSATSKY T, EURO SURVEILLANCE, V10
   Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203
   LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708
   Lively CM, 2006, ECOL LETT, V9, P1089, DOI 10.1111/j.1461-0248.2006.00969.x
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MASSAD E, 1987, EVOLUTION, V41, P1127, DOI [10.2307/2409198, 10.1111/j.1558-5646.1987.tb05883.x]
   Massad E, 1998, ECOSYST HEALTH, V4, P119, DOI 10.1046/j.1526-0992.1998.00079.x
   MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075
   MAYNE B, 1926, REPORTS US PUBLIC HL, V41, P986
   McMichael A.J, 1993, PLANETARY OVERLOAD G
   Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265
   Molineaux L, 1980, THE GARKI PROJECT
   *NAT ENV AG MIN EN, 2005, NEAS KEY OP STRAT DE
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   PROCHNOW O, 1908, THESIS BERLIN U
   Prochnow Oskar, 1907, Entomologische Zeitschrift Guben, V20
   RALISOA O, 1992, MADAGASCAR PARASITOL, V33, P219
   RODAHIN F, 1997, DENGUE DENGUE HEMORR
   ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0
   Russell Paul F., 1942, AMER JOUR TROP MED, V22, P517
   SCHUBERT W, 1928, Z AGEW ENTOMOLOGIE, V13, P129
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
   STRATMAN-THOMAS WARREN K., 1940, AMER JOUR TROP MED, V20, P703
   Sutherst RW, 1998, INT J PARASITOL, V28, P935, DOI 10.1016/S0020-7519(98)00056-3
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   THOMSON R. C. M., 1940, Journal of the Malaria Institute of India, V3, P323
   WHO, 1990, WHOPEP9010
NR 79
TC 33
Z9 33
U1 0
U2 64
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1571-0645
EI 1873-1457
J9 PHYS LIFE REV
JI Phys. Life Rev.
PD JUN
PY 2011
VL 8
IS 2
BP 169
EP 199
DI 10.1016/j.plrev.2011.01.001
PG 31
WC Biology; Biophysics
SC Life Sciences & Biomedicine - Other Topics; Biophysics
GA 805WV
UT WOS:000293762200016
PM 21257353
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Lopez, LF
   da Silva, DR
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Lopez, Luis Fernandez
   da Silva, Daniel Rodrigues
TI Entomological repercussions of increasing environmental temperatures
   Reply to comments on "Modeling the impact of global warming on
   vector-borne infections"
SO PHYSICS OF LIFE REVIEWS
LA English
DT Editorial Material
ID MASSAD
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; da Silva, Daniel Rodrigues] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; da Silva, Daniel Rodrigues] LIM01 HCFMUSP, Sao Paulo, SP, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Massad, E (corresponding author), Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Lopez, Luis
   F/C-4721-2012; Coutinho, Francisco A B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Coutinho, Francisco A B/0000-0003-3127-3071
CR Aguiar M, 2011, PHYS LIFE REV, V8, P202, DOI 10.1016/j.plrev.2011.02.008
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Rocklov J, 2011, PHYS LIFE REV, V8, P204, DOI 10.1016/j.plrev.2011.04.002
   Yang HM, 2011, PHYS LIFE REV, V8, P200, DOI 10.1016/j.plrev.2011.02.007
NR 4
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1571-0645
EI 1873-1457
J9 PHYS LIFE REV
JI Phys. Life Rev.
PD JUN
PY 2011
VL 8
IS 2
BP 206
EP 207
DI 10.1016/j.plrev.2011.05.001
PG 2
WC Biology; Biophysics
SC Life Sciences & Biomedicine - Other Topics; Biophysics
GA 805WV
UT WOS:000293762200020
DA 2020-12-16
ER

PT J
AU Massad, E
   Behrens, BC
   Coutinho, FAB
   Behrens, RH
AF Massad, Eduardo
   Behrens, Ben C.
   Coutinho, Francisco A. B.
   Behrens, Ronald H.
TI Cost risk benefit analysis to support chemoprophylaxis policy for
   travellers to malaria endemic countries
SO MALARIA JOURNAL
LA English
DT Article
ID SUB-SAHARAN AFRICA; TRANSMISSION; TOLERABILITY; PROPHYLAXIS; MEFLOQUINE;
   EFFICACY; TOURISTS
AB Background: In a number of malaria endemic regions, tourists and travellers face a declining risk of travel associated malaria, in part due to successful malaria control. Many millions of visitors to these regions are recommended, via national and international policy, to use chemoprophylaxis which has a well recognized morbidity profile. To evaluate whether current malaria chemo-prophylactic policy for travellers is cost effective when adjusted for endemic transmission risk and duration of exposure. a framework, based on partial cost-benefit analysis was used
   Methods: Using a three component model combining a probability component, a cost component and a malaria risk component, the study estimated health costs avoided through use of chemoprophylaxis and costs of disease prevention (including adverse events and pre-travel advice for visits to five popular high and low malaria endemic regions) and malaria transmission risk using imported malaria cases and numbers of travellers to malarious countries. By calculating the minimal threshold malaria risk below which the economic costs of chemoprophylaxis are greater than the avoided health costs we were able to identify the point at which chemoprophylaxis would be economically rational.
   Results: The threshold incidence at which malaria chemoprophylaxis policy becomes cost effective for UK travellers is an accumulated risk of 1.13% assuming a given set of cost parameters. The period a travellers need to remain exposed to achieve this accumulated risk varied from 30 to more than 365 days, depending on the regions intensity of malaria transmission.
   Conclusions: The cost-benefit analysis identified that chemoprophylaxis use was not a cost-effective policy for travellers to Thailand or the Amazon region of Brazil, but was cost-effective for travel to West Africa and for those staying longer than 45 days in India and Indonesia.
C1 [Massad, Eduardo; Coutinho, Francisco A. B.] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Massad, Eduardo; Coutinho, Francisco A. B.] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo; Behrens, Ronald H.] London Sch Hyg & Trop Med, London, England.
   [Behrens, Ben C.] Univ Sheffield, Dept Econ, Sheffield S10 2TN, S Yorkshire, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012;
   Massad, Eduardo/H-6143-2011
OI Coutinho, Francisco A B/0000-0003-3127-3071; Massad,
   Eduardo/0000-0002-7200-2916; 
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   FAPESP, CNPqNational Council for Scientific and Technological
   Development (CNPq)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [LIM01-HCFMUSP]; University College London Hospitals'
   Comprehensive Biomedical Research Centre
FX This work was partly supported through the grants from FAPESP, CNPq,
   LIM01-HCFMUSP, University College London Hospitals' Comprehensive
   Biomedical Research Centre. Thanks to Marie Blaze, Valerie Smith and
   Peter Chiodini of the Malaria Reference Laboratory for providing data on
   UK imported malaria.
CR [Anonymous], 2010, ANN SURVEY HOURS EAR
   Becker GS, 2005, AM ECON REV, V95, P277, DOI 10.1257/0002828053828563
   BEHRENS RH, 1994, BRIT MED J, V309, P918, DOI 10.1136/bmj.309.6959.918
   Behrens RH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-266
   Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235
   BRAIN WA, 1981, AM ECON REV, V71, P54
   Bryan JP, 2006, AM J TROP MED HYG, V75, P416, DOI 10.4269/ajtmh.2006.75.416
   Curtis L., 2009, UNIT COSTS HLTH SOCI
   LADISLAW JLB, 2006, SITUACAO MALARIA AMA
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Pistone T, 2008, HEALTH POLICY, V88, P186, DOI 10.1016/j.healthpol.2008.03.002
   *ROLL BACK MAL, 2010, ROLL BACK MAL 2010 U
   Rosen S., 1988, J RISK UNCERTAINTY, V1, P285, DOI DOI 10.1007/BF00056139
   SABATINELLI G, 2001, EUROSURVEILLANCE, V6, P213
   Schlagenhauf P, 2003, BRIT MED J, V327, P1078, DOI 10.1136/bmj.327.7423.1078
   Sonmez A, 2005, J INFECTION, V51, P253, DOI 10.1016/j.jinf.2005.01.014
   Spencer B, 2009, TRANSFUSION, V49, P2335, DOI 10.1111/j.1537-2995.2009.02290.x
   STEFFEN R, 1990, B WORLD HEALTH ORGAN, V68, P313
   STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W
   *TRAV SUP, 2 WEEK TRIP BRAZ AM
   *WHO, 2010, MAL INT TRAV HLTH 20, pCH7
NR 23
TC 16
Z9 16
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAY 17
PY 2011
VL 10
AR 130
DI 10.1186/1475-2875-10-130
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 784ZF
UT WOS:000292196500001
PM 21586155
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
TI The cost of dengue control
SO LANCET
LA English
DT Editorial Material
C1 [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med, Hosp Clin, Lab Invest Med 01, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; 
CR Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Reiter P, 2001, DENGUE DENGUE HEMORR, P425
   Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Taliberti H, 2010, REV PANAM SALUD PUBL, V27, P175, DOI 10.1590/S1020-49892010000300004
   World Health Organization, DENG DENG HAEM FEV F
   Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6
NR 12
TC 27
Z9 28
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 14
PY 2011
VL 377
IS 9778
BP 1630
EP 1631
DI 10.1016/S0140-6736(11)60470-4
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA 766JF
UT WOS:000290777700006
PM 21546075
DA 2020-12-16
ER

PT J
AU da Rocha, AF
   Rocha, FT
   Massad, E
AF da Rocha, Armando Freitas
   Rocha, Fabio Theoto
   Massad, Eduardo
TI The Brain as a Distributed Intelligent Processing System: An EEG Study
SO PLOS ONE
LA English
DT Article
ID GRAPH-THEORETICAL ANALYSIS; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY;
   NEURAL EFFICIENCY; NETWORKS; NEUROSCIENCE; PERFORMANCE; AGE
AB Background: Various neuroimaging studies, both structural and functional, have provided support for the proposal that a distributed brain network is likely to be the neural basis of intelligence. The theory of Distributed Intelligent Processing Systems (DIPS), first developed in the field of Artificial Intelligence, was proposed to adequately model distributed neural intelligent processing. In addition, the neural efficiency hypothesis suggests that individuals with higher intelligence display more focused cortical activation during cognitive performance, resulting in lower total brain activation when compared with individuals who have lower intelligence. This may be understood as a property of the DIPS.
   Methodology and Principal Findings: In our study, a new EEG brain mapping technique, based on the neural efficiency hypothesis and the notion of the brain as a Distributed Intelligence Processing System, was used to investigate the correlations between IQ evaluated with WAIS (Whechsler Adult Intelligence Scale) and WISC (Wechsler Intelligence Scale for Children), and the brain activity associated with visual and verbal processing, in order to test the validity of a distributed neural basis for intelligence.
   Conclusion: The present results support these claims and the neural efficiency hypothesis.
C1 [da Rocha, Armando Freitas; Rocha, Fabio Theoto] RANI, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RP da Rocha, AF (corresponding author), RANI, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   CHANDRASEKARAN B, 1981, IEEE T SYST MAN CYB, V11, P1, DOI 10.1109/TSMC.1981.4308573
   Colom R, 2004, PERS INDIV DIFFER, V36, P75, DOI 10.1016/S0191-8869(03)00053-9
   DAVIS R, 1983, ARTIF INTELL, V20, P63, DOI 10.1016/0004-3702(83)90015-2
   Deary IJ, 1997, TRENDS NEUROSCI, V20, P365, DOI 10.1016/S0166-2236(97)01070-9
   Doppelmayr M, 2005, NEUROSCI LETT, V381, P309, DOI 10.1016/j.neulet.2005.02.037
   Doppelmayr M, 2002, INTELLIGENCE, V30, P289, DOI 10.1016/S0160-2896(01)00101-5
   Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104
   Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031
   Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105
   Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104
   Fink A, 2006, INT J PSYCHOPHYSIOL, V62, P46, DOI 10.1016/j.ijpsycho.2006.01.001
   Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009
   Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100
   Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025
   HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5
   HEWITT C, 1991, IEEE T SYST MAN CYB, V21, P1409, DOI 10.1109/21.135685
   Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060
   Jackson DN, 2006, INTELLIGENCE, V34, P479, DOI 10.1016/j.intell.2006.03.005
   Jausovec N, 2000, INTELLIGENCE, V28, P213, DOI 10.1016/S0160-2896(00)00037-4
   Jausovec N, 2005, BRAIN COGNITION, V59, P277, DOI 10.1016/j.bandc.2005.08.001
   Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185
   Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036
   LESSER VR, 1991, IEEE T SYST MAN CYB, V21, P1347, DOI 10.1109/21.135681
   Lynn R, 1999, INTELLIGENCE, V27, P1, DOI 10.1016/S0160-2896(99)00009-4
   Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006
   Neubauer AC, 1997, PERS INDIV DIFFER, V22, P885, DOI 10.1016/S0191-8869(97)00003-2
   Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0
   Njemanze PC, 2005, BRAIN LANG, V92, P234, DOI 10.1016/j.bandl.2004.06.104
   Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007
   Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   Rocha AF, 2004, BRAIN
   Rocha AF, 1992, LECT NOTES ARTIFICIA
   Rocha AF, 2002, PROGR NEUROBIOLOGY, V64, P555
   Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008
   Schmid RG, 2002, CLIN NEUROPHYSIOL, V113, P1647, DOI 10.1016/S1388-2457(02)00212-2
   Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036
   Stauder JEA, 2003, INTELLIGENCE, V31, P257, DOI 10.1016/S0160-2896(02)00136-8
   Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846
   van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010
   Wats DJ, 1999, SMALL WORLDS DYNAMIC
NR 42
TC 11
Z9 15
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 15
PY 2011
VL 6
IS 3
AR e17355
DI 10.1371/journal.pone.0017355
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 736SH
UT WOS:000288513900007
PM 21423657
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Pinto, E
   Coelho, M
   Oliver, L
   Massad, E
AF Pinto, Edna
   Coelho, Micheline
   Oliver, Leuda
   Massad, Eduardo
TI The influence of climate variables on dengue in Singapore
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH
LA English
DT Article
DE dengue; Poisson Regression Model; Principal Component Analysis;
   temperature; relative risk
ID POPULATION
AB In this work we correlated dengue cases with climatic variables for the city of Singapore. This was done through a Poisson Regression Model (PRM) that considers dengue cases as the dependent variable and the climatic variables (rainfall, maximum and minimum temperature and relative humidity) as independent variables. We also used Principal Components Analysis (PCA) to choose the variables that influence in the increase of the number of dengue cases in Singapore, where PC1 (Principal component 1) is represented by temperature and rainfall and PC2 (Principal component 2) is represented by relative humidity. We calculated the probability of occurrence of new cases of dengue and the relative risk of occurrence of dengue cases influenced by climatic variable. The months from July to September showed the highest probabilities of the occurrence of new cases of the disease throughout the year. This was based on an analysis of time series of maximum and minimum temperature. An interesting result was that for every 2-10 degrees C of variation of the maximum temperature, there was an average increase of 22.2-184.6% in the number of dengue cases. For the minimum temperature, we observed that for the same variation, there was an average increase of 26.1-230.3% in the number of the dengue cases from April to August. The precipitation and the relative humidity, after analysis of correlation, were discarded in the use of Poisson Regression Model because they did not present good correlation with the dengue cases. Additionally, the relative risk of the occurrence of the cases of the disease under the influence of the variation of temperature was from 1.2-2.8 for maximum temperature and increased from 1.3-3.3 for minimum temperature. Therefore, the variable temperature (maximum and minimum) was the best predictor for the increased number of dengue cases in Singapore.
C1 [Pinto, Edna; Coelho, Micheline; Oliver, Leuda; Massad, Eduardo] Univ Sao Paulo, Dept Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Dept Med, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Coelho, Micheline S. Z. S./A-4480-2012; OLIVEIRA, LEUDA/C-5578-2016;
   Massad, Eduardo/B-1169-2012
OI Coelho, Micheline S. Z. S./0000-0002-9732-1278; OLIVEIRA,
   LEUDA/0000-0002-2762-3705; Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP);  [LIM01/HCFMUSP]
FX This work was partially supported by CNPq, CAPES, FAPESP and
   LIM01/HCFMUSP.
CR Andrade IS, 2004, ESTUDO INFLUENCIA EL
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Camara FP, 2009, REV SOC BRAS MED TRO, V42, P137, DOI 10.1590/S0037-86822009000200008
   Chen Chee Dhang, 2005, Trop Biomed, V22, P39
   Coelho-Zanotti MSS, 2007, THESIS DOUTORADO MET
   Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]
   Donalísio Maria Rita, 2002, Rev. bras. epidemiol., V5, P259, DOI 10.1590/S1415-790X2002000300005
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Husain Tahir, 2008, Int J Environ Res Public Health, V5, P204, DOI 10.3390/ijerph5040204
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Ministry of Health of Singapore (MOH), 2005, FIN REP EXP PAN DENG
   Murray CJ, 1996, GLOBAL BURDEN DIS
   National Environmental Agency (NEA), 2005, NEAS KEY OP STRAT DE
   Ooi EE, 2001, DENGUE B, V25
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Parry ML, 2007, CONTRIBUTION WORKING
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Wilder-Smith A, 2010, EPIDEMIOL INFECT, V138, P962, DOI 10.1017/S0950268810000683
   Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilks DS, 1995, STAT METHODS ATMOSPH, P467
   World Health Organization (WHO), 2010, DENG DENG HAEM
   Coelho MDZS, 2010, J ENVIRON PUBLIC HEA, V2010, DOI 10.1155/2010/209270
NR 26
TC 44
Z9 46
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0960-3123
EI 1369-1619
J9 INT J ENVIRON HEAL R
JI Int. J. Environ. Health Res.
PY 2011
VL 21
IS 6
BP 415
EP 426
DI 10.1080/09603123.2011.572279
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 883PT
UT WOS:000299646900003
PM 21557124
DA 2020-12-16
ER

PT J
AU Amaku, M
   Burattini, MN
   Coutinho, FAB
   Massad, E
AF Amaku, Marcos
   Burattini, Marcelo Nascimento
   Bezerra Coutinho, Francisco Antonio
   Massad, Eduardo
TI Modeling the Competition Between Viruses in a Complex Plant-Pathogen
   System
SO PHYTOPATHOLOGY
LA English
DT Article
DE virus competition
ID YELLOW DWARF VIRUS; APHID TRANSMISSION; ACCESS PERIODS; EVOLUTION;
   VIRULENCE
AB In this article, we propose a mathematical model that describes the competition between two plant virus strains (MAV and PAV) for both the host plant (oat) and their aphid vectors. We found that although PAV is transmitted by two aphids and MAV by only one, this fact, by itself, does not explain the complete replacement of MAV by PAV in New York State during the period from 1961 through 1976; an interpretation that is in agreement with the theories of A. G. Power. Also, although MAV wins the competition within aphids, we assumed that, in 1961, PAV mutated into a new variant such that this new variant was able to overcome MAV within the plants during a latent period. As shown below, this is sufficient to explain the swap of strains; that is, the dominant MAV was replaced by PAV, also in agreement with Power's expectations.
C1 [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Amaku, M (corresponding author), Univ Sao Paulo, Sch Vet Med, Sao Paulo, Brazil.
EM amaku@usp.br
RI Burattini, Marcelo N/J-9272-2014; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Coutinho, Francisco A
   B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Amaku,
   Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071
FU LIM 01 HCFMUSP; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX We thank J. R. Parra and J. R. S. Lopes of ESALQ-USP for their
   illuminating advice concerning the biology of the complex
   aphids-viruses-plants, and the editor and one anonymous reviewer for
   their very useful suggestion to improve this manuscript. This work was
   partially supported by LIM 01 HCFMUSP, FAPESP, and CNPq.
CR Amaku M, 2010, B MATH BIOL, V72, P1294, DOI 10.1007/s11538-009-9495-6
   Day T, 2001, EVOLUTION, V55, P2389, DOI 10.1111/j.0014-3820.2001.tb00754.x
   Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007
   GILDOW FE, 1980, PHYTOPATHOLOGY, V70, P122, DOI 10.1094/Phyto-70-122
   GRAY SM, 1991, PHYTOPATHOLOGY, V81, P539, DOI 10.1094/Phyto-81-539
   Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.1111/j.1558-5646.1996.tb03560.x, 10.2307/2410731]
   LIPSITCH M, 1995, J THEOR BIOL, V174, P427, DOI 10.1006/jtbi.1995.0109
   Manrubia SC, 2006, PHYS LIFE REV, V3, P65, DOI 10.1016/j.plrev.2005.11.002
   MASSAD E, 1997, EVOLUTION, V50, P916
   Massad E, 2008, APPL MATH COMPUT, V201, P161, DOI 10.1016/j.amc.2007.12.007
   Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107
   Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571
   POWER AG, 1991, PHYTOPATHOLOGY, V81, P545, DOI 10.1094/Phyto-81-545
   ROCHOW WF, 1979, PHYTOPATHOLOGY, V69, P655, DOI 10.1094/Phyto-69-655
   WEN F, 1991, J GEN VIROL, V72, P729
   Zhang XS, 2001, PHYTOPATHOLOGY, V91, P924, DOI 10.1094/PHYTO.2001.91.10.924
NR 16
TC 6
Z9 6
U1 0
U2 13
PU AMER PHYTOPATHOLOGICAL SOC
PI ST PAUL
PA 3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA
SN 0031-949X
J9 PHYTOPATHOLOGY
JI Phytopathology
PD OCT
PY 2010
VL 100
IS 10
BP 1042
EP 1047
DI 10.1094/PHYTO-10-09-0289
PG 6
WC Plant Sciences
SC Plant Sciences
GA 651XY
UT WOS:000281962100008
PM 20839939
OA Bronze
DA 2020-12-16
ER

PT J
AU da Rocha, AF
   Rocha, FT
   Burattini, MN
   Massad, E
AF da Rocha, Armando Freitas
   Rocha, Fabio Theoto
   Burattini, Marcelo Nascimento
   Massad, Eduardo
TI Neurodynamics of an election
SO BRAIN RESEARCH
LA English
DT Article
DE EEG; Decision-making; Voting; Brain networks; ERP; Distributed
   processing; Benefits; Risks
ID GRAPH-THEORETICAL ANALYSIS; DEFAULT MODE; DECISION-MAKING; HUMAN BRAIN;
   FUNCTIONAL CONNECTIVITY; MORAL JUDGMENT; SMALL-WORLD; NETWORKS; EEG;
   HYPOTHESIS
AB Variables influencing decision-making in real settings, as in the case of voting decisions, are uncontrollable and in many times even unknown to the experimenter. In this case, the experimenter has to study the intention to decide (vote) as close as possible in time to the moment of the real decision (election day). Here, we investigated the brain activity associated with the voting intention declared 1 week before the election day of the Brazilian Firearms Control Referendum about prohibiting the commerce of firearms. Two alliances arose in the Congress to run the campaigns for YES (for the prohibition of firearm commerce) and NO (against the prohibition of firearm commerce) voting. Time constraints imposed by the necessity of studying a reasonable number (here, 32) of voters during a very short time (5 days) made the EEG the tool of choice for recording the brain activity associated with voting decision. Recent fMRI and EEG studies have shown decision-making as a process due to the enrollment of defined neuronal networks. In this work, a special EEG technique is applied to study the topology of the voting decision-making networks and is compared to the results of standard ERP procedures. The results show that voting decision-making enrolled networks in charge of calculating the benefits and risks of the decision of prohibiting or allowing firearm commerce and that the topology of such networks was vote-(i.e., YES/NO-) sensitive. (C) 2010 Elsevier B.V. All rights reserved.
C1 [da Rocha, Armando Freitas; Rocha, Fabio Theoto] RANI Res Nat & Artificial Intelligence, BR-13207110 Jundiai, Brazil.
   [da Rocha, Armando Freitas; Rocha, Fabio Theoto; Burattini, Marcelo Nascimento; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-5405000 Sao Paulo, Brazil.
   [da Rocha, Armando Freitas; Rocha, Fabio Theoto; Burattini, Marcelo Nascimento; Massad, Eduardo] LIM01 HCFMUSP, BR-5405000 Sao Paulo, Brazil.
RP da Rocha, AF (corresponding author), Rua Tenente Ary Aps 172, BR-13207110 Jundiai, Brazil.
EM armando@enscer.com.br; fabio@enscer.com.br; mnburatti@usp.br;
   edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916
CR Alegre M, 2006, CLIN NEUROPHYSIOL, V117, P16, DOI 10.1016/j.clinph.2005.08.030
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Chen ACN, 2008, NEUROIMAGE, V41, P561, DOI 10.1016/j.neuroimage.2007.12.064
   Chen PF, 2009, BIOL PSYCHOL, V82, P111, DOI 10.1016/j.biopsycho.2009.06.007
   Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056
   Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001
   Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031
   DOSENBACH NUF, 2007, PNNAS, V104, P11703
   Esposito F, 2009, NEUROIMAGE, V47, P112, DOI 10.1016/j.neuroimage.2009.03.074
   Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381
   Ferri R, 2008, CLIN NEUROPHYSIOL, V119, P2026, DOI 10.1016/j.clinph.2008.04.294
   Foz FB, 2002, PEDIATR NEUROL, V26, P106, DOI 10.1016/S0887-8994(01)00368-X
   Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113
   Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017
   Goldman RI, 2009, NEUROIMAGE, V47, P136, DOI 10.1016/j.neuroimage.2009.03.062
   Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027
   Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100
   Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048
   Heldmann M, 2005, J PSYCHOPHYSIOL, V19, P270, DOI 10.1027/0269-8803.19.4.270
   Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024
   Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013
   Ino T, 2010, CORTEX, V46, P2, DOI 10.1016/j.cortex.2009.02.022
   Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060
   Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018
   Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7
   Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008
   Kliemann D, 2008, NEUROPSYCHOLOGIA, V46, P2949, DOI 10.1016/j.neuropsychologia.2008.06.010
   Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010
   Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104
   Marchiori M, 2000, PHYSICA A, V285, P539, DOI 10.1016/S0378-4371(00)00311-3
   McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907
   Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006
   Moll J, 2007, TRENDS COGN SCI, V11, P319, DOI 10.1016/j.tics.2007.06.001
   Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006
   Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027
   Poiezzi D, 2008, BEHAV BRAIN RES, V187, P116, DOI 10.1016/j.bbr.2007.09.001
   Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003
   Polezzi D, 2010, NEUROIMAGE, V49, P1886, DOI 10.1016/j.neuroimage.2009.08.068
   Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676
   Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010
   Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014
   ROCHA AF, 2009, J BIOL SYST, V17, P10
   Rocha AF, 2004, BRAIN FUZZY ARITHMET
   Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008
   Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013
   Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018
   Utku H, 2002, J NEUROSCI METH, V114, P25, DOI 10.1016/S0165-0270(01)00519-2
   van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057
NR 50
TC 6
Z9 6
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD SEP 10
PY 2010
VL 1351
BP 198
EP 211
DI 10.1016/j.brainres.2010.06.046
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 653UD
UT WOS:000282121500019
PM 20599820
DA 2020-12-16
ER

PT J
AU Chaib, E
   de Oliveira, MCF
   Galvao, FHF
   Silva, FD
   D'Albuquerque, LAC
   Massad, E
AF Chaib, Eleazar
   Franca de Oliveira, Maria Cristina
   Ferreira Galvao, Flavio Henrique
   Silva, Felipe Duarte
   Carneiro D'Albuquerque, Luiz Augusto
   Massad, Eduardo
TI Theoretical impact of an anti-HCV vaccine on the annual number of liver
   transplantation
SO MEDICAL HYPOTHESES
LA English
DT Article
ID HEPATITIS-C; WAITING-LIST; SAO-PAULO; BRAZIL; STATE
AB The development of an effective vaccine for hepatitis C is of paramount importance, given the global disease burden and its public health impact. We simulated a theoretical vaccine with 98% efficacy and coverage of 95% of the susceptible population, an achievable program. The simulated period of vaccination varied from 0 to 70 years and we calculated, through a mathematical model, the reduction in the number of liver transplantations carried out each year. The program is entirely inefficient until 20 years of vaccination and its impact rises linearly with time, reaching a maximum of 40% reduction. The model assumes that approximately 50% of all the liver transplantation carried out in our population are due to HCV infection. Therefore, the maximum reduction in the number of transplantation attained after 70 years is 10% less of the theoretical optimum. This is due to the 2% of primary vaccination failure plus the 5% in the coverage failure, which leaves a small proportion of susceptible individuals who will catch the infection and evolve to liver failure. In conclusion, the advent of a hepatitis C vaccine is welcome however, decision makers should be prepared for a very long time living with this scourge. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Massad, Eduardo] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Liver Transplantat Surg Unit,LIM 37, Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, Dept Med Informat, LIM 01, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Liver Transplantat Surg Unit,LIM 37, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Galvao, Flavio Henrique
   Ferreira/D-3487-2017; D'Albuquerque, Luiz Augusto Carneiro/A-8812-2013;
   Massad, Eduardo/B-1169-2012; D'ALBUQUERQUE, Luiz Carneiro
   Augusto/I-4011-2012
OI Galvao, Flavio Henrique Ferreira/0000-0003-1924-3208; D'Albuquerque,
   Luiz Augusto Carneiro/0000-0001-7607-7168; Massad,
   Eduardo/0000-0002-7200-2916; 
CR Boyer N, 2000, Forum (Genova), V10, P4
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chaib E, 2008, LIVER TRANSPLANT, V14, P1732, DOI 10.1002/lt.21611
   Gallegos-Orozco JF, 2009, LIVER TRANSPLANT, V15, P1872, DOI 10.1002/lt.21954
   Jawaid Ali, 2008, J Ayub Med Coll Abbottabad, V20, P129
   Lawrence S P, 2000, Adv Intern Med, V45, P65
   Massad E, 2009, EPIDEMIOL INFECT, V137, P241, DOI 10.1017/S0950268808000873
   Massad E, 2008, EPIDEMIOL INFECT, V136, P1153, DOI 10.1017/S0950268807009879
   Nicholson ML, 1997, TRANSPL P, V29, P1386, DOI 10.1016/S0041-1345(96)00605-7
   Stoll-Keller F, 2009, EXPERT REV VACCINES, V8, P333, DOI 10.1586/14760584.8.3.333
   Tanwar S, 2009, WORLD J GASTROENTERO, V15, P5511, DOI 10.3748/wjg.15.5511
   Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x
NR 12
TC 6
Z9 6
U1 0
U2 6
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD SEP
PY 2010
VL 75
IS 3
BP 324
EP 327
DI 10.1016/j.mehy.2010.03.013
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 647IF
UT WOS:000281611100014
PM 20392572
DA 2020-12-16
ER

PT J
AU Amaku, M
   Burattini, MN
   Coutinho, FAB
   Massad, E
AF Amaku, Marcos
   Burattini, Marcelo Nascimento
   Coutinho, Francisco Antonio Bezerra
   Massad, Eduardo
TI Modeling the Dynamics of Viral Evolution Considering Competition Within
   Individual Hosts and at Population Level: The Effects of Treatment
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Viral competition; Evolution; Anti-viral treatment; Mutation
ID WITHIN-HOST; PATHOGEN VIRULENCE; IN-VIVO; HIV; VIRUS; SUPERINFECTION;
   EPIDEMIOLOGY; TRANSMISSION; COINFECTION; SELECTION
AB We consider two viral strains competing against each other within individual hosts (at cellular level) and at population level (for infecting hosts) by studying two cases. In the first case, the strains do not mutate into each other. In this case, we found that each individual in the population can be infected by only one strain and that co-existence in the population is possible only when the strain that has the greater basic intracellular reproduction number, R (0c) , has the smaller population number R (0p) . Treatment against the one strain shifts the population equilibrium toward the other strain in a complicated way (see Appendix B). In the second case, we assume that the strain that has the greater intracellular number R (0c) can mutate into the other strain. In this case, individual hosts can be simultaneously infected by both strains (co-existence within the host). Treatment shifts the prevalence of the two strains within the hosts, depending on the mortality induced by the treatment, which is, in turn, dependent upon the doses given to each individual. The relative proportions of the strains at the population level, under treatment, depend both on the relative proportions within the hosts (which is determined by the dosage of treatment) and on the number of individuals treated per unit time, that is, the rate of treatment. Implications for cases of real diseases are briefly discussed.
C1 [Burattini, Marcelo Nascimento; Coutinho, Francisco Antonio Bezerra; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Burattini, Marcelo Nascimento; Coutinho, Francisco Antonio Bezerra; Massad, Eduardo] LIM01 HCFMUSP, BR-05405000 Sao Paulo, Brazil.
   [Amaku, Marcos] Univ Sao Paulo, Sch Vet Med, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Amaku, Marcos/D-5252-2012; Burattini,
   Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho, Francisco
   A B/H-5644-2011
OI Amaku, Marcos/0000-0003-4752-6774; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Coutinho,
   Francisco A B/0000-0003-3127-3071
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); LIM01-HCFMUSP
FX This work was partially supported by FAPESP, CNPq, and LIM01-HCFMUSP.
CR Ball CL, 2007, B MATH BIOL, V69, P2361, DOI 10.1007/s11538-007-9223-z
   BONHOEFFER S, 1994, P ROY SOC B-BIOL SCI, V258, P133, DOI 10.1098/rspb.1994.0153
   BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102
   Burattini M. N., 2008, BIOSCI HYPOTHESES, V1, P168, DOI DOI 10.1016/J.BIHY.2008.05.003
   Coombs D, 2007, THEOR POPUL BIOL, V72, P576, DOI 10.1016/j.tpb.2007.08.005
   Day T, 2001, EVOLUTION, V55, P2389, DOI 10.1111/j.0014-3820.2001.tb00754.x
   Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102
   Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a
   HOCHBERG ME, 1990, AM NAT, V136, P517, DOI 10.1086/285111
   Leontiev VV, 2008, INFECT GENET EVOL, V8, P40, DOI 10.1016/j.meegid.2007.09.008
   LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708
   Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.1111/j.1558-5646.1996.tb03560.x, 10.2307/2410731]
   LIPSITCH M, 1995, J THEOR BIOL, V174, P427, DOI 10.1006/jtbi.1995.0109
   Manrubia SC, 2006, PHYS LIFE REV, V3, P65, DOI 10.1016/j.plrev.2005.11.002
   MASSAD E, 1997, EVOLUTION, V50, P916
   MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138
   Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009
   Mosquera J, 1998, J THEOR BIOL, V195, P293, DOI 10.1006/jtbi.1998.0793
   Nowak MA, 2004, VIRUS DYNAMICS MATH
   Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107
   Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700
   Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571
   ROCHOW WF, 1979, PHYTOPATHOLOGY, V69, P655, DOI 10.1094/Phyto-69-655
   Sguanci L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S5
   van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004
   Wodarz D., 2007, KILLER CELL DYNAMICS
   Wodarz D, 2007, P ROY SOC B-BIOL SCI, V274, P2481, DOI 10.1098/rspb.2007.0413
   Zhang XS, 2001, PHYTOPATHOLOGY, V91, P924, DOI 10.1094/PHYTO.2001.91.10.924
NR 28
TC 9
Z9 9
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
J9 B MATH BIOL
JI Bull. Math. Biol.
PD JUL
PY 2010
VL 72
IS 5
BP 1294
EP 1314
DI 10.1007/s11538-009-9495-6
PG 21
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 627TL
UT WOS:000280065700011
PM 20091353
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Ma, S
   Burattini, MN
AF Massad, E.
   Coutinho, F. A. B.
   Ma, S.
   Burattini, M. N.
TI FOR DEBATE A hypothesis for the 2007 dengue outbreak in Singapore
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Aedes; dengue; haze; models; mosquito mortality
ID ANTHROPIC ENVIRONMENT; POPULATION-DYNAMICS; MOSQUITOS DIPTERA; BRAZIL;
   MALARIA; FEVER; CULICIDAE; DISEASE; SYSTEM
AB A previous mathematical model explaining dengue in Singapore predicted a reasonable outbreak of about 6500 cases for 2006 and a very mild outbreak with about 2000 cases for 2007. However, only 3051 cases were reported in 2006 while more than 7800 were reported in the first 44 weeks of 2007. We hypothesized that the combination of haze with other local sources of particulate matter had a significant impact on mosquito life expectancy, significantly increasing their mortality rate. To test the hypothesis a mathematical model based on the reproduction number of dengue fever and aimed at comparing the impact of several possible alternative control strategies was proposed. This model also aimed at contributing to the understanding of the causes of dengue resurgence in Singapore in the last decade. The model's simulation demonstrated that an increase in mosquito mortality in 2006 and either a reduction in mortality or an increase in the carrying capacity of mosquitoes in 2007 explained the patterned observed in Singapore. Based on the model's simulation we concluded that the fewer than expected number of dengue cases in Singapore in 2006 was caused by an increase in mosquito mortality due to the disproportionate haze affecting the country that year and that particularly favourable environmental conditions in 2007 propitiated mosquitoes with a lower mortality rate, which explains the greater than expected number of dengue cases in 2007. Whether our hypothesis is plausible or not should be debated further.
C1 [Massad, E.; Coutinho, F. A. B.; Burattini, M. N.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, E.] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
   [Ma, S.] Minist Hlth, Singapore, Singapore.
RP Massad, E (corresponding author), Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014;
   Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); Courage Fund for Infectious Diseases;  [LIM01-HCFMUSP]
FX This work was supported by LIM01-HCFMUSP, CNPq, FAPESP and the Courage
   Fund for Infectious Diseases.
CR Biran A, 2007, T ROY SOC TROP MED H, V101, P1065, DOI 10.1016/j.trstmh.2007.07.010
   Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   DAVIS EE, 1994, J AM MOSQUITO CONTR, V10, P316
   Dulhunty JM, 2000, ACTA TROP, V75, P185, DOI 10.1016/S0001-706X(00)00057-7
   Forattini O. P., 1996, MED CULICIDOLOGY
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   GUBLER DJ, 2001, DENGUE DENGUE HEMORR, P45
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   HARTLEY MK, 2006, AM MIDL NAT, V157, P92
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   *MIN HLTH SING, 2005, WEEKL INF DIS B, V1
   MOORE SJ, 2004, TRADITIONAL MED PLAN, P343
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Palsson K, 1999, ACTA TROP, V72, P39, DOI 10.1016/S0001-706X(98)00083-7
   Rodhain F., 2001, DENGUE DENGUE HEMORR, P45
   Tabuti JRS, 2008, J ETHNOPHARMACOL, V116, P33, DOI 10.1016/j.jep.2007.10.036
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
   2007, KEY ENV STAT
NR 26
TC 14
Z9 14
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2010
VL 138
IS 7
BP 951
EP 957
DI 10.1017/S0950268809990501
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 614RX
UT WOS:000279078500003
PM 19653928
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Ma, S
   Burattini, MN
AF Massad, E.
   Coutinho, F. A. B.
   Ma, S.
   Burattini, M. N.
TI The 2007 dengue outbreak in Singapore Reply
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Letter
C1 [Massad, E.] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
   [Ma, S.] Minist Hlth, Singapore, Singapore.
   [Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Natl Univ Singapore, Singapore, Singapore.
EM edmassad@dim.fm.usp.br
RI Burattini, Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916; 
CR Massad E, 2010, EPIDEMIOL INFECT, V138, P951, DOI 10.1017/S0950268809990501
NR 1
TC 0
Z9 0
U1 0
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2010
VL 138
IS 7
BP 959
EP 961
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 614RX
UT WOS:000279078500005
DA 2020-12-16
ER

PT J
AU Mondini, A
   Bronzoni, RVD
   Nunes, SHP
   Chiaravalloti-Neto, F
   Massad, E
   Alonso, WJ
   Zanotto, PMD
   Nogueira, ML
AF Mondini, Adriano
   de Moraes Bronzoni, Roberta Vieira
   Pereira Nunes, Silvia Helena
   Chiaravalloti-Neto, Francisco
   Massad, Eduardo
   Alonso, Wladimir J.
   de Andrade Zanotto, Pablo Marinho
   Nogueira, Mauricio Lacerda
TI Spatio-temporal tracking and phylodynamics of a DENV-3 outbreak in a
   city from Brazil
SO CLADISTICS
LA English
DT Meeting Abstract
CT 27th Annual Meeting of the Willi-Hennig-Society/8th Argentina Meeting of
   Cladistics and Biogeography
CY OCT 28-31, 2008
CL San Javier, ARGENTINA
SP Willi Hennig Soc
C1 [Mondini, Adriano; de Moraes Bronzoni, Roberta Vieira; Pereira Nunes, Silvia Helena; Chiaravalloti-Neto, Francisco; Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Massad, Eduardo; de Andrade Zanotto, Pablo Marinho] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Alonso, Wladimir J.] Fogarty Int Ctr, Bethesda, MD USA.
RI Nogueira, Mauricio L/B-7599-2012; de A. Zanotto, Paolo M./B-9286-2019;
   Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0748-3007
J9 CLADISTICS
JI Cladistics
PD APR
PY 2010
VL 26
IS 2
BP 218
EP 218
PG 1
WC Evolutionary Biology
SC Evolutionary Biology
GA 564LD
UT WOS:000275214800071
DA 2020-12-16
ER

PT J
AU Raimundo, SM
   Massad, E
   Yang, HM
AF Raimundo, Silvia Martorano
   Massad, Eduardo
   Yang, Hyun Mo
TI Modelling congenital transmission of Chagas' disease
SO BIOSYSTEMS
LA English
DT Article
DE Congenital transmission; Chagas' disease; Control strategy; Demography
AB The successful elimination of vectorial and transfusional transmission of Chagas' disease from some countries is a result of the reduction of domestic density of the primary vector Triatoma infestans, of almost 100% of coverage in blood serological selection and to the fact that the basic reproductive number of Chagas' disease is very close to one (1.25). Therefore, congenital transmission is currently the only way of acquiring Chagas' Disease in such regions. In this paper we propose a model of congenital transmission of Chagas' disease. Its aim is to provide an estimation of the time period it will take to eliminate this form of transmission in regions where vetorial transmission was reduced to close to zero, like in Brazil. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Raimundo, Silvia Martorano; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Raimundo, Silvia Martorano; Massad, Eduardo] HCFMUSP, LIM 01, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Dis, London, England.
   [Yang, Hyun Mo] Univ Estadual Campinas, IMECC, Dept Matemat Aplicada, BR-13081970 Campinas, SP, Brazil.
RP Raimundo, SM (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM silviamr@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012; Yang, Hyun M/K-6873-2014; Raimundo, Silvia
   Martorano/D-4624-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Yang, Hyun M/0000-0002-1711-363X;
   Raimundo, Silvia Martorano/0000-0002-9960-7341; 
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX Grant from FAPESP (Projeto Tematico) is acknowledged.
CR BITTENCOURT AL, 1976, AM J DIS CHILD, V130, P97, DOI 10.1001/archpedi.1976.02120020099020
   ESGOLTS L, 1970, DIFF EQUAT, P440
   Schijman AG, 2007, PERSP MED V, V13, P223, DOI 10.1016/S0168-7069(06)13012-8
   KIRCHHOFF LV, 2000, TROPICAL INFECT DIS
   Kribs-Zaleta CM, 1999, MATH BIOSCI, V160, P109, DOI 10.1016/S0025-5564(99)00031-0
   Kropf SP, 2003, SOC HIST MED, V16, P111, DOI 10.1093/shm/16.1.111
   LENT H, 1940, MEMORIAS I OWSALDO C, V89, P347
   Massad E, 2008, EPIDEMIOL INFECT, V136, P1153, DOI 10.1017/S0950268807009879
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   *PAHO, 2007, NEWSL PAN AM HLTH OR
   Schofield C J, 2000, Cad Saude Publica, V16 Suppl 2, P89
   SCHOFIELD CJ, 1994, TRIATOMINAE BIOL CON
   SMITH D, 1977, MATH DEMOGRAPHY
NR 13
TC 17
Z9 18
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0303-2647
EI 1872-8324
J9 BIOSYSTEMS
JI Biosystems
PD MAR
PY 2010
VL 99
IS 3
BP 215
EP 222
DI 10.1016/j.biosystems.2009.11.005
PG 8
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 569FL
UT WOS:000275581900007
PM 19962422
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Coutinho, FA
   Struchiner, CJ
AF Massad, Eduardo
   Burattini, Marcelo Nascimento
   Coutinho, Francisco Antonio
   Struchiner, Claudio Jose
TI The risk of acquiring the new influenza A(H1N1) for Brazilian travelers
   to Chile, Argentina and the USA
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE influenza A (H1N1); travelers; risk estimation; mathematical models
ID DENGUE
AB We estimate the risk of acquiring the new influenza A( H1N1) for Brazilian travelers to Chile, Argentina and the USA. This is done by a mathematical model that quantifies the intensity of transmission of the new virus in those countries and the probability that one individual has of acquiring the influenza depending on the date of arrival and time spent in the area. The maximum estimated risk reached 7.5 cases per 10,000 visitors to Chile, 17 cases per 10,000 travelers to Argentina and 23 cases per 10,000 travelers to the USA. The estimated number of imported cases until 27 July is 57 +/- 9 from Chile, 136 +/- 27 from the USA and 301 +/- 21 from Argentina, which are in accord with the official figures. Estimating the number of imported cases was particularly important for the moment of the disease introduction into this country, but it will certainly be important again as a tool to calculate the number of future imported cases from northern countries in our next inter-epidemic season, were imported cases can constitute again the majority of the new influenza burden to the Brazilian health services.
C1 [Massad, Eduardo; Burattini, Marcelo Nascimento; Coutinho, Francisco Antonio] Univ Sao Paulo, Fac Med, Rua Teodoro Sampaio 115,2 Andar, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London, England.
   [Struchiner, Claudio Jose] Fiocruz MS, Programa Comp Cient, BR-21045900 Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Rua Teodoro Sampaio 115,2 Andar, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Struchiner, Claudio J/M-9360-2013; Massad,
   Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Coutinho,
   Francisco A B/H-5644-2011
OI Struchiner, Claudio J/0000-0003-2114-847X; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890;
   Coutinho, Francisco A B/0000-0003-3127-3071
FU LIM01-HCFMUSP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX LIM01-HCFMUSP, CNPq, FAPESP, FAPERJ
CR ANDERSON R M, 1991
   Choisy M., 2007, ENCY INFECT DIS MODE, P379, DOI [10.1002/9780470114209.ch22, DOI 10.1002/9780470114209.CH22]
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Massad E, 2007, MED HYPOTHESES, V68, P442, DOI 10.1016/j.mehy.2006.07.041
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
NR 7
TC 6
Z9 6
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2010
VL 105
IS 2
BP 179
EP 183
DI 10.1590/S0074-02762010000200012
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 589MQ
UT WOS:000277152900012
PM 20428678
OA DOAJ Gold, Green Accepted
DA 2020-12-16
ER

PT J
AU de Araujo, DVP
   Zoboli, ELCP
   Massad, E
AF Pacheco de Araujo, Diego Vinicius
   Campos Pavone Zoboli, Elma Lourdes
   Massad, Eduardo
TI HOW TO MAKE CONSENT FORMS EASIER TO READ?
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
DE Consent Forms; Educational Status; Bioethics; Ethics Committees;
   Research
AB How TO MAKE CONSENT FORMS EASIER TO READ?
   OBJECITIVE. Define the literacy level of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HCMFUSP) outpatients, for the purpose of identifying recommendations to adapt writing of the informed consent form to the outpatients literacy level, since these can become the subject of research.
   METHODS. Quantitative cross sectional study with 399 subjects. The sample was intentional, selected from different outpatient care units of HCFMUSP Data collection used an instrument that contained a text with prose compatible for assessment of reading skills needed for comprehension of the consent form.
   RESULTS. More than 46.6% of the interviewees were classified as functionally illiterate, of these, 12.7% were even unable to understand the proposed task in the text they read. Nevertheless, nearly 50% of the interviewees reported having at least started high school.
   CONCLUSIONS. The results and the orientations for the text writing centered on the reader allowed us to make recommendations to render the consent form easier to read. We recommend that the researcher modifies the text to a structural narrative, addressed to the reader, using terms that are familiar, In other words, with terms common to the subjects' and to the medical language. In addition to improving the relationship between the subject and researcher; it is believed that these recommendations may reduce the time taken for the proceeding of research projects, since problems in the wording of consent forms contribute significantly to project delays. [Rev Assoc Med Bras 2010; 56(2): 151-6]
C1 [Pacheco de Araujo, Diego Vinicius; Campos Pavone Zoboli, Elma Lourdes; Massad, Eduardo] Univ Sao Paulo, Escola Enfermagem, BR-05403000 Sao Paulo, Brazil.
RP Zoboli, ELCP (corresponding author), Univ Sao Paulo, Escola Enfermagem, Av Dr Eneas de Carvalho Aguiar,419, BR-05403000 Sao Paulo, Brazil.
EM elma@usp.br
RI Massad, Eduardo/H-6143-2011; FUJIMORI, ELIZABETH/D-4623-2012; Massad,
   Eduardo/B-1169-2012; Zoboli, Elma LCP/C-5177-2012
OI FUJIMORI, ELIZABETH/0000-0002-7991-0503; Massad,
   Eduardo/0000-0002-7200-2916; Zoboli, Elma LCP/0000-0002-7324-5389
CR ASSUMPCAO MEO, 2006, RECOMENDACOES ESCREV
   BITTENCOURT VC, 2007, 27 S CIENT HOSP CLIN, V27, P273
   BOCCHINI MO, 1994, THESIS U SAO PAULO S
   Hulley SB, 2003, DELINEANDO PESQUISA
   *I PAUL MONT, 2005, 5 IND NAC ALF FUNC
   *I PAUL MONT, 2007, IN 2007 IND NAC ALF
   Lorenzo C., 2007, REV BIOETICA, V15, P268
   Miranda VD, 2009, REV ASSOC MED BRAS, V55, P328, DOI 10.1590/S0104-42302009000300028
   MOREIRA DA, 2000, ANALFABETISMO FUNCIO
   RIBEIRO VM, 2003, INDICADORES ALFABETI
   TANNOUS GS, 2009, 7 FORUM COMITES ETIC
NR 11
TC 5
Z9 7
U1 0
U2 4
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAR-APR
PY 2010
VL 56
IS 2
BP 151
EP 156
DI 10.1590/S0104-42302010000200011
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 594SO
UT WOS:000277558000010
PM 20498987
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Rocha, F
   Rocha, A
   Massad, E
AF Rocha, F.
   Rocha, A.
   Massad, E.
TI LEARNING DIFFICULTIES AND BEHAVIORAL MISCONDUCT
SO EUROPEAN PSYCHIATRY
LA English
DT Meeting Abstract
C1 [Rocha, F.; Rocha, A.; Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0924-9338
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PY 2010
VL 25
SU 1
PG 1
WC Psychiatry
SC Psychiatry
GA V21RX
UT WOS:000208225800445
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Amaku, M
AF Massad, E.
   Coutinho, F. A. B.
   Burattini, M. N.
   Amaku, M.
TI Estimation of R-0 from the initial phase of an outbreak of a
   vector-borne infection
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE basic reproduction number; epidemiology; mathematical models;
   vector-borne infections; dengue fever
ID THRESHOLD CONDITIONS; DENGUE; DYNAMICS; NUMBER; FEVER
AB The magnitude of the basic reproduction ratio R-0 of an epidemic can be estimated in several ways, namely, from the final size of the epidemic, from the average age at first infection, or from the initial growth phase of the outbreak. In this paper, we discuss this last method for estimating R-0 for vector-borne infections. Implicit in these models is the assumption that there is an exponential phase of the outbreaks, which implies that in all cases R-0 > 1. We demonstrate that an outbreak is possible, even in cases where R-0 is less than one, provided that the vector-to-human component of R-0 is greater than one and that a certain number of infected vectors are introduced into the affected population. This theory is applied to two real epidemiological dengue situations in the southeastern part of Brazil, one where R-0 is less than one, and other one where R-0 is greater than one. In both cases, the model mirrors the real situations with reasonable accuracy.
C1 [Massad, E.; Coutinho, F. A. B.; Burattini, M. N.] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Massad, E.; Coutinho, F. A. B.; Burattini, M. N.] LIM 01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
   [Amaku, M.] Univ Sao Paulo, Sch Vet Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014;
   Massad, Eduardo/B-1169-2012; Amaku, Marcos/D-5252-2012; Massad,
   Eduardo/H-6143-2011
OI Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Amaku,
   Marcos/0000-0003-4752-6774; 
CR ANDERSON R M, 1991
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Choisy M., 2007, ENCY INFECT DIS MODE, P379, DOI [10.1002/9780470114209.ch22, DOI 10.1002/9780470114209.CH22]
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Diekmann O, 2000, MATH EPIDEMIOLOGY IN
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Hale J. K., 1993, INTRO FUNCTIONAL DIF
   Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Lopez LF, 2000, J MATH BIOL, V40, P199, DOI 10.1007/s002850050178
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
NR 19
TC 34
Z9 34
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2010
VL 15
IS 1
BP 120
EP 126
DI 10.1111/j.1365-3156.2009.02413.x
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 531JU
UT WOS:000272662600017
PM 19891761
OA Bronze
DA 2020-12-16
ER

PT J
AU Massad, E
   Behrens, RH
   Burattini, MN
   Coutinho, FAB
AF Massad, Eduardo
   Behrens, Ronald H.
   Burattini, Marcelo N.
   Coutinho, Francisco A. B.
TI Modeling the risk of malaria for travelers to areas with stable malaria
   transmission
SO MALARIA JOURNAL
LA English
DT Article
ID YELLOW-FEVER; DENGUE
AB Background: Malaria is an important threat to travelers visiting endemic regions. The risk of acquiring malaria is complex and a number of factors including transmission intensity, duration of exposure, season of the year and use of chemoprophylaxis have to be taken into account estimating risk.
   Materials and methods: A mathematical model was developed to estimate the risk of non-immune individual acquiring falciparum malaria when traveling to the Amazon region of Brazil. The risk of malaria infection to travelers was calculated as a function of duration of exposure and season of arrival.
   Results: The results suggest significant variation of risk for non-immune travelers depending on arrival season, duration of the visit and transmission intensity. The calculated risk for visitors staying longer than 4 months during peak transmission was 0.5% per visit.
   Conclusions: Risk estimates based on mathematical modeling based on accurate data can be a valuable tool in assessing risk/benefits and cost/benefits when deciding on the value of interventions for travelers to malaria endemic regions.
C1 [Massad, Eduardo; Burattini, Marcelo N.; Coutinho, Francisco A. B.] Univ Sao Paulo, Sch Med, Dept Pathol, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo; Burattini, Marcelo N.; Coutinho, Francisco A. B.] LIM 01 HCFMUSP, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo; Behrens, Ronald H.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Dept Pathol, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@dim.fm.usp.br; Ron.Behrens@lshtm.ac.uk; mnburatt@usp.br;
   coutinho@dim.fm.usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Coutinho, Francisco A B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A B/0000-0003-3127-3071
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); LIM01-HCF-MUSP; Department of Health's NIHR Biomedical Research
   CentresNational Institute for Health Research (NIHR)
FX This work was partially supported by FAPESP, CNPq and LIM01-HCF-MUSP.;
   It was in part undertaken at UCLH/UCL who receive a proportion of
   funding from the Department of Health's NIHR Biomedical Research Centres
   funding scheme.
CR Askling HH, 2005, EMERG INFECT DIS, V11, P436, DOI 10.3201/eid1103.040677
   Behrens RH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-7
   Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234
   Dos Santos RL, 2004, J MED ENTOMOL, V41, P997
   Dos Santos RL, 2002, J MED ENTOMOL, V39, P926
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   House HR, 2008, EMERG MED CLIN N AM, V26, P499, DOI 10.1016/j.emc.2008.01.008
   LADISLAW JLB, 2006, SITUACAO MALARIA AMA
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Molineaux L., 1988, P913
   Molineaux L, 1980, GARKI PROJECT RES EP
   Noronha E, 2000, Rev Soc Bras Med Trop, V33, P185, DOI 10.1590/S0037-86822000000200005
   Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226
   Tada Yuki, 2008, Travel Med Infect Dis, V6, P368, DOI 10.1016/j.tmaid.2008.08.002
   TADEI W, 1997, ENTOMOLOGIA MALARIA, P157
   TAYLOR JR, 2001, INTRO ERROR ANAL STU, P126
   WYSE APP, 2007, THESIS LAB NACL COMP
NR 24
TC 19
Z9 19
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD DEC 16
PY 2009
VL 8
AR 296
DI 10.1186/1475-2875-8-296
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 545UK
UT WOS:000273762200001
PM 20015392
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Fernandes, GCVR
   Azevedo, RS
   Amaku, M
   Yu, ALF
   Massad, E
AF Fernandes, G. C. V. R.
   Azevedo, R. S.
   Amaku, M.
   Yu, A. L. F.
   Massad, E.
TI Seroepidemiology of Toxoplasma infection in a metropolitan region of
   Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Epidemiological parameters; incidence; mathematical modelling;
   seroepidemiology; toxoplasmosis
ID CONGENITAL TOXOPLASMOSIS; PREGNANT-WOMEN; SEROPREVALENCE; DIAGNOSIS;
   MOTHERS; STATE
AB Seroprevalence data from a representative population were used to estimate the annual incidence of congenital toxoplasmosis in Sao Paulo Metropolitan Region (SPMR). Retrospective anti-toxoplasma IgG serological analysis was conducted to determine age-dependent seroprevalence, force of infection, average age of acquisition of infection and curve of decay of maternally derived antibodies. Seroprevalence was used to calculate the number of new infections. Toxoplasmosis in pregnant women was estimated by total number of deliveries in a given year as a proxy for the number of pregnancies per year. Toxoplasma seroprevalence was 64.9% in women of childbearing age. Average age of acquisition of toxoplasmosis was 10.74 years. The estimated annual incidence of congenital toxoplasmosis varied from 9.5 to 10.6/1000 births in the studied period. The toxoplasmosis seroprevalence model allowed a good incidence estimation of congenital disease in SPMR compared to other published data, indicating that this mathematical approach is useful in calculating the potential demand of congenital disease due to Toxoplasma gondii in a given community.
C1 [Fernandes, G. C. V. R.; Azevedo, R. S.; Yu, A. L. F.; Massad, E.] Univ Sao Paulo, Fac Med, Dept Patol, BR-01246903 Sao Paulo, Brazil.
   [Fernandes, G. C. V. R.; Azevedo, R. S.; Yu, A. L. F.; Massad, E.] Univ Sao Paulo, Fac Med, LIM HC 01, BR-01246903 Sao Paulo, Brazil.
   [Amaku, M.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Lab Epidemiol & Bioestatist, BR-01246903 Sao Paulo, Brazil.
RP Fernandes, GCVR (corresponding author), Univ Sao Paulo, Fac Med, Dept Patol, Ave Doutor Arnaldo 455,Sala 1347, BR-01246903 Sao Paulo, Brazil.
EM gcrfernandes@usp.br
RI Massad, Eduardo/B-1169-2012; Frugis Yu, Ana Lucia/K-9092-2016; Amaku,
   Marcos/D-5252-2012; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Frugis Yu, Ana
   Lucia/0000-0003-2207-3940; Amaku, Marcos/0000-0003-4752-6774; Azevedo,
   Raymundo S/0000-0003-0660-2371; 
CR ADES AE, 1992, EPIDEMIOL INFECT, V108, P367, DOI 10.1017/S0950268800049839
   ADES AE, 1993, AM J EPIDEMIOL, V137, P1022, DOI 10.1093/oxfordjournals.aje.a116758
   ALMEIDA LNI, 2002, BRAZIL T ROYAL SOC T, V96, P605
   Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   ARNAKU M, MATH POPULA IN PRESS
   Avelino MM, 2003, EUR J OBSTET GYN R B, V108, P19, DOI 10.1016/S0301-2115(02)00353-6
   Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55
   Carvalheiro CG, 2005, EPIDEMIOL INFECT, V133, P485, DOI 10.1017/S095026880400353X
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009
   Evans R, 2000, EUR J CLIN MICROBIOL, V19, P829, DOI 10.1007/s100960000378
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   Goldenberg Paulete, 2005, Cad. Saúde Pública, V21, P1077, DOI 10.1590/S0102-311X2005000400010
   GomezMarin JE, 1997, AM J TROP MED HYG, V57, P180, DOI 10.4269/ajtmh.1997.57.180
   *IBGE, STAT REP LIV STILLB
   Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025
   KAWASAKI MIL, 2006, PEDIATRIA SDO PAULO, V28, P240
   LELAND NL, 1995, PUBLIC HEALTH REP, V110, P53
   Mattos CB, 2007, REV PANAM INFECTOL, V9, P24
   Montoya JG, 2005, CLIN PERINATOL, V32, P705, DOI 10.1016/j.clp.2005.04.011
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   MUENCH H, 1959, CATAL  WIC MODELS EP
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   Nobrega OD, 2005, REV SOC BRAS MED TRO, V38, P358, DOI 10.1590/S0037-86822005000400018
   NOKES DJ, 1993, PARASITOLOGY, V107, P33, DOI 10.1017/S0031182000079373
   Olbrich Neto Jaime, 2004, Rev. Soc. Bras. Med. Trop., V37, P28, DOI 10.1590/S0037-86822004000100008
   PAPOZ L, 1986, AM J EPIDEMIOL, V123, P154, DOI 10.1093/oxfordjournals.aje.a114210
   Baraidi AC, 2007, REV LAT-AM ENFERM, V15, P799, DOI 10.1590/S0104-11692007000700014
   Petersen E, 2007, SEMIN FETAL NEONAT M, V12, P214, DOI 10.1016/j.siny.2007.01.011
   Rorman E, 2006, REPROD TOXICOL, V21, P458, DOI 10.1016/j.reprotox.2005.10.006
   *SAO PAUL STAT I, DAT
   Segundo GRS, 2004, J TROP PEDIATRICS, V50, P50, DOI 10.1093/tropej/50.1.50
   SINIBALDI J, 1992, EUR J EPIDEMIOL, V8, P516, DOI 10.1007/BF00146369
   Spalding SM, 2005, REV SOC BRAS MED TRO, V38, P173, DOI 10.1590/S0037-86822005000200009
   Valentim J, 2008, VACCINE, V26, P6281, DOI 10.1016/j.vaccine.2008.07.021
   VAZ AJ, 1990, REV SAUDE PUBL, V24, P373, DOI 10.1590/S0034-89101990000500004
NR 36
TC 17
Z9 17
U1 1
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 2009
VL 137
IS 12
BP 1809
EP 1815
DI 10.1017/S0950268809002799
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 522AZ
UT WOS:000271971400021
PM 19470195
DA 2020-12-16
ER

PT J
AU Struchiner, CJ
   Massad, E
   Tu, ZJ
   Ribeiro, JMC
AF Struchiner, Claudio J.
   Massad, Eduardo
   Tu, Zhijian
   Ribeiro, Jose M. C.
TI THE TEMPO AND MODE OF EVOLUTION OF TRANSPOSABLE ELEMENTS AS REVEALED BY
   MOLECULAR PHYLOGENIES RECONSTRUCTED FROM MOSQUITO GENOMES
SO EVOLUTION
LA English
DT Article
DE Demography reconstruction; genomes; population dynamics; transposable
   element
ID POPULATION HISTORY; HORIZONTAL TRANSMISSION; MAXIMUM-LIKELIHOOD; DNA;
   DYNAMICS; SEQUENCE; RECOMBINATION; NUCLEOTIDE; DROSOPHILA; HIV-1
AB Although many mathematical models exist predicting the dynamics of transposable elements (TEs), there is a lack of available empirical data to validate these models and inherent assumptions. Genomes can provide a snapshot of several TE families in a single organism, and these could have their demographics inferred by coalescent analysis, allowing for the testing of theories on TE amplification dynamics. Using the available genomes of the mosquitoes Aedes aegypti and Anopheles gambiae, we indicate that such an approach is feasible. Our analysis follows four steps: (1) mining the two mosquito genomes currently available in search of TE families; (2) fitting, to selected families found in (1), a phylogeny tree under the general time-reversible (GTR) nucleotide substitution model with an uncorrelated lognormal (UCLN) relaxed clock and a nonparametric demographic model; (3) fitting a nonparametric coalescent model to the tree generated in (2); and (4) fitting parametric models motivated by ecological theories to the curve generated in (3).
C1 [Struchiner, Claudio J.] Fiocruz MS, ENSP, BR-21040360 Rio De Janeiro, Brazil.
   [Struchiner, Claudio J.] Univ Estado Rio De Janeiro, IMS, BR-21040360 Rio De Janeiro, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, FM, BR-01246903 Sao Paulo, Brazil.
   [Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.
   [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
RP Struchiner, CJ (corresponding author), Fiocruz MS, ENSP, Av Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM stru@fiocruz.br; edmassad@dim.fm.usp.br; jaketu@vt.edu;
   jribeiro@niaid.nih.gov
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Struchiner,
   Claudio J/M-9360-2013
OI Massad, Eduardo/0000-0002-7200-2916; Struchiner, Claudio
   J/0000-0003-2114-847X; Ribeiro, Jose/0000-0002-9107-0818
FU Intramural Research Program of the Division of Intramural ResearchUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; Regents of the University of CaliforniaUniversity of California
   System; Foundation for the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; Brazilian Research Council (CNPq)National Council for Scientific
   and Technological Development (CNPq); FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810,
   Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810,
   Z01AI000810, Z01AI000810] Funding Source: NIH RePORTER
FX We thank NIAID intramural editor B. R. Marshall for assistance and
   acknowledge support from the Intramural Research Program of the Division
   of Intramural Research, National Institute of Allergy and Infectious
   Diseases, National Institutes of Health. Because JMCR is a government
   employee and this is a government work, the work is in the public domain
   in the United States. Notwithstanding any other agreements, the NIH
   reserves the right to provide the work to PubMedCentral for display and
   use by the public, and PubMedCentral may tag or modify the work
   consistent with its customary practices. You can establish rights
   outside of the U.S. subject to a government use license. The work was
   funded in part by a grant to the Regents of the University of California
   from the Foundation for the National Institutes of Health through the
   Grand Challenges in Global Health initiative and by the Intramural
   Research Program of the National Institute of Allergy and Infectious
   Diseases. CJS and EM were partially supported by the Brazilian Research
   Council (CNPq), FAPESP, and FAPERJ. Note added in proof: The novel
   element named BossaNova in this paper is the same named Sola2 in W. Bao,
   M. G. Jurka, V. V. Kapitonov, and J. Jurka. 2009. New superfamilies of
   eukaryotic DNA transposons and their internal divisions. Mol Biol Evol.
   26:983-93.
CR Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102
   Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459
   Biedler JK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-112
   Brookfield JFY, 2005, CYTOGENET GENOME RES, V110, P383, DOI 10.1159/000084970
   Brookfield JFY, 2005, NAT REV GENET, V6, P128, DOI 10.1038/nrg1524
   Brookfield JFY, 2006, GENETICS, V173, P1115, DOI 10.1534/genetics.104.027219
   Carvajal-Rodriguez A, 2006, MOL BIOL EVOL, V23, P817, DOI 10.1093/molbev/msj102
   Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428
   DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2002, GENETICS, V161, P1307
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003
   Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019
   Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28
   Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9
   GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941
   GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079
   Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102
   Johnson LJ, 2006, MOL BIOL EVOL, V23, P235, DOI 10.1093/molbev/msj034
   Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979
   Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004
   Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x
   Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548
   KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI 10.1111/j.1558-5646.1993.tb02144.x
   Kuhner MK, 2006, MOL BIOL EVOL, V23, P2355, DOI 10.1093/molbev/msl106
   Le Rouzic A, 2005, GENET RES, V85, P171, DOI 10.1017/S0016672305007585
   Le Rouzic A, 2006, GENETICS, V174, P785, DOI 10.1534/genetics.105.052241
   Lemey P, 2005, MOL BIOL EVOL, V22, P942, DOI 10.1093/molbev/msi078
   Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100
   Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029
   Liang X, 2009, HEREDITY, V102, P342, DOI 10.1038/hdy.2009.1
   LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191
   Marjoram P, 2006, NAT REV GENET, V7, P759, DOI 10.1038/nrg1961
   Mongin E, 2004, TRENDS PARASITOL, V20, P49, DOI 10.1016/j.pt.2003.11.003
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nordborg M., 2001, HDB STAT GENETICS
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Opgen-Rhein R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-6
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Paraskevis D, 2004, J MOL EVOL, V59, P709, DOI 10.1007/s00239-004-2651-6
   Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9
   Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278
   Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321
   Quesneville H, 1998, THEOR POPUL BIOL, V54, P175, DOI 10.1006/tpbi.1997.1353
   *R DEV COR TEAM, 2007, R R LANG ENV STAT CO
   RAMBAUT A, 2006, FIGTREE FIGTREE VERS
   RAMBAUT A, 2006, TREESTAT TREESTAT VE
   RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10
   Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x
   Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003
   ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0
   Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187
   RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3
   SAUNDERS IW, 1984, ADV APPL PROBAB, V16, P471, DOI 10.2307/1427285
   Seo TK, 2002, GENETICS, V160, P1283
   Shao HG, 2001, INSECT MOL BIOL, V10, P421, DOI 10.1046/j.0962-1075.2001.00280.x
   Silva JC, 2004, CURR ISSUES MOL BIOL, V6, P57
   Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Struchiner CJ, 2005, J BIOL SYST, V13, P455, DOI 10.1142/S021833900500163X
   SVOBODA YHM, 1995, GENETICS, V139, P1601
   Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377
   *WINBUGS, 2008, WINBUGS DIFF INT WBD
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
NR 68
TC 9
Z9 9
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-3820
EI 1558-5646
J9 EVOLUTION
JI Evolution
PD DEC
PY 2009
VL 63
IS 12
BP 3136
EP 3146
DI 10.1111/j.1558-5646.2009.00788.x
PG 11
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA 522BV
UT WOS:000271973600010
PM 19656180
OA Green Accepted
DA 2020-12-16
ER

PT J
AU Da Rocha, AF
   Burattini, MN
   Rocha, FT
   Massad, E
AF Da Rocha, Armando Freitas
   Burattini, Marcelo Nascimento
   Rocha, Fabio Theoto
   Massad, Eduardo
TI A NEUROECONOMIC MODELING OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
   (ADHD)
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE AD/HD; Neuroeconomics; Modeling; Decision-Making; Risk; Reward Cost
   Benefit Evaluation
ID DEFICIT HYPERACTIVITY DISORDER; DECISION-MAKING; ANTERIOR CINGULATE;
   WORKING-MEMORY; PREFRONTAL CORTEX; BRAIN; REWARD; PREFERENCES;
   IMPULSIVITY; PERSPECTIVE
AB In this paper we present a new neuroeconomics model for decision-making applied to the Attention-Deficit/Hyperactivity Disorder (ADHD). The model is based on the hypothesis that decision-making is dependent on the evaluation of expected rewards and risks assessed simultaneously in two decision spaces: the personal (PDS) and the interpersonal emotional spaces (IDS). Motivation to act is triggered by necessities identified in PDS or IDS. The adequacy of an action in fulfilling a given necessity is assumed to be dependent on the expected reward and risk evaluated in the decision spaces. Conflict generated by expected reward and risk influences the easiness (cognitive effort) and the future perspective of the decision-making. Finally, the willingness (not) to act is proposed to be a function of the expected reward (or risk), adequacy, easiness and future perspective. The two most frequent clinical forms are ADHD hyperactive (AD/HDhyp) and ADHD inattentive (AD/HDdin). AD/HDhyp behavior is hypothesized to be a consequence of experiencing high rewarding expectancies for short periods of time, low risk evaluation, and short future perspective for decision-making. AD/HDin is hypothesized to be a consequence of experiencing high rewarding expectancies for long periods of time, low risk evaluation, and long future perspective for decision-making.
C1 [Da Rocha, Armando Freitas; Burattini, Marcelo Nascimento; Rocha, Fabio Theoto; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
RP Da Rocha, AF (corresponding author), Rua Tenente Ary Aps 172, BR-13207110 Jundiai, Brazil.
EM armando@enscer.com.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Rocha, Armando Freitas
   da/0000-0002-1301-8491
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [04/00743-4]
FX We would like to thank two anonymous referees because their interesting
   comments helped to improve this manuscript. We also acknowledge the
   partial financial support by CNPq to E. Massad and FAPESP - grant
   04/00743-4 to A. F. Rocha.
CR Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014
   American Psychiatric Association, 1994, DIAGN STAT MENT DIS, V4
   Ariely D, 2008, TRENDS COGN SCI, V12, P13, DOI 10.1016/j.tics.2007.10.008
   Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4
   BECHARA A, 2005, GAMES EC BEHAV
   Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011
   Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9
   Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2
   BOTVINICK MM, 2004, TRENDS COGN SCI, V2044, P529
   Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034
   Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013
   de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735
   Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011
   Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007
   Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002
   Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018
   Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004
   Graff-Guerrero A, 2005, NEUROIMAGE, V25, P1197, DOI 10.1016/j.neuroimage.2004.12.020
   Gray J.A., 2000, NEUROPSYCHOLOGY ANXI
   Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011
   Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046
   Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047
   Laibson D, 1998, EUR ECON REV, V42, P861, DOI 10.1016/S0014-2921(97)00132-3
   LeDoux J., 1996, EMOTIONAL BRAIN MYST
   McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907
   MICHELE F, 2005, INT J PSYCHOPHYSIOL, V58, P81
   O'Doherty J, 2001, NAT NEUROSCI, V4, P95
   Panksepp J., 1998, AFFECTIVE NEUROSCIEN
   Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027
   Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061
   Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   Rocha AF, 2004, BRAIN FUZZY ARITHMET
   Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008
   Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012
   Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165
   Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075
   Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976
   Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004
   Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019
   Sergeant JA, 2003, NEUROSCI BIOBEHAV R, V27, P583, DOI 10.1016/j.neubiorev.2003.08.004
   Seymour B, 2008, CURR OPIN NEUROBIOL, V18, P173, DOI 10.1016/j.conb.2008.07.010
   Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005
   Tobler PN, 2007, NEURON, V54, P167, DOI 10.1016/j.neuron.2007.03.004
   Valkalopoulos C, 2007, MED HYPOTHESES, V68, P210, DOI 10.1016/j.mehy.2006.07.018
   van Gaalen MM, 2006, BIOL PSYCHIAT, V60, P66, DOI 10.1016/j.biopsych.2005.06.005
   VANDENBERGH FS, 2007, PHARM BIOCH BEHAV, V85, P736
   Waldman ID, 2006, CLIN PSYCHOL REV, V26, P396, DOI 10.1016/j.cpr.2006.01.007
   Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339
   Weber B, 2007, NEUROIMAGE, V35, P441, DOI 10.1016/j.neuroimage.2006.11.034
   Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001
NR 51
TC 3
Z9 3
U1 0
U2 10
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3390
EI 1793-6470
J9 J BIOL SYST
JI J. Biol. Syst.
PD DEC
PY 2009
VL 17
IS 4
BP 597
EP 622
DI 10.1142/S021833900900306X
PG 26
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 541OT
UT WOS:000273426400004
DA 2020-12-16
ER

PT J
AU Chaib, E
   Fridman, C
   Massad, E
AF Chaib, E.
   Fridman, C.
   Massad, E.
TI Potential Effect of Using ABO-Compatible Living-Donor Liver
   Transplantation
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID SINGLE-CENTER EXPERIENCE; HEART-BEATING DONORS; WAITING-LIST; SAO-PAULO;
   SPLIT-LIVER; WHOLE LIVER; BRAZIL; STATE; MORTALITY; DYNAMICS
AB Liver transplantation increased 1.84-fold from 1988 to 2004. However, the number of patients on the waiting list for a liver increased 2.71-fold, from 553 to 1500. We used a mathematical equation to analyze the potential effect of using ABO-compatible living-donor liver transplantation (LDLT) on both our liver transplantation program and the waiting list. We calculated the prevalence distribution of blood groups (O, A, B, and AB) in the population and the probability of having a compatible parent or sibling for LDLT. The incidence of ABO compatibility in the overall population was as follows: A, 0.31; B, 0.133; O, 0.512; and AB, 0.04. The ABO compatibility for parent donors was blood group A, 0.174; B, 0.06; O, 0.152; and AB, 0.03; and for sibling donors was A, 0.121; B, 0.05; O, 0.354; and AB, 0.03. Use of LDLT can reduce the pressure on our liver transplantation waiting list by decreasing its size by at least 16.5% at 20 years after its introduction. Such a program could save an estimated 3600 lives over the same period.
C1 [Chaib, E.] Univ Sao Paulo, Hosp Clin, Dept Gastroenterol, Sch Med,Liver Surg Unit, BR-05403010 Sao Paulo, Brazil.
   [Massad, E.] Univ Sao Paulo, Sch Med, Dept Med Informat, LIM 01, BR-05403010 Sao Paulo, Brazil.
   [Chaib, E.; Massad, E.] Univ Sao Paulo, Sch Med, HCFMUSP, LIM 01, BR-05403010 Sao Paulo, Brazil.
   [Fridman, C.] Univ Sao Paulo, Sch Med, HCFMUSP, LIM 40, BR-05403010 Sao Paulo, Brazil.
   [Chaib, E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.
RP Chaib, E (corresponding author), Univ Sao Paulo, Hosp Clin, Dept Gastroenterol, Sch Med,Liver Surg Unit, Level 9,Ste 9025, BR-05403010 Sao Paulo, Brazil.
EM eleazarchaib@yahoo.co.uk
RI Fridman, Cintia/E-2657-2013; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012; Fridman, Cintia/G-1837-2012
OI Massad, Eduardo/0000-0002-7200-2916; Fridman, Cintia/0000-0003-2430-4888
CR Austin MT, 2007, ARCH SURG-CHICAGO, V142, P1079, DOI 10.1001/archsurg.142.11.1079
   Azeka E, 2009, CLINICS, V64, P127, DOI 10.1590/S1807-59322009000200010
   Bacchella T, 2004, TRANSPL P, V36, P929, DOI 10.1016/j.transproceed.2004.03.096
   Baiochi E, 2007, REV ASSOC MED BRAS, V53, P44, DOI 10.1590/S0104-42302007000100018
   Brown RS, 2008, GASTROENTEROLOGY, V134, P1802, DOI 10.1053/j.gastro.2008.02.092
   Bulmer M. G, 1985, MATH THEORY QUANTITA
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2008, CLINICS, V63, P121, DOI 10.1590/S1807-59322008000100020
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chaib E, 2007, TRANSPLANTATION, V84, P1209, DOI 10.1097/01.tp.0000287192.32090.2b
   Chaib E, 2007, HEPATO-GASTROENTEROL, V54, P688
   Chaib E, 2008, LIVER TRANSPLANT, V14, P1732, DOI 10.1002/lt.21611
   Gruessner R. W. G., 2008, LIVING DONOR ORGAN T
   Gruttadauria S, 2008, LIVER TRANSPLANT, V14, P220, DOI 10.1002/lt.21359
   Hoel P., 1984, INTRO MATH STAT
   Humar A, 2008, TRANSPLANTATION, V85, P1420, DOI 10.1097/TP.0b013e31816de1a3
   Muiesan P, 2006, AM J TRANSPLANT, V6, P1012, DOI 10.1111/j.1600-6143.2006.01293.x
   Nadalin S, 2006, HPB (Oxford), V8, P10, DOI 10.1080/13651820500465626
   RAIA S, 1989, LANCET, V2, P497
   Testa G, 2008, TRANSPLANTATION, V85, P681, DOI 10.1097/TP.0b013e3181665172
   *UN ORG SHAR, 2004, UNOS ANN REP BAS ORG
   Wojcicki M, 2007, TRANSPL P, V39, P2781, DOI 10.1016/j.transproceed.2007.08.066
NR 22
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPL P
JI Transplant. Proc.
PD NOV
PY 2009
VL 41
IS 9
BP 3775
EP 3778
DI 10.1016/j.transproceed.2009.05.035
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 524DL
UT WOS:000272123900048
PM 19917386
DA 2020-12-16
ER

PT J
AU Lopes, MHBD
   Ortega, NRS
   Massad, E
   Marin, HD
AF Baena De Moraes Lopes, Maria Helena
   Siqueira Ortega, Neli Regina
   Massad, Eduardo
   Marin, Heimar De Fatima
TI Model for Differential Nursing Diagnosis of Alterations in Urinary
   Elimination Based on Fuzzy Logic
SO CIN-COMPUTERS INFORMATICS NURSING
LA English
DT Article
DE Clinical; Decision support systems; Differential Diagnosis; Fuzzy logic;
   Nursing diagnosis; Urinary incontinence
ID EXPERT-SYSTEM; INCONTINENCE
AB Nursing diagnoses associated with alterations of urinary elimination require different interventions, Nurses, who are not specialists, require support to diagnose and manage patients with disturbances of urine elimination. The aim of this study was to present a model based on fuzzy logic for differential diagnosis of alterations in urinary elimination, considering nursing diagnosis approved by the North American Nursing Diagnosis Association, 2001-2002. Fuzzy relations and the maximum-minimum composition approach were used to develop the system. The model performance was evaluated with 195 cases from the database of a previous study, resulting in 79.0% of total concordance and 19.5% of partial concordance, when compared with the panel of experts. Total discordance was observed in only three cases (1.5%). The agreement between model and experts was excellent (kappa = 0.98, P < .0001) or substantial (kappa = 0.69, P < .0001) when considering the overestimative accordance (accordance was considered when at least one diagnosis was equal) and the underestimative discordance (discordance was considered when at least one diagnosis was different), respectively. The model herein presented showed good performance and a simple theoretical structure, therefore demanding few computational resources.
C1 [Baena De Moraes Lopes, Maria Helena] Univ Estadual Campinas, Fac Med Sci, Dept Nursing, Campinas, SP, Brazil.
   [Siqueira Ortega, Neli Regina; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Marin, Heimar De Fatima] Univ Fed Sao Paulo, Dept Nursing, Sao Paulo, Brazil.
RP Lopes, MHBD (corresponding author), Rua Conceicao,552 Apto,25 Cambui, BR-13010050 Campinas, SP, Brazil.
EM mhbaena@fcm.unicamp.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Ortega,
   Neli/C-6494-2013
OI Massad, Eduardo/0000-0002-7200-2916; Lopes, Maria Helena Baena de
   Moraes/0000-0001-7747-1140
FU Informatics for Global Health [1 1 D43 TW7015-01]; Fogarty International
   CenterUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC);
   NLMUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM);
   NIBIBUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Biomedical
   Imaging & Bioengineering (NIBIB); NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA; National
   Council of Scientific and Technological Development (Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico-CNPq)National Council for
   Scientific and Technological Development (CNPq); FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW007015, D43TW007015, D43TW007015, D43TW007015, D43TW007015,
   D43TW007015, D43TW007015, D43TW007015, D43TW007015, D43TW007015,
   D43TW007015] Funding Source: NIH RePORTER
FX This work was supported in part by a grant from Informatics for Global
   Health (1#1 D43 TW7015-01), Fogarty International Center, NLM, NIBIB,
   NIH (principal investigator, Dr Lucila Ohno Machado). It is also
   supported by the National Council of Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPq).
CR ABEL M, 1998, SISTEMAS ESPECIALIST
   ABRAMS P, 1988, SCAND J UROL NEPHROL, P5
   Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4
   AMENDOLA CS, SISTEMAS ESPECIALIST
   Lopes MHBD, 2005, REV BRAS ENFERM, V58, P27, DOI 10.1590/S0034-71672005000100005
   Brenner B, 1997, NEW ZEAL MED J, V110, P425
   CARPENTINO LJ, 1997, NURSING DIAGNOSIS AP
   Cruz Diná de Almeida Lopes Monteiro da, 2005, Rev. Latino-Am. Enfermagem, V13, P415, DOI 10.1590/S0104-11692005000300017
   Davis G, 1999, MIL MED, V164, P182
   Gallo M L, 1997, Nurse Pract, V22, P21
   Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8
   Im Eun-Ok, 2003, Nurs Philos, V4, P53, DOI 10.1046/j.1466-769X.2003.00116.x
   Ishiko O, 2000, INT J GYNECOL OBSTET, V68, P131, DOI 10.1016/S0020-7292(99)00182-4
   KLIR GJ, 1995, FUZZY SETS FUZZY LOG, P355
   LAKE S, 2000, ONE STEP EVOLUTION T, P468
   LANDIS JR, 1977, BIOMETRICS, V33, P174
   Laurikkala J, 1999, METHOD INFORM MED, V38, P125
   Laurikkala J, 2001, COMPUT BIOL MED, V31, P239, DOI 10.1016/S0010-4825(01)00003-8
   Laurikkala J, 1998, COMPUT METH PROG BIO, V55, P217, DOI 10.1016/S0169-2607(97)00067-9
   Lopes M H, 1997, Rev Bras Enferm, V50, P163
   LUNNEY M, 2004, PENSAMENTO CRITICO D
   *N AM NURS DIAGN A, 2002, DIAGN ENF NANDA DEF, P101
   Nascimento LFC, 2002, REV SAUDE PUBL, V36, P686, DOI [10.1590/S0034-89102002000700005, 10.1590/s0034-89102002000700005]
   Nobrega MML, 1994, UNIFORMIZACAO LINGUA, P32
   Pedrycz W., 1998, INTRO FUZZY SETS ANA, P465
   Reis R.B., 2003, ACTA CIR BRAS S5, V18, P47
   Reymert Jannike, 1994, Scandinavian Journal of Primary Health Care, V12, P180, DOI 10.3109/02813439409003696
   RISS PA, 1988, J PERINAT MED, V16, P283, DOI 10.1515/jpme.1988.16.4.283
   RISS PA, 1988, INT J BIOMED COMPUT, V22, P217, DOI 10.1016/0020-7101(88)90075-X
   Rolfe G, 1997, J ADV NURS, V25, P1070, DOI 10.1046/j.1365-2648.1997.19970251070.x
   SABBATINI RME, 1992, EXPERTMD MANUAL USO
   Woodtli A, 1995, Nurs Diagn, V6, P135
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
NR 33
TC 6
Z9 6
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1538-2931
EI 1538-9774
J9 CIN-COMPUT INFORM NU
JI CIN-Comput. Inform. Nurs.
PD SEP-OCT
PY 2009
VL 27
IS 5
BP 324
EP 329
DI 10.1097/NCN.0b013e3181b21e6d
PG 6
WC Computer Science, Interdisciplinary Applications; Medical Informatics;
   Nursing
SC Computer Science; Medical Informatics; Nursing
GA 495UL
UT WOS:000269920400008
PM 19726927
DA 2020-12-16
ER

PT J
AU Amaku, M
   Azevedo, RS
   de Castro, RM
   Massad, E
   Coutinho, FAB
AF Amaku, Marcos
   Azevedo, Raymundo Soares
   de Castro, Ruy Morgado
   Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
TI Relationship among epidemiological parameters of six childhood
   infections in a non-immunized Brazilian community
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE seroprevalence; viral diseases; epidemiology; average age; force of
   infection; Monte Carlo method
ID RESPIRATORY SYNCYTIAL VIRUS; SAO-PAULO STATE; RIO-DE-JANEIRO;
   VACCINATION STRATEGY; RUBELLA; TRANSMISSION; VARICELLA; INFANTS;
   MEASLES; MUMPS
AB Epidemiological parameters, such as age-dependent force of infection and average age at infection ((a) over bar) were estimated for rubella, varicella, rotavirus A, respiratory syncytial virus, hepatitis A and parvovirus B19 infections for a non-immunized Brazilian community, using the same sera samples. The (a) over bar for the aforementioned diseases were 8.45 years (yr) [95% CI: (7.23, 9.48) yr], 3.90 yr [95% CI: (3.51, 4.28) yr], 1.03 yr [95% CI: (0.96, 1.09) yr], 1.58 yr [95% CI: (1.39, 1.79) yr], 7.17 yr [95% CI: (6.48, 7.80) yr] and 7.43 yr [95% CI: (5.68, 9.59) yr], respectively. The differences between average ages could be explained by factors such as differences in the effectiveness of the protection conferred to newborns by maternally derived antibodies, competition between virus species and age-dependent host susceptibility. Our seroprevalence data may illustrate a case of the above-mentioned mechanisms working together within the same population.
C1 [Amaku, Marcos] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Fac Vet Med & Zootecnia, BR-05508270 Sao Paulo, Brazil.
   [Azevedo, Raymundo Soares; Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Hosp Clin, Dept Patol LIM 01, Fac Med, BR-05508270 Sao Paulo, Brazil.
   [de Castro, Ruy Morgado] Inst Estudos Avancados, Sao Jose Dos Campos, SP, Brazil.
RP Amaku, M (corresponding author), Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Fac Vet Med & Zootecnia, Av Prof Dr Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, Brazil.
EM amaku@usp.br
RI Castro, Ruy/X-1078-2018; Massad, Eduardo/H-6143-2011; Azevedo, Raymundo
   S/B-7593-2008; Coutinho, Francisco A B/H-5644-2011; Massad,
   Eduardo/B-1169-2012; Amaku, Marcos/D-5252-2012
OI Castro, Ruy/0000-0001-6873-9854; Azevedo, Raymundo
   S/0000-0003-0660-2371; Coutinho, Francisco A B/0000-0003-3127-3071;
   Massad, Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX Financial support: CNPq, FAPESP
CR Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   AZEVEDONETO RS, 1994, EPIDEMIOL INFECT, V113, P161
   Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012
   CANDEIAS J A N, 1989, Journal of Diarrhoeal Diseases Research, V7, P24
   Collins P. L., 2007, FIELDS VIROLOGY, P1601
   Cox MJ, 1998, EPIDEMIOL INFECT, V120, P327, DOI 10.1017/S0950268898008759
   Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2
   de Almeida LM, 2002, T ROY SOC TROP MED H, V96, P605, DOI 10.1016/S0035-9203(02)90325-1
   Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126
   Huatuco EMM, 2008, REV SAUDE PUBL, V42, P443, DOI [10.1590/S0034-89102008005000019, 10.1590/S0034-89102008000300008]
   Knipe D., 2007, FIELDS VIROLOGY
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   NASCIMENTO JP, 1990, REV I MED TROP, V32, P41, DOI 10.1590/S0036-46651990000100007
   Press WH, 1992, NUMERICAL RECIPES C
   Souza Vanda A. U. F., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P373, DOI 10.1590/S0036-46651994000400011
   Valentim J, 2008, VACCINE, V26, P6281, DOI 10.1016/j.vaccine.2008.07.021
   Vieira SE, 2007, CLINICS, V62, P709, DOI 10.1590/S1807-59322007000600009
   Yu ALF, 2001, EPIDEMIOL INFECT, V127, P493, DOI 10.1017/S0950268801006124
NR 21
TC 8
Z9 8
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2009
VL 104
IS 6
BP 897
EP 900
DI 10.1590/S0074-02762009000600013
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 514VT
UT WOS:000271424800013
PM 19876563
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Coutinho, FAB
   Massad, E
AF Burattini, M. N.
   Coutinho, F. A. B.
   Massad, E.
TI A hypothesis for explaining single outbreaks (like the Black Death in
   European cities) of vector-borne infections
SO MEDICAL HYPOTHESES
LA English
DT Article
ID CHIKUNGUNYA
AB We propose a mechanism by which single outbreaks of vector-borne infections can happen even when the value of the basic reproduction number, R-o, of the infection is below one. With this hypothesis we have shown that dynamical models simulations demonstrate that the arrival of a relatively small (with respect to the host population) number of infected vectors can trigger a short-lived epidemic but with a huge number of cases. These episodes are characterized by a sudden outbreak in a previously virgin area that last from weeks to a few months, and then disappear without leaving vestiges.
   The hypothesis proposed in this paper to explain those single outbreaks of vector-borne infections, even when total basic reproduction number, Ro, is less than one (which explain the fact that those infections fail to establish themselves at endemic levels), is that the vector-to-host component of Ro is greater than one and that a sufficient amount of infected vectors are imported to the vulnerable area, triggering the outbreak.
   We tested the hypothesis by performing numerical simulations that reproduce the observed outbreaks of chikungunya in Italy in 2007 and the plague in Florence in 1348.
   The theory proposed provides an explanation for isolated outbreaks of vector-borne infections, ways to calculate the size of those outbreaks from the number of infected vectors arriving in the affected areas. Given the ever-increasing worldwide transportation network, providing a high degree of mobility from endemic to virgin areas, the proposed mechanism may have important implications for public health planning. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Burattini, M. N.; Coutinho, F. A. B.; Massad, E.] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, SP, Brazil.
   [Burattini, M. N.; Coutinho, F. A. B.; Massad, E.] Univ Sao Paulo, HCFMUSP, LIM01, BR-05405000 Sao Paulo, SP, Brazil.
   [Massad, E.] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; 
CR CIMERMAN S, 1997, BRAZ J INFECT DIS, V1, P135
   Coutinho FAB, 2006, BIOMAT 2005, P213, DOI 10.1142/9789812773685_0013
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Kamath Sandhya, 2006, J Assoc Physicians India, V54, P725
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ZIEGLER P, 1984, BLACK DEATH
NR 11
TC 1
Z9 1
U1 0
U2 16
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD JUL
PY 2009
VL 73
IS 1
BP 110
EP 114
DI 10.1016/j.mehy.2009.01.036
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 452ZG
UT WOS:000266579100034
PM 19264416
DA 2020-12-16
ER

PT J
AU Massad, E
   Wilder-Smith, A
AF Massad, Eduardo
   Wilder-Smith, Annelies
TI Risk Estimates of Dengue in Travelers to Dengue Endemic Areas Using
   Mathematical Models
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
ID ILL RETURNED TRAVELERS; EPIDEMIOLOGY; FEVER
AB Dengue has emerged as a frequent problem in international travelers. The risk depends on destination, duration, and season of travel. However, data to quantify the true risk for travelers to acquire dengue are lacking.
   We used mathematical models to estimate the risk of nonimmune persons to acquire dengue when traveling to Singapore. From the force of infection, we calculated the risk of dengue dependent on duration of stay and season of arrival.
   Our data highlight that the risk for nonimmune travelers to acquire dengue in Singapore is substantial but varies greatly with seasons and epidemic cycles. For instance, for a traveler who stays in Singapore for 1 week during the high dengue season in 2005, the risk of acquiring dengue was 0.17%, but it was only 0.00423% during the low season in a nonepidemic year such as 2002.
   Risk estimates based on mathematical modeling will help the travel medicine provider give better evidence-based advice for travelers to dengue endemic countries.
C1 [Wilder-Smith, Annelies] Natl Univ Singapore, Travellers Screening & Vaccinat Clin, Dept Med, Singapore 119074, Singapore.
   [Massad, Eduardo] Univ Sao Paulo, Sao Paulo, Brazil.
RP Wilder-Smith, A (corresponding author), Natl Univ Singapore, Travellers Screening & Vaccinat Clin, Dept Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
EM epvws@pacific.net.sg
RI Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Wilder-Smith,
   Annelies/0000-0003-0362-5375
CR BURATTINI MN, 2007, EPIDEMIOL INFECT, V15, P1
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   O'Brien D, 2001, CLIN INFECT DIS, V33, P603, DOI 10.1086/322602
   Potasman I, 1999, EMERG INFECT DIS, V5, P824, DOI 10.3201/eid0506.990615
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   STEFFEN R, 1994, JAMA-J AM MED ASSOC, V272, P885, DOI 10.1001/jama.272.11.885
   Stienlauf S, 2005, J TRAVEL MED, V12, P136, DOI 10.2310/7060.2005.12308
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   TOURISM SECTOR PERFO
NR 13
TC 34
Z9 34
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD MAY-JUN
PY 2009
VL 16
IS 3
BP 191
EP 193
DI 10.1111/j.1708-8305.2009.00310.x
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA 445DK
UT WOS:000266029700006
PM 19538580
OA Bronze
DA 2020-12-16
ER

PT J
AU Mondini, A
   Bronzoni, RVD
   Nunes, SHP
   Neto, FC
   Massad, E
   Alonso, WJ
   Lazzaro, ESM
   Ferraz, AA
   Zanotto, PMD
   Nogueira, ML
AF Mondini, Adriano
   de Moraes Bronzoni, Roberta Vieira
   Pereira Nunes, Silvia Helena
   Chiaravalloti Neto, Francisco
   Massad, Eduardo
   Alonso, Wladimir J.
   Lazzaro, Eduardo S. M.
   Ferraz, Amena Alcantara
   de Andrade Zanotto, Paolo Marinho
   Nogueira, Mauricio Lacerda
TI Spatio-Temporal Tracking and Phylodynamics of an Urban Dengue 3 Outbreak
   in Sao Paulo, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; MOLECULAR EPIDEMIOLOGY; VIRUS CIRCULATION; YELLOW-FEVER;
   TRANSMISSION; DISPERSAL; POPULATION; EVOLUTION; TYPE-2; STATE
AB The dengue virus has a single-stranded positive-sense RNA genome of similar to 10.700 nucleotides with a single open reading frame that encodes three structural (C, prM, and E) and seven nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins. It possesses four antigenically distinct serotypes (DENV 1-4). Many phylogenetic studies address particularities of the different serotypes using convenience samples that are not conducive to a spatio-temporal analysis in a single urban setting. We describe the pattern of spread of distinct lineages of DENV-3 circulating in Sao Jose do Rio Preto, Brazil, during 2006. Blood samples from patients presenting dengue-like symptoms were collected for DENV testing. We performed M-N-PCR using primers based on NS5 for virus detection and identification. The fragments were purified from PCR mixtures and sequenced. The positive dengue cases were geo-coded. To type the sequenced samples, 52 reference sequences were aligned. The dataset generated was used for iterative phylogenetic reconstruction with the maximum likelihood criterion. The best demographic model, the rate of growth, rate of evolutionary change, and Time to Most Recent Common Ancestor (TMRCA) were estimated. The basic reproductive rate during the epidemics was estimated. We obtained sequences from 82 patients among 174 blood samples. We were able to geo-code 46 sequences. The alignment generated a 399-nucleotide-long dataset with 134 taxa. The phylogenetic analysis indicated that all samples were of DENV-3 and related to strains circulating on the isle of Martinique in 2000-2001. Sixty DENV-3 from Sao Jose do Rio Preto formed a monophyletic group (lineage 1), closely related to the remaining 22 isolates (lineage 2). We assumed that these lineages appeared before 2006 in different occasions. By transforming the inferred exponential growth rates into the basic reproductive rate, we obtained values for lineage 1 of R-0 = 1.53 and values for lineage 2 of R-0 = 1.13. Under the exponential model, TMRCA of lineage 1 dated 1 year and lineage 2 dated 3.4 years before the last sampling. The possibility of inferring the spatio-temporal dynamics from genetic data has been generally little explored, and it may shed light on DENV circulation. The use of both geographic and temporally structured phylogenetic data provided a detailed view on the spread of at least two dengue viral strains in a populated urban area.
C1 [Mondini, Adriano; de Moraes Bronzoni, Roberta Vieira; Pereira Nunes, Silvia Helena; Chiaravalloti Neto, Francisco; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Chiaravalloti Neto, Francisco] Superintendencia Controle Endemias, Sao Jose Do Rio Preto, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Fac Med, LIM HCFMUSP 01, Sao Paulo, Brazil.
   [Alonso, Wladimir J.] NIH, Forgarty Int Ctr, Bethesda, MD 20892 USA.
   [Lazzaro, Eduardo S. M.; Ferraz, Amena Alcantara] Secretaria Municipal Saude & Higiene Sao Jose do, Sao Jose Do Rio Preto, Brazil.
   [de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, LEMB, BR-05508 Sao Paulo, Brazil.
RP Mondini, A (corresponding author), Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil.
EM mauricio.nogueira@pq.cnpq.br
RI Mondini, Adriano/F-7446-2012; Massad, Eduardo/H-6143-2011; de A.
   Zanotto, Paolo M./B-9286-2019; Massad, Eduardo/B-1169-2012; Mondini,
   Adriano/AAB-4358-2020; Neto, Francisco Chiaravalloti/F-8006-2012;
   Nogueira, Mauricio L/B-7599-2012; Bronzoni, Roberta/J-8917-2012
OI Mondini, Adriano/0000-0002-5557-9721; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Massad, Eduardo/0000-0002-7200-2916; Mondini,
   Adriano/0000-0002-5557-9721; Neto, Francisco
   Chiaravalloti/0000-0003-2686-8740; Nogueira, Mauricio
   L/0000-0003-1102-2419; Alonso, Wladimir/0000-0001-7038-0801
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [04/11098-2, 06/01070-9]; FINEPCiencia Tecnologia e Inovacao (FINEP);
   CAPESCAPES
FX This work was supported by FAPESP grants to MLN (04/11098-2) and FCN
   (06/01070-9). MLN is supported by a FINEP grant (Genprot DENGUE). RVMB
   is a recipient of a FAPESP fellowship. AM is a recipient of a CAPES
   scholarship. This work is s supported in part by the Viral Genetic
   Diversity Network (FAPESP). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANDERSON R M, 1991
   Bartley LM, 2002, EPIDEMIOL INFECT, V128, P213, DOI 10.1017/S0950268801006495
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CHRISTOPHERS R, 1960, AEDES AEGYPTI YELLOW, P738
   Coelho FC, 2008, CAD SAUDE PUBLICA, V24, P853, DOI 10.1590/S0102-311X2008000400016
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   *CVE, 2008, CONF AUT DENG CAS PE
   da Costa AIP, 1998, REV SAUDE PUBL, V32, P232, DOI 10.1590/S0034-89101998000300005
   Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004
   DRUMMOND AJ, 2006, BEAST 1 4
   Espinoza-Gomez F, 2003, SALUD PUBLICA MEXICO, V45, P365, DOI 10.1590/s0036-36342003000500006
   Ferreira AC, 2007, REV SAUDE PUBL, V41, P915, DOI 10.1590/S0034-89102007000600005
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Galli B, 2008, REV SAUDE PUBL, V42, P656, DOI [10.1590/S0034-89102008005000032, 10.1590/s0034-89102008000400011]
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Innis Bruce L., 1995, P103
   Jarman RG, 2008, J VIROL, V82, P5494, DOI 10.1128/JVI.02728-07
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   MANTEL N, 1967, CANCER RES, V27, P209
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Monath TP, 1996, FIELDS VIROLOGY, P961
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Mondini A, 2007, REV SAUDE PUBL, V41, P922
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   *PAHO, 2008, 2007 NUMB REP CAS DE
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Salda LTD, 2005, AM J TROP MED HYG, V73, P796, DOI 10.4269/ajtmh.2005.73.796
   Schultz George W., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P369
   Swofford D. L., 2002, PAUP PHYLOGENETIC AN
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   *WHO, 1999, STRENGTH IMPL GLOB S
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Zaki A, 2008, TROP MED INT HEALTH, V13, P584, DOI 10.1111/j.1365-3156.2008.02037.x
   ZANOTTO PMA, 2002, MOL EPIDEMIOLOGY HUM, P167
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
   Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0
   Zwickl D.J., 2006, GENETIC ALGORITHM AP
NR 56
TC 49
Z9 50
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2009
VL 3
IS 5
AR e448
DI 10.1371/journal.pntd.0000448
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 461LH
UT WOS:000267268000017
PM 19478848
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Chaib, E
   Burattini, MN
AF Massad, E.
   Coutinho, F. A. B.
   Chaib, E.
   Burattini, M. N.
TI Cost-effectiveness analysis of a hypothetical hepatitis C vaccine
   compared to antiviral therapy
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Basic reproduction number; cost-effectiveness analysis; hepatitis C;
   modelling; vaccination
ID SAO-PAULO; INFECTION; VIRUS; HCV; PERSISTENCE; BEHAVIOR; HIV
AB We propose a mathematical model to simulate the dynamics of hepatitis C virus (HCV) infection in the state of Sao Paulo, Brazil. We assumed that a hypothetical vaccine, which cost was taken to be the initial cost of the vaccine against hepatitis B exists and it is introduced in the model. We computed its cost-effectiveness compared with the anti-HCV therapy. The calculated basic reproduction number was 1.20. The model predicts that without intervention a steady state exists with an HCV prevalence of 3%, in agreement with the Current epidemiological data. Starting from this steady state three interventions were simulated: indiscriminate vaccination, selective vaccination and anti-HCV therapy. Selective vaccination proved to be the strategy with the best cost-effectiveness ratio, followed by indiscriminate vaccination and anti-HCV therapy.
C1 [Massad, E.; Coutinho, F. A. B.; Burattini, M. N.] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Massad, E.; Coutinho, F. A. B.; Chaib, E.; Burattini, M. N.] HCFMUSP, LIM01, Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
   [Chaib, E.] Univ Oxford, Oxford, England.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455,7382, BR-01246903 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Burattini,
   Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071
CR Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505
   Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371
   Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   CHAIB E, 2004, HEPATOCELLULAR CARCI
   Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076
   CROFTS N, 1999, TECHNICAL REPORT SER, V3
   GAYOTTO LCC, 2001, DOENCAS FIGADO VIAS
   HOOFNAGLE JH, 2002, HEPATOLOGY, V36, P521
   Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081
   Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x
   *NIH, 2000, NIH CONS STAT REC, V75, P18
   Poynard T, 2000, BEST PRACT RES CL GA, V14, P211, DOI 10.1053/bega.1999.0071
   Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321
   Saltelli A., 2000, SENSITIVITY ANAL GAU
   Schinaia G, 2005, ADV COMPLEX SYST, V8, P33, DOI 10.1142/S021952590500035X
   SILVA LC, 2001, LIVER BILIARY TRACT, P470
   Strazza L, 2007, CAD SAUDE PUBLICA, V23, P197, DOI 10.1590/S0102-311X2007000100021
   WHO, 2000, WKLY EPIDEMIOL REC, V75, P18
   WONG JB, 1999 ANN M
NR 25
TC 19
Z9 19
U1 0
U2 11
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD FEB
PY 2009
VL 137
IS 2
BP 241
EP 249
DI 10.1017/S0950268808000873
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 399BG
UT WOS:000262774800015
PM 18631422
DA 2020-12-16
ER

PT S
AU dos Santos, FD
   Ortega, NRS
   Zanetta, DMT
   Massad, E
AF dos Santos, Fabiano de Sant'Ana
   Siqueira Ortega, Neli Regina
   Trevisan Zanetta, Dirce Maria
   Massad, Eduardo
BE LambertTorres, G
   Abe, JM
   Filo, JID
   Martins, HG
TI Fuzzy Dynamical Model of Epidemic Spreading Taking into Account the
   Uncertainties in Individual Infectivity
SO ADVANCES IN TECHNOLOGICAL APPLICATIONS OF LOGICAL AND INTELLIGENT SYSTEM
SE Frontiers in Artificial Intelligence and Applications
LA English
DT Proceedings Paper
CT 6th Congress of Logic Applied to Technology
CY NOV 21-23, 2007
CL Santos, BRAZIL
DE Fuzzy logic; Fuzzy epidemic; Reed-Frost; Epidemiological models
ID FINAL SIZE DISTRIBUTION; POPULATION
AB In this paper we present a fuzzy approach to the Reed-Frost model for epidemic spreading taking into account uncertainties in the diagnostic of the infection. The heterogeneities in the infected group is based on the clinical signals of the individuals (symptoms, laboratorial exams, medical findings, etc.), which are incorporated to the dynamic of the epidemic. The infectivity level is time-varying and the classification of the individuals is performed through fuzzy relations. Simulations considering a real problem data of the influenza epidemic in the baby daycare are performed and the results are compared with a stochastic Reed-Frost generalization developed by the authors in a previous work.
C1 [dos Santos, Fabiano de Sant'Ana; Trevisan Zanetta, Dirce Maria] Sch Med Sao Jose do Rio Preto, Dept Epidemiol & Publ Hlth, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP dos Santos, FD (corresponding author), Sch Med Sao Jose do Rio Preto, Dept Epidemiol & Publ Hlth, Av Brigadeiro Faria Lima 5-416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RI Ortega, Neli/C-6494-2013; Zanetta, Dirce M T/G-4950-2013; Massad,
   Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ABBEY HELEN, 1952, HUMAN BIOL, V24, P201
   Barros LC, 2000, ECOL MODEL, V128, P27, DOI 10.1016/S0304-3800(99)00223-9
   BARROS LC, 2003, COMPUT MATH APPL, V45, P1619, DOI DOI 10.1016/S0898-1221(03)00141-X
   Jafelice RM, 2004, B MATH BIOL, V66, P1597, DOI 10.1016/j.bulm.2004.03.002
   LEFEVRE C, 1990, ADV APPL PROBAB, V22, P25, DOI 10.2307/1427595
   MAIA JOC, 1952, HUM BIOL, V24, P167
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   MENEZES RX, 2004, B MATH BIOL, V66, P689
   Ortega N, 2003, KYBERNETES, V32, P460, DOI 10.1108/03684920310463876
   Ortega NRS, 2000, KYBERNETES, V29, P201, DOI 10.1108/03684920010312768
   Pearson DW, 1997, APPL MATH LETT, V10, P99, DOI 10.1016/S0893-9659(97)00043-8
   PICARD P, 1991, MATH BIOSCI, V107, P225, DOI 10.1016/0025-5564(91)90006-5
   SCALIATOMBA G, 1986, J APPL PROBAB, V23, P563, DOI 10.2307/3213998
   SEIKKALA S, 1987, FUZZY SET SYST, V24, P319, DOI 10.1016/0165-0114(87)90030-3
NR 15
TC 0
Z9 0
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6389
BN 978-1-58603-936-3
J9 FR ART INT
PY 2009
VL 186
BP 180
EP 193
DI 10.3233/978-1-58603-936-3-180
PG 14
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
SC Computer Science
GA BMT85
UT WOS:000273559500010
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Coutinho, FAB
AF Massad, E.
   Burattini, M. N.
   Coutinho, F. A. B.
BE Mondaini, RP
TI MODELING THE RISK OF FALCIPARUM MALARIA FOR TRAVELERS TO HOLOENDEMIC
   REGIONS
SO BIOMAT 2008
LA English
DT Proceedings Paper
CT International Symposium on Mathematical and Computational Biology
CY NOV 22-27, 2008
CL Campos do Jordao, BRAZIL
SP CAPES, Natl Res Council, PETROBRAS Oil Co, PETROBRAS - CENPES Res Ctr
ID DENGUE
AB Malaria has emerged as a frequent problem in international travelers. The risk depends on destination, duration and season of travel. However, data to quantify the true risk for travelers to acquire malaria are lacking. Methods: We used mathematical models to estimate the risk of non-immune persons to acquire malaria when traveling to the Amazon region. From the force of infection we calculated the risk of dengue dependent on duration of stay and season of arrival. Our data highlight that the risk for non-immune travelers to acquire malaria in the Amazon region is substantial but varies greatly with seasons and epidemic cycles. For instance, for a traveler who stays in the Amazon for 120 days during the high season, the risk of acquiring malaria was 0.16%. Risk estimates based on mathematical modelling will help the travel medicine provider give better evidence based advice for travelers to malarial countries.
C1 [Massad, E.; Burattini, M. N.; Coutinho, F. A. B.] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; 
CR Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   *FUNASA, 2001, MAN TER MAL
   Garnham P. C. C., 1988, Malaria: principles and practice of malariology. Volume 1., P61
   House HR, 2008, EMERG MED CLIN N AM, V26, P499, DOI 10.1016/j.emc.2008.01.008
   KROGSTAD DJ, 1999, TROPICAL INFECT DIS, P736
   LADISLAW JLB, 2006, SITUACAO MALARIA AMA
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Tada Yuki, 2008, Travel Med Infect Dis, V6, P368, DOI 10.1016/j.tmaid.2008.08.002
   White N. J., 1996, Manson's tropical diseases., P1087
   *WHO, 2004, BAS FACTS MAL
   WYSE APP, 2007, THESIS LAB NACL COMP
NR 14
TC 0
Z9 0
U1 0
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
PY 2009
BP 211
EP 222
DI 10.1142/9789814271820_0013
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BMO60
UT WOS:000273131300013
DA 2020-12-16
ER

PT J
AU Cohen, C
   Kelian, RL
   Oliveira, RA
   Gobbetti, GJ
   Massad, E
AF Cohen, Claudio
   Kelian, Rogerio L'Abbate
   Oliveira, Reinaldo Ayer
   Gobbetti, Gisele Joana
   Massad, Eduardo
TI SEXUAL HARASSMENT IN THE PHYSICIAN-PATIENT INTERACTION: ANALYSIS OF
   CHARGES AGAINST DOCTORS IN THE STATE OF SAO PAULO
SO CLINICS
LA English
DT Article
DE Sexual harassment; Sexual abuse; Physician-patient relationship; Medical
   errors; Physician impairment
ID CONTACT
AB OBJECTIVE: This research intends to discuss sexual harassment within the doctor-patient relationship based on four parameters: doctor's characteristics, accuser's characteristics, accusation characteristics, and the evaluation by the Medicine Council of Sao Paulo.
   METHOD: It is a descriptive, quantitative approach using a retrospective documental analysis. Studied subjects were doctors who were allegedly engaged in sexual harassment. This analysis considered all accusations made from January 2000 to December 2005 (n=150).
   RESULTS: For this type of sexual abuse, there was a prevalence of male professionals (96.6%) who committed abuse against female patients (90.3%) during adulthood (77.7%). The mean age of the accused was 46.87 years, ranging from 30-76 years, concentrated between 46-75 years. The intrinsic difficulty of understanding sexual harassment by a professional constrained ethical evaluation of the cases, with 24.1% of the cases being considered proceeding charges by the professional council. When the cases were recognized as proceeding, they were either filed (88.2%) or were considered to be ethical infringement (11.8%) becoming Professional Ethical Process (PEP). In the majority of proceeding cases (87%), there was a Police Occurrence Report enclosed.
   DISCUSSION AND CONCLUSION: The incidence of sexual abuse by professionals was independent of education, as the accused professionals came from a large variety of medical colleges, without significant differences related to institution. The predominance of accusations against older professionals may occur due to the frail personality structure that allows professional acting out. Objective evidence is very important in ethical evaluations compared to psychological and subjective evidence.
C1 [Cohen, Claudio; Kelian, Rogerio L'Abbate; Oliveira, Reinaldo Ayer; Gobbetti, Gisele Joana; Massad, Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
RP Cohen, C (corresponding author), Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
EM ccohen@usp.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR American Medical Association, 2007, AMA COD MED ETH
   Balint M., 1975, MED SEU PACIENTE DOE
   Bissoli Sidney da Silva Pereira, 2006, Paidéia (Ribeirão Preto), V16, P19, DOI 10.1590/S0103-863X2006000100004
   Caprara Andrea, 2004, Ciênc. saúde coletiva, V9, P139, DOI 10.1590/S1413-81232004000100014
   CLEMENT E, 1997, DICIONARIO PRATICO F
   *COD PEN BRAS, 2009, CRIM CONTR COST MAUS
   COHEN C, 1999, BIOETICA SEXUALIDADE
   COHEN C, 1993, INCESTO DESEJO
   COHEN C, 2002, BIOETICA, P86
   *CONS FED MED, 1998, COD ET MED
   CORREA CP, 2003, COGITO, V5, P31
   *COS REG MED EST S, 2007, DISP
   FARLEY MA, 1995, ENCY BIOETHICS
   Fortune MM, 1983, SEXUAL VIOLENCE UNME
   FOUCAULT M, 1990, GUILHON ALBUQUERQUE
   FOUCAULT M, 1988, TRAD M THEREZA COSTA
   FREUD S, 1980, OBRAS PSICOLOGICASS, V12
   FREUD S, 1974, FUTURO ILUSAO MAL ES
   Freud S, 1905, OBRAS PSICOLOGICAS C, V7
   GARTRELL N, 1986, AM J PSYCHIAT, V143, P1126
   GOMES JM, 2004, THESIS FACULDADE MED
   Helman C., 1984, CULTURE HLTH ILLNESS
   KARDENER SH, 1973, AM J PSYCHIAT, V130, P1077, DOI 10.1176/ajp.130.10.1077
   Laplanche Jean, 1988, VOCABULARIO PSICANAL
   Levi-Strauss C., 2003, ESTRUTURAS ELEMENTAR
   LIMBERT J, 1991, ONTARIO MED REV, V58, P9
   MCMURRAY RJ, 1991, JAMA-J AM MED ASSOC, V266, P2741, DOI 10.1001/jama.1991.03470190089035
   POPE KS, 1986, AM J PSYCHOTHER, V40, P564
   POPE KS, 1986, SEXUAL INTIMACY THER
   1976, DIALOGOS TRADUCAO J
NR 30
TC 3
Z9 3
U1 0
U2 3
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
J9 CLINICS
JI Clinics
PY 2009
VL 64
IS 11
BP 1075
EP 1083
DI 10.1590/S1807-59322009001100007
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 529AI
UT WOS:000272487700006
PM 19936181
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Wilder-Smith, A
   Chen, LH
   Massad, E
   Wilson, ME
AF Wilder-Smith, Annelies
   Chen, Lin H.
   Massad, Eduardo
   Wilson, Mary E.
TI Threat of Dengue to Blood Safety in Dengue-Endemic Countries
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; NOSOCOMIAL TRANSMISSION; HEMORRHAGIC-FEVER; NEW-YORK;
   TRANSFUSION; EPIDEMIC; DISEASES; VIREMIA; DONOR; RNA
AB Dengue, the most common arbovirus infection globally, is transmitted by mosquito vectors. Healthcare-related transmission, including transmission by blood products, has been documented, although the frequency of these occurrences is unknown. Dengue is endemic to Singapore, a city-state in Asia. Using mathematical modeling, we estimated the risk for dengue-infected blood transfusions in Singapore in 2005 to be 1.625-6/10,000 blood transfusions, assuming a ratio of asymptomatic to symptomatic infections of 2:1 to 10:1. However, the level of viremia required to cause clinical dengue cases is person-dependent and unknown. Further studies are needed to establish the magnitude of the threat that dengue poses to blood safety in countries where it is endemic. It will then be possible to assess whether screening is feasible and to identify approaches that are most cost-effective on the basis of characteristics of local populations and seasonality of dengue.
C1 [Wilder-Smith, Annelies] Natl Univ Singapore, Dept Med, Singapore 119407, Singapore.
   [Chen, Lin H.; Wilson, Mary E.] Harvard Univ, Sch Med, Boston, MA USA.
   [Wilson, Mary E.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.
   [Chen, Lin H.; Wilson, Mary E.] Mt Auburn Hosp, Cambridge, MA USA.
   [Massad, Eduardo] Univ Sao Paulo, Sao Paulo, Brazil.
RP Wilder-Smith, A (corresponding author), Natl Univ Singapore, Dept Med, Singapore 119407, Singapore.
EM epvws@pacific.net.sg
RI Massad, Eduardo/H-6143-2011; Wilder-Smith, Annelies/F-8751-2015; Massad,
   Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916; Wilder-Smith,
   Annelies/0000-0003-0362-5375; Chen, Lin/0000-0002-5684-8436
CR BERRY G. P., 1931, American Journal of Tropical Medicine, V11, P365
   Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   CDC, 2004, MMWR-MORBID MORTAL W, V53, P738
   *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P281
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1133
   Chen H, 2004, INT J PSYCHOL, V39, P60
   Chen L. H., 2005, Dengue Bulletin, V29, P18
   Chen LH, 2005, EMERG INFECT DIS, V11, P775, DOI 10.3201/eid1105.040934
   COOK GC, 1994, T ROY SOC TROP MED H, V88, P712, DOI 10.1016/0035-9203(94)90244-5
   de Wazieres B, 1998, LANCET, V351, P498, DOI 10.1016/S0140-6736(05)78686-4
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   HAMISH M, 2007, 56 ANN M AM SOC TROP
   HIRSCH JF, 1990, ANN MED INTERNE, V141, P629
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Langgartner J, 2002, J INFECTION, V44, P269, DOI 10.1053/jinf.2002.0994
   LIN C, 1 DOCUMENTED CASE TR
   LINNEN JB, 2006, ANN M AM ASS BLOOD B, P11
   LOW C, 1931, BRIT MED J, V2, P125
   Ludlam CA, 2006, LANCET, V367, P252, DOI 10.1016/S0140-6736(06)68036-7
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Nemes Z, 2004, EMERG INFECT DIS, V10, P1880, DOI 10.3201/eid1010.040464
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x
   DENGUE VIRUS TRANSFU
NR 36
TC 72
Z9 76
U1 0
U2 11
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2009
VL 15
IS 1
BP 8
EP 11
DI 10.3201/eid1501.071097
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 393AG
UT WOS:000262342700002
PM 19116042
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Garcia, MK
   Capusso, A
   Montans, D
   Massad, E
   Battistella, LR
AF Garcia, M. K.
   Capusso, A.
   Montans, D.
   Massad, E.
   Battistella, L. R.
TI Variations of the articular mobility of elbows, knees and ankles in
   patients with severe haemophilia submitted to free active movimentation
   in a pool with warm water
SO HAEMOPHILIA
LA English
DT Letter
C1 [Garcia, M. K.] Univ Sao Paulo, Div Rehabil Med, Hosp Clin, Sch Med, Sao Paulo, Brazil.
   Univ Sao Paulo, LIM01 HCFMUSP, Sao Paulo, Brazil.
RP Garcia, MK (corresponding author), Univ Sao Paulo, Div Rehabil Med, Hosp Clin, Sch Med, Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Battistella, Linamara Rizzo/I-7347-2019;
   Battistella, Linamara Rizzo/E-5131-2013; Massad, Eduardo/B-1169-2012;
   Garcia, Mauricio/G-6252-2011
OI Battistella, Linamara Rizzo/0000-0001-5275-0733; Massad,
   Eduardo/0000-0002-7200-2916; Garcia, Mauricio/0000-0003-0807-7048
CR BATTISTELLA LR, 1985, MED REABILITACAO HEM, V7, P136
   BECKER BE, 2000, TERAPIA AQUATICA MOD, P20
   CAMPION MR, 1997, HIDROTHERAPY PRINCIP, P7
   Cole AJ, 1997, AQUATIC REHABILITATI, P15
   MARQUES AP, 2003, MANUAL GONIOMETRIA, P81
   MEJIACARVAJAL C, 2008, IMPACT JOINT BLEEDIN
NR 6
TC 9
Z9 9
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1351-8216
J9 HAEMOPHILIA
JI Haemophilia
PD JAN
PY 2009
VL 15
IS 1
BP 386
EP 389
DI 10.1111/j.1365-2516.2008.01871.x
PG 4
WC Hematology
SC Hematology
GA 394TK
UT WOS:000262470600059
PM 18771424
DA 2020-12-16
ER

PT J
AU Botosso, VF
   Zanotto, PMDA
   Ueda, M
   Arruda, E
   Gilio, AE
   Vieira, SE
   Stewien, KE
   Peret, TCT
   Jamal, LF
   Pardini, MIDMC
   Pinho, JRR
   Massad, E
   Sant'Anna, OA
   Holmes, EC
   Durigon, EL
AF Botosso, Viviane F.
   Zanotto, Paolo M. de A.
   Ueda, Mirthes
   Arruda, Eurico
   Gilio, Alfredo E.
   Vieira, Sandra E.
   Stewien, Klaus E.
   Peret, Teresa C. T.
   Jamal, Leda F.
   Pardini, Maria I. de M. C.
   Pinho, Joao R. R.
   Massad, Eduardo
   Sant'Anna, Osvaldo A.
   Holmes, Eddie C.
   Durigon, Edison L.
CA VGDN Consortium
TI Positive Selection Results in Frequent Reversible Amino Acid
   Replacements in the G Protein Gene of Human Respiratory Syncytial Virus
SO PLOS PATHOGENS
LA English
DT Article
ID ATTACHMENT G-GLYCOPROTEIN; CARBOHYDRATE SIDE-CHAINS; SUBGROUP-A;
   MOLECULAR EPIDEMIOLOGY; GROUP-B; CIRCULATION PATTERNS; SOUTH-AFRICA;
   MONOCLONAL-ANTIBODIES; EVOLUTIONARY PATTERN; CONSECUTIVE SEASONS
AB Human respiratory syncytial virus (HRSV) is the major cause of lower respiratory tract infections in children under 5 years of age and the elderly, causing annual disease outbreaks during the fall and winter. Multiple lineages of the HRSVA and HRSVB serotypes co-circulate within a single outbreak and display a strongly temporal pattern of genetic variation, with a replacement of dominant genotypes occurring during consecutive years. In the present study we utilized phylogenetic methods to detect and map sites subject to adaptive evolution in the G protein of HRSVA and HRSVB. A total of 29 and 23 amino acid sites were found to be putatively positively selected in HRSVA and HRSVB, respectively. Several of these sites defined genotypes and lineages within genotypes in both groups, and correlated well with epitopes previously described in group A. Remarkably, 18 of these positively selected tended to revert in time to a previous codon state, producing a "flipflop'' phylogenetic pattern. Such frequent evolutionary reversals in HRSV are indicative of a combination of frequent positive selection, reflecting the changing immune status of the human population, and a limited repertoire of functionally viable amino acids at specific amino acid sites.
C1 [Botosso, Viviane F.; Sant'Anna, Osvaldo A.] Butantan Inst, Virol Branch, Sao Paulo, Brazil.
   [Zanotto, Paolo M. de A.; Stewien, Klaus E.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.
   [Ueda, Mirthes] Adolfo Lutz Inst, Div Med Biol, Sao Paulo, Brazil.
   [Arruda, Eurico] Univ Sao Paulo, Dept Cell Biol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Gilio, Alfredo E.; Vieira, Sandra E.] Univ Sao Paulo, Univ Hosp, Div Pediat, Sao Paulo, Brazil.
   [Peret, Teresa C. T.] Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, Natl Ctr Immunizat & Resp Dis, Gastroenteritis & Resp Viruses Lab Branch,Div Vir, Atlanta, GA USA.
   [Jamal, Leda F.] STD AIDS Reference & Training Ctr, Sao Paulo, Brazil.
   [Pardini, Maria I. de M. C.] State Univ Sao Paulo, Sao Paulo, Brazil.
   [Pinho, Joao R. R.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Dept Legal Med, Sao Paulo, Brazil.
   [Holmes, Eddie C.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, Mueller Lab, University Pk, PA 16802 USA.
   [Holmes, Eddie C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Durigon, Edison L.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Clin Virol, Sao Paulo, Brazil.
RP Botosso, VF (corresponding author), Butantan Inst, Virol Branch, Sao Paulo, Brazil.
EM pzanotto@usp.br
RI de A. Zanotto, Paolo M./B-9286-2019; Oliveira, Danielle BL/H-8030-2015;
   Holmes, Edward/Y-2789-2019; Wolff, Jose Luiz Caldas/H-4084-2018; Modena,
   Jose Luiz Proenca/C-8231-2014; Proenca-Modena, Jose Luiz/AAU-7622-2020;
   vieira, sandra/I-9456-2012; Botosso, Viviane/I-5591-2014; Campos,
   Angelica Cristine Almeida/Z-6089-2019; Schvartsman, Claudio/M-8706-2015;
   Pinho, Joao R. R./G-2850-2012; Massad, Eduardo/H-6143-2011;
   Richtzenhain, Leonardo J/U-1026-2017; de Freitas Oliveira, Carmem
   Aparecida/A-8969-2015; Gilio, Alfredo E/J-4229-2014; Moraes,
   Claudia/K-4708-2016; Gilio, Alfredo/A-8819-2010; Massad,
   Eduardo/B-1169-2012; Arruda, Eurico/E-4101-2012; Passos,
   Saulo/C-5166-2012
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Oliveira, Danielle
   BL/0000-0002-3452-1336; Holmes, Edward/0000-0001-9596-3552; Wolff, Jose
   Luiz Caldas/0000-0002-0541-5286; Modena, Jose Luiz
   Proenca/0000-0002-4996-3153; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; vieira, sandra/0000-0001-5100-8713; Botosso,
   Viviane/0000-0002-7876-3687; Campos, Angelica Cristine
   Almeida/0000-0003-0425-7498; Schvartsman, Claudio/0000-0001-5695-9331;
   Pinho, Joao R. R./0000-0003-3999-0489; Richtzenhain, Leonardo
   J/0000-0002-1419-3515; de Freitas Oliveira, Carmem
   Aparecida/0000-0002-3392-7617; Moraes, Claudia/0000-0001-6782-4790;
   Massad, Eduardo/0000-0002-7200-2916; Durigon,
   Edison/0000-0003-4898-6553; Passos, Saulo/0000-0002-0908-2677;
   /0000-0002-9608-5736; Grisi Candeias, Joao Manuel/0000-0003-1515-702X;
   Oliveira, Danielle/0000-0002-0534-0886
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [00/04205-6]; CNPq, BrazilNational Council for Scientific and
   Technological Development (CNPq)
FX This project was made possible by the VGDN program funded by FAPESP
   project #00/04205-6 and by CNPq, Brazil.
CR ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626
   CANE PA, 1992, VIRUS RES, V25, P15, DOI 10.1016/0168-1702(92)90096-R
   CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995
   Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0
   Cane PA, 1996, J MED VIROL, V48, P253, DOI 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7
   CANE PA, 1994, J CLIN MICROBIOL, V32, P1
   Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468
   Drummond A.J., 2006, BEAST V1 4
   Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951
   Frabasile S, 2003, J MED VIROL, V71, P305, DOI 10.1002/jmv.10484
   Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005
   GARCIA O, 1994, J VIROL, V68, P5448
   GARCIABARRENO B, 1990, EMBO J, V9, P4181, DOI 10.1002/j.1460-2075.1990.tb07642.x
   GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725
   Ison MG, 2002, CURR OPIN INFECT DIS, V15, P355, DOI 10.1097/00001432-200208000-00002
   JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987
   JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625
   Kuroiwa Y, 2005, J MED VIROL, V76, P241, DOI 10.1002/jmv.20348
   MADDISON WP, 2005, MAC CLADE 4 07
   Madhi SA, 2003, J CLIN VIROL, V27, P180, DOI 10.1016/S1386-6532(02)00174-9
   Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419
   Martinez I, 1999, J GEN VIROL, V80, P125, DOI 10.1099/0022-1317-80-1-125
   Matheson JW, 2006, J MED VIROL, V78, P1354, DOI 10.1002/jmv.20702
   Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411
   Montieri S, 2007, J MED VIROL, V79, P1935, DOI 10.1002/jmv.21012
   Moura FEA, 2004, J MED VIROL, V74, P156, DOI 10.1002/jmv.20159
   MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111
   Nagai K, 2004, J MED VIROL, V74, P161, DOI 10.1002/jmv.20160
   PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669
   Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E
   Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221
   Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103
   RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991
   RUEDA P, 1994, VIROLOGY, V198, P653, DOI 10.1006/viro.1994.1077
   RUEDA P, 1995, VIRAL IMMUNOL, V8, P37, DOI 10.1089/vim.1995.8.37
   Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005
   Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183
   SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991
   Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000
   SWOFFORD DL, 1998, PAUPI PHYLOGENETIC A
   Teng MN, 2001, VIROLOGY, V289, P283, DOI 10.1006/viro.2001.1138
   Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0
   Venter M, 2002, J MED VIROL, V68, P452, DOI 10.1002/jmv.10225
   Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117
   Viegas M, 2005, J MED VIROL, V77, P302, DOI 10.1002/jmv.20457
   Vieira Sandra E., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P125, DOI 10.1590/S0036-46652001000300002
   Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147
   Zhang Y, 2007, ARCH VIROL, V152, P1425, DOI 10.1007/s00705-007-0984-3
   Zheng HQ, 1996, J CLIN MICROBIOL, V34, P334, DOI 10.1128/JCM.34.2.334-337.1996
   Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005
   Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004
NR 55
TC 92
Z9 95
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7366
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2009
VL 5
IS 1
AR e1000254
DI 10.1371/journal.ppat.1000254
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 415IP
UT WOS:000263927800031
PM 19119418
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Nogueira, ML
   Mondini, A
   Bronzoni, RVM
   Alonso, WJ
   MAssad, E
   Lazaro, E
   Zanotto, P
   Chiaravalotti, F
AF Nogueira, M. L.
   Mondini, A.
   Bronzoni, R. V. M.
   Alonso, W. J.
   MAssad, E.
   Lazaro, E.
   Zanotto, P.
   Chiaravalotti-Neto, F.
TI Spatio-Temporal and Molecular Analyses of a DENV3 Outbreak Show the
   Dynamics of Dengue Infection (Viral Spread)
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Nogueira, M. L.; Mondini, A.; Bronzoni, R. V. M.; Chiaravalotti-Neto, F.] FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Alonso, W. J.] Fogarty Int Ctr, Bethesda, MD USA.
   [MAssad, E.; Zanotto, P.] Univ Sao Paulo, BR-09500900 Sao Paulo, Brazil.
   [Lazaro, E.] PMSJRP, Sao Jose Do Rio Preto, Brazil.
RI Nogueira, Mauricio L/B-7599-2012; de A. Zanotto, Paolo M./B-9286-2019;
   Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Massad, Eduardo/0000-0002-7200-2916; Bronzoni,
   Roberta/0000-0002-9403-5284
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2008
VL 12
BP E333
EP E333
DI 10.1016/j.ijid.2008.05.890
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 406II
UT WOS:000263287800835
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Chaib, E
   Massad, E
AF Chaib, Elleazar
   Massad, Eduardo
TI The Potential Impact of Using Donations After Cardiac Death on the Liver
   Transplantation Program and Waiting List in the State of Sao Paulo,
   Brazil
SO LIVER TRANSPLANTATION
LA English
DT Article
ID SINGLE-CENTER EXPERIENCE; ALLOCATION; MORTALITY; DYNAMICS; DISEASE
AB Liver transplantation was first performed at the University of Sao Paulo School of Medicine in 1968. Since then, the patient waiting list for liver transplantation has increased at a rate of 150 new cases per month. Liver transplantation itself rose 1.84-fold (from 160 to 295) from 1988 to 2004. However, the number of patients on the liver waiting list jumped 2.71-fold (from 553 to 1500). Consequently, the number of deaths on the liver waiting list moved to a higher level, from 321 to 671, increasing 2.09-fold. We have applied a mathematical model to analyze the potential impact of using a donation after cardiac death (DCD) policy on our liver transplantation program and on the waiting list. Five thousand one hundred people died because of accidents and other violent causes in our state in 2004; of these, only 295 were donors of liver grafts that were transplanted. The model assumed that 5% of these grafts would have been DCD. We found a relative reduction of 27% in the size of the liver transplantation waiting list if DCD had been used by assuming that 248 additional liver transplants would have been performed annually. In conclusion, the use of DCD in our transplantation program would reduce the pressure on our liver transplantation waiting list, reducing it by at least 27%. On the basis of this model, the projected number of averted deaths is about 41,487 in the next 20 years. Liver Transpl 14:1732-1736, 2008. (C) 2008 AASLD.
C1 [Chaib, Elleazar] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Liver & Transplantat Surg Unit, Sao Paulo, Brazil.
   [Chaib, Elleazar] Univ Sao Paulo, Sch Med, Lab Invest Med LIM 01, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Dept Med Informat, Sao Paulo, Brazil.
   [Chaib, Elleazar] Univ Oxford, John Radcliffe Hosp, Dept Transplantat Surg, Oxford OX3 9DU, England.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Chaib, E (corresponding author), Hosp Clin Sao Paulo, Liver Surg Unit, Ave Dr Eneas de Carvalho Aguiar 255,Level 9,Suite, BR-05403010 Sao Paulo, Brazil.
EM eleazarchaib@yahoo.co.uk
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); LIM 01 Hospital das Clinicas da Faculdade
   de Medicina da Universidade de Sao Paulo
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo, and LIM 01 Hospital das Clinicas da Faculdade de
   Medicina da Universidade de Sao Paulo.
CR Ahmad J, 2007, LIVER TRANSPLANT, V13, P1564, DOI 10.1002/lt.21262
   Austin MT, 2007, ARCH SURG-CHICAGO, V142, P1079, DOI 10.1001/archsurg.142.11.1079
   Bacchella T, 2004, TRANSPL P, V36, P929, DOI 10.1016/j.transproceed.2004.03.096
   BEECHER H K, 1968, Journal of the American Medical Association, V205, P337
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chaib E, 2007, TRANSPLANTATION, V84, P1209, DOI 10.1097/01.tp.0000287192.32090.2b
   Gruttadauria S, 2008, LIVER TRANSPLANT, V14, P220, DOI 10.1002/lt.21359
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Maksoud J G, 1991, AMB Rev Assoc Med Bras, V37, P193
   Massad E, 2009, EPIDEMIOL INFECT, V137, P241, DOI 10.1017/S0950268808000873
   Mies S, 1998, TRANSPL P, V30, P2880, DOI 10.1016/S0041-1345(98)00853-7
   Neto JS, 2007, LIVER TRANSPLANT, V13, P1153, DOI 10.1002/lt.21206
   Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730
   Nicholson ML, 1997, TRANSPL P, V29, P1386, DOI 10.1016/S0041-1345(96)00605-7
   STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659
   Wojcicki M, 2007, TRANSPL P, V39, P2781, DOI 10.1016/j.transproceed.2007.08.066
NR 17
TC 13
Z9 15
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1527-6465
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD DEC
PY 2008
VL 14
IS 12
BP 1732
EP 1736
DI 10.1002/lt.21611
PG 5
WC Gastroenterology & Hepatology; Surgery; Transplantation
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 382KL
UT WOS:000261604600006
PM 19025927
DA 2020-12-16
ER

PT J
AU Struchiner, CJ
   Luz, PM
   Codeco, CT
   Massad, E
AF Struchiner, Claudio Jose
   Luz, Paula Mendes
   Codeco, Claudia Torres
   Massad, Eduardo
TI The many faces of epidemiology: evolutionary epidemiology
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Evolutionary epidemiology; Infectious diseases; Virulence management;
   Molecular biology; Population genetics
ID VACCINE EFFICACY; MALARIA CONTROL; VIRULENCE; RESISTANCE; MOSQUITOS;
   IMMUNITY; VECTORS; PATHOGENS; GENETICS; HISTORY
AB We review important issues revealed by the application of the evolutionary theory to epidemiological problems. The scope is restricted to infectious diseases and the evolution of virulence as a consequence of public health strategies to control transmission. We focus on the discussion about the possibility of virulence management and explore current scenarios in which recent advances in molecular biology and genetics offer new tools to monitor and change diversity among pathogens, vertebrate and invertebrate hosts. We stress the need to integrate the analytical framework of epidemiology into population genetics and evolutionary theory. We anticipate as an outcome of this process the development of study designs and analytical tools to predict the evolutionary implications of control measures in the population and surveillance mechanisms to continuously monitor the changes in pathogen virulence patterns. Communication among modelers, epidemiologists and molecular biologists is essential in order to design model-driven field trials and to develop data-driven analytical tools leading to conclusive findings that can inform the public health oriented decision making process.
C1 [Struchiner, Claudio Jose] Escola Nacl Saude Publica, BR-21040360 Rio De Janeiro, Brazil.
   [Struchiner, Claudio Jose] Univ Estado Rio de Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Luz, Paula Mendes] Clin Evandro Chagas, Inst Pesquisa, Fiocruz, Brazil.
   [Codeco, Claudia Torres] Programa Computacao Cient, Fiocruz, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Fac Med, BR-05508 Sao Paulo, Brazil.
RP Struchiner, CJ (corresponding author), Escola Nacl Saude Publica, Fiocruz Av Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM stru@fiocruz.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Struchiner,
   Claudio J/M-9360-2013
OI Massad, Eduardo/0000-0002-7200-2916; Struchiner, Claudio
   J/0000-0003-2114-847X; Luz, Paula/0000-0001-9746-719X
CR Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   Baton LA, 2008, INSECT SCI, V15, P15, DOI 10.1111/j.1744-7917.2008.00184.x
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Boete C, 2003, TRENDS PARASITOL, V19, P32, DOI 10.1016/S1471-4922(02)00003-X
   Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061
   BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x
   CHEVILLON C, 2006, GENETICALLY MODIFIED, P117
   Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136
   Coleman M, 2007, J PESTIC SCI, V32, P69, DOI 10.1584/jpestics.R07-01
   Conway DJ, 2007, CLIN MICROBIOL REV, V20, P188, DOI 10.1128/CMR.00021-06
   Dieckmann U, 2005, ADAPTIVE DYNAMICS IN
   Diekmann O, 2000, MATH EPIDEMIOLOGY IN
   Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x
   Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3
   Ewald P. W., 1994, EVOLUTION INFECT DIS
   EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341
   Ferguson HM, 2002, P ROY SOC B-BIOL SCI, V269, P1217, DOI 10.1098/rspb.2002.2023
   Galvani AP, 2005, MICROBES INFECT, V7, P302, DOI 10.1016/j.micinf.2004.12.006
   Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2
   Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100
   Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a
   Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344
   Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x
   HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6
   Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990
   HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884
   HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498
   Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804
   Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07
   Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229
   McGuire M.T., 1998, DARWINIAN PSYCHIAT
   Otto S.P., 2007, BIOL GUIDE MATH MODE
   RIBEIRO JMC, 2002, EPIDEMIOLOGIA
   Stearns SC, 2008, EVOLUTION HLTH DIS
   Struchiner C., 2006, MATH STUDIES HUMAN D
   Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048
   Williams PD, 2008, MOL ECOL, V17, P485, DOI 10.1111/j.1365-294X.2007.03418.x
   Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128
   Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009
   Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569
NR 42
TC 2
Z9 2
U1 0
U2 6
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD NOV-DEC
PY 2008
VL 13
IS 6
BP 1743
EP 1752
DI 10.1590/S1413-81232008000600009
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 385QN
UT WOS:000261828800009
PM 18833351
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Almeida, MF
   Martorelli, LFA
   Aires, CC
   Barros, RF
   Massad, E
AF Almeida, M. F.
   Martorelli, L. F. A.
   Aires, C. C.
   Barros, R. F.
   Massad, E.
TI Vaccinating the vampire bat Desmodus rotundus against rabies
SO VIRUS RESEARCH
LA English
DT Article
DE Rabies; Vampire bats; Desmodus rotundus; Vaccine; Oral immunization
ID BRAZILIAN AMAZON; VIRUS
AB The objective of this study was to extend the previous work of indirect oral rabies immunization of vampire bats (Desmodus rotundus) maintained in captivity, which demonstrated the immunogenicity of the V-RG vaccine (Vaccinia-Rabies Glycoprotein) and indicated that although the results had been encouraging, a new method for concentrating the vaccine should be tested in order to avoid vaccine loss and increase the survival proportion of bats after rabies challenge. In this study, three groups of seven bats each were tested with vaccine concentrated by ultrafiltration through a cellulose membrane. The vaccine was homogenized in Vaseline paste and applied to the back of one vector bat, which was then reintroduced into its group. A dose of 10(5.0) MICLD50 rabies virus was used by intramuscular route to challenge the bats postvaccination. The survival proportion in the three groups after the challenge was 71.4%, 71.4% and 100%. (c) 2008 Elsevier B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   LIM01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
   [Almeida, M. F.; Martorelli, L. F. A.; Barros, R. F.] Zoonosis Control Ctr, Rabies Lab, Sao Paulo, Brazil.
   [Aires, C. C.] Univ Sao Paulo, Zool Museum, BR-04299970 Sao Paulo, Brazil.
RP Almeida, MF (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
EM marilene@prefeitura.sp.gov.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
FU LIM-HC/FMUSP; CNPqNational Council for Scientific and Technological
   Development (CNPq); Pronex
FX This work was supported by grants from LIM-HC/FMUSP, CNPq and Pronex.
CR Aguilar-Setien A, 2002, J WILDLIFE DIS, V38, P539, DOI 10.7589/0090-3558-38.3.539
   Almeida MF, 2005, VIRUS RES, V111, P77, DOI 10.1016/j.virusres.2005.03.013
   Almeida MF, 2005, EPIDEMIOL INFECT, V133, P523, DOI 10.1017/S0950268804003656
   Barbosa TFS, 2008, VIROLOGY, V370, P228, DOI 10.1016/j.virol.2007.10.005
   *BRAZ HLTH MIN, 2006, SER HIST RAIV HUM ES
   Constantine DG, 2003, EMERG INFECT DIS, V9, P17
   da Rosa EST, 2006, EMERG INFECT DIS, V12, P1197, DOI 10.3201/eid1708.050929
   Dean DJ, 1996, LAB TECHNIQUES RABIE, P88
   Dimitrov DT, 2007, J THEOR BIOL, V245, P498, DOI 10.1016/j.jtbi.2006.11.001
   FAVORETTO Silvana Regina, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P91, DOI 10.1590/S0036-46652002000200007
   Greenhall A. M., 1965, Mammalia, V29, P441, DOI 10.1515/mamm.1965.29.4.441
   KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0
   KOPROWSKI H, 1996, LAB TECHNIQUES RABIE
   LINHART SB, 1972, B OFIC SANIT PANAM, V73, P100
   MARTORELLI LFA, 2001, P 12 INT M RES ADV R
   *OPAS, 2006, B VIG EP RAB AM
   Rupprecht CE, 2006, DEV BIOLOGICALS, V125, P103
   Schneider M C, 2001, Cad Saude Publica, V17, P1531, DOI 10.1590/S0102-311X2001000600038
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
NR 19
TC 27
Z9 27
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD NOV
PY 2008
VL 137
IS 2
BP 275
EP 277
DI 10.1016/j.virusres.2008.07.024
PG 3
WC Virology
SC Virology
GA 374ML
UT WOS:000261047600016
PM 18761044
DA 2020-12-16
ER

PT J
AU Ortega, NRS
   Santos, FS
   Zanetta, DMT
   Massad, E
AF Ortega, Neli R. S.
   Santos, Fabiano S.
   Zanetta, Dirce M. T.
   Massad, Eduardo
TI A fuzzy Reed-Frost model for epidemic spreading
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE fuzzy logic; fuzzy epidemic; epidemiological models; Reed-Frost
ID SAO-PAULO; VACCINATION; SYSTEM; BRAZIL; POPULATION; PREDICTION;
   STRATEGY; RUBELLA
AB In this paper, we present a fuzzy approach to the Reed-Frost model for epidemic spreading taking into account uncertainties in the diagnostic of the infection. The heterogeneities in the infected group is based on the clinical signals of the individuals (symptoms, laboratorial exams, medical findings, etc.), which are incorporated into the dynamic of the epidemic. The infectivity level is time-varying and the classification of the individuals is performed through fuzzy relations. Simulations considering a real problem with data of the viral epidemic in a children daycare are performed and the results are compared with a stochastic Reed-Frost generalization.
C1 [Ortega, Neli R. S.; Massad, Eduardo] Univ Sao Paulo, Sch Med, Discipline Med Informat, LIM01 HCFMUSP, BR-05405000 Sao Paulo, Brazil.
   [Santos, Fabiano S.; Zanetta, Dirce M. T.] Univ Sao Jose do Rio Preto, Sch Med, Sao Jose Do Rio Preto, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England.
RP Ortega, NRS (corresponding author), Univ Sao Paulo, Sch Med, Discipline Med Informat, LIM01 HCFMUSP, Rua Teodoro Sampaio 115,2O Andar, BR-05405000 Sao Paulo, Brazil.
EM neli@dim.fm.usp.br
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Zanetta, Dirce M T/G-4950-2013
OI Massad, Eduardo/0000-0002-7200-2916; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX This work was supported by the CNPq and FAPESP grants.
CR ABBEY HELEN, 1952, HUMAN BIOL, V24, P201
   BARROS LC, 2003, COMPUT MATH APPL, V45, P1619, DOI DOI 10.1016/S0898-1221(03)00141-X
   Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Jafelice RM, 2004, B MATH BIOL, V66, P1597, DOI 10.1016/j.bulm.2004.03.002
   LEFEVRE C, 1990, ADV APPL PROBAB, V22, P25, DOI 10.2307/1427595
   Lopez LF, 2006, MATH COMPUT SIMULAT, V71, P131, DOI 10.1016/j.matcom.2006.01.004
   MAIA JOC, 1952, HUM BIOL, V24, P167
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2003, ARTIF INTELL MED, V29, P241, DOI 10.1016/S0933-3657(02)00070-2
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E, 2007, MED HYPOTHESES, V68, P442, DOI 10.1016/j.mehy.2006.07.041
   MENEZES RX, 2004, B MATH BIOL, V66, P689
   Nikravesh M., 2004, STUDIES FUZZINESS SO, V142
   Ortega N, 2003, KYBERNETES, V32, P460, DOI 10.1108/03684920310463876
   Ortega NRS, 2000, KYBERNETES, V29, P201, DOI 10.1108/03684920010312768
   Pearson DW, 1997, APPL MATH LETT, V10, P99, DOI 10.1016/S0893-9659(97)00043-8
   Pedrycz W., 1998, INTRO FUZZY SETS ANA
   Pereira JCR, 2004, BRAZ J MED BIOL RES, V37, P701, DOI 10.1590/S0100-879X2004000500012
   PICARD P, 1991, MATH BIOSCI, V107, P225, DOI 10.1016/0025-5564(91)90006-5
   Reis MAM, 2004, BRAZ J MED BIOL RES, V37, P755, DOI 10.1590/S0100-879X2004000500018
   SANCHEZ E, 1977, FUZZY AUTOMATA DECIS
   SEIKKALA S, 1987, FUZZY SET SYST, V24, P319, DOI 10.1016/0165-0114(87)90030-3
   Zanetta DMT, 2003, VACCINE, V21, P3795, DOI 10.1016/S0264-410X(03)00315-3
NR 27
TC 6
Z9 6
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD OCT
PY 2008
VL 70
IS 7
BP 1925
EP 1936
DI 10.1007/s11538-008-9332-3
PG 12
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 351WL
UT WOS:000259456500006
PM 18663537
OA Green Published
DA 2020-12-16
ER

PT J
AU Ortega, NRS
   Massad, E
   Struchiner, CJ
AF Ortega, Neli R. S.
   Massad, Eduardo
   Struchiner, Claudio Jose
TI A Bayesian approach to fuzzy hypotheses testing for the estimation of
   optimal age for vaccination against measles
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Article
DE Bayes test; fuzzy sets; measles; vaccine; epidemiology
ID SAO-PAULO STATE; INFORMATION; BRAZIL; STRATEGY; RUBELLA
AB Fuzzy Bayesian tests were performed to evaluate whether the mother's seroprevalence and children's seroconversion to measles vaccine could be considered as "high" or "low". The results of the tests were aggregated into a fuzzy rule-based model structure, which would allow an expert to influence the model results. The linguistic model was developed considering four input variables. As the model output, we obtain the recommended age-specific vaccine coverage. The inputs of the fuzzy rules are fuzzy sets and the outputs are constant functions, performing the simplest Takagi-Sugeno-Kang model. This fuzzy approach is compared to a classical one, where the classical Bayes test was performed. Although the fuzzy and classical performances were similar, the fuzzy approach was more detailed and revealed important differences. In addition to taking into account subjective information in the form of fuzzy hypotheses it can be intuitively grasped by the decision maker.
   Finally, we show that the Bayesian test of fuzzy hypotheses is an interesting approach from the theoretical point of view, in the sense that it combines two complementary areas of investigation, normally seen as competitive. (C) 2007 IMACS. Published by Elsevier B.V. All rights reserved.
C1 [Ortega, Neli R. S.; Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Ortega, Neli R. S.; Massad, Eduardo] HCFMUSP, LIM 01, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
   [Struchiner, Claudio Jose] Fiocruz MS, Fundacao Oswaldo Cruz, Program Sci Computat, BR-21045900 Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Struchiner, Claudio J/M-9360-2013; Ortega,
   Neli/C-6494-2013; Massad, Eduardo/B-1169-2012
OI Struchiner, Claudio J/0000-0003-2114-847X; Massad,
   Eduardo/0000-0002-7200-2916
FU FINEPCiencia Tecnologia e Inovacao (FINEP); CNPqNational Council for
   Scientific and Technological Development (CNPq) [LIM01/HCFMUSP]
FX This work was supported by FINEP and CNPq grants and LIM01/HCFMUSP.
CR Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   BABBOTT FL, 1954, AM J MED SCI, V228, P334
   CASALS MR, 1993, RAIRO-RECH OPER, V27, P189
   *CDC, 1998, P 1997 INT M COSP WH, V47, P1
   DELGADO M, 1979, ADV FUZZY THEORY APP, P307
   Dubois D., 1995, THEORETICAL ASPECTS, P147
   GIL MA, 1985, EUR J OPER RES, V22, P26, DOI 10.1016/0377-2217(85)90112-2
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   KLIR GJ, 1988, FUZZY SETS UNCERTAIN, P89
   LANDRIGAN PJ, 1973, JAMA-J AM MED ASSOC, V223, P1459, DOI 10.1001/jama.223.13.1459
   MARKOWITZ LE, 1994, VACCINES, P229
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   MENDEL J, 2000, UNCERTAIN RULE BASED
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   OKUDA T, 1978, INFORM CONTROL, V38, P135, DOI 10.1016/S0019-9958(78)90151-1
   Ortega N, 2003, KYBERNETES, V32, P460, DOI 10.1108/03684920310463876
   Ortega NRS, 2000, KYBERNETES, V29, P201, DOI 10.1108/03684920010312768
   Pedrycz W., 1998, INTRO FUZZY SETS ANA
   REED SC, 1999, VACCINES, P227
   Taheri SM, 2001, FUZZY SET SYST, V123, P39, DOI 10.1016/S0165-0114(00)00134-2
   Tanaka H., 1979, ADV FUZZY SETS THEOR, P303
   UEMURA Y, 1991, JPN J FUZZY THEORY S, P291
   VIERTL R, 1996, STAT METHODS NONPREC, P3
   Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5
   ZIMMERMAN HJ, 1996, FUZZY INFORMATION EN, P471
NR 26
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
EI 1872-7166
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD OCT
PY 2008
VL 79
IS 1
BP 1
EP 13
DI 10.1016/j.matcom.2007.08.019
PG 13
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 355QQ
UT WOS:000259723800001
DA 2020-12-16
ER

PT J
AU Rozman, MA
   Alves, IS
   Porto, MA
   Gomes, PO
   Ribeiro, NM
   Nogueira, LAA
   Caseiro, MM
   da Silva, VA
   Massad, E
   Burattini, MN
AF Rozman, Mauro Abrahao
   Alves, Igor Santino
   Porto, Marcela Alves
   Gomes, Patricia Oliveira
   Ribeiro, Nilva Maria
   Andrade Nogueira, Lucyene Aparecida
   Caseiro, Marcos Monteiro
   da Silva, Vera Aparecida
   Massad, Eduardo
   Burattini, Marcelo Nascimento
TI HIV infection and related risk behaviors in a community of recyclable
   waste collectors of Santos, Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE solid waste segregators; HIV; hepatitis B virus; hepacivirus; syphilis;
   risk factors; seroepidemiologic studies
ID SAO-PAULO; PARENTERAL TRANSMISSION; PRISON; HCV; INMATES; WOMEN; WARTS
AB OBJECTIVE: To estimate the seroprevalence of HIV, hepatitis B and C and syphilis and to describe risk behaviors associated to their transmission among recyclable waste collectors.
   METHODS: A seroepidemiological survey was carried out in the city of Santos, Southeastern Brazil, in 2005. A total of 315 individuals were enrolled in the survey, of which 253 subjects underwent serological testing HIV, hepatitis B and C and syphilis. Statistical analysis consisted of univariate and bivariate analyses (cross-tabulation and odds ratio) and multivariate analysis (by logistic regression), relating HIV infection with established risk behaviors and seropositivity.
   RESULTS: Overall seroprevalences were: HIV, 8.9%; hepatitis B, 34.4%; hepatitis C, 12.4%; and syphilis, 18.4%. Subjects were characterized by a predominance of males with low educational and economic levels, subjected to parenteral and sexual exposures to HIV and other sexually transmitted infections. Multivariate analysis results indicated that risk factors for both sexually and parenterally related exposure were significantly associated with HIV in this community.
   CONCLUSIONS: Seroprevalences found in the study were approximately 10 to 12 times higher than the national average. These communities are socially marginalized and generally not recognized by national programs as potentially endangered populations.
C1 [Rozman, Mauro Abrahao; Alves, Igor Santino; Porto, Marcela Alves; Gomes, Patricia Oliveira; Ribeiro, Nilva Maria; Andrade Nogueira, Lucyene Aparecida; Caseiro, Marcos Monteiro] Univ Catolica Santos, Ctr Ciencias Saude, Santos, SP, Brazil.
   [da Silva, Vera Aparecida; Massad, Eduardo; Burattini, Marcelo Nascimento] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London, England.
RP Burattini, MN (corresponding author), R Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Massad, Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916
CR Berthier HC, 2003, RESOUR CONSERV RECY, V39, P193, DOI 10.1016/S0921-3449(03)00027-2
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Burattini MN, 2005, INT J STD AIDS, V16, P836, DOI 10.1258/095646205774988136
   Carvalho Heraclito Barbosa De, 1996, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V12, P84
   Fonseca Maria Goretti P., 2003, Cad. Saúde Pública, V19, P1351, DOI 10.1590/S0102-311X2003000500013
   Fonseca MGP, 2002, REV SAUDE PUBL, V36, P678, DOI 10.1590/S0034-89102002000700004
   Goncalves MAG, 1999, INT J STD AIDS, V10, P803, DOI 10.1258/0956462991913583
   Goncalves MAG, 2003, INT J STD AIDS, V14, P309, DOI 10.1258/095646203321605503
   Goncalves MAG, 2003, TUMORI, V89, P9
   Hsu E, 2005, WASTE MANAGE, V25, P53, DOI 10.1016/j.wasman.2004.07.003
   Lwa nga S.K., 1991, SAMPLE SIZE DETERMIN
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   Masui T, 2000, EUR J OPER RES, V122, P405, DOI 10.1016/S0377-2217(99)00242-8
   *MIN SAUD, 2005, B EP AIDS DST, V1
   Rozman M, 1998, INT J STD AIDS, V9, P183, DOI 10.1258/0956462981921855
   Rozman MA, 2007, INT J STD AIDS, V18, P653, DOI 10.1258/095646207781568574
   SEGURADO AAC, 1995, J ACQ IMMUN DEF SYND, V10, P200
   Strazza L, 2004, BRAZ J MED BIOL RES, V37, P771, DOI 10.1590/S0100-879X2004000500020
   Strazza L, 2007, CAD SAUDE PUBLICA, V23, P197, DOI 10.1590/S0102-311X2007000100021
   Szwarcwald C L, 2000, Cad Saude Publica, V16, P135
   Szwarcwald C L, 2000, Cad Saude Publica, V16, P7
   Zanetta DMT, 1999, INT J STD AIDS, V10, P98, DOI 10.1258/0956462991913718
NR 23
TC 2
Z9 2
U1 0
U2 4
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD OCT
PY 2008
VL 42
IS 5
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 356AN
UT WOS:000259751200008
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Massad, E
AF Massad, E.
TI The elimination of Chagas' disease from Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Review
ID SAO-PAULO STATE; THRESHOLD CONDITIONS; YELLOW-FEVER; DENGUE; EPIDEMIC;
   HEALTH; RISK
AB On 9 June 2006 the Pan American Health Organization (PAHO) presented the Minister of Health of Brazil with the International Elimination of Transmission of Chagas' Disease Certificate. This act was the culmination of an intensive process that began in 1991 with the Southern Cone Initiative, a Joint agreement between the governments of Argentina, Bolivia, Brazil, Chile, Paraguay, Uruguay and Peru, to control Chagas' disease by the elimination of the main vector, Triatoma infestans. This initiative has been highly successful and the prevalence area of the vector diminished rapidly in the last years. As a consequence, the current seroprevalence in children aged between 0 and 5 years is of the order of 10(-5), a clear indication that transmission, if it is occurring, is only accidental. In this review I calculate the basic reproduction number, R, for Chagas' disease and demonstrate that its relatively low value (1.25) explains why vectorial transmission was interrupted relatively easily. In addition, I used a mathematical model to forecast how long the remaining cases of the disease, as well as the additional vertically transmitted cases will last.
C1 [Massad, E.] Univ Sao Paulo, Sch Med, LIM HCFMUSP 01, BR-05508 Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Allison Marvin J., 1993, P636, DOI 10.1017/CHOL9780521332866.087
   Beaty B.J., 1996, BIOL DIS VECTORS
   BITTENCOURT AL, 2000, REV PATOLOGIA TROP S, V29, P101
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Burnet Sir Frank Macfarlane, 1962, NATURAL HIST INFECT
   BUSVINE JR, 1947, B ENTOMOL RES, V38, P81, DOI 10.1017/S0007485300030182
   CAMARGO ME, 1984, REV I MED TROP, V26, P192, DOI 10.1590/S0036-46651984000400003
   Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   DiAS E., 1948, Brasil-Medico, V62, P185
   DIAS E, 1962, REV GOIANA MED S, V9, P233
   Dias J C, 1998, Rev Soc Bras Med Trop, V31, P373, DOI 10.1590/S0037-86821998000400007
   DIAS JCP, 1987, PARASITOL TODAY, V3, P336, DOI 10.1016/0169-4758(87)90117-7
   Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002
   DIAS JCP, 1997, CLIN TERAPEUTICA DOE
   Dias JCP, 1979, TRYPANOSOMA CRUZI DO
   DIAS JCP, 1982, THESIS U FEDERAL MIN
   Dias Joao Carlos Pinto, 2000, Memorias do Instituto Oswaldo Cruz, V95, P14
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   ELSGOLTS EL, 1966, INTRO THEORY DIFFERE
   Schijman AG, 2007, PERSP MED V, V13, P223, DOI 10.1016/S0168-7069(06)13012-8
   GEIGY E, 1955, ERREGER UBERTRAGER T
   Gorla David E, 2002, Ecol. austral, V12, P117
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   *INF NAC ENF CHAG, 1997, APR COM INT AV
   JUNQUEIRA LF, 1991, ARQUIVOS BRASILEIROS, V56, P420
   KIRCHHOFF LV, PRINCIPLES PRACTICE
   KIRCHHOFF LV, 2000, TROPICAL INFECT DIS
   Kropf SP, 2003, SOC HIST MED, V16, P111, DOI 10.1093/shm/16.1.111
   LENT H, 1994, MEM I OSWALDO CRUZ, V89, P347, DOI 10.1590/S0074-02761994000300008
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Macedo V. O., 1976, Revista de Patologia Tropical, V5, P33
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   MARSDEN PD, 1996, MANSONS TROPICAL DIS
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MOLINEAUX L, 1988, MALARIA
   Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001
   MORAESSOUZA H, 2000, REV PATOLOGIA TROP S, V29, P91
   MORTARA G, 1941, REV BRASILEIRA ESTAT, V3, P41
   Murray CJ, 1996, GLOBAL BURDEN DIS
   *ORG PAN SAL, 1994, 9421 PAHOHPCHCT
   *PAHO, NEWSL PAN AM HLTH OR
   Perleth M, 1997, HIST PHIL LIFE SCI, V19, P211
   PHILIP CB, 1973, HIST ENTOMOLOGY
   Prata A, 1986, Rev Soc Bras Med Trop, V19, P9, DOI 10.1590/S0037-86821986000100003
   Punukollu G, 2004, INT J CARDIOL, V95, P347, DOI 10.1016/j.ijcard.2003.04.046
   Rassi A, 2000, TRYPANOSOMA CRUZI DO
   REIS EJ, 2004, EC BRASIN SECULO 20
   RESENDE J, 2000, TRYPANOSOMA CRUZI DO
   Rey L., 2001, PARASITOLOGIA
   Romana C., 1948, ANALES I MED REGIONA, V2, P95
   SCHMUNIS GA, 1999, TRYPANOSOMA CRUZI DO
   Schofield C J, 2000, Cad Saude Publica, V16 Suppl 2, P89
   Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011
   SCHOFIELD CJ, 1991, MEM I OSWALDO CRUZ, V86, P285, DOI 10.1590/S0074-02761991000300002
   Schofield CJ, 1999, ADV PARASIT, V42, P1, DOI 10.1016/S0065-308X(08)60147-5
   SCHOFIELD CJ, 1994, TRIATOMINAE BIOL CON
   SCLIAR M, 2002, O CRUZ C CHAGAS BIRT
   Silveira A C, 2000, Cad Saude Publica, V16 Suppl 2, P35, DOI 10.1590/S0102-311X2000000800004
   SMITH D, 1977, MATH DEMOGRAPHY
   SOUZA AG, 1984, MEM I OSWALDO CRUZ S, V79, P125
   SOUZA HM, 1997, CLIN TERAPEUTICA DOE
   Vinhaes M C, 2000, Cad Saude Publica, V16 Suppl 2, P7, DOI 10.1590/S0102-311X2000000800002
   VINHAES MC, 2002, 11 M INT COMM SO CON
   WENDELL S, 1997, CLIN TERAPEUTICA DOE
   *WHO, 2000, WEEKLY EPIDEMIOL REC, V19, P153
   WHO (World Health Organization), 1991, WHO TECHN REP SER, V811
   World Bank, 1993, WORLD DEV REP 1993 I
NR 74
TC 38
Z9 41
U1 1
U2 11
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD SEP
PY 2008
VL 136
IS 9
BP 1153
EP 1164
DI 10.1017/S0950268807009879
PG 12
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 350DI
UT WOS:000259332400001
PM 18053273
OA Green Published
DA 2020-12-16
ER

PT J
AU Coelho, GE
   Burattini, MN
   Teixeira, MD
   Coutinho, FAB
   Massad, E
AF Coelho, Giovanini E.
   Burattini, Marcelo Nascimento
   Teixeira, Maria da Gloria
   Bezerra Coutinho, Francisco Antonio
   Massad, Eduardo
TI Dynamics of the 2006/2007 dengue outbreak in Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; larval index; basic reproduction number; force of infection
ID ANTHROPIC ENVIRONMENT; MOSQUITOS DIPTERA; YELLOW-FEVER; SOUTH-EASTERN;
   CULICIDAE
AB We analyzed dengue incidence in the period between October 2006-July 2007 of 146 cities around the country were Larval Index Rapid Assay (LIRA) surveillance was carried out in October 2006. Of these, we chosen 61 cities that had 500 or more cases reported during this period. We calculated the incidence coefficient, the force of infection (lambda) and the basic reproduction number (R-0) of dengue in those 61 cities and correlated those variables with the LIRA. We concluded that lambda and R-0 are more associated with the number of cases than LIRA. In addition, the average R-0 for the 2006/2007 dengue season was almost as high as that calculated for the 2001/2002 season, the worst in Brazilian history.
C1 [Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Fac Med, BR-05405000 Sao Paulo, Brazil.
   [Coelho, Giovanini E.] Minist Saude, Programa Nacl Controle Dengue, Brasilia, DF, Brazil.
   [Teixeira, Maria da Gloria] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Fac Med, R Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Teixeira, Maria Gloria/G-4808-2012; Massad, Eduardo/H-6143-2011;
   Burattini, Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/B-1169-2012
OI Teixeira, Maria Gloria/0000-0003-3318-3408; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); LIM01 HC-FMUSP
FX Financial support: CNPq, FAPESP, LIM01 HC-FMUSP
CR BANG YH, 1981, B WORLD HEALTH ORGAN, V59, P107
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   da Cunha R V, 1997, Rev Soc Bras Med Trop, V30, P379, DOI 10.1590/S0037-86821997000500005
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   GERMAIN M, 1980, AM J TROP MED HYG, V29, P929, DOI 10.4269/ajtmh.1980.29.929
   Gubler D, 1997, DENGUE DENGUE HEMORR
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   *MS MIN SAUD, 2005, DIAGN RAP NOS MUN VI
   *MS MIN SAUD, 2007, GRAPH SHOW HIST SER
   *MS MIN SAUD, 2007, EP B REP 2007 DENG O
NR 16
TC 41
Z9 42
U1 1
U2 11
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2008
VL 103
IS 6
BP 535
EP U7
DI 10.1590/S0074-02762008000600004
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 365DL
UT WOS:000260386000004
PM 18949321
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Coutinho, FAB
AF Massad, Eduardo
   Burattini, Marcelo Nascimento
   Bezerra Coutinho, Francisco Antonio
TI An optimization model for antibiotic use
SO APPLIED MATHEMATICS AND COMPUTATION
LA English
DT Article
DE antibiotics; evolution of resistance; mathematical model; optimization
ID ANTIMICROBIAL RESISTANCE; UNITED-STATES; TETRACYCLINE RESISTANCE;
   POPULATION-DYNAMICS; EVOLUTION; SUSCEPTIBILITY; DISSEMINATION;
   DETERMINANT; PROGRAM
AB There is a positive correlation between the intensity of use of a given antibiotic and the prevalence of resistant strains. The more you treat, more patients infected with resistant strains appears and, as a consequence, the higher the mortality due to the infection and the longer the hospitalization time. In contrast, the less you treat, the higher the mortality rates and the longer the hospitalization time of patients infected with sensitive strains that could be successfully treated. The hypothesis proposed in this paper is an attempt to solve such a conflict: there must be an optimum treatment intensity that minimizes both the additional mortality and hospitalization time due to the infection by both sensitive and resistant bacteria strains. In order to test this hypothesis we applied a simple mathematical model that allowed us to estimate the optimum proportion of patients to be treated in order to minimize the total number of deaths and hospitalization time due to the infection in a hospital setting. (C) 2007 Elsevier Inc. All rights reserved.
C1 [Massad, Eduardo; Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, LIM HCFMUSP 01, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Burattini, Marcelo Nascimento] LIM 03 HCFMUSP, BR-05405000 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, LIM HCFMUSP 01, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/H-6143-2011; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916
CR AMYES SGB, 2001, MAGIC BULLETS LOST H
   Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211
   AUSTIN DJ, 1999, STUDIES ANTIBIOTIC R
   Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025
   Flamm RK, 2004, ANTIMICROB AGENTS CH, V48, P2431, DOI 10.1128/AAC.48.7.2431-2436.2004
   Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004
   Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0
   Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016
   Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814
   KOPECKO DJ, 1980, PROG MOL SUBCELL BIO, V7, P135
   Laxminarayan R, 2001, J ENVIRON ECON MANAG, V42, P183, DOI 10.1006/jeem.2000.1156
   Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843
   Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46
   Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363
   Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312
   LUPSKI JR, 1987, REV INFECT DIS, V9, P357
   MALHOTRAKUMAR S, 2007, EFFECT AZITHROMYCIN
   MASSAD E, 1993, INT J BIOMED COMPUT, V33, P65, DOI 10.1016/0020-7101(93)90060-J
   MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033
   Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19
   MORSE SA, 1986, ANTIMICROB AGENTS CH, V30, P664, DOI 10.1128/AAC.30.5.664
   Opal SM, 2005, PRINCIPLES PRACTICE, P253
   Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786
   PAPADOPOULOU B, 1988, ANTIMICROB AGENTS CH, V32, P945, DOI 10.1128/AAC.32.6.945
   Rhomberg PR, 2004, INT J ANTIMICROB AG, V23, P52, DOI 10.1016/j.ijantimicag.2003.05.010
   ROBERTS MC, 1986, ANTIMICROB AGENTS CH, V29, P350, DOI 10.1128/AAC.29.2.350
   Sader HS, 2003, DIAGN MICR INFEC DIS, V47, P361, DOI 10.1016/S0732-8893(03)00052-X
   Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899
   Walsh C., 2003, ANTIBIOTICS ACTIONS
   Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x
NR 30
TC 14
Z9 16
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0096-3003
EI 1873-5649
J9 APPL MATH COMPUT
JI Appl. Math. Comput.
PD JUL 15
PY 2008
VL 201
IS 1-2
BP 161
EP 167
DI 10.1016/j.amc.2007.12.007
PG 7
WC Mathematics, Applied
SC Mathematics
GA 312HQ
UT WOS:000256660400015
DA 2020-12-16
ER

PT J
AU Chaib, E
   Massad, E
AF Chaib, Eleazar
   Massad, Eduardo
TI Calculating the liver lobe weight for transplantation
SO TRANSPLANT INTERNATIONAL
LA English
DT Letter
ID WAITING-LIST; BODY-WEIGHT; SAO-PAULO; ADULTS; BRAZIL; GENDER; STATE;
   SIZE
C1 Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, LIM 01, Sao Paulo, Brazil.
RP Chaib, E (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR BROELSCH CE, 1990, ANN SURG, V212, P368, DOI 10.1097/00000658-199009000-00015
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Chaib E, 2008, TRANSPL INT, V21, P290, DOI 10.1111/j.1432-2277.2007.00600.x
   Chan SC, 2006, WORLD J GASTROENTERO, V12, P2217, DOI 10.3748/wjg.v12.i4.2217
   Chouker A, 2004, LIVER TRANSPLANT, V10, P678, DOI 10.1002/lt.20113
   EMOND JC, 1990, ANN SURG, V212, P14, DOI 10.1097/00000658-199007000-00003
   Nadalin S, 2007, TRANSPL INT, V20, P312, DOI 10.1111/j.1432-2277.2006.00424.x
   PICHLMAYR R, 1988, LANGENBECK ARCH CHIR, V373, P127, DOI 10.1007/BF01262776
   Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654
NR 9
TC 1
Z9 1
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0934-0874
J9 TRANSPL INT
JI Transpl. Int.
PD JUL
PY 2008
VL 21
IS 7
BP 704
EP 706
DI 10.1111/j.1432-2277.2008.00661.x
PG 3
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 316BE
UT WOS:000256923100012
PM 18298588
OA Bronze
DA 2020-12-16
ER

PT J
AU Massad, E
   Struchiner, CJ
   Burattini, MN
   Coutinho, FAB
AF Massad, Eduardo
   Struchiner, Claudio Jose
   Burattini, Marcelo Nascimento
   Bezerra Coutinho, Francisco Antonio
TI An optimal vaccination strategy against rotavirus
SO VACCINE
LA English
DT Letter
ID SAO-PAULO STATE; RUBELLA; BRAZIL
C1 [Massad, Eduardo; Burattini, Marcelo Nascimento; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Struchiner, Claudio Jose] Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/H-6143-2011; Coutinho, Francisco A B/H-5644-2011; Struchiner,
   Claudio J/M-9360-2013
OI Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Struchiner, Claudio J/0000-0003-2114-847X
CR Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   1999, MMWR, V48, P1
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
J9 VACCINE
JI Vaccine
PD JUN 2
PY 2008
VL 26
IS 23
BP 2807
EP 2807
DI 10.1016/j.vaccine.2008.03.053
PG 1
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 312CA
UT WOS:000256645500001
PM 18448212
DA 2020-12-16
ER

PT J
AU Huatuco, EMM
   Durigon, EL
   Lebrun, FLAS
   Passos, SD
   Gazeta, RE
   Neto, RSA
   Massad, E
AF Huatuco, E. M. M.
   Durigon, E. L.
   Lebrun, F. L. A. S.
   Passos, S. D.
   Gazeta, R. E.
   Neto, R. S. Azevedo
   Massad, E.
TI Seroprevalence of human parvovirus B19 in a suburban population in Sao
   Paulo, Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
ID VACCINATION; INFECTION; RUBELLA; ANTIBODY; STATE
AB OBJECTIVE: To analyze the prevalence of IgG antibodies to human parvovirus B19.
   METHODS: Cross-sectional study in a suburban community in Sao Paulo, Southeastern Brazil, between November 1990 and January 1991. Randomly selected (N=435) representative samples of sera were collected from healthy children older than 15 days old and adults up to 40 years old. IgG antibodies were detected using ELISA.
   RESULTS: High prevalence of IgG antibodies to B 19 parvovirus was found in 87% of newborns. The prevalence of maternally derived IgG antibodies exponentially plunged up to the 19th month of age. Low prevalence of antibodies was found in the first 4 years of life, increasing up to 72% in those aged 3 1-40 years. It was estimated that the average age of first infection in this population is 21 7 years old and the optimal age for vaccination with a hypothetical vaccine would be 1 year of age.
   CONCLUSIONS: Parvovirus B19 IgG antibody prevalence was high in newborns and those aged 31-40 years. The analysis by age groups showed a pattern similar to that found in previous studies, i.e., low prevalence of infection in children that increases with age.
C1 [Massad, E.] FMUSP, Inst Oscar Freire, BR-05405000 Sao Paulo, SP, Brazil.
   [Passos, S. D.; Gazeta, R. E.] Fac Med Jundiai, Dept Pediat, Jundiai, SP, Brazil.
   [Huatuco, E. M. M.; Durigon, E. L.; Lebrun, F. L. A. S.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, SP, Brazil.
RP Massad, E (corresponding author), FMUSP, Inst Oscar Freire, R Teodoro Sampaio 115, BR-05405000 Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/B-1169-2012; Passos, Saulo/C-5166-2012
OI Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Durigon, Edison/0000-0003-4898-6553;
   Passos, Saulo/0000-0002-0908-2677
CR Abarca K, 2002, EPIDEMIOL INFECT, V128, P59, DOI 10.1017/S0950268801006203
   Abraham M, 2002, INDIAN J MED RES, V115, P139
   ANDERSON LJ, 1986, J CLIN MICROBIOL, V24, P522, DOI 10.1128/JCM.24.4.522-526.1986
   BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117
   BROWN KE, 1997, MG VIROLOGY, V20, P42
   BROWN T, 1984, LANCET, V2, P1033
   COCHRAN WG, 1977, SAMPLING TECHNIQUES, P2256
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   DEISS V, 1990, VIROLOGY, V175, P247, DOI 10.1016/0042-6822(90)90205-6
   FOTO F, 1993, J INFECT DIS, V167, P744, DOI 10.1093/infdis/167.3.744
   *FUND I BRAS GEOGR, 1983, 9 REC GER BRAS, P2256
   Gay N J, 1994, Commun Dis Rep CDR Rev, V4, pR104
   Guerri M L, 2000, Enferm Infecc Microbiol Clin, V18, P243
   KAJIGAYA S, 1997, MONOGR VIROL, V20, P120
   Laub R, 2002, PATHOL BIOL, V50, P339, DOI 10.1016/S0369-8114(02)00303-6
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   NASCIMENTO JP, 1990, REV I MED TROP, V32, P41, DOI 10.1590/S0036-46651990000100007
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   NETO RSDA, 1995, T ROY SOC TROP MED H, V89, P115, DOI 10.1016/0035-9203(95)90680-0
   Rodis JF, 1999, CLIN OBSTET GYNECOL, V42, P107, DOI 10.1097/00003081-199903000-00016
   Sodja I., 1995, Epidemiologie Mikrobiologie Imunologie, V44, P171
   VANREGENMORTEL MHV, 2000, 7 REP INT COMM TAX V, P2256
   Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5
NR 23
TC 12
Z9 15
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD JUN
PY 2008
VL 42
IS 3
BP 443
EP 449
DI 10.1590/S0034-89102008005000019
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 303PR
UT WOS:000256053300008
PM 18425294
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Massad, E
   Ma, S
   Burattini, MN
   Tun, Y
   Coutinho, FAB
   Ang, LW
AF Massad, Eduardo
   Ma, Stefan
   Burattini, Marcelo Nascimento
   Tun, Ye
   Coutinho, Francisco Antonio Bezerra
   Ang, Li Wei
TI The risk of chikungunya fever in a dengue-endemic area
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
ID THRESHOLD CONDITIONS; AEDES-AEGYPTI; YELLOW-FEVER; POPULATION-DYNAMICS;
   MOSQUITOS DIPTERA; SAO-PAULO; INFECTION; CULICIDAE; TRANSMISSION;
   VACCINATION
AB Background. Chikungunya, an alphavirus of the Togaviridae family, causes a febrile disease transmitted to humans by the bite of infected Aedes mosquitoes. This infection is reaching endemic levels in many Southeast Asian countries. Symptoms include sudden onset of fever, chills, headache, nausea, vomiting, joint pain with or without swelling, low back pain, and rash. According to the World Health Organization, there are 2 billion people living in Aedes-infested areas. In addition, traveling to these areas is popular, making the potential risk of infections transmitted by the bite of infected Aedes mosquitoes very high.
   Methods. We proposed a mathematical model to estimate the risk of acquiring chikungunya fever in an Aedes-infested area by taking the prevalence of dengue fever into account. The basic reproduction number for chikungunya fever R-0chik can be written as a function of the basic reproduction number of dengue R-0dengue by calculating the ratio R-0chik/R-0dengue. From R-0chik, we estimated the force of infection and the risk of acquiring the disease both for local residents of a dengue-endemic area and for travelers to this area.
   Results. We calculated that R-0chik is 64.4% that of R-0dengue. The model was applied to a hypothetical situation, namely, estimating the individual risk of acquiring chikungunya fever in a dengue-endemic area, both for local inhabitants (22% in steady state) and for visiting travelers (from 0.31% to 1.23% depending on the time spent in the area).
   Conclusions. The method proposed based on the output of a dynamical model is innovative and provided an estimation of the risk of infection, both for local inhabitants and for visiting travelers.
C1 [Massad, Eduardo; Burattini, Marcelo Nascimento; Coutinho, Francisco Antonio Bezerra] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London, England.
   [Ma, Stefan; Tun, Ye; Ang, Li Wei] Minist Hlth, Singapore, Singapore.
   [Massad, Eduardo] Natl Univ Singapore, Courage Fund Singapore, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, LIM 01-HCFMUSP,Rua Teodoro Sampaio,115,2nd Floor, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012;
   Massad, Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014
OI Coutinho, Francisco A B/0000-0003-3127-3071; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890;
   Ang, Li Wei/0000-0002-0036-255X
CR Abramowitz M, 1970, HDB MATH FUNCTIONS
   ANDERSON R M, 1991
   Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6
   Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   Canyon DV, 1999, B ENTOMOL RES, V89, P35, DOI 10.1017/S000748539900005X
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   Dos Santos RL, 2004, J MED ENTOMOL, V41, P997
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   GARRETJONES C, 1964, B WORLD HEALTH ORGAN, V30, P242
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Kamath Sandhya, 2006, J Assoc Physicians India, V54, P725
   KAY BH, 1979, J MED ENTOMOL, V16, P59, DOI 10.1093/jmedent/16.1.59
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARQUES C, 1994, T R SOC TROP MED HYG, V88, P88
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   *MIN HLTH SING, 2005, FIN REP EXP PAN DENG
   Mishra B, 2006, LANCET, V368, P918, DOI 10.1016/S0140-6736(06)69370-7
   Molineaux L, 1980, THE GARKI PROJECT
   Mourya DT, 2006, LANCET, V368, P186, DOI 10.1016/S0140-6736(06)69017-X
   MurraySmith S, 1996, AUST NZ J PUBL HEAL, V20, P545, DOI 10.1111/j.1467-842X.1996.tb01637.x
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   *WHO, CHIK DENG S W IND OC
   Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x
NR 35
TC 48
Z9 50
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD MAY-JUN
PY 2008
VL 15
IS 3
BP 147
EP 155
DI 10.1111/j.1708-8305.2008.00186.x
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA 304HZ
UT WOS:000256101900002
PM 18494691
OA Bronze
DA 2020-12-16
ER

PT J
AU Logullo, P
   de Carvalho, HB
   Saconi, R
   Massad, E
AF Logullo, Patricia
   de Carvalho, Heraclito Barbosa
   Saconi, Renata
   Massad, Eduardo
TI Factors affecting compliance with the measles vaccination schedule in a
   Brazilian city
SO SAO PAULO MEDICAL JOURNAL
LA English
DT Article
DE measles vaccine; communications media; guideline adherence;
   communication; compliance
ID SAO-PAULO; COVERAGE; INFANT; IMMUNIZATION; VACCINES; RUBELLA; STATE
AB CONTEXT AND OBJECTIVE: The success of vaccination campaigns depends on the degree of adherence to immunization initiatives and schedules. Risk factors associated with children's failure to receive the measles vaccine of the correct age were studied in the city of Sao Paulo, Brazil.
   DESIGN AND SETTING: Case-control and exploratory study, in the metropolitan area of Sao Paulo.
   METHODS: The caregivers of 122 children were interviewed regarding their perceptions and understanding about the measles vaccination and the disease.
   RESULTS: The results showed that age, region of residence, marital status and education level were unrelated to taking measles vaccines adequately. Most individuals remembered being informed about the lost annual vaccination campaign by television, but no communication channel was significantly associated with vaccination status. The answers to questions about knowledge of the disease or the vaccine, when analyzed alone, were not associated with taking measles vaccinations at the time indicated by health agencies. The results showed that, when parents felt sorry for their children who were going to receive shots, they delayed the vaccination. most of the children did not take the measles vaccination on the exactly recommended date, but delayed or anticipated the shots.
   CONCLUSION: It is clear that there is no compliance with the government's recommended measles vaccination schedule (i.e. first dose at nine and second at 15 months of age, as recommended in 1999 and 2000). Feeling so try for the children receiving shots can delay vaccination taking.
C1 [Saconi, Renata; Massad, Eduardo] Univ Sao Paulo, Fac Med, Dept Med Comp Sci, Sao Paulo, Brazil.
   [de Carvalho, Heraclito Barbosa] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil.
RP Logullo, P (corresponding author), Av Pedroso Morais 631,Conjunto 101, BR-05419000 Sao Paulo, Brazil.
EM patricia@palavraimpressa.com.br
RI Massad, Eduardo/H-6143-2011; Logullo, Patricia/I-3275-2019; Massad,
   Eduardo/B-1169-2012; Carvalho, Heraclito/C-1334-2012
OI Logullo, Patricia/0000-0001-8708-7003; Massad,
   Eduardo/0000-0002-7200-2916; Carvalho, Heraclito/0000-0002-7037-5655
CR Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6
   *CDCP, 1999, MMWR-MORBID MORTAL W, V47, P1109
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1124
   Cox MJ, 1998, T ROY SOC TROP MED H, V92, P227, DOI 10.1016/S0035-9203(98)90760-X
   CUTTS FT, 1991, B WORLD HEALTH ORGAN, V69, P1
   CUTTS FT, 1989, INT J EPIDEMIOL, V18, P427, DOI 10.1093/ije/18.2.427
   de Quadros C A, 1998, Bull World Health Organ, V76 Suppl 2, P47
   Fernandez RR, 2007, REV ESP QUIM, V20, P131
   Gebreel AO, 1997, WORLD HEALTH FORUM, V18, P32
   Guerra Fernando A, 2007, Paediatr Drugs, V9, P143, DOI 10.2165/00148581-200709030-00002
   Guttman N, 1997, HEALTH COMMUN, V9, P155, DOI 10.1207/s15327027hc0902_3
   HANLON P, 1988, J TROP MED HYG, V91, P29
   Lansley M, 2003, BRIT J GEN PRACT, V53, P657
   LASSO H P, 1986, Boletin de la Oficina Sanitaria Panamericana, V101, P39
   LEONE C, 1985, REV PAUL PEDIAT, V3, P23
   MACIEL W, 1985, FUNDAMENTOS PRATICA, P575
   MARKLAND RE, 1976, AM J PUBLIC HEALTH, V66, P168, DOI 10.2105/AJPH.66.2.168
   MARKS JS, 1979, PEDIATRICS, V64, P304
   Marshall GS, 2007, PEDIATR INFECT DIS J, V26, P496, DOI 10.1097/INF.0b013e31805d7f17
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Matsumura T, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-59
   McDivitt JA, 1997, HEALTH COMMUN, V9, P95, DOI 10.1207/s15327027hc0902_1
   *MIN SAUD, 1993, FUND NAC SAUD COORD
   MORAES JC, 1998, SARAMPO MED, V4, P69
   Nigenda-Lopez G, 1990, Salud Publica Mex, V32, P325
   NigendaLopez G, 1997, REV SAUDE PUBL, V31, P313, DOI 10.1590/S0034-89101997000300015
   O'Keefe GJ, 1998, HEALTH COMMUN, V10, P25, DOI 10.1207/s15327027hc1001_2
   Ong G., 2007, SMJ Singapore Medical Journal, V48, P656
   QUIRINO MD, 1998, THESIS U FEDERAL SAO
   REGIS MLM, 1983, THESIS U FEDERAL SAO
   Reichler MR, 1997, J INFECT DIS, V175, pS205, DOI 10.1093/infdis/175.Supplement_1.S205
   Schmitt HJ, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-11
   *SECR EST SAUD SAO, 2006, CAL VAC EST SAO PAUL
   Theeten H, 2007, VACCINE, V25, P4940, DOI 10.1016/j.vaccine.2007.03.032
   Torun SD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-125
   Vesikari T, 2007, PEDIATR INFECT DIS J, V26, P632, DOI 10.1097/INF.0b013e3180616c8f
   Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5
NR 38
TC 8
Z9 9
U1 0
U2 4
PU ASSOCIACAO PAULISTA MEDICINA
PI SAO PAULO
PA AV BRIG LUIS ANTONIO, 278-7 ANDAR, SAO PAULO, CEP01318-901, BRAZIL
SN 1516-3180
J9 SAO PAULO MED J
JI Sao Paulo Med. J.
PD MAY 1
PY 2008
VL 126
IS 3
BP 166
EP 171
DI 10.1590/S1516-31802008000300006
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 346GB
UT WOS:000259055600006
PM 18711656
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Chen, M
   Chow, A
   Coutinho, FAB
   Goh, KT
   Lopez, LF
   Ma, S
   Massad, E
AF Burattini, M. N.
   Chen, M.
   Chow, A.
   Coutinho, F. A. B.
   Goh, K. T.
   Lopez, L. F.
   Ma, S.
   Massad, E.
TI Modelling the control strategies against dengue in Singapore
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID SAO-PAULO STATE; THRESHOLD CONDITIONS; POPULATION-DYNAMICS;
   YELLOW-FEVER; TRANSMISSION; INFECTION; EPIDEMIC; SYSTEM; BRAZIL; RISK
AB Notified cases of dengue infections in Singapore reached historical highs in 2004 (9459 cases) and 2005 (13 817 cases) and the reason for such all increase is still to be established. We apply a mathematical model for dengue infection that takes into account the seasonal variation in incidence, characteristic of dengue fever, and which mimics the 2004-2005 epidemics in Singapore. We simulated a set of possible control strategies and confirmed the intuitive belief that killing adult mosquitoes is the most effective strategy to control an ongoing epidemic. On the other hand, the control of immature forms was very efficient ill preventing the resurgence of dengue epidemics. Since the control of immature forms allows the reduction of adulticide, it seems that the best strategy is to combine both adulticide and larvicide control measures during an outbreak, followed by the maintenance of larvicide methods after the epidemic has subsided. In addition, the model showed that the mixed strategy of adulticide and larvicide methods introduced by the government seems to be very effective in reducing the number of cases in the first weeks after the start of control.
C1 [Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Massad, E.] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   [Chen, M.] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore.
   [Chow, A.; Goh, K. T.; Ma, S.] Minist Hlth, Singapore, Singapore.
   [Massad, E.] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, LIM 01-HCFMUSP,Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Chen, Mark/Q-5605-2019; Coutinho, Francisco A B/H-5644-2011; Lopez, Luis
   F/C-4721-2012; Massad, Eduardo/H-6143-2011; Burattini, Marcelo
   N/J-9272-2014; Massad, Eduardo/B-1169-2012
OI Chen, Mark/0000-0001-9369-5830; Coutinho, Francisco A
   B/0000-0003-3127-3071; Lopez, Luis F/0000-0003-4097-6887; Burattini,
   Marcelo N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916
FU LIM01/HCFMUSP; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); CNPqNational Council for Scientific and Technological
   Development (CNPq); Courage Fund
FX This work was supported by LIM01/HCFMUSP, FAPESP, CNPq and the Courage
   Fund.
CR Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Forattini O. P., 1996, MED CULICIDOLOGY
   GOH KT, 1995, LANCET, V346, P1098, DOI 10.1016/S0140-6736(95)91771-3
   Gubler D, 1997, DENGUE DENGUE HEMORR
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   *MIN HLTH SING, 2005, FIN REP EXP PAN DENG
   *MOH, 2005, MOH WEEKL INF DIS B, V1
   *NAT ENV AG, 2005, MIN ENV WAT RES SING
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   WHO. World Health Organization, 2002, DENG DENG HAEM FEV
   Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x
NR 20
TC 97
Z9 99
U1 3
U2 26
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAR
PY 2008
VL 136
IS 3
BP 309
EP 319
DI 10.1017/S0950268807008667
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 348GF
UT WOS:000259198300003
PM 17540051
OA Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Pardini, MI
   Jamal, LF
   Durigon, EL
   Massad, E
   Perez, JF
   Pinho, JR
   Holmes, EC
   Zanotto, PM
AF de Moura Campos Pardini, Maria Ines
   Jamal, Leda Fatima
   Durigon, Edison Luiz
   Massad, Eduardo
   Perez, Jose Fernando
   Rebello Pinho, Joao Renato
   Holmes, Edward C.
   de Andrade Zanotto, Paolo Marinho
TI Boosting virology in Brazil
SO PLOS BIOLOGY
LA English
DT Editorial Material
C1 [Durigon, Edison Luiz; Massad, Eduardo; Rebello Pinho, Joao Renato; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Sao Paulo, Brazil.
   [de Moura Campos Pardini, Maria Ines] Univ Sao Paulo State, Sao Paulo, Brazil.
   [Jamal, Leda Fatima] STD AIDS Reference & Training Ctr Sao Paulo, Sao Paulo, Brazil.
   [Holmes, Edward C.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
RP Zanotto, PM (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.
EM pzanotto@usp.br
RI Pinho, Joao R. R./G-2850-2012; Massad, Eduardo/H-6143-2011; Holmes,
   Edward/Y-2789-2019; Massad, Eduardo/B-1169-2012; de A. Zanotto, Paolo
   M./B-9286-2019
OI Pinho, Joao R. R./0000-0003-3999-0489; Holmes,
   Edward/0000-0001-9596-3552; Massad, Eduardo/0000-0002-7200-2916; de A.
   Zanotto, Paolo M./0000-0002-8167-0625; Durigon,
   Edison/0000-0003-4898-6553; Pardini, Maria Ines de Moura
   Campos/0000-0001-6470-0944
CR *BRAZ MIN HLTH, 2007, REP HCPS CAS JUN 200
   Simpson AJG, 1998, NAT BIOTECHNOL, V16, P795, DOI 10.1038/nbt0998-795
   Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003
NR 3
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAR
PY 2008
VL 6
IS 3
BP 428
EP 429
AR e57
DI 10.1371/journal.pbio.0060057
PG 2
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 287PI
UT WOS:000254928600002
PM 18336070
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Chaib, E
   Massad, E
AF Chaib, Eleazar
   Massad, Eduardo
TI Expected number of deaths in the liver transplantation waiting list in
   the state of Sao Paulo, Brazil
SO TRANSPLANT INTERNATIONAL
LA English
DT Letter
ID DONORS
C1 [Chaib, Eleazar; Massad, Eduardo] Univ Sao Paulo, Sch Med, Dept Gastroenterol, BR-05508 Sao Paulo, Brazil.
   [Chaib, Eleazar; Massad, Eduardo] Univ Sao Paulo, Sch Med, LIM 01, BR-05508 Sao Paulo, Brazil.
RP Chaib, E (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, BR-05508 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   Garcia VD, 2005, J REG C MED S PAULO, V30, P1
   HOEL PG, 1984, INTRO MATH STAT, P409
   Laskowski IA, 1999, CLIN TRANSPLANT, V13, P281, DOI 10.1034/j.1399-0012.1999.130401.x
   Machado M C, 1972, Rev Hosp Clin Fac Med Sao Paulo, V27, P1
   Nicholson ML, 1997, TRANSPL P, V29, P1386, DOI 10.1016/S0041-1345(96)00605-7
NR 6
TC 9
Z9 9
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0934-0874
J9 TRANSPL INT
JI Transpl. Int.
PD MAR
PY 2008
VL 21
IS 3
BP 290
EP 291
DI 10.1111/j.1432-2277.2007.00600.x
PG 2
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 258XB
UT WOS:000252902400013
PM 18039317
OA Bronze
DA 2020-12-16
ER

PT J
AU Massad, E
   Ma, S
   Chen, M
   Struchiner, CJ
   Stollenwerk, N
   Aguiar, M
AF Massad, Eduardo
   Ma, Stefen
   Chen, Mark
   Struchiner, Claudio Jose
   Stollenwerk, Nico
   Aguiar, Maira
TI Scale-free network of a dengue epidemic
SO APPLIED MATHEMATICS AND COMPUTATION
LA English
DT Article
DE power-law; scale-free network; dengue; Singapore
ID SYSTEM
AB In this work we show that the dengue epidemic in the city of Singapore organized itself into a scale-free network of transmission as the 2000-2005 outbreaks progressed. This scale-free network of cluster comprised geographical breeding places for the aedes mosquitoes, acting as super-spreaders nodes in a network of transmission. The geographical organization of the network was analysed by the corresponding distribution of weekly number of new cases. Therefore, our hypothesis is that the distribution of dengue cases reflects the geographical organization of a transmission network, which evolved towards a power law as the epidemic intensity progressed until 2005. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Massad, Eduardo] Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, SP, Brazil.
   [Massad, Eduardo] Univ London, London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo] Natl Univ Singapore, Singapore 117548, Singapore.
   [Ma, Stefen] Epidemiol & Dis Control Div, Minist Educ, Singapore, Singapore.
   [Chen, Mark] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore.
   [Stollenwerk, Nico] Univ Porto, Fac Ciencias, Ctr Math, P-4100 Oporto, Portugal.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Aguiar, Maira/ABD-6780-2020; Aguiar,
   Maira/E-5448-2018; Chen, Mark/Q-5605-2019; Massad, Eduardo/B-1169-2012;
   Struchiner, Claudio J/M-9360-2013
OI Aguiar, Maira/0000-0001-8354-9944; Aguiar, Maira/0000-0001-8354-9944;
   Chen, Mark/0000-0001-9369-5830; Massad, Eduardo/0000-0002-7200-2916;
   Struchiner, Claudio J/0000-0003-2114-847X; Stollenwerk,
   Nico/0000-0001-9315-5586
CR Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47
   ANDERSON R M, 1991
   Anderson R. M., 1982, POPULATION DYNAMICS
   Bailey N., 1975, MATH THEORY INFECT D
   Bailey N.T.J., 1982, BIOMATHEMATICS MALAR
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003
   Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519
   GOH KT, 1995, LANCET, V346, P1098, DOI 10.1016/S0140-6736(95)91771-3
   Kiss IZ, 2006, J R SOC INTERFACE, V3, P55, DOI 10.1098/rsif.2005.0079
   MASSAD E, 2004, QUANTITATIVE METHODS
   Ministry of Health of Singapore (MOH), 2005, FIN REP EXP PAN DENG
   *MOH, 2006, EPIDEMIOLOGICAL NEWS, V32, P1
   *NEA, 2005, NEAS KEY OP STRAT DE
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983
   Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200
   Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   *WID, 2005, WEEKL INF DIS B, V1, P52
NR 22
TC 23
Z9 24
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0096-3003
EI 1873-5649
J9 APPL MATH COMPUT
JI Appl. Math. Comput.
PD FEB 1
PY 2008
VL 195
IS 2
BP 376
EP 381
DI 10.1016/j.amc.2007.04.102
PG 6
WC Mathematics, Applied
SC Mathematics
GA 262UP
UT WOS:000253173800003
DA 2020-12-16
ER

PT J
AU Cohen, C
   Vianna, JAR
   Battistella, LR
   Massad, E
AF Cohen, C.
   Vianna, J. A. R.
   Battistella, L. R.
   Massad, E.
TI Time variation of some selected topics in bioethical publications
SO JOURNAL OF MEDICAL ETHICS
LA English
DT Article
ID BIBLIOMETRIC ANALYSIS; EMPIRICAL-RESEARCH; AIDS LITERATURE;
   EPIDEMIOLOGY; JOURNALS
AB Objective: To analyse the time variation of topics in bioethical publications as a proxy of the relative importance.
   Methods: We searched the Medline database for bioethics publications using the words "ethics or bioethics'', and for 360 specific topics publications, associating Medical Subject Heading topic descriptors to those words. We calculated the ratio of bioethics publications to the total publications of Medline, and the ratio of each topic publications to the total bioethics publications, for five-year intervals, from 1970 to 2004. We calculated the time variation of ratios, dividing the difference between the highest and lowest ratio of each topic by its highest ratio. Four topics were described, selected to illustrate different patterns of variation: "Induced Abortion'', "Conflict of Interest'', "Acquired Immunodeficiency Syndrome'', "Medical Education.''
   Results: The ratio of bioethics publications to total Medline publications increased from 0.003 to 0.012. The variation of the topic's ratios was higher than 0.7 for 68% of the topics. The Induced Abortion ratios decreased from 0.12 to 0.02. Conflict of Interest ratios increased from zero to 0.07. The Acquired Immunodeficiency Syndrome ratios were nearly zero in the first three intervals, had a peak of 0.06 during 1985-9, followed by a decrease to 0.01. Medical Education ratios varied few, from 0.04 to 0.03.
   Conclusions: There was an increase of bioethical publications in the Medline database. The topics in bioethics literature have an important time variation. Some factors were suggested to explain this variation: current legal cases, resolution of the issue, saturation of a discussion and epidemiologic importance.
C1 [Cohen, C.; Vianna, J. A. R.; Battistella, L. R.; Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RP Vianna, JAR (corresponding author), Ave Macuco 550 Apt 54, BR-04523001 Sao Paulo, SP, Brazil.
EM j.a.y.m.e@uol.com.br
RI Vianna, Jayme/L-4307-2019; Battistella, Linamara Rizzo/E-5131-2013;
   Massad, Eduardo/B-1169-2012; Battistella, Linamara Rizzo/I-7347-2019;
   Massad, Eduardo/H-6143-2011
OI Vianna, Jayme/0000-0001-5302-7950; Battistella, Linamara
   Rizzo/0000-0001-5275-0733; Massad, Eduardo/0000-0002-7200-2916; 
CR Borry P, 2005, NEW ENGL J MED, V353, P852, DOI 10.1056/NEJMc051496
   Borry P, 2006, J MED ETHICS, V32, P240, DOI 10.1136/jme.2004.011478
   BORRY P, 2006, BMC MED ETHICS, V7, P1
   LEIGHT T, 2004, BRIT MED J, V328, P175
   Macias-Chapula CA, 2000, B MED LIBR ASSOC, V88, P56
   NARIN F, 1994, EVALUATION REV, V18, P65, DOI 10.1177/0193841X9401800107
   *NAT LIB MED, MED SUBJ HEAD MESH
   *NAT LIB MED, MESH AB
   *NAT LIB MED, DIFF MEDLINE PUBM
   *NAT LIBR MED, CIT MAINT TASKS XML
   *NAT REF CTR BIO L, 2005, LIBR CLASS SCH
   National Library of Medicine, MED SUBJ HEAD
   POST SG, 2003, ENCY BIO
   PRATT GF, 1992, B MED LIBR ASSOC, V80, P380
   Rodriguez Del Pozo Pablo, 2005, BMC Med Ethics, V6, pE6
   Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589
   SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160
   Sugarman J, 2004, J LAW MED ETHICS, V32, P226, DOI 10.1111/j.1748-720X.2004.tb00469.x
   Takahashi K, 1996, OCCUP ENVIRON MED, V53, P433, DOI 10.1136/oem.53.7.433
   U.S. National Library of Medicine, MESH CONFL INT
   Wallin JA, 2005, BASIC CLIN PHARMACOL, V97, P261, DOI 10.1111/j.1742-7843.2005.pto_139.x
   YOUNG H, 1983, ALA GLOSSARY LIBRARY
NR 22
TC 6
Z9 6
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-6800
EI 1473-4257
J9 J MED ETHICS
JI J. Med. Ethics
PD FEB 1
PY 2008
VL 34
IS 2
BP 81
EP 84
DI 10.1136/jme.2006.019091
PG 4
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA 257CJ
UT WOS:000252776500009
PM 18234943
DA 2020-12-16
ER

PT J
AU Logullo, P
   de Carvalho, HB
   Saconi, R
   Massad, E
AF Logullo, Patricia
   de Carvalho, Heraclito Barbosa
   Saconi, Renata
   Massad, Eduardo
TI Fear of injections is a reason for not to vaccinate their children, say
   caretakers
SO VACCINE
LA English
DT Letter
DE measles vaccine; communications; media; guideline adherence;
   communication; compliance
ID COVERAGE; MEASLES; IMMUNIZATION; INFANT; STRATEGY; RUBELLA; EUROPE
C1 [Logullo, Patricia] FMUSP, Sao Paulo, Brazil.
   [de Carvalho, Heraclito Barbosa] FMUSP, Dept Prevent Med, Sao Paulo, Brazil.
   [Saconi, Renata; Massad, Eduardo] FMUSP, Dept Med Comp Sci, Sao Paulo, Brazil.
RP Logullo, P (corresponding author), Av Pedroso Morais 631,Conjunto 101, BR-05419000 Sao Paulo, SP, Brazil.
EM plogullo@uol.com.br
RI Carvalho, Heraclito/C-1334-2012; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Logullo, Patricia/I-3275-2019
OI Carvalho, Heraclito/0000-0002-7037-5655; Massad,
   Eduardo/0000-0002-7200-2916; Logullo, Patricia/0000-0001-8708-7003
CR Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6
   *BRAS MIN SAUD, 1993, FUND NAC SAUD COORD
   *CAL VAC EST S PAU, 2006, SECR EST SAUD S PAUL
   CUTTS FT, 1989, INT J EPIDEMIOL, V18, P427, DOI 10.1093/ije/18.2.427
   de Quadros C A, 1998, Bull World Health Organ, V76 Suppl 2, P47
   Fernandez RR, 2007, REV ESP QUIM, V20, P131
   Guerra Fernando A, 2007, Paediatr Drugs, V9, P143, DOI 10.2165/00148581-200709030-00002
   Guttman N, 1997, HEALTH COMMUN, V9, P155, DOI 10.1207/s15327027hc0902_3
   HANLON P, 1988, J TROP MED HYG, V91, P29
   LASSO H P, 1986, Boletin de la Oficina Sanitaria Panamericana, V101, P39
   MARKLAND RE, 1976, AM J PUBLIC HEALTH, V66, P168, DOI 10.2105/AJPH.66.2.168
   MARKS JS, 1979, PEDIATRICS, V64, P304
   Marshall GS, 2007, PEDIATR INFECT DIS J, V26, P496, DOI 10.1097/INF.0b013e31805d7f17
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Matsumura T, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-59
   McDivitt JA, 1997, HEALTH COMMUN, V9, P95, DOI 10.1207/s15327027hc0902_1
   Nigenda-Lopez G, 1990, Salud Publica Mex, V32, P325
   NigendaLopez G, 1997, REV SAUDE PUBL, V31, P313, DOI 10.1590/S0034-89101997000300015
   O'Keefe GJ, 1998, HEALTH COMMUN, V10, P25, DOI 10.1207/s15327027hc1001_2
   Ong G., 2007, SMJ Singapore Medical Journal, V48, P656
   Reichler MR, 1997, J INFECT DIS, V175, pS205, DOI 10.1093/infdis/175.Supplement_1.S205
   Schmitt HJ, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-11
   Theeten H, 2007, VACCINE, V25, P4940, DOI 10.1016/j.vaccine.2007.03.032
   Torun SD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-125
   Vesikari T, 2007, PEDIATR INFECT DIS J, V26, P632, DOI 10.1097/INF.0b013e3180616c8f
NR 26
TC 7
Z9 7
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
J9 VACCINE
JI Vaccine
PD JAN 10
PY 2008
VL 26
IS 2
BP 141
EP 143
DI 10.1016/j.vaccine.2007.09.075
PG 3
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 261DT
UT WOS:000253060000001
PM 18061314
DA 2020-12-16
ER

PT J
AU Chaib, E
   Massad, E
AF Chaib, Eleazar
   Massad, Eduardo
TI Comparing the dynamics of kidney and liver transplantation waiting list
   in the state of Sao Paulo, Brazil
SO TRANSPLANTATION
LA English
DT Letter
ID HEART-BEATING DONORS; NONHEARTBEATING DONORS
C1 Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil.
RP Chaib, E (corresponding author), 30 Ridgeway Rd, Oxford OX3 8DR, England.
EM eleazarchaib@yahoo.co.uk
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Abt P, 2003, TRANSPLANTATION, V75, P1659, DOI 10.1097/01.TP.0000062574.18648.7C
   Chaib E, 2005, TRANSPLANT P, V37, P4329, DOI 10.1016/j.transproceed.2005.11.014
   D'Alessandro AM, 2000, SURGERY, V128, P579, DOI 10.1067/msy.2000.108421
   Feldman HI, 1996, NEPHROL DIAL TRANSPL, V11, P1306
   FREIRE J.G.C., 1968, REV ASSOC MED BRAS, V14, P133
   Garcia VD, 2005, J REG C MED S PAULO, V30, P1
   Garcia-Valdecasas JC, 1999, EUR SURG RES, V31, P447, DOI 10.1159/000008724
   Gonzalez-Segura C, 1998, TRANSPLANTATION, V65, P1465, DOI 10.1097/00007890-199806150-00010
   KOFMANN CG, 1993, TRANSPL P, V25, P1527
   Laskowski IA, 1999, CLIN TRANSPLANT, V13, P281, DOI 10.1034/j.1399-0012.1999.130401.x
   Machado M C, 1972, Rev Hosp Clin Fac Med Sao Paulo, V27, P1
   Metcalfe MS, 2000, LANCET, V356, P1853
   Nicholson ML, 1997, TRANSPL P, V29, P1386, DOI 10.1016/S0041-1345(96)00605-7
   VARTY K, 1994, BRIT J SURG, V81, P1459, DOI 10.1002/bjs.1800811018
   WIJNEN RMH, 1995, LANCET, V345, P1067, DOI 10.1016/S0140-6736(95)90815-3
   YOKOYAMA I, 1994, CLIN TRANSPLANT, V8, P101
NR 16
TC 6
Z9 6
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD NOV 15
PY 2007
VL 84
IS 9
BP 1209
EP 1211
DI 10.1097/01.tp.0000287192.32090.2b
PG 3
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 232PC
UT WOS:000251030600024
PM 17998880
DA 2020-12-16
ER

PT J
AU Rozman, MA
   Alves, IS
   Porto, MA
   Gomes, PO
   Ribeiro, NM
   Nogueira, LAA
   Caseiro, MM
   da Silva, VA
   Massad, E
   Burattini, MN
AF Rozman, Mauro Abrahao
   Alves, Igor Santino
   Porto, Marcela Alves
   Gomes, Patricia Oliveira
   Ribeiro, Nilva Maria
   Andrade Nogueira, Lucyene Aparecida
   Caseiro, Marcos Monteiro
   da Silva, Vera Aparecida
   Massad, Eduardo
   Burattini, Marcelo Nascimento
TI HIV and related infections in a sample of recyclable waste collectors of
   Brazil
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Letter
ID PARENTERAL TRANSMISSION; PRISONERS; HCV
C1 Univ Sao Paulo, Fac Med, Cent Lab, Hosp & Clin Dept Clin Pathol, BR-05403 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, Dept Pathol, BR-05405 Sao Paulo, Brazil.
   Univ London, London Sch Hyg & Trop Med, Dept Infect & Trop Med, London, England.
EM mnburaft@usp.br
RI Massad, Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916
CR Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Burattini MN, 2005, INT J STD AIDS, V16, P836, DOI 10.1258/095646205774988136
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   *MIN SAUD, 2005, B EP AIDST
   Strazza L, 2004, BRAZ J MED BIOL RES, V37, P771, DOI 10.1590/S0100-879X2004000500020
   Strazza L, 2007, CAD SAUDE PUBLICA, V23, P197, DOI 10.1590/S0102-311X2007000100021
   Zanetta DMT, 1999, INT J STD AIDS, V10, P98, DOI 10.1258/0956462991913718
   ZANIN M, METODOLOGIA INCUBACA
NR 8
TC 4
Z9 5
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD SEP
PY 2007
VL 18
IS 9
BP 653
EP 654
DI 10.1258/095646207781568574
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 209GA
UT WOS:000249375800024
PM 17785020
DA 2020-12-16
ER

PT J
AU Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
AF Lopez, L. F.
   Coutinho, Francisco A. B.
   Burattini, Marcelo N.
   Massad, Eduardo
TI A schematic age-structured compartment model of the impact of
   antiretroviral on HIV incidence and prevalence (vol 71, pg 131, 2006)
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Correction
C1 Univ Sao Paulo, BR-05405000 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Rua Teodoro Sampaio 155, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Lopez, Luis F/C-4721-2012; Massad,
   Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; Lopez, Luis F/0000-0003-4097-6887; 
CR Lopez LF, 2006, MATH COMPUT SIMULAT, V71, P131, DOI 10.1016/j.matcom.2006.01.004
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD FEB 6
PY 2007
VL 73
IS 6
BP 408
EP 408
DI 10.1016/j.matcom.2006.09.001
PG 1
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 132HG
UT WOS:000243933300006
DA 2020-12-16
ER

PT J
AU Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
AF Lopez, L. F.
   Coutinho, F. A. B.
   Burattini, M. N.
   Massad, E.
TI A schematic age-structured compartment model of the impact of
   antiretroviral therapy on HIV incidence and prevalence (vol 71, pg 131,
   2006)
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Correction
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, HCFMUSP, LIM01, BR-01246903 Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012; Massad,
   Eduardo/H-6143-2011; Coutinho, Francisco A B/H-5644-2011; Massad,
   Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Lopez, Luis
   F/0000-0003-4097-6887; Coutinho, Francisco A B/0000-0003-3127-3071;
   Massad, Eduardo/0000-0002-7200-2916
CR Lopez LF, 2006, MATH COMPUT SIMULAT, V71, P131, DOI 10.1016/j.matcom.2006.01.004
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD JAN 10
PY 2007
VL 73
IS 5
BP 341
EP 341
DI 10.1016/j.matcom.2006.05.001
PG 1
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 127NA
UT WOS:000243591800007
DA 2020-12-16
ER

PT J
AU Strazza, L
   Massad, E
   Azevedo, RS
   Carvalho, HB
AF Strazza, Leila
   Massad, Eduardo
   Azevedo, Raymundo S.
   Carvalho, Heraclito B.
TI Behavior associated with HIV and HCV infection in female prison inmates
   in Sao Paulo, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE women's health; acquired immunodeficiency syndrome; hepatitis C; prisons
ID HEPATITIS-C VIRUS; CORRECTIONAL FACILITIES; INCARCERATED WOMEN;
   RISK-FACTORS; SYPHILIS; PREVALENCE; TRANSMISSION; PROGRAM
AB An increase has been observed in AIDS and hepatitis C cases in women, including female prison inmates. This study focused on inmates' behavioral factors associated with risk of HIV and HCV transmission in a women's detention facility in S (a) over tildeo Paulo, Brazil. Behavioral questionnaires were applied and HIV and HCV serology were performed. The selected measure of association was odds ratio for both the bi and multivariate logistic regression analyses. 290 inmates participated in the study. HIV and HCV prevalence rates were 13.9% and 16.2%, respectively. Statistically significant associations were observed (p < 0.05) between HIV and the following variables: partner with AIDS OR = 6.9 (2.7-35.2); injection drug users (IDU) OR = 3.3 (1.6-14.7); regular partner OR = 3.7 (1.5-8.3), and between HCV and: IDU OR = 13.7 (4.4-42.7); IDU partner OR = 4.9 (1.9-12.2); previous arrest OR = 2.8 (1.2-6.5) adjusted for: partner with AIDS, IDU, IDU partner, drug user, and previous arrest. In conclusion, parenteral risk was associated with HIV and HCV infection and sexual risk with HIV. Appropriate and continuous preventive programs are recommended in the prison.
C1 [Strazza, Leila; Massad, Eduardo; Azevedo, Raymundo S.; Carvalho, Heraclito B.] Univ Sao Paulo, Fac Med, Dept Legal Med, BR-01246903 Sao Paulo, SP, Brazil.
RP Strazza, L (corresponding author), Univ Sao Paulo, Fac Med, Dept Legal Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM strazza@usp.br
RI Azevedo, Raymundo S/B-7593-2008; Massad, Eduardo/B-1169-2012; Carvalho,
   Heraclito/C-1334-2012; Massad, Eduardo/H-6143-2011
OI Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Carvalho, Heraclito/0000-0002-7037-5655; 
CR Altice FL, 2005, J URBAN HEALTH, V82, P312, DOI 10.1093/jurban/jti055
   Caiaffa WT, 2003, J URBAN HEALTH, V80, P106, DOI 10.1093/jurban/jtg106
   CASTILHO EA, 1997, POLITICAS I AIDS ENF, P17
   Catalan-Soares B C, 2000, Rev Soc Bras Med Trop, V33, P27, DOI 10.1590/S0037-86822000000100004
   de la Hoya PS, 2005, ENFERM INFEC MICR CL, V23, P53, DOI 10.1157/13071605
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   Esteban JL, 1992, BLOOD SAFETY CURRENT, P45
   FERREIRA MMC, 1997, THESIS U SAO PAULO S
   FLETCHER H, 2003, EPIDEMIOLOGIA CLIN
   Hellard ME, 2004, EPIDEMIOL INFECT, V132, P409, DOI 10.1017/S0950268803001882
   JARLAIS DCD, 1995, AIDS, V9, P611, DOI 10.1097/00002030-199506000-00013
   LOPES F, 1998, CAD SAUDE PUBLICA, V17, P1473
   Mann J, 1993, AIDS MUNDO
   Martin RE, 2005, CAN J PUBLIC HEALTH, V96, P97, DOI 10.1007/BF03403669
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   MESQUITA F, 1998, TROCA SERINGAS DROGA, P101
   *MIN SAUD, 2005, B EP AIDST
   Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001
   NDUMBE E, 1999, EPIDEMIOLOGY HEPATIT, P11
   PARKER R, 1997, POLITICAS I AIDS ENT
   Rich JD, 2001, AIDS PATIENT CARE ST, V15, P581, DOI 10.1089/108729101753287676
   Rotily M, 1997, INT J STD AIDS, V8, P753, DOI 10.1258/0956462971919228
   Skipper C, 2003, GUT, V52, P1500, DOI 10.1136/gut.52.10.1500
   SMITH PF, 1991, AM J PUBLIC HEALTH, V81, P35, DOI 10.2105/AJPH.81.Suppl.35
   Solomon L, 2004, J URBAN HEALTH, V81, P25, DOI 10.1093/jurban/jth085
   STRAZZA L, 2003, THESIS U SAO PAULO S
   STRAZZA L, 1999, THESIS U SAO PAULO S
   VAZ RG, 1995, INT J STD AIDS, V6, P42, DOI 10.1177/095646249500600109
NR 28
TC 24
Z9 30
U1 0
U2 13
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2007
VL 23
IS 1
BP 197
EP 205
DI 10.1590/S0102-311X2007000100021
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 270EN
UT WOS:000253703200021
PM 17187118
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
AF Massad, Eduardo
   Burattini, Marcelo Nascimento
   Coutinho, Francisco Antonio Bezerra
   Lopez, Luiz Fernandes
TI The 1918 influenza A epidemic in the city of Sao Paulo, Brazil
SO MEDICAL HYPOTHESES
LA English
DT Article
AB The 1918 pandernic H1N1 outbreak in the city of Sao Paulo is revisited. The outbreak lasted for 10 weeks and reached 116,771 officially recorded cases amongst 523,194 inhabitants. The total number of deaths summed up to 5331, with a letality rate of 4.5% and an overall mortality rate of around 1%. We propose a mathematical model that tallies available data with good accuracy and allows the estimation of the basic reproductive number, R-0. The model showed a remarkably good accuracy in retrieving the real data from Sao Paulo city outbreak considering the total number of recorded cases and deaths and the timing of the outbreak. The basic reproduction number calculated of 2.68 can be compared to estimates carried out for other flu strains, like the estimates for H3N2, whose values ranged from 1.5 to 2.5.
   We hypothesize that the Southern parts of the world in which there was relatively little impact of the Great War, like South America, suffered a much tower H1N1 influenza mortality as compared with that reported for the Northern hemisphere heavily affected by the I World War. (c) 2006 Elsevier Ltd. All. rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-05405000 Sao Paulo, Brazil.
   HCFMUSP, LIM01, BR-05405000 Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, London WC1, England.
   HCFMUSP, LIM47, BR-05405000 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Rua Teodoro Sampaio 115, BR-05405000 Sao Paulo, Brazil.
EM edmassad@usp.brb
RI Massad, Eduardo/B-1169-2012; Lopez, Luis F/C-4721-2012; Coutinho,
   Francisco A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; 
CR ANDERSON R M, 1991
   CROSBY AW, 1993, INFLUENZA CAMBRIDGE
   FILHO CB, 2003, GRIPE ESPANHOLA SAO, P393
   Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254
   LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8
   Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   NICHOLSON KG, 1998, TXB INFLUENZA
   O'Neill PD, 2001, J R STAT SOC C-APPL, V50, P283
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   TEIXEIRA AL, 2003, HIST CIENC SAUDE-MAN, V10, P757
NR 12
TC 40
Z9 40
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2007
VL 68
IS 2
BP 442
EP 445
DI 10.1016/j.mehy.2006.07.041
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 126WI
UT WOS:000243545800040
PM 17011139
DA 2020-12-16
ER

PT J
AU Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Massad, E
AF Coutinho, F. A. B.
   Burattini, M. N.
   Lopez, L. F.
   Massad, E.
TI Threshold conditions for a non-autonomous epidemic system describing the
   population dynamics of dengue
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE dengue; vector-borne; Aedes aegypti; Aedes albopictus; overwinter;
   vertical transmission; modeling; non-autonomous systems
ID MOSQUITOS; PERSISTENCE; GENERATIONS; BRAZIL; VIRUS
AB A non-autonomous dynamical system, in which the seasonal variation of a mosquito vector population is modeled, is proposed to investigate dengue overwintering. A time-dependent threshold, R(t), is deduced such that when its yearly average, denoted by (R) over bar, is less than 1, the disease does not invade the populations and when (R) over bar is greater than 1 it does. By not invading the population we mean that the number of infected individuals always decrease in subsequent seasons of transmission. Using the same threshold, all the qualitative features of the resulting epidemic can be understood. Our model suggests that trans-ovarial infection in the mosquitoes facilitates dengue overwintering. We also explain the delay between the peak in the mosquitoes population and the peak in dengue cases.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, LIM01, BR-01246903 Sao Paulo, Brazil.
   Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Burattini,
   Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012; Coutinho, Francisco A
   B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; Lopez, Luis F/0000-0003-4097-6887; Coutinho,
   Francisco A B/0000-0003-3127-3071
CR BANCROFT TL, 1906, AUSTRALAS MED GAZ, V25, P17
   Beaty B.J., 1996, BIOL DIS VECTORS
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   ELSGOLTS EL, 1966, INTRO THEORY DIFFERE
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   FORATTINI OP, 2002, MED CULICIDOLOGY EDU
   Gubler D, 1997, DENGUE DENGUE HEMORR
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MONATH TP, 1996, VIROLOGY, P961
   RODAHIN F, 1997, DENGUE DENGUE HEMORR
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
NR 15
TC 87
Z9 89
U1 1
U2 35
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD NOV
PY 2006
VL 68
IS 8
BP 2263
EP 2282
DI 10.1007/s11538-006-9108-6
PG 20
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 102FQ
UT WOS:000241796800018
PM 16952019
DA 2020-12-16
ER

PT J
AU da Rocha, AF
   Leite, CDC
   Rocha, FT
   Massad, E
   Cerri, GG
   Angelotti, SAD
   Gomes, EHG
   Oliveira, CCM
AF da Rocha, Armando Freitas
   Leite, Claudia da Costa
   Rocha, Fabio Theoto
   Massad, Eduardo
   Cerri, Giovanni Guido
   Angelotti, Sueli Aparecida de Oliveira
   Gomes, Eloisa Helena Garcia
   Oliveira, Carla Cristina M.
TI A MRI study of 146 Brazilian children
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE mental retardation; magnetic resonance image; maternal stress; cerebral
   lesion; agressiveness
ID CORPUS-CALLOSUM; BRAIN; STRESS; LANGUAGE; LESIONS
AB We report results of a magnetic ressonance imaging (MRI) study of 146 Brazilian children, whose intelligence quotient scored less than 70. 50% of MRI examinations did not exhibit any signal of structural lesion (N group), whereas a focal thinning at the junction of the body and splenium of the corpus callosum; ventricular asymmetry; periventricular leukomalacia; gliosis and arachnoid cysts were among the most frequent findings in the remaining of subjects (L group). Maternal stress and altered blood pressure were the most frequent findings in the pre-natal history of both N and L children. Familial antecedents of mental deficiency were reported in 30% of both groups, whereas familiar history of alcoholism was important in N group (60% in N versus 0% in L groups). Neuropsychomotor development was delayed in 80% of the children in both groups. Aggressiveness is the most frequent finding in the post-natal children history.
C1 FMUSP, Sch Med, BR-01246903 Sao Paulo, Brazil.
   FMUSP, HCF, LIM01, Sao Paulo, Brazil.
   FMUSP, Dept Radiol, Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, London WC1, England.
   APAE, Jundiai, Brazil.
RP Massad, E (corresponding author), FMUSP, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Leite, Claudia C/B-6036-2013; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Rocha, Armando Freitas
   da/0000-0002-1301-8491
CR ACCARDO PJ, 1996, DEV DISABILITIES INF
   AICARDI J, 1998, MENTAL RETARDATION D
   Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5
   Bryan RN, 1997, RADIOLOGY, V202, P47, DOI 10.1148/radiology.202.1.8988191
   Buitelaar JK, 2003, NEUROBIOL AGING, V24, pS53, DOI 10.1016/S0197-4580(03)00050-2
   Cans C, 1999, DEV MED CHILD NEUROL, V41, P233, DOI 10.1017/S001216229900050X
   Castro-Caldas A, 2000, NEUROSCIENTIST, V6, P475, DOI 10.1177/107385840000600610
   Chance SA, 2003, SCHIZOPHR RES, V62, P123, DOI 10.1016/S0920-9964(02)00344-4
   De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2
   de Weerth C, 2003, EARLY HUM DEV, V74, P139, DOI 10.1016/S0378-3782(03)00088-4
   Denis D, 2000, BRAIN DEV-JPN, V22, P475, DOI 10.1016/S0387-7604(00)00173-X
   Gilmore JH, 2001, SCHIZOPHR RES, V48, P219, DOI 10.1016/S0920-9964(00)00140-7
   Glynn LM, 2004, J PSYCHOSOM RES, V56, P47, DOI 10.1016/S0022-3999(03)00133-8
   Harel S, 1996, PEDIATR NEUROL, V15, P305, DOI 10.1016/S0887-8994(96)00222-6
   Ichihashi K, 2002, EARLY HUM DEV, V68, P55
   Kaufer D, 1999, NEUROSCIENTIST, V5, P173, DOI 10.1177/107385849900500314
   Krageloh-Mann I, 1999, ACTA PAEDIATR, V88, P897
   MCLEOD NA, 1987, NEUROLOGY, V37, P1240, DOI 10.1212/WNL.37.7.1240
   Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0
   Preis S, 2000, COGNITIVE BRAIN RES, V10, P37, DOI 10.1016/S0926-6410(00)00020-3
   Reichenheim ME, 2000, REV SAUDE PUBL, V34, P610, DOI 10.1590/S0034-89102000000600008
   Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X
   SUNDHEIM STP, 1998, TXB PEDIAT NEUROPSYC, P649
   Suresh PA, 2000, PEDIATR NEUROL, V22, P267, DOI 10.1016/S0887-8994(99)00157-5
   Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593
   VOLPE JJ, 1992, BIOL NEONATE, V62, P231
   von Plessen K, 2002, NEUROPSYCHOLOGIA, V40, P1035, DOI 10.1016/S0028-3932(01)00143-9
   YETKIN FZ, 1992, AM J ROENTGENOL, V159, P185, DOI 10.2214/ajr.159.1.1609695
   Yue NC, 1997, RADIOLOGY, V202, P33, DOI 10.1148/radiology.202.1.8988189
NR 29
TC 5
Z9 5
U1 0
U2 6
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2006
VL 64
IS 2A
BP 186
EP 192
DI 10.1590/S0004-282X2006000200003
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 050UC
UT WOS:000238113200003
PM 16791353
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
AF Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
TI A schematic age-structured compartment model of the impact of
   antiretroviral therapy on HIV incidence and prevalence
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Article
DE HAART; deterministic model; Brazil
ID IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-HISTORY; TRANSMISSION; INFECTION;
   PROBABILITY; PROGRAMS; PLASMA; RISK
AB A simple deterministic model is proposed to represent the basic aspects concerning the effects of different antiretroviral treatment schedules on HIV incidence and prevalence of affected populations. The model mimics current treatment guidelines applied in Brazil. However, the model does not intend to fit the data with any acceptable degree of accuracy since uncertainties on the values of the parameters and on the precise effect of the treatment put some limits on the practical implications of our model from which only orders of magnitude and some qualitative effects can be deduced. So, this paper intends to provide a conceptual and mechanistic understanding of the possible long-term effects of treatment on the dynamics of HIV transmission.
   According to the model, the effect of the treatment depends on the level of sexual activity of the subpopulations considered, being more pronounced on the subpopulations with the highest sexual activity levels. Also, inefficient treatment can be prejudicial depending on the level of sexual activity and on the capacity to provide adequate treatment coverages to the population affected. (c) 2006 IMACS. Published by Elsevier B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/B-1169-2012; Lopez, Luis F/C-4721-2012; Burattini,
   Marcelo N/J-9272-2014
OI Coutinho, Francisco A B/0000-0003-3127-3071; Massad,
   Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Burattini, Marcelo N/0000-0002-5407-6890
CR Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   ANDERSON RM, 1991, NATURE, V350, P356, DOI 10.1038/350356a0
   ANDERSON RM, 1988, TROP GEOG MED S, V3, pS30
   Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650
   CARLINI EA, 2002, LEVANTAMENTO DOMICIL, P299
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   Coutinho FAB, 1999, REV SAUDE PUBL, V33, P329, DOI 10.1590/S0034-89101999000400002
   Coutinho FAB, 2001, B MATH BIOL, V63, P1041, DOI 10.1006/bulm.2001.0257
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   Craib KJP, 2000, AIDS, V14, P303, DOI 10.1097/00002030-200002180-00013
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   ERB P, 1994, J ACQ IMMUN DEF SYND, V7, P261
   Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023
   Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   HANNA GJ, 2000, PRINCIPLES PRACTICE, P1479
   Levin BR, 1996, MATH BIOSCI, V132, P69, DOI 10.1016/0025-5564(95)00053-4
   Lopez LF, 2000, J MATH BIOL, V40, P199, DOI 10.1007/s002850050178
   Massad E, 2002, INT J STD AIDS, V13, P430, DOI 10.1258/095646202760029895
   MASTRO TD, 1994, LANCET, V343, P204, DOI 10.1016/S0140-6736(94)90990-3
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   Oxman GL, 1996, SEX TRANSM DIS, V23, P30, DOI 10.1097/00007435-199601000-00008
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303
   SZTERENFELD C, 1995, AIDS STD HLTH PROMOT, V4, P8
   Szwarcwald C L, 2000, Cad Saude Publica, V16, P113
   VELLA S, 2000, HIV 1 COPY NUMBER IN
NR 27
TC 4
Z9 5
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
EI 1872-7166
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD APR 11
PY 2006
VL 71
IS 2
BP 131
EP 148
DI 10.1016/j.matcom.2006.01.004
PG 18
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 030YN
UT WOS:000236671400005
DA 2020-12-16
ER

PT B
AU Coutinho, FAB
   Massad, E
   Lopez, LF
   Burattini, MN
AF Coutinho, Francisco A. B.
   Massad, Eduardo
   Lopez, Luiz F.
   Burattini, Marcelo N.
BE Mondaini, R
   Dilao, R
TI Modeling plague dynamics Endemic states, outbreaks and epidemic waves
SO BIOMAT 2005
LA English
DT Proceedings Paper
CT International Symposium on Mathematical and Computational Biology
   (BIOMAT 2005)
CY DEC 03-08, 2005
CL Petropolis, BRAZIL
SP CAPES, FINEP, Natl Lab Sci Comp
AB This paper is intended to contribute to the understanding of plague dynamics through a mathematical modelling of its natural history. Plague is a very complex system, comprising up to three type of hosts and two vectors. This implies in a multicompartment system with several (73 in our model) parameters, few of each have been measured. Therefore, we used reasonable values for those less known parameters and studied the behaviour of the system. The model was applied to describe two distinct epidemiological scenarios; one epidemic outbreak of short duration (Florence, 1348), and one endemic state (Viet Nam, present day).
C1 [Coutinho, Francisco A. B.; Massad, Eduardo; Lopez, Luiz F.; Burattini, Marcelo N.] Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England.
RP Coutinho, FAB (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Lopez, Luis F/C-4721-2012; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Mondaini, Rubem/G-7767-2014; Burattini,
   Marcelo N/J-9272-2014; Massad, Eduardo/H-6143-2011
OI Lopez, Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890; 
CR BARNETT SA, 2001, STORY RATS
   Beesley WN, 1998, ZOONOSES, P873
   Butler T., 1983, PLAGUE OTHER YERSINI
   Butler T, 2000, PRINCIPLES PRACTICE, P2406
   CAMPBELL GL, 1997, HARRISONS PRINCIPLES, P975
   DEFOE D, 1969, J PLAGUE YEAR
   DENNIS DT, 1999, TROPICAL INFECT DIS, P506
   Frean JA, 1996, ANTIMICROB AGENTS CH, V40, P2646, DOI 10.1128/AAC.40.11.2646
   Gratz N., 1994, RODENT PESTS THEIR C
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Lopez LF, 1999, MATH COMPUT MODEL, V29, P55, DOI 10.1016/S0895-7177(99)00062-X
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2001, THEOR POPUL BIOL, V60, P265, DOI 10.1006/tpbi.2000.1494
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MOORE J, 2002, PARASITES BEHAV ANIM
   Murray J. D., 1993, MATH BIOL
   Politzer R., 1954, WHO MONOGRAPH SERIES, V22
   SERVICE NW, 1986, LECT NOTES MED ENTOM
   SLACK P, 1989, T ROY SOC TROP MED H, V83, P461, DOI 10.1016/0035-9203(89)90247-2
   SMITH MD, 1996, MANSONS TROPICAL DIS, P918
   ZIEGLER P, 1984, BLACK DEATH
NR 21
TC 1
Z9 1
U1 0
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-256-797-0
PY 2006
BP 213
EP 230
DI 10.1142/9789812773685_0013
PG 18
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BGE68
UT WOS:000246340600013
DA 2020-12-16
ER

PT S
AU Lopes, MHBD
   Marin, HD
   Ortega, NRS
   Massad, E
AF de Moraes Lopes, Maria Helena Baena
   de Fatima Marin, Heimar
   Siqueira Ortega, Neli Regina
   Massad, Eduardo
BE Park, HA
   Murray, P
   Delaney, C
TI Fuzzy logic model based on the differential nursing diagnosis of
   alterations in urinary elimination
SO CONSUMER-CENTERED COMPUTER-SUPPPORTED CARE FOR HEALTHY PEOPLE
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 9th International Congress on Nursing Informatics
CY 2006
CL Seoul, SOUTH KOREA
SP Korean Soc Med Informat
DE fuzzy logic; decision support systems; clinical; nursing informatics;
   diagnosis; dferential; nursing diagnosis; urinary incontinence
ID INCONTINENCE
AB The nursing diagnoses associated with alterations in urinary elimination require different interventions, and nurses who are not specialists need support to diagnose and to manage patients with disturbances of urine elimination. The aim of this study was to present a model based on fuzzy logic,for making differential diagnosis of alterations in urinary elimination, considering the nursing diagnosis approved by the North American Nursing Diagnosis Association (NANDA), 2001-2002. The fuzzy maximum-minimum composition was used to develop this model. It was tested with 195 cases from a database of a previous study. The model was able to determine the diagnosis in total accordance with a panel of three experts for 79.5% of the cases. The model diagnosed 19% of the cases with partial concordance with the panel of experts. Only for 3 cases (1.5%) the model showed a different diagnosis. It is concluded that the model proposed here, despite of its simplicity, presents good performance. However, it is recommended more tests before widely used as support for clinical decision.
C1 [de Moraes Lopes, Maria Helena Baena] Univ Estadual Campinas, Fac Med Sci, Dept Nursing, Campinas, Brazil.
   [de Fatima Marin, Heimar] Univ Fed Sao Paulo, Brazilian Hlth Informat Sci, Dept Nursing, Sao Paulo, Brazil.
   [Siqueira Ortega, Neli Regina; Massad, Eduardo] Univ Sao Paulo, Sch Med, FMUSP LIM01, Sao Paulo, Brazil.
RP Lopes, MHBD (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Nursing, Campinas, Brazil.
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [1 D43 TW7015-01] Funding Source: Medline
CR ABRAMS P, 1988, SCAND J UROL NEPHROL, P5
   Carpenito L.J., 1997, NURSING DIAGNOSIS AP
   COLLAZOS K, 1996, AN 3 FOR NAC CIENC T, P713
   Davis G, 1999, MIL MED, V164, P182
   Gallo M L, 1997, Nurse Pract, V22, P21
   Georgopoulos V., 2002, ARTIF INTELL, V679, P1
   Ishiko O, 2000, INT J GYNECOL OBSTET, V68, P131, DOI 10.1016/S0020-7292(99)00182-4
   Laurikkala J, 1999, METHOD INFORM MED, V38, P125
   LOPES MHB, P NANDA NIC NOC C 20, P108
   *N AM NURS DIAGN A, 2002, DIAGN ENF NANDA DEF, P101
   Nascimento LFC, 2002, REV SAUDE PUBL, V36, P686, DOI [10.1590/S0034-89102002000700005, 10.1590/s0034-89102002000700005]
   Nobrega MML, 1994, UNIFORMIZACAO LINGUA, P32
   Reis MAM, 2004, BRAZ J MED BIOL RES, V37, P755, DOI 10.1590/S0100-879X2004000500018
   Reymert Jannike, 1994, Scandinavian Journal of Primary Health Care, V12, P180, DOI 10.3109/02813439409003696
   SABBATINI RME, 1992, EXPERTMD MANUAL USO
NR 15
TC 2
Z9 3
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 978-1-58603-622-5
J9 STUD HEALTH TECHNOL
PY 2006
VL 122
BP 117
EP +
PG 2
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications; Computer
   Science, Theory & Methods; Medical Informatics
SC Computer Science; Medical Informatics
GA BGD77
UT WOS:000246181100023
PM 17102230
DA 2020-12-16
ER

PT S
AU Marin, HF
   Massad, E
   Marques, EP
   Ohno-Machado, L
AF Marin, Heimar F.
   Massad, Eduardo
   Marques, Eduardo P.
   Ohno-Machado, Lucila
BE Park, HA
   Murray, P
   Delaney, C
TI A certificate program in health informatics: Brazil/USA experience
SO CONSUMER-CENTERED COMPUTER-SUPPPORTED CARE FOR HEALTHY PEOPLE
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 9th International Congress on Nursing Informatics
CY 2006
CL Seoul, SOUTH KOREA
SP Korean Soc Med Informat
DE education; curriculum; health informatics
AB Considering the continued demand for a large number of trained professionals we decided to offer a certificate program in health informatics. The objective is to prepare professionals to conduct research and implement the curriculum content in their original institutions. We selected 14 candidates from several national institutes. The disciplines are taught by Brazilian and US faculty. Researches conducted by the certificate students were relevant to Brazil's health needs. The goal is to promote better health informatics education, regardless of geographic distribution of students.
C1 [Marin, Heimar F.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Marques, Eduardo P.] Univ Estado Rio De Janeiro, Sch Med, Rio De Janeiro, Brazil.
   [Ohno-Machado, Lucila] Harvard MIT, Brigham & Womens Hosp, Decis Syst Grp, Boston, MA USA.
RP Marin, HF (corresponding author), Rua Dep Bady Bassit 440, BR-05517050 Sao Paulo, SP, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
FU Fogarty International CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC); NLMUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Library of Medicine (NLM); NIBIBUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Biomedical Imaging & Bioengineering (NIBIB); NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA;  [1 D43 TW7015-01]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW007015, D43TW007015, D43TW007015, D43TW007015, D43TW007015,
   D43TW007015, D43TW007015, D43TW007015, D43TW007015, D43TW007015,
   D43TW007015] Funding Source: NIH RePORTER
FX This work was partially funded by grant 1#1 D43 TW7015-01 for
   Informatics for Global Health; Fogarty International Center, NLM, NIBIB,
   NIH.
NR 0
TC 3
Z9 4
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 978-1-58603-622-5
J9 STUD HEALTH TECHNOL
PY 2006
VL 122
BP 800
EP 800
PG 1
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications; Computer
   Science, Theory & Methods; Medical Informatics
SC Computer Science; Medical Informatics
GA BGD77
UT WOS:000246181100182
PM 17102389
DA 2020-12-16
ER

PT J
AU Rocha, AF
   Massad, E
AF Rocha, A. F.
   Massad, E.
TI Ambiguous grammars and the chemical transactions of life - Part I:
   environmental constraints of grammar ambiguity
SO KYBERNETES
LA English
DT Article
DE cybernetics; fuzzy logic; biological taxonomy; modelling
ID GENETIC NETWORKS; LANGUAGE
AB Purpose - Since proposed by Darwin, evolution is considered to be dependent on a source of genetic vanability that must be constrained by environmental conditions in order to generate stable (adapted) phenotypes. Several sources and causes of this variability have been proposed so far. This paper aims to posit that ambiguity of fuzzy grammars is the main source of genetic variability on which natural selection operates.
   Design/methodology/approach - Formal grammars (FG) were proposed as the tool to deal with human and artificial languages. Fuzzy formal grammars (FFGs) are the extension of the formalism in the Theory of Fuzzy Logic and are ambiguous grammars. Here, the ambiguity of the ordered set of chemical interactions - the so-called signal transduction pathways (stp), linking membranes events to DNA reading and protein synthesis - is assumed as an inner source of variability that must be constrained by environmental conditions. Fuzzy formal languages (FFL) theory is used to mathematically formalize the biology concept of stp.
   Findings - The genome variability is the result of the constraints imposed by the environment on the grammar intrinsic ambiguity.
   Practical implications - The formalism of this model provides a new way to analyze and interpret the findings of the different genome sequencing projects.
   Originality/value - The theoretical framework developed here provides a new perspective of understanding the code of life and evolution.
C1 Univ Sao Paulo, Sch Med, HC FMUSP, Lim 01, Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
RP Rocha, AF (corresponding author), Univ Sao Paulo, Sch Med, HC FMUSP, Lim 01, Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Akutsu T, 2003, THEOR COMPUT SCI, V298, P235, DOI 10.1016/S0304-3975(02)00425-5
   Barbieri M., 2003, ORGANIC CODES INTRO
   Chomsky N., 1957, SYNTACTIC STRUCTURES
   DARWIN CR, 1959, ORIGIN SPECIES MEANS
   DAVIES K, 2001, CRACKING GENOME RACE
   DIETRICH MR, 1992, KEYWORDS EVOLUTIONAR
   HALDANE JBS, 1937, CAUSES EVOLUTION
   Hopcroft J.E., 1969, FORMAL LANGUAGES THE
   KIMURA M., 1983, NEUTRAL THEORY MOL E
   MAIENSCHEIN J, 1992, KEYWORDS EVOLUTIONAR
   MASSAD E, 2006, KYBERNETES, V35
   MIZUMOTO M, 1973, INFORMATION SCI, V5, P22
   Morgan TH, 1917, AM NAT, V51, P513, DOI 10.1086/279629
   Negoita C., 1975, APPL FUZZY SETS SYST
   Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771
   PEDRYCZ W, 1998, INTRO FUZZY SETS
   REANNEY D, 1976, BROOKH S BIOL GEN IN, V29, P248
   Rocha A. F., 1980, Fuzzy Sets and Systems, V3, P11, DOI 10.1016/0165-0114(80)90003-2
   Rocha AF, 1998, INFORM SCIENCES, V106, P123, DOI 10.1016/S0020-0255(97)10005-6
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   Sadegh-Zadeh K, 2000, ARTIF INTELL MED, V18, P1, DOI 10.1016/S0933-3657(99)00032-9
   Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255
   SEARLS DB, 1993, ARTIF INTELL, P46
   TUSZYNSKI JA, 2003, INTRO MOL BIOPHYSICS, P229
   van Someren EP, 2003, SIGNAL PROCESS, V83, P763, DOI 10.1016/S0165-1684(02)00473-5
   Williams RJP, 2003, J THEOR BIOL, V220, P323, DOI 10.1006/jtbi.2003.3152
   Zupan B, 2003, ARTIF INTELL MED, V29, P107, DOI 10.1016/S0933-3657(03)00048-4
NR 27
TC 1
Z9 1
U1 0
U2 2
PU EMERALD GROUP PUBLISHING LIMITED
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD BD8 9BY, W YORKSHIRE, ENGLAND
SN 0368-492X
J9 KYBERNETES
JI Kybernetes
PY 2006
VL 35
IS 9-10
BP 1414
EP 1430
DI 10.1108/03684920610662449
PG 17
WC Computer Science, Cybernetics
SC Computer Science
GA 109QA
UT WOS:000242322300008
DA 2020-12-16
ER

PT J
AU Massad, E
   Rocha, AF
AF Massad, E.
   Rocha, A. F.
TI Ambiguous grammars and the chemical transactions of life - Part II: the
   hierarchy of life's grammars
SO KYBERNETES
LA English
DT Article
DE kybernetics; fuzzy logic; language; genetics
AB Purpose - This second part of a companion paper seeks to extend the theory proposed to apply the hierarchy of fuzzy formal language to cope with the three major phenomenon of life: replication, control and shuffling of genetic information.
   Design/methodology/approach - In order to cope with the proposal, three new classes of FFG are proposed: replicating grammars: to formalize proper-ties and consequences of DNA duplication; self-controlled grammars: to provide the tools to control the grammar ambiguity and to improve adaptability, and recombinant grammars: to formalize properties and consequences of the sexual reproduction to life evolution. Considering all these facts, FFG are proposed as the key instrument to formalize the basic properties of the chemical transactions supporting life.
   Findings - The formalism of the model provides a new way to analyze and interpret the findings of the different genome sequencing projects.
   Originality/value - The theoretical framework developed here provides a new perspective of understanding the code of life and evolution.
C1 Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Barbieri M., 2003, ORGANIC CODES INTRO
   Bell G., 1982, MASTERPIECE NATURE E
   BRANDON RN, 1992, KEYWORDS EVOLUTIONAR
   Chomsky N., 1957, SYNTACTIC STRUCTURES
   CHOMSKY N, 1995, ASPECTS THEORY SYNTA
   DAVIES K, 2001, CRACKING GENOME RACE
   Hopcroft J.E., 1969, FORMAL LANGUAGES THE
   PEDRYCZ W, 1998, INTRO FUZZY SETS
   ROCHA AF, 2006, IN PRESS KYBERNETE 1
   Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255
   SEARLS DB, 1993, ARTIFICIAL INTELLIGE
   Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi
   Williams RJP, 2003, J THEOR BIOL, V220, P323, DOI 10.1006/jtbi.2003.3152
NR 13
TC 1
Z9 1
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
PY 2006
VL 35
IS 9-10
BP 1653
EP 1662
DI 10.1108/03684920610688649
PG 10
WC Computer Science, Cybernetics
SC Computer Science
GA 109QA
UT WOS:000242322300021
DA 2020-12-16
ER

PT S
AU Struchiner, CJ
   Luz, PM
   Codeco, CT
   Coelho, FC
   Massad, E
AF Struchiner, C. J.
   Luz, P. M.
   Codeco, C. T.
   Coelho, F. C.
   Massad, E.
BE Gumel, AB
TI Current research issues in mosquito-borne diseases modeling
SO MATHEMATICAL STUDIES ON HUMAN DISEASE DYNAMICS: EMERGING PARADIGMS AND
   CHALLENGES
SE Contemporary Mathematics
LA English
DT Proceedings Paper
CT AMS-IMS-SIAM Joint Summer Research Conference on Modeling the Dynamics
   of Human Diseases
CY JUL 17-21, 2005
CL Snowbird, UT
SP AMS, IMS, SIAM
DE mosquito-borne diseases; modeling; population genetics; molecular
   biology
ID YELLOW-FEVER VIRUS; VERTICAL TRANSMISSION; VACCINE EFFICACY; MALARIA
   VACCINES; AEDES-AEGYPTI; EVOLUTION; INFERENCE; DYNAMICS; EPIDEMIOLOGY;
   INFECTION
AB Mosquito-borne diseases modeling enters the mathematical literature through the hands of Ronald Ross. We have come a long way since Ross' seminal contribution. Recent advances in molecular biology and genetics provide new tools to monitor diversity among pathogens, vertebrate and invertebrate hosts. The genetic manipulation of pathogens and vectors also holds a promissing future. Current population dynamics paradigms seem ill-equiped to make appropriate predictions in this context and need to be expanded. We briefly review some of the current main research issues brought by these new technologies and argue that a new unifying modeling paradigm becomes necessary.
C1 Fundacao Oswaldo Cruz, Programa Computacao Cient, BR-21045900 Rio De Janeiro, Brazil.
RP Struchiner, CJ (corresponding author), Fundacao Oswaldo Cruz, Programa Computacao Cient, BR-21045900 Rio De Janeiro, Brazil.
EM stru@fiocruz.br; pluz@fiocruz.br; codeco@fiocruz.br;
   fccoelho@fiocruz.br; edmassad@usp.br
RI Struchiner, Claudio J/M-9360-2013; Massad, Eduardo/B-1169-2012; Coelho,
   Flavio Codeco/L-1089-2018; Massad, Eduardo/H-6143-2011; Coelho,
   Flavio/L-1089-2018
OI Struchiner, Claudio J/0000-0003-2114-847X; Massad,
   Eduardo/0000-0002-7200-2916; Coelho, Flavio Codeco/0000-0003-0635-8989;
   Coelho, Flavio/0000-0003-3868-4391
CR AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426
   Bailey N.T.J., 1982, BIOMATHEMATICS MALAR
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Berk R. A., 2002, STAT SCI, V17, P173, DOI DOI 10.1214/SS/1030550860
   Boete C, 2003, TRENDS PARASITOL, V19, P32, DOI 10.1016/S1471-4922(02)00003-X
   Boete Christophe, 2002, Malar J, V1, P3
   BRUCECHWATT L, 1980, RISE FALL MALARIA EU
   Burger R., 2000, WILEY SERIES MATH CO
   Cancre N, 2000, AM J EPIDEMIOL, V152, P760, DOI 10.1093/aje/152.8.760
   Chevillon C, 2003, TRENDS MICROBIOL, V11, P415, DOI 10.1016/S0966-842X(03)00206-3
   CHRISTIANSEN FB, 2000, WILEY SERIES MATH CO
   CURTIS CF, 1994, PARASITOL TODAY, V10, P371, DOI 10.1016/0169-4758(94)90222-4
   Day T, 2004, AM NAT, V163, pE40, DOI 10.1086/382548
   Day T, 2003, TRENDS ECOL EVOL, V18, P113, DOI 10.1016/S0169-5347(02)00049-6
   Diallo M, 2000, AM J TROP MED HYG, V62, P151, DOI 10.4269/ajtmh.2000.62.151
   DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347
   FINE PEM, 1975, P ROY SOC MED, V68, P547, DOI 10.1177/003591577506800903
   Fine PEM, 1975, TROPICAL DISEASES B, V72, P475
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2
   Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a
   Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344
   HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6
   Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990
   HALLORAN ME, 1991, EPIDEMIOLOGY, V2, P331, DOI 10.1097/00001648-199109000-00004
   HALLORAN ME, 1995, EPIDEMIOLOGY, V6, P142, DOI 10.1097/00001648-199503000-00010
   HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884
   HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498
   James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004
   KINGSOLVER JG, 1987, AM NAT, V130, P811, DOI 10.1086/284749
   KITRON U, 1987, INT J HEALTH SERV, V17, P295, DOI 10.2190/68UG-BAWQ-YXCT-HFKT
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   MACDONALD G, 1957, EPIDEMIOLOGY CONTROL
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2003, ARTIF INTELL MED, V29, P241, DOI 10.1016/S0933-3657(02)00070-2
   Molineaux L, 1980, GARKI PROJECT RES EP
   MOLINEAUX L, 1985, 14 UNDP WHOTDR
   Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188
   NAJERA JA, 1974, B WORLD HEALTH ORGAN, V50, P449
   NEDELMAN J, 1985, MATH BIOSCI, V73, P159, DOI 10.1016/0025-5564(85)90010-0
   Nye E., 1997, R ROSS MALARIOLOGIST
   Pack DW, 2004, NAT MATER, V3, P133, DOI 10.1038/nmat1084
   Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764
   RAFTERY AE, 1995, J AM STAT ASSOC, V90, P402, DOI 10.2307/2291048
   RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009
   Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410
   RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10
   Rice SH, 2004, EVOLUTIONARY THEORY
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   ROSEN L, 1987, CR ACAD SCI III-VIE, V304, P347
   Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546
   ROSS R, 1910, T SOC TROP MED HYG, V3, P383
   Ross R, 1921, BRIT MED J, V2, P1, DOI 10.1136/bmj.2.3157.1
   Skinner-Adams TS, 2003, TRENDS PARASITOL, V19, P17, DOI 10.1016/S1471-4922(02)00005-3
   SPIELMAN A, 1994, PARASITOL TODAY, V10, P374, DOI 10.1016/0169-4758(94)90223-2
   STRUCHINER CJ, 1989, MATH BIOSCI, V94, P87, DOI 10.1016/0025-5564(89)90073-4
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
NR 59
TC 7
Z9 7
U1 0
U2 1
PU AMER MATHEMATICAL SOC
PI PROVIDENCE
PA P.O. BOX 6248, PROVIDENCE, RI 02940 USA
SN 0271-4132
EI 1098-3627
BN 0-8218-3775-3
J9 CONTEMP MATH
PY 2006
VL 410
BP 349
EP 366
PG 18
WC Infectious Diseases; Mathematics, Applied
SC Infectious Diseases; Mathematics
GA BFM31
UT WOS:000243040400020
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Struchiner, CJ
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Struchiner, CJ
TI The impact of imperfect vaccines on the evolution of HIV virulence
SO MEDICAL HYPOTHESES
LA English
DT Article
ID INFECTION
AB A theoretical framework is proposed on which some hypotheses related to the impact of imperfect vaccines on the evolution of HIV virulence can be tested. For this, a linear increase of risk behaviour with vaccine efficacy is assumed. This is based on the hypothesis that people are prone to relax preventive measures by knowing that they and their partners are vaccinated and that this effect is more intense the more effective the vaccine is known to be. An additional, and perhaps more important hypothesis is related to the theoretical possibility that increased risk behaviour of some vaccinated individuals in partially protected populations could act as a selective pressure toward more virulent HIV strains. Those hypotheses were tested by a mathematical model that considers three different HIV strains competing against each other in a population partially protected by imperfect vaccines of distinct efficacies. Simulations of the model demonstrated that, under the above hypotheses, there is a shift in HIV virulence towards more aggressive strains with increase in vaccine efficacy, associated with a marked reduction in the total amount of transmission and, consequently, in the prevalence of HIV. Potential ways for further testing the theory/model and the implications of the results are discussed. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, LIM 01, HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   Univ London, London Sch Hyg & Trop Med, London, England.
   Fiocruz MS, Fundacao Oswaldo Cruz, Program Sci Computat, BR-21045900 Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Lopez, Luis F/C-4721-2012; Burattini,
   Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho, Francisco
   A B/H-5644-2011; Struchiner, Claudio J/M-9360-2013
OI Lopez, Luis F/0000-0003-4097-6887; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Coutinho,
   Francisco A B/0000-0003-3127-3071; Struchiner, Claudio
   J/0000-0003-2114-847X
CR Blower S, 2002, QUANTIATIVE EVALUATION OF HIV PREVENTION PROGRAMS, P260
   BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102
   Buchbinder S., 1999, IAVI REPORT, V4, P9
   Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007
   Coutinho FAB, 1999, REV SAUDE PUBL, V33, P329, DOI 10.1590/S0034-89101999000400002
   Gumel A.B., 2004, COMMUN NONLINEAR SCI, V9, P649, DOI DOI 10.1016/S1007-5704(03)00024-8
   Massad E, 1996, EVOLUTION, V50, P916, DOI [10.2307/2410863, 10.1111/j.1558-5646.1996.tb03900.x]
   Massad E, 2001, MATH COMPUT MODEL, V34, P345, DOI 10.1016/S0895-7177(01)00066-8
   *UNAIDS, 2004, UN JOINT PROGR HIV A
NR 9
TC 4
Z9 4
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2006
VL 66
IS 5
BP 907
EP 911
DI 10.1016/j.mehy.2005.11.042
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 028BA
UT WOS:000236459100006
PM 16442745
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Strazza, L
   Paoliello, AA
   de Carvalho, HB
   de Azevedo, RS
   Coutinho, FAB
   Massad, E
AF Burattini, MN
   Strazza, L
   Paoliello, AA
   de Carvalho, HB
   de Azevedo, RS
   Coutinho, FAB
   Massad, E
TI The change from intravenous to crack cocaine and its impact on reducing
   HIV incidence in Brazilian prisons
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Letter
ID PARENTERAL TRANSMISSION; HIV/AIDS; HCV
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, LIM 01, BR-01246903 Sao Paulo, Brazil.
   Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Azevedo, Raymundo S/B-7593-2008; Massad, Eduardo/H-6143-2011; Carvalho,
   Heraclito/C-1334-2012; Coutinho, Francisco A B/H-5644-2011; Massad,
   Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014
OI Azevedo, Raymundo S/0000-0003-0660-2371; Carvalho,
   Heraclito/0000-0002-7037-5655; Coutinho, Francisco A
   B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916; Burattini,
   Marcelo N/0000-0002-5407-6890
CR Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Burattini MN, 1998, MATH COMPUT MODEL, V28, P21, DOI 10.1016/S0895-7177(98)00095-8
   Lopes F, 2001, Cad Saude Publica, V17, P1473, DOI 10.1590/S0102-311X2001000600031
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   Rozman M, 1998, INT J STD AIDS, V9, P183, DOI 10.1258/0956462981921855
   Strazza L, 2004, BRAZ J MED BIOL RES, V37, P771, DOI 10.1590/S0100-879X2004000500020
NR 6
TC 7
Z9 9
U1 0
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD DEC
PY 2005
VL 16
IS 12
BP 836
EP 837
DI 10.1258/095646205774988136
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 994NK
UT WOS:000234038300019
PM 16336774
DA 2020-12-16
ER

PT J
AU Chaib, E
   Massad, E
AF Chaib, E
   Massad, E
TI Liver transplantation: Waiting list dynamics in the state of Sao Paulo,
   Brazil
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
AB Sao Paulo is the first Brazilian state to perform liver transplantation in 1968.(1) Since then the recipient waiting list has increased; now approximately 150 new cases per month are referred to the single list at the central organ procurement organization. Official data have shown 37.3 monthly deaths on the waiting list in the state of Sao Paulo. The number of liver transplants has increased after the creation of Sao Paulo transplant notification centers but are insufficient to deal with the increasing waiting list. The aim of this study was to demonstrate the performance of our state liver transplantation program and analyze when the number of liver transplantations will meet our waiting list demand.
C1 Univ Sao Paulo, Dept Gastroenterol, Sch Med, BR-04039060 Sao Paulo, Brazil.
RP Chaib, E (corresponding author), Univ Sao Paulo, Dept Gastroenterol, Sch Med, Rua Embau 206 Ap 131, BR-04039060 Sao Paulo, Brazil.
EM echaib@uol.com.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Ferraz AS, 1999, TRANSPLANT P, V31, P3075, DOI 10.1016/S0041-1345(99)00679-X
   Hoel P., 1984, INTRO MATH STAT
   Machado M C, 1972, Rev Hosp Clin Fac Med Sao Paulo, V27, P1
   MIES S, 1988, TRANSPLANT P, V30, P2880
NR 4
TC 15
Z9 15
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPLANT P
JI Transplant. Proc.
PD DEC
PY 2005
VL 37
IS 10
BP 4329
EP 4330
DI 10.1016/j.transproceed.2005.11.014
PG 2
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 999TH
UT WOS:000234412900047
PM 16387111
DA 2020-12-16
ER

PT J
AU Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Massad, E
AF Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Massad, E
TI An approximate threshold condition for non-autonomous system: An
   application to a vector-borne infection
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Article
DE non-autonomous systems; stability analysis; thresholds; dengue;
   epidemics
AB A non-autonomous system is proposed to model the seasonal pattern of dengue fever. We found that an approximate threshold condition for infection persistence describes all possible behaviors of the system.
   As far as we know, the kind of analysis here proposed is entirely new. No precise mathematical theorems are demonstrated but we give enough numerical evidence to support the conclusions. (c) 2005 IMACS. Published by Elsevier B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, LIM 01, BR-01246903 Sao Paulo, Brazil.
   Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Lopez, Luis F/C-4721-2012; Massad, Eduardo/H-6143-2011; Coutinho,
   Francisco A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Lopez, Luis F/0000-0003-4097-6887; Coutinho, Francisco A
   B/0000-0003-3127-3071; Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916
CR COUTINHO FAB, 2004, UNPUB B MATH BIOL
   ELSGOLTS EL, 1966, INTRO THEORY DIFFERE
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
NR 4
TC 27
Z9 29
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
EI 1872-7166
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD NOV 8
PY 2005
VL 70
IS 3
BP 149
EP 158
DI 10.1016/j.matcom.2005.06.003
PG 10
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 982YV
UT WOS:000233199200002
DA 2020-12-16
ER

PT J
AU Cox, MJ
   Elwin, K
   Massad, E
   Azevedo, RS
AF Cox, MJ
   Elwin, K
   Massad, E
   Azevedo, RS
TI Age-specific seroprevalence to an immunodominant Cryptosporidium
   sporozoite antigen in a Brazilian population
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID TRANSPLACENTAL ANTIBODY TRANSFER; IMMUNOGLOBULIN-G ANTIBODIES;
   LOW-BIRTH-WEIGHT; SAO-PAULO STATE; ENZYME-IMMUNOASSAY; SEROLOGIC
   RESPONSE; INFECTION; CHILDREN; PARVUM; SEROEPIDEMIOLOGY
AB The seroepidemiology of Cryptosporidium infection was investigated in a representative sample of a normal population in the State of Sao Paulo, Brazil using a recombinant form of the immunodominant 27-kDa sporozolte antigen. IgG seropositivity was low in infants following loss of maternal antibody but quickly increased to similar to 60% by 5 years, then 80% by the age of 10 years, after which prevalence remained constant. The broad range of antibody concentrations is consistent with previous reports that the IgG response to C. parvum is short-lived. There is also evidence that average antibody concentrations increase with age. Results suggest that the recombinant antigen may be a more sensitive method of measuring seroprevalence than the native antigen in Western blot. Although cross-sectional studies can provide an insight into the epidemiology of C. parvum in normal populations, further studies investigating the dynamics of the humoral immune responses to Cryptosporidium and the use of serology in epidemiological studies are required.
C1 Coventry Univ, Sch Sci & Environm, Coventry CV1 5FB, W Midlands, England.
   Singleton Hosp, Cryptosporidium Reference Unit, Swansea SA2 8QA, W Glam, Wales.
   HCFMUSP, LIM 01, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
RP Cox, MJ (corresponding author), Coventry Univ, Sch Sci & Environm, Coventry CV1 5FB, W Midlands, England.
EM M.Cox@coventry.ac.uk
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Azevedo,
   Raymundo S/B-7593-2008
OI Massad, Eduardo/0000-0002-7200-2916; Azevedo, Raymundo
   S/0000-0003-0660-2371
CR ANDERSON LJ, 1995, J INFECT DIS, V171, P1, DOI 10.1093/infdis/171.1.1
   Bonafonte MT, 2000, EXP PARASITOL, V96, P32, DOI 10.1006/expr.2000.4545
   Checkley W, 1997, AM J EPIDEMIOL, V145, P156, DOI 10.1093/oxfordjournals.aje.a009086
   Cox MJ, 1998, EPIDEMIOL INFECT, V120, P327, DOI 10.1017/S0950268898008759
   Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2
   de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202
   Egorov A, 2004, ANN EPIDEMIOL, V14, P129, DOI 10.1016/S1047-2797(03)00122-4
   Eisenberg JNS, 2001, EMERG INFECT DIS, V7, P1004, DOI 10.3201/eid0706.010614
   Farias EWC, 2002, BRAZ J MICROBIOL, V33, P41, DOI 10.1590/S1517-83822002000100008
   FRIEDMAN ND, 2001, J SEXUAL HLTH, V14, P21
   Frost F, 2003, CLIN DIAGN LAB IMMUN, V10, P193, DOI 10.1128/CDLI.10.1.193-194.2003
   Frost FJ, 1998, INFECT IMMUN, V66, P4008
   Frost FJ, 1998, EPIDEMIOL INFECT, V121, P205, DOI 10.1017/S0950268898008991
   Frost FJ, 1998, EPIDEMIOL INFECT, V121, P213, DOI 10.1017/S095026889800898X
   Frost FJ, 2001, EPIDEMIOL INFECT, V126, P301, DOI 10.1017/S0950268801005337
   Frost FJ, 2000, INT J EPIDEMIOL, V29, P376, DOI 10.1093/ije/29.2.376
   Gamba RD, 2000, BRAZ J MICROBIOL, V31, P151
   GARCIARODRIGUEZ JA, 1989, SERODIAG IMMUN INF D, V3, P367, DOI 10.1016/0888-0786(89)90054-1
   GROVES VJ, 1994, EPIDEMIOL INFECT, V113, P491, DOI 10.1017/S0950268800068503
   KUHLS TL, 1994, CLIN INFECT DIS, V18, P731, DOI 10.1093/clinids/18.5.731
   Leach CT, 2000, AM J TROP MED HYG, V62, P656, DOI 10.4269/ajtmh.2000.62.656
   McDonald AC, 2001, J INFECT DIS, V183, P1373, DOI 10.1086/319862
   MEAD JR, 1988, J PARASITOL, V74, P135, DOI 10.2307/3282489
   Mehnert DU, 1997, MEM I OSWALDO CRUZ, V92, P97, DOI 10.1590/S0074-02761997000100020
   MIRON D, 1994, PEDIATR RES, V35, pA188
   Moss DM, 2004, J PARASITOL, V90, P397, DOI 10.1645/GE-3267
   Moss DM, 1998, J INFECT DIS, V178, P827, DOI 10.1086/515377
   MOSS DM, 1994, J EUKARYOT MICROBIOL, V41, pS52
   MULLER APB, 2000, THESIS SAO PAULO U
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   Newman RD, 1999, J INFECT DIS, V180, P167, DOI 10.1086/314820
   Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x
   Perryman LE, 1996, MOL BIOCHEM PARASIT, V80, P137, DOI 10.1016/0166-6851(96)02681-3
   PETERSEN C, 1992, CLIN INFECT DIS, V15, P903, DOI 10.1093/clind/15.6.903
   Pollok RCG, 1998, GUT, V42, pA85
   Priest JW, 1999, J CLIN MICROBIOL, V37, P1385, DOI 10.1128/JCM.37.5.1385-1392.1999
   Priest JW, 2001, CLIN DIAGN LAB IMMUN, V8, P415, DOI 10.1128/CDLI.8.2.415-423.2001
   Riggs MW, 2002, MICROBES INFECT, V4, P1067, DOI 10.1016/S1286-4579(02)01631-3
   Smith LM, 2001, J PARASITOL, V87, P704, DOI 10.1645/0022-3395(2001)087[0704:HTABCI]2.0.CO;2
   Steinberg EB, 2004, AM J TROP MED HYG, V70, P83, DOI 10.4269/ajtmh.2004.70.83
   Tzipori S, 2002, MICROBES INFECT, V4, P1047, DOI 10.1016/S1286-4579(02)01629-5
   UNGAR BLP, 1988, J INFECT DIS, V157, P551, DOI 10.1093/infdis/157.3.551
   Vergara Castiblanco C, 2000, Rev Panam Salud Publica, V8, P373, DOI 10.1590/S1020-49892000001100001
   Wesumperuma HL, 1999, ANN TROP MED PARASIT, V93, P169, DOI 10.1080/00034989958654
   Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014
   ZU SX, 1994, AM J TROP MED HYG, V51, P1
NR 46
TC 6
Z9 10
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2005
VL 133
IS 5
BP 951
EP 956
DI 10.1017/S0950268805004036
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 974HH
UT WOS:000232581600024
PM 16181518
OA Green Published
DA 2020-12-16
ER

PT J
AU Almeida, MF
   Martorelli, LFA
   Aires, CC
   Sallum, PC
   Massad, E
AF Almeida, MF
   Martorelli, LFA
   Aires, CC
   Sallum, PC
   Massad, E
TI Indirect oral immunization of captive vampires, Desmodus rotundus
SO VIRUS RESEARCH
LA English
DT Article; Proceedings Paper
CT International Conference on Rabies in Americas
CY OCT, 2003
CL Philadelphia, PA
DE rabies; bats; Desmodus rotundus; vaccine; oral immunization
ID RABIES VIRUS; RED FOXES; GLYCOPROTEIN; PATHOGENESIS; VACCINATION;
   WILDLIFE; BATS
AB A vaccinia-rabies lycoprotein recombinant virus (V-RG) vaccine was tested in hematophagous bats (Desmodus rotundus) kept in captivity. The vaccine was applied in a neutral vehicle (Vaseline) spread on the back of one or two vector bats, which were then reintroduced into their groups. Our hypothesis was that, as in the case of vampire bat control by vampiricide paste, the administration of V-RG vaccine through paste to one bat could indirectly protect other bats front the same group. Eight groups were tested. The rabies virus strain used to challenge the bats was isolated from a naturally infected hematophagous bat (Desmodus rotundus). The survival proportion after the virus challenge ranged between 42.8 and 71.4%. The results are encouraging because a significant number of bats that did not receive the vaccine survived the challenge. The vaccine was shown to be safe and immunogenic to hematophagous bats. No adverse effects to vaccinia virus were observed. (c) 2005 Published by Elsevier B.V.
C1 Univ Sao Paulo, Sch Med, LIM01, HCFMUSP, BR-05508 Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
   Zoonosis Control Ctr Sao Paul Municipal, Rabies Lab, Sao Paulo, Brazil.
   Univ Sao Paulo, Zool Museum, BR-04299970 Sao Paulo, Brazil.
   Ctr Control Zoonosis Guarulhos, Sao Paulo, Brazil.
RP Almeida, MF (corresponding author), Univ Sao Paulo, Sch Med, LIM01, HCFMUSP, BR-05508 Sao Paulo, Brazil.
EM mfalmeida@uol.com.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Aguilar-Setien A, 2002, J WILDLIFE DIS, V38, P539, DOI 10.7589/0090-3558-38.3.539
   ALMEIDA MF, 2005, IN PRESS EPIDEMIOL I, V133
   ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS615
   BAER GM, 1972, J MAMMAL, V53, P231, DOI 10.2307/1378860
   BATISTADOCOSTA M, 1993, TROP MED PARASITOL, V44, P219
   BLANCOU J, 1979, REV MED VET-TOULOUSE, V130, P1001
   BLANCOU J, 1989, ANN RECH VET, V20, P195
   BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0
   BROCHIER B, 1989, J WILDLIFE DIS, V25, P540, DOI 10.7589/0090-3558-25.4.540
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1111
   CONSTANTINE DG, 1962, PUBLIC HEALTH REP, V77, P287, DOI 10.2307/4591470
   CONSTANTINE DG, 1967, PUBLIC HEALTH REP, V82, P867, DOI 10.2307/4593153
   Dean DJ, 1996, LAB TECHNIQUES RABIE, P88
   FAVORETTO Silvana Regina, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P91, DOI 10.1590/S0036-46652002000200007
   Greenhall A. M., 1965, Mammalia, V29, P441, DOI 10.1515/mamm.1965.29.4.441
   Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228
   Ito M, 2001, VIROLOGY, V284, P214, DOI 10.1006/viro.2000.0916
   JACKSON AC, 2002, RABIES, P473
   KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0
   KOPROWSKI H, 1996, LAB TECHNIQUES RABIE
   LINHART SB, 1972, B OFIC SANIT PANAM, V73, P100
   MacInnes CD, 2001, J WILDLIFE DIS, V37, P119, DOI 10.7589/0090-3558-37.1.119
   MARTORELLI LFA, 1989, P 12 INT M RES ADV R
   Massad E, 2001, THEOR POPUL BIOL, V60, P265, DOI 10.1006/tpbi.2000.1494
   MCLEAN RG, 1975, NATURAL HIST RABIES, V2, P53
   *MIN HLTH BRAZ, 2004, CAS RAIV HUM ESP AGR
   PARKER RL, 1966, AM J VET RES, V27, P33
   PASTORET PP, 1988, VET REC, V123, P481, DOI 10.1136/vr.123.19.481
   Schneider M C, 2001, Cad Saude Publica, V17, P1531, DOI 10.1590/S0102-311X2001000600038
   Setien AA, 1998, VACCINE, V16, P1122, DOI 10.1016/S0264-410X(98)80108-4
   SIKES RK, 1962, AM J VET RES, V23, P1041
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
NR 32
TC 17
Z9 17
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JUL
PY 2005
VL 111
IS 1
BP 77
EP 82
DI 10.1016/j.virusres.2005.03.013
PG 6
WC Virology
SC Virology
GA 933ZF
UT WOS:000229670900009
PM 15896405
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Struchiner, CJ
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Struchiner, CJ
TI Yellow fever vaccination: How much is enough?
SO VACCINE
LA English
DT Article
DE yellow fever; vaccination; adverse events
ID ADVANCED AGE; RISK-FACTOR; DENGUE; PERSISTENCE
AB In recent years, a growing number of serious adverse events (including deaths) associated with the yellow fever (YF) vaccine has been reported. If YF vaccination were incorporated in routine programs, administered to children, the risk of deaths from this vaccine would be minimized provided that mortality of children vaccinated below I year were negligible. However, in affected areas the vaccine is administered to all age groups. This poses a dilemma to public health authorities - what proportion of a population subject to low risk of YF outbreaks should be vaccinated in order to minimize the total number of serious adverse events (including deaths) due both to natural infection and vaccination? In other words, how much vaccination is safe?
   Our results suggest that, depending on the age-specific rates of developing vaccine-induced serious adverse events and the risk of yellow fever outbreaks, the optimum proportion to vaccinate may be lower than the proportion that would prevent an epidemics or even be zero. We also show that the vaccine should not be applied to individuals older than 60 years of age because the risk of serious adverse events (including deaths) is higher for that age class. Our work is instrumental to the discussion on the optimum strategy to vaccinate affected populations against yellow fever.
   Therefore, the aim of this work is to estimate the optimum proportion to vaccinate against YF taking into account the risks of serious adverse events associated with both the vaccine and natural infection. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   Univ London, London Sch Hyg & Trop Med, London, England.
   Fiocruz MS, Fdn Oswaldo Cruz, Program Sci Computat, BR-21045900 Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo,455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Lopez, Luis F/C-4721-2012; Massad, Eduardo/B-1169-2012; Struchiner,
   Claudio J/M-9360-2013; Massad, Eduardo/H-6143-2011; Coutinho, Francisco
   A B/H-5644-2011; Burattini, Marcelo N/J-9272-2014
OI Lopez, Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Struchiner, Claudio J/0000-0003-2114-847X; Coutinho, Francisco A
   B/0000-0003-3127-3071; Burattini, Marcelo N/0000-0002-5407-6890
CR ANDERSON R M, 1991
   Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P989
   Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7
   Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Gubler D, 1997, DENGUE DENGUE HEMORR
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Martin M, 2001, EMERG INFECT DIS, V7, P945, DOI 10.3201/eid0706.010605
   Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Monath T. P., 1990, Tropical and geographical medicine., P661
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   STRUCHINER CJ, 2004, EPIDEMIOL INFECT
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
NR 20
TC 36
Z9 36
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 10
PY 2005
VL 23
IS 30
BP 3908
EP 3914
DI 10.1016/j.vaccine.2005.03.002
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 936GR
UT WOS:000229844000006
PM 15917112
DA 2020-12-16
ER

PT J
AU Almeida, MF
   Martorelli, LFA
   Aires, CC
   Sallum, PC
   Durigon, EL
   Massad, E
AF Almeida, MF
   Martorelli, LFA
   Aires, CC
   Sallum, PC
   Durigon, EL
   Massad, E
TI Experimental rabies infection in haematophagous bats Desmodus rotundus
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID VIRUS; OUTBREAK; PATHOGENESIS; FOXES
AB In order to determine the susceptibility and serum neutralizing antibody response of Desmodus rotundus to rabies virus, bats were Inoculated with a virus isolated from a naturally infected haematophagous bat. Bats were divided into four groups of 10 animals each. Dilutions of rabies virus containing 100, 1000, 10000 and 100 000 MICLD50 (lethal dose 50% for mice inoculated by the intracerebral route) were administrated in the pectoral Muscle. The presence of rabies virus was detected in brain and salivary glands by fluorescent antibody, mouse inoculation and RT-PCR. The observed mortality for each virus dose was 0, 20, 20 and 60% respectively. Serum neutralizing antibodies were tested for by the rapid fluorescent focus inhibition test, and antibody titres greater than 0.5 IU/ml were found in 53% of bats 30 days after virus inoculation. Resistance to infection was seen in bats that developed low or no detectable antibody response as well as in bats with high titres. Among the 10 bats that died of rabies, eight showed signs of paralytic rabies and two bats showed no clinical signs.
C1 Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   FMUSP, LIM HC 01, Sao Paulo, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
   Zoonosis Control Ctr Sao Paulo Municipality, Lab Rabies, Sao Paulo, Brazil.
   Univ Sao Paulo, Museum Zool, Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biosci, Virol Lab, Sao Paulo, Brazil.
RP Almeida, MF (corresponding author), Rua Santa Eulalia,86 Santana, BR-02031020 Sao Paulo, Brazil.
EM mfalmeida@uol.com.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Durigon, Edison/0000-0003-4898-6553
CR Acha P N, 1967, Bull Off Int Epizoot, V67, P343
   BAER GM, 1972, J MAMMAL, V53, P231, DOI 10.2307/1378860
   BATISTADOCOSTA M, 1993, TROP MED PARASITOL, V44, P219
   BLANCOU J, 1979, REV MED VET-TOULOUSE, V130, P1001
   Caraballo AJ, 1996, REV SAUDE PUBL, V30, P483, DOI 10.1590/S0034-89101996000500012
   Carini A., 1911, ANN I PASTEUR, V25, P843
   Dean D. J., 1996, P88
   DIAZ AM, 1994, J VET MED B, V41, P153, DOI 10.1111/j.1439-0450.1994.tb00219.x
   Echevarria JE, 2001, J CLIN MICROBIOL, V39, P3678, DOI 10.1128/JCM.39.10.3678-3683.2001
   FAVORETTO Silvana Regina, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P91, DOI 10.1590/S0036-46652002000200007
   Haupt H., 1921, Z INFEKTIONS HYG HAU, V76-90, P104
   Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997
   Hurst EW, 1931, LANCET, V2, P622
   Ito M, 2001, VIROLOGY, V284, P214, DOI 10.1006/viro.2000.0916
   Kaplan M. M., 1996, P3
   Koprowski H., 1996, P80
   LAFON M, 2002, RABIES, P351
   LOPEZ A, 1992, LANCET, V339, P408, DOI 10.1016/0140-6736(92)90088-K
   MARTORELLI LFA, 2001, 12 INT M RES ADV RAB
   Massad E, 2001, THEOR POPUL BIOL, V60, P265, DOI 10.1006/tpbi.2000.1494
   MATTOS CA, 2000, J WILDLIFE DIS, V36, P231
   MCCARTHY TJ, 1989, AM J TROP MED HYG, V40, P320, DOI 10.4269/ajtmh.1989.40.320
   MCLEAN RG, 1975, NATURAL HIST RABIES, V2, P53
   Nadin-Davis SA, 2001, VIRUS RES, V74, P139, DOI 10.1016/S0168-1702(00)00259-8
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   PARKER RL, 1966, AM J VET RES, V27, P33
   Pawan J. L., 1936, Annals of Tropical Medicine and Parasitology, V30, P401
   Rodrigues YJL, 2000, REV FAC CS VETS, V41, P71
   SACRAMENTO D, 1991, MOL CELL PROBE, V5, P229, DOI 10.1016/0890-8508(91)90045-L
   Setien AA, 1998, VACCINE, V16, P1122, DOI 10.1016/S0264-410X(98)80108-4
   SIKES RK, 1962, AM J VET RES, V23, P1041
   Smith J, 2000, J VIROL METHODS, V84, P107, DOI 10.1016/S0166-0934(99)00124-X
   SMITH JS, 1992, J INFECT DIS, V166, P296, DOI 10.1093/infdis/166.2.296
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
   SMITH JS, 1988, REV INFECT DIS, V10, pS637
   TORRES S., 1936, Rev. Med. vet., V3, P165
   TORRES S, 1935, REV DEP NAC PROD ANI, V2, P1
   Warner CK, 1999, AM J TROP MED HYG, V60, P502, DOI 10.4269/ajtmh.1999.60.502
NR 38
TC 26
Z9 26
U1 0
U2 9
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUN
PY 2005
VL 133
IS 3
BP 523
EP 527
DI 10.1017/S0950268804003656
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 939NF
UT WOS:000230079000017
PM 15962559
OA Green Published
DA 2020-12-16
ER

PT J
AU Rocha, FT
   Rocha, AF
   Massad, E
   Menezes, R
AF Rocha, FT
   Rocha, AF
   Massad, E
   Menezes, R
TI Brain mappings of the arithmetic processing in children and adults
SO COGNITIVE BRAIN RESEARCH
LA English
DT Article
DE arithmetic learning; brain mapping; cognition; EEG
ID MENTAL NUMBER LINE; GENDER-DIFFERENCES; FACT RETRIEVAL; LANGUAGE;
   REPRESENTATION; CORTEX
AB Despite the increasing number of experimental mapping showing that human arithmetic cognition is supported by widely spread neural circuits; the theoretical reasoning about these data remains mostly metaphorical and guided by a connectionist approach. Although neurons at distinct areas in the brain are assumed to take charge of different duties in the solution of the experimental task, the results are always discussed by hypothesizing some association between the different areas without questioning any difference of behavior at the level of the neurons at each of these areas. Here, the brain is assumed as Distributed Intelligent Processing System (DIPS) formed by collections of loosely interacting specialized agents (neurons), each agent specializing, for example, in data collection (sensors), problem solving (associative neurons), data communication (interneuronal systems) and in acting upon the surrounding environment (motorneurons). A new technique for EEG brain mapping is proposed and used to study arithmetic cognition in elementary school aged children and adults. Factor analysis showed three distinct patterns of neuronal recruitment for arithmetic calculations in all experimental groups which varied according to the type of calculation, age and sex. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Sao Paulo, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, L1M01, Sao Paulo, Brazil.
   EINA, BR-13201813 Jundiai, SP, Brazil.
   Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands.
RP Rocha, AF (corresponding author), Univ Sao Paulo, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM eina@enscer.com.br; edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Burbaud P, 1999, NEUROSCI LETT, V273, P195, DOI 10.1016/S0304-3940(99)00641-2
   Butterworth B, 1999, MATH BRAIN
   Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752
   Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689
   Cowell SF, 2000, NEUROIMAGE, V12, P565, DOI 10.1006/nimg.2000.0640
   Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970
   Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6
   Dehaene Stanislas, 1997, NUMBER SENSE
   Fink GR, 2001, NEUROIMAGE, V13, P46, DOI 10.1006/nimg.2000.0673
   Foz FB, 2002, PEDIATR NEUROL, V26, P106, DOI 10.1016/S0887-8994(01)00368-X
   Gallagher AM, 2000, J EXP CHILD PSYCHOL, V75, P165, DOI 10.1006/jecp.1999.2532
   Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2
   GALLISTEL CR, 1991, NUMERICAL COGNITION
   GELMAN R, 1983, COGNITION, V13, P343, DOI 10.1016/0010-0277(83)90014-8
   Gobel S, 2001, NEUROIMAGE, V14, P1278, DOI 10.1006/nimg.2001.0927
   GROEN GJ, 1972, PSYCHOL REV, V79, P329, DOI 10.1037/h0032950
   Halpern D. F., 1992, SEX DIFFERENCES COGN
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764
   Huntley-Fenner G, 2001, COGNITION, V78, pB27, DOI 10.1016/S0010-0277(00)00122-0
   Iguchi Y, 2000, CLIN NEUROPHYSIOL, V111, P204, DOI 10.1016/S1388-2457(99)00244-8
   Jahanshahi M, 2000, NEUROIMAGE, V12, P713, DOI 10.1006/nimg.2000.0647
   KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556
   Kong J, 1999, NEUROSCI LETT, V260, P169, DOI 10.1016/S0304-3940(98)00974-4
   MCCLOSKEY M, 1991, J EXP PSYCHOL LEARN, V17, P377, DOI 10.1037/0278-7393.17.3.377
   McCulloch W.S., 1943, B MATH BIOPHYS, V5, P115, DOI [10.1007/BF02478259, DOI 10.1007/BF02478259]
   MCLOSKEY M, 1991, NUMERICAL COGNITION
   Menon V, 2000, COGNITIVE BRAIN RES, V9, P343, DOI 10.1016/S0926-6410(00)00010-0
   Mix KS, 1999, J EXP CHILD PSYCHOL, V74, P309, DOI 10.1006/jecp.1999.2533
   Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3
   Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493
   Nuerk HC, 2001, COGNITION, V82, pB25, DOI 10.1016/S0010-0277(01)00142-1
   PEDRYCZ W, 1995, IEEE T SYST MAN CYB, V25, P769, DOI 10.1109/21.376490
   PEDRYCZ W, 1998, INTRO FUZZY SETS
   Pereira A, 2002, FR ART INT, V85, P82
   Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980
   Ratinckx E, 2001, NEUROPSYCHOLOGIA, V39, P335, DOI 10.1016/S0028-3932(00)00143-3
   Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   ROCHA AF, 2001, PROGR NEUROBIOLOGY, V64, P555
   ROCHA AF, 2003, IN PRESS STUDIES FUZ
   ROCHA AF, 2003, MATH TODAY, V39, P81
   ROCHA AF, 1992, LECT NOTES ARTIF INT, P199
   Royer JM, 1999, CONTEMP EDUC PSYCHOL, V24, P181, DOI 10.1006/ceps.1999.1004
   Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a
   Siegler R.S., 1996, EMERGING MINDS
   Skrandies W, 1999, NEUROPSYCHOLOGIA, V37, P421, DOI 10.1016/S0028-3932(98)00103-1
   Spelke ES, 2001, COGNITION, V78, P45, DOI 10.1016/S0010-0277(00)00108-6
   Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240
   Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697
   Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a
NR 50
TC 20
Z9 22
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0926-6410
J9 COGNITIVE BRAIN RES
JI Cognit. Brain Res.
PD MAR
PY 2005
VL 22
IS 3
BP 359
EP 372
DI 10.1016/j.cogbrainres.2004.09.008
PG 14
WC Computer Science, Artificial Intelligence; Neurosciences; Neuroimaging
SC Computer Science; Neurosciences & Neurology
GA 907BW
UT WOS:000227691000005
PM 15722207
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Lopez, LF
   Coutinho, FAB
AF Massad, E
   Burattini, MN
   Lopez, LF
   Coutinho, FAB
TI Forecasting versus projection models in epidemiology: The case of the
   SARS epidemics
SO MEDICAL HYPOTHESES
LA English
DT Article
ID SAO-PAULO STATE; YELLOW-FEVER; DENGUE; VACCINATION; OUTBREAK; RISK
AB In this work we propose a simple mathematical model for the analysis of the impact of control measures against an emerging infection, namely, the severe acute respiratory syndrome (SARS). The model provides a testable hypothesis by considering a dynamical equation for the contact parameter, which drops exponentially with time, simulating control measures. We discuss the role of modelling in public health and we analyse the distinction between forecasting and projection models as assessing toots for the estimation of the impact of intervention strategies. The model is applied to the communities of Hong Kong and Toronto (Canada) and it mimics those epidemics with fairly good accuracy. The estimated values for the basic reproduction number, R-0, were 1.2 for Hong Kong and 1.32 for Toronto (Canada). The model projects that, in the absence of control, the final number of cases would be 320,000 in Hong Kong and 36,900 in Toronto (Canada). In contrast, with control measures, which reduce the contact rate to about 25 % of its initial value, the expected final number of cases is reduced to 1778 in Hong Kong and 226 in Toronto (Canada). Although SARS can be a devastating infection, early recognition, prompt isolation, and appropriate precaution measures, can be very effective to Limit its spread. (c) 2005 Elsevier Ltd. ALL rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, SP, Brazil.
   London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Lopez, Luis F/C-4721-2012; Burattini,
   Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; 
CR Amaku M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051907
   ANDERSON R M, 1991
   ANDERSON RM, 1988, TROP GEOGR MED, V40, pS30
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   CASWELL H, 1989, MATRIX POPULATION MO
   *CDC, 2003, SEV AC RESP SYNDR WH
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Chow PKH, 2004, EMERG INFECT DIS, V10, P249, DOI 10.3201/eid1002.030397
   Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515
   KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Meltzer MI, 2004, EMERG INFECT DIS, V10, P207, DOI 10.3201/eid1002.030426
   Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732
   *WER, 2003, WKLY EPIDEMIOL REC, V78, P1
   *WHO, 2004, EB11333 WHO
   WHO, 2003, SEV AC RESP SYNDR SA
   World Health Organization, 2003, CUM NUMB REP PROB CA
NR 23
TC 24
Z9 25
U1 2
U2 17
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2005
VL 65
IS 1
BP 17
EP 22
DI 10.1016/j.mehy.2004.09.029
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 932DW
UT WOS:000229535400003
PM 15893110
OA Green Published
DA 2020-12-16
ER

PT J
AU Coutinho, FAB
   Lopez, LF
   Massad, E
AF Coutinho, FAB
   Lopez, LF
   Massad, E
TI Comment on "The distribution of composite measurements: How to be
   certain of the uncertainties in what we measure," by M. P. Silverman, W.
   Strange, and T. C. Lipscombe [Am. J. Phys. 72 (8)9 1068-1081 (2004)]
SO AMERICAN JOURNAL OF PHYSICS
LA English
DT Editorial Material
C1 Univ Sao Paulo, Fac Med, BR-01240690 Sao Paulo, Brazil.
RP Coutinho, FAB (corresponding author), Univ Sao Paulo, Fac Med, BR-01240690 Sao Paulo, Brazil.
RI Lopez, Luis F/C-4721-2012; Coutinho, Francisco A B/H-5644-2011; Massad,
   Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Lopez, Luis F/0000-0003-4097-6887; Coutinho, Francisco A
   B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916; 
CR DENERY P, 1996, MATH PHYS, P237
   GILLESPIE DT, 1983, AM J PHYS, V51, P520, DOI 10.1119/1.13221
   Silverman MP, 2004, AM J PHYS, V72, P1068, DOI 10.1119/1.1738426
NR 3
TC 0
Z9 0
U1 0
U2 3
PU AMER ASSOC PHYSICS TEACHERS AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0002-9505
J9 AM J PHYS
JI Am. J. Phys.
PD DEC
PY 2004
VL 72
IS 12
BP 1530
EP 1530
DI 10.1119/1.1806483
PG 1
WC Education, Scientific Disciplines; Physics, Multidisciplinary
SC Education & Educational Research; Physics
GA 874IQ
UT WOS:000225344500012
DA 2020-12-16
ER

PT J
AU Costa, AJL
   Massad, E
   Ortega, NRS
   Araujo, ADC
AF Costa, AJL
   Massad, E
   Ortega, NRS
   Araujo, ADC
TI Perception of disability in a public health perspective: a model based
   on fuzzy logic
SO INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
LA English
DT Article; Proceedings Paper
CT 8th International Conference in Nursing Informatics
CY 2003
CL Rio de Janeiro, BRAZIL
SP Int Med Informat Assoc, Nursing Informat Special Interest Grp
DE fuzzy sets; disability; health states; health indicators; quality of
   life; public health informatics
ID STATUS INDEX
AB Measures of functional levels, commonly used to assess the safety and quality of life of individuals and populations, have not yet been derived from a fuzzy framework. The aim of this study is to estimate the degree of disability associated with varying functional levels, through a model based on fuzzy sets theory. A fuzzy linguistic model was developed to measure varying levels of functional disability, in accordance with the definitions of an individual's social and physical activities and mobility. One year of an adult's life whose mobility, social and physical activities were somewhat limited, was judged to be equivalent to 0.575 years free of functional disability. Results obtained from the fuzzy model approach those obtained with the quality of well-being scale (QWB), used as a conceptual framework. Such findings are encouraging, since the QWB is considered a consistent and valid approach for disability assessment and quality-of-life evaluation. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Publ Hlth Studies, NESC, Rio De Janeiro, Brazil.
   Univ Sao Paulo, Sch Med, HCFMUSP LIM01, Sao Paulo, Brazil.
   Evandro Chagas Hosp, Fiocruz, Brazil.
RP Massad, E (corresponding author), Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Ortega, Neli/C-6494-2013; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW001279, D43TW001279, D43TW001279,
   D43TW001279, D43TW001279] Funding Source: NIH RePORTER; FIC NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [1D43TW01279-01] Funding Source: Medline
CR Barro S., 2002, FUZZY LOGIC MED
   BERGNER M, 1985, MED CARE, V23, P696, DOI 10.1097/00005650-198505000-00028
   COX E, 1999, FUZZY SYSTEM HDB
   FANSHEL S, 1970, OPER RES, V18, P1021, DOI 10.1287/opre.18.6.1021
   KAPLAN RM, 1979, MED CARE, V17, P501, DOI 10.1097/00005650-197905000-00005
   KAPLAN RM, 1976, HEALTH SERV RES, V11, P478
   KAPLAN RM, 1983, MED CARE, V21, P193, DOI 10.1097/00005650-198302000-00007
   Klir G., 1988, FUZZY SETS UNCERTAIN
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MAMDANI EH, 1974, P I ELECTR ENG, V121, P1585, DOI 10.1049/piee.1974.0328
   MASSAD E, IN PRESS ARTIF INTEL
   McDowell I, 1987, MEASURING HLTH GUIDE
   MENDEL J, 2000, UNCERTAIN RULE BASED
   Murray CJL, 1996, GLOBAL BURDEN DIS CO, P1
   PATRICK DL, 1973, J HEALTH SOC BEHAV, V14, P6, DOI 10.2307/2136932
   Patrick DL, 1993, HLTH STATUS HLTH POL
   Pedrycz W., 1998, INTRO FUZZY SETS ANA
   Sadegh-Zadeh K, 1999, ARTIF INTELL MED, V17, P87, DOI 10.1016/S0933-3657(99)00015-9
   Szczepaniak P, 2000, FUZZY SYSTEMS MED
   TEODORESCU HN, 1999, FUZZY NEURO FUZZY SY
   WANG LX, 1992, IEEE T SYST MAN CYB, V22, P1414, DOI 10.1109/21.199466
   YAGER RR, 1994, ESSENTIAL FUZZY MODE
   Zadeh L, 1986, FUZZY SETS INFORM CO, V8, P338, DOI [10.1016/0165-0114(78)90029-5, DOI 10.1016/S0019-9958(65)90241-X]
NR 23
TC 8
Z9 8
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1386-5056
EI 1872-8243
J9 INT J MED INFORM
JI Int. J. Med. Inform.
PD AUG
PY 2004
VL 73
IS 7-8
BP 647
EP 656
DI 10.1016/j.ijmedinf.2004.04.010
PG 10
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 841LU
UT WOS:000222932300015
PM 15246046
DA 2020-12-16
ER

PT J
AU De Menezes, RX
   Ortega, NRS
   Massad, E
AF De Menezes, RX
   Ortega, NRS
   Massad, E
TI A Reed-Frost model taking into account uncertainties in the diagnostic
   of the infection
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
ID FINAL SIZE DISTRIBUTION; EPIDEMIC MODELS
AB In this paper, we model the epidemic course of a pathogen infection within a semi-closed group which generates clinical signals which do not necessarily permit its ready and certain identification. Typical examples of such a pathogen are influenza-type viruses. We allow for time-varying infectivity levels among individuals, and model the probability of infection per contact as a function of the clinical signals. In order to accomplish this, we introduce a modified chain-binomial Reed-Frost model. We obtain an expression for the basic reproduction ratio and determine conditions which guarantee that the epidemic does not survive in the long-term. These conditions being functions of the signal's distribution, they can be used to design and evaluate interventions, such as treatment protocols. (C) 2003 Society for Mathematical Biology. Published by Elsevier Ltd. All rights reserved.
C1 Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands.
   Univ Sao Paulo, Sch Med, Discipline Med Informat, BR-05508 Sao Paulo, Brazil.
RP De Menezes, RX (corresponding author), Leiden Univ, Med Ctr, Dept Med Stat, Postbus 9604, NL-2300 RC Leiden, Netherlands.
EM r.x.menezes@lumc.nl
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ABBEY HELEN, 1952, HUMAN BIOL, V24, P201
   ANDERSON R M, 1991
   Bailey N., 1975, MATH THEORY INFECT D
   BECKER NG, 1979, ANAL INFECT DIS DATA
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   LEFEVRE C, 1990, ADV APPL PROBAB, V22, P25, DOI 10.2307/1427595
   MAIA JOC, 1952, HUM BIOL, V24, P167
   PICARD P, 1991, MATH BIOSCI, V107, P225, DOI 10.1016/0025-5564(91)90006-5
   SCALIATOMBA G, 1986, J APPL PROBAB, V23, P563, DOI 10.2307/3213998
NR 10
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD JUL
PY 2004
VL 66
IS 4
BP 689
EP 706
DI 10.1016/j.bulm.2003.10.003
PG 18
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 838QG
UT WOS:000222727400006
PM 15210313
OA Green Published
DA 2020-12-16
ER

PT J
AU Strazza, L
   Azevedo, RS
   Carvalho, HB
   Massad, E
AF Strazza, L
   Azevedo, RS
   Carvalho, HB
   Massad, E
TI The vulnerability of Brazilian female prisoners to HIV infection
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Advances in Medical Research
CY MAR 21-22, 2003
CL SAO PAULO, BRAZIL
DE HIV; HCV; syphilis; vulnerable populations; women; prisoners
ID SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS;
   RISK-FACTORS; SYPHILIS; WOMEN; PREVALENCE; BEHAVIORS; INMATES; AIDS;
   PENITENTIARY
AB The purpose of the present study was to determine the vulnerability of women in prison to HIV infection. The study was carried out from August to October 2000 in a S (a) over tildeo Paulo State Penitentiary, where 299 female prisoners were serving time. We interviewed and obtained a blood sample from 290 females who agreed to enter the study. Sera were tested for the presence of antibodies to HIV, hepatitis C virus (HCV) and syphilis and the odds ratio (OR) was calculated for variables related to HIV positivity on the basis of a questionnaire. The overall prevalence data were: 13.9% for HIV (37 of 267), 22.8% for syphilis (66 of 290), and 16.2% for HCV (47 of 290). Sexual partnership variables were significantly related to HIV infection. These included HIV-positive partners (OR = 7.36, P = 0.0001), casual partners (OR = 8.96, P = 0.009), injectable drug user partners (OR = 4.7, P = 0.0001), and history of sexually transmitted disease (OR = 2.07, P = 0.05). In addition, a relationship was detected between HIV infection and drug use (OR = 2.48, P = 0.04) and injectable drug use (OR = 4.2, P = 0.002). Even women with only one partner presented a significant OR for HIV infection (OR = 2.57, P = 0.009), reflecting their vulnerability due to their trust in their partner, who did not use a condom. Although the use of injectable substances is associated with HIV infection, our results point to sexual behavior as the most important component of HIV transmission in the female prisoner population.
C1 USP, FM, HC, Disciplina Informat Med,Lab Invest Med, BR-01246903 Sao Paulo, Brazil.
   USP, FM, Dept Patol, BR-01246903 Sao Paulo, Brazil.
   USP, FM, Dept Prevent Med, BR-01246903 Sao Paulo, Brazil.
   USP, FM, Dept Legal Med, BR-01246903 Sao Paulo, Brazil.
RP Strazza, L (corresponding author), USP, FM, HC, Disciplina Informat Med,Lab Invest Med, Av Dr Arnaldo 455,3o Andar,LIM01, BR-01246903 Sao Paulo, Brazil.
EM strazza@usp.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Carvalho,
   Heraclito/C-1334-2012; Azevedo, Raymundo S/B-7593-2008
OI Massad, Eduardo/0000-0002-7200-2916; Carvalho,
   Heraclito/0000-0002-7037-5655; Azevedo, Raymundo S/0000-0003-0660-2371
CR ALTMAN MIS, 1999, NY TIMES        0109, P14
   AZEVEDO LS, 1999, THESIS U SAO PAULO
   Beltrami JF, 1997, AM J PUBLIC HEALTH, V87, P1423, DOI 10.2105/AJPH.87.9.1423
   Blank S, 1999, J INFECT DIS, V180, P1159, DOI 10.1086/315038
   Calzavara L, 1999, Can HIV AIDS Policy Law Newsl, V5, P32
   CANTERBURY RJ, 1995, J ADOLESCENT HEALTH, V17, P173, DOI 10.1016/1054-139X(95)00043-R
   Carvalho Heraclito Barbosa De, 1996, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V12, P84
   CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107
   *COORD NACL DST AI, 1998, AIDS BRAS ESF CONJ G
   *CTR REF TRAT DST, 2002, B EP AN 21 NUM
   *CTR VIG EP, 1998, B EP AIDS SEC EST SA
   DIXON PS, 1993, AM J MED, V95, P629, DOI 10.1016/0002-9343(93)90359-W
   DOLAN K, 1995, AIDS, V9, P825, DOI 10.1097/00002030-199508000-00001
   FERREIRA MMC, 1997, THESIS U SAO PAULO S
   HORSBURGH CR, 1990, AM J PUBLIC HEALTH, V80, P209, DOI 10.2105/AJPH.80.2.209
   Kassira EN, 2001, J URBAN HEALTH, V78, P256, DOI 10.1093/jurban/78.2.256
   Lopes F, 2001, Cad Saude Publica, V17, P1473, DOI 10.1590/S0102-311X2001000600031
   MARTIN V, 1994, TUBERCLE LUNG DIS, V75, P49, DOI 10.1016/0962-8479(94)90102-3
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001
   Morris RE, 1995, J ADOLESCENT HEALTH, V17, P334, DOI 10.1016/1054-139X(95)00098-D
   Perez-Molina Jose A, 2002, HIV Clin Trials, V3, P139
   Rich JD, 2001, AIDS PATIENT CARE ST, V15, P581, DOI 10.1089/108729101753287676
   ROTILY M, 1994, AIDS, V8, P1341, DOI 10.1097/00002030-199409000-00020
   Rozman M, 1998, INT J STD AIDS, V9, P183, DOI 10.1258/0956462981921855
   SHAFER MA, 1994, SEX TRANSM DIS, V21, P181, DOI 10.1097/00007435-199405000-00009
   SHAFER MA, 1993, SEX TRANSM DIS, V20, P307, DOI 10.1097/00007435-199320060-00002
   Simbulan NP, 2001, SOC SCI MED, V52, P599, DOI 10.1016/S0277-9536(00)00163-5
   Skolnick AA, 1998, JAMA-J AM MED ASSOC, V279, P97, DOI 10.1001/jama.279.2.97
   SMITH PF, 1991, AM J PUBLIC HEALTH, V81, P35, DOI 10.2105/AJPH.81.Suppl.35
   VAZ RG, 1995, INT J STD AIDS, V6, P42, DOI 10.1177/095646249500600109
   Wolfe MI, 2001, AM J PUBLIC HEALTH, V91, P1220, DOI 10.2105/AJPH.91.8.1220
NR 32
TC 21
Z9 22
U1 0
U2 5
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAY
PY 2004
VL 37
IS 5
BP 771
EP 776
DI 10.1590/S0100-879X2004000500020
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 820EK
UT WOS:000221369800020
PM 15107941
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Rocha, AF
   Massad, E
   Coutinho, FAB
AF Rocha, AF
   Massad, E
   Coutinho, FAB
TI Can the human brain do quantum computing?
SO MEDICAL HYPOTHESES
LA English
DT Article
ID DENDRITIC SPINES; LOCATION; DYNAMICS
AB The electrical membrane properties have been the key issues in the understanding of the cerebra[ physiology for more than almost two centuries. But, molecular neurobiology has now discovered that biochemical transactions play an important rote in neuronal computations. Quantum computing (QC) is becoming a reality both from the theoretical point of view as well as from practical applications. Quantum mechanics is the most accurate description at atomic level and it ties behinds all chemistry that provides the basis for biology...maybe the magic of entanglement is also crucial for life. The purpose of the present paper is to discuss the dendrite spine as a quantum computing device, taking into account what is known about the physiology of the glutamate receptors and the cascade of biochemical transactions triggered by the glutamate binding to these receptors. (C) 2004 Published by Elsevier Ltd.
C1 Univ Sao Paulo, Sch Med, FMUSP, BR-01246903 Sao Paulo, Brazil.
   Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England.
RP Rocha, AF (corresponding author), Rua Maria Inez Carleti,26, BR-13201813 Jundiai, Brazil.
EM eina@enscer.com.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071
CR Bischof HJ, 2002, BEHAV BRAIN RES, V133, P317, DOI 10.1016/S0166-4328(02)00016-5
   BOUWMEESTER D, 2000, PHYS QUANTUM INFORMA
   Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1
   Fox K, 2003, CURR BIOL, V13, pR143, DOI 10.1016/S0960-9822(03)00077-0
   Gulde S, 2003, NATURE, V421, P48, DOI 10.1038/nature01336
   HAMEROFF S, 1998, TRENDS COGN SCI, V2, P4
   Helmchen F, 2002, TRENDS NEUROSCI, V25, P438, DOI 10.1016/S0166-2236(02)02232-4
   Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7
   Jozsa R., 2000, PHYS QUANTUM INFORM, P104
   Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0
   KIELPINSKI D, 2003, NATURE, V422, P410
   Lieshoff C, 2003, BEHAV BRAIN RES, V140, P87, DOI 10.1016/S0166-4328(02)00271-1
   Nielsen M. A., 2000, QUANTUM COMPUTATION
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   ROCHA AF, 2001, PROGR NEUROBIOLOGY, V64, P555
   Rocha AF, 2004, BRAIN FUZZY ARITHMET
   Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1
   Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X
   Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494
   Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X
   Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9
   Vedral V, 2003, NATURE, V425, P28, DOI 10.1038/425028a
   Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896
NR 23
TC 5
Z9 5
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2004
VL 63
IS 5
BP 895
EP 899
DI 10.1016/j.mehy.2004.03.044
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 867OU
UT WOS:000224852700022
PM 15488665
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
TI The Eyam plague revisited: did the village isolation change transmission
   from fleas to pulmonary?
SO MEDICAL HYPOTHESES
LA English
DT Article
AB Back in the 17th century the Derbyshire village of Eyam fell victim to the Black Death, which is thought to have arrived from London in some old clothes brought by a travelling tailor. The village population was 350 at the commencement of plague, of which only 83 survived. Led by the church leaders, the village community realized that the whole surrounding region was at risk from the epidemic, and therefore decided to seat themselves off from the other surrounding villages. In the first 275 days of the outbreak, transmission was predominantly from infected fleas to susceptible humans. From then onward, mortality sharply increased, which indicates a changing in transmission pattern. We hypothesize that the confinement facilitated the spread of the infection by increasing the contact rate through direct transmission among humans. This would be more consistent with pulmonary plague, a deadlier form of the disease. In order to test the above hypothesis we designed a mathematical model for plague dynamics, incorporating both the indirect (fleas-rats-humans) and direct (human-to-human) transmissions of the infection. Our results show remarkable agreement between data and the model, [ending support to our hypotheses. The Eyam plague episode is celebrated as a remarkable act of collective self-sacrifice. However, to the best of our knowledge, there were no evidence before that the confinement actually increased the burden payed by the commoners.
   In the light of our results, it can be said that the hypothesis that confinement facilitated the spread of the infection by increasing the contact rate through direct transmission is plausible. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo,455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Lopez, Luis F/C-4721-2012; Coutinho, Francisco A
   B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Coutinho, Francisco A B/0000-0003-3127-3071
CR BARNET SA, 2001, STORY RATS
   Butler T., 1983, PLAGUE OTHER YERSINI
   DENNIS DT, 1999, TROPICAL INFECT DIS, P506
   Gratz N., 1994, RODENT PESTS THEIR C
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   MOORE J, 2002, PARASITES BEHAV ANIM
   SERVICE NW, 1986, LECT NOTES MED ENTOM
   SLACK P, 1989, T ROY SOC TROP MED H, V83, P461, DOI 10.1016/0035-9203(89)90247-2
   SMITH MD, 1996, MANSONS TROPICAL DIS, P918
   ZIEGLER P, 1984, BLACK DEATH
NR 10
TC 18
Z9 18
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2004
VL 63
IS 5
BP 911
EP 915
DI 10.1016/j.mehy.2004.03.028
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 867OU
UT WOS:000224852700025
PM 15488668
DA 2020-12-16
ER

PT S
AU Marin, HF
   Massad, E
   Marques, EP
   Ohno-Machado, L
AF Marin, HF
   Massad, E
   Marques, EP
   Ohno-Machado, L
BE Fieschi, M
   Coiera, E
   Li, YCJ
TI International training in health informatics: A Brazilian experience
SO MEDINFO 2004: PROCEEDINGS OF THE 11TH WORLD CONGRESS ON MEDICAL
   INFORMATICS, PT 1 AND 2
SE STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS
LA English
DT Proceedings Paper
CT 11th World Congress on Medical Informatics
CY SEP 07-11, 2004
CL Amer Med Informat Assoc, San Francisco, CA
SP Int Med Informat Assoc
HO Amer Med Informat Assoc
DE computer-supported training; information; continuing professional
   education; health informatics education
AB Technology is transforming not only the practice of healthcare but also professional training and educational models. Developing countries, such as Brazil, are increasingly suffering from a severe shortage of health informatics specialists. Training of professionals in this field is expensive, and there is a limited supply of high-quality teaching resources available. We envision that training in health informatics can be better achieved if cultural and technological barriers are anticipated and the training program is prepared accordingly. We describe our four-year experience of a Brazil/USA training program and discuss lessons learned during its implementation. Eleven onsite courses, one seminar, and two conferences were developed under this unique initiative, which made possible the collaboration among different countries and distinguished leaders in the field of medical informatics.
C1 Univ Fed Sao Paulo, BR-04024002 Sao Paulo, Brazil.
RP Marin, HF (corresponding author), Univ Fed Sao Paulo, Rua Napoleao de Barros 754, BR-04024002 Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916; Ohno-Machado,
   Lucila/0000-0002-8005-7327
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW001279, D43TW001279, D43TW001279,
   D43TW001279, D43TW001279] Funding Source: NIH RePORTER; FIC NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [1D43TW01279-01] Funding Source: Medline
CR OHNOMACHADO L, P AMIA S 2000, P625
   OHNOMACHADO L, MEDINFO 2001
   2001, P 1 BRAZ S MATH COMP
NR 3
TC 2
Z9 2
U1 0
U2 2
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 1-58603-444-8
J9 ST HEAL T
PY 2004
VL 107
BP 898
EP 902
PG 5
WC Computer Science, Information Systems; Medical Informatics
SC Computer Science; Medical Informatics
GA BBO53
UT WOS:000226723300180
PM 15360942
DA 2020-12-16
ER

PT J
AU Massad, E
   Ortega, NRS
   Struchiner, CJ
   Burattini, MN
AF Massad, E
   Ortega, NRS
   Struchiner, CJ
   Burattini, MN
TI Fuzzy epidemics
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article
DE epidemiology; risk analysis; infectious diseases; fuzzy logic; fuzzy
   clustering
ID MEASLES OUTBREAK; REPRESENTATION; VACCINATION; COMMUNITY; SYSTEMS; VIRUS
AB The purpose of this paper is to provide a review of the current state of fuzzy logic theory in epidemioloy, which is a recent area of research. We present four applications of fuzzy logic theory in epidemic problems, using linguistic fuzzy models, possibility measure, probability of fuzzy events and fuzzy decision making techniques. The results demonstrate that the applications of fuzzy sets in epidemiology is a very promising area of research. The final discussion sets the future stage of fuzzy sets application in epidemiology. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Publ Hlth, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Phys, Rio De Janeiro, Brazil.
   Fiocruz MS, Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Ortega, Neli/C-6494-2013; Struchiner, Claudio J/M-9360-2013; Burattini,
   Marcelo N/J-9272-2014; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012
OI Struchiner, Claudio J/0000-0003-2114-847X; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916
CR ADLASSNIG KP, 2000, FUZZY DIAGNOSTIC THE
   ANDERSON R M, 1991
   BELLMAN RE, 1970, MANAGE SCI B-APPL, V17, pB141
   BRAVO R, 1995, MED CLIN-BARCELONA, V104, P530
   Ferson S, 1996, RELIAB ENG SYST SAFE, V54, P133, DOI 10.1016/S0951-8320(96)00071-3
   GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593
   Helgason CM, 1998, NEURAL NETWORKS, V11, P549, DOI 10.1016/S0893-6080(97)00149-4
   HUGHES C, 1989, MED INFORM, V14, P269, DOI 10.3109/14639238908999281
   HUTCHINS SS, 1990, AM J EPIDEMIOL, V132, P157, DOI 10.1093/oxfordjournals.aje.a115627
   Klir G. J., 1995, FUZZY SETS FUZZY LOG
   MARKOWITZ LE, 1994, VACCINES, P229
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   Ortega NRS, 2000, KYBERNETES, V29, P201, DOI 10.1108/03684920010312768
   Rothman K.J., 1998, MODERN EPIDEMIOLOGY
   Sadegh-Zadeh K, 1999, ARTIF INTELL MED, V17, P87, DOI 10.1016/S0933-3657(99)00015-9
   Shafer G., 1987, ANAL FUZZY INFORMATI, V1, P51
   WEEKS RM, 1992, B WORLD HEALTH ORGAN, V70, P317
   Yager RR, 1994, ESSENTIALS FUZZY MOD
   Yen J, 1999, FUZZY LOGIC INTELLIG
   Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5
   ZADEH LA, 1968, J MATH ANAL APPL, V23, P421, DOI 10.1016/0022-247X(68)90078-4
   ZADEH LA, 1973, IEEE T SYST MAN CYB, VSMC3, P28, DOI 10.1109/TSMC.1973.5408575
   ZIMMERMAN HJ, 1996, FUZZY INFORMATION EN, P471
NR 25
TC 26
Z9 26
U1 1
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0933-3657
EI 1873-2860
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD NOV
PY 2003
VL 29
IS 3
BP 241
EP 259
AR PII S0933-3657(02)00070-2
DI 10.1016/S0933-3657(02)00070-2
PG 19
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 755LT
UT WOS:000187404900004
PM 14656489
DA 2020-12-16
ER

PT J
AU Luz, PM
   Codeco, CT
   Massad, E
   Struchiner, CJ
AF Luz, PM
   Codeco, CT
   Massad, E
   Struchiner, CJ
TI Uncertainties regarding dengue modeling in Rio de Janeiro, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue modeling; uncertainties; vector density spatial heterogeneity;
   control measures of arthropod-borne diseases; Rio de Janeiro; Brazil
ID AEDES-AEGYPTI DIPTERA; PUERTO-RICO; DISEASE TRANSMISSION; LIFE TABLE;
   CULICIDAE; FEVER; EPIDEMIOLOGY; DISPERSAL; SURVIVAL; VIRUS
AB Dengue fever is currently the most important arthropod-borne viral disease in Brazil. Mathematical modeling of disease dynamics is a very useful tool for the evaluation of control measures. To be used in decision-making, however, a mathematical model must be carefully parameterized and validated with epidemiological and entomological data. In this work, we developed a simple dengue model to answer three questions: (i) which parameters are worth pursuing in the field in order to develop a dengue transmission model for Brazilian cities; (ii) how vector density spatial heterogeneity influences control efforts; (iii) with a degree of uncertainty, what is the invasion potential of dengue virus type 4 (DEN-4) in Rio de Janeiro city. Our model consists of an expression for the basic reproductive number (R-0) that incorporates vector density spatial heterogeneity. To deal with the uncertainty regarding parameter values, we parameterized the model using a priori probability density functions covering a range of plausible values for each parameter. Using the Latin Hypercube Sampling procedure, values for the parameters were generated. We conclude that, even in the presence of vector spatial heterogeneity, the two most important entomological parameters to be estimated in the field are the mortality rate and the extrinsic incubation period. The spatial heterogeneity of the vector population increases the risk of epidemics and makes the control strategies more complex. At last, we conclude that Rio de Janeiro is at risk of a DEN-4 invasion. Finally, we stress the point that epidemiologists, mathematicians, and entomologists need to interact more to find better approaches to the measuring and interpretation of the transmission dynamics of arthropod-borne diseases.
C1 Univ Sao Paulo, Fac Med, Disciplina Informat Med, Sao Paulo, Brazil.
   Fundacao Oswaldo Cruz, Programa Comp Cientif, BR-21045900 Rio De Janeiro, Brazil.
RP Luz, PM (corresponding author), Univ Sao Paulo, Fac Med, Disciplina Informat Med, Sao Paulo, Brazil.
EM pluz@procc.fiocruz.br
RI Struchiner, Claudio J/M-9360-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Struchiner, Claudio J/0000-0003-2114-847X; Massad,
   Eduardo/0000-0002-7200-2916; Luz, Paula/0000-0001-9746-719X
CR ANDERSON R M, 1991
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Costero A, 1998, J MED ENTOMOL, V35, P809, DOI 10.1093/jmedent/35.5.809
   da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   *FUND NAC SAUD MIN, 2002, PROGR NAC CONTR DENG
   *FUNF NAC SAUD MIN, 2002, GUIA DOENC DENG 2002
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Hernandez-Suarez CM, 2002, J THEOR BIOL, V215, P83, DOI 10.1006/jtbi.2001.2496
   Honorio NA, 2001, REV SAUDE PUBL, V35, P385, DOI 10.1590/S0034-89102001000400009
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Nogueira RMR, 1999, MEM I OSWALDO CRUZ, V94, P297, DOI 10.1590/S0074-02761999000300004
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Porco TC, 1998, THEOR POPUL BIOL, V54, P117, DOI 10.1006/tpbi.1998.1366
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   *SECR MUN SAUD PRE, 2002, COMB DENG IND PEND I
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Teixeira  M G, 2001, Rev Soc Bras Med Trop, V34, P269
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Watson TM, 1999, J MED ENTOMOL, V36, P508, DOI 10.1093/jmedent/36.4.508
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
NR 28
TC 77
Z9 77
U1 1
U2 26
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT
PY 2003
VL 98
IS 7
BP 871
EP 878
DI 10.1590/S0074-02762003000700002
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 748RD
UT WOS:000186874100002
PM 14765541
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Zanetta, DMT
   Cabrera, EMS
   Azevedo, RS
   Burattini, MN
   Massad, E
AF Zanetta, DMT
   Cabrera, EMS
   Azevedo, RS
   Burattini, MN
   Massad, E
TI Seroprevalence of rubella antibodies in the State of Sao Paulo, Brazil,
   8 years after the introduction of vaccine
SO VACCINE
LA English
DT Article
DE rubella; seroepidemiology; vaccination
ID MEASLES; STRATEGY; MUMPS; FINLAND
AB Rubella vaccine was introduced in the official immunization calendar of the State of Sao Paulo, in 1992, at 15 months of age, following a mass vaccination targeting all children between 1 and 10 years of age. This mixed strategy was designed taking into account serological data and mathematical models to estimate the optimal ages for vaccination. To evaluate the efficacy of routine vaccination on rubella infection in Sao Jose do Rio Preto, State of Sao Paulo, 8 years after the introduction of vaccine, a seroprevalence survey was carried out in December 2000, comprising 1536 subjects aging from 6 months to 25 years. Rubella specific IgG was detected in blood samples by enzyme-linked immunosorbent assay (ELISA). From 18 months to 5 years of age (covered by a mass vaccination campaign 6 months before the Study) the seroprevalence was above 90%. From 6 to 8 years of age (vaccinated by routine schedule at 15 months), the seroprevalence was 76%. Front 9 to 18 years of age (vaccinated at the mass campaign that introduced the vaccine 8 years before) the seroprevalence was about 85%. After 20 years of age, protection was acquired by previous infection, as they were not covered by any vaccine program. From 20 to 25 years of age, the seroprevalence was 70%. As the seroprevalence remains low at ages not vaccinated, it should be expected low infection rates at this age window. Despite this, the present situation deserves care, as routine vaccination is given a protection below the minimum level necessary (80%). The efficacy of the proposed strategy depends on better routine vaccination coverage. A second dose of vaccine should also be considered. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Med Sch Sao Jose Rio Preto, Dept Epidemiol & Publ Hlth, FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   HCFMUSP, LIM 01, Sao Paulo, Brazil.
RP Zanetta, DMT (corresponding author), Med Sch Sao Jose Rio Preto, Dept Epidemiol & Publ Hlth, FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
RI Zanetta, Dirce M T/G-4950-2013; Azevedo, Raymundo S/B-7593-2008;
   Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Cabrera, Eliana/B-3190-2016
OI Azevedo, Raymundo S/0000-0003-0660-2371; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Cabrera,
   Eliana/0000-0002-6967-5773
CR ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   AZEVEDONETO RS, 1994, EPIDEMIOL INFECT, V113, P161
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   Davidkin I, 2000, VACCINE, V18, P3106, DOI 10.1016/S0264-410X(00)00139-0
   HETHCOTE HW, 1983, AM J EPIDEMIOL, V117, P2, DOI 10.1093/oxfordjournals.aje.a113511
   Johnson CE, 1996, PEDIATR INFECT DIS J, V15, P687, DOI 10.1097/00006454-199608000-00010
   KNOX EG, 1980, INT J EPIDEMIOL, V9, P13, DOI 10.1093/ije/9.1.13
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   Peltola H, 2000, JAMA-J AM MED ASSOC, V284, P2643, DOI 10.1001/jama.284.20.2643
   Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69
   van Druten J A, 1986, Dev Biol Stand, V65, P53
NR 12
TC 7
Z9 8
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
J9 VACCINE
JI Vaccine
PD SEP 8
PY 2003
VL 21
IS 25-26
BP 3795
EP 3800
DI 10.1016/S0264-410X(03)00315-3
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 719YY
UT WOS:000185233700039
PM 12922113
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
AF Massad, E
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
TI Dengue and the risk of urban yellow fever reintroduction in Sao Paulo
   State, Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE yellow fever, epidemiology; dengue, epidemiology; mathematical models;
   disease outbreaks; Aedes; yellow fever vaccine
AB Objective To propose a mathematical method for the estimation of the Basic Reproduction Number, R-0, of urban yellow fever in a dengue-infested area.
   Methods The method is based on the assumption that, as the same vector (Aedes aegypti) causes both infections, all the quantities related to the mosquito, estimated from the initial phase of dengue epidemic, could be applied to yellow fever dynamics. It is demonstrated that R-0 for yellow fever is, on average, 43% lower than that for dengue. This difference is due to the longer dengue viremia and its shorter extrinsic incubation period.
   Results In this study the analysis was expanded to the epidemiological situation of dengue in Sao Paulo in the year 2001. The total number of dengue cases increased from 3,582 in 2000 to 51,348 in 2001. It was then calculated R-0 for yellow fever for every city which have shown R-0 of dengue greater than 1. It was also estimated the total number of unprotected people living in highly risky areas for urban yellow fever.
   Conclusions Currently there is a great number of non-vaccinated people living in Aedes aegypti infested area in the state of Sao Paulo.
C1 Univ Sao Paulo, Fac Med, BR-01246903 Sao Paulo, SP, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Fac Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Massad, Eduardo/H-6143-2011; Lopez,
   Luis F/C-4721-2012; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Lopez, Luis
   F/0000-0003-4097-6887; Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916
CR ANDERSON R M, 1991
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   Degallier N, 1996, B SOC PATHOL EXOT, V89, P128
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   FORATTINI OP, 2002, CULICIDOLOGIA MED ID, V2, P498
   FRAIHA H, 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P289
   Franco O, 1969, Rev Bras Malariol Doencas Trop, V21, P729
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Molineaux L, 1980, THE GARKI PROJECT
   Monath T. P., 1990, Tropical and geographical medicine., P661
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   Monath TP, 1999, VACCINES, P815
NR 15
TC 46
Z9 47
U1 0
U2 15
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 2003
VL 37
IS 4
BP 477
EP 484
DI 10.1590/S0034-89102003000400013
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 723EW
UT WOS:000185420300012
PM 12937709
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Goncalves, MAG
   Burattini, MN
   Donadi, EA
   Massad, E
AF Goncalves, MAG
   Burattini, MN
   Donadi, EA
   Massad, E
TI Anogenital warts contributing to the risk of squamous intraepithelial
   lesions among HIV-positive women of Sao Paulo, Brazil
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Article
DE human papillomavirus; human immunodeficiency virus; squamous
   intraepithelial lesions; cervical intraepithelial neoplasia; acquired
   immunodeficiency syndrome
ID HUMAN-PAPILLOMAVIRUS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS;
   CERVICAL-CANCER; NEOPLASIA; HPV; IMMUNOSUPPRESSION
AB Unsafe sexual practices may expose HIV-positive women to high-grade squamous intraepithelial lesions (SIL) and to infection with oncogenic human papillomavirus (HPV) types. A cross sectional study of 141 HIV-positive women was designed to evaluate risk factors for the development of cervico-vaginal SIL and HPV-DNA detection/typing. Uni- and multivariate forward stepwise analysis was used to determine the relationship between risk variables and HPV infection and between risk behaviour, HPV and HIV infection with development of SIL. Univariate analysis showed that HPV-DNA infection was related to previous and recurrent anogenital warts, male genital warts and cytological alteration. For final multivariate analysis, both HPV type (undetermined- and high-risk, OR=29.3 and 112.0, respectively) were statistically associated (P=0.019) with high-grade cervico-vaginal SIL. The presence of anogenital warts as well as high- and undetermined-risk HPV infection may alert to cyto/histopathological alterations. These results point out the importance of the use of barrier methods and routine early genitoscopy/treatment for HIV-infected partners.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, Discipline Med Informat, BR-14049900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, HCFMUSP, LIM01, BR-14049900 Sao Paulo, Brazil.
RP Goncalves, MAG (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
RI donadi, eduardo A/H-7080-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014
OI donadi, eduardo A/0000-0002-9457-9601; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890
CR BRAUN L, 1994, AM J PATHOL, V144, P209
   Cappiello G, 1997, INT J CANCER, V72, P982
   CAVALCANTI SMB, 1997, P BRAS PATHOL, V33, P62
   CONTI M, 1993, GYNECOL ONCOL, V49, P344, DOI 10.1006/gyno.1993.1137
   DEAN AG, 1994, EPIINFO VERRSION 6 W
   DEPALO G, 1993, MANUALE COLPOSCOPIA
   DIXON WJ, 1992, BMDP STAT SOFTWARE M, V1
   ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18
   FRANCO EL, 1994, JNCI-J NATL CANCER I, V86, P1558, DOI 10.1093/jnci/86.20.1558
   FRANCO EL, 1995, J INFECT DIS, V172, P856
   Goncalves MAG, 1999, INT J STD AIDS, V10, P803, DOI 10.1258/0956462991913583
   GROSS EG, 1997, HUMAN PAPILLOMAVIRUS
   Heard I, 2000, OBSTET GYNECOL, V96, P403, DOI 10.1016/S0029-7844(00)00948-0
   HO GYF, 1994, INT J CANCER, V56, P788, DOI 10.1002/ijc.2910560605
   *INT AG RES CANC, 1995, IARC MON HUM PAP, V64
   KURMAN RJ, 1994, BETHESDA SYSTEM REPO
   LEY C, 1991, J NATL CANCER I, V83, P997, DOI 10.1093/jnci/83.14.997
   MEISELS A, 1976, ACTA CYTOL, V20, P505
   Palefsky J M, 1998, J Natl Cancer Inst Monogr, P15
   PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205
   PETRY KU, 1994, INT J CANCER, V57, P836, DOI 10.1002/ijc.2910570612
   PUROLA E, 1977, ACTA CYTOL, V21, P26
   REID R, 1985, AM J OBSTET GYNECOL, V153, P611, DOI 10.1016/S0002-9378(85)80244-1
   SCHIFFMAN MH, 1993, J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958
   SECK AC, 1994, INT J STD AIDS, V5, P189
   Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903
   SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M
   TWEDDEL G, 1994, GYNECOL ONCOL, V52, P161, DOI 10.1006/gyno.1994.1024
   VERNON SD, 1994, J INFECT DIS, V169, P1108, DOI 10.1093/infdis/169.5.1108
   Villa LL, 1997, ADV CANCER RES, V71, P321, DOI 10.1016/S0065-230X(08)60102-5
   WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205
   WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591
   WRIGHT TC, 1996, HUMAN PAPILLOMAVIRUS
NR 33
TC 4
Z9 6
U1 0
U2 0
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND
SN 0956-4624
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD MAY
PY 2003
VL 14
IS 5
BP 309
EP 313
DI 10.1258/095646203321605503
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 677MG
UT WOS:000182811700004
PM 12803937
DA 2020-12-16
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Azevedo, RS
   Burattini, MN
   Lopez, LF
   Massad, E
AF Amaku, M
   Coutinho, FAB
   Azevedo, RS
   Burattini, MN
   Lopez, LF
   Massad, E
TI Vaccination against rubella: Analysis of the temporal evolution of the
   age-dependent force of infection and the effects of different contact
   patterns
SO PHYSICAL REVIEW E
LA English
DT Article
ID SAO-PAULO STATE; MEASLES; STABILITY; THRESHOLD; PROGRAMS; STRATEGY;
   MUMPS
AB In this paper, we analyze the temporal evolution of the age-dependent force of infection and incidence of rubella, after the introduction of a very specific vaccination program in a previously nonvaccinated population where rubella was in endemic steady state. We deduce an integral equation for the age-dependent force of infection, which depends on a number of parameters that can be estimated from the force of infection in a steady state prior to the vaccination program. We present the results of our simulations, which are compared with observed data. We also examine the influence of contact patterns among members of a community on the age-dependent intensity of transmission of rubella and on the results of vaccination strategies. As an example of the theory proposed, we calculate the effects of vaccination strategies for four communities from Caieiras (Brazil), Huixquilucan (Mexico), Finland, and the United Kingdom. The results for each community differ considerably according to the distinct intensity and pattern of transmission in the absence of vaccination. We conclude that this simple vaccination program is not very efficient (very slow) in the goal of eradicating the disease. This gives support to a mixed strategy, proposed by Massad , accepted and implemented by the government of the State of Sao Paulo, Brazil.
C1 Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, BR-05508000 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, LIM01, BR-01246903 Sao Paulo, Brazil.
RP Amaku, M (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Ave Prof Dr Orlando Marques de Paiva 87, BR-05508000 Sao Paulo, Brazil.
EM amaku@vps.fmvz.usp.br
RI Massad, Eduardo/H-6143-2011; Amaku, Marcos/D-5252-2012; Burattini,
   Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012; Azevedo, Raymundo
   S/B-7593-2008; Coutinho, Francisco A B/H-5644-2011; Massad,
   Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Burattini, Marcelo
   N/0000-0002-5407-6890; Lopez, Luis F/0000-0003-4097-6887; Azevedo,
   Raymundo S/0000-0003-0660-2371; Coutinho, Francisco A
   B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916
CR ANDERSON R M, 1991
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1048
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233
   GOLUBJATNIKOV R, 1971, AM J TROP MED HYG, V20, P958, DOI 10.4269/ajtmh.1971.20.958
   GREENHALGH D, 1987, IMA J MATH APPL MED, V4, P109
   GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126
   INABA H, 1990, J MATH BIOL, V28, P411
   Kot M., 2000, ELEMENTS MATH ECOLOG
   Lopez LF, 2000, J MATH BIOL, V40, P199, DOI 10.1007/s002850050178
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   MASSAD E, UNPUB, P44301
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   PLOTKI SA, 1999, VACCINES, P44301
   Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1
   TRUCCO E, 1965, B MATH BIOPHYS, V27, P285, DOI 10.1007/BF02478406
   Ukkonen P, 1996, SCAND J INFECT DIS, V28, P31, DOI 10.3109/00365549609027146
   van der Heijden OG, 1998, EPIDEMIOL INFECT, V121, P653, DOI 10.1017/S0950268898001472
NR 22
TC 26
Z9 26
U1 0
U2 4
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1539-3755
EI 1550-2376
J9 PHYS REV E
JI Phys. Rev. E
PD MAY
PY 2003
VL 67
IS 5
AR 051907
DI 10.1103/PhysRevE.67.051907
PN 1
PG 11
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 689GA
UT WOS:000183482200060
PM 12786178
DA 2020-12-16
ER

PT J
AU Ortega, N
   Barros, LC
   Massad, E
AF Ortega, N
   Barros, LC
   Massad, E
TI Fuzzy gradual rules in epidemiology
SO KYBERNETES
LA English
DT Article
DE cybernetics; fuzzy logics; medicine; epidemiology
ID DIFFERENTIAL-EQUATIONS; BRAZIL; SEROPREVALENCE; MODEL
AB This paper presents an application of the fuzzy gradual rules in an epidemic study of canine rabies in Sao Paulo city, Brazil. A linguistic epidemiological model was elaborated through fuzzy rules built by the Extension Principle. We used both the inference method of Mamdani and of Dubois et al. The results were compared with real data from Sao Paulo and with another MISO Model, which is entirely based on expert knowledge presented in a previous work. Questions about application of fuzzy techniques in epidemiology, different inference methods and the Dubois et al. methodology are discussed.
C1 Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   Univ Campinas, Inst Math Stat & Sci Computat, Sao Paulo, Brazil.
RP Ortega, N (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Barros, Laecio/G-3236-2012; Massad,
   Eduardo/B-1169-2012; Ortega, Neli/C-6494-2013
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Almeida MF, 2001, J WILDLIFE DIS, V37, P394, DOI 10.7589/0090-3558-37.2.394
   BARROS LC, 1992, THESIS U CAMPINAS SA
   BASSANEZI RC, 1995, KYBERNETES, V24, P91
   Bastian A, 2000, FUZZY SET SYST, V113, P333, DOI 10.1016/S0165-0114(98)00086-4
   *BRAZ MIN HLTH, 1999, CARAIVA8699
   Coutinho FAB, 1999, REV SAUDE PUBL, V33, P329, DOI 10.1590/S0034-89101999000400002
   DEGANI R, 1987, FUZZY SET SYST, V24, P345, DOI 10.1016/0165-0114(87)90032-7
   Dubois D, 1997, IEEE T FUZZY SYST, V5, P398, DOI 10.1109/91.618276
   Dubois D., 1995, THEORETICAL ASPECTS, P147
   GERSTENKORN T, 1994, FUZZY SET SYST, V68, P327, DOI 10.1016/0165-0114(94)90187-2
   JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541
   KALEVA O, 1987, FUZZY SET SYST, V24, P301, DOI 10.1016/0165-0114(87)90029-7
   Klir G. J., 1995, FUZZY SETS FUZZY LOG
   LI B, 1996, ECOLOGICAL MODELLING, V90
   Lopez LF, 1999, MATH COMPUT MODEL, V29, P55, DOI 10.1016/S0895-7177(99)00062-X
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MASSAD E, 2003, FUZZY EPIDEMICS
   MASSAD E, 1997, P SOFT COMP SOCO 97, P58
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   Nguyen H. T., 1997, 1 COURSE FUZZY LOGIC
   Ortega NRS, 2000, KYBERNETES, V29, P201, DOI 10.1108/03684920010312768
   Pearson DW, 1997, APPL MATH LETT, V10, P99, DOI 10.1016/S0893-9659(97)00043-8
   Sallum PC, 2000, PREV VET MED, V44, P131, DOI 10.1016/S0167-5877(00)00110-0
   Sanchez E, 1996, FUZZY SET SYST, V84, P155, DOI 10.1016/0165-0114(96)00063-2
   SEIKKALA S, 1987, FUZZY SET SYST, V24, P319, DOI 10.1016/0165-0114(87)90030-3
   Struchiner CJ, 1999, INT J EPIDEMIOL, V28, P776, DOI 10.1093/ije/28.4.776
   STRUCHINER CJ, 1997, P SOFT COMP SOCO 97, P64
   Sugeno M., 1974, THESIS TOKYO I TECHN
   WANG LX, 1992, IEEE T SYST MAN CYB, V22, P1414, DOI 10.1109/21.199466
   *WHO, 1994, WHOEMCZOO963
   Yager RR, 1994, ESSENTIALS FUZZY MOD
   Yen J, 1999, FUZZY LOGIC INTELLIG
   ZADEH LA, 1975, INFORM SCIENCES, V8, P301, DOI 10.1016/0020-0255(75)90046-8
   ZADEH LA, 1975, INFORM SCIENCES, V9, P43, DOI 10.1016/0020-0255(75)90017-1
   ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90036-5
NR 36
TC 38
Z9 38
U1 0
U2 4
PU EMERALD
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD BD8 9BY, W YORKSHIRE, ENGLAND
SN 0368-492X
J9 KYBERNETES
JI Kybernetes
PY 2003
VL 32
IS 3-4
BP 460
EP 477
DI 10.1108/03684920310463876
PG 18
WC Computer Science, Cybernetics
SC Computer Science
GA 671AR
UT WOS:000182443000018
DA 2020-12-16
ER

PT J
AU Goncalves, MAG
   Burattini, MN
   Donadi, EA
   Massad, E
AF Goncalves, MAG
   Burattini, MN
   Donadi, EA
   Massad, E
TI Risk factors associated with genital warts in HIV-positive Brazilian
   women
SO TUMORI
LA English
DT Article
DE antiretroviral therapy; cervical intraepithelial neoplasia; human
   immunodeficiency virus; human papillomavirus
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA;
   HUMAN-PAPILLOMAVIRUS; INFECTED WOMEN; SEROPOSITIVE WOMEN; VIRAL LOAD;
   LESIONS; HPV; ABNORMALITIES; DYSPLASIA
AB Aims and background: In Brazil, the female population has been, increasingly infected with human immunodeficiency virus (HIV), and uterine cervix carcinoma now represents the second highest cause of mortality. Although HIV infection among women is associated with an increased prevalence of cervical cancer precursors, the co-infection with human papillomavirus (HPV) is considered to be a necessary but not sufficient factor to induce genital lesions. This study was conducted to identify risk factors associated with the history of genital warts among HIV-positive women.
   Methods: A comparative cross-sectional evaluation was applied to 141 HIV-positive women. All patients were submitted to colposcopy, smear cytology, directed biopsy, and HPV-DNA detection. The chi-square, Fisher's exact test, and the odds ratio (OR, 95%; confidence interval, CI) were used to evaluate associations between history of genital warts and risk factors.
   Results: A history of genital warts presented associations with: a) age at first sexual intercourse :517 years (OR, 0.42; Cl, 0.16-1.11); b) history of genital warts in sex partners (OR, 11.39; Cl, 4.21-30.76), especially with recurrent episodes (OR, 6.60; Cl, 2.69-16.12); c) drug addiction (OR, 2.38; Cl, 1.09-5.19), especially in crack users (OR, 5.34; Cl, 1.64-17.41); d) cervical HPV infection (OR, 2.75; Cl 1.09-6.90); e) cervical infection caused by only one HPV type (OR, 2.77; Cl 1.06-7.20); f) perianal HPV infection (OR, 2.30; Cl, 0.70-7.56), associated with negative results for undetermined risk HPV (OR, 8.41; P = 0.04); and g) no antiretroviral therapy (OR, 3.41; P = 0.07).
   Conclusions: Evaluation of behavioral risk factors associated with a genital wart history is an important tool to prevent and reduce persistent HPV infection, and consequently genital cancer precursors in HIV infected women.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sch Med, Discipline Med Informat, LMO1 HCFMUSP, Sao Paulo, Brazil.
RP Goncalves, MAG (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, Brazil.
RI Massad, Eduardo/H-6143-2011; donadi, eduardo A/H-7080-2013; Massad,
   Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014
OI donadi, eduardo A/0000-0002-9457-9601; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890
CR Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165
   Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P1
   [Anonymous], 1990, Wkly Epidemiol Rec, V65, P221
   Cardillo M, 2001, CANCER CYTOPATHOL, V93, P111, DOI 10.1002/cncr.9016
   CONTI M, 1993, GYNECOL ONCOL, V49, P344, DOI 10.1006/gyno.1993.1137
   CREAGH T, 1995, J CLIN PATHOL, V48, P59, DOI 10.1136/jcp.48.1.59
   Cubie HA, 2000, SEX TRANSM INFECT, V76, P257, DOI 10.1136/sti.76.4.257
   Davis AT, 2001, GYNECOL ONCOL, V80, P350, DOI 10.1006/gyno.2000.6104
   Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031
   ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18
   Fruchter RG, 1996, OBSTET GYNECOL, V87, P338, DOI 10.1016/0029-7844(95)00408-4
   Goncalves MAG, 1999, INT J STD AIDS, V10, P803, DOI 10.1258/0956462991913583
   GONCALVES MAG, 2002, INT J STD AIDS, V13, P1
   Grimm JW, 1997, PHYSIOL BEHAV, V61, P755, DOI 10.1016/S0031-9384(96)00532-X
   Heard I, 2000, OBSTET GYNECOL, V96, P403, DOI 10.1016/S0029-7844(00)00948-0
   Heard I, 1998, AIDS, V12, P1459, DOI 10.1097/00002030-199812000-00007
   Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703
   *INT AG RES CANC, 1995, IARC MON HUM PAP, V64
   KING TS, 1993, J PHARMACOL EXP THER, V264, P29
   KREISS JK, 1992, SEX TRANSM DIS, V19, P54, DOI 10.1097/00007435-199201000-00011
   Londesborough P, 1996, INT J CANCER, V69, P364
   MAIMAN M, 1991, OBSTET GYNECOL, V78, P84
   MANDELBLATT JS, 1999, CANCER EPIDEM BIOMAR, V8, P729
   Mayrand MH, 2000, J CLIN MICROBIOL, V38, P3388, DOI 10.1128/JCM.38.9.3388-3393.2000
   Palefsky Joel, 2002, AIDS Clin Care, V14, P44
   PETRY KU, 1994, INT J CANCER, V57, P836, DOI 10.1002/ijc.2910570612
   SPURRETT B, 1988, LANCET, V1, P237
   WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591
   WRIGHT TC, 1996, PAPILOMAVIRUS HUMANO, V2, P837
NR 29
TC 13
Z9 19
U1 0
U2 2
PU PENSIERO SCIENTIFICO EDITOR
PI ROME
PA VIA BRADANO 3/C, 00199 ROME, ITALY
SN 0300-8916
J9 TUMORI
JI Tumori
PD JAN-FEB
PY 2003
VL 89
IS 1
BP 9
EP 15
PG 7
WC Oncology
SC Oncology
GA 672RE
UT WOS:000182534600003
PM 12729354
DA 2020-12-16
ER

PT J
AU Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
AF Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
TI Threshold conditions for infection persistence in complex host-vectors
   interactions
SO COMPTES RENDUS BIOLOGIES
LA English
DT Article
DE basic reproductive number; vector-borne infections; yellow fever
ID FIRST RECORDED OUTBREAK; YELLOW-FEVER; DISEASE; KENYA
AB As classically defined by Macdonald in the early 1950s, for the case of diseases with one vector and one host, the Basic Reproduction Number, R-0. is defined as the number of secondary infections caused by a single infective of the same type (vector or host) during, its infectiousness period in an entirely susceptible population. In the case of a disease which has one vector and one host, it is easy to show that R-0 coincides with the threshold for the establishment of an endemic state: if R-0 > 1 (< 1), the disease can invade (cannot invade) the host population. In this paper we examine various epidemic situations in which there are more than one vector and/or host. We show that in those more complex systems it is not possible to deduce a single R-0 but rather a threshold for infection persistence which is a composite of several quantities closely related to the classical expression of R-0 Another definition of R-0 given by Diekmann, Heesterbeek and Metz, and denoted in this paper R-0(NGO) is discussed and applied as an alternative to calculate the thresholds for infection establishment.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, LIMO1, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Lopez, Luis F/C-4721-2012; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Coutinho,
   Francisco A B/H-5644-2011
OI Lopez, Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071
CR Beaty B.J., 1996, BIOL DIS VECTORS
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Digoutte JP, 1999, B SOC PATHOL EXOT, V92, P343
   GODDARD J, 2000, INFECT DIS ARTHROPOD
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Monath T. P., 1990, Tropical and geographical medicine., P661
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   Monath TP, 1999, VACCINES, P815
   Murray J. D., 1993, MATH BIOL
   NOLD A, 1980, MATH BIOSCI, V52, P227, DOI 10.1016/0025-5564(80)90069-3
   Palmer S.R., 1998, ZOONOSES BIOL CLIN P, P3
   Reiter P, 1998, AM J TROP MED HYG, V59, P650, DOI 10.4269/ajtmh.1998.59.650
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644, DOI 10.4269/ajtmh.1998.59.644
NR 17
TC 39
Z9 40
U1 0
U2 11
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE
SN 1631-0691
J9 CR BIOL
JI C. R. Biol.
PD NOV
PY 2002
VL 325
IS 11
BP 1073
EP 1084
DI 10.1016/S1631-0691(02)01534-2
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 628UU
UT WOS:000180015600001
PM 12506721
DA 2020-12-16
ER

PT J
AU de Almeida, LM
   Amaku, M
   Azevedo, RS
   Cairncross, S
   Massad, E
AF de Almeida, LM
   Amaku, M
   Azevedo, RS
   Cairncross, S
   Massad, E
TI The intensity of transmission of hepatitis A and heterogeneities in
   socio-environmental risk factors in Rio de Janeiro, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE hepatitis A; transmission; environmental risk factors; deterministic
   model; force of infection; Brazil
ID PREVALENCE; AGE; EPIDEMIOLOGY; POPULATION; ANTIBODIES; INFECTION;
   CHILDREN
AB The objective of this work was to assess the intensity of transmission of hepatitis A in Rio de Janeiro, Brazil. We also used the estimation of the parameters of a deterministic model to study the effects of risk factors. Age-specific seroprevalence of antibodies against hepatitis A virus (HAV) was obtained from a survey screening in a city of the metropolitan area of Rio de Janeiro, in 1997. From the seroprevalence data, we estimated the age-dependent force of infection (lambda()) and the average age of first infection (A), using a deterministic model. To evaluate the influence of the environmental risk factors, we estimated the same parameters stratifying the sample for the selected socio-environmental risk factors: the number of years of schooling of the female responsible for the house, crowding within the bedroom, number of water taps and fittings, and the presence of sewage in front of the house. For the whole sample, the maximum force of infection estimated was 0.12/year and the average age of infection was 10.1 years. This last parameter decreased as the number of persons per bedroom increased, and also when the number of water taps and the number of years of schooling of the woman responsible for the house decreased. The proposed environmental interventions may lead to a decrease in the intensity of transmission of HAV and an increase in the average age of first infection in the next few years. This may have public health implications, since hepatitis A is more severe in adults. In this context, specific vaccination programmes may be necessary, as in developed countries.
C1 Univ Sao Paulo, Fac Med, Dept Patol, Disciplina Informat Med, BR-01246903 Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, BR-21941590 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Fac Med Vet, Dept Vet Prevent & Social, Sao Paulo, Brazil.
   Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1E 7HT, England.
RP Azevedo, RS (corresponding author), Univ Sao Paulo, Fac Med, Dept Patol, Disciplina Informat Med, Dr Arnaldo,455,Sub Solo,Cerqueira Cesar, BR-01246903 Sao Paulo, Brazil.
EM razevedo@usp.br
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Amaku,
   Marcos/D-5252-2012; Azevedo, Raymundo S/B-7593-2008
OI Massad, Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774;
   Azevedo, Raymundo S/0000-0003-0660-2371
CR Almeida LM, 2001, EPIDEMIOL INFECT, V127, P327, DOI 10.1017/S0950268801005945
   ALMEIDA LM, 1998, CAD SAUDE COLETIV S1, V6, P39
   AMAKU M, 2001, THESIS U SAO PAULO B
   AMAKU M, 2001, TENDENCIAS MATEMATIC, V2, P23
   ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   [Anonymous], 1999, MMWR Recomm Rep, V48, P1
   Ballesteros J, 1996, EPIDEMIOL INFECT, V117, P145, DOI 10.1017/S0950268800001242
   Barros H, 1999, J VIRAL HEPATITIS, V6, P249, DOI 10.1046/j.1365-2893.1999.00144.x
   Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x
   CALDWELL JC, 1994, HTLH TRANSITION REV, V4, P111
   de Almeida LM, 1999, T ROY SOC TROP MED H, V93, P401, DOI 10.1016/S0035-9203(99)90133-5
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   *FIBGE, 1991, CENS BRAS 1991
   GIESECKE J, 1994, MODERN INFECT DIS EP
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   JOHNSON Z, 1995, INT J EPIDEMIOL, V24, P821, DOI 10.1093/ije/24.4.821
   KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150
   Koff RS, 1998, LANCET, V351, P1643, DOI 10.1016/S0140-6736(98)01304-X
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   Mausezahl D, 1996, INT J EPIDEMIOL, V25, P1271, DOI 10.1093/ije/25.6.1271
   MORALES JL, 1992, INFECTION, V20, P194, DOI 10.1007/BF02033057
   SCHENZLE D, 1979, AM J EPIDEMIOL, V110, P70, DOI 10.1093/oxfordjournals.aje.a112790
   SHAPIRO CN, 1992, VACCINE, V10, pS59, DOI 10.1016/0264-410X(92)90545-U
   SIEBKE JC, 1982, AM J EPIDEMIOL, V115, P185, DOI 10.1093/oxfordjournals.aje.a113290
   Struchiner CJ, 1999, INT J EPIDEMIOL, V28, P776, DOI 10.1093/ije/28.4.776
   Tanaka J, 2000, VACCINE, V18, pS57, DOI 10.1016/S0264-410X(99)00466-1
   Tapia-Conyer R, 1999, AM J TROP MED HYG, V61, P825, DOI 10.4269/ajtmh.1999.61.825
   WHITE GF, 1972, DRAWERS WATER DOMEST, P140
   YANG GL, 1990, MATH BIOSCI, V98, P157, DOI 10.1016/0025-5564(90)90121-E
   ZANETTA DM, 1996, 7 INT C INF DIS HONG, P118
   1993, PROGRAMA SANEAMENTO, V1
NR 31
TC 17
Z9 17
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD NOV-DEC
PY 2002
VL 96
IS 6
BP 605
EP 610
DI 10.1016/S0035-9203(02)90325-1
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 648RW
UT WOS:000181165200007
PM 12625132
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
AF Massad, E
   Burattini, MN
   Coutinho, FAB
   Lopez, LF
TI Which phase of the natural history of HIV infection is more
   transmissible?
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Letter
ID IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMA
C1 Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RI Burattini, Marcelo N/J-9272-2014; Lopez, Luis F/C-4721-2012; Massad,
   Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Coutinho, Francisco A
   B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Lopez, Luis
   F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916; Coutinho,
   Francisco A B/0000-0003-3127-3071
CR Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650
   Coutinho FAB, 2001, B MATH BIOL, V63, P1041, DOI 10.1006/bulm.2001.0257
   Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602
   Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303
NR 6
TC 2
Z9 2
U1 0
U2 5
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND
SN 0956-4624
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD JUN
PY 2002
VL 13
IS 6
BP 430
EP 431
DI 10.1258/095646202760029895
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 557JF
UT WOS:000175904900016
PM 12015021
DA 2020-12-16
ER

PT J
AU Saldiva, SRM
   Carvalho, HB
   Castilho, VP
   Struchiner, CJ
   Massad, E
AF Saldiva, SRM
   Carvalho, HB
   Castilho, VP
   Struchiner, CJ
   Massad, E
TI Malnutrition and susceptibility to enteroparasites: reinfection rates
   after mass chemotherapy
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
ID ASCARIS-LUMBRICOIDES; NUTRITIONAL-STATUS; TRICHURIS-TRICHIURA;
   PRESCHOOL-CHILDREN; PHYSICAL GROWTH; SCHOOL-CHILDREN; HELMINTHS;
   INFECTION; HOOKWORM; ASSOCIATION
AB The evidence that relates malnutrition to enteroparasite infections arises from studies that demonstrate the improvement of nutritional indicators after antiparasitism treatment. However, the role of malnutrition as an aggravating factor to the susceptibility to enteroparasite infections is still not fully understood. We investigated the correlation between malnutrition and enteroparasite infection after mass chemotherapy, in a poor city of Sao Paulo State, Brazil. The sample comprised 759 children between 1 and 10 years of age of whom 585 were followed up for a period of 1 year and periodically assessed for reinfection with enteroparasites. One year of follow-up after mass chemotherapy demonstrated that 38% of the undernourished children were reinfected with enteroparasites, as compared with 25% of the eutrophic children (P = 0.033). The survival multivariate analysis demonstrated that, after controlling for the potential confounding variables, maternal literacy and per capita income rate, malnutrition was associated with susceptibility to reinfection (P = 0.13). We demonstrate that, although maternal literacy and per capita income rate are indeed confounding variables, malnutrition contributes to an increase in the risk of enteroparasite infections.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Fiocruz MS, Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Struchiner, Claudio J/M-9360-2013; Massad,
   Eduardo/B-1169-2012; Saldiva, Silvia RDM/G-5859-2012; Carvalho,
   Heraclito/C-1334-2012
OI Struchiner, Claudio J/0000-0003-2114-847X; Massad,
   Eduardo/0000-0002-7200-2916; Carvalho, Heraclito/0000-0002-7037-5655
CR Ananthakrishnan S, 1997, NATL MED J INDIA, V10, P67
   CABRERA BD, 1980, COLLECTED PAPERS CON, P181
   Chandra R. K., 1977, NUTR IMMUNITY INFECT
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   CROLL NA, 1982, T ROY SOC TROP MED H, V76, P187, DOI 10.1016/0035-9203(82)90272-3
   DESILVA NR, 1906, SE ASIAN J TROPICAL, V27, P36
   DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P749
   DUPONT H. L., 1980, INFECT GASTROINTESTI
   ELKINS DB, 1986, T ROY SOC TROP MED H, V80, P774, DOI 10.1016/0035-9203(86)90384-6
   GUPTA MC, 1977, LANCET, V2, P108
   HAGEL I, 1995, T ROY SOC TROP MED H, V89, P562, DOI 10.1016/0035-9203(95)90109-4
   HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607
   Hoffman W, 1934, PUERTO RICO J PUBLIC, V9, P281, DOI DOI 10.1590/S0037-86822012000300024
   ISMAIL MM, 1989, COLLECTED PAPERS CON, V4, P23
   Kightlinger LK, 1998, J PARASITOL, V84, P480, DOI 10.2307/3284709
   LUNN PG, 1993, P NUTR SOC, V52, P101, DOI 10.1079/PNS19930042
   MATA LJ, 1978, CHILDREN SANTA MARIA
   MONTEIRO CA, 1995, VELHOS NOVOS MALES S, P93
   Moreira-Silva SF, 2000, J TROP PEDIATRICS, V46, P167, DOI 10.1093/tropej/46.3.167
   MURRAY MJ, 1977, LANCET, V1, P123
   Nozais JP, 1998, B SOC PATHOL EXOT, V91, P416
   Oberhelman RA, 1998, AM J TROP MED HYG, V58, P470, DOI 10.4269/ajtmh.1998.58.470
   PARMER KB, 1995, SURVIVAL ANAL PRACTI
   Saldiva SR, 1999, PAEDIATR PERINAT EP, V13, P89
   San Sebastian M, 1999, J TROP PEDIATRICS, V45, P379, DOI 10.1093/tropej/45.6.379
   SCRIMSHAW NS, 1959, AM J MED SCI, V237, P367
   STEPHENSON LS, 1993, J NUTR, V123, P656
   STEPHENSON LS, 1993, J NUTR, V123, P1036
   Stoltzfus RJ, 1996, AM J TROP MED HYG, V55, P399, DOI 10.4269/ajtmh.1996.55.399
   Thein-Hlaing, 1985, Ascariasis and its public health significance, P83
   THEINHLAING, 1991, T ROY SOC TROP MED H, V85, P519, DOI 10.1016/0035-9203(91)90241-P
   Vermeulen M, 1998, S AFR MED J, V88, P1217
   WILLETT WC, 1979, AM J PUBLIC HEALTH, V69, P987, DOI 10.2105/AJPH.69.10.987
NR 33
TC 7
Z9 10
U1 0
U2 0
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0269-5022
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD APR
PY 2002
VL 16
IS 2
BP 166
EP 171
DI 10.1046/j.1365-3016.2002.00402.x
PG 6
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA 551CW
UT WOS:000175542800010
PM 12064270
DA 2020-12-16
ER

PT S
AU Rocha, AF
   Massad, E
AF Rocha, AF
   Massad, E
BE Abe, JM
   DaSilaFilho, JL
TI Evolving arithmetical knowledge in a distributed intelligent processing
   system
SO ADVANCES IN LOGIC, ARTIFICIAL INTELLIGENCE AND ROBOTICS
SE FRONTIERS IN ARTIFICIAL INTELLIGENCE AND APPLICATIONS
LA English
DT Proceedings Paper
CT 3rd Congress of Logic Applied to Technology (LAPTEC 2002)
CY NOV 11-13, 2002
CL Sao Paulo, BRAZIL
SP SENAC, Coll Comp Sci & Technol
AB A new class of fuzzy numbers, called K Fuzzy Numbers, (KFN) is proposed to implement arithmetical knowledge in a Distributed Intelligent Processing System (DIPS). The proposed system intends to simulate brain functioning and experimental data about arithmetic capability in man and animals. KFN main property is the dependence of the size of the base alpha(1), alpha(2) of its membership function mu(di) (sigma) to the value of the number d(i) encoding sigma. Three populations of (Controllers; Accumulators and Quantifiers) agents are assumed to handle KFN in DIPS. Also, it is proposed that Accumulator evolution changing from monotonic to periodical evaluation strategies, may be the way to use KFN to create Crisp Base Numbers (CBN), like our decimal numeric system.
C1 Univ Sao Paulo, Sch Med, LIM01, HCF,MUSP, BR-01246903 Sao Paulo, Brazil.
RP Rocha, AF (corresponding author), Univ Sao Paulo, Sch Med, LIM01, HCF,MUSP, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Butterworth B, 1999, MATH BRAIN
   Dehaene Stanislas, 1997, NUMBER SENSE
   FAYO M, 1990, LENFANT NOMBRE COMPT
   MASSAD E, 2002, IN PRESS P IPMU
   PEDRYCZ W, 1995, IEEE T SYST MAN CYB, V25, P769, DOI 10.1109/21.376490
   Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4
   ROCHA AF, 2001, PROGR NEUROBIOLOGY, V64, P555
   Siegler R.S., 1996, EMERGING MINDS
NR 8
TC 1
Z9 1
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6389
BN 1-58603-292-5
J9 FR ART INT
PY 2002
VL 85
BP 68
EP 74
PG 7
WC Computer Science, Artificial Intelligence; Robotics
SC Computer Science; Robotics
GA BAZ97
UT WOS:000224340200009
DA 2020-12-16
ER

PT S
AU Massad, E
   Rocha, AF
AF Massad, E
   Rocha, AF
BE Abe, JM
   DaSilaFilho, JL
TI Meme-gene coevolution and cognitive mathematics
SO ADVANCES IN LOGIC, ARTIFICIAL INTELLIGENCE AND ROBOTICS
SE FRONTIERS IN ARTIFICIAL INTELLIGENCE AND APPLICATIONS
LA English
DT Proceedings Paper
CT 3rd Congress of Logic Applied to Technology (LAPTEC 2002)
CY NOV 11-13, 2002
CL Sao Paulo, BRAZIL
SP SENAC, Coll Comp Sci & Technol
AB After presenting the basic aspect of the new science of memetics and the basic mechanism of meme-gene coevolution we discuss the role of memes in the evolution of brain size and complexity. We also address the issue of cognitive mathematics, that is, how the human brain deals with number and present some hypothesis on the evolution of our mathematical abilities. We end the paper with a brief discussion of the future perspectives of memetics and cognitive mathematics, arguing that this is a very rich field of investigation, still in its infancy.
C1 Univ Sao Paulo, Sch Med, LIM01, HCF,MUSP, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, LIM01, HCF,MUSP, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Blackmore SJ, 1997, BRIT J PSYCHOL, V88, P683, DOI 10.1111/j.2044-8295.1997.tb02665.x
   Blackmore Susan, 1999, MEME MACHINE
   CONROY GC, 1997, RECONSTRUCTING HUMAN
   Dawkins R., 1976, SELFISH GENE
   Dehaene S, 1997, NUMBER SENSE MIND CR
   GABORA L, 1997, J MEMETICS EVOLUTION
   KENDAL JR, J MEMETICS EVOLUTION, V4
   ROLAND PE, 1985, J NEUROPHYSIOL, V53, P1219
NR 8
TC 0
Z9 0
U1 0
U2 1
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6389
BN 1-58603-292-5
J9 FR ART INT
PY 2002
VL 85
BP 75
EP 81
PG 7
WC Computer Science, Artificial Intelligence; Robotics
SC Computer Science; Robotics
GA BAZ97
UT WOS:000224340200010
DA 2020-12-16
ER

PT S
AU Sacchetta, TEP
   Ortega, N
   Menezes, RX
   Massad, E
AF Sacchetta, TEP
   Ortega, N
   Menezes, RX
   Massad, E
BE Abe, JM
   DaSilaFilho, JL
TI A fuzzy reed-frost model for epidemic spreading
SO ADVANCES IN LOGIC, ARTIFICIAL INTELLIGENCE AND ROBOTICS
SE FRONTIERS IN ARTIFICIAL INTELLIGENCE AND APPLICATIONS
LA English
DT Proceedings Paper
CT 3rd Congress of Logic Applied to Technology (LAPTEC 2002)
CY NOV 11-13, 2002
CL Sao Paulo, BRAZIL
SP SENAC, Coll Comp Sci & Technol
DE fuzzy relations; Reed Frost model; epidemiology; beta distribution
AB In this work, we propose a generalization of the classical Reed-Frost model considering heterogeneities in the population. In the Fuzzy Reed-Frost model the signals (symptoms, medical findings etc.) are included in the dynamics of the epidemic. Each individual presents a set of clinical indicators, which are used to determine his/her infectivity degree through a fuzzy decision process. The model is compared with a stochastic Reed-Frost model developed by some of the authors in a previous work.
C1 Univ Sao Paulo, Sch Med, LIMO1, HCFMUSP, Sao Paulo, Brazil.
RP Sacchetta, TEP (corresponding author), Univ Sao Paulo, Sch Med, LIMO1, HCFMUSP, Sao Paulo, Brazil.
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ABBEY HELEN, 1952, HUMAN BIOL, V24, P201
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   JACQUEZ JA, 1987, MATH BIOSCI, V87, P73, DOI 10.1016/0025-5564(87)90034-4
   Klir G. J., 1995, FUZZY SETS FUZZY LOG
   LEFREVE C, 1989, MATH BIOSCI, V95, P27
   MAIA JOC, 1952, HUM BIOL, V24, P167
   MASSAD E, 2001, IMA C MATH MOD STAT, P1
   MENEZES R, 2002, APPL B MATH BIOL
   PICARD P, 1991, MATH BIOSCI, V107, P225, DOI 10.1016/0025-5564(91)90006-5
   SCALIATOMBA G, 1986, J APPL PROBAB, V23, P563, DOI 10.2307/3213998
NR 10
TC 0
Z9 0
U1 0
U2 1
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6389
BN 1-58603-292-5
J9 FR ART INT
PY 2002
VL 85
BP 258
EP 264
PG 7
WC Computer Science, Artificial Intelligence; Robotics
SC Computer Science; Robotics
GA BAZ97
UT WOS:000224340200031
DA 2020-12-16
ER

PT S
AU Marques, EP
   Marin, HF
   Massad, E
   Fraser, H
   Ohno-Machado, L
AF Marques, EP
   Marin, HF
   Massad, E
   Fraser, H
   Ohno-Machado, L
BE Surjan, G
   Engelbrecht, R
   McNair, P
TI Training in health informatics in Brazil
SO HEALTH DATA IN THE INFORMATION SOCIETY
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 17th International Conference of the
   European-Federation-of-Medical-Informatics (MIE 2002)
CY AUG 25-29, 2002
CL BUDAPEST, HUNGARY
AB Developing countries, such as Brazil, are increasingly suffering from a severe shortage of health informatics specialists. Training of professionals in this field is expensive, and there is a limited supply of high-quality teaching resources available. We report on five initiatives of the Brazil/USA training program in health informatics. The main goal of this program is to train professionals in establishing medical informatics programs in Brazilian universities and major healthcare facilities.
C1 Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Marques, EP (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
EM eduardo@marques.com
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Fraser, Hamish/0000-0003-4383-2854;
   Ohno-Machado, Lucila/0000-0002-8005-7327
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [1D43TW01279-01] Funding Source: Medline; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW001279, D43TW001279, D43TW001279, D43TW001279, D43TW001279]
   Funding Source: NIH RePORTER
CR Ohno-Machado L, 2000, J AM MED INFORM ASSN, P625
   OHNOMACHADO L, 2001, MEDINFO
   2001, P 1 BRAZ S MATH COMP
NR 3
TC 1
Z9 2
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
EI 1879-8365
BN 1-58603-279-8
J9 STUD HEALTH TECHNOL
PY 2002
VL 90
BP 757
EP 760
PG 4
WC Computer Science, Information Systems; Medical Informatics
SC Computer Science; Medical Informatics
GA BV43G
UT WOS:000178928400143
PM 15460793
DA 2020-12-16
ER

PT B
AU Strazza, L
   Azevedo, R
   Tessari, O
   Massad, E
AF Strazza, L
   Azevedo, R
   Tessari, O
   Massad, E
GP MONDUZZI EDITORE
   MONDUZZI EDITORE
TI The unconsciousness of the female prisoners at a prison about the
   transmission of AIDS through their partners' Behavior - Sao Paulo-SP
   Brazil
SO XIV INTERNATIONAL AIDS CONFERENCE: SOCIAL SCIENCES
LA English
DT Proceedings Paper
CT 14th International AIDS Conference
CY JUL 07-12, 2002
CL BARCELONA, SPAIN
SP Univ N Carolina, Gen Clin Res Ctr, UNC Ctr AIDS Res, Natl Inst Hlth, Swiss Natl AIDS Res Program, Bristol-Myers Squibb Co, Boehringer Ingelheim, GlaxoWellcome Res & Dev, HIV Antiviral Res
C1 Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RP Strazza, L (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Azevedo,
   Raymundo S/B-7593-2008
OI Massad, Eduardo/0000-0002-7200-2916; Azevedo, Raymundo
   S/0000-0003-0660-2371
CR ALBERTYN C, 2000, INT AIDS C DURB
   STRAZZA L, 1994, SIMBOLICO PRISAO FEM
NR 2
TC 0
Z9 0
U1 0
U2 1
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
PY 2002
BP 41
EP 42
PG 2
WC Public, Environmental & Occupational Health; Social Issues; Social
   Sciences, Biomedical
SC Public, Environmental & Occupational Health; Social Issues; Biomedical
   Social Sciences
GA BV85R
UT WOS:000180241900009
DA 2020-12-16
ER

PT J
AU Yu, ALF
   Amaku, M
   Burattini, MN
   Massad, E
   Azevedo, RS
AF Yu, ALF
   Amaku, M
   Burattini, MN
   Massad, E
   Azevedo, RS
TI Varicella transmission in two samples of children with different social
   behaviour in the State of Sao Paulo, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID ZOSTER-VIRUS; AGE; INFECTION; MEASLES; MUMPS
AB In order to establish the differences in transmission pattern of varicella-zoster virus (VZV), a comparative seroepidemiological study was carried out in two different children samples. Children aged 1-11 years, were randomly selected from state schools of Sao Paulo city, Brazil. Individuals aged 1-15 years were sampled by cluster from Caieiras city. Children aged 3 years or under from Caieiras were not attending school, while those from Sao Paulo were attending all-day nurseries or kindergarten. The presence of antibodies to VZV was analysed by ELISA technique. The force of infection and contact rate were determined by mathematical techniques. The average age of first infection was 2.87 +/- 0.14 years and 4.07 +/- 0.47 years for Sao Paulo and Caieiras, respectively. The average force of infection estimated was 0.29 year(-1) for Sao Paulo and was 0.26 year(-1) for Caieiras. The proportion of seropositivity and the force of infection were higher in Sao Paulo school children up to 3 years of age compared with Caieiras children, where the social contact starts later. In conclusion, social changes affecting contact among children may influence varicella epidemiology.
C1 Univ Sao Paulo, Sch Med, Disciplina Informat Med, HCFMUSP,LIM 01, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Phys, BR-01246903 Sao Paulo, Brazil.
RP Yu, ALF (corresponding author), Univ Sao Paulo, Sch Med, Disciplina Informat Med, HCFMUSP,LIM 01, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Frugis Yu, Ana Lucia/K-9092-2016;
   Burattini, Marcelo N/J-9272-2014; Azevedo, Raymundo S/B-7593-2008;
   Amaku, Marcos/D-5252-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Frugis Yu, Ana
   Lucia/0000-0003-2207-3940; Burattini, Marcelo N/0000-0002-5407-6890;
   Azevedo, Raymundo S/0000-0003-0660-2371; Amaku,
   Marcos/0000-0003-4752-6774; 
CR ANDERSON R M, 1991
   ARVIN AM, 1996, FIELDS VIROLOGY, P2547
   CRISTOFANI LM, 1991, VACCINE, V9, P873, DOI 10.1016/0264-410X(91)90006-R
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308
   GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P495, DOI 10.1017/S0950268800050007
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3
   KANGRO HO, 1994, J MED VIROL, V43, P91, DOI 10.1002/jmv.1890430117
   LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   MASSAD E, 1990, MATH COMPUT MODEL, V13, P101, DOI 10.1016/0895-7177(90)90057-T
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   PREBLUD SR, 1981, PEDIATRICS, V68, P14
   ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801
   TAKAHASHI M, 1994, VACCINES, P387
   Yu Ana Lucia Frugis, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P125, DOI 10.1590/S0036-46652000000300002
NR 18
TC 9
Z9 9
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 2001
VL 127
IS 3
BP 493
EP 500
DI 10.1017/S0950268801006124
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 518LV
UT WOS:000173670600015
PM 11811883
OA Green Published, Bronze
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
TI A model-independent analysis of the demographic impact of HIV/AIDS in
   the state of Sao Paulo, Brazil
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE demography; HIV; AIDS; mortality; life expectancy
ID HIV-INFECTION; DRUG-USERS; AIDS; MORTALITY; AFRICA
AB The devastating figures that recently emerged from a demographic study of the impact of HIV/AIDS in some African countries mark the return to the conditions of the XIXth century, when high birth rates were neutralized by equally high death rates. In the State of Sao Paulo, Brazil, AIDS is the second cause of death among men aged twenty to forty nine years and the first cause of death of women in the same age class. In this work we propose a mathematical treatment to evaluate the impact of AIDS mortality on the age structure of an affected population, namely, that of the state of Sao Paulo, Brazil. We propose four indicators for the estimation of the impact of AIDS mortality. The first is the age-dependent differences in ten years survival probabilities attributable to AIDS. The second is the difference in the average age of survivors after 10 years of AIDS. The next is the conventional life expectancy at birth for children born in 1996 and with AIDS prevalence assumed at its maximum value and remaining in steady-state afterwards, Finally, we calculate the differences in the life expectancy of individuals considering the effect of AIDS for only ten years. We found that, in the period between 1987 and 1996 the effects were small but very interesting. However, projecting to the future the conditions of 1996, we calculate that the population of the state of Sao Paulo would lose 3 years in the average life expectancy at birth.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Lopez, Luis F/C-4721-2012; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/H-6143-2011; Burattini,
   Marcelo N/J-9272-2014
OI Lopez, Luis F/0000-0003-4097-6887; Massad, Eduardo/0000-0002-7200-2916;
   Coutinho, Francisco A B/0000-0003-3127-3071; Burattini, Marcelo
   N/0000-0002-5407-6890
CR ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0
   Burattini MN, 1998, MATH COMPUT MODEL, V28, P21, DOI 10.1016/S0895-7177(98)00095-8
   Carvalho Heraclito Barbosa De, 1996, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V12, P84
   GARNETT GP, 1993, T ROY SOC TROP MED H, V87, P19, DOI 10.1016/0035-9203(93)90522-R
   Heath KV, 1998, INT J EPIDEMIOL, V27, P685, DOI 10.1093/ije/27.4.685
   Hogg RS, 1997, INT J EPIDEMIOL, V26, P657, DOI 10.1093/ije/26.3.657
   LOWBEER D, INT C AIDS 1996
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   PEARCE F, 1998, NEW SCI         1017, P12
   Ragni MV, 1996, J ACQ IMMUN DEF SYND, V13, P160, DOI 10.1097/00042560-199610010-00007
   SCOTT S, 1998, HUMAN DEMOGRAPHY DIS
   *SECR HLTH STAT SA, 1998, B EP, P11
   TRUCCO E, 1965, B MATH BIOPHYS, V27, P285, DOI 10.1007/BF02478406
   *UN, 1994, AIDS DEM AFR
   WAY PO, INT C AIDS 1994
   Zanetta DMT, 1999, INT J STD AIDS, V10, P98, DOI 10.1258/0956462991913718
NR 17
TC 0
Z9 0
U1 0
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE
SN 0218-3390
J9 J BIOL SYST
JI J. Biol. Syst.
PD DEC
PY 2001
VL 9
IS 4
BP 255
EP 267
DI 10.1142/S0218339001000402
PG 13
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 515DJ
UT WOS:000173479900003
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Sallum, PC
   Lopez, LF
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Sallum, PC
   Lopez, LF
TI A mixed ectoparasite-microparasite model for bat-transmitted rabies
SO THEORETICAL POPULATION BIOLOGY
LA English
DT Article
DE vampire bats; rabies; control; modeling
ID TRANSMISSION; INFECTIONS; DYNAMICS
AB This paper considers the transmission of rabies to domestic livestock by vampire bats. Vampire bats act as ectoparasites on cattle both by ingesting a small amount of blood every night and by prolonging bleeding by the action of anticoagulant substances in their saliva. In addition to this parasitic action bats may also transmit rabies, inflicting important losses on affected herds by the inevitable mortality due to the infection. We modeled this complex interaction and we also demonstrate that bat control measures are more effective in reducing rabies prevalence and mortality by rabies than cattle vaccination. (C) 2001 Elsevier Science.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Lopez, Luis F/C-4721-2012; Coutinho, Francisco A
   B/H-5644-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Lopez, Luis F/0000-0003-4097-6887;
   Coutinho, Francisco A B/0000-0003-3127-3071
CR ANDERSON R M, 1991
   ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS707
   BERAN GW, 1981, CRC HDB SERIES ZOONO, V2
   Brass D. A., 1994, RABIES BATS NATURAL
   BURATTINI MN, 1999, J BIOL SYST, V6, P337
   Constantine D.G., 1988, P167
   DARLING K, 1997, KOMODO DRAGON
   DELPIETRO HA, 1992, PREV VET MED, V14, P13, DOI 10.1016/0167-5877(92)90080-Y
   ELSGOLTS EL, 1966, INTRO THEORY DIFFERE
   FENTON M. B., 1992, BATS
   GOODWIN GEORGE G., 1961, BULL AMER MUS NAT HIST, V122, P187
   GREENHALL AM, 1970, P 4 VERT PEST C CAL
   HARINASUTA T, 1990, TROPICAL GEOGRAPHICA, pCH55
   JOHNSON RT, 1982, VIRAL INFECT NERVOUS
   Lomnicki A., 1988, POPULATION ECOLOGY I
   Lopez LF, 1999, MATH COMPUT MODEL, V29, P55, DOI 10.1016/S0895-7177(99)00062-X
   MACDONAL.G, 1965, T ROY SOC TROP MED H, V59, P489, DOI 10.1016/0035-9203(65)90152-5
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MASSAD E, 1987, EVOLUTION, V41, P1127, DOI [10.2307/2409198, 10.1111/j.1558-5646.1987.tb05883.x]
   May R.M., 1973, STABILITY COMPLEXITY
   MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X
   MAYR E., 1970, POPULATIONS SPECIES
   Mead DG, 2000, SCIENCE, V287, P485, DOI 10.1126/science.287.5452.485
   Pianka E.R., 1983, EVOLUTIONARY ECOLOGY
   Pulliam H.R., 1989, P25
   Roughgarden J., 1979, THEORY POPULATION GE
   STEELE JH, 1973, SCAND J INFECT DIS, V5, P299, DOI 10.3109/inf.1973.5.issue-4.12
   THOMPSON RD, 1977, J WILDLIFE MANAGE, V41, P736, DOI 10.2307/3799998
   *WHO, 1957, 121 WHO EXP COMM RAB
   *WHO, 1966, 321 WHO EXP COMM RAB
   *WHO, 1984, 709 WHO EXP COMM RAB
   *WHO, 1973, 523 WHO EXP COMM RAB
   Yang HM, 1997, J THEOR BIOL, V188, P495, DOI 10.1006/jtbi.1997.0479
NR 34
TC 12
Z9 14
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0040-5809
EI 1096-0325
J9 THEOR POPUL BIOL
JI Theor. Popul. Biol.
PD DEC
PY 2001
VL 60
IS 4
BP 265
EP 279
DI 10.1006/tpbi.2000.1494
PG 15
WC Ecology; Evolutionary Biology; Genetics & Heredity; Mathematical &
   Computational Biology
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity; Mathematical & Computational Biology
GA 533CA
UT WOS:000174510800001
PM 11878829
DA 2020-12-16
ER

PT J
AU Coutinho, FAB
   Lopez, LF
   Burattini, MN
   Massad, E
AF Coutinho, FAB
   Lopez, LF
   Burattini, MN
   Massad, E
TI Modelling the natural history of HIV infection in individuals and its
   epidemiological implications
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; VIRAL LOAD; PLASMA;
   TRANSMISSION; TYPE-1; RNA; PROGRESSION; AIDS; VIREMIA
AB The variation of viraemia in the natural course of HIV infection is expected to have major influence on the probability of transmission and, consequently, on the epidemiology of HIV/AIDS.
   In this paper we propose a model which takes into account the time evolution of HIV viraemia (measured as HIV-RNA copies per ml of blood) in an infected individual and its impact on the threshold for the establishment of an endemic level, and mainly on the relative contribution of each of the clinical phases of the infection to the total transmission of HIV per infected individual. We consider that an infected individual passes through three phases of viraemia. The first phase, which lasts for 6-7 weeks. is characterized by very high viraemia. In the second phase, which lasts about 10 years., the viraemia is much lower., increasing again in the last phase, which lasts up to two years. and ends in full-blown AIDS.
   We show that the relative contribution of each phase to the total transmission of HIV is very sensitive to the model we assume for the dependence of the transmissibility of HIV on the viral load. For instance, if we assume that transmissibility is proportional to the decimal logarithm of viraemia, then the second phase predominates always, Due to the epidemiological importance of this fact, it is clear that further improvement on virological research to better understand the dependence of HIV transmissibility on the viral concentration in biological fluids is necessary. (C) 2001 Society for Mathematical Biology.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   LIM01 HCFMUSP, BR-01246903 Sao Paulo, Brazil.
RP Coutinho, FAB (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Burattini,
   Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011; Lopez, Luis
   F/C-4721-2012
OI Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Lopez, Luis F/0000-0003-4097-6887
CR AHLGREN DJ, 1990, J ACQ IMMUN DEF SYND, V3, P631
   ANDERSON R M, 1991
   AOKISEI S, 1992, AIDS RES HUM RETROV, V8, P1263, DOI 10.1089/aid.1992.8.1263
   Arfken G, 1970, MATH METHODS PHYSICI
   BAGASRA O, 1992, NEW ENGL J MED, V326, P1385, DOI 10.1056/NEJM199205213262103
   BAGNARELLI P, 1991, J MED VIROL, V34, P89, DOI 10.1002/jmv.1890340204
   Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650
   BRAVO R, 1995, MED CLIN-BARCELONA, V104, P530
   Brookmeyer R, 1994, AIDS EPIDEMIOLOGY QU
   CAMERON DW, 1989, LANCET, V2, P403
   CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993
   COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   Coutinho FAB, 1999, REV SAUDE PUBL, V33, P329, DOI 10.1590/S0034-89101999000400002
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599
   EASTERBROOK PJ, 1994, AIDS, V8, P1179, DOI 10.1097/00002030-199408000-00023
   ERB P, 1994, J ACQ IMMUN DEF SYND, V7, P261
   Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602
   GRAZIOSI C, 1993, P NATL ACAD SCI USA, V90, P6405, DOI 10.1073/pnas.90.14.6405
   Griffel D.H., 1981, APPL FUNCTIONAL ANAL
   HENRARD DR, 1992, LANCET, V340, P1470, DOI 10.1016/0140-6736(92)92660-8
   HETHCOTE HW, 1992, MODELLING HIV TRANSM
   HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401
   HOLODNIY M, 1991, J INFECT DIS, V163, P862, DOI 10.1093/infdis/163.4.862
   HOUN HY, 1987, ANN CLIN LAB SCI, V17, P279
   HYMAN JM, 1988, MATH BIOSCI, V90, P415, DOI 10.1016/0025-5564(88)90078-8
   JACKSON J B, 1988, Clinical Microbiology Reviews, V1, P124
   JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169
   JURRIAANS S, 1995, THESIS U AMSTERDAM
   KEET IPM, 1993, AIDS, V7, P51, DOI 10.1097/00002030-199301000-00008
   KIEVITS T, 1991, J VIROL METHODS, V35, P273, DOI 10.1016/0166-0934(91)90069-C
   Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009
   LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E
   Levin BR, 1996, MATH BIOSCI, V132, P69, DOI 10.1016/0025-5564(95)00053-4
   LIFSON AR, 1991, J INFECT DIS, V163, P959, DOI 10.1093/infdis/163.5.959
   Lopez LF, 2000, J MATH BIOL, V40, P199, DOI 10.1007/s002850050178
   MASSAD E, 1989, MATH COMPUT MODEL, V12, P89, DOI 10.1016/0895-7177(89)90448-2
   MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   OSMOND D, 1988, AM J PUBLIC HEALTH, V78, P944, DOI 10.2105/AJPH.78.8.944
   PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089
   PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233
   Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303
   SANO K, 1987, J CLIN MICROBIOL, V25, P2415, DOI 10.1128/JCM.25.12.2415-2417.1987
   SIMMONDS P, 1990, AIDS (London), V4, pS77
   SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504
   VANGRIENSVEN GJP, 1990, AM J EPIDEMIOL, V132, P203
   Vella S, 2000, ANTIVIR RES, V47, P189, DOI 10.1016/S0166-3542(00)00107-8
NR 49
TC 19
Z9 19
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD NOV
PY 2001
VL 63
IS 6
BP 1041
EP 1062
DI 10.1006/bulm.2001.0257
PG 22
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 492WP
UT WOS:000172190800003
PM 11732175
DA 2020-12-16
ER

PT J
AU Zanetta, RAC
   Amaku, M
   Azevedo, RS
   Zanetta, DMT
   Burattini, MN
   Massad, E
AF Zanetta, RAC
   Amaku, M
   Azevedo, RS
   Zanetta, DMT
   Burattini, MN
   Massad, E
TI Optimal age for vaccination against measles in the State of Sao Paulo,
   Brazil, taking into account the mother's serostatus
SO VACCINE
LA English
DT Article
DE measles; vaccine; mathematical modeling; seroprevalence; seroconversion;
   optimal ages for vaccination
ID INFANTS; IMMUNITY; ANTIBODY; 6-MONTH-OLD; WOMEN; MODEL
AB In order to investigate if the changing levels of measles antibody in women resulting from extensive vaccination programs influence the susceptibility of children, we measured the seroprevalence of measles virus antibody of children in the first year of life and of their mothers. We compared maternal antibody decay of two groups of children: those whose mothers were 25 years old or more (mothers born in the pre-vaccination era), and less than 25 years old (mothers born in the vaccination era). Therefore, the 25-year-age cut-off was chosen to distinguish between vaccinated and non-vaccinated mothers. We also compared the immunogenicity of measles vaccine in children from 6 to 12 months of age, in these two groups and also according to their mother's serostatus. The optimal age of vaccination for a routine program was estimated by means of mathematical models.
   This study was carried out in a sample of 1216 mothers and their respective children, Our results indicate that the optimal age for vaccination of the whole sample was 15 months, 17 months for children born from older mothers, 14 months for children born from younger mothers, 17 months for children born from seropositive mothers and 12 months for children born from seronegative mothers. Therefore, a change to an earlier age of routine vaccination is not justified by our results. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, Discipline Med Informat, Fac Med, BR-01246903 Sao Paulo, Brazil.
   LIM01 HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Fis, BR-01246903 Sao Paulo, Brazil.
   Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Discipline Med Informat, Fac Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Amaku,
   Marcos/D-5252-2012; Azevedo, Raymundo S/B-7593-2008; Zanetta, Dirce M
   T/G-4950-2013; Massad, Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Amaku, Marcos/0000-0003-4752-6774; Azevedo,
   Raymundo S/0000-0003-0660-2371; 
CR ANDERSON R M, 1991
   *CDC, 1998, P 1997 INT M COSP WH, V47, P1
   DAGAN R, 1995, PEDIATR INFECT DIS J, V14, P965, DOI 10.1097/00006454-199511000-00008
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   JOHNSON CE, 1994, PEDIATRICS, V93, P939
   KACICA MA, 1995, J MED VIROL, V45, P227, DOI 10.1002/jmv.1890450220
   KRUGMAN S, 1965, J PEDIATR-US, V66, P471, DOI 10.1016/S0022-3476(65)80112-3
   Kumar ML, 1998, VACCINE, V16, P2047, DOI 10.1016/S0264-410X(98)00083-8
   LENNON JL, 1986, J PEDIATR-US, V108, P671, DOI 10.1016/S0022-3476(86)81039-3
   MALDONADO YA, 1995, PEDIATRICS, V96, P447
   Markowitz LE, 1996, PEDIATRICS, V97, P53
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1990, MATH COMPUT MODEL, V13, P101, DOI 10.1016/0895-7177(90)90057-T
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   Nates SV, 1998, PEDIATR INFECT DIS J, V17, P313, DOI 10.1097/00006454-199804000-00009
   Orenstein W A, 1986, Dev Biol Stand, V65, P13
   PABST HF, 1992, PEDIATR INFECT DIS J, V11, P525, DOI 10.1097/00006454-199207000-00004
   REDD SC, 1999, VACCINES, P227
NR 20
TC 20
Z9 21
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 12
PY 2001
VL 20
IS 1-2
BP 226
EP 234
DI 10.1016/S0264-410X(01)00267-5
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 481GR
UT WOS:000171512000033
PM 11567768
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Struchiner, CJ
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
   Struchiner, CJ
TI Modeling the impact of imperfect HIV vaccines on the incidence of the
   infection
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
DE HIV; vaccines; transmission dynamics; mathematical modeling; control
   strategies
ID SEROPREVALENCE; EFFICACY; TRIALS
AB One concern about HIV vaccine trials is that participants might develop a false sense of security and increase their risk behavior. This fear has (at least partially) impaired the development of extensive clinical trials on HIV vaccines and are, in principle, justified. In this paper, we develop a dynamical model which allows experiments on the effects of an imperfect vaccine on a population prone to change its risk behavior. Our results show that even the poorest of the candidate vaccines to be seriously considered, may have beneficial effects on reducing transmission, even when risk behaviors increases. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Procc Fiocruz, Rio De Janeiro, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Coutinho,
   Francisco A B/H-5644-2011; Struchiner, Claudio J/M-9360-2013; Lopez,
   Luis F/C-4721-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Struchiner, Claudio J/0000-0003-2114-847X; Lopez, Luis
   F/0000-0003-4097-6887; 
CR ANDERSON R M, 1991
   Anderson R. M., 1982, POPULATION DYNAMICS
   Buchbinder S., 1999, IAVI REPORT, V4, P9
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   CHAISSON RE, 2000, PRINCIPLES PRACTICES, P1398
   Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007
   Coutinho FAB, 1999, MATH COMPUT MODEL, V30, P97, DOI 10.1016/S0895-7177(99)00119-3
   Desai KN, 1999, EPIDEMIOL INFECT, V123, P65, DOI 10.1017/S0950268899002642
   Frey SE, 1999, INFECT DIS CLIN N AM, V13, P95, DOI 10.1016/S0891-5520(05)70045-3
   Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990
   HALLORAN ME, 1994, STAT MED, V13, P357, DOI 10.1002/sim.4780130404
   Jackson DJ, 1999, AIDS, V13, P583, DOI 10.1097/00002030-199904010-00007
   Kahne T, 1999, INT J MOL MED, V4, P3
   Limpakarnjanarat K, 1999, SEX TRANSM INFECT, V75, P30, DOI 10.1136/sti.75.1.30
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075
   Ohshige K, 1999, Nihon Koshu Eisei Zasshi, V46, P61
   Pal BB, 1999, INDIAN J MED RES, V109, P199
   Perez Gonzalez K, 1999, Gac Sanit, V13, P7
   van Gorkom J, 1999, E AFR MED J, V76, P452
   VOELKER R, JAMA, V281, P889
   1998, LANCET, V352, P24
NR 22
TC 15
Z9 15
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-7177
EI 1872-9479
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PD AUG
PY 2001
VL 34
IS 3-4
BP 345
EP 351
DI 10.1016/S0895-7177(01)00066-8
PG 7
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 443CF
UT WOS:000169321300010
DA 2020-12-16
ER

PT J
AU Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
AF Massad, E
   Coutinho, FAB
   Burattini, MN
   Lopez, LF
TI The risk of yellow fever in a dengue-infested area
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE vector-borne infections; dengue; yellow fever; basic reproduction
   number; modelling; trends; vaccination coverage; Brazil
ID 1ST RECORDED OUTBREAK; KENYA
AB Yellow fever and dengue are viral infections that in urban centres are transmitted by the same arthropod vector, a mosquito of the genus Aedes. In order to estimate the risk of an epidemic of urban yellow fever in a dengue-infested area we calculated the threshold in the basic reproduction number, R-0, of dengue, above which any single sylvatic yellow fever-infected individual will trigger an urban yellow fever epidemic. Specifically, we analysed the relationship between the extrinsic incubation period and the duration of viraemia, from which it is possible to define the R-0 for dengue that would also suggest an outbreak potential for yellow fever. We also calculated the critical proportion of people to vaccinate against yellow fever in order to prevent an epidemic in a dengue-endemic area. The theory proposed is illustrated by the case of Sao Paulo State in southern Brazil, where dengue is endemic and the risk of urban yellow fever is already imminent.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Lopez, Luis F/C-4721-2012; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Coutinho, Francisco A
   B/H-5644-2011
OI Lopez, Luis F/0000-0003-4097-6887; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Coutinho,
   Francisco A B/0000-0003-3127-3071
CR ANDERSON R M, 1991
   Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O
   Digoutte JP, 1999, B SOC PATHOL EXOT, V92, P343
   Halstead S. B., 1990, Tropical and geographical medicine., P675
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Molineaux L, 1980, THE GARKI PROJECT
   Monath T. P., 1990, Tropical and geographical medicine., P661
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   Monath TP, 1999, VACCINES, P815
   Monath TP, 1996, FIELDS VIROLOGY, P961
   Reiter P, 1998, AM J TROP MED HYG, V59, P650, DOI 10.4269/ajtmh.1998.59.650
   RICE CM, 1996, VIROLOGY, P931
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644, DOI 10.4269/ajtmh.1998.59.644
   *SEADE, 2000, FUND SIST EST AN DAD
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
   Woodring Jennifer L., 1996, P51
   1999, LANCET, V353, P1546
NR 18
TC 87
Z9 90
U1 1
U2 31
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL-AUG
PY 2001
VL 95
IS 4
BP 370
EP 374
DI 10.1016/S0035-9203(01)90184-1
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 478GJ
UT WOS:000171336900006
PM 11579875
DA 2020-12-16
ER

PT J
AU Almeida, MF
   Massad, E
   Aguiar, EAC
   Martorelli, LFA
   Joppert, AMS
AF Almeida, MF
   Massad, E
   Aguiar, EAC
   Martorelli, LFA
   Joppert, AMS
TI Neutralizing antirabies antibodies in urban terrestrial wildlife in
   Brazil
SO JOURNAL OF WILDLIFE DISEASES
LA English
DT Article
DE antibody; marsupials; primates; rabies virus; wildlife reservoir
ID RABIES
AB The prevalence of rabies neutralizing antibodies (NA) in sera of wild animals from Sao Paulo City (Brazil) was investigated using the Rapid Fluorescent Focus Inhibition Test between 1994 and 1997. Sera from 547 specimens were examined. Marsupials represented 45% of the sample and primates 37%: carnivores, rodents, deer and edentates represented 6, 6, 3 and 2%, respectively. The overall prevalence of NA was 14%. The prevalence of NA was 18% in primates; whereas in marsupials, carnivores, edentates and rodents it was 13, 9, 8 and 6%, respectively. The stratification according to sex, age, and site of capture of the marsupials and primates showed a small predominance in males versus females and a large predominance of adults versus juveniles. The same relationship was seen in specimens captured near human habitations versus specimens captured in their own habitat. It is evident that there is circulation of rabies virus in wild animals, which are not recommended as pets since they represent a potential risk of exposure to rabies virus for both humans and domestic animals.
C1 Ctr Controle Zoonoses, BR-02031020 Santana, SP, Brazil.
   Univ Sao Paulo, Fac Med, BR-01246903 Sao Paulo, Brazil.
   Div Tecn Med Vet & Biol Fauna, BR-04030000 Sao Paulo, Brazil.
RP Almeida, MF (corresponding author), Ctr Controle Zoonoses, Rua Santa Eulalia 86, BR-02031020 Santana, SP, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ANDRADE MCR, 1997, THESIS I OSWALDO CRU
   Armitage P., 1994, STAT METHODS MED RES
   Ballard WB, 1997, J WILDLIFE DIS, V33, P242, DOI 10.7589/0090-3558-33.2.242
   BERAN GW, 1981, C R C HDB SERIES ZOO
   Carey A.B., 1985, P23
   Emmons L. H., 1990, NEOTROPICAL RAINFORE
   FONSECA GAB, 1994, FUNDACAO BIODIVERSIT
   GASCOYNE SC, 1993, J WILDLIFE DIS, V29, P396, DOI 10.7589/0090-3558-29.3.396
   Greenwood RJ, 1997, J WILDLIFE DIS, V33, P226, DOI 10.7589/0090-3558-33.2.226
   HILL RE, 1992, J WILDLIFE DIS, V28, P377, DOI 10.7589/0090-3558-28.3.377
   McLean R.G., 1975, P53
   *MIN SAUD BRAS, PROGR NAC PROF RAIV
   *ORG PAN SAL, 1994, B VIG EP RAB AM BUEN, V26
   *ORG PAN SAL, 1997, B VIG EP RAB AM BUEN, V29
   ROSATTE R C, 1984, Journal of Wildlife Diseases, V20, P171
   *SEC HLTH STAT SAO, 1999, PROF RAIV HUM
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
   *WHO, 1973, 523 WHO
   ZUMPT I F, 1969, Journal of the South African Veterinary Medical Association, V40, P319
NR 19
TC 14
Z9 14
U1 1
U2 5
PU WILDLIFE DISEASE ASSN, INC
PI LAWRENCE
PA 810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA
SN 0090-3558
J9 J WILDLIFE DIS
JI J. Wildl. Dis.
PD APR
PY 2001
VL 37
IS 2
BP 394
EP 398
DI 10.7589/0090-3558-37.2.394
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 421RP
UT WOS:000168077600027
PM 11310897
DA 2020-12-16
ER

PT J
AU Almeida, LNB
   Azevedo, RS
   Amaku, M
   Massad, E
AF Almeida, LNB
   Azevedo, RS
   Amaku, M
   Massad, E
TI Cytomegalovirus seroepidemiology in an urban community of Sao Paulo,
   Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE cytomegalovirus infections, transmission; seroepidemiologic studies;
   mathematical models; cytomegalovirus infections, epidemiology
   cytomegalovirus infections, congenital; enzyme-linked immunosorbent
   assay; utilization; disease transmission vertical; disease transmission
   horizontal; age factors
ID INFECTION; EPIDEMIOLOGY
AB Introduction
   After the era of rubella vaccine, cytomegalovirus (CMV) infection is one of the most frequently causes of mental retardation and congenital deafness. Seroepidemiological studies are necessary to understand the transmission dynamics of the disease. The purpose of the study was to quantify the transmission rate of CMV disease in a community in the state of Sao Paulo, Brazil.
   Methods
   Using ELISA test (IgG), a retrospective serological survey looking for CMV antibodies was performed in an non-immunized community. Frozen sera from 443 individuals, randomly selected by cluster sampling technique in the town of Caieiras, Sao Paulo, were collected from November 1990 to January 1991. Seroprevalence was stratified by age (0-40 years). Mathematical techniques were applied to determine the age-dependent decay function of maternal antibodies during the first year of life, the age-dependent seroprevalence function and the force of infection for CMV in this community.
   Results
   It was observed a descending phase of seropositivity in the first 9 months, but changes in antibody titration were observed between 8 months old and one year of age. The average age of the first infection was 5.02 months of age and 19.84 years, when the age-dependent seroprevalence and the force of infection were analyzed between 10 months of age and 10 years of age and from 10 to 40 years old, respectively.
   Conclusion
   CMV infection is highly prevalent among the population studied and infection occurs in the first year of life. This study shows that most women at reproductive age are vulnerable to the first infection, increasing the risk for congenital infection.
C1 Univ Sao Paulo, Fac Med, Dept Patol, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil.
RP Almeida, LNB (corresponding author), Univ Sao Paulo, Fac Med, Dept Patol, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/H-6143-2011; Azevedo,
   Raymundo S/B-7593-2008; Massad, Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Azevedo, Raymundo
   S/0000-0003-0660-2371; Massad, Eduardo/0000-0002-7200-2916
CR AZEVEDONETO RS, 1994, EPIDEMIOL INFECT, V113, P161
   Candeias J A, 1974, Rev Saude Publica, V8, P257, DOI 10.1590/S0034-89101974000300002
   Carvalho R P, 1976, Rev Inst Med Trop Sao Paulo, V18, P1
   DOERR HW, 1985, KLIN WOCHENSCHR, V63, P241, DOI 10.1007/BF01731469
   DREW WL, 1981, J INFECT DIS, V143, P188, DOI 10.1093/infdis/143.2.188
   DWORSKY M, 1983, PEDIATRICS, V72, P295
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   FUNDACAO IBG, 1992, ANN REPORT
   GOLD E, 1989, VIRAL INFECT HUMANS, V8, P169
   HANSHAW JB, 1982, AM J DIS CHILD, V136, P886, DOI 10.1001/archpedi.1982.03970460016002
   HUTTO C, 1985, PEDIATR INFECT DIS J, V4, P149, DOI 10.1097/00006454-198503000-00008
   Mello Ana L. R. De, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P165
   PANNUTI CS, 1985, REV I MED TROP, V27, P105, DOI 10.1590/S0036-46651985000200010
   REYNOLDS DW, 1973, NEW ENGL J MED, V289, P1, DOI 10.1056/NEJM197307052890101
   VERONESI R, 1959, REV HOSP CLIN FAC ME, V14, P249
NR 15
TC 30
Z9 34
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 2001
VL 35
IS 2
BP 124
EP 129
DI 10.1590/S0034-89102001000200004
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 431PF
UT WOS:000168639200004
PM 11359197
OA DOAJ Gold
DA 2020-12-16
ER

PT B
AU Costa, AJL
   Massad, E
   Ortega, NRS
   Araujo, AD
AF Costa, AJL
   Massad, E
   Ortega, NRS
   Araujo, AD
BE Smith, MH
   Gruver, WA
   Hall, LO
TI Estimation of the degree of functional disability through a fuzzy model
SO JOINT 9TH IFSA WORLD CONGRESS AND 20TH NAFIPS INTERNATIONAL CONFERENCE,
   PROCEEDINGS, VOLS. 1-5
LA English
DT Proceedings Paper
CT 9th International-Fuzzy-Systems-Association World Congress/20th
   North-American-Fuzzy-Information-Processing-Society, International
   Conference
CY JUL 25-28, 2001
CL VANCOUVER, CANADA
SP Int Fuzzy Syst Assoc, N Amer Fuzzy Informat Proc Soc, IEEE Syst, Man & Cybernet Soc, IEEE, Neural Networks Council
AB Measures of functional levels are commonly used to assess the quality of life of individuals and populations. Although essentially subjective, such measures have not yet been derived from a fuzzy framework.
   A fuzzy linguistic model (MISO) was developed to measure varying levels of functional disability, based on definitions of an individual's social and physical activities and mobility, considered together.
   From the fuzzy model, one year of an adult's life who works but performs restrictively other social activities, needs help to use public transport and walks with physical limitations was judged to be equivalent to 0.575 years of well life, in the absence of any kind of functional disability.
   The amount of well years of life can be used as a common denominator to assess the impact of medical and public health interventions, both preventive and curative. When applied at a population level, it serves as a useful tool for priority setting and decision making purposes in public health.
C1 Univ Fed Rio de Janeiro, Sch Med, NESC, Rio De Janeiro, Brazil.
RP Costa, AJL (corresponding author), Univ Fed Rio de Janeiro, Sch Med, NESC, Rio De Janeiro, Brazil.
RI Massad, Eduardo/H-6143-2011; Ortega, Neli/C-6494-2013; Massad,
   Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Mc Dowell I, 1987, MEASURING HLTH GUIDE, P12
   Murray CJL, 1996, GLOBAL BURDEN DIS CO, P1
   PATRICK DL, 1973, J HEALTH SOC BEHAV, V14, P6, DOI 10.2307/2136932
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
NR 4
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7078-3
PY 2001
BP 459
EP 463
PG 5
WC Computer Science, Artificial Intelligence; Mathematics, Applied
SC Computer Science; Mathematics
GA BT52S
UT WOS:000173245100081
DA 2020-12-16
ER

PT B
AU Ortega, NRS
   de Barros, LC
   Massad, E
AF Ortega, NRS
   de Barros, LC
   Massad, E
BE Smith, MH
   Gruver, WA
   Hall, LO
TI A fuzzy epidemic model based on gradual rules and extension principle
SO JOINT 9TH IFSA WORLD CONGRESS AND 20TH NAFIPS INTERNATIONAL CONFERENCE,
   PROCEEDINGS, VOLS. 1-5
LA English
DT Proceedings Paper
CT 9th International-Fuzzy-Systems-Association World Congress/20th
   North-American-Fuzzy-Information-Processing-Society, International
   Conference
CY JUL 25-28, 2001
CL VANCOUVER, CANADA
SP Int Fuzzy Syst Assoc, N Amer Fuzzy Informat Proc Soc, IEEE Syst, Man & Cybernet Soc, IEEE, Neural Networks Council
C1 Univ Sao Paulo, Inst Phys, BR-01246903 Sao Paulo, SP, Brazil.
RP Ortega, NRS (corresponding author), Univ Sao Paulo, Inst Phys, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Dubois D., 1995, THEORETICAL ASPECTS, P147
   Ortega NRS, 2000, KYBERNETES, V29, P201, DOI 10.1108/03684920010312768
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7078-3
PY 2001
BP 2287
EP 2288
PG 2
WC Computer Science, Artificial Intelligence; Mathematics, Applied
SC Computer Science; Mathematics
GA BT52S
UT WOS:000173245100403
DA 2020-12-16
ER

PT J
AU Anantraman, V
   Weber, G
   Fraser, H
   Marin, H
   Marques, E
   Massad, E
   Ohno-Machado, L
AF Anantraman, V
   Weber, G
   Fraser, H
   Marin, H
   Marques, E
   Massad, E
   Ohno-Machado, L
TI International training in medical informatics: The second year of the
   Brazil/USA project
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Meeting Abstract
C1 Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USA.
   Harvard Univ, Childrens Hosp, Sch Med, Informat Program, Boston, MA 02115 USA.
   Univ Fed Sao Paulo, Dept Enfermagem, Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Disciplina Med Informat, Sao Paulo, Brazil.
   Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 1
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107 USA
SN 1067-5027
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
PY 2001
SU S
BP 852
EP 852
PG 1
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA 494CZ
UT WOS:000172263400212
DA 2020-12-16
ER

PT J
AU O'Neill, PD
   Dietz, K
   Massad, E
   Greenhalgh, D
   Nagelkerke, NJD
   Critchley, F
   Edmunds, WJ
   Halloran, ME
   Keiding, M
   Longini, IM
   Yip, PSF
AF O'Neill, PD
   Dietz, K
   Massad, E
   Greenhalgh, D
   Nagelkerke, NJD
   Critchley, F
   Edmunds, WJ
   Halloran, ME
   Keiding, M
   Longini, IM
   Yip, PSF
TI Estimation of the basic reproduction number for infectious diseases from
   age-stratified serological survey data - Discussion
SO JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
LA English
DT Editorial Material
ID VACCINE EFFICACY; TRANSMISSION; PERIODICITY; INFERENCE; DESIGN; MODELS;
   RATIO; HIV
C1 Univ Nottingham, Nottingham NG7 2RD, England.
   Univ Tubingen, D-72074 Tubingen, Germany.
   Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   Univ Strathclyde, Glasgow, Lanark, Scotland.
   Erasmus Univ, Rotterdam, Netherlands.
   Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.
   Open Univ, Milton Keynes MK7 6AA, Bucks, England.
   Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.
   Emory Univ, Atlanta, GA 30322 USA.
   Univ Copenhagen, DK-1168 Copenhagen, Denmark.
   Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
RP O'Neill, PD (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ANDERSON R M, 1991
   ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   BAILEY NTJ, 1955, J R STAT SOC B, V17, P35
   BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553
   Becker N. G., 1996, LECT NOTES STAT, V114, P267
   BECKER NG, 1990, LECT NOTES BIOMATH, V86, P90, DOI DOI 10.1007/978-3-662-10067-7-9
   Bernoulli D., 1766, MEM MATH PHYS ACAD R, P1
   Bobashev G. V., 2008, MATH POPUL STUD, V8, P1, DOI [DOI 10.1080/08898480009525471, 10.1080/08898480009525471]
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   DAW R. H., 1979, Journal of the Institute of Actuaries, V106, P299
   De Angelis D, 1998, J ROY STAT SOC C-APP, V47, P449, DOI 10.1111/1467-9876.00123
   De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dietz K, 2000, NATURE, V408, P513, DOI 10.1038/35046270
   Dietz K, 1975, EPIDEMIOLOGY, P104
   Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131
   EVANS AA, 1992, AM J EPIDEMIOL, V135, P1156, DOI 10.1093/oxfordjournals.aje.a116216
   GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209
   GREENHALGH D, 1994, MATH BIOSCI, V124, P9, DOI 10.1016/0025-5564(94)90023-X
   HALLORAN ME, 1994, AM J EPIDEMIOL, V140, P81, DOI 10.1093/oxfordjournals.aje.a117238
   HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498
   HALLORAN ME, 1994, MATH BIOSCI, V121, P193, DOI 10.1016/0025-5564(94)90070-1
   KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150
   Longini IM, 1998, STAT MED, V17, P1121, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1121::AID-SIM824>3.0.CO;2-E
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Mollison D., 1995, EPIDEMIC MODELS THEI, P17
   SEAL HL, 1977, BIOMETRIKA, V64, P429, DOI 10.2307/2345318
   SENETA E, 1972, NONNEGATIVE MATRICES
   Sfikas N., 1999, THESIS U STRATHCLYDE
   Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437
   WACHMANN CH, 1997, THESIS U COPENHAGEN
   Yip PSF, 1998, J STAT PLAN INFER, V71, P229, DOI 10.1016/S0378-3758(98)00087-1
   Yip PSF, 2000, AUST NZ J STAT, V42, P367, DOI 10.1111/1467-842X.00133
   YIP PSF, 2000, 282 U HONG KONG DEP
NR 35
TC 2
Z9 2
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0035-9254
EI 1467-9876
J9 J R STAT SOC C-APPL
JI J. R. Stat. Soc. Ser. C-Appl. Stat.
PY 2001
VL 50
BP 283
EP 292
PN 3
PG 10
WC Statistics & Probability
SC Mathematics
GA 457BU
UT WOS:000170117900002
DA 2020-12-16
ER

PT S
AU Massad, E
   Ortega, NRS
AF Massad, E
   Ortega, NRS
BE Abe, JM
   SilvaFilho, JID
TI The logic of medical diagnosis
SO LOGIC, ARTIFICIAL INTELLIGENCE AND ROBOTICS
SE FRONTIERS IN ARTIFICIAL INTELLIGENCE AND APPLICATIONS
LA English
DT Proceedings Paper
CT 2nd Congress of Logic Applied to Technology (LAPTEC 2001)
CY NOV 12-14, 2001
CL SAO PAULO, BRAZIL
SP SENAC-Coll Comp Sci & Technol, FAPESP, IEEE CNPq, Inst Adv Stud, Univ Sao Paul, Himeji Inst Technol, Shizuoka Univ, Teikyo Heisei Univ, Escola Engenhar Itajuba, Univ Brasil, Soc Brasileira Comp, Soc Brasileira Para Progress Cienc
AB In the history of medicine many theoretical aspects of the medical cognition have been studied, and mathematical structures have been used to modelled this kind of human thinking. The increase development of expert systems, decision making models, clinical guidelines, epidemiological studies and diagnostic systems are just some examples of how mathematics and artificial intelligence techniques could help the professionals; of heath in them daily work, and in the acquisition of deep knowledge of the medical procedures and epidemiological dynamics. In this work is presented a overview of the logic of medical diagnosis and some mathematical techniques is discussed.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Adlassnig K. P., 1982, APPROXIMATE REASONIN, P219
   ADLASSNIG KP, 1985, COMPUT BIOL MED, V15, P315, DOI 10.1016/0010-4825(85)90014-9
   ADLASSNIG KP, 2000, OSTERREICHISCHE COMP
   ADLASSNIG KP, 1986, APPROXIMATE REASONIN, P203
   Bellamy JEC, 1997, J AM VET MED ASSOC, V210, P390
   de Dombal F. T., 1972, BRIT MED J, V1, P376
   DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950
   Esogbue A. O., 1980, Fuzzy Sets and Systems, V3, P1, DOI 10.1016/0165-0114(80)90002-0
   Esogbue A. O., 1979, Fuzzy Sets and Systems, V2, P279, DOI 10.1016/0165-0114(79)90002-2
   ESOGBUE AO, 1983, FUZZY SET SYST, V10, P223, DOI 10.1016/S0165-0114(83)80117-1
   FORDON WA, 1979, ADV FUZZY SET THEORY, P445
   Klir G. J., 1995, FUZZY SETS FUZZY LOG
   KOLARZ G, 1986, Journal of Medical Systems, V10, P395, DOI 10.1007/BF00992439
   Luger G, 1998, ARTIFICIAL INTELLIGE
   MACARTNEY FJ, 1987, BMJ-BRIT MED J, V295, P1325, DOI 10.1136/bmj.295.6609.1325
   MILLER MC, 1981, MATH MODELS MED DIAG
   MORDESON JN, 2000, FUZZY MATH MED
   Sackett D. L., 1997, EVIDENCE BASED MED P
   Sackett DL, 1991, CLIN EPIDEMIOLOGY BA
   Sanchez E., 1979, Fuzzy Sets and Systems, V2, P75, DOI 10.1016/0165-0114(79)90017-4
   Shafer G., 1976, MATH THEORY EVIDENCE
   Szczepaniak P, 2000, FUZZY SYSTEMS MED
   Turing Alan Matheson, 1950, MIND, V59, P453
NR 23
TC 0
Z9 0
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0922-6389
BN 1-58603-206-2
J9 FR ART INT
PY 2001
VL 7
BP 156
EP 165
PG 10
WC Computer Science, Artificial Intelligence; Robotics
SC Computer Science; Robotics
GA BT69K
UT WOS:000173778400020
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Massad, E
   Rozman, M
   Azevedo, RS
   Carvalho, HB
AF Burattini, MN
   Massad, E
   Rozman, M
   Azevedo, RS
   Carvalho, HB
TI Correlation between HIV and HCV in Brazilian prisoners: evidence for
   parenteral transmission inside prison
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE acquired immunodeficiency syndrome, epidemiology; hepatitis
   epidemiology; HIV seroprevalence; prisoners; substance-related
   disorders; risk factors; seroepidemiologic studies; drug usage; male
   prisioners
ID HEPATITIS-C VIRUS; RISK; INFECTION; INMATES
AB Objective It is an accepted fact that confinement conditions increase the risk of some infections related to sexual and/or injecting drugs practices. Mathematical techniques were applied to estimate time-dependent incidence densities of HIV infection among inmates.
   Methods A total of 631 prisoners from a Brazilian prison with 4,900 inmates at that time were interviewed and their blood drawn. Risky behavior for HIV infection was analyzed, and serological tests for HIV, hepatitis C and syphilis were performed, intended as surrogates for parenteral and sexual HIV transmission, respectively. Mathematical techniques were used to estimate the incidence density ratio, as related to the time of imprisonment.
   Results Prevalence were: HIV - 16%; HCV - 34%; and syphilis - 18%. The main risk behaviors related to HIV infection were HCV prevalence (OR=10.49) and the acknowledged use of injecting drugs (OR=3.36). Incidence density ratio derivation showed that the risk of acquiring HIV infection increases with the time of imprisonment, peaking around three years after incarceration.
   Conclusions The correlation between HIV and HCV seroprevalence and the results of the mathematical analysis suggest that HIV transmission in this population is predominantly due to parenteral exposure by injecting drug, and that it increases with time of imprisonment.
C1 Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Ave Doutor Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Carvalho, Heraclito/C-1334-2012; Massad, Eduardo/H-6143-2011; Burattini,
   Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Azevedo, Raymundo
   S/B-7593-2008
OI Carvalho, Heraclito/0000-0002-7037-5655; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Azevedo,
   Raymundo S/0000-0003-0660-2371
CR *AISN SOFTW, 1992, JAND SCI TABL VERS 3
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   DESENCLOS JC, 1995, PRESSE MED, V24, P7
   Diaz RS, 1999, AIDS, V13, P1417, DOI 10.1097/00002030-199907300-00024
   GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293
   LORENCO R, 1992, THESIS SAO PAULO ESC
   LWANGA SK, 1991, SAMPLE SIZES DETERMI
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   Massad E, 1999, EUR J EPIDEMIOL, V15, P439, DOI 10.1023/A:1007523027876
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MCKEE KJ, 1995, AIDS CARE, V7, P159, DOI 10.1080/09540129550126687
   Muench H, 1959, CATALYTIC MODELS EPI
   MUTTER RC, 1994, ARCH INTERN MED, V154, P793, DOI 10.1001/archinte.154.7.793
   PEIXINHO ZF, 1990, NAT IMMUN CELL GROW, V9, P133
   PONT J, 1994, EUR J EPIDEMIOL, V10, P285, DOI 10.1007/BF01719351
   POWER KG, 1992, BRIT J ADDICT, V87, P35
   ROTILY M, 1994, AIDS, V8, P1341, DOI 10.1097/00002030-199409000-00020
   Rozman M, 1998, INT J STD AIDS, V9, P183, DOI 10.1258/0956462981921855
   WATTS DM, 1994, T ROY SOC TROP MED H, V88, P55, DOI 10.1016/0035-9203(94)90495-2
   *WHO COLL STUD GRO, 1994, FIN REP WHO PSA PROG
   Zanetta DMT, 1999, INT J STD AIDS, V10, P98, DOI 10.1258/0956462991913718
NR 22
TC 42
Z9 49
U1 0
U2 9
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD OCT
PY 2000
VL 34
IS 5
BP 431
EP 436
DI 10.1590/S0034-89102000000500001
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 377CV
UT WOS:000165495100001
PM 11105105
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Sallum, PC
   Almeida, MF
   Massad, E
AF Sallum, PC
   Almeida, MF
   Massad, E
TI Rabies seroprevalence of street dogs from Sao Paulo City, Brazil
SO PREVENTIVE VETERINARY MEDICINE
LA English
DT Article
DE dog; rabies virus; vaccination; modeling; population control
AB A sample of 602 street dogs captured by the Sao Paulo zoonosis-control municipal service was analyzed for the presence of serum antibodies against the rabies virus and compared to a control sample of 37 dogs from the kennel of the police of Sao Paulo. Data were stratified into 4 age intervals and the age from the street-dog sample was estimated by general aspects and dental observation according to standard techniques. We assumed that seropositivity was due to previous vaccination (no sub-clinical infection). From the prevalence data, we estimated the age-dependent incidence-density rate of vaccination by a simple mathematical model, which also allowed the estimation of the period of antibody protection given by the supposed vaccination. Crude seroprevalence in the street-dog sample was 16.5% and in the sample from the police-kennel dogs was 80%. The average age of first vaccination calculated for the street-dog sample was 5 years of age (if we assumed an average period of vaccine protection of 3 years) - but 5 months of age for the police-kennel sample. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Publ Hlth, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ALEMIDA MF, 1999, UNPUB J WILDLIFE DIS
   ANDERSON R M, 1991
   ARMITAGE B, 1994, STAT METHODS MED RES
   BERAN GW, 1982, COMP IMMUNOL MICROB, V5, P265, DOI 10.1016/0147-9571(82)90047-9
   *BRAZ MIN HLTH, 1999, CARAIVA8699 BRAZ MIN
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   Childs JE, 1998, PREV VET MED, V33, P207, DOI 10.1016/S0167-5877(97)00039-1
   CHOMEL B, 1988, REV INFECT DIS, V10, pS697
   GERMANO PML, 1990, ARQ BIOL TECNOL, V33, P551
   GUILLEMIN F, 1981, J BIOL STAND, V9, P147, DOI 10.1016/S0092-1157(81)80019-4
   Lwa nga S.K., 1991, SAMPLE SIZE DETERMIN
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1
   Scillato-Yane G.J., 1995, ANATOMIA ANIMALES DO, V12, P183
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
   WANDELER AI, 1988, REV INFECT DIS, V10, pS684
   *WHO, 1994, WHOEMCZ99963
NR 17
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-5877
EI 1873-1716
J9 PREV VET MED
JI Prev. Vet. Med.
PD APR 28
PY 2000
VL 44
IS 3-4
BP 131
EP 139
DI 10.1016/S0167-5877(00)00110-0
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA 307ZT
UT WOS:000086684600001
PM 10760397
DA 2020-12-16
ER

PT J
AU Ohno-Machado, L
   Lacson, R
   Massad, E
AF Ohno-Machado, L
   Lacson, R
   Massad, E
TI Decision trees and fuzzy logic: A comparison of models for the selection
   of measles vaccination strategies in Brazil
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Article; Proceedings Paper
CT Annual Symposium of the American-Medical-Informatics-Association
CY NOV 04-08, 2000
CL LOS ANGELES, CALIFORNIA
SP Amer Med Informat Assoc
AB In 1997, health authorities of the state of Sao Paulo, Brazil designed a vaccination campaign against measles based on a decision model that utilized fuzzy logic. The chosen mass vaccination strategy was implemented and changed the natural course of the epidemic in that state. We have built a model using a decision tree and compare it to the fuzzy logic model. Using essentially the same set of assumptions about this problem, we contrast the two approaches. The models identify the same strategy as being the best one, but exhibit differences in the ranking of the remaining strategies.
C1 Harvard Univ, Brigham & Womens Hosp, Sch Med, MIT,Div Hlth Sci & Technol,Decis Syst Grp, Boston, MA 02115 USA.
   Univ Sao Paulo, Fac Med, Disciplina Informat Med, Sao Paulo, Brazil.
RP Ohno-Machado, L (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, MIT,Div Hlth Sci & Technol,Decis Syst Grp, Boston, MA 02115 USA.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Ohno-Machado,
   Lucila/0000-0002-8005-7327
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW001279, D43TW001279, D43TW001279,
   D43TW001279, D43TW001279] Funding Source: NIH RePORTER; FIC NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW001279, 1D43TW01279-01] Funding Source: Medline
CR Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140
   DETSKY AS, 1990, ANN INTERN MED, V113, P147, DOI 10.7326/0003-4819-113-2-147
   LANGLOTZ CP, 1988, MED DECIS MAKING, V8, P290, DOI 10.1177/0272989X8800800410
   MASON JJ, 1995, JAMA-J AM MED ASSOC, V273, P1919, DOI 10.1001/jama.273.24.1919
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad E, 1999, INT J EPIDEMIOL, V28, P550, DOI 10.1093/ije/28.3.550
   Ohno-Machado L, 1993, Proc Annu Symp Comput Appl Med Care, P429
   OMEARA JJ, 1994, NEW ENGL J MED, V330, P1864, DOI 10.1056/NEJM199406303302605
   Sanders GD, 1999, MED DECIS MAKING, V19, P157, DOI 10.1177/0272989X9901900206
NR 9
TC 9
Z9 9
U1 0
U2 2
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107 USA
SN 1067-5027
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
PY 2000
SU S
BP 625
EP 629
PG 5
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA 458RC
UT WOS:000170207500128
PM 11079959
DA 2020-12-16
ER

PT J
AU Ohno-Machado, L
   Boxwala, A
   Fraser, H
   Greenes, R
   Kohane, I
   Marin, H
   Marques, E
   Massad, E
   Rocha, B
   Rocha, R
   Smeaton, L
   Szolovits, P
AF Ohno-Machado, L
   Boxwala, A
   Fraser, H
   Greenes, R
   Kohane, I
   Marin, H
   Marques, E
   Massad, E
   Rocha, B
   Rocha, R
   Smeaton, L
   Szolovits, P
TI First steps towards implementing an international training program in
   medical informatics: The Brazil/USA project
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Meeting Abstract
C1 Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Childrens Hosp Informat Program, Boston, MA USA.
   Univ Fed Sao Paulo, Dept Enfermagem, Sao Paulo, Brazil.
   Univ Estadual Rio De Janeiro, Rio De Janeiro, Brazil.
   Univ Sao Paulo, Disciplina Informat Med, Sao Paulo, Brazil.
   Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
   Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.
   MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.
RI Kohane, Isaac Kohane/K-3716-2012; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Kohane, Isaac Kohane/0000-0003-2192-5160; Massad,
   Eduardo/0000-0002-7200-2916; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107 USA
SN 1067-5027
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
PY 2000
SU S
BP 1105
EP 1105
PG 1
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA 458RC
UT WOS:000170207500356
DA 2020-12-16
ER

PT J
AU Ortega, NRS
   Sallum, PC
   Massad, E
AF Ortega, NRS
   Sallum, PC
   Massad, E
TI Fuzzy dynamical systems in epidemic modelling
SO KYBERNETES
LA English
DT Article
DE cybernetics; fuzzy logic; dynamic model; disease; predictive techniques
ID LOGIC CONTROLLER
AB Proposes an application of fuzzy set theory to model epidemiological problems. Fuzzy logic has been revealed as a powerful predictive tool in the epidemiology of infectious diseases and some ideas are presented on how this could be done. This work presents an attempt to model the dynamics of rabies among a population of partially vaccinated dogs. This study demonstrates how a dynamical system can be modelled by fuzzy linguistic rules compared to the classical differential equations approach. The results are very encouraging and the approach through a more complex dynamical system is discussed in the final section.
C1 Univ Sao Paulo, Inst Phys, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Publ Hlth, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RP Ortega, NRS (corresponding author), Univ Sao Paulo, Inst Phys, BR-05508 Sao Paulo, Brazil.
RI Ortega, Neli/C-6494-2013; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ANDERSON R M, 1991
   BARROS LC, 1992, THESIS U CAMPINAS SA
   BARROS LC, 1997, THESIS U CAMPINAS SA
   BASSANEZI RC, 1995, KYBERNETES, V24, P91
   Klir G. J., 1995, FUZZY SETS FUZZY LOG
   LEE CC, 1990, IEEE T SYST MAN CYB, V20, P404, DOI 10.1109/21.52551
   LEE CC, 1990, IEEE T SYST MAN CYB, V20, P419, DOI 10.1109/21.52552
   MASSAD E, 1997, SOFT COMPUTING SOCO, P58
   MASSAD E, 1998, J EPIDEMIOLOGY
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   Muench H, 1959, CATALYTIC MODELS EPI
   Pearson DW, 1997, APPL MATH LETT, V10, P99, DOI 10.1016/S0893-9659(97)00043-8
   PEARSON DW, 1997, SOFT COMPUTING SOCO, P203
   SALLUM P, 1997, THESIS U SAO PAULO B
   SEIKKALA S, 1987, FUZZY SET SYST, V24, P319, DOI 10.1016/0165-0114(87)90030-3
   STRUCHINER CJ, 1997, SOFT COMPUTING SOCO, P64
   Yager RR, 1994, ESSENTIALS FUZZY MOD
   Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5
NR 18
TC 23
Z9 23
U1 1
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
PY 2000
VL 29
IS 1-2
BP 201
EP 218
DI 10.1108/03684920010312768
PG 18
WC Computer Science, Cybernetics
SC Computer Science
GA 309ZL
UT WOS:000086799700015
DA 2020-12-16
ER

PT J
AU Goncalves, MAG
   Massad, E
   Burattini, MN
   Villa, LL
AF Goncalves, MAG
   Massad, E
   Burattini, MN
   Villa, LL
TI Relationship between human papillomavirus (HPV) genotyping and genital
   neoplasia in HIV-positive patients of Santos City, Sao Paulo, Brazil
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Article
DE human papillomavirus (HPV); human immunodeficiency virus (HIV); acquired
   immunodeficiency syndrome (AIDS); cervical intraepithelial neoplasia
   (CIN); squamous intraepithelial lesion (SIL); colposcopy
ID HUMAN-IMMUNODEFICIENCY-VIRUS; WOMEN; INFECTION; RISK; AMPLIFICATION;
   POLYMERASE; LESIONS; CERVIX; DNA
AB Among HIV-positive women, infection with multiple human papillomavirus (HPV) types is known to be more frequent and persistent, as well as a greater prevalence of high-grade genital lesions. This study aims to characterize, for the first time in Brazil, HPV presence and types among HIV-positive women of a high-risk population for genital intraepithelial neoplasia (GIN) development. A non-anonymous, voluntary, cross-sectional epidemiological survey was conducted, from June 1996 to April 1997, among 141 HIV-positive women followed at the Center of Reference in AIDS (CRAIDS). They were submitted to gynaecological examination, cytological screening and biopsies whenever necessary, for GIN and HPV DNA detection through polymerase chain reaction (PCR) technique. Positive HPV DNA were found in 80.8% patients. Two or more HPV types were detected in 45% of the samples. The most frequent HPV types detected were 16, 18 (30.5%); 61, 53 (24.4%), and non-identified types (18.7%). According to the oncogenic potential, 34.8% were considered of high-risk types. Among these HIV-positive patients, a great variety of HPV types, including high-risk types, was found in anogenital environment, as well as among young women, a gr eat prevalence of high-grade genital lesions. Thus, it should strengthen the need for a periodical careful gynaecological examination among those women.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI VILLA, LUISA/AAH-4761-2019; Massad, Eduardo/B-1169-2012; Burattini,
   Marcelo N/J-9272-2014; Massad, Eduardo/H-6143-2011
OI VILLA, LUISA/0000-0003-4074-2335; Massad, Eduardo/0000-0002-7200-2916;
   Burattini, Marcelo N/0000-0002-5407-6890; 
CR BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077
   DEAN AG, 1994, EPILNFO VERSION 6 WO
   DIXON WJ, 1992, BMDP STAT SOFTWARE M, V1
   GROSS EG, 1997, HUMAN PAPILLOMA VIRU
   HO GYF, 1994, INT J CANCER, V56, P788, DOI 10.1002/ijc.2910560605
   JOHNSON JC, 1992, OBSTET GYNECOL, V79, P321, DOI 10.1097/00006250-199203000-00001
   KURMAN RJ, 1994, BETHESDA SYSTEM REPO
   LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002
   MANOS MM, 1989, CANCER CEL, V7, P209
   MEISELS A, 1976, ACTA CYTOL, V20, P505
   MEMAR OM, 1995, J INVEST DERMATOL, V105, pS99, DOI 10.1111/1523-1747.ep12316241
   Miotti PG, 1996, J INFECT DIS, V173, P714, DOI 10.1093/infdis/173.3.714
   PETRY KU, 1994, INT J CANCER, V57, P836, DOI 10.1002/ijc.2910570612
   PUROLA E, 1977, ACTA CYTOL, V21, P26
   RICHART RM, 1990, OBSTET GYNECOL, V75, P131
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SPITZER M, 1993, GYNECOL ONCOL, V49, P243, DOI 10.1006/gyno.1993.1115
   Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903
   SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M
   TWEDDEL G, 1994, GYNECOL ONCOL, V52, P161, DOI 10.1006/gyno.1994.1024
   VERNON SD, 1994, J INFECT DIS, V169, P1108, DOI 10.1093/infdis/169.5.1108
   Villa LL, 1997, ADV CANCER RES, V71, P321, DOI 10.1016/S0065-230X(08)60102-5
NR 22
TC 32
Z9 39
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD DEC
PY 1999
VL 10
IS 12
BP 803
EP 807
DI 10.1258/0956462991913583
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 260FR
UT WOS:000083939300007
PM 10639061
DA 2020-12-16
ER

PT J
AU Struchiner, CJ
   de Almeida, LM
   de Azevedo, RS
   Massad, E
AF Struchiner, CJ
   de Almeida, LM
   de Azevedo, RS
   Massad, E
TI Hepatitis A incidence rate estimates from a pilot seroprevalence survey
   in Rio de Janeiro, Brazil
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE hepatitis A; sanitation; water decontamination; waste disposal; current
   status data; NPMLE; monotonic splines
ID DIARRHEAL DISEASES; WATER-SUPPLIES; SANITATION; HEALTH; TRANSMISSION;
   PREVALENCE; INTERVENTIONS; INVESTMENTS; REGRESSION; MORBIDITY
AB Background To assess the impact of water sanitation and sewage disposal, part of a major environmental control programme In Rio de Janeiro, we carried out seroprevalence studies for Hepatitis A virus (HAV) in three micro-regions in Rio de Janeiro. Each region varied with regard to level of sanitation. We are interested in assessing the discriminating power of age-specific prevalence curves for HAV as a proxy for improvement in sanitation. These curves will serve as baseline information to future planned surveys as the sanitation programme progresses.
   Methods Incidence rate curves from prevalence data are estimated parametrically via a Weibull-like survival function, and non-parametrically via maximum likelihood and monotonic splines. Sera collected from children and adults in the three areas are used to detect antibodies against HAV through ELISA.
   Results We compare baseline incidence curves at the three sites estimated by the three methods. We observe a strong negative correlation between level of sanitation and incidence rates for HAV infection. Incidence estimates yielded by the parametric and non-parametric approaches tend to agree at early ages in the microregion showing the best level of sanitation and to increasingly disagree in the other two.
   Conclusion Our results support the choice of HAV as a sentinel disease that is associated with level of sanitation. We also introduce monotonic splines as a novel non-parametric approach to estimate incidence from prevalence data. This approach outperforms current estimating procedures.
C1 Fundacao Oswaldo Cruz, PROCC, BR-21045900 Rio De Janeiro, Brazil.
   Univ Estado Rio De Janeiro, IMS, BR-20559900 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, NESC, BR-21941590 Rio De Janeiro, Brazil.
   HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med, Dept Patol, BR-01246903 Sao Paulo, Brazil.
RP Struchiner, CJ (corresponding author), Fundacao Oswaldo Cruz, PROCC, Av Brasil 4365,Residencia Oficial, BR-21045900 Rio De Janeiro, Brazil.
RI Azevedo, Raymundo S/B-7593-2008; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Struchiner, Claudio J/M-9360-2013
OI Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Struchiner, Claudio J/0000-0003-2114-847X
CR ADES AE, 1993, AM J EPIDEMIOL, V137, P1022, DOI 10.1093/oxfordjournals.aje.a116758
   ALMEIDA LM, THESIS U ESTADO RIO
   [Anonymous], 1997, S PLUS 4 GUID STAT
   BALAYAN MS, 1992, VACCINE, V10, pS27, DOI 10.1016/0264-410X(92)90537-T
   BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357
   BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473
   BRISCOE J, 1984, AM J EPIDEMIOL, V120, P449, DOI 10.1093/oxfordjournals.aje.a113909
   Brunet RC, 1996, THEOR POPUL BIOL, V50, P209, DOI 10.1006/tpbi.1996.0029
   Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x
   Cvjetanovic B, 1986, World Health Stat Q, V39, P105
   DANIELS DL, 1990, B WORLD HEALTH ORGAN, V68, P455
   ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757
   ESREY SA, 1988, AM J PUBLIC HEALTH, V78, P1451, DOI 10.2105/AJPH.78.11.1451
   ESREY SA, 1986, EPIDEMIOL REV, V8, P117, DOI 10.1093/oxfordjournals.epirev.a036290
   Gil A, 1997, EPIDEMIOL INFECT, V118, P189, DOI 10.1017/S0950268896007297
   GROENEBOON P, 1992, INFORMATION BOUNDS N
   GRUMMERSTRAWN LM, 1993, J AM STAT ASSOC, V88, P758, DOI 10.2307/2290760
   GUST ID, 1993, MED J AUSTRALIA, V159, P691, DOI 10.5694/j.1326-5377.1993.tb138085.x
   HARPHAM T, 1991, World Health Statistics Quarterly, V44, P62
   Hastie TJ, 1990, GEN ADDITIVE MODELS
   Huet S., 1996, STAT TOOLS NONLINEAR
   HUTTLY S R A, 1990, World Health Statistics Quarterly, V43, P118
   KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150
   KINDZIERSKI WB, 1995, WATER ENVIRON RES, V67, P749, DOI 10.2175/106143095X135985
   KNIGHT SM, 1992, INT J EPIDEMIOL, V21, P812, DOI 10.1093/ije/21.4.812
   Marschner IC, 1997, BIOMETRICS, V53, P1384, DOI 10.2307/2533505
   MOORE HA, 1966, AM J PUBLIC HEALTH N, V56, P276, DOI 10.2105/AJPH.56.2.276
   OKUN DA, 1988, AM J PUBLIC HEALTH, V78, P1463, DOI 10.2105/AJPH.78.11.1463
   Ramsay J. O., 1988, STAT SCI, V3, P425, DOI DOI 10.1214/SS/1177012761
   SHAPIRO CN, 1992, VACCINE, V10, pS59, DOI 10.1016/0264-410X(92)90545-U
   SHUVAL HI, 1981, B WORLD HEALTH ORGAN, V59, P243
   Struchiner CJ, 1995, JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3, P851, DOI 10.1142/S0218339095000770
   VANDERSLICE J, 1994, B WORLD HEALTH ORGAN, V72, P589
   VICTORA CG, 1988, INT J EPIDEMIOL, V17, P651, DOI 10.1093/ije/17.3.651
NR 34
TC 17
Z9 20
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD AUG
PY 1999
VL 28
IS 4
BP 776
EP 781
DI 10.1093/ije/28.4.776
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 232AR
UT WOS:000082344000027
PM 10480710
OA Bronze
DA 2020-12-16
ER

PT J
AU Coutinho, FAB
   Massad, E
   Menezes, RX
   Burattini, MN
AF Coutinho, FAB
   Massad, E
   Menezes, RX
   Burattini, MN
TI A theoretical model of the evolution of virulence in sexually
   transmitted HIV/AIDS
SO REVISTA DE SAUDE PUBLICA
LA English
DT Editorial Material
DE acquired inmunodeficiency syndrome; virulence; models statistical
ID IMMUNODEFICIENCY-VIRUS TYPE-1; RISK-FACTORS; MALE TRANSMISSION;
   HIV-INFECTION; FEMALE; SEROCONVERSION; MEN
AB Introduction The evolution of virulence in host-parasite relationships has been the subject of several publications. In the case of HIV virulence, some authors suggest that the evolution of HIV Virulence correlates with the rate of acquisition of new sexual partners. In contrast some other authors argue that the level of HIV virulence is independent of the sexual activity of the host population.
   Methods Provide a mathematical model for the study of the potential influence of human sexual behaviour on the evolution of virulence of HIV is provided.
   Results The results indicated that, when the probability of acquisition of infection is a function both of the sexual activity and of the virulence level of HIV strains, the evolution of HIV virulence correlates positively with the rate of acquisition of new sexual partners.
   Conclusion It is concluded that in the case of a host population with a low (high) rate of exchange of sexual partners the evolution of HIV virulence is such that the less (more) virulent strain prevails.
C1 Univ Sao Paulo, Fac Med, Dept Patol, Lab Invest Med 01, Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; 
CR BERKLEY SF, 1989, J INFECT DIS, V160, P22, DOI 10.1093/infdis/160.1.22
   BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102
   BURCHAM JL, 1989, MED J AUSTRALIA, V150, P634, DOI 10.5694/j.1326-5377.1989.tb136727.x
   CAMERON DW, 1989, LANCET, V2, P403
   Ewald P. W., 1994, EVOLUTION INFECT DIS
   FENNER F., 1957, JOUR HYG, V55, P149
   LATIF AS, 1989, AIDS, V3, P519, DOI 10.1097/00002030-198908000-00006
   Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203
   LIPSITCH M, 1995, J THEOR BIOL, V174, P427, DOI 10.1006/jtbi.1995.0109
   MASSAD E, 1987, EVOLUTION, V41, P1127, DOI [10.2307/2409198, 10.1111/j.1558-5646.1987.tb05883.x]
   MASSAD E, 1995, MATH MODEL SCI COMPU, V26, P810
   MASTRO TD, 1994, LANCET, V343, P204, DOI 10.1016/S0140-6736(94)90990-3
   May R.M., 1983, P186
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   PAPE JW, 1990, J ACQ IMMUN DEF SYND, V3, P995
   PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233
   Ratcliffe F. N., 1965, MYXOMATOSIS
   SIMMONDS P, 1990, AIDS S1, V4, pS77
   WEISER B, 1994, P NATL ACAD SCI USA, V91, P8037, DOI 10.1073/pnas.91.17.8037
NR 19
TC 5
Z9 5
U1 0
U2 5
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 1999
VL 33
IS 4
BP 329
EP 333
DI 10.1590/S0034-89101999000400002
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 250VR
UT WOS:000083410200002
PM 10542465
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Coutinho, FAB
   Massad, E
   Lopez, LF
   Burattini, MN
   Struchiner, CJ
   Azevedo-Neto, RS
AF Coutinho, FAB
   Massad, E
   Lopez, LF
   Burattini, MN
   Struchiner, CJ
   Azevedo-Neto, RS
TI Modelling heterogeneities in individual frailties in epidemic models
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
DE infectious diseases; heterogeneities; force of infection; functional
   analysis; basic reproduction number
ID POPULATIONS; THRESHOLD
AB A central question in epidemiology is how heterogeneity, in its different manifestations, influences the dynamics and intensity of infections. The individual differences have been named frailty in the demography literature in the context of susceptibility to death. In epidemic theory, heterogeneity in the host population has not be treated systematically before, except for variations in the ability to transmit the disease. In this paper, we propose an epidemic model, taking into account the phenomenon of frailty in the various transition rates, and analyse its effect on the observable rates. We develop expressions for the steady state distribution of the force of infection, number of infected and various observed epidemic parameters. In particular, we show how apparently age-dependent parameters may arise fi om heterogeneity in situations where no explicit age-dependence is built into the model. Using standard linearization methods, the basic reproduction number is determined. Finally, we show how the force of infection can be determined from an integral equation and apply the methods of functional analysis to prove existence and uniqueness of the endemic equilibrium. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Coutinho, FAB (corresponding author), Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/H-6143-2011; Struchiner, Claudio J/M-9360-2013; Burattini,
   Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011; Lopez, Luis
   F/C-4721-2012
OI Massad, Eduardo/0000-0002-7200-2916; Azevedo, Raymundo
   S/0000-0003-0660-2371; Struchiner, Claudio J/0000-0003-2114-847X;
   Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; Lopez, Luis F/0000-0003-4097-6887
CR AALEN OO, 1988, STAT MED, V7, P1121, DOI 10.1002/sim.4780071105
   Abramowitz M., 1965, HDB MATH FUNCTIONS
   ANDERSON R M, 1991
   ANDREASEN V, 1996, P 3 EUR C MATH APPL, P329
   Athreya K.B., 1972, BRANCHING PROCESSES
   BECKER NG, 1990, LECT NOTES BIOMATH, V86, P90, DOI DOI 10.1007/978-3-662-10067-7-9
   CASTILLOCHAVES CC, 1989, LECT NOTES BIOMATHEM, V83
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Griffel D.H., 1981, APPL FUNCTIONAL ANAL
   Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858
   HASIBEDER G, 1996, MODELS INFECT HUMAN
   Hethcote H, 1996, MODELS INFECT HUMAN
   Hethcote H. W., 1992, LECT NOTES BIOMATHEM, V95
   HOUGAARD P, 1984, BIOMETRIKA, V71, P75, DOI 10.1093/biomet/71.1.75
   HOUGAARD P, 1986, BIOMETRIKA, V73, P387, DOI 10.1093/biomet/73.2.387
   INABA H, 1990, J MATH BIOL, V28, P411
   JOHNSON AM, 1996, MODELS INFECT HUMAN
   Jordan D.W, 1977, NONLINEAR ORDINARY D
   Krasnosel'skii MA, 1964, POSITIVE SOLUTIONS O
   LIN XD, 1993, MATH BIOSCI, V118, P181, DOI 10.1016/0025-5564(93)90051-B
   Longini IM, 2006, APPL STAT, V45, P165, DOI 10.2307/2986152
   Lopez LF, 1999, MATH COMPUT MODEL, V29, P55, DOI 10.1016/S0895-7177(99)00062-X
   LOPEZ LF, UNPUB J MATH BIOL
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   Massad Eduardo, 1995, Journal of Biological Systems, V3, P803, DOI 10.1142/S0218339095000733
   Morris M, 1996, MODELS INFECT HUMAN
   Muench H, 1959, CATALYTIC MODELS EPI
   Segel LA, 1980, MATH MODELS MOL CELL
   VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224
NR 31
TC 32
Z9 32
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-7177
EI 1872-9479
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PD JUL
PY 1999
VL 30
IS 1-2
BP 97
EP 115
DI 10.1016/S0895-7177(99)00119-3
PG 19
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 222DZ
UT WOS:000081769300008
DA 2020-12-16
ER

PT J
AU de Almeida, LM
   Azevedo, RS
   Guimaraes, AAM
   Coutinho, EDF
   Struchiner, CJ
   Massad, E
AF de Almeida, LM
   Azevedo, RS
   Guimaraes, AAM
   Coutinho, EDF
   Struchiner, CJ
   Massad, E
TI Detection of antibodies against hepatitis A virus in eluates of blood
   spotted on filter-paper: a pilot study in Rio de Janeiro, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE hepatitis A; epidemiological survey; filter paper blood collection;
   validation; Brazil
ID SAO-PAULO; RUBELLA
AB The validity of blood spotted on to filter-paper (BSOFP) eluates for the detection of antibodies against hepatitis A virus (HAV) was investigated in 718 individuals (children and adults) during a field study in a small area in Rio de Janeiro State, Brazil. Serum samples were considered the 'gold standard'. BSOFP eluates were analysed by 2 different techniques: microplate competitive enzyme-linked immunosorbent assay (ELISA) of the whole study group and microparticle enzyme immune assay (MEIA) of a subsample of 59 individuals. For BSOFP eluates by ELISA, sensitivity and specificity were 89.6% (95% CI: 84.7-93.1) and 97.5% (95% CI: 95.6-98.7), respectively. For a seroprevalence of anti-HAV antibodies of 32%, the positive predictive value was 94.5% (95% CI: 90.3-97.0) and the negative predictive value was 95.2% (95% CI: 92.8-96.8). The test efficiency was 95.0% (95% CI: 93.1-96.4). Similar results were found for BSOFP eluates by MEIA. Agreement between the 2 techniques used for BSOFP (ELISA and MEIA) was also high (kappa = 0.93). These results encourage the more widespread application of BSOFP as a means of surveillance for large-scale epidemiological studies for hepatitis A.
C1 Univ Fed Rio de Janeiro, NESC, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Virol Lab, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Inst Microbiol Professor Paulo de Goes, BR-21941590 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Fac Med, Dept Patol, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med, HCFMUSP, BR-01246903 Sao Paulo, Brazil.
   Fdn Oswaldo Cruz, ENSP, BR-21040210 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Inst Social Med, BR-20559900 Rio De Janeiro, Brazil.
RP de Almeida, LM (corresponding author), Univ Fed Rio de Janeiro, NESC, Av Brigadeiro Trompowski S-N,Edificio HUCFF,5 And, BR-21941590 Rio De Janeiro, Brazil.
RI Coutinho, Evandro S/E-2408-2011; Struchiner, Claudio J/M-9360-2013;
   Azevedo, Raymundo S/B-7593-2008; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Struchiner, Claudio J/0000-0003-2114-847X; Azevedo, Raymundo
   S/0000-0003-0660-2371; Massad, Eduardo/0000-0002-7200-2916; 
CR ALMEIDA LM, 1997, SANEAMENTO SAUDE EM, P324
   AZEVEDONETO RS, 1996, 7 INT C INF DIS INT, P17
   CONNELL JA, 1990, LANCET, V335, P1366, DOI 10.1016/0140-6736(90)91245-6
   DONNER A, 1992, STAT MED, V11, P1511, DOI 10.1002/sim.4780111109
   Fleiss J. L., 1981, STAT METHODS RATES P, P38
   Gil A, 1997, EPIDEMIOL INFECT, V118, P189, DOI 10.1017/S0950268896007297
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   NETO RSDA, 1995, T ROY SOC TROP MED H, V89, P115, DOI 10.1016/0035-9203(95)90680-0
   Rothman K.J., 1998, MODERN EPIDEMIOLOGY
   STRONGIN W, 1992, P211
   Vai S, 1987, G Batteriol Virol Immunol, V80, P253
   ZOULEK G, 1985, B WORLD HEALTH ORGAN, V63, P935
NR 12
TC 14
Z9 14
U1 0
U2 5
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL-AUG
PY 1999
VL 93
IS 4
BP 401
EP 404
DI 10.1016/S0035-9203(99)90133-5
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 229RC
UT WOS:000082207500021
PM 10674088
DA 2020-12-16
ER

PT J
AU Massad, E
   Burattini, MN
   Ortega, NRS
AF Massad, E
   Burattini, MN
   Ortega, NRS
TI Fuzzy Logic and measles vaccination: designing a control strategy
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE measles; vaccination; fuzzy decision making; control strategies
ID CONTROL-SYSTEMS; COMMUNITY; OUTBREAK
AB Background The State of Sao Paulo, the most populous in Brazil, was virtually free of measles from 1987 until the end of 1996 when the number of cases started to rise. It reached alarming numbers in the middle of 1997 and local health authorities decided to implement a mass vaccination campaign.
   Methods Fuzzy Decision Making techniques are applied to the design of the vaccination campaign.
   Results The mass vaccination strategy chosen changed the natural course of the epidemic. It had a significant impact on the epidemic in the metropolitan area of Sao Paulo city, but a second epidemic in the State's interior forced the public health authorities to implement a second mass vaccination campaign 2 months after the first.
   Conclusions Fuzzy Logic techniques are a powerful tool for the design of control strategies against epidemics of infectious diseases.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   HCFMUSP, LIM01, BR-01246903 Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Burattini,
   Marcelo N/J-9272-2014; Ortega, Neli/C-6494-2013
OI Massad, Eduardo/0000-0002-7200-2916; Burattini, Marcelo
   N/0000-0002-5407-6890; 
CR ANDERSON R M, 1991
   BELLMAN RE, 1970, MANAGE SCI B-APPL, V17, pB141
   HUTCHINS SS, 1990, AM J EPIDEMIOL, V132, P157, DOI 10.1093/oxfordjournals.aje.a115627
   Klir G. J., 1995, FUZZY SETS FUZZY LOG
   LEE CC, 1990, IEEE T SYST MAN CYB, V20, P404, DOI 10.1109/21.52551
   LEE CC, 1990, IEEE T SYST MAN CYB, V20, P419, DOI 10.1109/21.52552
   MARKOWITZ LE, 1994, VACCINES, P229
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1997, SOFT COMPUTING SOCO, P58
   MURRAY CJL, 1996, GLOBAL HLTH STAT GLO, V2
   Nokes DJ, 1997, TRENDS MICROBIOL, V5, P14, DOI 10.1016/S0966-842X(97)81769-6
   STRUCHINER CJ, 1997, SOFT COMPUTING SOCO, P64
   WEEKS RM, 1992, B WORLD HEALTH ORGAN, V70, P317
   Yager RR, 1994, ESSENTIALS FUZZY MOD
   Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5
   ZADEH LA, 1973, IEEE T SYST MAN CYB, VSMC3, P28, DOI 10.1109/TSMC.1973.5408575
   ZIMMERMAN HJ, 1996, FUZZY INFORMATION EN, P471
NR 17
TC 40
Z9 40
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD JUN
PY 1999
VL 28
IS 3
BP 550
EP 557
DI 10.1093/ije/28.3.550
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 213XP
UT WOS:000081298800029
PM 10405863
OA Bronze
DA 2020-12-16
ER

PT J
AU Massad, E
   Rozman, M
   Azevedo, RS
   Silveira, ASB
   Takey, K
   Yamamoto, YI
   Strazza, L
   Ferreira, MMC
   Carvalho, HB
   Burattini, MN
AF Massad, E
   Rozman, M
   Azevedo, RS
   Silveira, ASB
   Takey, K
   Yamamoto, YI
   Strazza, L
   Ferreira, MMC
   Carvalho, HB
   Burattini, MN
TI Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners:
   Preponderance of parenteral transmission
SO EUROPEAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE AIDS; hepatitis C; injecting drug abusers; prisoners; seroprevalence
ID HEPATITIS-C VIRUS; DRUG-USERS; RISK-FACTORS; INFECTION; INMATES; AIDS;
   SURVEILLANCE; PREVALENCE; SPREAD; MISUSE
AB Between November 1993 and April 1994, our physicians' team interviewed and took blood samples of 631 prisoners randomly drawn from the largest prison of South America, which counted about 4700 inmates at that time. The interview consisted of questions related to risk behaviour for HIV infection, and the subjects were asked to provide blood for serological tests for HIV, hepatitis C and syphilis. Our main purpose was to investigate the relationship between HCV and injecting drug use as related to HIV seropositivity. Participation in the study was voluntary and confidentiality was guaranteed. Overall prevalences found were as follows: HIV: 16% (95% confidence interval (CI): 13-19%); HCV: 34% (95% CI: 30-38%), and syphilis: 18% (95% CI: 15-21%). Acknowledged use of ever injecting drug was 22% and no other parenteral risk was reported. Our results, as compared with other studies in the same prison, suggest that HIV prevalence has been stable in recent years, and that the major risk factor for HIV infection in this population is parenteral exposure by injecting drug use.
C1 Univ Sao Paulo, NUPAIDS, Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Av Doutor Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Massad, Eduardo/H-6143-2011; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Carvalho,
   Heraclito/C-1334-2012
OI Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890;
   Carvalho, Heraclito/0000-0002-7037-5655
CR Abeni D, 1998, SOC AS AIDS, P168
   Bastos F, 1998, SOC AS AIDS, P149
   BIRD AG, 1992, AIDS, V6, P725, DOI 10.1097/00002030-199207000-00017
   BIRD AG, 1994, AIDS, V8, P1345, DOI 10.1097/00002030-199409000-00021
   BREWER TF, 1988, AIDS, V2, P363, DOI 10.1097/00002030-198810000-00005
   CARVALHO HB, 1996, PUB C, V1099, P454
   CARVELL ALM, 1990, BRIT MED J, V300, P1383, DOI 10.1136/bmj.300.6736.1383
   CDC, 1986, MMWR-MORBID MORTAL W, V35, P195
   *CDCP, 1993, MMWR RECOMM REP, V7, P1
   *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P313
   DEAN AD, 1990, EPI INFO VERSION 5 W
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   DESENCLOS JC, 1995, PRESSE MED, V24, P7
   DOLAN K, 1995, AIDS, V9, P825, DOI 10.1097/00002030-199508000-00001
   DYE S, 1991, BRIT MED J, V302, P1506, DOI 10.1136/bmj.302.6791.1506
   FERREIRA OC, 1994, J ACQ IMMUN DEF SYND, V7, P1124
   GAUGHWIN MD, 1991, HIV AIDS PRIS C P CA
   GORE SM, 1995, BRIT MED J, V311, P1135, DOI 10.1136/bmj.311.7013.1135
   GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293
   HARDING TW, 1987, LANCET, V2, P1260
   HORSBURGH CR, 1990, AM J PUBLIC HEALTH, V80, P209, DOI 10.2105/AJPH.80.2.209
   IWARSON S, 1995, CLIN INFECT DIS, V20, P1361, DOI 10.1093/clinids/20.5.1361
   KENNEDY DH, 1991, BRIT MED J, V302, P1507, DOI 10.1136/bmj.302.6791.1507
   LORENCO R, 1992, THESIS ESCOLA PAULIS
   LWANGA SK, 1994, SAMPLE SIZES DETERMI
   MARTIN V, 1994, TUBERCLE LUNG DIS, V75, P49, DOI 10.1016/0962-8479(94)90102-3
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MASSAD E, 1996, PUB C, V1146, P461
   MCKEE KJ, 1992, SCOT MED J, V37, P132, DOI 10.1177/003693309203700502
   Mesquita F, 1998, SOC AS AIDS, P243
   MULLER T, 1995, SOZ PRAVENTIV MED, V40, P285, DOI 10.1007/BF01299196
   *NUPAIDS, 1996, HIV AIDS EM POP CONF
   OSMOND DH, 1993, J INFECT DIS, V167, P66, DOI 10.1093/infdis/167.1.66
   PEIXINHO ZF, 1990, NAT IMMUN CELL GROW, V9, P133
   ROTILY M, 1994, AIDS, V8, P1341, DOI 10.1097/00002030-199409000-00020
   ROZMAN MA, 1996, 7 INT C INF DIS, P12
   ROZMAN MA, 1995, THESIS U SAO PAULO S
   *STAT EP RES CORP, 1990, EGR REF MAN
   STRANG J, 1993, CRIM BEHAV MENT HEAL, V3, P393
   Strathdee S A, 1998, AIDS, V12 Suppl A, pS71
   *US NAT COMM AIDS, 1990, REP HIV DIS CORR FAC
   VLAHOV D, 1991, JAMA-J AM MED ASSOC, V265, P1129, DOI 10.1001/jama.265.9.1129
   WATTS DM, 1994, T ROY SOC TROP MED H, V88, P55, DOI 10.1016/0035-9203(94)90495-2
   *WHO, 1987, LANCET, V2, P1263
   *WHO INT COLL GROU, 1994, MULT STUD DRUG INJ R
   WORMSER GP, 1983, ANN INTERN MED, V98, P297, DOI 10.7326/0003-4819-98-3-297
NR 46
TC 33
Z9 39
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0393-2990
EI 1573-7284
J9 EUR J EPIDEMIOL
JI Eur. J. Epidemiol.
PD MAY
PY 1999
VL 15
IS 5
BP 439
EP 445
DI 10.1023/A:1007523027876
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 209ME
UT WOS:000081051200004
PM 10442469
DA 2020-12-16
ER

PT J
AU Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
AF Lopez, LF
   Coutinho, FAB
   Burattini, MN
   Massad, E
TI Modelling the spread of infections when the contact rate among
   individuals is short ranged: Propagation of epidemic waves
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
DE epidemic models; force of infection; epidemic waves; geographical spread
AB Integral equations for the force of infection were derived taking into account spatial variables. Those equations were studied both numerically and with functional analysis techniques. Threshold conditions for the establishment of the infection were also derived. The existence of travelling waves of the infection was investigated. An integral equation for the shape of the wave front was deduced. Conditions for the existence of those waves were derived independently of the velocity of propagation. The model differs from previous studies in that we allow recovery from the infectious status and/or demographic structure in the host population, that is, deaths and births of individuals. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, Discipline Med Informat, BR-01246903 Sao Paulo, Brazil.
RP Lopez, LF (corresponding author), Univ Sao Paulo, Sch Med, Discipline Med Informat, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM lopez@dns2.fm.usp.br
RI Massad, Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014; Lopez,
   Luis F/C-4721-2012
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; Burattini, Marcelo N/0000-0002-5407-6890; Lopez,
   Luis F/0000-0003-4097-6887
CR ANDERSON R M, 1991
   ATKINSON C, 1976, MATH PROC CAMBRIDGE, V80, P315, DOI 10.1017/S0305004100052944
   Cliff AD, 1995, EPIDEMIC MODELS THEI, P119
   CLIFF AD, 1980, STATISTICAL APPLICAT, P5
   DIEKMANN O, 1978, J MATH BIOL, V6, P109, DOI 10.1007/BF02450783
   Griffel D.H., 1981, APPL FUNCTIONAL ANAL
   Krasnosel'skii MA, 1964, POSITIVE SOLUTIONS O
   LOPEZ LF, UNPUB J MATH BIOL
   METZ JAJ, 1995, EPIDEMIC MODELS THEI, P150
   MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283
   SAATY TL, 1967, MODERN NONLINEAR EQU
   THIEME HR, 1977, J MATH BIOL, V4, P337, DOI 10.1007/BF00275082
NR 12
TC 6
Z9 6
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-7177
EI 1872-9479
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PD APR
PY 1999
VL 29
IS 7
BP 55
EP 69
DI 10.1016/S0895-7177(99)00062-X
PG 15
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 194EX
UT WOS:000080180100005
DA 2020-12-16
ER

PT J
AU Zanetta, DMT
   Strazza, L
   Azevedo, RS
   Carvalho, HB
   Massad, E
   Menezes, RX
   Ferreira, DP
   Burattini, MN
AF Zanetta, DMT
   Strazza, L
   Azevedo, RS
   Carvalho, HB
   Massad, E
   Menezes, RX
   Ferreira, DP
   Burattini, MN
TI HIV infection and related risk behaviours in a disadvantaged youth
   institution of Sao Paulo, Brazil
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Article
DE HIV; disadvantaged youth; seroepidemiology; risk behaviour; illicit drug
   use and sex behaviours
ID STREET YOUTH; SUBSTANCE USE; DRUG-USE; VIRUS-INFECTION; SEXUAL-BEHAVIOR;
   BELO-HORIZONTE; AIDS KNOWLEDGE; ADOLESCENTS; PREVENTION; PROFILE
AB Ln order to study the prevalence of HIV and related risky behaviours among disadvantaged youth, we interviewed and bled, between December 1994 and April 1995, 1122 young males and 93 young; females who were serving time in FEBEM, a state institution that cares for homeless and offender youth of Sao Paulo, Brazil. Our questionnaire covered the following areas: sexual practices and use of illicit drugs; knowledge of HIV and STDs and their prevention; and myths and beliefs about AIDS. Seroprevalence of HN was assessed and related with risk-taking behaviours by means of uni-, bi- and multivariate analysis. We found 2.6% of the males and 10.3% of the females to be positive to HIV. The prevalence of hepatitis C virus (HCV) antibodies resulted in 5.9% for males and 4.6% for females, respectively. The risk for parenterally transmitted HIV among the males was higher than that for sexually related transmission. The inverse relationship was found among the females.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Zanetta, Dirce M T/G-4950-2013; Massad, Eduardo/H-6143-2011; Carvalho,
   Heraclito/C-1334-2012; Massad, Eduardo/B-1169-2012; Burattini, Marcelo
   N/J-9272-2014; Azevedo, Raymundo S/B-7593-2008
OI Carvalho, Heraclito/0000-0002-7037-5655; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890;
   Azevedo, Raymundo S/0000-0003-0660-2371
CR ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3
   Bodsworth NJ, 1996, GENITOURIN MED, V72, P118
   CAMPOS R, 1994, CHILD DEV, V65, P319
   Clements K, 1997, J ADOLESCENT HEALTH, V20, P343, DOI 10.1016/S1054-139X(97)00033-5
   deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012
   Dukarm CP, 1996, ARCH PEDIAT ADOL MED, V150, P797, DOI 10.1001/archpedi.1996.02170330023004
   Earl Daniel Thad, 1995, Journal of the American Osteopathic Association, V95, P725
   EISENSTEIN E, 1993, J PAEDIATR CHILD H, V29, pS46, DOI 10.1111/j.1440-1754.1993.tb02261.x
   FENDRICH M, 1995, INT J ADDICT, V30, P1363, DOI 10.3109/10826089509055838
   FORD K, 1995, J ACQ IMMUN DEF SYND, V10, P569, DOI 10.1097/00042560-199510050-00011
   HEIN K, 1980, PEDIATRICS, V66, P239
   HENDEE WR, 1990, JAMA-J AM MED ASSOC, V263, P987
   Kandel DB, 1996, ARCH GEN PSYCHIAT, V53, P71
   Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1
   KIPKE MD, 1995, ARCH PEDIAT ADOL MED, V149, P513, DOI 10.1001/archpedi.1995.02170180043006
   KoniakGriffin D, 1995, NURS RES, V44, P340
   Kral AH, 1997, INT J STD AIDS, V8, P109, DOI 10.1258/0956462971919651
   LURIE P, 1995, AIDS, V9, pS31
   LYNSKEY MT, 1993, NEW ZEAL MED J, V106, P511
   MACDONALD NE, 1994, PEDIATR INFECT DIS J, V13, P690, DOI 10.1097/00006454-199408000-00003
   Metsch LR, 1995, J PSYCHOACTIVE DRUGS, V27, P435, DOI 10.1080/02791072.1995.10471707
   MILLSTEIN SG, 1995, J ADOLESCENT HEALTH, V17, P83, DOI 10.1016/1054-139X(95)00065-Z
   OH MK, 1994, SEX TRANSM DIS, V21, P127, DOI 10.1097/00007435-199405000-00001
   RAFFAELLI M, 1995, AIDS EDUC PREV, V7, P287
   ROTHERAMBORUS MJ, 1995, AIDS EDUC PREV, V7, P320
   Rozman M, 1998, INT J STD AIDS, V9, P183, DOI 10.1258/0956462981921855
   Sullivan TR, 1996, HEALTH SOC WORK, V21, P58, DOI 10.1093/hsw/21.1.58
   Suwanagool S, 1995, J Med Assoc Thai, V78, P355
   Tubman JG, 1996, J ADOLESCENT HEALTH, V18, P182, DOI 10.1016/1054-139X(95)00128-F
   *UNAIDS WHO WORK G, 1997, REP GLOB HIV AIDS EP
   WALSH A, 1995, SOC BIOL, V42, P95
   Yee BWK, 1995, HEALTH PSYCHOL, V14, P622, DOI 10.1037/0278-6133.14.7.622
NR 32
TC 21
Z9 25
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD FEB
PY 1999
VL 10
IS 2
BP 98
EP 104
DI 10.1258/0956462991913718
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 164TQ
UT WOS:000078480000005
PM 10215114
DA 2020-12-16
ER

PT J
AU Saldiva, SR
   Silveira, AS
   Philippi, ST
   Torres, DM
   Mangini, AC
   Dias, RMD
   da Silva, RM
   Buratini, MN
   Massad, E
AF Saldiva, SR
   Silveira, AS
   Philippi, ST
   Torres, DM
   Mangini, AC
   Dias, RMD
   da Silva, RM
   Buratini, MN
   Massad, E
TI Ascaris-Trichuris association and malnutrition in Brazilian children
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
ID PROTEIN-ENERGY MALNUTRITION; INFECTION; LUMBRICOIDES; TRICHIURA; GROWTH;
   ALBENDAZOLE; HOOKWORM; PREDISPOSITION; GUATEMALA; HISTORY
AB This work was designed to evaluate the role of intestinal parasites on nutritional status in three rural areas of Brazil. A total of 520 children aged 1-12 years were studied through a questionnaire concerning housing, socio-economic conditions and a 24-h food intake recall. Measurements of weight and height were also performed, and three stool samples were collected on consecutive days for parasitological analysis. Scores of the standard deviation (z-scores) for the weight-for-height and height-for-age were used to characterise the growth profile. A high prevalence of intestinal parasites was detected, with Giardia lamblia (44%), Endolimax nana (43%), Ascaris lumbricoides (41%) and Trichuris trichiura (40%) being the most prevalent. Eleven per cent of the children were classified as showing stunting. Inadequate daily caloric intake was observed in 78% of the population and the proportion of those with inadequate protein intake was 34%. Logistic regression analysis was employed for the multivariate study. Stunting was significantly associated with estimators of low economic income, inadequate protein intake and polyparasitism, especially the association between Ascaris lumbricoides and Trichuris trichiura.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, HCFMUSP, LIM01, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Publ Hlth, Sao Paulo, Brazil.
   Adolfo Lutz Inst, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; DIAS, ROGERIO/G-4022-2012; Philippi,
   Sonia/C-4895-2013; Saldiva, Silvia RDM/G-5859-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; 
CR ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165
   ANDERSON TJC, 1993, MEM I OSWALDO CRUZ, V88, P53, DOI 10.1590/S0074-02761993000100010
   [Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1
   [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929
   ARMITAGE P, 1994, STAT METHODS MED RES, pCH4
   BLOEMBERG BPM, 1989, AM J EPIDEMIOL, V130, P1047, DOI 10.1093/oxfordjournals.aje.a115405
   BLUMENTHAL DS, 1976, AM J TROP MED HYG, V25, P682, DOI 10.4269/ajtmh.1976.25.682
   BUNDY DAP, 1992, PARASITOLOGY, V104, pS105, DOI 10.1017/S0031182000075284
   BUZZARD IM, 1994, AM J CLIN NUTR, V59, p275S, DOI 10.1093/ajcn/59.1.275S
   CHAN L, 1994, PARASITOLOGY, V108, P77, DOI 10.1017/S0031182000078549
   CHAN L, 1994, T ROY SOC TROP MED H, V88, P46, DOI 10.1016/0035-9203(94)90492-8
   COOPER ES, 1990, EUR J CLIN NUTR, V44, P285
   COOPER ES, 1992, PARASITOLOGY, V104, pS91, DOI 10.1017/S0031182000075272
   CROMPTON DWT, 1992, T ROY SOC TROP MED H, V86, P577, DOI 10.1016/0035-9203(92)90133-W
   DIXON WJ, 1990, BMDP STAT SOFTWARE I
   FARTHING MJG, 1986, AM J CLIN NUTR, V43, P395
   FOO LC, 1990, TROP GEOGR MED, V42, P8
   GELTZ R, 1984, FOOD PROCESSOR NUTR
   GILMAN RH, 1983, T ROY SOC TROP MED H, V77, P432, DOI 10.1016/0035-9203(83)90103-7
   GUPTA MC, 1990, J TROP PEDIATRICS, V36, P189, DOI 10.1093/tropej/36.4.189
   GUPTA MC, 1977, LANCET, V2, P108
   HALL A, 1993, T ROY SOC TROP MED H, V87, P241, DOI 10.1016/0035-9203(93)90108-3
   HALL A, 1994, T ROY SOC TROP MED H, V88, P110, DOI 10.1016/0035-9203(94)90525-8
   HLAING T, 1993, PARASITOLOGY, V107, pS125, DOI 10.1017/S0031182000075557
   Hoffman W, 1934, PUERTO RICO J PUBLIC, V9, P281, DOI DOI 10.1590/S0037-86822012000300024
   Hosmer DW, 1989, APPL LOGISTIC REGRES
   Jellife DB, 1968, EVALUACION ESTADO NU
   Latham M C, 1984, Food Nutr (Roma), V10, P5
   LATHAM MC, 1982, T ROY SOC TROP MED H, V76, P734, DOI 10.1016/0035-9203(82)90093-1
   LUNN PG, 1993, P NUTR SOC, V52, P101, DOI 10.1079/PNS19930042
   LYTLE LA, 1993, J AM DIET ASSOC, V93, P1431, DOI 10.1016/0002-8223(93)92247-U
   *NATL CTR HLTH STA, 1976, MONTHL VIT STAT RE S, V25
   PRENTICE AM, 1988, LANCET, V2, P1066
   SALEM G, 1994, REV EPIDEMIOL SANTE, V42, P322
   *SCI COORD CTR PAR, 1992, PARTN CHILD DEV INT
   STEPHENSON LS, 1993, J NUTR, V123, P656
   STEPHENSON LS, 1993, J NUTR, V123, P1036
   THEINHLAING, 1991, T ROY SOC TROP MED H, V85, P523, DOI 10.1016/0035-9203(91)90242-Q
   WAKELIN D, 1986, T ROY SOC TROP MED H, V80, P742, DOI 10.1016/0035-9203(86)90373-1
   WALKERSMITH JA, 1986, DIARRHEA MALNUTRITIO
NR 40
TC 42
Z9 51
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD JAN
PY 1999
VL 13
IS 1
BP 89
EP 98
PG 10
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA 159RV
UT WOS:000078188800013
PM 9987788
DA 2020-12-16
ER

PT J
AU Cox, MJ
   James, VLA
   Azevedo, RS
   Massad, E
   Medley, GF
AF Cox, MJ
   James, VLA
   Azevedo, RS
   Massad, E
   Medley, GF
TI Infection with group C rotavirus in a suburban community in Brazil
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE rotavirus; seroepidemiology; transmission; population; Brazil
ID MONOCLONAL-ANTIBODIES; FAMILY OUTBREAK; GROUP-A; SEROEPIDEMIOLOGY;
   GASTROENTERITIS; EPIDEMIOLOGY; CHILDREN; SEQUENCE; EFFICACY; VACCINE
AB Group C rotaviruses are associated with sporadic outbreaks of gastroenteritis worldwide. Age-specific seroprevalence of group C rotavirus antibodies was investigated in sera, randomly collected and representative of a suburban community in Brazil which had previously been screened for group A rotavirus antibodies. Antibody prevalence to group C rotavirus was low in children under 5 years and increased slowly with age to 36% seropositivity in adults, reflecting continuous exposure to primary infection in all age groups. This suggests a higher incidence of infection than disease might predict. Adult antibody prevalence tvas similar to that in other geographical settings. No obvious patterns of infection with group A and group C rotavirus were found within individuals, which suggests independent transmission. However, further epidemiological studies are required to understand group C rotavirus dynamics and possible interactions with group A rotavirus transmission and immunity.
C1 Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
   Southampton Gen Hosp, Publ Hlth Lab, Southampton, Hants, England.
   Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   LIM01 HCFMUSP, Sao Paulo, Brazil.
RP Cox, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
EM cox@oikos.warwick.ac.uk
RI Massad, Eduardo/H-6143-2011; Medley, Graham/B-7289-2008; Massad,
   Eduardo/B-1169-2012; Azevedo, Raymundo S/B-7593-2008
OI Medley, Graham/0000-0002-0030-7278; Massad, Eduardo/0000-0002-7200-2916;
   Azevedo, Raymundo S/0000-0003-0660-2371
CR BROWN DWG, 1988, J CLIN MICROBIOL, V26, P2410, DOI 10.1128/JCM.26.11.2410-2414.1988
   Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104
   CAUL EO, 1990, J MED VIROL, V30, P201, DOI 10.1002/jmv.1890300311
   Cox MJ, 1998, EPIDEMIOL INFECT, V120, P327, DOI 10.1017/S0950268898008759
   FIELDING PA, 1994, VIROLOGY, V204, P442, DOI 10.1006/viro.1994.1551
   GABBAY YB, 1989, MEM I OSWALDO CRUZ, V84, P5, DOI 10.1590/S0074-02761989000100002
   ISHIMARU Y, 1990, Acta Paediatrica Japonica, V32, P523
   James VLA, 1997, J MED VIROL, V52, P86, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;86::AID-JMV14&gt;3.0.CO;2-Z
   Jiang B, 1996, ARCH VIROL, V141, P381, DOI 10.1007/BF01718407
   JIANG BM, 1992, VIROLOGY, V190, P542, DOI 10.1016/0042-6822(92)91250-X
   Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0
   Kapikian A. Z., 1996, FIELDS VIROLOGY, V2, P1657
   Kuzuya M, 1998, J CLIN MICROBIOL, V36, P6, DOI 10.1128/JCM.36.1.6-10.1998
   MAUNULA L, 1992, ARCH VIROL, V124, P269, DOI 10.1007/BF01309808
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   OISHI I, 1993, MICROBIOL IMMUNOL, V37, P505, DOI 10.1111/j.1348-0421.1993.tb03243.x
   Pereira H G, 1983, Mem Inst Oswaldo Cruz, V78, P245
   PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701
   Rennels MB, 1996, PEDIATRICS, V97, P7
   RiepenhoffTalty M, 1997, J CLIN MICROBIOL, V35, P486, DOI 10.1128/JCM.35.2.486-488.1997
   TSUNEMITSU H, 1992, VIROLOGY, V191, P272, DOI 10.1016/0042-6822(92)90189-V
   TSUNEMITSU H, 1992, J CLIN MICROBIOL, V30, P2129, DOI 10.1128/JCM.30.8.2129-2134.1992
   White LJ, 1998, IMA J MATH APPL MED, V15, P211
NR 23
TC 11
Z9 12
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD NOV
PY 1998
VL 3
IS 11
BP 891
EP 895
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 147MH
UT WOS:000077571000009
PM 9855402
DA 2020-12-16
ER

PT J
AU Burattini, MN
   Massad, E
   Coutinho, FAB
   Azevedo-Neto, RS
   Menezes, RX
   Lopes, LF
AF Burattini, MN
   Massad, E
   Coutinho, FAB
   Azevedo-Neto, RS
   Menezes, RX
   Lopes, LF
TI A mathematical model of the impact of crack-cocaine use on the
   prevalence of HIV/AIDS among drug users
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
DE crack-cocaine; HIV/AIDS; mathematical modelling; nonlinear system
   dynamics
ID SAO-PAULO; VACCINATION STRATEGY; EPIDEMIC; RUBELLA; BRAZIL; ABUSE; HIV
AB We propose a dynamic model to study the impact of the introduction of crack-cocaine among illicit drug users, considering the population divided into susceptible to drug use, crack-cocaine users, intravenous drug users, and users of both types of drugs. With respect to HIV infection status each one of these classes can, in turn, be susceptible to or infected with HIV or have already developed full-blown AIDS. Simulations were performed considering different transmission intensities for both parenterally and sexually transmitted HN in each class of drug use. Differential mortality rates for each class of drug use and of HIV infection status was also considered. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
RP Burattini, MN (corresponding author), Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM mnburatt@usp.br
RI Lopes, Luis Felipe Dias/I-5809-2012; Azevedo, Raymundo S/B-7593-2008;
   Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Coutinho, Francisco A B/H-5644-2011
OI Lopes, Luis Felipe Dias/0000-0002-2438-0226; Azevedo, Raymundo
   S/0000-0003-0660-2371; Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A B/0000-0003-3127-3071
CR ANDERSON R M, 1991
   Blank-Reid C, 1996, J Neurosci Nurs, V28, P19
   Cornish JW, 1996, ANNU REV PUBL HEALTH, V17, P259
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   HUNTER GM, 1995, ADDICTION, V90, P1397, DOI 10.1046/j.1360-0443.1995.9010139711.x
   Kandel DB, 1996, ARCH GEN PSYCHIAT, V53, P71
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   MASSAD E, 1989, MATH COMPUT MODEL, V12, P89, DOI 10.1016/0895-7177(89)90448-2
   Massad E, 1996, M D COMPUT, V13, P147
   *MIN HLTH BRAZ NAT, 1997, AIDS EP B YEAR 10
   *MMWR, 1996, MMWR-MORBID MORTAL W, V45, P151
   Mollison D, 1995, EPIDEMIC MODELS THEI
   Nappo SA, 1996, SUBST USE MISUSE, V31, P565, DOI 10.3109/10826089609045827
   *UNAIDS WHO WORK G, 1997, REP GLOB HIV AIDS EP
   Weissman G, 1995, J PSYCHOACTIVE DRUGS, V27, P401, DOI 10.1080/02791072.1995.10471704
NR 17
TC 11
Z9 11
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-7177
EI 1872-9479
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PD AUG
PY 1998
VL 28
IS 3
BP 21
EP 29
DI 10.1016/S0895-7177(98)00095-8
PG 9
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 116GY
UT WOS:000075717200003
DA 2020-12-16
ER

PT J
AU Cox, MJ
   Azevedo, RS
   Cane, PA
   Massad, E
   Medley, GF
AF Cox, MJ
   Azevedo, RS
   Cane, PA
   Massad, E
   Medley, GF
TI Seroepidemiological study of respiratory syncytial virus in Sao Paulo
   State, Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE epidemiology; transmission; infection; antibody; seasonality; ELISA
ID PRIMARY INFECTION; SERUM ANTIBODY; EPIDEMIOLOGY; CHILDREN; WASHINGTON;
   INFANTS; RISK; AGE
AB Transmission of respiratory syncytial virus is thought to be highly seasonal based on reported clinical cases, although transmission resulting in mild disease in all age groups has been little studied. This has been investigated in a seroepidemiological survey using sera from Sao Paulo, Brazil. Seroprevalence was found to increase rapidly with age, reaching over 90% by three years of age. This is typical of viral infections, which produce life-long immunity following primary infection. One-hundred percent seropositivity was attained by five years of age and maintained throughout adulthood, whereas mean antibody titers continued to increase with age. The mean duration of maternal antibodies was estimated to be 3.3 months with antibody decay demonstrated in paired samples from infants. The results are discussed in relation to possible mechanisms generating such a profile. (C) 1998 Wiley-Liss, Inc.
C1 Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
   Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   HCFMUSP, Sao Paulo, Brazil.
   Univ Birmingham, Sch Med, Dept Infect, Birmingham, W Midlands, England.
RP Cox, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
EM cox@oikos.warwick.ac.uk
RI Massad, Eduardo/B-1169-2012; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/H-6143-2011; Medley, Graham/B-7289-2008
OI Massad, Eduardo/0000-0002-7200-2916; Azevedo, Raymundo
   S/0000-0003-0660-2371; Medley, Graham/0000-0002-0030-7278
FU Wellcome TrustWellcome Trust Funding Source: Medline
CR ANDERSON LJ, 1995, J INFECT DIS, V171, P1, DOI 10.1093/infdis/171.1.1
   ANDERSON R M, 1991
   Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y
   BRANDT CD, 1973, AM J EPIDEMIOL, V98, P355, DOI 10.1093/oxfordjournals.aje.a121565
   BRUSSOW H, 1991, J INFECT DIS, V163, P679, DOI 10.1093/infdis/163.3.679a
   Cane PA, 1996, J MED VIROL, V48, P253, DOI 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7
   CANE PA, 1991, J GEN VIROL, V72, P349, DOI 10.1099/0022-1317-72-2-349
   CANE PA, 1994, J CLIN MICROBIOL, V32, P1
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   Collins P.L., 1996, FIELDS VIROLOGY, P1313
   COX MJ, 1989, EPIDEMIOL INFECT, V102, P147, DOI 10.1017/S0950268800029770
   GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026
   HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826
   JOHNSON KM, 1961, JAMA-J AM MED ASSOC, V176, P663
   KIM HW, 1973, AM J EPIDEMIOL, V98, P216, DOI 10.1093/oxfordjournals.aje.a121550
   KOHLER PF, 1966, NATURE, V210, P1070, DOI 10.1038/2101070a0
   MUFSON MA, 1973, AM J EPIDEMIOL, V98, P88, DOI 10.1093/oxfordjournals.aje.a121542
   MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986
   NASCIMENTO JP, 1991, REV I MED TROP, V33, P287, DOI 10.1590/S0036-46651991000400008
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   NOKES DJ, 1986, J HYG-CAMBRIDGE, V96, P291, DOI 10.1017/S0022172400066067
   Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976
   WHITE L, 1998, IN PRESS J MATH APPL
   WINTER GF, 1987, J INFECTION, V15, P103, DOI 10.1016/S0163-4453(87)91651-3
NR 24
TC 30
Z9 32
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUL
PY 1998
VL 55
IS 3
BP 234
EP 239
DI 10.1002/(SICI)1096-9071(199807)55:3<234::AID-JMV9>3.0.CO;2-2
PG 6
WC Virology
SC Virology
GA ZR677
UT WOS:000074002700009
PM 9624612
DA 2020-12-16
ER

PT J
AU Massad, E
   Forattini, OP
AF Massad, E
   Forattini, OP
TI Modelling the temperature sensitivity of some physiological parameters
   of epidemiologic significance
SO ECOSYSTEM HEALTH
LA English
DT Article
ID CLIMATE-CHANGE; TRANSMISSION
AB Anthropogenic emissions of greenhouse gases are enhancing the natural greenhouse effect. It is almost universally accepted that this will lead to a warming of the earth's surface. It is also accepted that this warming will lead to a spread of the insects that transmit several infections, currently restricted to the tropics, such as malaria, leishmaniasis, yellow fever, and dengue fever, among others. We calculated the expected increase in the density of female adult forms of anopheline mosquitoes by assuming temperature-dependent functions on the rates of the mosquitoes life cycles. Other mosquito characteristics, such as the feeding interval, were also calculated as functions of environmental temperature. The resultant increase in the density of adult females as a function of the increase in temperature was related to an increase in malaria risk by the calculations of the basic reproductive ratio and the vectorial capacity, which permitted the application of the mathematical model for malarial transmission.
C1 Univ Sao Paulo, Sch Med, Discipline Med Informat, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, NUPTEM, Sao Paulo, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Discipline Med Informat, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
EM edmassad@usp.br
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ANDERSON R M, 1991
   Bates M, 1949, NATURAL HIST MOSQUIT
   Bates Marston, 1947, ANN ENT SOC AMERICA, V40, P1, DOI 10.1093/aesa/40.1.1
   Bishopp FC, 1915, J ECON ENTOMOL, V8, P54, DOI 10.1093/jee/8.1.54
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   Carpenter S.J., 1955, MOSQUITOES N AM
   DOBSON A, 1993, LANCET, V342, P1096, DOI 10.1016/0140-6736(93)92069-6
   DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245
   ENNIS CA, 1996, BIOL CONSEQUENCES GL
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   GILL C. A., 1921, Indian Journal of Medical Research, V8, P633
   Hasselmann K, 1997, SCIENCE, V276, P914, DOI 10.1126/science.276.5314.914
   Hay SI, 1996, ANN TROP MED PARASIT, V90, P1
   Houghton J.T., 1996, CLIMATE CHANGE 1995
   Karlen A., 1995, MAN MICROBES DIS PLA
   KAUPPI PE, 1995, SCIENCE, V270, P1454, DOI 10.1126/science.270.5241.1454
   Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584
   MAYNE B, 1926, REPORTS US PUBLIC HL, V41, P986
   MITCHELL JFB, 1990, INTERGOVERNMENTAL PA, P131
   Molineaux L, 1980, THE GARKI PROJECT
   PATZ J, 1996, P EC SUMM COP 1996, P41
   PROCHNOW O, 1908, THESIS BERLIN U
   Prochnow Oskar, 1907, Entomologische Zeitschrift Guben, V20
   RALISOA O, 1992, PARASITOLOGIA, V33, P219
   REEVES WC, 1994, J MED ENTOMOL, V31, P323, DOI 10.1093/jmedent/31.3.323
   ROGERS DJ, 1993, LANCET, V342, P1282, DOI 10.1016/0140-6736(93)92367-3
   ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0
   Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007
   ROSS R, 1908, REPORT PREVENTION MA
   Ross R., 1911, PREVENTION MALARIA
   Russell Paul F., 1942, AMER JOUR TROP MED, V22, P517
   SCHUBERT W, 1928, Z AGEW ENTOMOLOGIE, V13, P129
   Singer SF, 1996, SCIENCE, V271, P581, DOI 10.1126/science.271.5249.581
   STONE R, 1995, SCIENCE, V267, P957, DOI 10.1126/science.7863337
   STRATMAN-THOMAS WARREN K., 1940, AMER JOUR TROP MED, V20, P703
   THOMSON R. C. M., 1940, Journal of the Malaria Institute of India, V3, P323
   UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1
NR 39
TC 13
Z9 14
U1 0
U2 9
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1076-2825
J9 ECOSYST HEALTH
JI Ecosyst. Health
PD JUN
PY 1998
VL 4
IS 2
BP 119
EP 129
DI 10.1046/j.1526-0992.1998.00079.x
PG 11
WC Ecology; Environmental Studies
SC Environmental Sciences & Ecology
GA ZX387
UT WOS:000074510600006
DA 2020-12-16
ER

PT J
AU Cox, MJ
   Azevedo, RS
   Nokes, DJ
   Beards, GM
   McCrae, MA
   Massad, E
   Medley, GF
AF Cox, MJ
   Azevedo, RS
   Nokes, DJ
   Beards, GM
   McCrae, MA
   Massad, E
   Medley, GF
TI Seroepidemiology of group A rotavirus in suburban Sao Paulo, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID DIFFERENT AGE-GROUPS; INFECTION; ANTIBODY; CHILDREN; PREVALENCE;
   INFANTS; SERUM; GASTROENTERITIS; POPULATION; DIARRHEA
AB Age-specific patterns of rotavirus infection were investigated using a randomly selected and representative sample of sera from a suburban community of Sao Paulo, Brazil screened for class-specific antibodies to group A rotavirus. Age-serology of anti-rotavirus IgG showed primary infection predominant in young infants with a median age of around 18 months consistent with IgM serology suggesting highest rates of recent infection between ages 4 and 48 months. Anti-rotavirus serum IgA prevalence increased gradually with age. Paired samples from infants, collected 1 month apart, indicated high exposure rates with seroconversion occurring in several infants during the reported low transmission season. Between 5 and 10% of adults had elevated IgM levels indicative of recent infection and, potentially, of an important contribution adults may play to rotavirus transmission. Further understanding of the dynamics of rotavirus transmission within populations, at group and serotype level, would benefit the design and monitoring of future immunization programmes.
C1 Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
   Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   HCFMUSP, LIM01, Sao Paulo, Brazil.
   Birmingham Heartlands & Solihull NHS Trust, Publ Hlth Lab, Heartlands Hosp, Birmingham B9 5SS, W Midlands, England.
RP Cox, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
RI Azevedo, Raymundo S/B-7593-2008; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Medley, Graham/B-7289-2008
OI Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Medley, Graham/0000-0002-0030-7278; Beards,
   Graham/0000-0002-9928-1302
CR ANDERSON R M, 1991
   Andrade GP, 1996, J MED VIROL, V49, P212, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;212::AID-JMV9&gt;3.0.CO;2-7
   [Anonymous], 1997, Wkly Epidemiol Rec, V72, P35
   Beards G, 1995, J DIARRHOEAL DIS RES, V13, P235
   BEARDS GM, 1989, J VIROL METHODS, V24, P103, DOI 10.1016/0166-0934(89)90012-8
   BRUSSOW H, 1990, J INFECT DIS, V162, P615, DOI 10.1093/infdis/162.3.615
   BRUSSOW H, 1988, J INFECT DIS, V157, P1014, DOI 10.1093/infdis/157.5.1014
   CANDEIAS J A N, 1989, Journal of Diarrhoeal Diseases Research, V7, P24
   CHRYSTIE IL, 1978, LANCET, V1, P1176
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   COULSON BS, 1990, J CLIN MICROBIOL, V28, P1367, DOI 10.1128/JCM.28.6.1367-1374.1990
   COX MJ, 1989, EPIDEMIOL INFECT, V102, P147, DOI 10.1017/S0950268800029770
   DAVIDSON GP, 1983, INFECT IMMUN, V40, P447, DOI 10.1128/IAI.40.2.447-452.1983
   ELIAS MM, 1977, J HYG-CAMBRIDGE, V79, P365, DOI 10.1017/S0022172400053201
   GLASS RI, 1994, SCIENCE, V265, P1389, DOI 10.1126/science.8073280
   GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1408, DOI 10.1128/JCM.32.5.1408-1409.1994
   GRIMWOOD K, 1988, J CLIN MICROBIOL, V26, P732, DOI 10.1128/JCM.26.4.732-738.1988
   Heath RR, 1997, J GEN VIROL, V78, P1065, DOI 10.1099/0022-1317-78-5-1065
   JESUDOSS ES, 1978, INDIAN J MED RES, V68, P383
   KAPIKIAN AZ, 1996, FIELDS VIROLOGY, pCH55
   KIM HW, 1977, JAMA-J AM MED ASSOC, V238, P404, DOI 10.1001/jama.238.5.404
   MATSON DO, 1994, J VIROL METHODS, V48, P293, DOI 10.1016/0166-0934(94)90128-7
   MEHNERT DU, 1993, APPL ENVIRON MICROB, V59, P140, DOI 10.1128/AEM.59.1.140-143.1993
   MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   NOKES DJ, 1986, J HYG-CAMBRIDGE, V96, P291, DOI 10.1017/S0022172400066067
   OFFIT PA, 1989, J VIROL, V63, P3507, DOI 10.1128/JVI.63.8.3507-3512.1989
   OFFIT PA, 1994, ADV VIRUS RES, V44, P161, DOI 10.1016/S0065-3527(08)60329-2
   Omoigberale AI, 1996, E AFR MED J, V73, P688
   Ramachandran M, 1996, J CLIN MICROBIOL, V34, P436, DOI 10.1128/JCM.34.2.436-439.1996
   Ryan MJ, 1996, J INFECT DIS, V174, pS12, DOI 10.1093/infdis/174.Supplement_1.S12
   SACK DA, 1980, J CLIN MICROBIOL, V11, P530, DOI 10.1128/JCM.11.5.530-532.1980
   STEWIEN KE, 1993, J DIARRHOEAL DIS RES, V11, P148
   STIEHM ER, 1966, PEDIATRICS, V37, P715
   URASAWA S, 1984, ARCH VIROL, V81, P1, DOI 10.1007/BF01309292
   WHITE L, IN PRESS IMA J MATH
NR 36
TC 9
Z9 11
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUN
PY 1998
VL 120
IS 3
BP 327
EP 334
DI 10.1017/S0950268898008759
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 104QJ
UT WOS:000075025000016
PM 9692612
OA Green Published
DA 2020-12-16
ER

PT J
AU Forattini, OP
   Massad, E
AF Forattini, OP
   Massad, E
TI Culicidae vectors and anthropic changes in a Southern Brazil natural
   ecosystem
SO ECOSYSTEM HEALTH
LA English
DT Article
ID MOSQUITOS DIPTERA; EASTERN BRAZIL; IRRIGATION DEVELOPMENT; MAHAWELI
   PROJECT; ADULT BEHAVIOR; SRI-LANKA; ENVIRONMENT; CULEX
AB The influences of human-caused changes in a natural ecosystem of Southern Brazil on mosquitoes of the family Culicidae, which may be vectors of diseases, were investigated. Particular attention was given to the effects of deforestation and human settlements with artificial irrigation. The work assumes a preserved environment as representative of the natural ecosystem before human intervention. Another collection site, 50 kilometers from the primitive forest, that presented the same fauna and flora of the former some 50 years ago was chosen as the modified environment. The results clearly showed that some species, such as the Kerteszia subgenus, do not survive these changes, whereas others have found such conditions favorable and have proliferated.
C1 Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, NUPTEM,Inst, BR-01246903 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Med, Discipline Med Informat, BR-01246903 Sao Paulo, Brazil.
RP Forattini, OP (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, NUPTEM,Inst, Av Dr Arnaldo 715 & 455, BR-01246903 Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR AMERASINGHE FP, 1991, J MED ENTOMOL, V28, P387, DOI 10.1093/jmedent/28.3.387
   AMERASINGHE FP, 1990, J MED ENTOMOL, V27, P789, DOI 10.1093/jmedent/27.5.789
   BIGARELLA J.J., 1978, SERRA MAR PORCAO ORI
   CALISHER CH, 1982, AM J TROP MED HYG, V31, P1260, DOI 10.4269/ajtmh.1982.31.1260
   CALISHER CH, 1983, AM J TROP MED HYG, V32, P424, DOI 10.4269/ajtmh.1983.32.424
   Clements AN, 1992, BIOL MOSQUITOES, V1
   Consolim J., 1979, Arquivos de Biologia e Tecnologia (Curitiba), V22, P173
   Detinova TS, 1962, WHO MONOGR SER, V47, P1
   Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   Forattini O. P., 1962, ENTOMOLOGIA MED, V1
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P20, DOI 10.1590/S0034-89101995000100005
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P271, DOI 10.1590/S0034-89101995000400003
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P100, DOI 10.1590/S0034-89101995000200003
   HADDOW A. J., 1960, BULL ENT RES, V50, P759, DOI 10.1017/S000748530005478X
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199, DOI 10.1017/S0007485300026900
   Kronka FJN, 1993, INVENTARIO FLORESTAL
   LACEY LA, 1990, J AM MOSQUITO CON S2, V6, P1038
   LAMBERTI A, 1969, FAC FIL CIENC LETR U, V317
   LEPSCH F, 1990, MACROZOCAMENTO TERRA
   MITCHELL CJ, 1984, J MED ENTOMOL, V21, P34, DOI 10.1093/jmedent/21.1.34
   MITCHELL CJ, 1986, REV SAUDE PUBL, V20, P171, DOI 10.1590/S0034-89101986000300001
   NIELSEN E, 1963, OIKOS, V14, P9, DOI 10.2307/3564956
   NIELSEN ET, 1961, NATURE, V190, P878, DOI 10.1038/190878a0
   NUORTEVA PEKKA, 1963, ANN ENTOMOL FENNICA, V29, P1
   POVOLNY D, 1971, FLIES DIS
   REINERT J F, 1991, Mosquito Systematics, V23, P209
   REINERT J F, 1975, Mosquito Systematics, V7, P105
   REINERT J F, 1982, Mosquito Systematics, V14, P124
   RIBEIRO H, 1990, Bulletin of the Society for Vector Ecology, V15, P185
   Rizzini C. T., 1976, TRATADO FITOGEOGRAFI
   SCHIAVI A, 1945, ARQUIV HIG SAUDE PUB, V10, P60
   Service M.W, 1993, MOSQUITO ECOLOGY FIE
   SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002
   WALTER H, 1984, ECOLOGICAL SYSTEMS G
NR 36
TC 12
Z9 14
U1 1
U2 3
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1076-2825
J9 ECOSYST HEALTH
JI Ecosyst. Health
PD MAR
PY 1998
VL 4
IS 1
BP 9
EP 19
DI 10.1046/j.1526-0992.1998.00067.x
PG 11
WC Ecology; Environmental Studies
SC Environmental Sciences & Ecology
GA ZW241
UT WOS:000074389800004
DA 2020-12-16
ER

PT J
AU Rozman, M
   Massad, E
   Silveira, ASB
   Azevedo-Neto, RS
   Takey, K
   Yamamoto, YI
   Strazza, L
   Meneghin, P
   Ferreira, MMC
   Carvalho, HB
   Buchalla, CM
   Schechtman, M
   Burattini, M
AF Rozman, M
   Massad, E
   Silveira, ASB
   Azevedo-Neto, RS
   Takey, K
   Yamamoto, YI
   Strazza, L
   Meneghin, P
   Ferreira, MMC
   Carvalho, HB
   Buchalla, CM
   Schechtman, M
   Burattini, M
TI HIV/AIDS in a Brazilian prison
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Letter
C1 Univ Sao Paulo, NUPAIDS, BR-01246903 Sao Paulo, Brazil.
RP Rozman, M (corresponding author), Univ Sao Paulo, NUPAIDS, Ave Doutor Arnaldo 455, BR-01246903 Sao Paulo, Brazil.
RI Buchalla, Cassia Maria/D-3169-2013; Azevedo, Raymundo S/B-7593-2008;
   Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012; Carvalho, Heraclito/C-1334-2012
OI Azevedo, Raymundo S/0000-0003-0660-2371; Burattini, Marcelo
   N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916; Carvalho,
   Heraclito/0000-0002-7037-5655; Buchalla, Cassia
   Maria/0000-0001-5169-5533
CR CARVALHO HB, 1996, 11 INT C AIDS, V2, P454
   Carvalho Heraclito Barbosa De, 1996, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V12, P84
   LORENCO R, 1992, THESIS ESCOLA PAULIS
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MASSAD E, 1996, 11 INT C AIDS, V2, P461
   PEIXINHO ZF, 1990, NAT IMMUN CELL GROW, V9, P133
   ROZMAN MA, 1996, 7 INT C INF DIS, P12
NR 7
TC 7
Z9 9
U1 0
U2 3
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND
SN 0956-4624
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD MAR
PY 1998
VL 9
IS 3
BP 183
EP 184
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA YZ553
UT WOS:000072265600016
PM 9530910
DA 2020-12-16
ER

PT J
AU Cox, MJ
   Azevedo, RS
   Massad, E
   Fooks, AR
   Nokes, DJ
AF Cox, MJ
   Azevedo, RS
   Massad, E
   Fooks, AR
   Nokes, DJ
TI Measles antibody levels in a vaccinated population in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE measles; immunization; seroprevalence; Brazil
ID SAO-PAULO; ENZYME IMMUNOASSAYS; NEUTRALIZATION TEST; VIRUS; IMMUNITY;
   RUBELLA; NUCLEOPROTEIN; EXPRESSION; CHILDREN; PROTEIN
AB An epidemiological study of measles-specific immunoglobulin G antibody levels was conducted using a representative sample of a vaccinated suburban population in Sao Paulo State, Brazil. The study aimed to determine immunity status in relation to age and infection or vaccination experience. 549 age-structured samples of sera, collected in 1990, were screened and calibrated to the international reference serum, using measles nucleoprotein in an enzyme immunoassay. In the age group with direct experience of vaccination (9 months to 15 years), whether routine or campaign, over 90% had detectable antibody greater than or equal to 50 miu/mL. However, 14% of these had antibody concentrations between 50 and 100 miu/mL and 30% between 50 and 255 miu/mL. In those over 15 years of age, 94% had antibody levels >255 miu/mL, assumed to be the result of past infection. The study suggested that, within highly vaccinated populations, a proportion of individuals had measles antibody levels which may be insufficient to protect against reinfection or clinical disease. The implications of these results, and similar findings elsewhere, in relation to the persistence of measles requires investigation; this has particular relevance in Sao Paulo following the recent measles outbreak.
C1 Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
   Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   HCF MUSP, LIM01, Sao Paulo, Brazil.
   Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England.
RP Cox, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
RI Massad, Eduardo/B-1169-2012; Azevedo, Raymundo S/B-7593-2008; Fooks,
   Anthony R/F-5418-2010; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; Azevedo, Raymundo
   S/0000-0003-0660-2371; 
CR ALBRECHT P, 1981, J VIROL METHODS, V3, P251, DOI 10.1016/0166-0934(81)90062-8
   ANDERSON R M, 1991
   BABAD HR, 1995, EPIDEMIOL INFECT, V114, P319, DOI 10.1017/S0950268800057976
   Calvert N, 1996, EPIDEMIOL INFECT, V116, P65, DOI 10.1017/S0950268800058969
   CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036
   CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   ERDMAN DD, 1991, J CLIN MICROBIOL, V29, P1466, DOI 10.1128/JCM.29.7.1466-1471.1991
   FOOKS AR, 1993, J GEN VIROL, V74, P1439, DOI 10.1099/0022-1317-74-7-1439
   FORSEY T, 1991, BIOLOGICALS, V19, P237, DOI 10.1016/1045-1056(91)90042-I
   Gay N, 1997, Commun Dis Rep CDR Rev, V7, pR21
   Gay N, 1997, Commun Dis Rep CDR Rev, V7, pR17
   HUMMEL KB, 1992, J CLIN MICROBIOL, V30, P2874, DOI 10.1128/JCM.30.11.2874-2880.1992
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   Miller E, 1997, Commun Dis Rep CDR Rev, V7, pR26
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   NORRBY E, 1962, P SOC EXP BIOL MED, V111, P814, DOI 10.3181/00379727-111-27930
   PANNUTI CS, 1991, B WORLD HEALTH ORGAN, V69, P557
   PEDERSEN IR, 1989, VACCINE, V7, P345, DOI 10.1016/0264-410X(89)90199-0
   Ratnam S, 1996, CAN J PUBLIC HEALTH, V87, P407
   RATNAM S, 1995, J CLIN MICROBIOL, V33, P811, DOI 10.1128/JCM.33.4.811-815.1995
   SAMB B, 1995, PEDIATR INFECT DIS J, V14, P203, DOI 10.1097/00006454-199503000-00007
   Sokal R. R, 1981, BIOMETRY
   Ukkonen P, 1996, SCAND J INFECT DIS, V28, P31, DOI 10.3109/00365549609027146
   WARNES A, 1994, J VIROL METHODS, V49, P257, DOI 10.1016/0166-0934(94)90141-4
NR 25
TC 13
Z9 14
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR-APR
PY 1998
VL 92
IS 2
BP 227
EP 230
DI 10.1016/S0035-9203(98)90760-X
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ZN081
UT WOS:000073606800030
PM 9764341
DA 2020-12-16
ER

PT J
AU Halloran, ME
   Anderson, RM
   Azevedo-Neto, RS
   Bellini, WJ
   Branch, O
   Burke, MA
   Compans, R
   Day, K
   Gooding, L
   Gupta, S
   Katz, J
   Kew, O
   Keyserling, H
   Krause, R
   Lal, AA
   Massad, E
   McLean, AR
   Rosa, P
   Rota, P
   Wiener, P
   Wynn, SG
   Zanetta, DMT
AF Halloran, ME
   Anderson, RM
   Azevedo-Neto, RS
   Bellini, WJ
   Branch, O
   Burke, MA
   Compans, R
   Day, K
   Gooding, L
   Gupta, S
   Katz, J
   Kew, O
   Keyserling, H
   Krause, R
   Lal, AA
   Massad, E
   McLean, AR
   Rosa, P
   Rota, P
   Wiener, P
   Wynn, SG
   Zanetta, DMT
TI Population biology, evolution, and immunology of vaccination and
   vaccination programs
SO AMERICAN JOURNAL OF THE MEDICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT Workshop on Population Biology, Evolution, and Control of Infectious
   Diseases
CY FEB 22-23, 1995
CL EMORY UNIV, ATLANTA, GA
HO EMORY UNIV
DE immunology; modeling; populations; vaccines
ID MEASLES-VIRUS; TRANSMISSION DYNAMICS; SEVERE MALARIA; CHOLERA-TOXIN;
   B-SUBUNIT; SAO-PAULO; WILD-TYPE; INFECTION; IMMUNITY; VACCINES
AB The purpose of prophylactic vaccination is to reduce morbidity and mortality in a population. Many questions related to the design of vaccines and vaccination programs require a population standpoint for their sharp formulation and laboratory and field studies to understand their immunologic background. Practical suggestions of the workshop included increased studies of age-specific immunity, better immunoepidemiologic surveillance, better design of efficacy studies, and more systematic sampling of parasite strains to study the evolutionary pressure exerted by vaccines. Theoretical immunology has much to contribute. One of the realizations of the workshop was the value of a strong interdisciplinary approach in vaccine development, utilizing relevant contributions from immunology, population biology, mathematical modeling, epidemiology, molecular biology, and virology.
C1 Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA.
   Emory Univ, Sch Med, Atlanta, GA 30322 USA.
   Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   Univ Sao Paulo, Sch Med, Dept Pathol, Discipline Med Informat, BR-05508 Sao Paulo, Brazil.
   Ctr Dis Control, Atlanta, GA 30333 USA.
   Fogarty Inst, Bethesda, MD USA.
   NIAID, Rocky Mt Labs, Hamilton, MT 59840 USA.
RP Halloran, ME (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.
RI Compans, Richard/I-4087-2013; Day, Karen/F-3697-2015; Massad,
   Eduardo/H-6143-2011; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/B-1169-2012; Zanetta, Dirce M T/G-4950-2013
OI Compans, Richard/0000-0003-2360-335X; Day, Karen/0000-0002-6115-6135;
   Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Anderson, Roy/0000-0002-9528-3175
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32-AI07442, R01-AI32042, R29-AI3105]
   Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI032042, T32AI007442, T32AI007442,
   R01AI032042, T32AI007442, R01AI032042, R01AI032042, T32AI007442,
   R01AI032042, R01AI032042, R01AI032042, T32AI007442, R01AI032042,
   R01AI032042, T32AI007442, T32AI007442, T32AI007442, T32AI007442,
   R01AI032042, R01AI032042, R01AI032042, R01AI032042, R01AI032042,
   R01AI032042, R01AI032042, T32AI007442, R01AI032042] Funding Source: NIH
   RePORTER
CR ANDERSON R M, 1991
   ANDERSON RM, 1994, PHILOS T R SOC B, V346, P457, DOI 10.1098/rstb.1994.0162
   AZEVEDONETO RS, 1995, T R SOC TROP MED HYG, V89, P115
   BELLINI WJ, 1994, J INFECT DIS, V170, pS15, DOI 10.1093/infdis/170.Supplement_1.S15
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   COX NJ, 1994, EUR J EPIDEMIOL, V10, P467, DOI 10.1007/BF01719678
   CUSI MG, 1993, ARCH VIROL, V129, P337, DOI 10.1007/BF01316909
   EDMONSON MB, 1990, JAMA-J AM MED ASSOC, V263, P2467, DOI 10.1001/jama.263.18.2467
   ERDMAN DD, 1993, J MED VIROL, V41, P44, DOI 10.1002/jmv.1890410110
   Forsyth K. P., 1988, The epidemiology and ecology of infectious disease agents. Proceedings of a Royal Society discussion meeting held on 17 and 18 February 1988., P159
   FRANCESCHI C, 1995, IMMUNOL TODAY, V16, P12, DOI 10.1016/0167-5699(95)80064-6
   FRANCIS DP, 1982, ANN INTERN MED, V97, P362, DOI 10.7326/0003-4819-97-3-362
   Francis TJ, 1960, P AM PHILOS SOC, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806
   FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478
   GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075
   GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293
   HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6
   HALLORAN ME, 1994, AM J EPIDEMIOL, V140, P81, DOI 10.1093/oxfordjournals.aje.a117238
   HALLORAN ME, 1995, EPIDEMIOLOGY, V6, P142, DOI 10.1097/00001648-199503000-00010
   HALLORAN ME, 1994, MATH BIOSCI, V121, P193, DOI 10.1016/0025-5564(94)90070-1
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0
   HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0
   HOLMGREN J, 1993, VACCINE, V11, P1179, DOI 10.1016/0264-410X(93)90039-Z
   HUNTER RL, 1994, AM J TROP MED HYG, V50, P52, DOI 10.4269/ajtmh.1994.50.52
   JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169
   KIKUTA K, 1990, VACCINE, V8, P595, DOI 10.1016/0264-410X(90)90016-F
   KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955
   KNOX EG, 1987, INT J EPIDEMIOL, V16, P569, DOI 10.1093/ije/16.4.569
   LENNON JL, 1986, J PEDIATR-US, V108, P671, DOI 10.1016/S0022-3476(86)81039-3
   MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075
   MCLEAN AR, 1995, LANCET, V345, P272, DOI 10.1016/S0140-6736(95)90272-4
   MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707
   Mestecky Jiri, 1994, Acta Paediatrica Japonica, V36, P537
   MICHIE C, 1994, LANCET, V343, P1259, DOI 10.1016/S0140-6736(94)92153-9
   MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0
   MORGANCAPNER P, 1983, BRIT MED J, V286, P1616, DOI 10.1136/bmj.286.6378.1616
   MOSIER DE, 1993, P NATL ACAD SCI USA, V90, P2443, DOI 10.1073/pnas.90.6.2443
   MULHOLLAND K, 1995, LANCET, V345, P305, DOI 10.1016/S0140-6736(95)90282-1
   NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0
   PABST HF, 1992, PEDIATR INFECT DIS J, V11, P525, DOI 10.1097/00006454-199207000-00004
   POWERS DC, 1992, J AM GERIATR SOC, V40, P81, DOI 10.1111/j.1532-5415.1992.tb01835.x
   ROTA JS, 1994, VIRUS RES, V31, P317, DOI 10.1016/0168-1702(94)90025-6
   ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086
   ROUDERFER V, 1994, MATH BIOSCI, V124, P59, DOI 10.1016/0025-5564(94)90024-8
   TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795
NR 51
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9629
EI 1538-2990
J9 AM J MED SCI
JI Am. J. Med. Sci.
PD FEB
PY 1998
VL 315
IS 2
BP 76
EP 86
DI 10.1097/00000441-199802000-00003
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA YV976
UT WOS:000071883300003
PM 9472906
DA 2020-12-16
ER

PT J
AU Silveira, PSP
   Massad, E
AF Silveira, PSP
   Massad, E
TI Modeling and simulating morphological evolution in an artificial life
   environment
SO COMPUTERS AND BIOMEDICAL RESEARCH
LA English
DT Article
DE computer simulations; artificial life; genetic algorithm; cellular
   automata; medical informatics; ecology; modeling
AB This paper presents a computer-based environment designed to study biological evolution considering morphological aspects. It was inspired on cellular automata and evolutionary algorithm principles. Simple rules are used to determine the genotype and phenotype of individuals and their relationships with behavioral aspects in a square matrix environment, where individuals can evolve. Two methods to simulate mutational errors and to introduce variability of mutations are discussed. A series of four simulations show that the model promotes phenotype evolution depending on the distribution of food over the environment; morphology evolved as to favor movement of the individuals towards the portion of the environment in which the food has been distributed or to capture falling food, (C) 1998 academic Press.
C1 Univ Sao Paulo, Sch Med, Dept Med Informat, Sao Paulo, Brazil.
   FMUSP, LIMQ1HC, Sao Paulo, Brazil.
RP Silveira, PSP (corresponding author), Univ Sao Paulo, Sch Med, Dept Med Informat, Sao Paulo, Brazil.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Silveira,
   Paulo SP/C-9077-2014
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ALBERCH P, 1980, AM ZOOL, V20, P653
   Alberch P., 1982, EVOL DEV, V20, P313
   Dawkins R., 1986, BLIND WATCHMAKER
   HEITKOTTER J, 1995, HITCH HIKERS GUIDE E
   KOT M, 1992, B MATH BIOL, V54, P619, DOI 10.1016/S0092-8240(05)80079-5
   MAYNARDSMITH J, 1987, PROBLEMS BIOL
   Murray J. D., 1993, MATH BIOL
   OSTER G, 1982, EVOLUTION, V36, P444, DOI 10.1111/j.1558-5646.1982.tb05066.x
   Pianka E.R., 1983, EVOLUTIONARY ECOLOGY
   PRUSINKIEWICZ P, 1995, ARTIF LIFE, P61
   SILVEIRA PSP, 1996, MATH MODELLING SCI C, V6, P793
   SILVEIRA PSP, 1995, ENV MANAGEMENT HLTH, V6, P19
   TAYLOR C, 1995, ARTIFICIAL LIFE OVER, P1
NR 13
TC 3
Z9 3
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0010-4809
J9 COMPUT BIOMED RES
JI Comput. Biomed. Res.
PD FEB
PY 1998
VL 31
IS 1
BP 1
EP 17
DI 10.1006/cbmr.1997.1464
PG 17
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA ZL085
UT WOS:000073397300001
PM 9561807
DA 2020-12-16
ER

PT J
AU Yang, HM
   Coutinho, FAB
   Massad, E
AF Yang, HM
   Coutinho, FAB
   Massad, E
TI Acquired immunity on a schistosomiasis transmission model - Fitting the
   data
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
ID POPULATION-DYNAMICS; MATHEMATICAL-MODELS; MANSONI; INFECTION; HOST;
   EPIDEMIOLOGY; HAEMATOBIUM; BRAZIL
AB A semi-stochastic model is proposed to analyse the effects of acquired immunity on the transmission of schistosomiasis in the human host. The basic model's assumptions are as follows. The human host is assumed to build up an immune response after elapsing a fixed period of time L from the first infection. This acquired immunity is assumed to be partially effective and it is never lost. The parasite infection event is a Poisson process with multiple occurrences, i.e., in each event one or more cercaria are assumed to invade the host. The model treats deterministically the age distribution of human host. The model shows a good retrieving capacity of real data from two endemic areas of schistosomiasis: Touros, Brazil (Schistosoma mansoni) and Misungwi, Tanzania (Schistosoma haematobium). (C) 1997 Academic Press Limited.
C1 UNIV SAO PAULO, FM, ARNALDO, SP, BRAZIL.
RP Yang, HM (corresponding author), UNIV ESTADUAL CAMPINAS, IMECC, DEPT MAT APLICADA, CAIXA POSTAL 6065, BR-13081970 CAMPINAS, SP, BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Yang, Hyun Mo/K-6873-2014
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; Yang, Hyun Mo/0000-0002-1711-363X
CR ANDERSON R M, 1991
   ANDERSON RM, 1985, NATURE, V315, P493, DOI 10.1038/315493a0
   BANANEZ MG, 1994, PARASITOLOGY, V108, P115
   BARBOUR AD, 1993, J MATH BIOL, V31, P157, DOI 10.1007/BF00171224
   BRADLEY DJ, 1973, T ROY SOC TROP MED H, V67, P491, DOI 10.1016/0035-9203(73)90080-1
   Bundy D. A. P., 1992, World Health Statistics Quarterly, V45, P168
   BUTTERWORTH AE, 1994, PARASITOL TODAY, V10, P378, DOI 10.1016/0169-4758(94)90225-9
   CLEGG JA, 1970, PARASITOLOGY, V61, P87, DOI 10.1017/S0031182000040889
   COSTA MFFDE, 1985, T ROY SOC TROP MED H, V79, P539, DOI 10.1016/0035-9203(85)90090-2
   Cox DR, 1992, THEORY STOCHASTIC PR
   CROMBIE JA, 1985, NATURE, V315, P491, DOI 10.1038/315491a0
   DIAS LCS, 1989, REV I MED TROP, V31, P110, DOI 10.1590/S0036-46651989000200009
   FULFORD AJ, 1993, SOME MATH STAT ISSUE
   FULFORD AJC, 1995, PARASITOLOGY, V110, P307, DOI 10.1017/S0031182000080896
   GRYSEELS B, 1994, PARASITOL TODAY, V10, P380, DOI 10.1016/0169-4758(94)90226-7
   HAGAN P, 1987, BIOL CHISTOSOMES GEN
   HAIRSTON NG, 1965, B WORLD HEALTH ORGAN, V33, P163
   HARRIS ARC, 1984, T ROY SOC TROP MED H, V78, P385, DOI 10.1016/0035-9203(84)90129-9
   MAHMOUD AAF, 1990, PRINCIPLES PRACTICES
   MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X
   MCCULLOUGH FS, 1973, T ROY SOC TROP MED H, V67, P475, DOI 10.1016/0035-9203(73)90079-5
   MOTTA EGF, 1977, PAINEL PROGRAMA ESPE
   NASELL I, 1977, B I STAT I, V47, P3
   PRESS WH, 1989, NUMERICAL RECIPES AR
   Stuart A., 1987, KENDALLS ADV THEORY
   TERRY RJ, 1994, PARASITOL TODAY, V10, P377, DOI 10.1016/0169-4758(94)90224-0
   VERMUND SH, 1983, AM J TROP MED HYG, V32, P1040, DOI 10.4269/ajtmh.1983.32.1040
   Williams CB, 1937, ANN APPL BIOL, V24, P404, DOI 10.1111/j.1744-7348.1937.tb05042.x
   WOOLHOUSE MEJ, 1991, NATURE, V351, P757, DOI 10.1038/351757a0
   WOOLHOUSE MEJ, 1991, ACTA TROP, V49, P241, DOI 10.1016/0001-706X(91)90077-W
   WOOLHOUSE MEJ, 1992, ACTA TROP, V50, P189, DOI 10.1016/0001-706X(92)90076-A
   YANG HM, 1985, THESIS USP
   YANG HM, 1990, THESIS USP
   Yang Hyun Mo, 1995, Journal of Biological Systems, V3, P379
NR 34
TC 9
Z9 9
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD OCT 21
PY 1997
VL 188
IS 4
BP 495
EP 506
DI 10.1006/jtbi.1997.0479
PG 12
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA YH104
UT WOS:A1997YH10400004
PM 9367736
DA 2020-12-16
ER

PT J
AU do Amaral, MB
   Hartmann, R
   Nascimento, M
   Moura, L
   Novaes, M
   Massad, E
AF do Amaral, MB
   Hartmann, R
   Nascimento, M
   Moura, L
   Novaes, M
   Massad, E
TI Applying ASTM E31 standard guidelines for modeling the Sao Paulo
   University Hospital computerized medical record: Comparing the real
   world with the E1384-96 described standard model
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Med Sch Hosp, BR-05508 Sao Paulo, Brazil.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ACKERMAN MJ, 1994, J AM MED INFORM ASSN, V1, P1
   *ASTM, 1996, AM SOC TEST MAT, V14
NR 2
TC 0
Z9 0
U1 0
U2 1
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107 USA
SN 1067-5027
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
PY 1997
SU S
BP 909
EP 909
PG 1
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA V3182
UT WOS:000171774300238
DA 2020-12-16
ER

PT J
AU Forattini, OP
   Kakitani, I
   Massad, E
   Marucci, D
AF Forattini, OP
   Kakitani, I
   Massad, E
   Marucci, D
TI Studies on mosquitoes (Diptera: Culicidae) and anthropic environment
   .12. Host-seeking behaviour of Anopheles albitarsis s l in South-Eastern
   Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Anopheles; ecology, vectors
ID RICE IRRIGATION SYSTEM; ARGENTINA; MALARIA; COMPLEX; ADULTS
AB Results obtained with Anopheles albitarsis s.l. catches mainly performed through human bait at the Ribeira Valley region, SP (Brazil), are reported. Two species of the complex were recognized, namely An. albitarsis s.s. and species B. This latter predominated both in the rice fields and in the dwelling environments. The crepuscular rhythms showed an unimodal sunset pattern with most blood-seeking females caught during dusk. The absence of differences between indoor and outdoor behavior was confirmed for both species of the complex.
C1 UNIV SAO PAULO, DEPT EPIDEMIOL FAC SAUDE PUBL, SAO PAULO, SP, BRAZIL.
   UNIV SAO PAULO, DEPT PATOL FAC MED, SAO PAULO, SP, BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR CHADEE DD, 1992, J MED ENTOMOL, V29, P567, DOI 10.1093/jmedent/29.3.567
   DEANE LM, 1988, REV I MED TROP, V30, P153, DOI 10.1590/S0036-46651988000300005
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P20, DOI 10.1590/S0034-89101995000100005
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   HADDOW A. J., 1960, BULL ENT RES, V50, P759, DOI 10.1017/S000748530005478X
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199, DOI 10.1017/S0007485300026900
   NARANG SK, 1993, BIOCHEM GENET, V31, P97, DOI 10.1007/BF02399823
   NIELSEN E, 1963, OIKOS, V14, P9, DOI 10.2307/3564956
   NIELSEN ET, 1961, NATURE, V190, P878, DOI 10.1038/190878a0
   ROSAFREITAS MG, 1989, MEM I OSWALDO CRUZ, V84, P535, DOI 10.1590/S0074-02761989000400011
   ROSAFREITAS MG, 1990, MEM I OSWALDO CRUZ, V85, P275, DOI 10.1590/S0074-02761990000300004
   RUBIOPALIS Y, 1992, MED VET ENTOMOL, V6, P325, DOI 10.1111/j.1365-2915.1992.tb00628.x
   Wilkerson RC, 1995, MEM I OSWALDO CRUZ, V90, P721, DOI 10.1590/S0074-02761995000600013
   WILKERSON RC, 1995, J MED ENTOMOL, V32, P697, DOI 10.1093/jmedent/32.5.697
NR 16
TC 2
Z9 2
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 1996
VL 30
IS 4
BP 299
EP 303
DI 10.1590/S0034-89101996000400002
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VR710
UT WOS:A1996VR71000002
PM 9201890
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU deCarvalho, HB
   Mesquita, F
   Massad, E
   Bueno, RC
   Lopes, GT
   Ruiz, MA
   Burattini, MN
AF deCarvalho, HB
   Mesquita, F
   Massad, E
   Bueno, RC
   Lopes, GT
   Ruiz, MA
   Burattini, MN
TI HIV and infections of similar transmission patterns in a drug injectors
   community of Santos, Brazil
SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
LA English
DT Article
DE HIV; HTLV (1 and 2); hepatitis B; hepatitis C; syphilis; injecting drug
   users; cocaine; Brazil
ID HEPATITIS-C VIRUS; BLOOD-DONORS; NON-A; ANTIBODIES
AB To study the prevalence of HIV and infections with related transmission patterns, we interviewed and obtained blood samples from 110 injecting drug users (IDUs), sampled by snowballing, from the city of Santos in the state of Sao Paulo, Brazil, where the estimated number of IDUs (10,000) comprises similar to 2% of the entire population. Seroprevalence of HIV, hepatitis B and C. syphilis, and HTLV (1 and 2) was assessed and compared with that in 197 blood donors from the same city, matched for age and gender. Risk behavior related to HIV was assessed by a standard questionnaire applied to the IDU sample. Univariate and multivariate analyses of the risk factors were performed. Seroprevalences found were 62% for HIV, 75% for HCV. 75% for HBV, 34% for syphilis, and 25% for HTLV (1 and 2) among IDUs, which compare with 0.0%, 2%, 23%, 12%, and 1% for blood donors, respectively. The risk for parenterally transmitted infections in this IDU community was higher than that for sexually transmitted infections (odds ratio for syphilis, 3.57; hepatitis B. 10.0: and hepatitis C, 100). The results of the multivariate risk analysis showed that daily rate of ID use >5 times/day (OR = 6.73), not changing behavior to avoid AIDS (OR = 3.28), ID use >15 days/month (OR = 2.72), and ID use in the last 2 months (OR = 2.23) were the risk behaviors significantly associated with HIV infection.
C1 UNIV SAO PAULO,NUPAIDS,BR-05508 SAO PAULO,BRAZIL.
   IEPAS,SANTOS,BRAZIL.
   SECRETARIA ESTADO SAUDE SAO PAULO,SAO PAULO,BRAZIL.
   ESCOLA PAULISTA MED,DISCIPLINA DOENCAS INFECC,SAO PAULO,BRAZIL.
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Carvalho, Heraclito/C-1334-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Carvalho, Heraclito/0000-0002-7037-5655;
   Mesquita, Fabio/0000-0002-8297-0224
CR Andrade ALSS, 1989, REV SAUDE PUBL, V23, P20, DOI DOI 10.1590/S0034-89101989000100004
   BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   DAWSON GJ, 1991, J CLIN MICROBIOL, V29, P551, DOI 10.1128/JCM.29.3.551-556.1991
   DEAN AG, 1990, EPIINFO VERSION 5 WO
   Des Jarlais D. C., 1994, Scientific American, V270, P56
   Esteban JL, 1992, BLOOD SAFETY CURRENT, P45
   FOLLETT EAC, 1991, LANCET, V338, P1024, DOI 10.1016/0140-6736(91)91891-W
   HSU HH, 1991, GASTROENTEROLOGY, V101, P1724, DOI 10.1016/0016-5085(91)90413-F
   KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467
   LIMA ES, 1994, ADDICTION, V89, P689, DOI 10.1111/j.1360-0443.1994.tb00955.x
   LIMA VCP, 1992, 8 INT C AIDS AMST JU
   LONG S, 1990, GUARDIAN        0305
   LONGO MA, 1994, 6 INT C INF DIS PRAG, V1, P414
   Mann J, 1992, AIDS WORLD
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MESQUITA F, 1992, TEMPOS AIDS AIDS DRO
   *MIN HLTH BRAZ, 1994, EP B, V8
   Poshyachina V., 1993, Bulletin on Narcotics, V45, P77
   ROGGENDORF M, 1989, LANCET, V2, P324
   Sarkar S., 1993, Bulletin on Narcotics, V45, P91
   *SECR HLTH CIT SAN, 1984, EP B, V2
   *SECR HLTH CIT SAT, 1994, EP B, V14
   Stimson G. V., 1993, Bulletin on Narcotics, V45, P3
   Tramont EC, 1990, PRINCIPLES PRACTICE, P1794
   VANDERBORGHT BOM, 1993, VOX SANG, V65, P122, DOI 10.1111/j.1423-0410.1993.tb02128.x
   VAZ AJ, 1990, REV SAUDE PUBL, V24, P373, DOI 10.1590/S0034-89101990000500004
   *WHO, 1994, IN PRESS FIN REP WHO
   WILCOX RR, 1966, B WHO S, V35, P1
   1993, B NARCOTICS, V45, P19
NR 30
TC 54
Z9 62
U1 0
U2 5
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 1077-9450
J9 J ACQ IMMUN DEF SYND
JI J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
PD MAY 1
PY 1996
VL 12
IS 1
BP 84
EP 92
DI 10.1097/00042560-199605010-00012
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA UK146
UT WOS:A1996UK14600012
PM 8624766
DA 2020-12-16
ER

PT J
AU Massad, E
AF Massad, E
TI Transmission rates and the evolution of HIV virulence
SO EVOLUTION
LA English
DT Article
DE AIDS; HIV; mathematical models; sexual activity; virulence
ID DISEASE
RP Massad, E (corresponding author), UNIV SAO PAULO, SCH MED, AV DR ARNALDO 455, BR-01246903 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ANDERSON R M, 1991
   BLOWER SM, 1993, J ACQ IMMUN DEF SYND, V6, P1347
   Ewald P W, 1991, Hum Nat, V2, P1, DOI 10.1007/BF02692179
   Ewald P. W., 1994, EVOLUTION INFECT DIS
   LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708
   MASSAD E, 1993, INT J BIOMED COMPUT, V33, P65, DOI 10.1016/0020-7101(93)90060-J
   NOWAK MA, 1990, AIDS, V4, P1095, DOI 10.1097/00002030-199011000-00007
   NOWAK MA, 1992, J THEOR BIOL, V155, P1, DOI 10.1016/S0022-5193(05)80545-4
   NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012
   PERKINS HA, 1987, BLOOD, V70, P1604
   VANDERMEER J, 1981, ELEMENTARY MATH ECOL
   VANGRIENSVEN GJP, 1990, AM J EPIDEMIOL, V132, P203
   WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406
NR 13
TC 10
Z9 10
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-3820
EI 1558-5646
J9 EVOLUTION
JI Evolution
PD APR
PY 1996
VL 50
IS 2
BP 916
EP 918
DI 10.2307/2410863
PG 3
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA UJ156
UT WOS:A1996UJ15600040
PM 28568912
OA Bronze
DA 2020-12-16
ER

PT J
AU Forattini, OP
   Kakitani, I
   Massad, E
   Marucci, D
AF Forattini, OP
   Kakitani, I
   Massad, E
   Marucci, D
TI Studies on mosquitoes (Diptera:Culicidae) and anthropic environment .11.
   Biting activity and blood-seeking parity of Anopheles (Kerteszia) in
   south-eastern Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Anopheles, physiology; ecology, vectors
AB An. (Ker.) cruzii and An. (Ker.) bellator were monitored by the use of human bait and Shannon trap collections during a one-year period in 1994. Indoor and outdoor collections were made on human bait and inside the forest environment a Shannon trap was used. Both were undertaken in the evening crepuscular period. Results showed a greater abundance of An. cruzii in the forest, where as An. bellator was more abundant in the domiciliary environment. Through the application of the Polovodova method an age grading was established. Computing the parous and nulliparous females with Christopher's Stage III and above, more than 30.0% of blood-seeking specimens of both anophelines had had a previous blood meal. The higher abundance of An. bellator as compared with that of An. cruzii in the domiciliary environment may be explained by the influence of the neighboring low-lying coastal islands of the estuary system.
C1 UNIV SAO PAULO,FAC SAUDE PUBL,DEPT EPIDEMIOL,BR-05508 SAO PAULO,BRAZIL.
   UNIV SAO PAULO,FAC MED,DEPT PATOL,BR-05508 SAO PAULO,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR Clements AN, 1992, BIOL MOSQUITOES, V1
   DETINOVA TS, 1962, WHO MONOGR SER, V47
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P1
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P101, DOI 10.1590/S0034-89101990000200004
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   GILLIES M. T., 1955, ANN TROP MED AND PARASITOL, V49, P320
   GILLIES MT, 1954, ANN TROP MED PARASIT, V48, P58, DOI 10.1080/00034983.1954.11685599
   HADDOW A. J., 1960, BULL ENT RES, V50, P759, DOI 10.1017/S000748530005478X
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199, DOI 10.1017/S0007485300026900
   HANNAH L, 1994, AMBIO, V23, P246
   Sokolova M. I., 1994, Bulletin of the Society for Vector Ecology, V19, P53
   VELOSO HENRIQUE P., 1956, MEM INST OSWALDO CRUZ, V54, P517, DOI 10.1590/S0074-02761956000300007
NR 12
TC 19
Z9 22
U1 0
U2 5
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 1996
VL 30
IS 2
BP 107
EP 114
DI 10.1590/S0034-89101996000200001
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA UW586
UT WOS:A1996UW58600001
PM 9077008
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Massad, E
AF Massad, E
TI Mathematical and computer models in epidemiology
SO M D COMPUTING
LA English
DT Article
ID TRANSMISSION; AIDS
RP Massad, E (corresponding author), UNIV SAO PAULO, SCH MED, DEPT MED INFORMAT, AV DR ARNALDO 455, BR-01246903 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ANDERSON R M, 1991
   Anderson R.M., 1982, P67
   ANDERSON RM, 1988, TROP GEOGR MED, V40, pS30
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   Bailey N. T. J., 1964, ELEMENTS STOCHASTIC
   BECKER N, 1979, BIOMETRICS, V35, P295, DOI 10.2307/2529951
   Bradley D.J., 1982, P320
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   DANIELS JD, 1986, J ELECTROPHYSIOL TEC, V13, P95
   ELMAGHABY SE, 1968, J INDIAN ENG, V19, P6
   GOODMAN B, 1994, SCIENCE, V264, P1862, DOI 10.1126/science.8009211
   HETHCOTE HW, 1992, HIV TRANSMISSION AID
   HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401
   LEDUC J, 1994, ARTHROPOD BORNE  DEC, P2
   LEVY JA, 1988, JAMA-J AM MED ASSOC, V259, P3037, DOI 10.1001/jama.259.20.3037
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1995, INT J EPIDEMIOL, V24, P842, DOI 10.1093/ije/24.4.842
   MASSAD E, 1993, MATH COMPUT MODEL, V17, P7, DOI 10.1016/0895-7177(93)90013-O
   Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007
   Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546
   ROSS R, 1928, STUDIES MALARIA
   Ross R., 1911, PREVENTION MALARIA
   SEGEL LA, 1984, MODELLING DYNAMIC PH
   SELIK RM, 1993, JAMA-J AM MED ASSOC, V269, P2991, DOI 10.1001/jama.269.23.2991
   Shannon RE, 1975, SYSTEMS SIMULATION A
   SILVEIRA PSP, IN PRESS MATH MODEL
   SILVEIRA PSP, 1995, ENV MANAGEMENT HLTH, V6, P19
   TAUBES G, 1994, SCIENCE, V265, P886, DOI 10.1126/science.8052845
   1994, NEW SCI, V142, P11
NR 31
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0724-6811
J9 M D COMPUT
JI M D Comput.
PD MAR-APR
PY 1996
VL 13
IS 2
BP 147
EP 154
PG 8
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA TY608
UT WOS:A1996TY60800008
PM 8684277
DA 2020-12-16
ER

PT J
AU Engel, AB
   Massad, E
   Pulino, P
AF Engel, AB
   Massad, E
   Pulino, P
TI Biocybernetics: Fitting the oxyhaemoglobin dissociation curve
SO KYBERNETES
LA English
DT Article
ID HUMAN-BLOOD
AB Proposes a modified Hill model for the oxyhaemoglobin dissociation curve. The model fits normal oxyhaemoglobin dissociation experimental data quite accurately, and can easily be adapted to experimental data of subjects suffering haemoglobinopathies when available. Discusses the Adair equation, as well as correcting factors for varying temperature and pH.
C1 UNIV SAO PAULO,BR-05508 SAO PAULO,BRAZIL.
   UNIV CAMPINAS,CAMPINAS,BRAZIL.
RP Engel, AB (corresponding author), ROCHESTER INST TECHNOL,ROCHESTER,NY 14623, USA.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ADAIR GS, 1923, J PHYSL, V8
   BENISRAEL A, 1966, J MATH ANAL APPL, V15, P243, DOI 10.1016/0022-247X(66)90115-6
   Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x
   ENGEL AB, 1983, KYBERNETES, V12, P243, DOI 10.1108/eb005661
   FENNE DW, 1960, J APPL PHYSIOL, V15, P315
   HILL AV, 1910, J PHYSL, V40, P14
   MARGARIA R, 1963, CLIN CHEM, V9, P745
   MARGARIR, 1993, J BIOL CHEM, V102, P611
   ROUGHTON FJ, 1973, J APPL PHYSIOL, V35, P861
   ROUGHTON FJW, 1954, P ROY SOC LONDON, V144, P929
   SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599
   Verhulst P.-F., 1845, NOUVEAUX MEMOIRES AC, V18, P1
NR 12
TC 0
Z9 0
U1 0
U2 3
PU MCB UNIV PRESS LTD
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD, W YORKSHIRE, ENGLAND BD8 9BY
SN 0368-492X
J9 KYBERNETES
JI Kybernetes
PY 1996
VL 25
IS 1
BP 51
EP &
DI 10.1108/03684929610106410
PG 11
WC Computer Science, Cybernetics
SC Computer Science
GA TZ058
UT WOS:A1996TZ05800004
DA 2020-12-16
ER

PT J
AU SEGURADO, AAC
   SUMITA, LM
   ROZMANN, M
   MASSAD, E
   SOUZA, VAUF
   PANNUTI, CS
AF SEGURADO, AAC
   SUMITA, LM
   ROZMANN, M
   MASSAD, E
   SOUZA, VAUF
   PANNUTI, CS
TI HTLV-I AND HTLV-II INFECTIONS IN INMATES OF SAO-PAULO-STATE-PRISON,
   SAO-PAULO, BRAZIL
SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
LA English
DT Meeting Abstract
C1 UNIV SAO PAULO,SCH MED,DEPT INFECT DIS,BR-05508 SAO PAULO,BRAZIL.
   UNIV SAO PAULO,SCH MED,DEPT PATHOL,BR-05508 SAO PAULO,BRAZIL.
RI Segurado, Aluisio C/K-2229-2012; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012
OI Segurado, Aluisio C/0000-0002-6311-8036; Massad,
   Eduardo/0000-0002-7200-2916
NR 0
TC 1
Z9 2
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 1077-9450
J9 J ACQ IMMUN DEF SYND
JI J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
PD OCT 1
PY 1995
VL 10
IS 2
BP 200
EP 200
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA RW330
UT WOS:A1995RW33000216
DA 2020-12-16
ER

PT J
AU MASSAD, E
   AZEVEDONETO, RS
   BURATTINI, MN
   ZANETTA, DMT
   COUTINHO, FAB
   YANG, HM
   MORAES, JC
   PANNUTI, CS
   SOUZA, VAUF
   SILVEIRA, ASB
   STRUCHINER, CJ
   OSELKA, GW
   CAMARGO, MCC
   OMOTO, TM
   PASSOS, SD
AF MASSAD, E
   AZEVEDONETO, RS
   BURATTINI, MN
   ZANETTA, DMT
   COUTINHO, FAB
   YANG, HM
   MORAES, JC
   PANNUTI, CS
   SOUZA, VAUF
   SILVEIRA, ASB
   STRUCHINER, CJ
   OSELKA, GW
   CAMARGO, MCC
   OMOTO, TM
   PASSOS, SD
TI ASSESSING THE EFFICACY OF A MIXED VACCINATION STRATEGY AGAINST RUBELLA
   IN SAO-PAULO, BRAZIL
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE RUBELLA; CRS; VACCINATION; SEROEPIDEMIOLOGY; CONTROL STRATEGIES
AB Background. In 1992 a major vaccination strategy against measles-mumps-rubella was introduced in the State of Sao Paulo, Brazil. This strategy was based on mathematical models and comprised a pulse vaccination covering all children aged 1-10 years, followed by the inclusion of this vaccine in the routine calendar at 15 months of age. The present work reports the evaluation of the efficacy of this mixed vaccination strategy.
   Methods. A rubella seroprevalence survey was carried out immediately and one year after the campaign, comprising 4953 children aged 1-15 years.
   Results. We show that average rubella seroprevalence increased from 0.40 to 0.97 and that the reported number of congenital rubella syndrome (CRS) cases dropped dramatically,
   Conclusions. The mixed vaccination strategy adopted against rubella has proved to be very effective in reducing the number of CRS cases in Sao Paulo.
C1 UNIV SAO PAULO,HCFM,BR-01246903 SAO PAULO,BRAZIL.
   UNIV SAO PAULO,INST FIS,BR-01246903 SAO PAULO,BRAZIL.
   ESCOLA PAULISTA MED,BR-04023 SAO PAULO,BRAZIL.
   FAC CIENCIAS MED SANTA CASA,SAO PAULO,BRAZIL.
   SECRETARIA ESTADO SAUDE SAO PAULO,SAO PAULO,BRAZIL.
   FIOCRUZ MS,ESCOLA NACL SAUDE PUBL,RIO JANEIRO,BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO,FAC MED,AVE DOUTOR ARNALDO 455,BR-01246903 SAO PAULO,BRAZIL.
RI Pannuti, Claudio/B-7649-2012; Azevedo, Raymundo S/B-7593-2008; Massad,
   Eduardo/H-6143-2011; Zanetta, Dirce M T/G-4950-2013; Passos, Saulo
   Duarte/C-5166-2012; Coutinho, Francisco A B/H-5644-2011; Yang, Hyun
   M/K-6873-2014; Massad, Eduardo/B-1169-2012; Burattini, Marcelo
   N/J-9272-2014; Struchiner, Claudio J/M-9360-2013
OI Azevedo, Raymundo S/0000-0003-0660-2371; Passos, Saulo
   Duarte/0000-0002-0908-2677; Coutinho, Francisco A B/0000-0003-3127-3071;
   Yang, Hyun M/0000-0002-1711-363X; Massad, Eduardo/0000-0002-7200-2916;
   Burattini, Marcelo N/0000-0002-5407-6890; Struchiner, Claudio
   J/0000-0003-2114-847X
CR ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   BRUNET RC, 1993, MATH BIOSCI, V116, P111, DOI 10.1016/0025-5564(93)90063-G
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   FIELD PR, 1988, J CLIN MICROBIOL, V26, P990, DOI 10.1128/JCM.26.5.990-994.1988
   Francis T, 1955, AM J PUBLIC HEALTH N, V45, P1
   Greenwood M, 1915, Proc R Soc Med, V8, P113
   HALLORAN ME, 1994, STAT MED, V13, P357, DOI 10.1002/sim.4780130404
   HORSTMANN DM, 1989, VIRAL INFECTIONS HUM
   Kendrick P, 1939, AM J HYG, V29, P133, DOI 10.1093/oxfordjournals.aje.a118485
   KIRSH L, 1965, SURVEY SAMPLING
   LINDEGREN ML, 1991, EPIDEMIOL REV, V13, P341, DOI 10.1093/oxfordjournals.epirev.a036077
   Lwa nga S.K., 1991, SAMPLE SIZE DETERMIN
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   NETO RSD, 1994, EPIDEMIOL INFECT, V113, P161, DOI 10.1017/S095026880005158X
   PELISSERO C, 1993, EUR J EPIDEMIOL, V9, P322, DOI 10.1007/BF00146271
   Souza Vanda A. U. F., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P373, DOI 10.1590/S0036-46651994000400011
   SOUZA VAU, 1993, 29 P C BRAZ SOC TROP, P107
   SOUZA VAU, 1993, REV I MED TROPICAL S, V35, pS58
   WYLL SA, 1973, JAMA-J AM MED ASSOC, V225, P1472, DOI 10.1001/jama.225.12.1472
NR 19
TC 45
Z9 46
U1 0
U2 10
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0300-5771
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD AUG
PY 1995
VL 24
IS 4
BP 842
EP 850
DI 10.1093/ije/24.4.842
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA RQ192
UT WOS:A1995RQ19200025
PM 8550284
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT -
   10-SURVEY OF ADULT BEHAVIOR OF CULEX NIGRIPALPUS AND OTHER SPECIES OF
   CULEX (CULEX) IN SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE CULEX; ECOLOGY, VECTORS; ST LOUIS ENCEPHALITIS; TRANSMISSION
ID S-PAULO STATE; RIBEIRA VALLEY; ENCEPHALITIS
AB A survey of adult behaviour of Culex (Culex) species was carried out from August 1992 through December 1993 in a human modified (anthropic) environment in the Ribeira Valley, S. Paulo State, Brazil. Culex nigripalpus dominated the catches at several sites and it's tendency to increase in the anthropic environment became quite clear. Nevertheless no high level of synanthropy was demonstrated. So it seems that the mosquito may have a restricted role in natural arbovirus cycles. Nonetheless, Cx. nigripalpus must be considered a potential vector of arboviruses, especially St. Louis encephalitis virus outside dwellings.
C1 UNIV SAO PAULO, FAC MED, DEPT PATOL, BR-01246904 SAO PAULO, BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO, FAC SAUDE PUBL, DEPT EPIDEMIOL, AV DR ARNALDO 715, BR-01246904 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR BELLE EA, 1964, AM J TROP MED HYG, V13, P452, DOI 10.4269/ajtmh.1964.13.452
   CHAMBERLAIN RW, 1964, AM J TROP MED HYG, V13, P456, DOI 10.4269/ajtmh.1964.13.456
   CUPP EW, 1986, AM J TROP MED HYG, V35, P851, DOI 10.4269/ajtmh.1986.35.851
   DOW RP, 1964, AM J TROP MED HYG, V13, P462, DOI 10.4269/ajtmh.1964.13.462
   Dutary B E, 1984, Rev Med Panama, V9, P200
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1989, REV SAUDE PUBL, V23, P307, DOI 10.1590/S0034-89101989000400006
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1989, REV SAUDE PUBL, V23, P9, DOI 10.1590/S0034-89101989000100003
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P101, DOI 10.1590/S0034-89101990000200004
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P1, DOI 10.1590/S0034-89101986000100001
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P178, DOI 10.1590/S0034-89101986000300002
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P100, DOI 10.1590/S0034-89101995000200003
   FORATTINI OP, 1994, REV SAUDE PUBL, V28, P395, DOI 10.1590/S0034-89101994000600001
   GUIMARAES A E, 1985, Memorias do Instituto Oswaldo Cruz, V80, P171, DOI 10.1590/S0074-02761985000200008
   GUIMARAES A E, 1987, Memorias do Instituto Oswaldo Cruz, V82, P277, DOI 10.1590/S0074-02761987000200016
   Guimaraes A. E., 1984, Memorias do Instituto Oswaldo Cruz, V79, P309, DOI 10.1590/S0074-02761984000300004
   IVERSSON LB, 1988, ARBOVIRUSES EPIDEMIO, V4, P77
   Lourenco-de-Oliveira R., 1985, Memorias do Instituto Oswaldo Cruz, V80, P123
   Lourenco-de-Oliveira R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P479
   Lourenco-de-Oliveira R., 1986, Memorias do Instituto Oswaldo Cruz, V81, P15
   MITCHELL CJ, 1979, MOSQ NEWS, V39, P263
   MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945
   Morris C.D., 1992, Journal of the Florida Mosquito Control Association, V63, P23
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
   WEBB PA, 1988, ARBOVIRUSES EPIDEMIO, V5, P1
NR 29
TC 15
Z9 19
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 1995
VL 29
IS 4
BP 271
EP 278
DI 10.1590/S0034-89101995000400003
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA TH104
UT WOS:A1995TH10400003
PM 8729276
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .9.
   SYNANTHROPY AND EPIDEMIOLOGIC VECTOR ROLE OF AEDES-SCAPULARIS IN
   SOUTHEASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE AEDES; ECOLOGY, VECTORS; ARBOVIRUS INFECTIONS, TRANSMISSION
ID IRRIGATION DEVELOPMENT; MAHAWELI PROJECT; RIBEIRA VALLEY; SRI-LANKA;
   SAO-PAULO; VIRUS
AB Behaviour comparisons of Aedes scapularis and Ae. serratus are presented. Results were obtained by sampling Aedes adult mosquitoes at several places in the rural anthropic environment in the Ribeira Valley region of S. Paulo State, Brazil. Aedes dominance was shared by those two species, but Ae. scapularis showed a clear tendency to frequent the modified environment, while Ae. serratus was to be found in the more preserved ones, here represented by the vestigial patchy forests. Regarding the open cultivated land and the dwelling environments, Ae, scapularis preponderates. Considering the regional developmental phases, this mosquito showed a remarkable increase in the modified environment differently from Ae. serratus that underwent a considerable decrease in migrating from the forest to the anthropic environment. As a consequence of these results it is reasonable to conclude that Ae. scapularis may be considered as an epidemiologically efficient vector and that it quite probably played this role in the Rocio encephalitis and other arbovirus epidemics.
C1 UNIV SAO PAULO, SCH MED, DEPT PATHOL, BR-05508 SAO PAULO, BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO, NUPTEM, SCH PUBL HLTH, DEPT EPIDEMIOL, TAXONOMETR & SYST RES MED ENTOMOL UNIT, BR-01246904 SAO PAULO, BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR AMERASINGHE FP, 1991, J MED ENTOMOL, V28, P387, DOI 10.1093/jmedent/28.3.387
   AMERASINGHE FP, 1990, J MED ENTOMOL, V27, P789, DOI 10.1093/jmedent/27.5.789
   ARNELL J H, 1976, Contributions of the American Entomological Institute, V13, P1
   FORATTINI O. P., 1961, MOSQUITO NEWS, V21, P295
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   Forattini O P, 1978, Rev Saude Publica, V12, P297, DOI 10.1590/S0034-89101978000300005
   Forattini O P, 1978, Rev Saude Publica, V12, P476, DOI 10.1590/S0034-89101978000400008
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P101, DOI 10.1590/S0034-89101990000200004
   FORATTINI OP, 1987, REV SAUDE PUBL, V21, P188, DOI 10.1590/S0034-89101987000300003
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P1, DOI 10.1590/S0034-89101986000100001
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P178, DOI 10.1590/S0034-89101986000300002
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P100, DOI 10.1590/S0034-89101995000200003
   FORATTINI OP, 1994, REV SAUDE PUBL, V28, P395, DOI 10.1590/S0034-89101994000600001
   FORATTINI OP, 1988, J AM MOSQUITO CONTR, V4, P175
   FORATTINI OP, 1965, ENTOMOLGIA MED, V2
   GONZALEZ OF, 1984, REV CUB MED TROP, V36, P59
   Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99
   IVERSSON LB, 1988, ARBOVIRUSES EPIDEMIO, V4, P77
   Lhuillier M., 1981, Medecine Tropicale, V41, P73
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   Lourenco-de-Oliveira R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P479
   Lourenco-de-Oliveira R., 1986, Memorias do Instituto Oswaldo Cruz, V81, P15
   MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945
   MITCHELL CJ, 1984, J MED ENTOMOL, V21, P34, DOI 10.1093/jmedent/21.1.34
   MITCHELL CJ, 1986, REV SAUDE PUBL, V20, P171, DOI 10.1590/S0034-89101986000300001
   ROBERTS D R, 1985, Boletin de la Oficina Sanitaria Panamericana, V98, P417
   Roberts D R, 1981, Bol Oficina Sanit Panam, V91, P379
   Walton T.E., 1988, ARBOVIRUSES EPIDEMIO, P203
NR 30
TC 45
Z9 47
U1 0
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD JUN
PY 1995
VL 29
IS 3
BP 199
EP 207
DI 10.1590/S0034-89101995000300007
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA RX667
UT WOS:A1995RX66700007
PM 8539531
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   SALLUM, MAM
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   SALLUM, MAM
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .8.
   SURVEY OF ADULT BEHAVIOR OF SPISSIPES SECTION SPECIES OF CULEX
   (MELANOCONION) IN SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE CULICIDAE; ECOLOGY, VECTORS; CULEX
ID EQUINE ENCEPHALITIS; ARBOVIRUS INVESTIGATIONS; RIBEIRA VALLEY;
   ARGENTINA; IDENTIFICATION; DOMICILIATION; ISOLATIONS; WESTERN; VIRUS;
   PAULO
AB A study of Spissipes Section of Culex (Melanoconion) adults behaviour was carried out from August 1992 through December 1993 in human dominated (anthropic) environment in the Ribeira Valley, S.Paulo State, Brazil, By sampling at several sites it the dominance of Culex ribeirensis and Cx. sacchettae became evident even through a total number of ten species was recorded. Those two mosquitoes showed a clear tendency to frequent the domiciliary environment where they were caught, both indoor and outdoor, through the use of the human bait. In the outside environments, the residual patchy forests seems to display a concentration role, from which these adults spread to the open land and reach the dwellings. As their vector competence has been demonstrated through the virus isolations in natural conditions, it is advisable to pay attention to the presence of these mosquitoes in the man-made environment.
C1 UNIV SAO PAULO, SCH MED, DEPT PATHOL, SAO PAULO, BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO, SCH PUBL HLTH, DEPT EPIDEMIOL, TAXON & SYSTEMAT RES MED ENTOMOL UNIT, BR-01246904 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Sallum, Maria
   Anice Mureb/B-8537-2012
OI Massad, Eduardo/0000-0002-7200-2916; Sallum, Maria Anice
   Mureb/0000-0002-7051-2891
CR CALISHER CH, 1982, AM J TROP MED HYG, V31, P1260, DOI 10.4269/ajtmh.1982.31.1260
   CALISHER CH, 1983, AM J TROP MED HYG, V32, P424, DOI 10.4269/ajtmh.1983.32.424
   CALISHER CH, 1985, AM J TROP MED HYG, V34, P956, DOI 10.4269/ajtmh.1985.34.956
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P20, DOI 10.1590/S0034-89101995000100005
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P1
   FORATTINI OP, 1989, REV SAUDE PUBL, V23, P9, DOI 10.1590/S0034-89101989000100003
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P101, DOI 10.1590/S0034-89101990000200004
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P398, DOI 10.1590/S0034-89101993000600002
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P1, DOI 10.1590/S0034-89101986000100001
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P178, DOI 10.1590/S0034-89101986000300002
   FORATTINI OP, 1991, REV SAUDE PUBL, V25, P257, DOI 10.1590/S0034-89101991000400004
   FORATTINI OP, 1988, J AM MOSQUITO CONTR, V4, P175
   HADDOW A. J., 1960, BULL ENT RES, V50, P759, DOI 10.1017/S000748530005478X
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199, DOI 10.1017/S0007485300026900
   HANNAH L, 1994, AMBIO, V23, P246
   IVERSSON LB, 1988, ARBOVIRUSES EPIDEMIO, V4, P77
   MITCHELL CJ, 1987, AM J TROP MED HYG, V36, P107, DOI 10.4269/ajtmh.1987.36.107
   MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945
   NUORTEVA PEKKA, 1963, ANN ENTOMOL FENNICA, V29, P1
   POVOLNY D, 1971, FLIES DISEASE, V1
   SALLUM MAM, 1994, THESIS FACULDADE SAU
NR 24
TC 9
Z9 11
U1 0
U2 0
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 1995
VL 29
IS 2
BP 100
EP 107
DI 10.1590/S0034-89101995000200003
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA RN873
UT WOS:A1995RN87300003
PM 8525318
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAS, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAS, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .7.
   BEHAVIOR OF ADULTS NYSSORHYNCHUS ANOPHELINES WITH SPECIAL REFERENCE TO
   ANOPHELES ALBITARSIS SL IN SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE ANOPHELES; ECOLOGY; VECTORS; MALARIA; TRANSMITION
ID WESTERN VENEZUELA; MALARIA; ARGENTINA; ISOLATIONS
AB Results obtained with catches performed at several sites of the Ribeira Valley, SP (Brazil) are reported. Collections with Shannon type traps showed a concentration of An.albitarsis s.l. in the Experimental Farm of Pariquera-Acu County, associated with the development of irrigated rice cultivation. Two species of the complex, named A and B, were recognized. Species B predominated in the samples. Indoor and outdoor crepuscular human bait captures were performed a the domiciliary environment. The two species showed a generally low William's media valve of 0.2, the highest value obtained was 1.6. No differences were found between indoor and outdoor behaviours between the two species of the complex.
C1 UNIV SAO PAULO, TAXON & SYSTEMATT RES MED ENTOMOL UNIT, BR-01246904 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, SCH MED, DEPT PATHOL, BR-05508 SAO PAULO, BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO, SCH PUBL HLTH, DEPT EPIDEMIOL, AV DR ARNALDO 715, BR-01246904 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR CHADEE DD, 1992, J MED ENTOMOL, V29, P567, DOI 10.1093/jmedent/29.3.567
   Consolin J., 1974, Archivos Biol Tecnol Curitiba, V17, P24
   DEANE LM, 1988, REV I MED TROP, V30, P153, DOI 10.1590/S0036-46651988000300005
   DEARRUDA M, 1986, AM J TROP MED HYG, V35, P873, DOI 10.4269/ajtmh.1986.35.873
   DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   Forattini O P, 1978, Rev Saude Publica, V12, P297, DOI 10.1590/S0034-89101978000300005
   Forattini O P, 1978, Rev Saude Publica, V12, P476, DOI 10.1590/S0034-89101978000400008
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1994, REV SAUDE PUBL, V28, P329, DOI 10.1590/S0034-89101994000500003
   Forattini OP, 1962, ENTOMOLOGIA MED
   HADDOW A. J., 1960, BULL ENT RES, V50, P759, DOI 10.1017/S000748530005478X
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199, DOI 10.1017/S0007485300026900
   Lacey L. A., 1990, Journal of the American Mosquito Control Association, V6, P1
   MITCHELL CJ, 1987, AM J TROP MED HYG, V36, P107, DOI 10.4269/ajtmh.1987.36.107
   MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945
   Quinones M. L., 1992, Journal of the American Mosquito Control Association, V8, P305
   ROSAFREITAS MG, 1990, MEM I OSWALDO CRUZ, V85, P275, DOI 10.1590/S0074-02761990000300004
   Rubio-Palis Y., 1992, Journal of the American Mosquito Control Association, V8, P307
   RUBIOPALIS Y, 1992, ACTA TROP, V52, P167, DOI 10.1016/0001-706X(92)90033-T
   RUBIOPALIS Y, 1992, MED VET ENTOMOL, V6, P325, DOI 10.1111/j.1365-2915.1992.tb00628.x
   SCHIAVI A, 1945, ARQUIV HIG SAUDE PUB, V10, P60
   VANDERKUYP E, 1985, SUR MED B, V9, P108
   WILKERSON RC, IN PRESS J MED ENTOM
NR 25
TC 10
Z9 12
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD FEB
PY 1995
VL 29
IS 1
BP 20
EP 26
DI 10.1590/S0034-89101995000100005
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA RJ761
UT WOS:A1995RJ76100005
PM 8525310
OA DOAJ Gold
DA 2020-12-16
ER

PT B
AU Yang, HM
   Coutinho, FAB
   Massad, E
AF Yang, HM
   Coutinho, FAB
   Massad, E
BE Jean, RV
   Auger, PM
   Demongeot, J
TI Modelling the role of immunity in macroparasite infections
SO JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3: SPECIAL ISSUE: 2ND ECMBM-LYON, PTS
   1-4
LA English
DT Proceedings Paper
CT 2nd European Conference on Mathematics Applied to Biology and Medicine
   (2nd ECMBM)
CY DEC 15-18, 1993
CL ECOLE NORMALE SUPERIEURE LYON, LYON, FRANCE
SP European Soc Math & Theoret Biol
HO ECOLE NORMALE SUPERIEURE LYON
DE stochastic model; schistosomiasis; immunity
C1 UNIV SAO PAULO, SCH MED, BR-01246903 SAO PAULO, BRAZIL.
RI Massad, Eduardo/H-6143-2011; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/B-1169-2012
OI Coutinho, Francisco A B/0000-0003-3127-3071; Massad,
   Eduardo/0000-0002-7200-2916
NR 0
TC 1
Z9 1
U1 0
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
PY 1995
BP 379
EP 387
PG 9
WC Biochemical Research Methods; Cell Biology; Mathematics, Applied;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Cell Biology; Mathematics;
   Pharmacology & Pharmacy
GA BF06V
UT WOS:A1995BF06V00034
DA 2020-12-16
ER

PT B
AU Massad, E
   Neto, RSD
   Yang, HM
   Burattini, MN
   Coutinho, FAB
AF Massad, E
   Neto, RSD
   Yang, HM
   Burattini, MN
   Coutinho, FAB
BE Jean, RV
   Auger, PM
   Demongeot, J
TI Modelling age-dependent transmission rates for childhood infections
SO JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3: SPECIAL ISSUE: 2ND ECMBM-LYON, PTS
   1-4
LA English
DT Proceedings Paper
CT 2nd European Conference on Mathematics Applied to Biology and Medicine
   (2nd ECMBM)
CY DEC 15-18, 1993
CL ECOLE NORMALE SUPERIEURE LYON, LYON, FRANCE
SP European Soc Math & Theoret Biol
HO ECOLE NORMALE SUPERIEURE LYON
DE epidemiology; rubella; age-dependent transmission; infections
C1 UNIV SAO PAULO, SCH MED, BR-01246903 SAO PAULO, BRAZIL.
RI Burattini, Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011;
   Azevedo, Raymundo S/B-7593-2008; Yang, Hyun M/K-6873-2014; Massad,
   Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Burattini, Marcelo N/0000-0002-5407-6890; Coutinho, Francisco A
   B/0000-0003-3127-3071; Azevedo, Raymundo S/0000-0003-0660-2371; Yang,
   Hyun M/0000-0002-1711-363X; Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
PY 1995
BP 803
EP 812
PG 10
WC Biochemical Research Methods; Cell Biology; Mathematics, Applied;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Cell Biology; Mathematics;
   Pharmacology & Pharmacy
GA BF06V
UT WOS:A1995BF06V00072
DA 2020-12-16
ER

PT B
AU Struchiner, CJ
   Brunet, RC
   Halloran, ME
   Massad, E
   AzevedoNeto, RS
AF Struchiner, CJ
   Brunet, RC
   Halloran, ME
   Massad, E
   AzevedoNeto, RS
BE Jean, RV
   Auger, PM
   Demongeot, J
TI On the use of state-space models for the evaluation of health
   interventions
SO JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3: SPECIAL ISSUE: 2ND ECMBM-LYON, PTS
   1-4
LA English
DT Proceedings Paper
CT 2nd European Conference on Mathematics Applied to Biology and Medicine
   (2nd ECMBM)
CY DEC 15-18, 1993
CL ECOLE NORMALE SUPERIEURE LYON, LYON, FRANCE
SP European Soc Math & Theoret Biol
HO ECOLE NORMALE SUPERIEURE LYON
DE vaccine evaluation; state-space models; prevalence data
C1 ESCOLA NACL SAUDE PUBLICA, FDN OSWALDO CRUZ, BR-21041 RIO DE JANEIRO, BRAZIL.
RI Azevedo, Raymundo S/B-7593-2008; Struchiner, Claudio J/M-9360-2013;
   Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Azevedo, Raymundo S/0000-0003-0660-2371; Struchiner, Claudio
   J/0000-0003-2114-847X; Massad, Eduardo/0000-0002-7200-2916
NR 0
TC 2
Z9 4
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
PY 1995
BP 851
EP 865
DI 10.1142/S0218339095000770
PG 15
WC Biochemical Research Methods; Cell Biology; Mathematics, Applied;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Cell Biology; Mathematics;
   Pharmacology & Pharmacy
GA BF06V
UT WOS:A1995BF06V00076
DA 2020-12-16
ER

PT J
AU NETO, RSDA
   RICHARDS, A
   NOKES, DJ
   SILVEIRA, ASB
   COHEN, BJ
   PASSOS, SD
   DESOUZA, VAUF
   BROWN, DWG
   PANNUTI, CS
   MASSAD, E
AF NETO, RSDA
   RICHARDS, A
   NOKES, DJ
   SILVEIRA, ASB
   COHEN, BJ
   PASSOS, SD
   DESOUZA, VAUF
   BROWN, DWG
   PANNUTI, CS
   MASSAD, E
TI SALIVARY ANTIBODY DETECTION IN EPIDEMIOLOGIC SURVEYS - A PILOT-STUDY
   AFTER A MASS VACCINATION CAMPAIGN AGAINST RUBELLA IN SAO-PAULO, BRAZIL
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE RUBELLA; SALIVARY ANTIBODY; VACCINATION; BRAZIL
ID ASSAYS; MEASLES; MUMPS; IGM
AB The sensitivity and specificity of salivary rubella antibody detection was investigated using samples collected from 301 children after a mass vaccination campaign in the state of Sao Paulo, Brazil. Saliva samples were collected by 2 different methods: directly dribbling into a container or using a commercial collecting device. Corresponding finger-prick blood samples were collected on filter paper. Rubella specific immunoglobulin G (IgG) was measured in saliva by antibody capture radioimmunoassay and in blood samples by indirect enzyme-linked immunosorbent assay. The detection of salivary rubella specific IgG showed good correlation with the detection of rubella antibody in the blood samples. For both collecting techniques the predictive value for a positive saliva test was >99% compared with the results from the blood tests. However, the predictive value for a negative saliva test was only 58.3% for a dribbled sample, compared to 100% for saliva collected using the commercial device. Moreover, collecting saliva by dribbling from children less than 4 years old was difficult. The detection of rubella specific IgG in saliva collected using a commercial device proved to be sensitive and specific in this epidemiological study, encouraging its more widespread application as a means of surveillance after mass vaccination.
C1 HCFMUSP,LIM 01,SAO PAULO,BRAZIL.
   CENT PUBL HLTH LAB,DIV VIRUS REFERENCE,LONDON,ENGLAND.
   UNIV OXFORD,DEPT ZOOL,PARASITE EPIDEMIOL RES GRP,OXFORD OX1 3PS,ENGLAND.
   UNIV SAO PAULO,FAC MED,INST TROP MED,BR-05508 SAO PAULO,BRAZIL.
RP NETO, RSDA (corresponding author), USP,FAC MED,DEPT PATOL,AVE DOUTOR ARNALDO 455,BR-01246903 SAO PAULO,BRAZIL.
RI Pannuti, Claudio/B-7649-2012; Massad, Eduardo/H-6143-2011; Massad,
   Eduardo/B-1169-2012; Azevedo, Raymundo S/B-7593-2008; Passos,
   Saulo/C-5166-2012
OI Massad, Eduardo/0000-0002-7200-2916; Azevedo, Raymundo
   S/0000-0003-0660-2371; Passos, Saulo/0000-0002-0908-2677
CR CONNELL JA, 1990, LANCET, V335, P1366, DOI 10.1016/0140-6736(90)91245-6
   DUERMEYER W, 1979, J MED VIROL, V4, P25, DOI 10.1002/jmv.1890040104
   FIELD PR, 1988, J CLIN MICROBIOL, V26, P990, DOI 10.1128/JCM.26.5.990-994.1988
   Kish L., 1965, SURVEY SAMPLING
   MASSAD E, 1993, FAPESP9205614 PART R
   MORGANCAPNER P, 1988, BRIT MED J, V297, P770, DOI 10.1136/bmj.297.6651.770
   MORTIMER PP, 1991, REV MED VIROL, V1, P73
   MORTIMER PP, IN PRESS CLIN DIAGNO
   NETO RSA, 1992, THESIS U SAO PAULO
   NOKES DJ, 1993, T ROY SOC TROP MED H, V87, P353, DOI 10.1016/0035-9203(93)90001-7
   NOKES DJ, 1993, T ROY SOC TROP MED H, V87, P398
   PARRY JV, 1987, LANCET, V2, P72, DOI 10.1016/S0140-6736(87)92737-1
   PERRY KR, 1993, J MED VIROL, V40, P235, DOI 10.1002/jmv.1890400312
   ROITT IM, 1983, IMMUNOLOGY ORAL DISE
   SOUZA VAU, 1993, REV I MED TROPICAL S, V35, pS58
   STRONGIN W, 1992, DIAGNOSTIC TESTS DEF
   TEDDER RS, 1982, J HYG-CAMBRIDGE, V88, P335, DOI 10.1017/S0022172400070182
NR 17
TC 25
Z9 26
U1 0
U2 3
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JAN-FEB
PY 1995
VL 89
IS 1
BP 115
EP 118
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA QY300
UT WOS:A1995QY30000032
PM 7747294
DA 2020-12-16
ER

PT J
AU DEARAUJO, MCK
   SCHULTZ, R
   VAZ, FAC
   MASSAD, E
   FEFERBAUM, R
   RAMOS, JLD
AF DEARAUJO, MCK
   SCHULTZ, R
   VAZ, FAC
   MASSAD, E
   FEFERBAUM, R
   RAMOS, JLD
TI A CASE-CONTROL STUDY OF HISTOLOGICAL CHORIOAMNIONITIS AND NEONATAL
   INFECTION
SO EARLY HUMAN DEVELOPMENT
LA English
DT Article
DE CHORIOAMNIONITIS; FETAL MEMBRANES, PREMATURE RUPTURE; INFANT, NEWBORN;
   INFECTION; PLACENTA
ID SEPSIS; MANAGEMENT; MEMBRANES; INFANTS; RUPTURE
AB The authors report a prospective study of the correlation between histopathological alterations in the placenta and the umbilical cord and neonatal infection in 223 newborns, The pathological studies were specifically concerned with the presence of infection as shown by a polymorphonuclear infiltrate at these sites. Inflammatory lesions were demonstrated in 26.9% of specimens and were highest in those with prolonged premature rupture of membranes and in the least mature placentas, Among the cases of histological chorioamnionitis, only 23.3% of infants had documented infection, Neonatal infection was diagnosed in 7.2% of the newborns and was 10 times more frequent in preterm newborns. Among the cases of infected newborns, 87.5% of placentas had histological chorioamnionitis. Pneumonia and septicemia were the most frequent conditions found among infected newborns. There was a strong correlation between histological chorioamnionitis and neonatal infection. The data obtained in this investigation suggest that histological chorioamnionitis is an important indicator of neonatal infection.
C1 UNIV SAO PAULO,FMUSP,HC,DIV PATHOL,BR-05508 SAO PAULO,BRAZIL.
RP DEARAUJO, MCK (corresponding author), HOSP UNIV SAO PAULO,DIV PEDIAT,HC,HU,FMUSP,AVE PROF LINEU PRESTES 2565,CIDADE UNIV,BR-05508900 SAO PAULO,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ALTSHULER G, 1992, NEONATAL PERINATAL M
   BENIRSCHKE K, 1959, J PEDIATR-US, V54, P11, DOI 10.1016/S0022-3476(59)80031-7
   Benirschke K, 1990, PATHOLOGY HUMAN PLAC
   CHELLAM VG, 1985, BRIT J OBSTET GYNAEC, V92, P808, DOI 10.1111/j.1471-0528.1985.tb03050.x
   COWLES TA, 1992, NEONATAL PERINATAL M
   GERDES JS, 1991, CLIN PERINATOL, V18, P361
   GIBBS RS, 1990, INFECTIOUS DISEASES
   GUZICK DS, 1985, OBSTET GYNECOL, V65, P11
   KITAJIMA H, 1990, EARLY HUM DEV, V21, P59, DOI 10.1016/0378-3782(90)90111-U
   KLEIN JO, 1990, INFECTIOUS DISEASES
   LEMOINE J P, 1990, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V19, P529
   MANROE BL, 1979, J PEDIATR-US, V95, P89, DOI 10.1016/S0022-3476(79)80096-7
   NAYE RL, 1970, NEW ENGL J MED, V283, P555
   NEWTON ER, 1988, OBSTET GYNECOL, V71, P198
   NORDENVALL M, 1990, EUR J OBSTET GYN R B, V36, P59, DOI 10.1016/0028-2243(90)90050-B
   OHLSSON A, 1987, AM J OBSTET GYNECOL, V156, P407, DOI 10.1016/0002-9378(87)90294-8
   OUBOWITZ LMS, 1970, J PEDIATR, V77, P1
   OVERBACH AM, 1970, J PEDIATR-US, V76, P22, DOI 10.1016/S0022-3476(70)80125-1
   Russell P, 1979, AM J DIAGNOSTIC GYNE, V2, P127
   SIEGEL JD, 1981, NEW ENGL J MED, V304, P642, DOI 10.1056/NEJM198103123041105
   SILVA HF, 1985, DIAGNOSTICO, V16, P64
   STGEME JW, 1984, J PEDIATR-US, V104, P608, DOI 10.1016/S0022-3476(84)80562-4
   USHER R, 1987, NEONATOLOGY PATHOPHY
   WILSON CB, 1964, AM J DIS CHILD, V197, P74
   YODER MC, 1986, PEDIATR CLIN N AM, V33, P481
NR 25
TC 25
Z9 25
U1 0
U2 1
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0378-3782
J9 EARLY HUM DEV
JI Early Hum. Dev.
PD DEC 16
PY 1994
VL 40
IS 1
BP 51
EP 58
DI 10.1016/0378-3782(94)90099-X
PG 8
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA QC871
UT WOS:A1994QC87100006
PM 7712961
DA 2020-12-16
ER

PT J
AU NITRINI, R
   LEFEVRE, BH
   MATHIAS, SC
   CARAMELLI, P
   CARRILHO, PEM
   SAUAIA, N
   MASSAD, E
   TAKIGUTI, C
   DASILVA, IO
   PORTO, CS
   MAGILA, MC
   SCAFF, M
AF NITRINI, R
   LEFEVRE, BH
   MATHIAS, SC
   CARAMELLI, P
   CARRILHO, PEM
   SAUAIA, N
   MASSAD, E
   TAKIGUTI, C
   DASILVA, IO
   PORTO, CS
   MAGILA, MC
   SCAFF, M
TI BRIEF AND EASY-TO-ADMINISTER NEUROPSYCHOLOGICAL TESTS IN THE DIAGNOSIS
   OF DEMENTIA
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE DEMENTIA; EVALUATION; NEUROPSYCHOLOGICAL TESTS
AB Thirty patients with dementia defined by DSM-III-R criteria (Alzheimer's disease (22), vascular dementia (3), Parkinson's disease, frontal lobe dementia, possible diffuse Lewy body dementia, normal pressure hydrocephalus and uncertain diagnosis), with scores below 24 points in the Mini-Mental Status Examination and more than 4 years of education were submitted to a neuropsychological evaluation. The scores in the neuropsychological tests were compared to those obtained by thirty normal volunteers paired for age, sex and education. Sensivity, specificity and accuracy of the tests in the distinction of demented and normal volunteers were determined. The accuracies were calculated using ROC curves. Blessed's information-memory-concentration test showed greatest accuracy, followed by copy of simple figures, delayed memory of 10 figures (after 5 minutes), recognition of 10 figures and verbal fluency test (animals). A linear discriminant function, composed by 6 tests: visual perception, incidental memory, delayed memory (after 5 minutes), drawing of a clock, verbal fluency (animals) and calculation tests, was able to discriminate all controls from patients and only one patient was wrongly classified as normal control. These tests were chosen because they can be applied in less than 10 minutes and are very easy to interpret. This discriminant function must be applied in another group of patients and controls in order to demonstrate its value. When associated to the MMSE it may be useful to discriminate patients with dementia from normal people in epidemiological studies.
C1 UNIV SAO PAULO, FAC MED, DEPT NEUROL, SAO PAULO, BRAZIL.
   UNIV SAO PAULO, FAC MED, DEPT INFORMAT MED, SAO PAULO, BRAZIL.
   UNIV SAO PAULO, FAC MED, DEPT MED PREVENT, SAO PAULO, BRAZIL.
RI CARAMELLI, PAULO/H-9735-2012; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Nitrini, Ricardo/B-8703-2013
OI CARAMELLI, PAULO/0000-0002-4786-6990; Massad,
   Eduardo/0000-0002-7200-2916; Nitrini, Ricardo/0000-0002-5721-1525;
   Silva, Ivaldo/0000-0002-2370-943X
CR ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730
   BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797
   CONN HO, 1977, AM J DIG DIS, V22, P541, DOI 10.1007/BF01072510
   CRYSTAL HA, 1990, NEUROLOGY, V40, P1523, DOI 10.1212/WNL.40.10.1523
   DEAN AD, 1990, EPI INFO VERSION 5 W
   ESLINGER PJ, 1985, JAMA-J AM MED ASSOC, V253, P670, DOI 10.1001/jama.253.5.670
   FILLENBAUM GG, 1987, ARCH NEUROL-CHICAGO, V44, P924, DOI 10.1001/archneur.1987.00520210026014
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   GALASKO D, 1990, ARCH NEUROL-CHICAGO, V47, P49, DOI 10.1001/archneur.1990.00530010061020
   LEFEVRE B H, 1985, Arquivos de Neuro-Psiquiatria, V43, P119
   MCKEITH IG, 1992, PSYCHOL MED, V22, P911, DOI 10.1017/S0033291700038484
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017
   MORRIS JC, 1991, NEUROLOGY, V41, P469, DOI 10.1212/WNL.41.4.469
   MOSSMAN D, 1991, J NEUROPSYCH CLIN N, V3, P330
   NIE NH, 1975, STATISTICAL PACKAGE
   NITRINI R, 1993, THESIS FM U SAO PAUL
   ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250
   ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356
   STORANDT M, 1989, ARCH NEUROL-CHICAGO, V46, P383, DOI 10.1001/archneur.1989.00520400037017
   STORANDT M, 1984, ARCH NEUROL-CHICAGO, V41, P497, DOI 10.1001/archneur.1984.04050170043013
   SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   TIERNEY MC, 1987, ARCH NEUROL-CHICAGO, V44, P720, DOI 10.1001/archneur.1987.00520190032013
   UHLMANN RF, 1991, J AM GERIATR SOC, V39, P876, DOI 10.1111/j.1532-5415.1991.tb04454.x
   Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223
   Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71
   WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016
   1987, DIAGNOSTIC STATISTIC
NR 29
TC 65
Z9 116
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1994
VL 52
IS 4
BP 457
EP 465
DI 10.1590/S0004-282X1994000400001
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA PU552
UT WOS:A1994PU55200001
PM 7611936
OA Other Gold
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .6.
   BREEDING IN EMPTY CONDITIONS OF RICE FIELDS IN SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE MOSQUITOS; ECOLOGY, VECTORS; LARVA
ID VIRUS
AB Studies on culicid breeding in empty rice fields were carried out during the cultivation cycle from May to November 1993. This period corresponded to stages 1 and 2, when empty conditions prevailed. Breeding occurred in stage 1 and the first part of stage 2, corresponding respectively to fallow uncultivated and ploughing situations. No breeding was found to take place during the second part of stage 2 when transient floods and harrowing occurred. The predominant species were Aedes scapularis, Culex nigripalpus and Cx. mollis. The Pilosus Group of Culex (Melartoconion) was found at lower densities. Some epidemiological considerations are presented.
C1 UNIV SAO PAULO, SCH MED, DEPT PATHOL, BR-01246904 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, NUPTEM, TAXONOM & SYSTEMAT RES MED ENTOMOL UNIT, SAO PAULO, BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO, SCH PUBL HLTH, DEPT EPIDEMIOL, AV DR ARNALDO 715, BR-01246904 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR CUPP EW, 1986, AM J TROP MED HYG, V35, P851, DOI 10.4269/ajtmh.1986.35.851
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1988, REV SAUDE PUBL, V22, P84, DOI 10.1590/S0034-89101988000200003
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P178, DOI 10.1590/S0034-89101986000300002
   FORATTINI OP, 1994, REV SAUDE PUBL, V28, P329, DOI 10.1590/S0034-89101994000500003
   MATTINGLY P F, 1976, Mosquito Systematics, V8, P223
   MITCHELL CJ, 1985, AM J TROP MED HYG, V34, P945, DOI 10.4269/ajtmh.1985.34.945
NR 8
TC 7
Z9 7
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 1994
VL 28
IS 6
BP 395
EP 399
DI 10.1590/S0034-89101994000600001
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA QV590
UT WOS:A1994QV59000002
PM 7660043
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU MASSAD, E
   COUTINHO, FAB
   YANG, HM
   DECARVALHO, HB
   MESQUITA, F
   BURATTINI, MN
AF MASSAD, E
   COUTINHO, FAB
   YANG, HM
   DECARVALHO, HB
   MESQUITA, F
   BURATTINI, MN
TI THE BASIC REPRODUCTION RATIO OF HIV AMONG INTRAVENOUS-DRUG-USERS
SO MATHEMATICAL BIOSCIENCES
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMISSION; PATHOGENESIS; NEEDLES; AIDS
AB A new approach for the estimation of the Basic Reproduction Ratio Ro for HIV among intravenous drug users (IVDU) is proposed. This approach is based in an adaptation of the models proposed by Ross and Macdonald for vector-borne infections. A straightforward adaptation of Macdonald's model is presented first: biological vectors are replaced by needles and syringes and we consider a homogeneous population of IVDUs; next we present a modified model where several heterogeneities are considered. Some of those heterogeneities are due to intrinsic differences between needles and syringes and biological vectors; others, such as those related to movements of individuals between communities, should apply to both biological vectors and injection apparatuses. An example of the calculations of R(0) for a real IVDUs community is presented.
C1 UNIV SAO PAULO, NUPAIDS, BR-01246903 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, SCH MED, SAO PAULO, BRAZIL.
   UNIV SAO PAULO, INST PHYS, BR-05508 SAO PAULO, BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO, SCH MED, LIM01HCFMUSP, AV DR ARNALDO 455, BR-01246903 SAO PAULO, BRAZIL.
RI Carvalho, Heraclito/C-1334-2012; Massad, Eduardo/H-6143-2011; Burattini,
   Marcelo N/J-9272-2014; Coutinho, Francisco A B/H-5644-2011; Yang, Hyun
   M/K-6873-2014; Massad, Eduardo/B-1169-2012
OI Carvalho, Heraclito/0000-0002-7037-5655; Burattini, Marcelo
   N/0000-0002-5407-6890; Coutinho, Francisco A B/0000-0003-3127-3071;
   Yang, Hyun M/0000-0002-1711-363X; Massad, Eduardo/0000-0002-7200-2916;
   Mesquita, Fabio/0000-0002-8297-0224
CR ANDERSON R M, 1991
   Anderson R.M., 1982, P67
   ANDERSON RM, 1992, SCI AM, V266, P58, DOI 10.1038/scientificamerican0592-58
   Bailey N. T. J., 1964, ELEMENTS STOCHASTIC
   BARATA LCB, 1990, REV SAUDE PUBL, V24, P321, DOI 10.1590/S0034-89101990000400011
   Brachman PS, 1990, PRINCIPLES PRACTICE, P155
   DOBKIN JF, 1990, PRINCIPLES PRACTICE, P2276
   DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401
   KAPLAN EH, 1989, REV INFECT DIS, V11, P289
   KAPLAN EH, 1993, INTERFACES, V23, P7, DOI 10.1287/inte.23.1.7
   KRASNOV ML, 1983, FUNCIONES VARIABLE C
   LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E
   LEVY JA, 1989, JAMA-J AM MED ASSOC, V261, P2997, DOI 10.1001/jama.261.20.2997
   LEVY JA, 1988, JAMA-J AM MED ASSOC, V259, P3037, DOI 10.1001/jama.259.20.3037
   LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993
   LIFTON AR, 1992, AIDS ETHIOLOGY DIAGN, P111
   M.O.P.U. Direccion General de Puertos y Costas, 1991, TECHNICAL REPORT
   MACDONALD G, 1950, Trop Dis Bull, V47, P907
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Macdonald G., 1953, Tropical Diseases Bulletin, V50, P871
   MCKEGANY N, 1992, AIDS DRUGS SEXUAL RI
   Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007
   Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546
   Ross R., 1911, PREVENTION MALARIA
   SYDEL R, 1988, EQUILIBRIUM CHAOS PR
   1983, TECHNICAL REPORT AID
NR 28
TC 34
Z9 35
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-5564
EI 1879-3134
J9 MATH BIOSCI
JI Math. Biosci.
PD OCT
PY 1994
VL 123
IS 2
BP 227
EP 247
DI 10.1016/0025-5564(94)90013-2
PG 21
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA PP586
UT WOS:A1994PP58600006
PM 7827421
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT -
   5-BREEDING OF ANOPHELES-ALBITARSIS IN FLOODED RICE FIELDS IN
   SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE ECOLOGY, VECTORS; ANOPHELES; MOSQUITO CONTROL
ID IRRIGATION
AB Studies on breeding Anopheles albitarsis and association with rice growth in irrigated paddy fields were carried out during the rice cultivation cycle from December 1993 to March 1994.  This period corresponded to the length of time of permanent paddy flooding.  Breeding occurred in the early stage up until five weeks after transplantation when rice plant height was small.  That inverse correlation may give potential direction to control measures.
C1 UNIV SAO PAULO,SCH PUBL HLTH,DEPT EPIDEMIOL,TAXONOM & SYSTEMAT RES MED ENTOMOL UNIT,SAO PAULO,BRAZIL.
   UNIV SAO PAULO,SCH MED,DEPT PATHOL,SAO PAULO,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR AMERASINGHE FP, 1990, J MED ENTOMOL, V27, P789, DOI 10.1093/jmedent/27.5.789
   ASIMENG EJ, 1993, J AM MOSQUITO CONTR, V9, P17
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   LINDSAY SW, 1991, J TROP MED HYG, V94, P313
   SHARMA S N, 1991, Indian Journal of Malariology, V28, P83
NR 6
TC 5
Z9 6
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD OCT
PY 1994
VL 28
IS 5
BP 329
EP 331
DI 10.1590/S0034-89101994000500003
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA QG602
UT WOS:A1994QG60200002
PM 7660032
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU NETO, RSD
   SILVEIRA, ASB
   NOKES, DJ
   YANG, HM
   PASSOS, SD
   CARDOSO, MRA
   MASSAD, E
AF NETO, RSD
   SILVEIRA, ASB
   NOKES, DJ
   YANG, HM
   PASSOS, SD
   CARDOSO, MRA
   MASSAD, E
TI RUBELLA SEROEPIDEMIOLOGY IN A NONIMMUNIZED POPULATION OF SAO-PAULO
   STATE, BRAZIL
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID INFECTION; MEASLES; VACCINATION; MUMPS
AB A rubella serological survey of 476 individuals selected by cluster sampling technique from Caieiras, a small town located in the outskirts of Sao Paulo city, southeastern Brazil, was carried out over the period November 1990-January 1991. The aim of the study was to characterize rubella epidemiology in a representative non-immunized community in south east Brazil. The survey comprised a seroprevalence study, stratified by age (0-40 years) and a seroconversion study of rubella vaccine in non-infected children below 2 years of age. Mathematical techniques were applied to resultant data sets to determine the age dependent rates of decay in the proportion of individuals with maternally derived antibodies, vaccine seroconversion, and infection of susceptibles, termed the force of infection, and to estimate the average age at first infection.
C1 UNIV SAO PAULO, FAC MED, DEPT PATOL, BR-01246 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, FAC MED, HOSP CLIN, LIM01, SAO PAULO, BRAZIL.
   UNIV CAMBRIDGE, ISAAC NEWTON INST MATH SCI, CAMBRIDGE, ENGLAND.
   CTR VIGILANCIA EPIDEMIOL, SECRETARIA ESTADO SAUDE, SAO PAULO, BRAZIL.
   UNIV OXFORD, DEPT ZOOL, PARASITE EPIDEMIOL RES GRP, OXFORD OX1 3PS, ENGLAND.
   UNIV SAO PAULO, FAC SAUDE PUBL, SAO PAULO, BRAZIL.
RI Azevedo, Raymundo S/B-7593-2008; Massad, Eduardo/H-6143-2011; Cardoso,
   Maria Regina A/J-7280-2012; Massad, Eduardo/B-1169-2012; Passos,
   Saulo/C-5166-2012
OI Azevedo, Raymundo S/0000-0003-0660-2371; Massad,
   Eduardo/0000-0002-7200-2916; Passos, Saulo/0000-0002-0908-2677
CR ANDERSON R M, 1991
   ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   ASSAAD F, 1985, REV INFECT DIS, V7, pS29
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   DOWDLE WR, 1970, B WORLD HEALTH ORGAN, V42, P419
   ENDERSRUCKLE G, 1969, AM J DIS CHILD, V118, P139, DOI 10.1001/archpedi.1969.02100040141023
   ENDERSRUCKLE G, 1960, 23RD P S MICR STAND
   EVANS AS, 1967, WHO CHRON, V21, P185
   FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126
   KARCHMER AW, 1969, AM J DIS CHILD, V118, P197, DOI 10.1001/archpedi.1969.02100040199007
   KENDALL M, 1977, ADV THEORY STATISTIC
   Kish L., 1965, SURVEY SAMPLING
   KNOX EG, 1980, INT J EPIDEMIOL, V9, P13, DOI 10.1093/ije/9.1.13
   MASSAD E, 1994, EPIDEMIOL INFECT, V112, P579, DOI 10.1017/S0950268800051281
   MASSAD E, 1990, MATH COMPUT MODEL, V13, P101, DOI 10.1016/0895-7177(90)90057-T
   Muench H, 1959, CATALYTIC MODELS EPI
   NOKES DJ, 1986, J HYG-CAMBRIDGE, V96, P291, DOI 10.1017/S0022172400066067
   PAUL JR, 1963, YALE J BIOL MED, V36, P2
   PAUL JR, 1961, JAMA-J AM MED ASSOC, V175, P601, DOI 10.1001/jama.1961.63040070003014
   SATO H, 1979, AM J DIS CHILD, V133, P1240, DOI 10.1001/archpedi.1979.02130120032005
   SCHATZMAYR HG, 1985, REV INFECT DIS, V7, pS53
   SILVEIRA JAM, 1992, THESIS U SAO PAULO
   1970, WHO TECH REP SER, V454
   1959, WHO TECH REP SER, V181
   1992, FUNDACAO I BRASILEIR
NR 27
TC 41
Z9 41
U1 0
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD AUG
PY 1994
VL 113
IS 1
BP 161
EP 173
DI 10.1017/S095026880005158X
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA PE014
UT WOS:A1994PE01400019
PM 8062873
OA Green Published
DA 2020-12-16
ER

PT J
AU MASSAD, E
   BURATTINI, MN
   NETO, RSD
   YANG, HM
   COUTINHO, FAB
   ZANETTA, DMT
AF MASSAD, E
   BURATTINI, MN
   NETO, RSD
   YANG, HM
   COUTINHO, FAB
   ZANETTA, DMT
TI A MODEL-BASED DESIGN OF A VACCINATION STRATEGY AGAINST RUBELLA IN A
   NONIMMUNIZED COMMUNITY OF SAO-PAULO STATE, BRAZIL
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID MEASLES; INFECTION; PROGRAMS; RATES
AB A mixed vaccination strategy against rubella is proposed. We describe how the vaccination strategy was designed with the help of mathematical techniques. The strategy was designed for application in a non-immunized community of the State of Sao Paulo, Brazil, and was implemented by local health authorities in 1992. This strategy comprises a pulse vaccination campaign, covering the age interval between 1 and 10 years, followed by the introduction of the vaccine in the immunization calendar at 15 months of age. The expected impact of the proposed strategy is discussed.
C1 UNIV SAO PAULO, FAC MED, HOSP & CLIN, LIM-01, BR-01246903 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, INST PHYS, SAO PAULO, BRAZIL.
   ESCOLA PAULISTA MED, DISCIPLINE INFECT DIS, SAO PAULO, BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO, SCH MED, DISCIPLINE MED INFORMAT, SAO PAULO, BRAZIL.
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/H-6143-2011; Azevedo,
   Raymundo S/B-7593-2008; Massad, Eduardo/B-1169-2012; Coutinho, Francisco
   A B/H-5644-2011; Zanetta, Dirce M T/G-4950-2013; Yang, Hyun
   Mo/K-6873-2014
OI Burattini, Marcelo N/0000-0002-5407-6890; Azevedo, Raymundo
   S/0000-0003-0660-2371; Massad, Eduardo/0000-0002-7200-2916; Coutinho,
   Francisco A B/0000-0003-3127-3071; Yang, Hyun Mo/0000-0002-1711-363X
CR Abramowitz M, 1970, HDB MATH FUNCTIONS
   ANDERSON R M, 1991
   Anderson R.M., 1982, POPULATION DYNAMICS, P1
   ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839
   ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   COUTINHO FAB, 1993, IMA J MATH APPL MED, V10, P187
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   GRIFFEL DH, 1981, APPLIED FUNCTIONAL A
   Hethcote H. W., 1985, MATH COMPUTERS BIOME, P283
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   MASSAD E, 1990, MATH COMPUT MODEL, V13, P101, DOI 10.1016/0895-7177(90)90057-T
   Muench H, 1959, CATALYTIC MODELS EPI
   NETO RSA, 1993, UNPUB EPIDEMIOL INFE
   PANNUTI CS, 1991, B WORLD HEALTH ORGAN, V69, P557
   THACKER SB, 1991, AM J EPIDEMIOL, V133, P517, DOI 10.1093/oxfordjournals.aje.a115923
   1991, SNDIR003 MIN HLTH CT
NR 18
TC 52
Z9 52
U1 0
U2 9
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUN
PY 1994
VL 112
IS 3
BP 579
EP 594
DI 10.1017/S0950268800051281
PG 16
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA NU193
UT WOS:A1994NU19300015
PM 8005224
OA Green Published
DA 2020-12-16
ER

PT J
AU SALDIVA, PHN
   LICHTENFELS, AJFC
   PAIVA, PSO
   BARONE, IA
   MARTINS, MA
   MASSAD, E
   PEREIRA, JCR
   XAVIER, VP
   SINGER, JM
   BOHM, GM
AF SALDIVA, PHN
   LICHTENFELS, AJFC
   PAIVA, PSO
   BARONE, IA
   MARTINS, MA
   MASSAD, E
   PEREIRA, JCR
   XAVIER, VP
   SINGER, JM
   BOHM, GM
TI ASSOCIATION BETWEEN AIR-POLLUTION AND MORTALITY DUE TO
   RESPIRATORY-DISEASES IN CHILDREN IN SAO-PAULO, BRAZIL - A
   PRELIMINARY-REPORT
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
ID TIME-SERIES ANALYSIS; EXPOSURE; HEALTH; LONDON
AB This work presents the results of a time series study relating air pollution and respiratory mortality in children under 5 years of age in the metropolitan area of Sao Paulo, Brazil. Daily records of mortality (excluding neonatal mortality) for the period May 1990 to April 1991 were collected along with daily records of relative humidity, temperature, SO2, CO, particulates (PM10), O-3, and NOx concentrations. Using multiple regression methods we demonstrated a significant association between mortality due to respiratory diseases and the NOx levels. After controlling for weather and season effects, the odds of dying due to respiratory diseases, considering the mean levels of NOx in Sao Paulo, was estimated at 1.3 (+/-0.13). This result is in accord with previous animal studies conducted by our group and indicates that air pollution in Sao Paulo has reached levels high enough to have adverse health effects on the exposed population. (C) 1994 Academic Press, Inc.
C1 UNIV SAO PAULO,INST MATEMAT & ESTAT,DEPT ESTAT,SAO PAULO,BRAZIL.
RP SALDIVA, PHN (corresponding author), UNIV SAO PAULO,FAC MED,INST CORACAO,POLUICAO ATMOSFER EXPEL,SAO PAULO,BRAZIL.
RI Pereira, Julio/B-1886-2008; Singer, Julio M/C-1232-2013; Massad,
   Eduardo/B-1169-2012; Martins, Milton A/L-7541-2017; Saldiva, Paulo
   HN/D-7385-2012; Massad, Eduardo/H-6143-2011; Martins, Milton
   A/D-6658-2012; Lichtenfels, Ana Julia/D-4072-2015
OI Pereira, Julio/0000-0002-4920-320X; Singer, Julio M/0000-0001-6515-9643;
   Massad, Eduardo/0000-0002-7200-2916; Saldiva, Paulo
   HN/0000-0003-2005-8253; 
CR ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.2307/2332343
   BOHM GM, 1989, ENVIRON RES, V49, P208, DOI 10.1016/S0013-9351(89)80066-0
   DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587
   FAIRLEY D, 1990, ENVIRON HEALTH PERSP, V89, P159, DOI 10.2307/3430912
   Firket J, 1936, T FARADAY SOC, V32, P1192, DOI 10.1039/tf9363201192
   MASSAD E, 1986, ENVIRON RES, V40, P479, DOI 10.1016/S0013-9351(86)80123-2
   MAZUMDAR S, 1982, ARCH ENVIRON HEALTH, V37, P213, DOI 10.1080/00039896.1982.10667567
   MELIA RJW, 1980, B PHYSIOPATHOL RESPI, V16, P7
   POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P211, DOI 10.1080/00039896.1992.9938351
   SALDIVA PHN, 1992, ENVIRON RES, V57, P19, DOI 10.1016/S0013-9351(05)80016-7
   SCHIMMEL H, 1978, B NEW YORK ACAD MED, V54, P1052
   SCHNIZLEIN CT, 1980, ENVIRON RES, V23, P362, DOI 10.1016/0013-9351(80)90071-7
   SCHWARTZ J, 1992, AM J EPIDEMIOL, V135, P12, DOI 10.1093/oxfordjournals.aje.a116195
   SCHWARTZ J, 1991, ENVIRON RES, V56, P204, DOI 10.1016/S0013-9351(05)80009-X
   SCHWARTZ J, 1990, AM J EPIDEMIOL, V131, P185, DOI 10.1093/oxfordjournals.aje.a115473
   SCHWARTZ J, 1992, AM REV RESPIR DIS, V145, P600, DOI 10.1164/ajrccm/145.3.600
   SPEIZER FE, 1980, AM REV RESPIR DIS, V121, P3
   WICHMANN HE, 1989, ENVIRON HEALTH PERSP, V79, P89, DOI 10.2307/3430534
   WOLFF RK, 1986, ENVIRON HEALTH PERSP, V66, P223, DOI 10.2307/3430237
   1954, 95 PUBL HLTH MED SUB
   1982, AIR QUALITY CRITERIA
   1991, RELATORIO QUALIDADE
NR 22
TC 131
Z9 143
U1 0
U2 14
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0013-9351
J9 ENVIRON RES
JI Environ. Res.
PD MAY
PY 1994
VL 65
IS 2
BP 218
EP 225
DI 10.1006/enrs.1994.1033
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA NN495
UT WOS:A1994NN49500005
PM 8187738
DA 2020-12-16
ER

PT J
AU MARQUES, CA
   FORATTINI, OP
   MASSAD, E
AF MARQUES, CA
   FORATTINI, OP
   MASSAD, E
TI THE BASIC REPRODUCTION NUMBER FOR DENGUE FEVER IN SAO-PAULO STATE,
   BRAZIL - 1990-1991 EPIDEMIC
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Note
C1 UNIV SAO PAULO, FAC SAUDE PUBL, BR-01246 SAO PAULO, SP, BRAZIL.
   UNIV SAO PAULO, FAC MED, BR-01246 SAO PAULO, SP, BRAZIL.
RP MARQUES, CA (corresponding author), SUPERINTENDENCIA CONTROLE ENDEMIAS ESTADO SAO PAU, SAO PAULO, SP, BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Marques,
   Cristiano/H-9661-2014
OI Massad, Eduardo/0000-0002-7200-2916; Marques,
   Cristiano/0000-0001-7792-6547
CR ANDERSON R M, 1991
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   PONTES RJS, 1992, 2ND P BRAZ C EP BEL, P60
   SIVAGNANASUNDRAM C, 1973, J TROP MED HYG, V76, P83
NR 4
TC 44
Z9 45
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JAN-FEB
PY 1994
VL 88
IS 1
BP 58
EP 59
DI 10.1016/0035-9203(94)90498-7
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA MY063
UT WOS:A1994MY06300018
PM 8154004
DA 2020-12-16
ER

PT J
AU BURATTINI, MN
   MASSAD, E
   COUTINHO, FAB
AF BURATTINI, MN
   MASSAD, E
   COUTINHO, FAB
TI MALARIA TRANSMISSION RATES ESTIMATED FROM SEROLOGICAL DATA
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
AB A mathematical model was used to estimate malaria transmission rates based on serological data. The model is minimally stochastic and assumes an age-dependent force of infection for malaria. The transmission rates estimated were applied to a simple compartmental model in order to mimic the malaria transmission.
   The model has shown a good retrieving capacity for serological and parasite prevalence data.
C1 HCFMUSP, SAO PAULO, BRAZIL.
   ESCOLA PAULISTA MED, BR-04023 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, INST PHYS, BR-01498 SAO PAULO, BRAZIL.
RP BURATTINI, MN (corresponding author), UNIV SAO PAULO, SCH MED, AV DR ARNALDO 455, CEP 01246-903, SAO PAULO, BRAZIL.
RI Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Coutinho,
   Francisco A B/H-5644-2011; Massad, Eduardo/H-6143-2011
OI Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; 
CR Arfken G, 1970, MATH METHODS PHYSICI
   Aron J.L., 1982, P139
   ARON JL, 1988, MATH BIOSCI, V90, P385, DOI 10.1016/0025-5564(88)90076-4
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   Bruce-Chwatt L.J., 1985, ESSENTIAL MALARIOLOG
   BRUCECHWATT LJ, 1973, LANCET, V2, P547
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P525, DOI 10.1017/S0950268800057253
   BURATTINI MN, 1987, THESIS SAO PAULO
   BURATTINI MN, 1989, THESIS SAO PAULO
   BURATTINI MN, 1986, REV SOC BRAS MED T S, V19, P88
   BURATTINI MN, 1988, P INT C INFECTIOUS D, P153
   CARNEVALE P, 1978, B WORLD HEALTH ORGAN, V56, P147
   CLYDE DF, 1958, AM J TROP MED HYG, V7, P543, DOI 10.4269/ajtmh.1958.7.543
   COLLINS WE, 1968, AM J EPIDEMIOL, V87, P592, DOI 10.1093/oxfordjournals.aje.a120849
   Dietz K., 1988, P1091
   DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347
   DRAGNA A, 1969, B WORLD HEALTH ORGAN, V40, P753
   DRAPER CC, 1972, AM J TROP MED HYG, V21, P696, DOI 10.4269/ajtmh.1972.21.696
   DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9
   FEYNMAN RP, 1965, QUANTUM MECHANICS PA
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   LUBY JP, 1967, AM J TROP MED HYG, V16, P255, DOI 10.4269/ajtmh.1967.16.255
   MACDONALD G, 1950, Trop Dis Bull, V47, P907
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Macdonald G., 1953, Tropical Diseases Bulletin, V50, P871
   MERLIN M, 1986, B SOC PATHOL EXOT, V79, P707
   MEUWISSEN JHET, 1978, ISRAEL J MED SCI, V14, P687
   Molineaux L., 1988, P913
   MOLINEAUX L, 1985, T ROY SOC TROP MED H, V79, P743, DOI 10.1016/0035-9203(85)90107-5
   Molineaux L, 1980, THE GARKI PROJECT
   Morse P. M., 1953, METHODS THEORETICAL, V1
   MUIRHEADTHOMSON RC, 1951, BRIT MED J, V1, P1114, DOI 10.1136/bmj.1.4715.1114
   NEDELMAN J, 1985, MATH BIOSCI, V73, P159, DOI 10.1016/0025-5564(85)90010-0
   PAPOULIS A, 1981, PROBABILITY RANDOM V
   Ross R, 1917, P R SOC LOND A-CONTA, V93, P225, DOI 10.1098/rspa.1917.0015
   Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007
   Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546
   Ross R., 1911, PREVENTION MALARIA
   VANDRUTEN JAM, 1981, THESIS KATHOLIEK U N
   1988, TDRIMMALFIELDMALSWG2
NR 40
TC 13
Z9 14
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 1993
VL 111
IS 3
BP 503
EP 523
DI 10.1017/S0950268800057241
PG 21
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA MQ156
UT WOS:A1993MQ15600011
PM 8270011
OA Green Published
DA 2020-12-16
ER

PT J
AU BURATTINI, MN
   MASSAD, E
   COUTINHO, FAB
   BARUZZI, RG
AF BURATTINI, MN
   MASSAD, E
   COUTINHO, FAB
   BARUZZI, RG
TI MALARIA PREVALENCE AMONGST BRAZILIAN INDIANS ASSESSED BY A NEW
   MATHEMATICAL-MODEL
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
AB An alternative way to estimate the endemic level of malaria amongst Brazilian indians is proposed. This is achieved by estimating the age-related 'force of infection' of malaria (the effective inoculation rate), applying a mathematical model, described elsewhere, to serological data. In addition we present a way to estimate the Basic Reproductive Rate of malaria in the same area. The results have shown a good degree of accuracy in describing the endemic pattern of malaria in the area, and also indicate some relevant aspects of its age distribution related to the design of control strategies.
C1 ESCOLA PAULISTA MED,BR-04023 SAO PAULO,BRAZIL.
   UNIV SAO PAULO,INST PHYS,SAO PAULO,BRAZIL.
   ESCOLA PAULISTA MED,DEPT PREVENT MED,BR-04023 SAO PAULO,BRAZIL.
RP BURATTINI, MN (corresponding author), UNIV SAO PAULO,SCH MED,SAO PAULO,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011;
   Massad, Eduardo/H-6143-2011; Burattini, Marcelo N/J-9272-2014
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; Burattini, Marcelo N/0000-0002-5407-6890
CR Bruce-Chwatt L.J., 1985, ESSENTIAL MALARIOLOG
   BRUCECHA.LJ, 1969, T ROY SOC TROP MED H, V63, P131, DOI 10.1016/0035-9203(69)90100-X
   BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P503, DOI 10.1017/S0950268800057241
   BURATTINI MN, 1987, THESIS SAO PAULO
   BURATTINI MN, 1989, THESIS SAO PAULO
   BURATTINI MN, 1986, REV SOC BRAS MED T S, V19, P88
   BURATTINI MN, 1988, P INT C INFECTIOUS D, P153
   Dietz K., 1988, P1091
   DRAPER CC, 1972, AM J TROP MED HYG, V21, P696, DOI 10.4269/ajtmh.1972.21.696
   GUTHE T, 1964, B WORLD HEALTH ORGAN, V31, P87
   MACDONALD G, 1968, B WORLD HEALTH ORGAN, V38, P743
   Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Macdonald G., 1953, Tropical Diseases Bulletin, V50, P871
   MACDONALD G, 1955, P ROY SOC MED, V48, P295, DOI 10.1177/003591575504800409
   MACDONALD G, 1957, EPIDEMIOLOGY CONTROL
   MEETSELAAR D, 1959, TROP GEOGR MED, V11, P157
   Molineaux L., 1988, P999
   MOLINEAUX L, 1988, MALARIA PRINCIPLES P, P913
   MUENCH H, 1959, CATALYTIC MODELS CPI
   PAPOULIS A, 1981, PROBABILITY RANDOM V
   Picq J.J., 1982, Medecine Tropicale, V42, P365
   ROSS R, 1928, STUDIES MALARIA
   Ross R., 1911, PREVENTION MALARIA
   SULZER AJ, 1969, AM J TROP MED HYG, V18, P199, DOI 10.4269/ajtmh.1969.18.199
   TURNER PR, 1989, NUMERICAL ANAL
   VANDRUTEN JAM, 1981, THESIS KATHOLIEK U
   WERNSDORFER WH, 1988, MALARIA PRINCPILES P
   1979, 17640 ORG MUND SAL I
   1974, 16549 ORG MUND SAL I
   1951, WHOMAL38 COMM EXP MA
NR 31
TC 6
Z9 6
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211
SN 0950-2688
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 1993
VL 111
IS 3
BP 525
EP 537
DI 10.1017/S0950268800057253
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA MQ156
UT WOS:A1993MQ15600012
PM 8270012
OA Green Published
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .4.
   SURVEY OF RESTING ADULTS AND SYNANTHROPIC BEHAVIOR IN SOUTH-EASTERN,
   BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE MOSQUITOS; ECOLOGY, VECTORS
ID ANOPHELES-ALBIMANUS; RIBEIRA VALLEY; SAO-PAULO; PLAIN; CULEX
AB Resting adults Culicidae were collected from January 1992 through January 1993 in several habitats of the Ribeira Valley region. The diversity of species found among them suggested that the vegetation remaining within human settlements favored the survival and the population increase of some mosquitoes. Among there are: Ae. scapularis, Ae. serratus, Cx. (Culex), Cx. nigripalpus and Cx. (Melanoconion) such as Cx. ribeirensis. That preservation role may be attributed to the rearing of livestock and the consequent increase in the number of blood sources. These species may be classified as hemisynanthropes and Cx. oedipus apparently evolving to the eusynanthropic status. On the other hand, An. cruzii showed an asynanthropic behaviour, with a low degree of survival in the modified human environment. Epidemiological implications of the data are mentioned.
C1 UNIV SAO PAULO,SCH MED,DEPT PATHOL,SAO PAULO,BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO,SCH PUBL HLTH,DEPT EPIDEMIOL,TAXONOM & SYSTEMAT RES MED ENTMOL UNIT,BR-01246904 SAO PAULO,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR BREELAND SG, 1972, AM J TROP MED HYG, V21, P751, DOI 10.4269/ajtmh.1972.21.751
   BREELAND SG, 1972, MOSQ NEWS, V32, P99
   Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P313, DOI 10.1590/S0034-89101993000500001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P1
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P101, DOI 10.1590/S0034-89101990000200004
   FORATTINI OP, 1987, REV SAUDE PUBL, V21, P171, DOI 10.1590/S0034-89101987000300002
   FORATTINI OP, 1987, REV SAUDE PUBL, V21, P188, DOI 10.1590/S0034-89101987000300003
   FORATTINI OP, 1991, REV SAUDE PUBL, V25, P257, DOI 10.1590/S0034-89101991000400004
   GOMES AD, 1990, REV SAUDE PUBL, V24, P394
   IRBY WS, 1992, J MED ENTOMOL, V29, P150, DOI 10.1093/jmedent/29.2.150
   NASCI RS, 1981, MOSQ NEWS, V41, P808
   NATAL D, 1991, Revista Brasileira de Entomologia, V35, P539
   NAVARRO O, 1987, REV CUBANA MED TROP, V39, P33
   NAVARRO OA, 1986, REV CUBANA MED TROP, V38, P21
   NUORTEVA PEKKA, 1963, ANN ENTOMOL FENNICA, V29, P1
   Povolny D., 1971, FLIES DISEASE, P16
   REINERT J F, 1975, Mosquito Systematics, V7, P105
   REINERT J F, 1982, Mosquito Systematics, V14, P124
   REISEN WK, 1982, T ROY SOC TROP MED H, V76, P437, DOI 10.1016/0035-9203(82)90131-6
   Service M.W, 1993, MOSQUITO ECOLOGY FIE
   SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184
   SUBIOPALIS Y, 1992, MED VET ENTOMOL, V6, P325
   1989, B CLIMATOL I OCEANOG, P1
NR 25
TC 41
Z9 45
U1 1
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 1993
VL 27
IS 6
BP 398
EP 411
DI 10.1590/S0034-89101993000600002
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NG813
UT WOS:A1993NG81300003
PM 7997810
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT -
   3-SURVEY OF ADULT STAGES AT THE RICE IRRIGATION SYSTEM AND THE EMERGENCE
   OF ANOPHELES-ALBITARSIS IN SOUTH-EASTERN, BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE MOSQUITOS; ECOLOGY, VECTORS; ANOPHELES
ID RIBEIRA VALLEY; SRI-LANKA; PROJECT; PAULO
AB A study of adult Culicidae ecology was carried out from January 1992 through January 1993 at the rice irrigation system of the Ribeira Valley Experimental Station. The adaptation of Anopheles albitarsis to the anthropic environment became evident through the adult collections made at its various habitats represented by the irrigation system and the edge of the residual pond, as well as at those made within the local patchy residual woods. Other potential disease vectors were prevalent in the irrigated system too. There were Aedes scapularis, Culex nigripalpus and Cx. ribeirensis that were collected at various habitats. Remarkable differences among their prevalences were obtained such as between the natural forest and anthropic environments. In the former An. albitarsis was practically non-existent, thus suggesting that it might be considered as eusynathropic. As the populations of other species seemed to increase in the anthropic environment, they may be regarded as hemisynanthropes. Observations suggest die hypothesis that the development of irrigated land may be a factor in the emergence of An. albitarsis, and some other species, as well as the possibility of an increase in the transmission of mosquito-borne diseases such as malaria.
C1 UNIV SAO PAULO,SCH PUBL HLTH,TAXON & SYSTEMAT RES MED ENTOMOL UNIT,SAO PAULO,BRAZIL.
   UNIV SAO PAULO,SCH MED,DEPT PATHOL,SAO PAULO,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR AMERASINGHE FP, 1991, AM J TROP MED HYG, V45, P226, DOI 10.4269/ajtmh.1991.45.226
   Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P227, DOI 10.1590/S0034-89101993000400001
   FORATTINI OP, 1989, REV SAUDE PUBL, V23, P307, DOI 10.1590/S0034-89101989000400006
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P1
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P1, DOI 10.1590/S0034-89101986000100001
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P178, DOI 10.1590/S0034-89101986000300002
   GIGLIOLI G, 1963, B WORLD HEALTH ORGAN, V29, P131
   Lacey L A, 1990, J Am Mosq Control Assoc Suppl, V2, P1
   MCINTYRE L, 1980, NTL GEOGR MAG, V157, P693
   NUORTEVA PEKKA, 1963, ANN ENTOMOL FENNICA, V29, P1
   POVOLNY D, 1971, FLIES DISEASE, V1
   RAMASAMY R, 1992, AM J TROP MED HYG, V47, P547, DOI 10.4269/ajtmh.1992.47.547
   REINERT J F, 1975, Mosquito Systematics, V7, P105
   REINERT J F, 1982, Mosquito Systematics, V14, P124
   ROBERT LL, 1986, J AM MOSQUITO CONTR, V2, P485
   1989, B CLIMATOL I OCEANOG, P1
NR 18
TC 31
Z9 34
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD OCT
PY 1993
VL 27
IS 5
BP 313
EP 325
DI 10.1590/S0034-89101993000500001
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MX322
UT WOS:A1993MX32200001
PM 7911593
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   MARUCCI, D
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .2.
   IMMATURE STAGES RESEARCH AT A RICE IRRIGATION SYSTEM LOCATION IN
   SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE ECOLOGY VECTORS; ANOPHELES; AEDES; CULEX; MALARIA, TRANSMISSION
AB A relation between a rice irrigation system and mosquito breeding was established in a study undertaken at the Ribeira Valley Experimental Station, from January through December 1992. Flooding favoured Anopheles (Nyssorhynchus) and Culex (Melanoconion) species, while empty paddies condition were propitious to Aedes scapularis and Culex (Culex) species. Compared with a more primitive area of the same region, several species showed high a degree of adaptation to the anthropic environment. Among them, Anopheles albitarsis, a potential malaria vector that breeds in the irrigation system, has shown immature stage production thirteen times higher than at the natural breeding sites. In addition, Ae. scapularis, An. oswaldoi, Cx. bastagarius, and Cx. chidesteri presented high levels of synanthropy.
C1 UNIV SAO PAULO,SCH PUBL HLTH,DEPT EPIDEMIOL,TAXON & SYST RES MED ENTOMOL UNIT,SAO PAULO,BRAZIL.
   UNIV SAO PAULO,SCH MED,DEPT PATHOL,SAO PAULO,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR BISSET J, 1989, Revista Cubana de Medicina Tropical, V41, P86
   BRITO MD, 1987, REV BRAS GEOGR, V49, P139
   Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411
   Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001
   FORATTINI OP, 1989, REV SAUDE PUBL, V23, P307, DOI 10.1590/S0034-89101989000400006
   FORATTINI OP, 1993, REV SAUDE PUBL, V27, P1
   KELLER ECD, 1977, GEOGRAFIA BRASIL REG, V3, P383
   Lacey L A, 1990, J Am Mosq Control Assoc Suppl, V2, P1
   MATTINGLY P F, 1976, Mosquito Systematics, V8, P223
   POVOLNY D, 1971, FLIES DISEASE, V1
   SERVICE MW, 1989, PARASITOL TODAY, V5, P162, DOI 10.1016/0169-4758(89)90083-5
   1989, S PAULO B CLIMATOLOG, P1
NR 12
TC 32
Z9 34
U1 0
U2 4
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 1993
VL 27
IS 4
BP 227
EP 236
DI 10.1590/S0034-89101993000400001
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MQ738
UT WOS:A1993MQ73800001
PM 7911592
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU MASSAD, E
   LUNDBERG, S
   YANG, HM
AF MASSAD, E
   LUNDBERG, S
   YANG, HM
TI MODELING AND SIMULATING THE EVOLUTION OF RESISTANCE AGAINST ANTIBIOTICS
SO INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING
LA English
DT Article
DE MODELING; SIMULATION; EPIDEMIOLOGY; EVOLUTION; ANTIBIOTICS
ID AMINOGLYCOSIDE ANTIBIOTICS
AB An epidemiological model is proposed for the spread of resistance against antibiotics in populations of bacterial pathogens. The host population, which is assumed to be constant, is divided into three compartments, viz. susceptible, hosts infected by an antibiotic-sensitive strain and hosts infected by a resistant strain. It is further assumed that susceptibles can be infected by either strain and that there is a possibility for cross-infection between hosts infected by the two strains. The rate of cross-infection can be enhanced by mutations or the transfer of plasmids conferring resistance. Equilibrium analysis was performed in order to determine which of the strain 'wins' the competition by the host. It is assumed that the eventual shift in the competition between the two strains is due to treatment by antibiotic (selective pressure).
C1 UNIV SAO PAULO, SCH MED, LIMOL, HCFMUSP, BR-01246-903 SAO PAULO, BRAZIL.
   LUND UNIV, DEPT ECOL, S-22362 LUND, SWEDEN.
RP MASSAD, E (corresponding author), UNIV SAO PAULO, SCH MED, DISCIPLINE MED INFORMAT, AV DR ARANALDO 455, BR-01246-903 SAO PAULO, BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Yang, Hyun
   M/K-6873-2014
OI Massad, Eduardo/0000-0002-7200-2916; Yang, Hyun M/0000-0002-1711-363X
CR ANDERSON RM, 1983, J HYG, V90, P295
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   BARBER M, 1960, BRIT MED J, V1, P11, DOI 10.1136/bmj.1.5165.11
   BLUMER JL, 1983, PEDIATR CLIN N AM, V30, P195
   BRYSON V, 1955, ADV GENET, V7, P1, DOI 10.1016/S0065-2660(08)60092-9
   Cavalli-Sforza LL, 1981, CULTURAL TRANSMISSIO
   COHEN LS, 1962, NEW ENGL J MED, V266, P367, DOI 10.1056/NEJM196202222660801
   COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050
   DAVIES JE, 1983, REV INFECT DIS S2, V5, P261
   DONACHIE WD, 1965, NATURE, V205, P1084, DOI 10.1038/2051084a0
   EICKHOFF TC, 1986, HOSPITAL INFECTIONS
   FALKOW S, 1975, INFECTIOUS MULTIPLE
   FINLAND M, 1970, J INFECT DIS, V122, P419, DOI 10.1093/infdis/122.5.419
   GARROD LP, 1985, ANTIBIOTIC CHEMOTHER
   Hardy K., 1986, BACTERIAL PLASMIDS
   KRUS V P, 1971, Advances in Applied Probability, V3, P206, DOI 10.2307/1426158
   LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708
   MANDELL GL, 1985, ANTIINFECTIVE THERAP
   MASTERS M, 1965, NATURE, V209, P1084
   NEU HC, 1987, MED CLIN N AM, V71, P1051, DOI 10.1016/S0025-7125(16)30796-9
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   NICOLELIS MAL, 1987, BRAZ J MED BIOL RES, V20, P35
   NICOLELIS MAL, 1991, J CLIN EPIDEMIOL, V44, P191, DOI 10.1016/0895-4356(91)90266-C
   PANCOAST SJ, 1988, MED CLIN N AM, V72, P581, DOI 10.1016/S0025-7125(16)30760-X
   SHAPIRO JA, 1987, J BACTERIOL, V169, P142, DOI 10.1128/jb.169.1.142-156.1987
   TEPPER BS, 1969, BIOL POPULATION
   VANDERMEER J, 1981, ELEMENTARY MATH ECOL
   WATANABE T, 1963, BACTERIOL REV, V27, P87, DOI 10.1128/MMBR.27.1.87-115.1963
   WILLIAMS FD, 1978, ANNU REV MICROBIOL, V32, P101, DOI 10.1146/annurev.mi.32.100178.000533
   WILLIANS WW, 1986, HOSPITAL INFECTIONS
NR 30
TC 40
Z9 40
U1 0
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0020-7101
J9 INT J BIOMED COMPUT
JI Int. J. Bio-Med. Comput.
PD JUL
PY 1993
VL 33
IS 1
BP 65
EP 81
DI 10.1016/0020-7101(93)90060-J
PG 17
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA LL928
UT WOS:A1993LL92800005
PM 8349360
DA 2020-12-16
ER

PT J
AU MASSAD, E
   BURATTINI, MN
   COUTINHO, FAB
   YANG, HM
   RAIMUNDO, SM
AF MASSAD, E
   BURATTINI, MN
   COUTINHO, FAB
   YANG, HM
   RAIMUNDO, SM
TI MODELING THE INTERACTION BETWEEN AIDS AND TUBERCULOSIS
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS-INFECTION; HIV INFECTION; EPIDEMIOLOGY;
   POPULATION; INCUBATION; DISEASES; PERIODS; IMPACT
AB A deterministic model is proposed for the study of the dynamics of acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) co-infection. The model is comprised by a set of sixteen ordinary differential equations representing different states of both diseases, and it is intended to provide a theoretical framework for the study of the interaction between both infections. Numerical simulations of the model resulted in three striking outcomes: first, the pathogenicity of Human Immunodeficiency Virus (HIV) is enhanced by the presence of TB, and vice-versa; second, the prevalence of AIDS is higher in the presence of TB; and third, relative risk analysis demonstrated a much stronger influence of AIDS on TB than the other way around.
C1 ESCOLA PAULISTA MED,BR-04023 SAO PAULO,BRAZIL.
   UNIV SAO PAULO,INST PHYS,SAO PAULO,BRAZIL.
   HCFMUSP,BR-01246 SAO PAULO,BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO,SCH MED,BR-01246 SAO PAULO,BRAZIL.
RI Coutinho, Francisco A B/H-5644-2011; Raimundo, Silvia
   Martorano/D-4624-2012; Yang, Hyun M/K-6873-2014; Massad,
   Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Burattini, Marcelo
   N/J-9272-2014
OI Coutinho, Francisco A B/0000-0003-3127-3071; Raimundo, Silvia
   Martorano/0000-0002-9960-7341; Yang, Hyun M/0000-0002-1711-363X; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890
CR ANDERSON RM, 1988, J ROY STAT SOC A STA, V151, P66, DOI 10.2307/2982185
   ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0
   AZUMA Y, 1975, B WORLD HEALTH ORGAN, V52, P313
   BAILEY NTJ, 1982, BIOMATHEMATICS MALAR, P178
   BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307
   BLACK S, 1989, 5TH AIDS INT C MONTR
   BLYTHE SP, 1988, IMA J MATH APPL MED, V5, P1
   CHAISSON RE, 1989, J INFECT DIS, V159, P96, DOI 10.1093/infdis/159.1.96
   FITZGERALD JM, 1991, CHEST, V100, P191, DOI 10.1378/chest.100.1.191
   KAULT DA, 1991, MATH BIOSCI, V103, P17, DOI 10.1016/0025-5564(91)90088-Z
   KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P140
   MASSAD E, 1989, MATH COMPUT MODEL, V12, P89, DOI 10.1016/0895-7177(89)90448-2
   MAY RM, 1974, STABILITY COMPLEXITY, P19
   MORGENSTERN H, 1980, INT J EPIDEMIOL, V9, P97, DOI 10.1093/ije/9.1.97
   PEPIN J, 1989, AIDS, V3, P3, DOI 10.1097/00002030-198903010-00002
   PILZ L, 1988, METHOD INFORM MED, V27, P153
   PRESS WH, 1989, NUMERICAL RECIPES AR, P254
   REVELLE CS, 1967, AM REV RESPIR DIS, V96, P893
   RIEDER HL, 1989, ARCH INTERN MED, V149, P1268, DOI 10.1001/archinte.149.6.1268
   RIEDER HL, 1989, EPIDEMIOL REV, V11, P79, DOI 10.1093/oxfordjournals.epirev.a036046
   RIEDER HL, 1989, JAMA-J AM MED ASSOC, V268, P3385
   SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901
   SMITH PG, 1988, INT J EPIDEMIOL, V17, P705, DOI 10.1093/ije/17.4.705
   STYBLO K, 1989, REV INFECT DIS, V11, pS339
   SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362
   THEUER CP, 1990, J INFECT DIS, V162, P8, DOI 10.1093/infdis/162.1.8
   WAALER HANS, 1962, AMER JOUR PUBL HEALTH, V52, P1002, DOI 10.2105/AJPH.52.6.1002
   WAALER HT, 1969, B WORLD HEALTH ORGAN, V41, P75
   WAALER HT, 1968, AM REV RESPIR DIS, V98, P591
   1989, 1988 TECHN ADV M AID
   1987, MMWR S15, V36, P35
   1991, MMWR, V39, P944
   1989, WHOGPAINF894
   1985, 1984 TUBERCULOSIS ST, P85
   1990, MMWR, V39, P153
NR 36
TC 11
Z9 11
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0895-7177
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PD MAY
PY 1993
VL 17
IS 9
BP 7
EP 21
DI 10.1016/0895-7177(93)90013-O
PG 15
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA LL848
UT WOS:A1993LL84800002
OA Green Published
DA 2020-12-16
ER

PT J
AU FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   GOMES, AD
AF FORATTINI, OP
   KAKITANI, I
   MASSAD, E
   GOMES, AD
TI STUDIES ON MOSQUITOS (DIPTERA, CULICIDAE) AND ANTHROPIC ENVIRONMENT .1.
   PARITY OF BLOOD SEEKING ANOPHELES (KERTESZIA) IN SOUTH-EASTERN BRAZIL
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE ANOPHELES, PHYSIOLOGY; PARITY; ENDOPHAGY; DOMICILIATION
AB Populations of Anopheles (Kerteszia) were sampled fortnightly over a one-year period (August 1991 to July 1992) at Ribeira Valley, S. Paulo State, Brazil. Indoor and outdoor collections were made on human bait at evening crepuscular period. The Polovodova technique for age grading was applied to 3,501 females of Anopheles cruzii and to 416 females of An. bellator. That sample represented 34.4% of the total number of mosquitoes collected. The most abundant species found was An. cruzii. However, An. bellator showed an endophagy that was almost three times greater than that of An. cruzii. The overall parous rate was 25.4% and uniparity was practically dominant one. A proportion of 26.9% of An. cruzii and 12.0% of An. bellator were found to be uniparous. Only three outdoor females of the former species (0.1%) showed biparity. Parity of An. cruzii was higher in females caught indoors than in those caught outdoors. Nevertheless, 497 nulliparous females examined (417 cruzii and 80 bellator) had ovaries that had advanced to Christophers and Mer stages III to V. These results imply that these females had already practised hematophagy. Relating these results to those from the parous females, a high statistical significance was found, leading to the conclusion that gonothophic discordance is a common pattern among these anophelines. Further, these results obtained with human bait catches strongly suggest that nearly 38.0% of these host-seeking females had already taken at least one previous blood-meal. So it is possible that enough Lime could thus be available for the plasmodian development in the vectors.
C1 UNIV SAO PAULO, TAXON & SYSTEMAT RES MED ENTOMOL UNIT, SAO PAULO, BRAZIL.
   UNIV SAO PAULO, SCH MED, DEPT PATHOL, SAO PAULO, BRAZIL.
RP FORATTINI, OP (corresponding author), UNIV SAO PAULO, SCH PUBL HLTH, DEPT EPIDEMIOL, AV DR ARNALDO 715, BR-01246-904 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR CARVAJAL H, 1989, T ROY SOC TROP MED H, V83, P609, DOI 10.1016/0035-9203(89)90372-6
   Consolim J., 1979, Arquivos de Biologia e Tecnologia (Curitiba), V22, P173
   DETINOVA TS, 1968, ANNU REV ENTOMOL, V13, P427, DOI 10.1146/annurev.en.13.010168.002235
   DETINOVA TS, 1962, AGING GROUPING METHO
   DYE C, 1986, Parasitology Today, V2, P203
   Forattini O P, 1968, Rev Saude Publica, V2, P111
   FORATTINI OP, 1990, REV SAUDE PUBL, V24, P101, DOI 10.1590/S0034-89101990000200004
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P1, DOI 10.1590/S0034-89101986000100001
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P178, DOI 10.1590/S0034-89101986000300002
   Forattini OP, 1962, ENTOMOLOGIA MED
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71
   Luz E., 1979, Arquivos de Biologia e Tecnologia, V22, P63
   MURILLO VC, 1989, REV SAUDE PUBL, V23, P363
   Quinones M. L., 1984, Biomedica, V4, P5
   Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39
   RIBEIRO H, 1990, Bulletin of the Society for Vector Ecology, V15, P185
NR 17
TC 17
Z9 20
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD FEB
PY 1993
VL 27
IS 1
BP 1
EP 8
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LQ691
UT WOS:A1993LQ69100002
PM 8310263
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU COUTINHO, FAB
   MASSAD, E
   BURATTINI, MN
   YANG, HM
   NETO, RSD
AF COUTINHO, FAB
   MASSAD, E
   BURATTINI, MN
   YANG, HM
   NETO, RSD
TI EFFECTS OF VACCINATION PROGRAMS ON TRANSMISSION RATES OF INFECTIONS AND
   RELATED THRESHOLD CONDITIONS FOR CONTROL
SO IMA JOURNAL OF MATHEMATICS APPLIED IN MEDICINE AND BIOLOGY
LA English
DT Article
DE EPIDEMIOLOGY; CHILDHOOD INFECTIONS; VACCINATION; THRESHOLD THEOREMS;
   CONTRACTION MAPPING THEOREM; FUNCTIONAL ANALYSIS
ID ZAGREB MEASLES-VACCINE; EDMONSTON-ZAGREB; RUBELLA; MODEL; IMMUNIZATION;
   STRATEGIES; AGES
AB This study addresses the problem of the existence of conditions for persistence or eradication of age-dependent directly transmitted infections. The usual system of differential equations describing the dynamics of the disease is transformed into integral equations. The authors show how to solve these equations and, by applying the contraction mapping theorem, give conditions for the persistence or eradication of the infection. A practical illustration of the application of the methods proposed is sketched, using data for rubella collected from a small Brazilian community.
C1 UNIV SAO PAULO, SCH MED, DISCIPLINE MED INFORMAT, BR-01246 SAO PAULO, BRAZIL.
RI Coutinho, Francisco A B/H-5644-2011; Azevedo, Raymundo S/B-7593-2008;
   Burattini, Marcelo N/J-9272-2014; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011
OI Coutinho, Francisco A B/0000-0003-3127-3071; Azevedo, Raymundo
   S/0000-0003-0660-2371; Burattini, Marcelo N/0000-0002-5407-6890; Massad,
   Eduardo/0000-0002-7200-2916; 
CR AABY P, 1988, LANCET, V2, P809
   Abramowitz M, 1970, HDB MATH FUNCTIONS
   ANDERSON R M, 1991
   Anderson R.M., 1982, POPULATION DYNAMICS, P1
   ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839
   ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   AZEVEDO RSN, 1992, THESIS U SAO PAULO
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   GRIFFEL DH, 1981, APPLIED FUNCTIONAL A
   Hethcote H. W., 1985, MATH COMPUTERS BIOME, P283
   HETHCOTE HW, 1988, MATH BIOSCI, V89, P29, DOI 10.1016/0025-5564(88)90111-3
   HETHCOTE HW, 1983, AM J EPIDEMIOL, V117, P2, DOI 10.1093/oxfordjournals.aje.a113511
   INABA H, 1990, J MATH BIOL, V28, P411
   KATZMANN W, 1984, THEOR POPUL BIOL, V25, P125, DOI 10.1016/0040-5809(84)90016-9
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   KNOX EG, 1980, INT J EPIDEMIOL, V9, P13, DOI 10.1093/ije/9.1.13
   MARKOWITZ LE, 1987, PEDIATR INFECT DIS J, V6, P809, DOI 10.1097/00006454-198709000-00001
   MASSAD E, 1990, MATH COMPUT MODEL, V13, P101, DOI 10.1016/0895-7177(90)90057-T
   MCLEAN AR, 1985, LECTURE NOTES BIOMAT, V65
   Muench H, 1959, CATALYTIC MODELS EPI
   NOKES DJ, 1990, INT J EPIDEMIOL, V19, P703, DOI 10.1093/ije/19.3.703
   TIDJANI O, 1989, LANCET, V2, P1357
   VLADIMIROV VS, 1971, EQUATIONS MATH PHYSI
   WALTMAN P, 1974, LECTURE NOTES BIOMAT, V1
   WHITTLE H, 1988, LANCET, V2, P811
NR 28
TC 24
Z9 24
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0265-0746
J9 IMA J MATH APPL MED
JI IMA J. Math. Appl. Med. Biol.
PY 1993
VL 10
IS 3
BP 187
EP 206
PG 20
WC Mathematics, Interdisciplinary Applications
SC Mathematics
GA MG610
UT WOS:A1993MG61000004
PM 8263359
DA 2020-12-16
ER

PT J
AU MASSAD, E
AF MASSAD, E
TI MODELING THE EFFECTS OF AIR-POLLUTION ON THE SUSCEPTIBILITY TO
   RESPIRATORY-INFECTIONS
SO ECOLOGICAL MODELLING
LA English
DT Article
ID EXPOSURE; TOXICITY
AB On the classical S-I-R epidemic compartimental model, I have applied two ad-hoc functions describing the increased susceptibility to respiratory infections and the excess of deaths due to air pollutants. The model is intended to provide a theoretical framework upon which several realistic situations can be mimicked. Numerical simulation of the model is performed, and the results of a particular case are analysed here. Future work will involve the experimental testing of the model.
C1 UNIV SAO PAULO, SCH MED, EXPTL AIR POLLUT LAB, BR-01246 SAO PAULO, BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO, SCH MED, DISCIPLINE MED INFORMAT, CP 2921, BR-01246 SAO PAULO, BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   CHINN S, 1981, J EPIDEMIOL COMMUN H, V35, P174, DOI 10.1136/jech.35.3.174
   GARDNER DE, 1979, ENVIRON HEALTH PERSP, V30, P23, DOI 10.2307/3429098
   GARDNER DE, 1982, AIR POLLUTION PHYSL, P47
   GOLDSTEIN E, 1976, ANNU REV PHARMACOL, V16, P447, DOI 10.1146/annurev.pa.16.040176.002311
   GREEN GM, 1973, MED CLIN N AM, V57, P547, DOI 10.1016/S0025-7125(16)32259-3
   KASS EH, 1966, BACTERIOL REV, V30, P488, DOI 10.1128/MMBR.30.3.488-497.1966
   KIM M, 1976, J INFECT DIS, V133, P310, DOI 10.1093/infdis/133.3.310
   LOGAN WPD, 1956, BMJ-BRIT MED J, V1, P722, DOI 10.1136/bmj.1.4969.722
   LOGAN WPD, 1953, LANCET, V264, P336
   MASSAD E, 1986, ENVIRON RES, V40, P479, DOI 10.1016/S0013-9351(86)80123-2
   MORRIS SC, 1976, ARCH ENVIRON HEALTH, V31, P248, DOI 10.1080/00039896.1976.10667228
   PECORA DV, 1958, NEW ENGL J MED, V258, P71, DOI 10.1056/NEJM195801092580204
NR 14
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3800
EI 1872-7026
J9 ECOL MODEL
JI Ecol. Model.
PD NOV
PY 1990
VL 52
IS 1-2
BP 21
EP 28
DI 10.1016/0304-3800(90)90004-Z
PG 8
WC Ecology
SC Environmental Sciences & Ecology
GA EU093
UT WOS:A1990EU09300003
DA 2020-12-16
ER

PT J
AU MASSAD, E
   RAIMUNDO, SM
   SILVEIRA, ASB
AF MASSAD, E
   RAIMUNDO, SM
   SILVEIRA, ASB
TI A CONTINUOUS FUNCTION MODEL FOR THE AGE-RELATED FORCE OF INFECTION
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
RP MASSAD, E (corresponding author), UNIV SAO PAULO,SCH MED,AVE DR ARNALDO 455,CEP 246,SAO PAULO,SP,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Raimundo,
   Silvia Martorano/D-4624-2012
OI Massad, Eduardo/0000-0002-7200-2916; Raimundo, Silvia
   Martorano/0000-0002-9960-7341
CR ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X
   ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839
   ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   Bevington P.R., 1969, DATA REDUCTION ERROR
   BLACK FL, 1959, J IMMUNOL, V83, P74
   BLACK FRANCIS L., 1959, YALE JOUR BIOL AND MED, V32, P44
   BURATTINI MN, IN PRESS MALARIAL TR
   CHERRY JD, 1987, TXB PEDIATRIC INFECT, P181
   DIETZ K, 1984, CELEBRATION STATISTI
   Dietz K, 1975, EPIDEMIOLOGY, P104
   ENDERSRUCKLE G, 1969, AM J DIS CHILD, V118, P137
   ENGEL AB, 1983, KYBERNETES, V12, P243, DOI 10.1108/eb005661
   FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5
   GERALD CF, 1984, APPLIED NUMERICAL AN
   GOLUBJATNIKOV R, 1971, AM J TROP MED HYG, V20, P958, DOI 10.4269/ajtmh.1971.20.958
   GRENFELL BT, J HYG CAMB, V95, P419
   GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126
   HENDERSON RH, 1984, BELLAGIO C PROTECT W
   HETHCOTE HW, 1983, AM J EPIDEMIOL, V117, P2, DOI 10.1093/oxfordjournals.aje.a113511
   HORWITZ O, 1974, AM J EPIDEMIOL, V100, P136, DOI 10.1093/oxfordjournals.aje.a112016
   MASSAD E, IN PRESS INT J EPID
   MCLEAN A, 1986, LECT NOTES BIOMATH, V65, P171
   MEHTA NA, 1972, INDIAN J MED RES, V60, P661
   MUENCH H, 1959, CATALYTIC MODELS EPD
   PAULE CL, 1979, JAMA-J AM MED ASSOC, V241, P1474, DOI 10.1001/jama.241.14.1474
   Schenzle D., 1985, LECT NOTES BIOMATH, V57, P171
   Sokal R. R, 1981, BIOMETRY
   VANDRUTEN AM, 1981, THESIS U NIJMEGEN
   WITTE JJ, 1969, AM J DIS CHILD, V118, P107, DOI 10.1001/archpedi.1969.02100040109018
NR 30
TC 6
Z9 6
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0895-7177
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PY 1990
VL 13
IS 4
BP 101
EP 112
DI 10.1016/0895-7177(90)90057-T
PG 12
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA DD445
UT WOS:A1990DD44500010
DA 2020-12-16
ER

PT J
AU BOHM, GM
   SALDIVA, PHN
   PASQUALUCCI, CAG
   MASSAD, E
   MARTINS, MD
   ZIN, WA
   CARDOSO, WV
   CRIADO, PMP
   KOMATSUZAKI, M
   SAKAE, RS
   NEGRI, EM
   LEMOS, M
   CAPELOZZI, VD
   CRESTANA, C
   DASILVA, R
AF BOHM, GM
   SALDIVA, PHN
   PASQUALUCCI, CAG
   MASSAD, E
   MARTINS, MD
   ZIN, WA
   CARDOSO, WV
   CRIADO, PMP
   KOMATSUZAKI, M
   SAKAE, RS
   NEGRI, EM
   LEMOS, M
   CAPELOZZI, VD
   CRESTANA, C
   DASILVA, R
TI BIOLOGICAL EFFECTS OF AIR-POLLUTION IN SAO-PAULO AND CUBATAO
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO,INST BIOFIS CARLOS CHAGAS FILHO,RIO DE JANEIRO,RJ,BRAZIL.
RP BOHM, GM (corresponding author), UNIV SAO PAULO,FAC MED,POLUICAO ATMOSFER LAB,AV DR ARNALDO 455,BR-01246 SAO PAULO,SP,BRAZIL.
RI Martins, Milton A/L-7541-2017; Zin, Walter/H-8220-2013; Saldiva, Paulo
   HN/D-7385-2012; Martins, Milton A/D-6658-2012; Capelozzi, Vera
   Luiza/C-6363-2013; Lemos, Miriam/N-4720-2014; Massad,
   Eduardo/B-1169-2012; CAPELOZZI, VERA LUIZA/N-1737-2019; Negri, Elnara
   M/F-3643-2019; Massad, Eduardo/H-6143-2011
OI Zin, Walter/0000-0001-8226-9123; Saldiva, Paulo HN/0000-0003-2005-8253;
   Lemos, Miriam/0000-0002-2574-3228; Massad, Eduardo/0000-0002-7200-2916;
   CAPELOZZI, VERA LUIZA/0000-0001-9732-5853; Negri, Elnara
   M/0000-0002-6428-6066; delmonte, samuel/0000-0002-3289-4577; Cardoso,
   Wellington/0000-0002-2550-3697
CR AULER JOC, 1986, EUR J RESPIR DIS, V69, P261
   BOHM GM, 1986, 7TH P WORLD CLEAN AI, P247
   BOHM GM, 1983, DEV SCI PRACTICE TOX, P479
   BOUHUYS A, 1979, LUNG, V156, P129, DOI 10.1007/BF02714001
   CALDEIRA MPR, 1988, RESP PHYSIOL, V73, P43, DOI 10.1016/0034-5687(88)90126-0
   CORDEIRO JO, 1987, 4887 U CAMP TECHN RE
   FERIN J, 1973, AM IND HYG ASSOC J, V34, P260, DOI 10.1080/0002889738506843
   LOPEZVIDRIERO MT, 1978, BRIT MED BULL, V34, P63, DOI 10.1093/oxfordjournals.bmb.a071461
   MASSAD E, 1986, ENVIRON RES, V40, P479, DOI 10.1016/S0013-9351(86)80123-2
   MASSAD E, 1985, TOXICOL LETT, V26, P187, DOI 10.1016/0378-4274(85)90165-1
   MORGAN KT, 1984, FUND APPL TOXICOL, V4, P58, DOI 10.1016/0272-0590(84)90219-7
   SALDIVA PHN, 1985, BRAZ J MED BIOL RES, V18, P573
   SALDIVA PHN, 1987, J APPL PHYSIOL, V63, P1711
   SALDIVA PHN, 1988, BRAZ J MED BIOL RES, V21, P863
   SALDIVA PHN, 1985, J APPL TOXICOL, V5, P286
   SALDIVA PHN, 1985, ACTA PHYSL LATINOAME, V35, P16
   SHY CM, 1979, AM J EPIDEMIOL, V110, P661, DOI 10.1093/oxfordjournals.aje.a112847
   ZIN WA, 1982, J APPL PHYSIOL, V52, P1266
   1987, QUALIDADE AR REGIAO
   1985, AM REV RESPIR DIS, V131, P666
NR 20
TC 33
Z9 36
U1 0
U2 8
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0013-9351
J9 ENVIRON RES
JI Environ. Res.
PD AUG
PY 1989
VL 49
IS 2
BP 208
EP 216
DI 10.1016/S0013-9351(89)80066-0
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA AJ053
UT WOS:A1989AJ05300008
PM 2753007
DA 2020-12-16
ER

PT J
AU MASSAD, E
AF MASSAD, E
TI A HOMOGENEOUSLY MIXING POPULATION-MODEL FOR THE AIDS EPIDEMIC
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
C1 UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT PURE & APPL BIOL,LONDON SW7 2BB,ENGLAND.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Anderson R. M., 1982, Population biology of infectious diseases. (Report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin, 1982, March 14-19.) (Life Sciences Research Report, 25), P149
   ANDERSON RM, 1986, ROYAL SOC M BIOL INV
   ANDERSON RM, IN PRESS PRELIMINARY
   Bailey N.T.J., 1975, MATH THEORY INFECTIO
   BARKIN S, 1986, American Journal of Epidemiology, V123, P1013
   BYER H, 1984, LANCET, V2, P1347
   COFFIN J, 1986, SCIENCE, V232, P697, DOI 10.1126/science.3008335
   COLLEMAN DL, 1986, ARCH INTERN MED, V146, P713
   CURRAN JW, 1985, SCIENCE, V229, P1352, DOI 10.1126/science.2994217
   DANIELS UG, 1985, AIDS ACQUIRED IMMUNO
   DIETZ K, 1986, 4TH IMA C MATH THEOR
   GRECO D, 1986, BRIT MED J, V293, P451, DOI 10.1136/bmj.293.6544.451-c
   GROOPMAN JE, 1985, ANN INTERN MED, V102, P334, DOI 10.7326/0003-4819-102-3-334
   HARDY AM, 1985, JAMA-J AM MED ASSOC, V253, P215, DOI 10.1001/jama.253.2.215
   JAFFE HW, 1985, ANN INTERN MED, V103, P210, DOI 10.7326/0003-4819-103-2-210
   KUNGJONG L, 1986, P NATL ACAD SCI USA, V83, P3051
   MARTHURWAGH V, 1984, LANCET, V1, P1033
   MARX JL, 1986, SCIENCE, V231, P450, DOI 10.1126/science.3001937
   MASSAD E, 1987, EVOLUTION, V41, P1127, DOI [10.2307/2409198, 10.1111/j.1558-5646.1987.tb05883.x]
   MCKUSICK L, 1985, AM J PUBLIC HEALTH, V75, P493, DOI 10.2105/AJPH.75.5.493
   MELBYE M, 1986, BRIT MED J, V292, P5, DOI 10.1136/bmj.292.6512.5
   METROKA CE, 1983, ANN INTERN MED, V99, P585, DOI 10.7326/0003-4819-99-5-585
   MOSS AR, 1985, J INFECT DIS, V152, P152, DOI 10.1093/infdis/152.1.152
   TUCKOSON D, 1985, AIDS ORYX SCI BIBLIO, V1
   1986, MMWR, V35, P17
   1977, AGE SPECIFIC FERTILI
   1978, MMWR, V34, P573
   1985, MMWR, V34, P373
NR 28
TC 5
Z9 5
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0895-7177
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PY 1989
VL 12
IS 1
BP 89
EP 96
DI 10.1016/0895-7177(89)90448-2
PG 8
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA T1611
UT WOS:A1989T161100007
DA 2020-12-16
ER

PT J
AU MASSAD, E
AF MASSAD, E
TI TRANSMISSION RATES AND THE EVOLUTION OF PATHOGENICITY
SO EVOLUTION
LA English
DT Note
C1 UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT PURE & APPL BIOL,LONDON SW7 2BB,ENGLAND.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360
   ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005
   Dietz K, 1976, LECTURE NOTES BIOMAT, V11, P1
   Dietz K, 1975, EPIDEMIOLOGY, P104
   FENNER F., 1957, JOUR HYG, V55, P149
   FENNER F, 1983, PROC R SOC SER B-BIO, V218, P259, DOI 10.1098/rspb.1983.0039
   FENNER F, 1956, J Hyg (Lond), V54, P284
   Fenner F., 1978, Viruses and environment, P539
   Levin B. R., 1982, Population biology of infectious diseases. (Report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin, 1982, March 14-19.) (Life Sciences Research Report, 25), P213
   Levin S.A., 1983, COEVOLUTION, P21
   MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075
   MEADBRIGGS AR, 1975, J HYG-CAMBRIDGE, V75, P237, DOI 10.1017/S0022172400047276
   Ratcliffe F. N., 1965, MYXOMATOSIS
   YORKE JA, 1979, AM J EPIDEMIOL, V109, P103, DOI 10.1093/oxfordjournals.aje.a112666
NR 14
TC 42
Z9 43
U1 0
U2 10
PU SOC STUDY EVOLUTION
PI LAWRENCE
PA 810 E 10TH STREET, LAWRENCE, KS 66044
SN 0014-3820
J9 EVOLUTION
JI Evolution
PD SEP
PY 1987
VL 41
IS 5
BP 1127
EP 1130
DI 10.2307/2409198
PG 4
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA K1760
UT WOS:A1987K176000016
PM 28563417
OA Bronze
DA 2020-12-16
ER

PT J
AU MASSAD, E
   ENGEL, AB
   NICOLELIS, MAL
AF MASSAD, E
   ENGEL, AB
   NICOLELIS, MAL
TI A MATHEMATICAL-MODEL FOR SPIROMETRY
SO COMPUTERS AND BIOMEDICAL RESEARCH
LA English
DT Article
C1 INST MATH STAT & COMPUTAT SCI,CAMPINAS,BRAZIL.
   UNIV SAO PAULO,FAC MED,DEPT PATHOL,DISCIPLINE MED INFORMAT,SAO PAULO,SP,BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO,FAC MED,DEPT PATHOL,EXPT AIR POLLUT LAB,SAO PAULO,SP,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR APOSTOL TM, 1969, CALCULUS, V2, P604
   BENISRAEL A, 1981, OPTIMALITY NONLINEAR
   BLUMBERG AA, 1968, J THEOR BIOL, V21, P42, DOI 10.1016/0022-5193(68)90058-1
   ENGEL AB, 1983, KYBERNETES, V12, P243, DOI 10.1108/eb005661
   ENGEL AB, IN PRESS J INFERENTI
   Gompertz B., 1825, PHILOS T R SOC LON B, V115, P513, DOI DOI 10.1098/RSTL.1825.0026
   MASSAD E, 1985, METHOD INFORM MED, V24, P197
   MOORE JW, 1963, PHYS TECH, V6, P77
   OSTLER DV, 1984, COMPUT BIOMED RES, V17, P229, DOI 10.1016/S0010-4809(84)80014-2
   SALDIVA PHN, 1985, ACTA PHYS PHARM LATI, V30, P109
   Verhulst P.F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0010-4809
J9 COMPUT BIOMED RES
JI Comput. Biomed. Res.
PD APR
PY 1987
VL 20
IS 2
BP 105
EP 112
DI 10.1016/0010-4809(87)90038-3
PG 8
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA H2672
UT WOS:A1987H267200001
PM 3595094
DA 2020-12-16
ER

PT J
AU NICOLELIS, MAL
   MASSAD, E
   HUTZLER, RU
   ENGEL, A
   RODRIGUES, E
   BAZZONE, JC
   TOMIDA, M
AF NICOLELIS, MAL
   MASSAD, E
   HUTZLER, RU
   ENGEL, A
   RODRIGUES, E
   BAZZONE, JC
   TOMIDA, M
TI MATHEMATICAL-MODEL OF KLEBSIELLA-PNEUMONIAE RESISTANCE TO AMIKACIN AND
   GENTAMICIN
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
C1 UNIV SAO PAULO,HOSP CLIN,FAC MED,BR-01246 SAO PAULO,BRAZIL.
RP NICOLELIS, MAL (corresponding author), UNIV SAO PAULO,FAC MED,DEPT PATOL,DISCIPLINA INFORMAT MED,AV DR ARNALDO 455,BR-01246 SAO PAULO,SP,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
CR BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   BLUMER JL, 1983, PEDIATR CLIN N AM, V30, P195
   DAVIES J, 1980, ANTIBIOTICS LABORATO, P474
   DAVIES J, 1975, REV INFECTIOUS DISEA, V1, P23
   DELORME J, 1980, AM J CLIN PATHOL, V74, P51
   ENGEL AB, 1983, KYBERNETES, V12, P243, DOI 10.1108/eb005661
   KOBERNICK SD, 1979, AM J CLIN PATHOL, V72, P444
   LEVINE JF, 1985, J INFECT DIS, V151, P295, DOI 10.1093/infdis/151.2.295
   OBRIEN TF, 1978, JAMA-J AM MED ASSOC, V239, P1518, DOI 10.1001/jama.239.15.1518
   PHILLIPS I, 1984, BRIT MED BULL, V40, P28, DOI 10.1093/oxfordjournals.bmb.a071943
   PRICE KE, 1976, J INFECT DIS       S, V134, P249
   REYNOLDS AV, 1979, RECENT ADV INFECTION, P165
   SCHWARTZ M, 1975, SIGNAL PROCESSING DI, P109
   UMEZAWA H, 1975, DRUG INACTIVATING EN, P103
   VERMEULEN GD, 1972, AM J CLIN PATHOL, V57, P413
NR 15
TC 5
Z9 5
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1987
VL 20
IS 1
BP 35
EP 41
PG 7
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA H7771
UT WOS:A1987H777100004
PM 3318975
DA 2020-12-16
ER

PT J
AU KRUKENBERG, CC
   MISCHLER, PG
   MASSAD, EN
   MOORE, LA
   CHANDLER, AD
AF KRUKENBERG, CC
   MISCHLER, PG
   MASSAD, EN
   MOORE, LA
   CHANDLER, AD
TI STABILITY OF 1-PERCENT RIFAMPIN SUSPENSIONS PREPARED IN 5 SYRUPS
SO AMERICAN JOURNAL OF HOSPITAL PHARMACY
LA English
DT Article
C1 MERRELL DOW PHARMACEUT INC,MERRELL DOW RES INST,DEPT ANALYT CHEM,INDIANAPOLIS,IN 46268.
   MERRELL DOW PHARMACEUT INC,MERRELL DOW RES INST,DEPT TOXICOL,INDIANAPOLIS,IN 46268.
RP KRUKENBERG, CC (corresponding author), MERRELL DOW PHARMACEUT INC,MERRELL DOW RES INST,PHARM RES DEPT,POB 68470,INDIANAPOLIS,IN 46268, USA.
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Gallo G. G., 1976, ANAL PROFILES DRUG S, V5, P467, DOI DOI 10.1016/S0099-5428(88)60328-7
   MAGGI N, 1968, J MED CHEM, V11, P936, DOI 10.1021/jm00311a004
   MAGGI N, 1966, CHEMOTHERAPY, V11, P285, DOI 10.1159/000220462
   SEYDEL JK, 1970, ANTIBIOT CHEMOTHER, V16, P380
   1980, US PHARMACOPEIA, P882
   1980, US PHARMACOPEIA, P1265
   1985, PHYSICIANS DESK REFE, P1382
NR 7
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814
SN 0002-9289
J9 AM J HOSP PHARM
JI Am. J. Hosp. Pharm.
PD SEP
PY 1986
VL 43
IS 9
BP 2225
EP 2228
DI 10.1093/ajhp/43.9.2225
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA D9320
UT WOS:A1986D932000034
PM 3766578
DA 2020-12-16
ER

PT J
AU MASSAD, E
   SALDIVA, PHN
   SALDIVA, CD
   CALDEIRA, MPD
   CARDOSO, LMN
   DEMORAIS, AMS
   CALHEIROS, DF
   DASILVA, R
   BOHM, GM
AF MASSAD, E
   SALDIVA, PHN
   SALDIVA, CD
   CALDEIRA, MPD
   CARDOSO, LMN
   DEMORAIS, AMS
   CALHEIROS, DF
   DASILVA, R
   BOHM, GM
TI TOXICITY OF PROLONGED EXPOSURE TO ETHANOL AND GASOLINE AUTOENGINE
   EXHAUST-GASES
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
C1 UNIV SAO PAULO,DEPT MATH & STAT,SAO PAULO,SP,BRAZIL.
RP MASSAD, E (corresponding author), UNIV SAO PAULO,SCH MED,EXPTL AIR POLLUT LAB,SAO PAULO,SP,BRAZIL.
RI Cardoso, Luis/J-8310-2013; Massad, Eduardo/B-1169-2012; Massad,
   Eduardo/H-6143-2011; Saldiva, Paulo HN/D-7385-2012
OI Cardoso, Luis/0000-0002-6145-7560; Massad, Eduardo/0000-0002-7200-2916;
   Saldiva, Paulo HN/0000-0003-2005-8253
CR AMDUR MO, 1958, AM J PHYSIOL, V192, P364
   BOHM GM, 1983, DEV SCI PRACTICE TOX, P479
   BOUHUYS A, 1979, LUNG, V156, P129, DOI 10.1007/BF02714001
   BUECHLEY RW, 1973, ARCH ENVIRON HEALTH, V27, P134, DOI 10.1080/00039896.1973.10666341
   Cassell G.H., 1979, LABORATORY RAT, VI, P243
   CLAYTON GD, 1978, PATTYS IND HYGIENE T, V1, P595
   FERIN J, 1973, AM IND HYG ASSOC J, V34, P260, DOI 10.1080/0002889738506843
   JAEGER MC, 1982, AIR POLLUTION PHYSL, P81
   MCGRATH TJ, 1982, AIR POLLUTION PHYSL, P147
   MITRUKA BM, 1969, APPL MICROBIOL, V18, P1072, DOI 10.1128/AEM.18.6.1072-1076.1969
   NETER J, 1974, APPL LINEAR STAT MOD, P473
   Ringer D.H., 1979, LABORATORY RAT, V1, P105
   SAFREIRE AJ, 1983, 1 S ENG AUT, P1
   SALDIVA PHN, 1985, ACTA PHYSL LATINOAME, V35, P16
   SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8
   Schreck R M, 1981, J Appl Toxicol, V1, P67, DOI 10.1002/jat.2550010205
   SCHWARTZ E, 1973, TOXICOL APPL PHARM, V25, P515, DOI 10.1016/0041-008X(73)90020-3
   Zimmerman HJ, 1979, CLIN DIAGNOSIS MANAG, P347
NR 18
TC 14
Z9 14
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0013-9351
J9 ENVIRON RES
JI Environ. Res.
PD AUG
PY 1986
VL 40
IS 2
BP 479
EP 486
DI 10.1016/S0013-9351(86)80123-2
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA D4745
UT WOS:A1986D474500024
PM 2426102
DA 2020-12-16
ER

PT J
AU SALDIVA, PHN
   MASSAD, E
   CALDEIRA, MPD
   CALHEIROS, DF
   SALDIVA, CD
   BOHM, GM
AF SALDIVA, PHN
   MASSAD, E
   CALDEIRA, MPD
   CALHEIROS, DF
   SALDIVA, CD
   BOHM, GM
TI THE STUDY OF MECHANICAL-PROPERTIES OF RATS LUNGS BY WHOLE-BODY
   PLETHYSMOGRAPHY
SO ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA
LA English
DT Article
C1 UNIV SAO PAULO,DEPT MATH & STAT,RA-01246 SAO PAULO,BRAZIL.
RP SALDIVA, PHN (corresponding author), UNIV SAO PAULO,SCH MED,EXPTL AIR POLLUT LAB,AV DR ARNALDO 455,RA-01246 SAO PAULO,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Saldiva, Paulo
   HN/D-7385-2012
OI Massad, Eduardo/0000-0002-7200-2916; Saldiva, Paulo
   HN/0000-0003-2005-8253
CR ADOLPH EF, 1960, J APPL PHYSIOL, V15, P1075
   BOHM GM, 1983, DEV SCI PRACTICE TOX, P479
   CALDWELL EJ, 1969, J APPL PHYSIOL, V27, P280
   Cassell G.H., 1979, LABORATORY RAT, VI, P243
   DIAMOND L, 1977, J APPL PHYSIOL, V43, P942
   DIXON WJ, 1981, BMDP STATISTICAL SOF
   DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281
   Gross K B, 1981, J Appl Toxicol, V1, P116, DOI 10.1002/jat.2550010211
   GROSS KB, 1979, FED P, V38, P325
   Hatai S, 1913, AM J ANAT, V15, P87, DOI 10.1002/aja.1000150104
   HOLUB D, 1979, J APPL PHYSIOL, V46, P394
   KING TKC, 1966, J APPL PHYSIOL, V21, P259
   LAI YL, 1978, J APPL PHYSIOL, V45, P255
   MACHADO DC, 1977, J PATHOL, V121, P205, DOI 10.1002/path.1711210403
   MASSAD E, 1984, THESIS U SAO PAULO B
   MAUDERLY JL, 1979, FED P, V38, P325
   Mitruka B. M., 1976, Animals for research,, P65
   PALECEK F, 1969, J APPL PHYSIOL, V27, P149
NR 18
TC 6
Z9 6
U1 0
U2 1
PU ASOC LATINOAMER CIENC FISIOL
PI BUENOS AIRES
PA CC 241, 1425 BUENOS AIRES, ARGENTINA
SN 0001-6764
J9 ACTA PHYSIOL PHARM L
PY 1985
VL 35
IS 1
BP 109
EP 117
PG 9
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA AJK72
UT WOS:A1985AJK7200007
PM 2932886
DA 2020-12-16
ER

PT J
AU SALDIVA, PHN
   MASSAD, E
   CALDEIRA, MPR
   CALHEIROS, DF
   SALDIVA, CD
   NICOLELIS, MAL
   BOHM, GM
AF SALDIVA, PHN
   MASSAD, E
   CALDEIRA, MPR
   CALHEIROS, DF
   SALDIVA, CD
   NICOLELIS, MAL
   BOHM, GM
TI PULMONARY-FUNCTION OF RATS EXPOSED TO ETHANOL AND GASOLINE FUMES
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
C1 UNIV SAO PAULO,INST MATEMAT,DEPT ESTAT,BR-01246 SAO PAULO,SP,BRAZIL.
RP SALDIVA, PHN (corresponding author), UNIV SAO PAULO,FAC MED,POLUICAO ATMOSFER EXPTL,AV DR ARNALDO 455,BR-01246 SAO PAULO,SP,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011; Saldiva, Paulo
   HN/D-7385-2012
OI Massad, Eduardo/0000-0002-7200-2916; Saldiva, Paulo
   HN/0000-0003-2005-8253
CR AYRES SM, 1973, ARCH ENVIRON HEALTH, V27, P168, DOI 10.1080/00039896.1973.10666347
   BOHM GM, 1983, DEV SCI PRACTICE TOX, P479
   BOUHUYS A, 1979, LUNG, V156, P129, DOI 10.1007/BF02714001
   BOUHUYS A, 1977, PHYSL BREATHING, P202
   Cassell G.H., 1979, LABORATORY RAT, VI, P243
   FERIN J, 1973, AM IND HYG ASSOC J, V34, P260, DOI 10.1080/0002889738506843
   JOSEPH H, 1983, 1 BRAZ S AUT ENG BRA
   MASSAD E, 1985, METHODS INFORMATION
   MASSAD E, 1985, ENV RES
   MASSAD E, 1985, TOXICOLOGY LETT
   NEFUSSI N, 1981, 11 BRAZ C AMB SAN EN
   Neter J., 1974, APPLIED LINEAR STATI
   SALDIVA PHN, 1985, ACTA PHYSIOL PHARM L, V35, P109
   SALDIVA PHN, 1985, J APPLIED TOXICOLOGY
   1981, BMDP STATISTICAL SOF, P726
NR 15
TC 5
Z9 6
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1985
VL 18
IS 4
BP 573
EP 577
PG 5
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA A2111
UT WOS:A1985A211100024
PM 2425877
DA 2020-12-16
ER

PT J
AU SALDIVA, PHN
   CALDEIRA, MPD
   MASSAD, E
   CALHEIROS, DF
   CARDOSO, LMN
   BOHM, GM
   SALDIVA, CD
AF SALDIVA, PHN
   CALDEIRA, MPD
   MASSAD, E
   CALHEIROS, DF
   CARDOSO, LMN
   BOHM, GM
   SALDIVA, CD
TI EFFECTS OF FORMALDEHYDE AND ACETALDEHYDE INHALATION ON RAT PULMONARY
   MECHANICS
SO JOURNAL OF APPLIED TOXICOLOGY
LA English
DT Article
C1 UNIV SAO PAULO,SCH MED,EXPTL AIR POLLUT LAB,SAO PAULO,SP,BRAZIL.
   UNIV SAO PAULO,DEPT MATH & STAT,SAO PAULO,SP,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Saldiva, Paulo HN/D-7385-2012; Massad,
   Eduardo/B-1169-2012
OI Saldiva, Paulo HN/0000-0003-2005-8253; Massad,
   Eduardo/0000-0002-7200-2916
CR ALTSHULLER A, 1961, ANAL CHEM, V33, P621, DOI 10.1021/ac60172a043
   APPELMAN LM, 1982, TOXICOLOGY, V23, P293, DOI 10.1016/0300-483X(82)90068-3
   BOHM GM, 1983, DEV SCI PRACTICE TOX, P479
   BOUHUYS A, 1977, PHYSL BREATHING
   BRABEC MJ, 1981, IND HYGIENE TOXICOLO, P26
   BRODERSON JR, 1976, AM J PATHOL, V85, P115
   CALABRESE EJ, 1978, METHODOLOGICAL APPRO, P344
   CHERNIACK NS, 1980, PULMONARY DIS, P317
   DALHAMN T, 1971, ARCHIV OTOLARYNGOL, V93, P496
   DESILVA AMT, 1973, J APPL PHYSL, V34, P361
   DESPAS PJ, 1972, J CLIN INVEST, V51, P3235, DOI 10.1172/JCI107150
   DIXON WJ, 1981, BMDP STATISTICAL SOF
   GOUVEIA MA, 1984, J PATHOL, V142, pA9
   Gross K B, 1981, J Appl Toxicol, V1, P116, DOI 10.1002/jat.2550010211
   GUYATT AR, 1973, AM REV RESPIR DIS, V108, P1111
   HOLUB D, 1979, J APPL PHYSIOL, V46, P394
   JOHANSON WG, 1973, J CLIN INVEST, V52, P2921, DOI 10.1172/JCI107488
   KAZEMI H, 1976, DISORDERS RESPIRATOR, P52
   KERNS WD, 1983, CANCER RES, V43, P4382
   KING TKC, 1966, J APPL PHYSIOL, V21, P259
   KRUYSSE A, 1970, TNO R3270 CENTR I NU
   LAI YL, 1978, J APPL PHYSIOL, V45, P255
   MASSAD E, 1984, THESIS U SAO PAULO B
   MCFADDEN ER, 1973, CLIN RES, V21, P667
   MEAD J, 1967, J APPL PHYSIOL, V22, P95
   Mitruka B. M., 1976, Animals for research,, P65
   MORGAN KT, 1983, FORMALDEHYDE TOXICOL, P193
   PALECEK F, 1969, J APPL PHYSIOL, V27, P149
   PAVKOV KL, 1982, CHEM IND I TOXICOLOG, P1
   SAAD EG, 1981, SAFETY HYGIENE OCCUP
   SALDIVA PHN, 1985, ACTA PHYSL LATINOAME, V35, P16
   SALEM H, 1960, TOXICOL APPL PHARM, V2, P183, DOI 10.1016/0041-008X(60)90047-8
   SCHAUENSTEIN E, 1907, ALDEHYDES BIOL SYSTE
   SERRANO MIP, 1984, J PNEUMOLOGIA S, V10, P201
   SKOG E, 1950, ACTA PHARMACOL TOX, V6, P299
   STEINHAGEN WH, 1984, TOXICOL APPL PHARM, V72, P495, DOI 10.1016/0041-008X(84)90126-1
   SWENBERG JA, 1980, CANCER RES, V40, P3398
   WIDDICOMBE JG, 1972, HDB SENSORY PHYSL EN, P80
   WIENER BJ, 1971, STATISTICAL PRINCIPL
   WOUTERSEN RA, 1984, TOXICOLOGY, V31, P123, DOI 10.1016/0300-483X(84)90004-0
NR 40
TC 12
Z9 12
U1 0
U2 2
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0260-437X
J9 J APPL TOXICOL
JI J. Appl. Toxicol.
PY 1985
VL 5
IS 5
BP 288
EP 292
PG 5
WC Toxicology
SC Toxicology
GA ASJ62
UT WOS:A1985ASJ6200004
PM 4056306
DA 2020-12-16
ER

PT J
AU MASSAD, E
   FURUIE, SS
   MOURA, LD
   SALDIVA, PHN
   NICOLELIS, MA
   BOHM, GM
AF MASSAD, E
   FURUIE, SS
   MOURA, LD
   SALDIVA, PHN
   NICOLELIS, MA
   BOHM, GM
TI THE USE OF A PERSONAL-COMPUTER IN THE PULMONARY-FUNCTION TESTS OF
   LABORATORY RATS
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article
C1 UNIV SAO PAULO,FAC MED,DEPT PATHOL,EXPTL AIR POLLUT LAB,AV DR ARNALDO 455,SAO PAULO,SP,BRAZIL.
   UNIV SAO PAULO,FAC MED,INST CORACAO HC,SAO PAULO,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Saldiva, Paulo
   HN/D-7385-2012; Furuie, Sergio S/A-7219-2008
OI Massad, Eduardo/0000-0002-7200-2916; Saldiva, Paulo
   HN/0000-0003-2005-8253; Furuie, Sergio S/0000-0002-1557-3018
CR Dammann J F, 1969, Biomed Sci Instrum, V5, P17
   DOUGLAS NJ, 1980, J APPL PHYSIOL, V48, P903
   ENGLEMANN B, 1984, BYTE, V9, P94
   LEVENTHAL LA, 1979, 6502 ASSEMBLY LANGUA
   LORINO H, 1980, J APPL PHYSIOL, V48, P911
   SALDIVA PHN, 1985, ACTA PHYSIOL PHARM L, V35, P109
   SYKES TW, 1977, AM REV RESPIR DIS, V115, P581
NR 7
TC 1
Z9 1
U1 0
U2 0
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 1985
VL 24
IS 4
BP 197
EP 199
PG 3
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA AUG97
UT WOS:A1985AUG9700005
PM 4058317
DA 2020-12-16
ER

PT J
AU MASSAD, E
   SALDIVA, CD
   CARDOSO, LMN
   DASILVA, R
   SALDIVA, PHN
   BOHM, GM
AF MASSAD, E
   SALDIVA, CD
   CARDOSO, LMN
   DASILVA, R
   SALDIVA, PHN
   BOHM, GM
TI ACUTE TOXICITY OF GASOLINE AND ETHANOL AUTOMOBILE ENGINE EXHAUST-GASES
SO TOXICOLOGY LETTERS
LA English
DT Article
C1 UNIV SAO PAULO,SCH MED,EXPTL AIR POLLUT LAB,AV DR ARNALDO 455 CEP,BR-01246 SAO PAULO,BRAZIL.
RI Massad, Eduardo/H-6143-2011; Massad, Eduardo/B-1169-2012; Saldiva, Paulo
   HN/D-7385-2012
OI Massad, Eduardo/0000-0002-7200-2916; Saldiva, Paulo
   HN/0000-0003-2005-8253
CR BOHM GM, 1983, DEV SCI PRACTICE TOX, P479
   Finney D.J., 1971, PROBIT ANAL
   FINNEY DJ, 1978, STATISTICAL METHOD B
   FUREY RL, 1977, 12 P INT EN CONV ENG
   GOUVEIA MA, 1984, J PATHOL, V142, pA9
   LINKE Z, 1983, 1 S ENG AUT BRAS
   MASSAD E, ENV RES
   MATSUNO M, 1979, 3 P INT S ALC FUELS
   NEFUSSI N, 1981, 11 C BRAS ENG SAN AM
   OBLANDER K, 1981, INFLUENCE METHANOL E
NR 10
TC 12
Z9 12
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PY 1985
VL 26
IS 2-3
BP 187
EP 192
DI 10.1016/0378-4274(85)90165-1
PG 6
WC Toxicology
SC Toxicology
GA ARA19
UT WOS:A1985ARA1900016
PM 2412311
DA 2020-12-16
ER

PT J
AU MASSAD, E
AF MASSAD, E
TI BIOMEDICAL APPLICATIONS OF PARTICLE-INDUCED X-RAY-EMISSION
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV SAO PAULO,FAC MED,DEPT FIS EXPTL & PATOL,SAO PAULO,SP,BRAZIL.
RI Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011
OI Massad, Eduardo/0000-0002-7200-2916; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1982
VL 15
IS 4-5
BP 328
EP 328
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA PW022
UT WOS:A1982PW02200083
DA 2020-12-16
ER

EF